<SEC-DOCUMENT>0001193125-24-217313.txt : 20240911
<SEC-HEADER>0001193125-24-217313.hdr.sgml : 20240911
<ACCEPTANCE-DATETIME>20240911171241
ACCESSION NUMBER:		0001193125-24-217313
CONFORMED SUBMISSION TYPE:	PREM14A
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240911
FILED AS OF DATE:		20240911
DATE AS OF CHANGE:		20240911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KELLANOVA
		CENTRAL INDEX KEY:			0000055067
		STANDARD INDUSTRIAL CLASSIFICATION:	GRAIN MILL PRODUCTS [2040]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				380710690
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		PREM14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04171
		FILM NUMBER:		241293273

	BUSINESS ADDRESS:	
		STREET 1:		412 N WELLS ST
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60654
		BUSINESS PHONE:		2699612000

	MAIL ADDRESS:	
		STREET 1:		412 N WELLS ST
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60654

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KELLOGG CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>PREM14A
<SEQUENCE>1
<FILENAME>d893453dprem14a.htm
<DESCRIPTION>PREM14A
<TEXT>
<HTML><HEAD>
<TITLE>PREM14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>the Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material under <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>KELLANOVA </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name
of registrant as Specified in its Charter) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">N/A </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>PRELIMINARY PROXY STATEMENT&#8201;-&#8201;SUBJECT TO COMPLETION
</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>DATED SEPTEMBER 11, 2024 </B></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g893453g96r99.jpg" ALT="LOGO" STYLE="width:1.91438in;height:0.474318in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KELLANOVA </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">412 N. Wells Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chicago,
Illinois 60654 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&#9679;], 2024 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To Our Shareowners: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend a special meeting of shareowners (the &#147;Special Meeting&#148;) of Kellanova (which we refer to as
&#147;Kellanova,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;) virtually, to be held at [&#9679;] [a.m./p.m.] Central Time, on [&#9679;], 2024. The Special Meeting will be conducted via live webcast at
www.virtualshareholdermeeting.com/K2024SM. For purposes of attendance at the Special Meeting, all references in the accompanying proxy statement to &#147;present in person,&#148; &#147;in person&#148; or &#147;attend&#148; will mean virtually
present at or to attend virtually the Special Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;13, 2024, Kellanova entered into an Agreement and Plan of Merger
(as it may be amended, supplemented or otherwise modified in accordance with its terms, the &#147;Merger Agreement&#148;) (a copy of which is attached as Annex A to the accompanying proxy statement) with Acquiror 10VB8, LLC, a Delaware limited
liability company (&#147;Acquiror&#148;), Merger Sub 10VB8, LLC, a Delaware limited liability company and a wholly owned subsidiary of Acquiror (&#147;Merger Sub&#148;), and, solely for purposes of Section&nbsp;6.2(b), Section&nbsp;6.5,
Section&nbsp;6.18 and Section&nbsp;9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation (&#147;Mars&#148;). Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and&nbsp;into
Kellanova, with Kellanova surviving as a wholly owned subsidiary of Acquiror (the &#147;Merger&#148;). If the Merger is completed, the holders of the common stock, par value $0.25 per share, of Kellanova (the &#147;Common Stock&#148;), will receive
$83.50 in cash, without interest and subject to any applicable withholding taxes, for each share of Common Stock that they own immediately prior to the time the Merger becomes effective (the &#147;Effective Time&#148;), other than shares owned (or
held in treasury) by Kellanova, shares held, directly or indirectly, by Mars or any of its subsidiaries (including Acquiror and its subsidiaries) or any wholly owned subsidiary of Kellanova immediately prior to the Effective Time, or shares held by
a holder who properly demands appraisal of&nbsp;such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the Delaware General Corporation Law. For more information, please see the section of the accompanying proxy
statement entitled &#147;The Merger Agreement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Special Meeting, you will be asked to consider and vote on: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a proposal to adopt and approve the Merger Agreement (the &#147;Merger Proposal&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a proposal to approve, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, the compensation
that may be paid or become payable to Kellanova&#146;s named executive officers that is based on or otherwise relates to the Merger (the &#147;Advisory Compensation Proposal&#148;); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a proposal to approve one or more adjournments of the Special Meeting, if necessary, to solicit additional
proxies if a quorum is not present or there are not sufficient votes cast at the Special Meeting to approve the Merger Proposal (the &#147;Adjournment Proposal&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Kellanova board of directors (the &#147;Board&#148;) carefully reviewed and considered the terms and conditions of the Merger Agreement
and the transactions contemplated by the Merger Agreement, including the Merger. After due and careful discussion and consideration, the Board unanimously (i)&nbsp;determined that the terms of the Merger Agreement and the transactions contemplated
thereby, including the Merger, are fair to, and in the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
best interests of, Kellanova and Kellanova shareowners, (ii)&nbsp;determined that it is in the best interests of Kellanova and Kellanova shareowners, and declared it advisable, to enter into the
Merger Agreement providing for the Merger, upon the terms and subject to the conditions set forth therein and in accordance with the applicable provisions of the Delaware General Corporation Law (&#147;DGCL&#148;), (iii)&nbsp;approved the execution
and delivery of the Merger Agreement, the performance of Kellanova&#146;s covenants and other obligations thereunder and the consummation of the Merger upon the terms and subject to the conditions set forth in the Merger Agreement,
(iv)&nbsp;resolved to recommend that Kellanova shareowners adopt the Merger Agreement in accordance with the DGCL and (v)&nbsp;directed that the adoption of the Merger Agreement be submitted for consideration by Kellanova shareowners at a meeting
thereof. <B>Accordingly, the Board unanimously recommends that Kellanova shareowners vote &#147;FOR&#148; the Merger Proposal, &#147;FOR&#148; the Advisory Compensation Proposal and &#147;FOR&#148; the Adjournment Proposal.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Contemporaneously and in connection with the execution of the Merger Agreement, Acquiror entered into voting agreements (each, a &#147;Voting
Agreement&#148;) with each of (1)&nbsp;W.K. Kellogg Foundation Trust, a Michigan charitable trust for the sole benefit of the W.K. Kellogg Foundation (the &#147;Kellogg Foundation Trust&#148;), (2) certain entities and trusts affiliated with G.
Zachary Gund (collectively, the &#147;G. Zachary Gund Entities&#148;) and (3)&nbsp;KeyBank National Association solely in its capacity as trustee of certain trusts affiliated with the Gund family (collectively, the &#147;Gund Trusts&#148; and, each
of the Kellogg Foundation Trust, the G. Zachary Gund Entities and the Gund Trusts, a &#147;Voting Agreement Shareowner&#148;) (copies of which are attached as Annexes&nbsp;B, C and D to the accompanying proxy statement, respectively), pursuant to
which each Voting Agreement Shareowner agreed, upon the terms and subject to the conditions of its respective Voting Agreement, among other things, to vote all of the shares of Common Stock held by it in favor of the Merger Proposal at the Special
Meeting. For more information, please see the section of the accompanying proxy statement entitled &#147;The Voting Agreements.&#148; For more information regarding the security ownership of the Kellogg Foundation Trust, G. Zachary Gund Entities and
Gund Trusts, please see the section of the accompanying proxy statement entitled &#147;Certain Beneficial Owners of Common Stock.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The accompanying proxy statement provides you with more specific information about the Special Meeting, the Merger Agreement, the Merger and
the other transactions contemplated by the Merger Agreement. <B>You should carefully read the entire proxy statement, including the annexes and documents referred to or incorporated by reference therein.</B> You may also obtain more information
about Kellanova from the documents Kellanova files with the Securities and Exchange Commission (the &#147;SEC&#148;), including those incorporated by reference into the accompanying proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Your vote is very important</B>. If a quorum is present at the Special Meeting, approval of the Merger Proposal requires the affirmative
vote of the holders of a majority of the outstanding shares of Common Stock entitled to vote thereon. The failure of any Kellanova shareowner to vote will have the same effect as a vote against the Merger Agreement. If a quorum is present at the
Special Meeting, approval of the Adjournment Proposal and the Advisory Compensation Proposal requires the affirmative vote of the holders of a majority of the Common Stock entitled to vote thereon and present in person or represented by proxy at the
Special Meeting. Properly executed proxy cards with no instructions indicated on the proxy card will be voted &#147;<B>FOR</B>&#148; the Merger Proposal, &#147;<B>FOR</B>&#148; the Advisory Compensation Proposal and &#147;<B>FOR</B>&#148; the
Adjournment Proposal. Even if you plan to attend the Special Meeting virtually, Kellanova requests that you complete, sign, date and return the enclosed proxy card in the accompanying envelope prior to the Special Meeting to ensure that your shares
will be represented and voted at the Special Meeting if you later decide not to or become unable to attend virtually. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">You may also submit
a proxy over the Internet using the Internet address on the enclosed proxy card or by telephone using the toll-free number on the enclosed proxy card. If you submit your proxy through the Internet or by telephone, you will be asked to provide the
control number from the enclosed proxy card. If you are not a shareowner of record, but instead hold your shares in &#147;street name&#148; through a broker, bank, trust or other nominee, you must provide a proxy executed in your favor from your
broker, bank, trust or other nominee in order to be able to vote at the Special Meeting. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Please vote as promptly as possible, regardless of whether or not you plan to attend the
Special Meeting virtually. If your shares are held in the name of a broker, bank, trust or other nominee, please vote by following the instructions on the voting instruction form furnished by the broker, bank, trust or other nominee. If you hold
your shares in your own name, submit a proxy to vote your shares as promptly as possible by (i)&nbsp;visiting the Internet site listed on the proxy card, (ii)&nbsp;calling the toll-free number listed on the proxy card or (iii)&nbsp;submitting your
proxy card by mail by using the self-addressed, stamped envelope provided. Submitting a proxy will not prevent you from voting virtually at the Special Meeting, but it will help to secure a quorum and avoid added solicitation costs. Any eligible
holder of Common Stock entitled to vote at the Special Meeting and who is virtually present at the Special Meeting may vote, thereby revoking any previous proxy of such shareowner. In addition, a proxy may also be revoked in writing before the
Special Meeting in the manner described in the accompanying proxy statement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If you have any questions concerning the Merger
Proposal, the Advisory Compensation Proposal, the Adjournment Proposal, the Merger or the accompanying proxy statement, would like additional copies of these materials or need help voting your shares of Common Stock, please contact: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D.F. King&nbsp;&amp; Co., Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48
Wall Street, 22nd Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10005 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free: (800) <FONT STYLE="white-space:nowrap">791-3319</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: K@dfking.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thank you for your
cooperation and continued support. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steve
Cahillane </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Chairman, President and Chief Executive Officer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>The Merger has not been approved or disapproved by the SEC or any state securities commission. Neither the SEC nor any state securities
commission has passed upon the merits or fairness of the Merger or upon the adequacy or accuracy of the information contained in this document or the accompanying proxy statement. Any representation to the contrary is a criminal offense. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY STATEMENT IS DATED [</B>&#9679;<B></B><B>], 2024 AND IS FIRST BEING MAILED
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO SHAREOWNERS OF KELLANOVA ON OR ABOUT [</B>&#9679;<B></B><B>], 2024. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g893453g96r99.jpg" ALT="LOGO" STYLE="width:1.91438in;height:0.474318in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KELLANOVA </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">412 N. Wells Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chicago,
Illinois 60654 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF SPECIAL MEETING OF SHAREOWNERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD [</B>&#9679;<B></B><B>], 2024 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To Our Shareowners: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A special meeting of
shareowners (the &#147;Special Meeting&#148;) of Kellanova, a Delaware corporation (which we refer to as &#147;Kellanova,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;us&#148; or &#147;our&#148;), will be held virtually at [&#9679;]
[a.m./p.m.] Central Time, on [&#9679;], 2024. The Special Meeting will be conducted via live webcast at www.virtualshareholdermeeting.com/K2024SM for the following purposes: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1&#8195;<B>&#8195;Adoption and Approval of the Merger Agreement</B>. To vote on a proposal to adopt and approve the Agreement and Plan of
Merger, dated as of August&nbsp;13, 2024 (as it may be amended, supplemented or otherwise modified in accordance with its terms, the &#147;Merger Agreement&#148;) by and among Kellanova, Acquiror 10VB8, LLC, a Delaware limited liability company
(&#147;Acquiror&#148;), Merger Sub 10VB8, LLC, a Delaware limited liability company and a wholly owned subsidiary of Acquiror (&#147;Merger Sub&#148;), and, solely for purposes of Section&nbsp;6.2(b), Section&nbsp;6.5, Section&nbsp;6.18 and
Section&nbsp;9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, pursuant to which, upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Kellanova, with Kellanova
surviving as a wholly owned subsidiary of Acquiror (such merger, the &#147;Merger&#148; and such proposal, the &#147;Merger Proposal&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2&#8195;<B>&#8195;Advisory Compensation Proposal</B>. To vote on a proposal to approve, on a
<FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation that may be paid or become payable to Kellanova&#146;s named executive officers that is based on or otherwise relates to the Merger (the &#147;Advisory Compensation
Proposal&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3&#8195;<B>&#8195;Adjournment Proposal</B>. To vote on a proposal to approve one or more adjournments of the Special
Meeting, if necessary, to solicit additional proxies if a quorum is not present or there are not sufficient votes cast at the Special Meeting to approve the Merger Proposal (the &#147;Adjournment Proposal&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Kellanova board of directors (the &#147;Board&#148;), at a meeting duly called and held, has by unanimous vote (i)&nbsp;determined that
the terms of the Merger Agreement and the transactions contemplated thereby, including the Merger, are fair to, and in the best interests of, Kellanova and the holders of the outstanding shares of Kellanova&#146;s common stock, par value $0.25 per
share (the &#147;Common Stock&#148; and such holders, the &#147;Kellanova shareowners&#148;); (ii) determined that it is in the best interests of Kellanova and Kellanova shareowners, and declared it advisable, to enter into the Merger Agreement
providing for the Merger, upon the terms and subject to the conditions set forth therein and in accordance with the applicable provisions of the DGCL (as defined below); (iii)&nbsp;approved the execution and delivery of the Merger Agreement, the
performance of Kellanova&#146;s covenants and other obligations thereunder and the consummation of the Merger upon the terms and subject to the conditions set forth in the Merger Agreement; (iv)&nbsp;resolved to recommend that Kellanova shareowners
adopt the Merger Agreement in accordance with the DGCL; and (v)&nbsp;directed that the adoption of the Merger Agreement be submitted for consideration by Kellanova shareowners at a meeting thereof. <B>Accordingly, the Board unanimously recommends
that Kellanova shareowners vote &#147;FOR&#148; the Merger Proposal, &#147;FOR&#148; the Advisory Compensation Proposal and &#147;FOR&#148; the Adjournment Proposal.</B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova will transact no other business at the Special Meeting or any adjournment or
postponement thereof, except such business as may properly be brought before the Special Meeting or any adjournment or postponement thereof by or at the direction of the Board. This proxy statement, of which this notice is a part, describes the
proposals listed above in more detail. Please refer to the attached documents, including the Merger Agreement and all other annexes and any documents incorporated by reference, for further information with respect to the business to be transacted at
the Special Meeting. You are encouraged to read the entire document carefully before voting. In particular, please see the section entitled &#147;The Merger Agreement&#148; beginning on page&nbsp;82 of this proxy statement for a description of the
transactions contemplated by the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of attendance at the Special Meeting, all references in the proxy
statement to &#147;present in person,&#148; &#147;in person&#148; or &#147;attend&#148; will mean virtually present at or to attend virtually the Special Meeting. If a quorum is present at the Special Meeting, approval of the Merger Proposal by the
affirmative vote of the holders of a majority of the outstanding shares of Common Stock entitled to vote thereon is required to complete the Merger. The failure to vote will have the same effect as a vote against the Merger Proposal. Kellanova
shareowners will also be asked to approve the Advisory Compensation Proposal and the Adjournment Proposal. If a quorum is present at the Special Meeting, approvals of the Adjournment Proposal and the Advisory Compensation Proposal (which are not
conditions to the consummation of the Merger) each requires the affirmative vote of the holders of a majority of the Common Stock entitled to vote thereon and present in person or represented by proxy at the Special Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A shareowner who does not vote in favor of the Merger Proposal will have the right to seek appraisal of the fair value of its shares if the
Merger is completed, but only if such shareowner submits a written demand for appraisal to Kellanova prior to the time the vote is taken on the Merger Proposal and strictly complies with the procedures set forth in Section&nbsp;262 of the Delaware
General Corporation Law (&#147;DGCL&#148;). A copy of the applicable DGCL statutory provisions may be accessed without subscription or cost at the following publicly available website:<I>
https://delcode.delaware.gov/title8/c001/sc09/index.html#262</I>, and a summary of these provisions can be found under the section entitled &#147;Appraisal Rights&#148; beginning on page&nbsp;115 of this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board has fixed the close of business on [&#9679;], 2024 as the record date (the &#147;Record Date&#148;) for the determination of the
Kellanova shareowners entitled to receive notice of, and to virtually vote at, the Special Meeting or any adjournment or postponement thereof. The Kellanova shareowners of record as of the close of business on the Record Date are the only Kellanova
shareowners that are entitled to receive notice of, and to virtually vote at, the Special Meeting and any adjournment or postponement thereof unless a new record date is fixed in connection with any adjournment or postponement of the Special
Meeting. Regardless of whether there is a quorum, the presiding chairman may adjourn the Special Meeting. For additional information regarding the Special Meeting, please see the section entitled &#147;The Special Meeting of Kellanova&#146;s
Shareowners&#148; beginning on page&nbsp;31 of this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>To ensure your shares are represented and voted at the Special
Meeting, please vote as promptly as possible, regardless of whether or not you plan to attend the Special Meeting virtually</B>. If your shares are held in the name of a broker, bank, trust or other nominee, please vote by following the instructions
on the voting instruction form furnished by the broker, bank, trust or other nominee. If you hold your shares in your own name, please submit a proxy to vote your shares as promptly as possible by (i)&nbsp;visiting the Internet site listed on the
proxy card, (ii)&nbsp;calling the toll-free number listed on the proxy card or (iii)&nbsp;submitting your proxy card by mail by using the self-addressed, stamped envelope provided. Submitting a proxy will not prevent you from voting virtually at the
Special Meeting, but it will help to secure a quorum and avoid added solicitation costs. Any eligible holder of Common Stock entitled to vote at the Special Meeting and who is virtually present at the Special Meeting may vote, thereby revoking any
previous proxy of such shareowner. In addition, a proxy may also be revoked in writing before the Special Meeting in the manner described in this proxy statement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If you have any questions or need assistance voting your shares, please contact: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D.F. King&nbsp;&amp; Co., Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48
Wall Street, 22nd Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10005 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free: (800) <FONT STYLE="white-space:nowrap">791-3319</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: K@dfking.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By Request of the Chair of
the Board, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Todd Haigh </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Senior Vice President, Chief
Legal Officer and Secretary </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chicago, Illinois </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&#9679;], 2024 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>YOUR VOTE IS IMPORTANT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHETHER OR NOT YOU PLAN TO ATTEND THE SPECIAL MEETING VIRTUALLY, WE ENCOURAGE YOU TO SUBMIT YOUR PROXY OR VOTING INSTRUCTIONS AS PROMPTLY AS
POSSIBLE BY (i)&nbsp;TELEPHONE USING THE TOLL-FREE NUMBER ON YOUR PROXY CARD, (ii)&nbsp;VISITING THE INTERNET SITE LISTED ON THE PROXY CARD OR (iii)&nbsp;SUBMITTING YOUR PROXY OR VOTING INSTRUCTION CARD BY MAIL BY USING THE SELF-ADDRESSED, STAMPED
ENVELOPE PROVIDED. YOU MAY REVOKE YOUR PROXY OR CHANGE YOUR VOTING INSTRUCTIONS AT ANY TIME BEFORE IT IS VOTED AT THE SPECIAL MEETING. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Properly executed proxy cards with no instructions indicated on the proxy card will be voted &#147;<B>FOR</B>&#148; the Merger Proposal,
&#147;<B>FOR</B>&#148; the Advisory Compensation Proposal and &#147;<B>FOR</B>&#148; the Adjournment Proposal. Even if you plan to attend the Special Meeting virtually, Kellanova requests that you complete, sign, date and return the enclosed proxy
card in the accompanying envelope prior to the Special Meeting to ensure that your shares will be represented and voted at the Special Meeting if you later decide not to or become unable to attend virtually. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">You may also submit a proxy over the Internet using the Internet address on the enclosed proxy card or by telephone using the toll-free number
on the enclosed proxy card. If you submit your proxy through the Internet or by telephone, you will be asked to provide the control number from the enclosed proxy card. If you are not a shareowner of record, but instead hold your shares in
&#147;street name&#148; through a broker, bank, trust or other nominee, you must provide a proxy executed in your favor from your broker, bank, trust or other nominee in order to be able to vote at the Special Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Please vote as promptly as possible, regardless of whether or not you plan to attend the Special Meeting virtually. If your shares are held in
the name of a broker, bank, trust or other nominee, please vote by following the instructions on the voting instruction form furnished by the broker, bank, trust, or other nominee. If you hold your shares in your own name, please submit a proxy to
vote your shares as promptly as possible by (i)&nbsp;visiting the Internet site listed on the proxy card, (ii)&nbsp;calling the toll-free number listed on the proxy card, or (iii)&nbsp;submitting your proxy card by mail by using the self-addressed,
stamped envelope provided. Submitting a proxy will not prevent you from voting virtually at the Special Meeting, but it will help to secure a quorum and avoid added solicitation costs. Any eligible holder of Common Stock entitled to vote at the
Special Meeting who is virtually present at the Special Meeting may vote, thereby revoking any previous proxy of such shareowner. In addition, a proxy may also be revoked in writing before the Special Meeting in the manner described in this proxy
statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This proxy statement provides a detailed description of the Merger, the Merger Agreement and the other matters to be
considered at the Special Meeting. We urge you to carefully read this proxy statement, including any documents incorporated by reference, and the annexes in their entirety. If you have any questions concerning the Merger Proposal, the Advisory
Compensation Proposal, the Adjournment Proposal, the Merger or this proxy statement, would like additional copies of these materials or need help voting your shares of Common Stock, please contact: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D.F. King&nbsp;&amp; Co., Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48
Wall Street, 22nd Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10005 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free: (800) <FONT STYLE="white-space:nowrap">791-3319</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: K@dfking.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_1">SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_2">QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_3">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4">THE PARTIES TO THE MERGER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_5">Kellanova</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_6">Mars, Incorporated</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_7">Acquiror 10VB8, LLC</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_8">Merger Sub 10VB8, LLC</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_9">THE SPECIAL MEETING OF KELLANOVA&#146;S SHAREOWNERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_10">General</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_11">Date, Time and Place</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_12">Purpose of the Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_13">Recommendation of the Board</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_14">Record Date; Shareowners Entitled to Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_15">Quorum; Adjournment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_16">Required Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_17">Abstentions and Broker
<FONT STYLE="white-space:nowrap">Non-Votes</FONT></A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_18">Failure to Vote</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_19">Voting by Kellanova&#146;s Directors and Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_20">Voting at the Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_21">Revocation of Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_22">Solicitation of Proxies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_23">Tabulation of Votes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_24">Householding of Special Meeting Materials</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_25">Questions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_26">Assistance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_27">THE MERGER (PROPOSAL 1)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_28">Background of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_29">Recommendation of the Board and Its Reasons for the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_30">Certain Unaudited Forecasted Financial Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_31">Opinions of Financial Advisors to Kellanova</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_32">Financing of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_33">Certain Effects of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_34">Effects on Kellanova if the Merger Is Not Completed</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_35">Interests of Kellanova&#146;s Directors and Executive Officers in the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_36">Agreements with Acquiror Following the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_37">Summary of Potential Transaction Payments to Named Executive
Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_38">Indemnification, Exculpation and Insurance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_39">U.S. Federal Income Tax Considerations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_40">Litigation Related to the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_41">Regulatory Approvals</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_42">Required Vote of Shareowners</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_43">THE MERGER AGREEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_44">Explanatory Note Regarding the Merger Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_451">Structure of the Merger; Certificate of Incorporation, Bylaws and Directors
 and Officers of the Surviving Corporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_452">When the Merger Becomes Effective; Closing and Effective
Time</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_453">Effect of the Merger on the Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_454">Withholding Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_455">Treatment of Kellanova Incentive Awards</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_456">Payment for Common Stock in the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_457">Representations and Warranties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_458">Conduct of Business Pending the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_459">Other Covenants and Agreements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4510">Conditions to Consummation of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4511">Termination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4512">Termination Fee</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4513">Reverse Termination Fee</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4514">Expenses</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4515">Specific Performance; Remedies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4516">Amendment; Waiver</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4517">Governing Law and Jurisdiction</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4518">Guarantee</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4519">THE VOTING AGREEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4520">CERTAIN BENEFICIAL OWNERS OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4521">Five Percent Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4522">Officer and Director Stock Ownership</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4523">THE ADVISORY COMPENSATION PROPOSAL (PROPOSAL 2)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4524">Required Vote of Shareowners</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4525">ADJOURNMENT PROPOSAL (PROPOSAL 3)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4526">Required Vote of Shareowners</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4527">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4528">APPRAISAL RIGHTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4529">DEADLINE FOR RECEIPT OF SHAREOWNER PROPOSALS FOR FUTURE ANNUAL
MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4530">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4531">ANNEX A &#150; Merger Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4534">ANNEX B &#150; Voting Agreement of W.K. Kellogg Foundation
Trust</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4535">ANNEX C &#150; Voting Agreement of the G. Zachary Gund
Entities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4536">ANNEX D &#150; Voting Agreement of the Gund Trusts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4537">ANNEX E &#150; Opinion of Goldman Sachs&nbsp;&amp; Co. LLC</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom893453_4538">ANNEX F &#150; Opinion of Lazard Fr&egrave;res&nbsp;&amp; Co.
LLC</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_1"></A>SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>For your convenience, provided below is a brief summary of certain information contained in this proxy statement. This summary highlights
selected information from this proxy statement and does not contain all of the information that may be important to you as a Kellanova shareowner. To understand the Merger (as defined below) fully and for a more complete description of the terms of
the Merger, you should read this entire proxy statement carefully, including its annexes and the other documents to which you are referred. Additionally, important information, which you are urged to read, is contained in the documents incorporated
by reference into this proxy statement. See the section entitled &#147;Where You Can Find More Information&#148; beginning on page&nbsp;122. Items in this summary include a page reference directing you to a more complete description of those items.
In this proxy statement, the terms &#147;Kellanova,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;our&#148; and &#147;us&#148; refer to Kellanova, its divisions and subsidiaries taken as a whole, unless the context requires otherwise.
</I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Parties to the Merger (See page <U></U>30) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Kellanova </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova is a leader in
global snacking, international cereal and noodles, and North America frozen foods with a legacy stretching back more than 100 years. Powered by differentiated brands including Pringles<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, <FONT
STYLE="white-space:nowrap">Cheez-It</FONT><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, <FONT STYLE="white-space:nowrap">Pop-Tarts</FONT><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Kellogg&#146;s Rice Krispies Treats<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, RXBAR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Eggo<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, MorningStar
Farms<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Special K<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Coco Pops<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, and more, Kellanova&#146;s vision is to become
the world&#146;s best-performing <FONT STYLE="white-space:nowrap">snacks-led</FONT> company, unleashing the full potential of our differentiated brands and our passionate people. Our net sales for 2023 were $13&nbsp;billion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova was incorporated in Delaware in 1922. Our principal executive offices are located at 412 N. Wells Street, Chicago, Illinois 60654
and our telephone number is (269) <FONT STYLE="white-space:nowrap">961-2000.</FONT> Our website address is www.kellanova.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A detailed
description of Kellanova&#146;s business is contained in Kellanova&#146;s Annual Report filed on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;30, 2023, which is incorporated by reference into this proxy
statement. See the section entitled &#147;Where You Can Find More Information&#148; beginning on page 122. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova&#146;s common stock,
par value $0.25 per share (&#147;Common Stock&#148;), is listed and traded on The New York Stock Exchange (&#147;NYSE&#148;) under the ticker symbol &#147;K.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Mars, Incorporated </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mars,
Incorporated, a Delaware corporation, which we refer to as &#147;Mars,&#148; is a global, family-owned business, Mars employs over 150,000 associates. With more than $50&nbsp;billion in annual sales, Mars produces some of the most well-known brands
including Ben&#146;s Original<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, CESAR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Cocoavia<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, DOVE<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, EXTRA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, KIND<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>,
M&amp;M&#146;s<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, SNICKERS<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, PEDIGREE<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, ROYAL CANIN<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, and WHISKAS<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>. Mars has a global network of pet hospitals and diagnostic services &#150; including AniCura, BANFIELD<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, BLUEPEARL<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, Linnaeus and VCA<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> &#150; and it develops programs in genetic
health screening and DNA testing. Mars has its executive offices located at 1676 International Drive, Suite 1000, McLean, Virginia 22102. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Acquiror
10VB8, LLC </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Acquiror 10VB8, LLC, which we refer to as &#147;Acquiror,&#148; is a Delaware limited liability company and a wholly
owned subsidiary of Mars that was formed solely for the purpose of entering into the Merger Agreement (as defined below) and consummating the transactions contemplated by the Merger Agreement. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Merger Sub 10VB8, LLC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Merger Sub 10VB8, LLC, which we refer to as &#147;Merger Sub,&#148; is a Delaware limited liability company and a wholly owned subsidiary of
Acquiror that was formed solely for the purpose of entering into the Merger Agreement (as defined below) and consummating the transactions contemplated by the Merger Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Special Meeting of Kellanova&#146;s Shareowners (See page <U></U>31) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A special meeting of Kellanova (the &#147;Special Meeting&#148;) will be held virtually at www.virtualshareholdermeeting.com/K2024SM, on
[&#9679;], 2024, at [&#9679;] [a.m./p.m.] Central Time. The Special Meeting is being held to consider and vote on the following proposals: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to vote on a proposal to adopt and approve the Agreement and Plan of Merger, dated as of August&nbsp;13, 2024 (as
it may be amended, supplemented or otherwise modified in accordance with its terms, the &#147;Merger Agreement&#148;), by and among Kellanova, Acquiror, Merger Sub, and, solely for purposes of Section&nbsp;6.2(b), Section&nbsp;6.5, Section&nbsp;6.18
and Section&nbsp;9.15, Mars, pursuant to which, upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Kellanova, with Kellanova surviving as a wholly owned subsidiary of Acquiror (the
&#147;Merger&#148; and such proposal, the &#147;Merger Proposal&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to vote on a proposal to approve, on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis, the
compensation that may be paid or become payable to Kellanova&#146;s named executive officers that is based on or otherwise relates to the Merger (the &#147;Advisory Compensation Proposal&#148;); and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to vote on a proposal to approve one or more adjournments of the Special Meeting, if necessary, to solicit
additional proxies if a quorum is not present or there are not sufficient votes cast at the Special Meeting to approve the Merger Proposal (the &#147;Adjournment Proposal&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Completion of the Merger is conditioned on, among other things, the approval of the Merger Proposal by the requisite holders of Common Stock
(&#147;Kellanova shareowners&#148;). Approval of the Adjournment Proposal and the Advisory Compensation Proposal are not conditions to the obligation of the parties to complete the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Only holders of record of outstanding shares of Common Stock as of the close of business on [&#9679;], 2024 (the &#147;Record Date&#148;) are
entitled to receive notice of, and to vote at, the Special Meeting and any adjournment or postponement of the Special Meeting unless a new record date is fixed in connection with any adjournment or postponement of the Special Meeting. Kellanova
shareowners may cast one vote for each share of Common Stock owned as of the close of business on the Record Date for each proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As
of the close of business on the Record Date, there were [&#9679;] shares of Common Stock issued and outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If a quorum is present
at the Special Meeting, approval of the Merger Proposal requires the affirmative vote of holders of a majority of the outstanding shares of Common Stock entitled to vote thereon. <B>Accordingly, a Kellanova shareowner&#146;s abstention from voting
or the failure of a Kellanova shareowner to vote (including the failure of a Kellanova shareowner who holds shares in &#147;street name&#148; through a bank, broker, trust or other nominee to give any voting instructions to that bank, broker, trust
or other nominee) will have the same effect as a vote &#147;AGAINST&#148; the Merger Proposal.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Bylaws of Kellanova (as
amended, the &#147;Bylaws&#148;), if a quorum is present at the Special Meeting, approval of the Adjournment Proposal and the Advisory Compensation Proposal requires the affirmative vote of the holders of a majority of the Common Stock entitled to
vote thereon and present in person or represented by proxy at the Special Meeting. Accordingly, with respect to a Kellanova shareowner who is present in person or </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
represented by proxy at the Special Meeting and who abstains from voting on either the Advisory Compensation Proposal or the Adjournment Proposal, such shareowner&#146;s abstention will be
counted in connection with the determination of whether a quorum is present with respect to such proposal and will have the same effect as a vote &#147;<B>AGAINST</B>&#148; such proposal. The failure of a Kellanova shareowner of record who is not
present in person or represented by proxy at the Special Meeting to vote on either proposal, as well as the failure of a Kellanova shareowner who holds shares in &#147;street name&#148; through a bank, broker, trust or other nominee to give any
voting instructions to the bank, broker, trust or other nominee, will have no effect on the outcome of either the Advisory Compensation Proposal or the Adjournment Proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Merger and the Merger Agreement (See page 82) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">You are being asked to adopt and approve the Merger Agreement. Upon the terms and subject to the conditions set forth in the Merger Agreement,
at the Closing (as defined below), Merger Sub will merge with and into Kellanova, with Kellanova surviving as a wholly owned subsidiary of Acquiror. The Merger and other transactions contemplated by the Merger Agreement are referred to in this proxy
statement as the &#147;transactions&#148; and the closing thereof as the &#147;Closing.&#148; The terms and conditions of the Merger are contained in the Merger Agreement, a copy of which is attached as Annex&nbsp;A to this proxy statement. You are
encouraged to read the Merger Agreement carefully and in its entirety, as it is the primary legal document that governs the Merger. Following the Merger, the Common Stock will be delisted from the NYSE, will be deregistered under Section&nbsp;14(a)
of the Securities Exchange Act of 1934 (as amended, the &#147;Exchange Act&#148;) and will cease to be publicly traded. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When the Merger is Expected to
be Completed (See page 25) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova and Mars are working to be in a position to complete the Merger as quickly as possible after the
Special Meeting. Kellanova currently anticipates that the Merger will be completed within the first half of 2025. In order to complete the Merger, Kellanova must obtain the required Kellanova shareowner approval and approval under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations thereunder (the &#147;HSR Act&#148;), certain other regulatory approvals and a number of other closing conditions under the Merger Agreement must be
satisfied or waived. See the section entitled &#147;The Merger Agreement&#151;Conditions to Consummation of the Merger.&#148; Accordingly, there can be no assurances that the Merger will be completed at all, or if completed, that it will be
completed within the first half of 2025. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Merger Consideration (See page 85) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the time the Merger becomes effective (the &#147;Effective Time&#148;), each share of Common Stock issued and outstanding immediately prior
to the Effective Time (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder
properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the Delaware General Corporation Law (&#147;DGCL&#148;)), will be converted into the right to receive $83.50 per share in cash, without
interest and subject to any applicable withholding taxes (the &#147;Merger Consideration&#148;). In addition, in respect of each such share of Common Stock, if Kellanova declares and sets a record date for a dividend as permitted under the Merger
Agreement (as further described in the section entitled &#147;The Merger Agreement&#151;Conduct of Business Pending the Merger&#148; beginning on page&nbsp;88), and the Effective Time occurs after the record date for such dividend and prior to the
payment date for such dividend, such dividend (and any applicable dividend equivalent rights to the extent any holder of a Kellanova equity award is entitled to such rights under the terms of such equity awards as in effect on the date Kellanova
declares the applicable dividend) will be paid as of such record date on the scheduled payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any shares of Common Stock held by
Kellanova as treasury stock immediately prior to the Effective Time will automatically be canceled and retired and not be entitled to receive the Merger Consideration, and any shares of Common Stock held, directly or indirectly, by Mars, Acquiror or
Merger Sub, or any wholly owned </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subsidiary of Kellanova, immediately prior to the Effective Time will remain outstanding and will not be converted into the right to receive the Merger Consideration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Agreements (See page 106) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Contemporaneously and in connection with the execution of the Merger Agreement, Acquiror entered into voting agreements (each, a &#147;Voting
Agreement&#148;), pursuant to which each Voting Agreement Shareowner (as defined below) agreed, among other things, subject to the terms and conditions of its respective Voting Agreement, to vote all of the shares of Common Stock held by it in favor
of the Merger Proposal at the Special Meeting. For more information, please see the section entitled &#147;The Voting Agreements.&#148; For more information regarding the security ownership of the W.K. Kellogg Foundation Trust, a Michigan charitable
trust for the sole benefit of the W.K. Kellogg Foundation (the &#147;Kellogg Foundation Trust&#148;), certain entities and trusts affiliated with G. Zachary Gund (collectively, the &#147;G. Zachary Gund Entities&#148;) and KeyBank National
Association solely in its capacity as trustee of certain trusts affiliated with the Gund family (collectively, the &#147;Gund Trusts&#148;, and, each of the Kellogg Foundation Trust, the G. Zachary Gund Entities and the Gund Trusts, a &#147;Voting
Agreement Shareowner&#148;), please see the section entitled &#147;Certain Beneficial Owners of Common Stock&#148; beginning on page&nbsp;108. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recommendation of the Board and Its Reasons for the Merger (See page 46) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Kellanova board of directors (the &#147;Board&#148;) has unanimously (i)&nbsp;determined that the Merger Agreement, the Merger and the
other transactions contemplated by the Merger Agreement are advisable and fair to, and in the best interests of, Kellanova and the Kellanova shareowners, (ii)&nbsp;approved, authorized, adopted and declared advisable the Merger Agreement, the Merger
and the other transactions contemplated by the Merger Agreement and (iii)&nbsp;resolved to recommend that the Kellanova shareowners vote in favor of the adoption of the Merger Agreement, the Merger and the other transactions contemplated by the
Merger Agreement. Accordingly, the Board unanimously recommends that Kellanova shareowners vote &#147;<B>FOR</B>&#148; the Merger Proposal, &#147;<B>FOR</B>&#148; the Advisory Compensation Proposal and &#147;<B>FOR</B>&#148; the Adjournment
Proposal. For additional information on the factors considered by the Board in reaching this decision and the recommendation of the Board, please see the section entitled &#147;The Merger&#151;Recommendation of the Board and Its Reasons for the
Merger.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinions of Financial Advisors to Kellanova (See page 54) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova retained each of Goldman Sachs&nbsp;&amp; Co. LLC (&#147;Goldman Sachs&#148;) and Lazard Fr&egrave;res&nbsp;&amp; Co. LLC
(&#147;Lazard&#148;) to act as financial advisors to the Board in connection with the proposed Merger. At the meeting of the Board on August&nbsp;13, 2024, Goldman Sachs and Lazard each rendered its oral opinion, subsequently confirmed in writing,
that as of such date, and based on and subject to various assumptions and limitations described in their respective opinions, the Merger Consideration to be received by the holders of Common Stock (other than shares owned (or held in treasury) by
Kellanova as treasury stock, shares held by Mars or any of its subsidiaries (including Acquiror and its subsidiaries), or any wholly owned subsidiary of Kellanova, immediately prior to the Effective Time or shares for which a holder properly
perfects its appraisal rights under the DGCL) pursuant to the Merger Agreement was fair, from a financial point of view, to such holders. The full texts of the written opinions of Goldman Sachs, dated August&nbsp;13, 2024, and of Lazard, dated
August&nbsp;13, 2024, which set forth, among other things, the various assumptions made, procedures followed, matters considered and qualifications and limitations on the scope of the review undertaken by each of Goldman Sachs and Lazard in
rendering its opinion, are attached to this proxy statement as Annex E and Annex F, respectively. You are encouraged to read the opinions carefully and in their entirety. The summary of the opinions of Goldman Sachs and Lazard set forth herein is
qualified in its entirety by reference to the full texts of the respective opinions. Goldman Sachs&#146;s and Lazard&#146;s opinion were each rendered for the benefit of the Board, in its capacity as such, and addressed only the fairness from a
financial point of view, as of the date of such opinion, of the Merger Consideration to such holders of Common Stock. Goldman Sachs&#146;s and Lazard&#146;s opinions did not address any </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other aspects or implications of the Merger, including the relative merits of the Merger as compared to any other alternative business transaction, or other alternatives, or the fairness of the
amount or nature of the compensation to any officers, directors or employees of Kellanova, or any class of such persons, relative to the Merger Consideration to be received by the holders of shares of Common Stock pursuant to the Merger Agreement.
Goldman Sachs and Lazard did not express any opinion or recommendation as to how the Kellanova shareowners should vote at the Special Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interests of Kellanova&#146;s Directors and Executive Officers in the Merger (See page 71) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In considering the recommendation of the Board that Kellanova shareowners vote to approve the Merger Proposal, Kellanova shareowners should be
aware that Kellanova&#146;s directors and executive officers may have interests in the Merger that are different from, or in addition to, the interests of Kellanova shareowners generally. These interests include, among others: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the treatment of Options, RSUs, PSUs and DSUs (each as defined below) held by directors and executive officers
and the treatment of purchase rights under the Kellanova Amended and Restated 2002 Employee Stock Purchase Plan (the &#147;ESPP&#148;), in each case, under the Merger Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kellanova&#146;s executive officers participate in the Kellanova Change of Control Severance Policy for Key
Executives (the &#147;COC Severance Policy&#148;), which provides for certain severance payments or benefits in the event of a qualifying termination of employment following the completion of the Merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential tax <FONT STYLE="white-space:nowrap">&#147;gross-up&#148;</FONT> payments to mitigate the impact of
Section&nbsp;4999 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), on our executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the treatment of annual bonuses for the year in which the Effective Time occurs in accordance with the terms of
the Merger Agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continued indemnification coverage under a tail directors&#146; and officers&#146; liability insurance policy
following the Merger, in accordance with the terms of the Merger Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board was aware of these interests and
considered them, among other matters, in evaluating and approving the Merger Agreement and the Merger, and in recommending the approval of the Merger Proposal and the Advisory Compensation Proposal to the Kellanova shareowners. See the section
entitled &#147;The Merger&#151;&#8201;Interests of Kellanova&#146;s Directors and Executive Officers in the Merger.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Treatment of Kellanova
Incentive Awards (See page 84) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each option to purchase a share of Common Stock (an &#147;Option&#148;) that is outstanding and unexercised as of
immediately prior to the Effective Time, by virtue of the Merger, will cease to be outstanding and will be converted into the right to receive an amount in cash, without interest, equal to the product of the total number of shares subject to such
Option and the excess, if any, of the per share Merger Consideration over the exercise price per share of Common Stock underlying the Option, subject to tax withholding. Any Option with a per share exercise price equal to or greater than the per
share Merger Consideration will be cancelled as of the Effective Time without payment. All Options are currently fully vested. For more information, see the section entitled &#147;The Merger Agreement&#151;Treatment of Kellanova Incentive
Awards&#151;Treatment of Options&#148; beginning on page 84. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of RSUs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each restricted stock unit of Kellanova subject to vesting solely based on service (an &#147;RSU&#148;) that was granted
prior to the date of the Merger Agreement and that is outstanding immediately prior to the Effective Time (including any restricted stock unit granted in 2022 that was originally subject to vesting based on service and performance goals), by virtue
of the Merger, will be deemed fully vested as to the number of shares of Common Stock issuable pursuant to such RSU, will cease to be outstanding and will be converted into the right to receive an amount in cash, without interest, equal to the sum
of the product of such number of shares of Common Stock issuable pursuant to the RSU and the per share Merger Consideration, plus all dividend equivalents accrued or credited with respect to such RSU, subject to tax withholding. Each RSU granted on
or after the date of the Merger Agreement that is outstanding and unvested immediately prior to the Effective Time will automatically be cancelled and converted into the contractual right to receive a payment in an amount of cash (without interest
and subject to applicable tax withholdings) equal to the sum of the per share Merger Consideration multiplied by the total number of shares of Common Stock issuable pursuant to such RSU as of immediately prior to the Effective Time plus all dividend
equivalents accrued or credited with respect to such RSU (each, a &#147;Converted RSU Cash Award&#148;). Each Converted RSU Cash Award will generally be subject to the same terms and conditions as applied to such RSU immediately prior to the
Effective Time and will become payable in accordance with the original vesting schedule applicable to the corresponding RSU or, if earlier, upon a qualifying termination of employment. For more information, see the section entitled &#147;The Merger
Agreement&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of RSUs&#148; beginning on page 84. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of PSUs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each performance stock unit of Kellanova subject to vesting based on service and performance goals (a &#147;PSU&#148;)
that is outstanding immediately prior to the Effective Time, by virtue of the Merger, will be deemed fully vested as to the number of shares of Common Stock (i)&nbsp;if the performance period applicable to such PSU ends prior to the Effective Time,
issuable pursuant to such PSU assuming maximum level of performance, and (ii)&nbsp;if the performance period applicable to such PSU does not end prior to the Effective Time, issuable pursuant to such PSU at the greater of target or actual level of
performance, as determined by Kellanova in good faith. All PSUs will cease to be outstanding and will be converted into the right to receive an amount in cash, without interest, equal to the sum of the product of such number of shares of Common
Stock issuable pursuant to the PSU (based on the level of vesting as described above) and the per share Merger Consideration, plus all dividend equivalents accrued or credited with respect to such PSU, subject to tax withholding. Holders of PSUs
that do not pay out in full at maximum level of performance at the Effective Time will also be entitled to a cash retention payment based on the difference between the value of their PSUs at maximum level of performance and the payment received by
such holder at the Effective Time, which will be payable on the last day of the performance period applicable to the corresponding PSU, subject to the holder&#146;s continued employment through such date or, if earlier, upon a qualifying termination
of employment. For more information, see the section entitled &#147;The Merger Agreement&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of PSUs&#148; beginning on page 85. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of DSUs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time,
each deferred stock unit of Kellanova (a &#147;DSU&#148;) that is outstanding immediately prior to the Effective Time, by virtue of the Merger, will cease to be outstanding and will be converted into the right to receive, at the time specified in
the applicable company benefit plan and in accordance with Section&nbsp;409A of the Code, an amount in cash, without interest, equal to the sum of the product of such number of shares of Common Stock underlying the DSU and the per share Merger
Consideration, plus all dividend equivalents accrued or credited with respect to such DSU, subject to tax withholding. For more information, see the section entitled &#147;The Merger Agreement&#151;Treatment of Kellanova Incentive
Awards&#151;Treatment of DSUs&#148; beginning on page 85. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of Employee Stock Purchase Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Prior to the Effective Time, Kellanova may, in its discretion, amend the ESPP to freeze all participant payroll deduction elections in effect
as of the date of the Merger Agreement under the ESPP, and is required to take all actions necessary to (i)&nbsp;provide that, contingent on the Effective Time: (1)&nbsp;no new purchasing period under the ESPP will commence following the date of the
Merger Agreement; (2)&nbsp;there will be no increase in the amount of participants&#146; payroll deduction elections under the ESPP and no contributions other than previously elected payroll deductions during the current offering period from those
in effect as of the date of the Merger Agreement; (3)&nbsp;no individual will commence participation in the ESPP during the period from the date of the Merger Agreement through the Effective Time; (4)&nbsp;each purchase right issued pursuant to the
ESPP will be fully exercised on the earlier of the scheduled purchase date for such purchasing period and the date that is immediately prior to the Effective Time, (ii)&nbsp;notify each participant that the purchase date for his or her purchase
right issued pursuant to the ESPP has been changed and (iii)&nbsp;terminate the ESPP effective as of immediately prior to the Effective Time. For more information, see the section entitled &#147;The Merger Agreement&#151;Treatment of Kellanova
Incentive Awards&#151;Treatment of Employee Stock Purchase Plan&#148; beginning on page 85. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Treatment of Certain Indebtedness (See page 98) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova will, and will cause its subsidiaries to, deliver all notices and take all other actions reasonably requested by Acquiror that are
required to, in accordance with the terms thereof, terminate all commitments outstanding under the <FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Agreement, dated as of December&nbsp;19, 2023, by and among Kellanova, JPMorgan Chase Bank,
N.A., as administrative agent, and the lenders and other parties from time to time party thereto (as amended, restated, replaced, refinanced, supplemented or otherwise modified from time to time, the
<FONT STYLE="white-space:nowrap">&#147;364-Day</FONT> Credit Agreement&#148;), and the Five-Year Credit Agreement, dated as of December&nbsp;21, 2021, by and among Kellanova (as successor in interest to the Kellogg Company), JPMorgan Chase Bank,
N.A., as administrative agent, and the lenders and other parties from time to time party thereto (as amended, restated, replaced, refinanced, supplemented or otherwise modified from time to time, the &#147;Five-Year Credit Agreement&#148; and,
together with the <FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Agreement, the &#147;Credit Agreements&#148;), repay in full all obligations, if any, outstanding thereunder, and facilitate the release of all liens, if any, securing such
obligations, and the release of all guarantees, if any, in connection therewith, in each case, as of the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mars, Acquiror
or any of their affiliates may, or may request Kellanova to, in which case Kellanova will use its reasonable best efforts, commence as promptly as practicable following receipt of such request, one or more consent solicitations regarding certain
proposed amendments to Kellanova&#146;s indentures dated as of March&nbsp;15, 2001, May&nbsp;21, 2009 and May&nbsp;6, 2024 which govern Kellanova&#146;s existing notes (collectively and, in each case, as amended, supplemented or otherwise modified
from time to time, the &#147;Indentures&#148;), as reasonably requested by Mars, including to eliminate, waive or amend the change of control provisions and to amend the reporting covenants in such Indentures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financing of the Merger (See page 69) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement does not contain any financing-related closing condition. However, the Merger Agreement does require Acquiror and Mars to
undertake to obtain financing on or prior to the Closing in an amount, when taken together with available cash on hand and other sources of funds available to Mars and Acquiror, to consummate the transactions. Acquiror obtained debt financing
commitments for the Merger consisting of a bridge loan facility in an aggregate principal amount equal to $29,000,000,000, subject to certain customary mandatory commitment reductions, which will be available to Acquiror on the terms and subject to
the conditions set forth in a commitment letter, dated August&nbsp;13, 2024 (the &#147;Debt Commitment Letter&#148;). The obligations of the lenders to provide the Debt Financing under the Debt Commitment Letter are subject to a number of customary
conditions. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement further provides that Kellanova will provide customary cooperation that
may be reasonably requested for arranging, obtaining, syndicating and consummating the debt financing for the transaction (or any issuance, sale or offering of debt securities and/or delayed draw term loans, in each case, in lieu thereof as
contemplated by the Debt Commitment Letter) or any exchange offer to exchange all or a portion of Kellanova&#146;s outstanding notes for securities of Mars. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conditions to Consummation of the Merger (See page 100) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each party&#146;s obligation to effect the Merger is subject to the fulfillment on or prior to the Closing Date (as defined below), or waiver
(to the extent not prohibited under applicable law) at Closing, of each of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the adoption of the Merger Agreement by the affirmative vote of the holders of a majority of the issued and
outstanding shares of Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any order or law that temporarily or permanently prohibits, enjoins or makes illegal the
consummation of the Merger (any such order or law, a &#147;Legal Restraint&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expiration or termination of the applicable waiting period under the HSR Act, and receipt of all other
clearances or approvals under other applicable antitrust, competition, trade regulation or foreign investment laws (collectively, &#147;Antitrust Laws&#148;). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition, Acquiror&#146;s and Merger Sub&#146;s obligation to effect the Merger is subject to the fulfillment on or prior to the Closing
Date, or waiver (to the extent not prohibited under applicable law) at Closing, of each of the following additional conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accuracy of the representations and warranties of Kellanova (subject to certain materiality and material
adverse effect qualifications); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kellanova&#146;s performance and compliance with the covenants and agreements in the Merger Agreement in all
material respects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of a material adverse effect relating to Kellanova that is continuing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the delivery of an officer&#146;s certificate, dated as of the Closing Date, by Kellanova certifying the matters
of the three preceding bullets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no Burdensome Condition (as defined in the section entitled &#147;The Merger Agreement&#151;Efforts to Complete
the Merger; Regulatory Approvals&#148; beginning on page 95) shall have been a condition to receipt of any regulatory approval, there is not in effect at or upon the Closing any order or law resulting, individually or in the aggregate, in a
Burdensome Condition and no regulatory approval contains, includes or imposes any Burdensome Condition; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receipt of the Closing Tax Opinion (as defined and discussed further in the section entitled &#147;The Merger
Agreement&#151;Tax Matters&#148; beginning on page 98) from Acquiror Tax Counsel (as defined in the section entitled &#147;The Merger Agreement&#151;Conditions to Consummation of the Merger&#148; beginning on page 100), provided that receipt of the
Closing Tax Opinion from Acquiror Tax Counsel is not a condition to the consummation of the Merger to the extent that Acquiror Tax Counsel determines that it cannot render the Closing Tax Opinion for reasons other than as a result of material
changes in law or facts prior to the Closing Date. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova&#146;s obligation to effect the Merger is subject to the
fulfillment on or prior to the Closing Date, or waiver (to the extent not prohibited under applicable law) at Closing, of each of the following additional conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accuracy of the representations and warranties of Acquiror (subject to certain materiality and material
adverse effect qualifications); </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Acquiror&#146;s and Merger Sub&#146;s performance or compliance with the covenants and agreements in the Merger
Agreement in all material respects; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the delivery of an officer&#146;s certificate, dated as of the Closing Date, by Acquiror certifying the matters
of the two preceding bullets. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Solicitation of Acquisition Proposals by Kellanova (See page 91) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as expressly permitted by the Merger Agreement, Kellanova will, and will cause each of its subsidiaries to and will use its reasonable
best efforts to cause its and its subsidiaries&#146; representatives to (i)&nbsp;immediately cease and terminate any ongoing solicitation, encouragement, discussions or negotiations with any person (other than Mars and its subsidiaries, including
Acquiror and their representatives) with respect to a Company Takeover Proposal (as defined in the section entitled &#147;The Merger Agreement&#151;Other Covenants and <FONT STYLE="white-space:nowrap">Agreements&#151;Non-Solicitation;</FONT>
Takeover Proposals&#148; beginning on page 91) and (ii)&nbsp;not, directly or indirectly: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">solicit, initiate, knowingly encourage or knowingly facilitate any inquiries regarding, or the making of any
proposal or offer that constitutes, or would reasonably be expected to lead to, a Company Takeover Proposal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any
other person any <FONT STYLE="white-space:nowrap">non-public</FONT> information with the intent of inducing the making of, or knowingly encouraging or knowingly facilitating, a Company Takeover Proposal, other than (A)&nbsp;solely in response to an
unsolicited inquiry, exclusively to refer the inquiring person to the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement or (B)&nbsp;upon receipt of a bona fide, unsolicited written Company Takeover Proposal
that did not result from a material breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement solely to the extent necessary to ascertain facts or clarify terms in order for the Board to have
sufficient information to assess whether such Company Takeover Proposal is or could reasonably be expected to lead to a Company Superior Proposal (as defined in the section entitled &#147;The Merger Agreement&#151;Other Covenants and <FONT
STYLE="white-space:nowrap">Agreements&#151;Non-Solicitation;</FONT> Takeover Proposals&#148; beginning on page 91); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approve, adopt, publicly recommend or enter into, or publicly propose to approve, adopt, recommend or enter into,
any letter of intent or similar document, agreement, commitment or agreement in principle with respect to a Company Takeover Proposal (other than to enter into a confidentiality agreement in accordance with the terms of the Merger Agreement);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">take any action to make the provisions of any &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control share
acquisition,&#148; &#147;business combination&#148; or other similar anti-takeover statute or regulation (including any transaction under, or a third party becoming an &#147;interested stockholder&#148; under, Section&nbsp;203 of the DGCL)
inapplicable to any person (other than Acquiror and its affiliates) or to any transactions constituting or contemplated by a Company Takeover Proposal; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">resolve or agree to do any of the foregoing. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if at any time after the date of the Merger Agreement and prior to the approval of the Merger Proposal (but not
after), in the event that (i)&nbsp;Kellanova or any of its representatives receives a bona fide unsolicited written Company Takeover Proposal that does not result from a material breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT>
provisions of the Merger Agreement and (ii)&nbsp;the Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that such Company Takeover Proposal constitutes or could reasonably be expected to
result in a Company Superior Proposal (as defined in the section entitled &#147;The Merger Agreement&#151;Other Covenants and <FONT STYLE="white-space:nowrap">Agreements&#151;Non-Solicitation;</FONT> Takeover Proposals&#148; beginning on page 91),
Kellanova may, prior to the approval of the Merger Proposal (but not after): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">furnish information with respect to Kellanova to the party making such Company Takeover Proposal pursuant to an
acceptable confidentiality agreement; and </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engage in discussions or negotiations with such party regarding such Company Takeover Proposal.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If Kellanova receives a Company Takeover Proposal, Kellanova must: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as promptly as practicable (and in any event within 48 hours after receipt) notify Acquiror of the receipt of any
Company Takeover Proposal or a request for information relating to Kellanova or its subsidiaries that constitutes or contemplates a Company Takeover Proposal, including the identity of the person making such Company Takeover Proposal and a
description of the material terms and conditions thereof; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">keep Acquiror reasonably informed, on a reasonably current basis, as to the status of the Company Takeover
Proposal including any developments, discussions or negotiations in respect thereof (including by as promptly as practicable (and in any event within 48 hours after receipt) providing to Acquiror a description of any changes to the material terms
and conditions of such Company Takeover Proposal). </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Termination of the Merger Agreement (See page 102) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by mutual written agreement of Kellanova and Acquiror; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either Kellanova or Acquiror: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Merger is not consummated on or before August&nbsp;13, 2025 (the &#147;Outside Date&#148;); provided, that
if, on the Outside Date, the conditions to the Closing set forth in the Merger Agreement relating to (i)&nbsp;the absence of a Legal Restraint, (ii)&nbsp;the expiration of the waiting period applicable to the Merger under the HSR Act and the receipt
of the clearances or approvals under applicable Antitrust Laws in the jurisdictions set forth on the specified Company Disclosure Schedule (as defined below) and (iii)&nbsp;the absence of a Burdensome Condition (in the case of each of clauses
(i)&nbsp;through (iii), as it relates to an Antitrust Law) are not fulfilled but all other conditions to the Closing set forth in the Merger Agreement have been waived or fulfilled (other than those conditions that by their terms cannot be satisfied
prior to the Closing, but which conditions would be satisfied if the Closing occurred on such date), then the Outside Date will be automatically extended by six months to February&nbsp;13, 2026; provided, further, that if, on February&nbsp;13, 2026,
the conditions to the Closing set forth in the Merger Agreement relating to (i)&nbsp;the absence of a Legal Restraint, (ii)&nbsp;the expiration of the waiting period applicable to the Merger under the HSR Act and the receipt of the clearances or
approvals under applicable Antitrust Laws in the jurisdictions set forth on the specified section of the Company Disclosure Schedule and (iii)&nbsp;the absence of a Burdensome Condition (in the case of each of clauses (i)&nbsp;through (iii), as it
relates to an Antitrust Law) are not fulfilled but all other conditions to the Closing set forth in the Merger Agreement, have been waived or fulfilled (other than those conditions that by their terms cannot be satisfied prior to the Closing, but
which conditions would be satisfied if the Closing occurred on such date), then the Outside Date will again be extended by six months to August&nbsp;13, 2026 (however, the right to terminate the Merger Agreement pursuant to this bullet will not be
available to any party if the failure of the Closing to have occurred on or before the Outside Date was primarily due to the failure of such party to perform any of its obligations under the Merger Agreement); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if any Legal Restraint that has become final and nonappealable permanently restrains, enjoins or otherwise
prohibits or makes illegal the consummation of the Merger (however, the party </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
seeking to terminate the Merger Agreement pursuant to this bullet must comply in all material respects with its obligations under the Merger Agreement to contest, appeal and remove such Legal
Restraint and the right to terminate the Merger Agreement pursuant to this bullet will not be available to any party&nbsp;if the issuance of the Legal Restraint or the occurrence of any such other action was primarily due to the failure of such
party to perform any of its obligations under the Merger Agreement (which failure constitutes a material breach of the Merger Agreement)); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the required approval of the Merger Proposal at the Special Meeting (or at any adjournment or postponement
thereof) is not obtained at which a vote was taken on the matter. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Acquiror: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if Kellanova has (i)&nbsp;breached any representation, warranty, covenant or other agreement contained in the
Merger Agreement (other than an intentional and material breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement), which breach would result in the failure to satisfy the closing conditions relating
to Kellanova&#146;s representations and warranties or covenants and (ii)&nbsp;such breach is not curable or, if curable, is not cured by the earlier of (A)&nbsp;the Outside Date or any extension thereof as applicable, and (B) 20 business days
following Acquiror&#146;s written notice to Kellanova (however, Acquiror will not have the right to terminate the Merger Agreement pursuant to this bullet if Acquiror is in breach of any representation, warranty, covenant or other agreement
contained in the Merger Agreement (which breach would result in the failure to satisfy the closing conditions relating to Acquiror&#146;s representations, warranties and covenants)); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) at any time following an Adverse Recommendation Change (as defined in the section entitled &#147;Merger
Agreement&#151;Other Covenants and <FONT STYLE="white-space:nowrap">Agreements&#151;Non-Solicitation;</FONT> Takeover Proposals&#151;The Company Recommendation; Adverse Recommendation Change; Fiduciary Exception&#148; beginning on page 93) or
(ii)&nbsp;if Kellanova has intentionally and materially breached the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement (however, in each case, Acquiror&#146;s right to terminate the Merger Agreement pursuant
to this bullet will expire upon receipt of approval of the transactions by Kellanova&#146;s shareowners). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Kellanova: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if Acquiror or Merger Sub has (i)&nbsp;breached any representation, warranty, covenant or other agreement
contained in the Merger Agreement, which breach would result in the failure to satisfy the closing conditions relating to Acquiror&#146;s and Merger Sub&#146;s representations and warranties or covenants and (ii)&nbsp;such breach is not curable or,
if curable, is not cured by the earlier of (A)&nbsp;the Outside Date or any extension thereof as applicable, and (B) 20 business days following Kellanova&#146;s written notice to Acquiror. However, Kellanova will not have the right to terminate the
Merger Agreement pursuant to this bullet if Kellanova is in breach of any representation, warranty, covenant or other agreement contained in the Merger Agreement (which breach would result in the failure to satisfy the closing conditions relating to
Kellanova&#146;s representations, warranties and covenants); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the receipt of approval of the transactions by Kellanova&#146;s shareowners, in order to substantially
concurrently with such termination enter into a definitive agreement relating to a Company Superior Proposal to the extent permitted by and subject to the terms of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision in the Merger
Agreement, subject to the prior or concurrent payment of the Termination Fee (as defined below) to Acquiror. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Expenses (See page <U></U>104) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in the Merger Agreement, whether or not the Merger is consummated, all costs and expenses incurred in connection
with the transactions will be paid by the party incurring or required to incur such expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Termination Fee (See page 103) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger Agreement is terminated in specified circumstances, Kellanova will be required to pay or cause to be paid to Acquiror a
termination fee of $800,000,000 (the &#147;Termination Fee&#148;). Acquiror would be entitled to receive the Termination Fee from Kellanova if the Merger Agreement is terminated: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Acquiror, because Kellanova has made an Adverse Recommendation Change or is in material breach of the <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement giving rise to Acquiror&#146;s right to terminate the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Kellanova, prior to the receipt of approval of the transactions by Kellanova&#146;s shareowners, subject to
compliance with specified <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement, in order to substantially concurrently with such termination enter into a definitive agreement relating to a Company Superior
Proposal; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">under certain specified circumstances (as described in the section entitled &#147;The Merger
Agreement&#151;Termination Fee&#148; beginning on page 103), including if within 12 months of such termination, Kellanova consummates or enters into a definitive agreement with respect to an acquisition proposal for more than 50% of Common Stock or
consolidated assets, or assets from which 50% or more of the consolidated revenues or earnings of Kellanova are derived. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">These triggers for the termination fee are subject to additional conditions or qualifications, which are described in greater detail in the
section entitled &#147;The Merger Agreement&#151;Termination Fee&#148; beginning on page&nbsp;103. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reverse Termination Fee (See page 104) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger Agreement is terminated in specified circumstances, Acquiror will be required to pay or cause to be paid to Kellanova a
termination fee of $1,250,000,000 (the &#147;Reverse Termination Fee&#148;). Kellanova would be entitled to receive the Reverse Termination Fee from Acquiror if either Acquiror or Kellanova terminates the Merger Agreement: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">because of a failure of the Closing to occur by the Outside Date or any extension thereof as applicable, and at
such time any of the closing conditions related to (i)&nbsp;the absence of a Legal Restraint (solely as a result of a Legal Restraint in respect of an Antitrust Law issued or entered after the date of the Merger Agreement), (ii) the expiration of
the waiting period applicable to the Merger under the HSR Act and the receipt of the clearances or approvals under applicable Antitrust Laws in the jurisdictions set forth on the specified section of the disclosure schedule delivered by Kellanova to
Acquiror immediately prior to the execution of the Merger Agreement (the &#147;Company Disclosure Schedule&#148;) and (iii)&nbsp;the absence of a Burdensome Condition have not been fulfilled (or waived to the extent permissible under applicable
law), but all other closing conditions either have been waived or fulfilled or would be fulfilled if the closing of the Merger were to occur on such date; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">because any Legal Restraint in respect of an Antitrust Law issued or entered after the date of the Merger
Agreement has become final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> that permanently restrains, enjoins or otherwise prohibits or makes illegal the consummation of the Merger. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">These triggers for the Reverse Termination Fee are subject to additional conditions or
qualifications, which are described in greater detail in the section entitled &#147;The Merger Agreement&#151;Reverse Termination Fee&#148; beginning on page 104. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Income Tax Considerations (See page 78) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The receipt of cash by U.S. holders (as defined in the section entitled &#147;The Merger&#151;U.S. Federal Income Tax Considerations&#148;
beginning on page 78) in exchange for shares of Common Stock pursuant to the Merger will generally be a taxable transaction for U.S. federal income tax purposes. In general, for U.S. federal income tax purposes, a U.S. holder who receives cash in
exchange for shares of Common Stock pursuant to the Merger will recognize capital gain or loss in an amount equal to the difference, if any, between (i)&nbsp;the amount of cash received in the Merger and (ii)&nbsp;the U.S. holder&#146;s adjusted tax
basis in its Common Stock exchanged therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any gain realized by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (as defined
in the section entitled &#147;The Merger&#151;U.S. Federal Income Tax Considerations&#148; beginning on page 78) pursuant to the Merger generally will not be subject to U.S. federal income tax unless such
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has certain connections to the United States. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>This proxy statement contains a
general discussion of U.S. federal income tax considerations relating to the Merger. No information is provided with respect to the tax consequences of the Merger under any U.S. federal law other than income tax laws (including, for example the U.S.
federal estate, gift, Medicare and alternative minimum tax laws), or any applicable state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws. Consequently, holders of Common Stock should consult their tax advisors as to the tax
consequences of the Merger relevant to their particular circumstances, including the applicability and effect of the alternative minimum tax and any state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> or other tax laws and of changes in
those laws. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Regulatory Matters (See page 80) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The completion of the Merger is subject to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable waiting period (and any extension thereof, including under any agreement between a party and a
governmental authority agreeing not to consummate the Merger prior to a certain date) under the HSR Act relating to the consummation of the Merger having expired or been terminated; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each other clearance or approval under any Antitrust Law in the jurisdiction set forth in the specified section
of the Company Disclosure Schedule shall have been obtained (or deemed obtained) or their respective authority concluded no jurisdiction; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no governmental authority of competent jurisdiction has entered any order that remains in effect and no law has
been adopted or is effective, in each case, that temporarily or permanently prohibits, enjoins or makes illegal the consummation of the Merger. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the HSR Act and related rules, certain transactions, including the Merger, may not be completed until required information and materials
are furnished to the Antitrust Division of the U.S. Department of Justice (&#147;Antitrust Division&#148;) and the Federal Trade Commission (the &#147;FTC&#148;) and statutory waiting period requirements have been satisfied. Following the filing by
Kellanova and Acquiror of their respective Notification and Report Forms, the waiting period under the HSR Act is expected to expire thirty days later unless earlier terminated or extended by the issuance of a request for additional information and
documentary material (a &#147;Second Request&#148;) to the parties by the FTC or the Antitrust Division prior to that time. If the FTC or the Antitrust Division issues a Second Request, the waiting period with respect to the Merger will be extended
for an additional period of 30 calendar days following both parties&#146; substantial compliance with that request unless earlier terminated by the FTC or the Antitrust Division. After that time, the waiting period may be extended only by court
order or with the consent of the parties. At any time before or after the consummation of any such transactions, the FTC or the </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Antitrust Division could take such action under the Antitrust Laws of the United States as it deems necessary or desirable in the public interest, including seeking to enjoin the Merger. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Beneficial Ownership (See page 108) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At
the close of business on September&nbsp;3, 2024, Kellanova&#146;s directors and current executive officers and their affiliates, as a group, beneficially owned and were entitled to vote approximately 4,745,073&nbsp;shares of Common Stock,
collectively representing approximately 1.4% of the shares of Common Stock outstanding on that date. Kellanova currently expects that all of its directors and executive officers will vote their shares &#147;<B>FOR</B>&#148; the Merger Proposal,
&#147;<B>FOR</B>&#148; the Advisory Compensation Proposal and &#147;<B>FOR</B>&#148; the Adjournment Proposal (if necessary). For more information regarding the security ownership of Kellanova directors and executive officers, please see the section
entitled &#147;Certain Beneficial Owners of Common Stock.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the Voting Agreements and subject to the terms and conditions
thereof, (1)&nbsp;the Kellogg Foundation Trust has agreed to vote 50,830,838 shares of Common Stock, representing 14.78% of the issued and outstanding Common Stock as of August 9, 2024 (less any shares of Common Stock sold pursuant to the Kellogg
Foundation Trust&#146;s existing <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan), and any shares of Common Stock acquired by the Kellogg Foundation Trust thereafter, (2)&nbsp;the G. Zachary Gund Entities have agreed to vote 1,644,365
shares of Common Stock, representing 0.48% of the issued and outstanding Common Stock as of August&nbsp;9, 2024, and any shares of Common Stock acquired by the G. Zachary Gund Entities thereafter and (3)&nbsp;the Gund Trusts have agreed to vote
18,327,318 shares of Common Stock, representing 5.40% of the issued and outstanding Common Stock as of August&nbsp;9, 2024, and any shares of Common Stock acquired by the Gund Trusts thereafter, in each case, in favor of the Merger Proposal at the
Special Meeting. For a more complete discussion of the Voting Agreements, please see the section entitled &#147;The Voting Agreements.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock
Exchange Delisting; Deregistration (See page 71) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the Effective Time, Kellanova will, and will cause its subsidiaries to,
reasonably cooperate with Acquiror and use reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under applicable laws and rules and policies
of the NYSE to cause the delisting of the Common Stock from the NYSE by Kellanova, as the surviving corporation in the Merger (&#147;Surviving Corporation&#148;), as promptly as practicable after the Effective Time and the deregistration of the
Common Stock under the Exchange Act as promptly as practicable after such delisting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Litigation Related to the Merger (See page <U></U>80) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement, no shareowner litigation related to the Merger Agreement has been brought against Kellanova or any
members of the Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Appraisal Rights (See page 115) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the DGCL, a holder of Common Stock who does not vote in favor of the Merger Proposal will have the right to seek appraisal of the fair
value of its shares of Common Stock as determined by the Court of Chancery of the State of Delaware (the &#147;Delaware Court of Chancery&#148;) if the Merger is completed, but only if such stockholder strictly complies with the procedures set forth
in Section&nbsp;262 of the DGCL (&#147;Section&nbsp;262&#148;). This appraisal amount could be more than, the same as or less than the Merger Consideration. Any holder of Common Stock intending to exercise appraisal rights must, among other things,
submit a written demand for an appraisal to us prior to the vote on the Merger Proposal at the Special Meeting and must not vote or otherwise submit a proxy in favor of the Merger Proposal. Your failure to follow exactly the procedures specified
under the DGCL will result in the loss of your appraisal rights. The requirements of the DGCL for exercising appraisal </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
rights are summarized in this proxy statement, including Section&nbsp;262, the text of which can be accessed without subscription or cost at the following publicly available
website:<I></I><I>&nbsp;https://delcode.delaware.gov/title8/c001/sc09/index.html#262</I>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Price of the Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Consideration represents a premium of approximately 44% to Kellanova&#146;s
<FONT STYLE="white-space:nowrap">unaffected&nbsp;30-trading&nbsp;day</FONT> volume weighted average price and a premium of approximately 33% to Kellanova&#146;s <FONT STYLE="white-space:nowrap">unaffected&nbsp;52-week&nbsp;high</FONT> as of
August&nbsp;2, 2024. On [&#9679;], 2024, which is the latest practicable trading day before this proxy statement was printed, the closing price of a share of Common Stock on the NYSE was $[&#9679;]. You are encouraged to obtain current market
quotations for the Common Stock in connection with voting your shares of Common Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">You can find more information about Kellanova in the periodic reports and other information we file with the Securities and Exchange Commission
(the &#147;SEC&#148;). The information is available at the website maintained by the SEC at www.sec.gov. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_2"></A>QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING AND THE MERGER
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>The following questions and answers briefly address some commonly asked questions about the Special Meeting and the Merger. They
may not include all the information that is important to Kellanova shareowners. Kellanova shareowners should carefully read this entire proxy statement, including the annexes and the other documents referred to herein and incorporated by reference.
</I></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why am I receiving this proxy statement? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You are receiving this proxy statement because Kellanova has agreed to be acquired pursuant to an <FONT
STYLE="white-space:nowrap">all-cash</FONT> merger transaction. Pursuant to the Merger Agreement, at the Effective Time, Merger Sub will merge with and into Kellanova, the separate corporate existence of Merger Sub will cease and Kellanova will
continue as the Surviving Corporation as a wholly owned subsidiary of Acquiror. The Merger Agreement governs the terms of the Merger of Merger Sub and Kellanova and is attached to this proxy statement as Annex A. You are receiving this proxy
statement in connection with the solicitation of proxies by the Board in favor of the Merger Proposal and the other matters to be voted on at the Special Meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">In order to complete the Merger, among other things, Kellanova shareowners must adopt the Merger Agreement in accordance with the DGCL. This
proxy statement, which you should carefully read in its entirety together with any documents incorporated by reference and the annexes, contains important information about the Special Meeting, the Merger and other matters. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen in the Merger? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Merger Agreement sets forth the terms and conditions of the proposed Merger. Under the Merger Agreement,
Merger Sub will merge with and into Kellanova, the separate corporate existence of Merger Sub will cease and Kellanova will continue as the Surviving Corporation and a wholly owned subsidiary of Acquiror. The Merger Agreement is attached to this
proxy statement as Annex A. For a more complete discussion of the proposed Merger, its effects and the other transactions contemplated by the Merger Agreement, please see the section entitled &#147;The Merger.&#148; </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What are Kellanova shareowners being asked to vote on? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kellanova is holding the Special Meeting to vote on the Merger Proposal, pursuant to which each outstanding
share of Common Stock will be cancelled and converted into the right to receive the Merger Consideration, other than shares owned (or held in treasury) by Kellanova as treasury stock, shares held, directly or indirectly, by Mars or any of its
subsidiaries (including Acquiror and its subsidiaries) or any wholly owned subsidiary of Kellanova, immediately prior to the Effective Time, or shares held by a holder that properly perfects its appraisal rights under the DGCL. Kellanova shareowners
will also be asked to approve the Advisory Compensation Proposal (on a <FONT STYLE="white-space:nowrap">non-binding,</FONT> advisory basis) and the Adjournment Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Your vote is very important, regardless of the number of shares of Common Stock that you own. The approval of the Merger Proposal is a
condition to the obligations of Mars and Kellanova to complete the Merger. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How important is my vote as a Kellanova shareowner? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Your vote &#147;<B>FOR</B>&#148; each proposal presented at the Special Meeting is very important, and you are
encouraged to submit a proxy as soon as possible. The Merger cannot be completed without the approval of the Merger Proposal by the Kellanova shareowners. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What constitutes a quorum, and what vote is required to approve each proposal at the Special Meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The holders of a majority of the outstanding shares of Common Stock as of the Record Date must be represented
at the Special Meeting in person or by proxy in order to constitute a quorum. Virtual attendance by shareowners of record at the Special Meeting will constitute presence in person for the purpose of determining the presence of a quorum for the
transaction of business at the Special Meeting. The inspector of election appointed for the Special Meeting will determine whether a quorum is present. The inspector of election will treat abstentions as present for purposes of determining the
presence of a quorum. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are shares held by a broker, bank, trust
or other nominee that are present in person or represented by proxy and entitled to vote at the Special Meeting, but with respect to which the broker, bank, trust or other nominee is not instructed by the beneficial owner of such shares on how to
vote on a particular proposal and such broker, bank, trust or nominee does not have discretionary voting power on such proposal. Because brokers, banks, trusts and other nominee holders of record do not have discretionary voting authority with
respect to any of the three proposals to be presented at the Special Meeting, if a beneficial owner of shares of Common Stock held in &#147;street name&#148; does not give voting instructions to the broker, bank, trust or other nominee with respect
to any of the proposals, then those shares will not be present in person or represented by proxy and entitled to vote at the Special Meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">If you provide voting instructions to your broker, bank, trust or other nominee on one or more of the proposals but not on one or more of the
other proposals, then your shares will not be treated as present or entitled to vote for the purposes of determining a quorum on any proposal for which you fail to provide instructions, and will not be voted on any such proposal, but will be treated
as present and entitled to vote for the purposes of determining a quorum, and will be voted on any proposal for which you provide instructions. To make sure that your shares are voted with respect to each of the proposals, you should instruct your
bank, broker, trust or other nominee how you wish to vote your shares in accordance with the procedures provided by your bank, broker, trust or other nominee regarding the voting of your shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">If a quorum is present, approval of the Merger Proposal requires the affirmative vote of holders of a majority of the outstanding shares of
Common Stock as of the Record Date entitled to vote thereon. Accordingly, a Kellanova shareowner&#146;s abstention from voting or the failure of a Kellanova shareowner to vote (including the failure of a Kellanova shareowner who holds shares in
&#147;street name&#148; through a bank, broker, trust or other nominee to give any voting instructions to that bank, broker, trust or other nominee) will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Merger Proposal. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">If a quorum is present, approval of each of the Adjournment Proposal and the Advisory Compensation Proposal requires the affirmative vote of
the holders of a majority of the Common Stock as of the Record Date entitled to vote thereon and present in person or represented by proxy at the Special Meeting. Accordingly, with respect to a Kellanova shareowner who is present in person or
represented by proxy at the Special Meeting, such shareowner&#146;s abstention from voting on either the Advisory Compensation Proposal or the Adjournment Proposal will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Advisory
Compensation Proposal or the Adjournment Proposal. Regardless of whether there is a quorum, the presiding chairman may adjourn the Special Meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">As of the close of business on the Record Date, there were [&#9679;] shares of Common Stock issued and outstanding. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How can I attend the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kellanova shareowners as of the Record Date may attend, vote and submit questions virtually at the Special
Meeting (or any adjournment or postponement thereof) by logging in at www.virtualshareholdermeeting.com/K2024SM. To log in, Kellanova shareowners (or their authorized representatives) will need the control number provided on their proxy card, voting
instruction form or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
notice. If you are not a Kellanova shareowner or do not have a control number, you may still access the meeting as a guest, but you will not be able to participate. </TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Are there any Kellanova shareowners who have already committed to voting in favor of any of the proposals at
the Special Meeting? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Contemporaneously and in connection with the execution of the Merger Agreement, Acquiror entered into the
Voting Agreements with the Voting Agreement Shareowners, pursuant to which each Voting Agreement Shareowner agreed, among other things, subject to the terms and conditions of its respective Voting Agreement, to vote all of the shares of Common Stock
held by it in favor of the Merger Proposal at the Special Meeting. For more information, please see the section entitled &#147;Voting Agreements.&#148; For more information regarding the security ownership of the Kellogg Foundation Trust, G. Zachary
Gund Entities and Gund Trusts, please see the section entitled &#147;Certain Beneficial Owners of Common Stock.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will Kellanova shareowners receive if the Merger is completed? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Merger is completed, shares of Common Stock outstanding at the Effective Time will automatically be
cancelled and converted into right to receive the Merger Consideration of $83.50 per share in cash without interest and subject to any applicable withholding taxes, unless the holder of such shares properly perfects its appraisal rights under the
DGCL. Notwithstanding the foregoing, any shares of Common Stock held by Kellanova as treasury stock immediately prior to the Effective Time will automatically be cancelled and retired and not be entitled to receive the Merger Consideration, and any
shares of Common Stock held by Mars or any of its subsidiaries (including Acquiror and its subsidiaries), or any wholly owned subsidiary of Kellanova, immediately prior to the Effective Time will remain outstanding and will not be converted into the
right to receive the Merger Consideration. You will not be entitled to receive shares in the Surviving Corporation, Acquiror or Mars. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">For more information regarding the Merger Consideration to be received by Kellanova shareowners if the Merger is completed, please see the
section entitled &#147;The Merger Agreement&#151;Effect of the Merger on the Common Stock&#148; beginning on page 83. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen to the Company Options, Company Restricted Stock Units, Company Performance Stock Units and
Company Deferred Stock Units that I hold? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Treatment of Options</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each Option that is outstanding and unexercised as of immediately prior to the Effective Time, by virtue of the Merger,
will cease to be outstanding and will be converted into the right to receive an amount in cash, without interest, equal to the product of the total number of shares of Common Stock subject to such Option and the excess, if any, of the per share
Merger Consideration over the exercise price per share of Common Stock underlying the Option, subject to tax withholding. Any Option with a per share exercise price equal to or greater than the per share Merger Consideration will be canceled as of
the Effective Time without payment. All Options are currently fully vested. For more information, see the section entitled &#147;The Merger Agreement&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of Options.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><I>Treatment of RSUs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">At the
Effective Time, each RSU that was granted prior to the date of the Merger Agreement and that is outstanding immediately prior to the Effective Time (including any restricted stock unit granted in 2022 that was originally subject to vesting based on
service and performance goals), by virtue of the Merger, will be deemed fully vested as to the number of shares of Common Stock issuable pursuant to such RSU, will cease to be outstanding and will be converted into the right to receive an amount in
cash, without interest, equal to the sum of the product of such number of shares of Common Stock issuable pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">
the RSU and the per share Merger Consideration, plus all dividend equivalents accrued or credited with respect to such RSU, subject to tax withholding. Each RSU granted on or after the date of
the Merger Agreement that is outstanding and unvested immediately prior to the Effective Time will automatically be cancelled and converted into a Converted RSU Cash Award equal to the per share Merger Consideration with respect to such RSU, plus
all dividend equivalents accrued or credited with respect to such RSU. Each Converted RSU Cash Award will generally be subject to the same terms and conditions as applied to such RSU immediately prior to the Effective Time and will become payable in
accordance with the original vesting schedule applicable to the corresponding RSU or, if earlier, upon a qualifying termination of employment. For more information, see the section entitled &#147;The Merger Agreement&#151;Treatment of Kellanova
Incentive Awards&#151;Treatment of RSUs.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><I>Treatment of PSUs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each PSU that is outstanding immediately prior to the Effective Time, by virtue of the Merger, will be deemed fully
vested as to the number of shares of Common Stock (i)&nbsp;if the performance period applicable to such PSU ends prior to the Effective Time, issuable pursuant to such PSU assuming maximum level of performance, and (ii)&nbsp;if the performance
period applicable to such PSU does not end prior to the Effective Time, issuable pursuant to such PSU at the greater of target or actual level of performance, as determined by Kellanova in good faith. All PSUs will cease to be outstanding and will
be converted into the right to receive an amount in cash, without interest, equal to the sum of the product of such number of shares of Common Stock issuable pursuant to the PSU (based on the level of vesting as described above) and the per share
Merger Consideration, plus all dividend equivalents accrued or credited with respect to such PSU, subject to tax withholding. Holders of PSUs that do not pay out in full at maximum level of performance at the Effective Time will also be entitled to
a cash retention payment based on the difference between the value of their PSUs at maximum level of performance and the payment received by such holder at the Effective Time, which will be payable on the last day of the performance period
applicable to the corresponding PSU, subject to the holder&#146;s continued employment through such date or, if earlier, upon a qualifying termination of employment. For more information, see the section entitled &#147;The Merger
Agreement&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of PSUs.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><I>Treatment of DSUs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each DSU that is outstanding immediately prior to the Effective Time, by virtue of the Merger, will cease to be
outstanding and will be converted into the right to receive, at the time specified in the applicable company benefit plan and in accordance with Section&nbsp;409A of the Code, an amount in cash, without interest, equal to the sum of the product of
such number of shares of Common Stock underlying the DSU and the per share Merger Consideration, plus all dividend equivalents accrued or credited with respect to such DSU, subject to tax withholding. For more information, see the section entitled
&#147;The Merger Agreement&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of DSUs.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Will I be able to continue participating in the ESPP? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Prior to the Effective Time, Kellanova may, in its discretion, amend the ESPP to freeze all participant payroll
deduction elections in effect as of the date of the Merger Agreement under the ESPP, and is required to take all actions necessary to (i)&nbsp;provide that, contingent on the Effective Time: (1)&nbsp;no new purchasing period under the ESPP will
commence following the date of the Merger Agreement; (2)&nbsp;there will be no increase in the amount of participants&#146; payroll deduction elections under the ESPP and no contributions other than previously elected payroll deductions during the
current offering period from those in effect as of the date of the Merger Agreement; (3)&nbsp;no individual will commence participation in the ESPP during the period from the date of the Merger Agreement through the Effective Time; (4)&nbsp;each
purchase right issued pursuant to the ESPP will be fully exercised on the earlier of the scheduled purchase </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
date for such purchasing period and the date that is immediately prior to the Effective Time, (ii)&nbsp;notify each participant that the purchase date for his or her purchase right issued
pursuant to the ESPP has been changed and (iii)&nbsp;terminate the ESPP effective as of immediately prior to the Effective Time. For more information, see the section entitles &#147;The Merger Agreement&#151;Treatment of Kellanova Incentive
Awards&#151;Treatment of Employee Stock Purchase Plan.&#148; </TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How does the Board recommend that I vote at the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board unanimously recommends that you vote &#147;<B>FOR</B>&#148; the Merger Proposal,
&#147;<B>FOR</B>&#148; the Advisory Compensation Proposal and &#147;<B>FOR</B>&#148; the Adjournment Proposal. For additional information regarding the recommendation of the Board, please see the section entitled &#147;The Merger&#151;Recommendation
of the Board and Its Reasons for the Merger.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who is entitled to vote at the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All holders of shares of Common Stock who held shares at the close of business on the Record Date are entitled
to receive notice of, and to vote at, the Special Meeting or any adjournment or postponement thereof. Each such holder of Common Stock is entitled to cast one vote on each matter properly brought before the Special Meeting or any adjournment or
postponement thereof for each share of Common Stock that such holder owned of record as of the close of business on the Record Date. Please see the section entitled &#147;The Special Meeting of Kellanova&#146;s Shareowners&#151;Voting at the Special
Meeting&#148; for instructions on how to vote your shares without attending the Special Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What is a proxy? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A shareowner&#146;s legal designation of another person to vote shares of such shareowner&#146;s common stock
at a special or annual meeting is referred to as a proxy. The document used to designate a proxy to vote your shares of common stock is called a proxy card. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How many votes do I have for the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each Kellanova shareowner is entitled to one vote for each share of Common Stock held of record as of the close
of business on the Record Date for each matter properly brought before the Special Meeting or any adjournment or postponement thereof. As of the close of business on the Record Date, there were [&#9679;] outstanding shares of Common Stock.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if the Merger is not completed? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the requisite Kellanova shareowners do not approve the Merger Proposal or if the Merger is not completed for
any other reason, Kellanova shareowners will not receive any Merger Consideration or other payment for their shares of Common Stock in connection with the Merger. Instead, Kellanova expects that its management will operate Kellanova&#146;s business
in a manner similar to that in which it is being operated today and Kellanova will remain an independent public company, the Common Stock will continue to be listed and traded on the NYSE, the Common Stock will continue to be registered under the
Exchange Act and Kellanova shareowners will continue to own their shares of Common Stock and will continue to be subject to the same general risks and opportunities as they currently are with respect to ownership of Common Stock. Under certain
circumstances, if the Merger is not completed, Kellanova may be obligated to pay to Acquiror the Termination Fee. Please see the section of entitled &#147;The Merger Agreement&#151;Termination Fee.&#148; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What conditions must be satisfied to complete the Merger? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In addition to the approval of the Merger Proposal, the Merger is subject to the satisfaction or waiver of
various other conditions, including (i)&nbsp;the absence of a Legal Restraint, (ii)&nbsp;the expiration or termination of the applicable waiting period under the HSR Act, and receipt of all other clearances or approvals under other specified
antitrust, competition, trade regulation and foreign investment laws, (iii)&nbsp;the accuracy of the representations and warranties contained in the Merger Agreement (subject to certain materiality and material adverse effect qualifications) and
compliance with the covenants and agreements in the Merger Agreement in all material respects by the parties to the Merger Agreement, (iv)&nbsp;in the case of Acquiror and Merger Sub, the absence of a material adverse effect relating to Kellanova
that is continuing and (v)&nbsp;in the case of Acquiror and Merger Sub, receipt of the Closing Tax Opinion (as defined and discussed further in the section entitled &#147;The Merger Agreement&#151;Other Covenants and Agreements&#151;Tax
Matters&#148; beginning on page 98) from Acquiror Tax Counsel (as defined in the section entitled &#147;The Merger Agreement&#151;Conditions to Consummation of the Merger&#148; beginning on page 100), provided that receipt of the Closing Tax Opinion
from Acquiror Tax Counsel is not a condition to the consummation of the Merger to the extent that Acquiror Tax Counsel determines that it cannot render the Closing Tax Opinion for reasons other than as a result of material changes in law or facts
prior to the Closing Date. For a more complete summary of the conditions that must be satisfied or waived (in accordance with the terms of the Merger Agreement) prior to the completion of the Merger, see the section entitled &#147;The Merger
Agreement&#151;Conditions to Consummation of the Merger.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What effects will the Merger have on Kellanova? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Our Common Stock is currently registered under the Exchange Act, and it is quoted on the NYSE under the symbol
&#147;K.&#148; As a result of the Merger, Kellanova will cease to be a publicly traded company and will become a wholly owned subsidiary of Acquiror. Following the consummation of the Merger, our Common Stock will be delisted from the NYSE and
deregistered under the Exchange Act and Kellanova will no longer be required to file periodic reports with the SEC with respect to our Common Stock, in each case, in accordance with applicable law, rules and regulations. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How does the Merger Consideration compare to the market price of our Common Stock prior to the announcement
of Kellanova&#146;s entry into the Merger Agreement? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Merger Consideration of $83.50 per share in cash represents a premium of approximately 44% to
Kellanova&#146;s unaffected <FONT STYLE="white-space:nowrap">30-trading</FONT> day volume weighted average price and a premium of approximately 33% to Kellanova&#146;s unaffected <FONT STYLE="white-space:nowrap">52-week</FONT> high as of
August&nbsp;2, 2024. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How can I vote my shares and participate at the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We urge you to read this proxy statement carefully, including its annexes and the documents incorporated by
reference in this proxy statement, and to consider how the Merger affects you. If you are a Kellanova shareowner of record as of the close of business on the Record Date, you may submit your proxy before the Special Meeting in one of the following
ways: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Telephone</B>: use the toll-free number shown on your proxy card; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Internet</B>: visit the website shown on your proxy card to vote via the Internet; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Mail</B>: complete, sign, date and return the enclosed proxy card in the enclosed postage-paid envelope.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If you are a Kellanova shareowner of record as of the close of business on the Record Date, you may also cast your vote
virtually at the Special Meeting by attending the Special Meeting virtually at www.virtualshareholdermeeting.com/K2024SM. If you decide to attend the Special Meeting virtually and vote at the meeting, your vote will revoke any proxy previously
submitted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Special Meeting will begin promptly at [&#9679;] [a.m./p.m.] Central Time, on [&#9679;], 2024. Kellanova encourages its
shareowners to access the meeting prior to the start time, leaving ample time for <FONT STYLE="white-space:nowrap">check-in.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Please follow the instructions as outlined in this proxy statement. Even if you plan to attend the Special Meeting virtually, Kellanova requests that you complete, sign, date and return your
proxy in advance as described below so that your shares will be represented and voted at the Special Meeting if you later decide not to or become unable to attend the Special Meeting. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How can I vote my shares without attending the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Whether you hold your shares directly as a shareowner of record of Kellanova or beneficially in &#147;street
name,&#148; as of the close of business on the Record Date, you may direct your vote by proxy without attending the Special Meeting. You can submit your proxy by mail, over the Internet or by telephone by following the instructions provided on the
enclosed proxy card. Please note that if you hold shares beneficially in &#147;street name,&#148; you should follow the voting instructions provided by your bank, broker, trust or other nominee. Additional information on voting procedures can be
found in the section entitled &#147;The Special Meeting of Kellanova&#146;s Shareowners.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>When and where is the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Special Meeting will be held virtually at www.virtualshareholdermeeting.com/K2024SM, on [&#9679;], 2024, at
[&#9679;] [a.m./p.m.] Central Time. Online access will begin at [&#9679;] [a.m./p.m.] Central Time, and Kellanova encourages its shareowners to access the meeting prior to the start time, leaving ample time for
<FONT STYLE="white-space:nowrap">check-in.</FONT> Even if you plan to attend the Special Meeting virtually, Kellanova requests that you complete, sign, date and return your proxy in advance as described above so that your shares will be represented
and voted at the Special Meeting if you later decide not to or become unable to attend the Special Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What is the difference between holding shares as a shareowner of record and as a beneficial owner of shares
held in &#147;street name&#148;? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If your shares are held in &#147;street name&#148; in a stock brokerage account or by a broker, bank, trust or
other nominee, you must provide your bank, broker, trust or other nominee with instructions on how to vote your shares. Please follow the voting instructions provided by your broker, bank, trust or other nominee. Please note that you may not vote
shares held in street name by returning a proxy card directly to Kellanova or by voting in person at the Special Meeting unless you provide a &#147;legal proxy,&#148; which you must obtain from your broker, bank, trust or other nominee.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What if my shares of Common Stock are held in &#147;street name&#148; by my bank, broker, trust or other
nominee? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> are shares held by a broker, bank, trust or other
nominee that are present in person or represented by proxy and entitled to vote at the Special Meeting, but with respect to which the broker, bank, trust or other nominee is not instructed by the beneficial owner of such shares on how to vote on a
particular proposal and such broker, bank, trust or nominee does not have discretionary voting power on such proposal. Because brokers, banks, trusts and other nominee holders of record do not have discretionary voting authority with respect to any
of the three proposals to be presented at the Special Meeting, if a beneficial owner of shares of Common Stock held in &#147;street name&#148; does not give voting instructions to the broker, bank, trust or other nominee with respect to any of the
proposals, then those shares will not be present in person or represented by proxy and entitled to vote at the Special Meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">If you provide voting instructions to your broker, bank, trust or other nominee on one or more of the proposals but not on one or more of the
other proposals, then your shares will not be treated as present or entitled to vote for the purposes of determining a quorum on any proposal for which you fail to provide instructions, and will not be voted on any such proposal, but will be treated
as present and entitled to vote for the purposes of determining a quorum, and will be voted on any proposal for which you provide instructions. To make sure that your shares are voted with respect to each of the proposals, you should
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">
instruct your bank, broker, trust or other nominee how you wish to vote your shares in accordance with the procedures provided by your bank, broker, trust or other nominee regarding the voting of
your shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>The effect of not instructing your bank, broker, trust or other nominee how you wish to vote your shares on any of the
proposals will be the same as a vote &#147;AGAINST&#148; the Merger Proposal and will not have any effect on the outcome of the Adjournment Proposal or the Advisory Compensation Proposal</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>If you instruct your bank, broker, trust or other nominee on how you wish to vote your shares on some proposals but not the Merger Proposal,
the resulting broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will have the same effect as voting &#147;AGAINST&#148; the Merger Proposal.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>If you instruct your bank, broker, trust or other nominee on how you wish to vote your shares on some proposals but not the Advisory
Compensation Proposal, the resulting broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will not have any effect on the outcome of Advisory Compensation Proposal.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>If you instruct your bank, broker, trust or other nominee on how you wish to vote your shares on some proposals but not the Adjournment
Proposal, the resulting broker <FONT STYLE="white-space:nowrap">non-vote</FONT> will not have any effect on the outcome of Adjournment Proposal.</B> </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What should I do if I receive more than one set of voting materials for the Special Meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you hold shares of Common Stock in &#147;street name&#148; and also directly in your name as a shareowner of
record or otherwise, or if you hold shares of Common Stock in more than one brokerage account, you may receive more than one set of voting materials relating to the Special Meeting. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><I>Record Holders</I>. For shares held directly, please complete, sign, date and return each proxy card, or you may submit your proxy by
telephone or Internet as provided on each proxy card, or otherwise follow the voting instructions provided in this proxy statement in order to ensure that all of your shares of Common Stock are voted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><I>&#147;Street Name</I>&#148; <I>Holders</I>. For shares held in &#147;street name&#148; through a bank, broker, trust or other nominee, you
should follow the procedures provided by your bank, broker, trust or other nominee to vote your shares. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Should I send in my stock certificates or other evidence of ownership now? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. After the Merger is completed, you will receive a letter of transmittal and related materials from the
payment agent for the Merger with detailed written instructions for exchanging your shares of Common Stock for the Merger Consideration. If your shares of Common Stock are held in &#147;street name&#148; by your broker, bank, trust or other nominee,
you may receive instructions from your broker, bank, trust or other nominee as to what action, if any, you need to take to effect the surrender of your &#147;street name&#148; shares in exchange for the Merger Consideration. Do not send in your
certificates now. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>I do not know where my stock certificate is&#151;how will I get the Merger Consideration for my shares?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Merger is completed, the transmittal materials you will receive after the completion of the Merger will
include the procedures that you must follow to receive the Merger Consideration, including, in the case of holders of stock certificates, if you cannot locate your stock certificate(s). This will include an affidavit that you will need to sign
attesting to the loss of your stock certificate(s). Kellanova may also require that you provide a customary indemnity agreement to Kellanova in order to cover any potential loss. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If a shareowner gives a proxy, how are the shares of Common Stock voted? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Regardless of the method you choose to vote, the individuals named on the enclosed proxy card will vote your
shares of Common Stock in the way that you indicate. When completing the proxy card or the Internet or telephone processes, you may specify whether your shares of Common Stock should be voted for or against, or abstain from voting on, all, some or
none of the specific items of business to come before the Special Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How will my shares of Common Stock be voted if I return a blank proxy? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you sign, date and return your proxy card and do not indicate how you want your shares of Common Stock to be
voted, then your shares of Common Stock will be voted &#147;<B>FOR</B>&#148; the Merger Proposal, &#147;<B>FOR</B>&#148; the Advisory Compensation Proposal and &#147;<B>FOR</B>&#148; the Adjournment Proposal. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Can I change my vote of shares of Common Stock after I have submitted my proxy? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Any shareowner of record as of the close of business on the Record Date giving a proxy has the right to
revoke it before the proxy is voted at the Special Meeting by: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subsequently submitting a new proxy, whether by submitting a new proxy card or by submitting a proxy via the
Internet or telephone, that is received by the deadline specified on the accompanying proxy card; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">giving written notice of your revocation to Kellanova&#146;s Secretary; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">attending the Special Meeting virtually and voting. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">Your attendance at the Special Meeting will not revoke your proxy unless you give written notice of revocation to Kellanova&#146;s Secretary
before your proxy is exercised or unless you vote your shares in person at the Special Meeting. Execution or revocation of a proxy will not in any way affect your right to attend the Special Meeting and vote. Written notices of revocation and other
communications with respect to the revocation of proxies should be addressed to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kellanova </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn: Office of the Secretary </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">412
N. Wells Street, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chicago, Illinois 60654 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">For more information, please see the section entitled &#147;The Special Meeting of Kellanova&#146;s Shareowners&#151;Revocation of
Proxies.&#148; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If I hold my shares in &#147;street name,&#148; can I change my voting instructions after I have submitted
voting instructions to my bank, broker, trust or other nominee? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If your shares are held in the name of a bank, broker, trust or other nominee and you previously provided
voting instructions to your bank, broker, trust or other nominee, you should follow the instructions provided by your bank, broker, trust or other nominee to revoke or change your voting instructions. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Where can I find the voting results of the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The preliminary voting results for the Special Meeting will be announced at the Special Meeting. In addition,
within four business days of the Special Meeting, Kellanova intends to file the final voting results of the Special Meeting with the SEC on a Current Report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Am I entitled to appraisal rights? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Under Section&nbsp;262 of the DGCL, a shareowner who does not vote in favor of the Merger Proposal will be
entitled to seek appraisal of its shares if such shareowner takes certain actions and certain criteria are satisfied. For more information, see the section entitled &#147;Appraisal Rights.&#148; A copy of Section&nbsp;262 of the DGCL may be a copy
of which may be accessed without subscription or cost at the following publicly available website:<I> https://delcode.delaware.gov/title8/c001/sc09/index.html#262</I>. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Do any of the officers or directors of Kellanova have interests in the Merger that may differ from or be in
addition to my interests as a Kellanova shareowner? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. In considering the recommendation of the Board that Kellanova shareowners vote to approve the Merger
Proposal, Kellanova shareowners should be aware that Kellanova&#146;s directors and executive officers may have interests in the Merger that are different from, or in addition to, the interests of Kellanova shareowners generally. The Board was aware
of these interests and considered, among other matters, in evaluating and approving the Merger Agreement and the Merger, and in recommending the approval of the Merger Proposal and the Advisory Compensation Proposal to Kellanova&#146;s shareowners.
See the section entitled &#147;The Merger&#151;Interests of Kellanova&#146;s Directors and Executive Officers in the Merger.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why am I being asked to vote on the Advisory Compensation Proposal? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The SEC rules require Kellanova to seek approval on a <FONT STYLE="white-space:nowrap">non-binding,</FONT>
advisory basis with respect to certain payments that will or may be made to Kellanova&#146;s named executive officers in connection with the Merger. Approval of the Advisory Compensation Proposal is not required to complete the Merger. Accordingly,
because Kellanova is contractually obligated to pay the compensation, if the Merger Proposal is adopted by Kellanova shareowners and the Merger is completed, the compensation will be payable, subject only to the conditions applicable thereto,
regardless of the outcome of this advisory, <FONT STYLE="white-space:nowrap">non-binding</FONT> vote. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if I sell my shares of Common Stock after the Record Date but before the Special Meeting?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Record Date is earlier than the date of the Special Meeting. If you transfer your shares of Common Stock
after the Record Date but before the Special Meeting, you will, unless special arrangements are made, retain your right to vote at the Special Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>When is the Merger expected to be completed? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kellanova and Mars are working to be in a position to complete the Merger as quickly as possible after the
Special Meeting. Kellanova currently anticipates that the Merger will be completed in the first half of 2025. In order to complete the merger, we must obtain the required Kellanova shareowner approval, approval under the HSR Act and certain other
regulatory approvals, and a number of other closing conditions under the Merger Agreement must be satisfied or waived. See the section entitled &#147;The Merger Agreement&#151;Conditions to Consummation of the Merger.&#148; Accordingly, there can be
no assurances that the Merger will be completed at all, or if completed, that it will be completed in the first half of 2025. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What are the United States federal income tax considerations of the Merger for Kellanova shareowners?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The receipt of cash by U.S. holders (as defined in the section entitled &#147;The Merger&#151;U.S. Federal
Income Tax Considerations&#148;) in exchange for shares of Common Stock pursuant to the Merger will generally be a taxable transaction for U.S. federal income tax purposes. In general, for U.S. federal income tax purposes,
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
a U.S. holder who receives cash in exchange for shares of Common Stock pursuant to the Merger will recognize capital gain or loss in an amount equal to the difference, if any, between
(i)&nbsp;the amount of cash received in the Merger and (ii)&nbsp;the U.S. holder&#146;s adjusted tax basis in its Common Stock exchanged therefor. Any gain realized by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (as defined in the
section entitled &#147;The Merger&#151;U.S. Federal Income Tax Considerations&#148;) pursuant to the Merger generally will not be subject to U.S. federal income tax unless such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has certain
connections to the United States. For a more detailed summary of the U.S. federal income tax consequences of the Merger, see the section entitled &#147;The Merger&#151;U.S. Federal Income Tax Considerations&#148; beginning on page 78 of this proxy
statement. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B>This proxy statement contains a general discussion of U.S. federal income tax considerations relating to the
Merger. No information is provided with respect to the tax consequences of the Merger under any U.S. federal law other than income tax laws (including, for example the U.S. federal estate, gift, Medicare and alternative minimum tax laws), or any
applicable state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws. Consequently, holders of Common Stock should consult their tax advisors as to the tax consequences of the Merger relevant to their particular circumstances,
including the applicability and effect of the alternative minimum tax and any state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> or other tax laws and of changes in those laws. </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What should I do now? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You should read this proxy statement carefully and in its entirety, including the annexes and documents
incorporated by reference, and return your completed, signed and dated proxy card by mail in the enclosed postage-paid envelope, or you may submit your voting instructions by telephone or over the Internet as soon as possible so that your shares
will be voted in accordance with your instructions. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What is householding and how does it affect me? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The SEC permits companies to send a single set of proxy materials to any household at which two or more
shareowners reside, unless contrary instructions have been received, but only if the company provides advance notice and follows certain procedures. In such cases, each shareowner continues to receive a separate notice of the meeting and proxy card.
Certain brokerage firms may have instituted householding for beneficial owners of common stock held through brokerage firms. If your family has multiple accounts holding common stock, you may have already received a householding notification from
your broker. Please contact your broker directly if you have any questions or require additional copies of this proxy statement. The broker will arrange for delivery of a separate copy of this proxy statement promptly upon your written or oral
request. You may decide at any time to revoke your decision to household, and thereby receive multiple copies. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who will count the vote? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A representative of Broadridge Financial Solutions, Inc. will tabulate the votes. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who will solicit and bear the cost of soliciting votes for the Special Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kellanova will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy
materials. In addition to the mailing of these proxy materials, the solicitation of proxies or votes may be made in person, by telephone or by electronic and facsimile transmission by our directors, officers and employees, who will not receive any
additional compensation for such solicitation activities. Kellanova has engaged D.F. King&nbsp;&amp; Co., Inc. to assist in the solicitation of proxies for the Special Meeting. Kellanova may reimburse its transfer agent, brokerage firms and other
persons representing beneficial owners of shares of Common Stock for their expenses in forwarding solicitation material to such beneficial owners. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Where can I find more information about Kellanova? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You can find more information about us from various sources described in the section entitled &#147;Where You
Can Find More Information&#148; beginning on page 122. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Whom do I call if I have questions about the Special Meeting or the Merger? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>A:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you have more questions about the Special Meeting or the Merger or how to submit your proxy, or if you need
additional copies of this proxy statement or the enclosed proxy card or voting instructions, please contact the Investor Relations Department, Kellanova, P.O. Box 3599, Battle Creek, MI 49016-3599 (phone: (269)
<FONT STYLE="white-space:nowrap">961-2800),</FONT> or investor.relations@kellanova.com. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman">You may also wish to consult
your legal, tax and/or financial advisors with respect to any aspect of the Merger, the Merger Agreement or other matters discussed in this proxy statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_3"></A>CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Certain statements and information in this proxy statement and the documents incorporated by reference herein may constitute
&#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995, Section&nbsp;27A of the Securities Act of 1933, as amended and Section&nbsp;21E of the Exchange Act, including statements regarding
the Merger, shareowner and regulatory approvals, the expected timetable for completing the Merger and any other statements regarding the Company&#146;s future expectations, beliefs, plans, objectives, financial conditions, assumptions or future
events or performance that are not historical facts. The words &#147;believe,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;plan,&#148; &#147;intend,&#148; &#147;foresee,&#148; &#147;predict,&#148; &#147;budget,&#148; &#147;should,&#148;
&#147;would,&#148; &#147;could,&#148; &#147;attempt,&#148; &#147;appears,&#148; &#147;forecast,&#148; &#147;outlook,&#148; &#147;estimate,&#148; &#147;continue,&#148; &#147;project,&#148; &#147;projection,&#148; &#147;goal,&#148; &#147;model,&#148;
&#147;target,&#148; &#147;potential,&#148; &#147;may,&#148; &#147;will,&#148; &#147;objective,&#148; &#147;guidance,&#148; &#147;outlook,&#148; &#147;effort,&#148; &#147;are likely&#148; and other similar expressions are intended to identify
forward-looking statements, which are generally not historical in nature and convey the uncertainty of future events or outcomes, although not all forward-looking statements contain such identifying words. These forward-looking statements are based
on Kellanova&#146;s current expectations and beliefs concerning future developments and their potential effect on their respective businesses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The forward-looking statements contained in this document speak only as of the date of this proxy statement and are largely based on
Kellanova&#146;s expectations for the future, which reflect certain estimates and assumptions made by Kellanova management, and Kellanova undertakes no obligation to update or revise any forward-looking statements made herein, except as required by
law. These estimates and assumptions reflect Kellanova&#146;s best judgment based on currently known market conditions, operating trends and other factors. Although Kellanova believes such estimates and assumptions to be reasonable, they are
inherently uncertain and involve a number of risks and uncertainties that are beyond Kellanova&#146;s control. As such, Kellanova management&#146;s assumptions about future events may prove to be inaccurate. For a more detailed description of the
risks and uncertainties involved, see &#147;Risk Factors&#148; in Kellanova&#146;s most recently filed Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> subsequent Quarterly Reports on Form
<FONT STYLE="white-space:nowrap">10-Q,</FONT> Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and other SEC filings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">These cautionary statements qualify all forward-looking statements attributable to Kellanova, or persons acting on Kellanova&#146;s behalf.
Kellanova management cautions you that the forward-looking statements contained in this proxy statement are not guarantees of future performance, and Kellanova cannot assure you that such statements will be realized or that the events and
circumstances they describe will occur. Kellanova can give no assurance that the conditions to the Merger will be satisfied, or that it will close within the anticipated time period.&nbsp;Factors that could cause actual results to differ materially
from those anticipated or implied in the forward-looking statements herein include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to obtain the required vote of Kellanova&#146;s shareowners in connection with the Merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that Mars or Kellanova may be unable to obtain governmental and regulatory approvals required for the
transaction, or that required governmental and regulatory approvals may delay the transaction or result in the imposition of conditions that could reduce the anticipated benefits from the Merger or cause the parties to abandon the Merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that a condition to Closing may not be satisfied or waived; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the length of time necessary to consummate the Merger, which may be longer than anticipated for various reasons,
and the risk that the Merger may not be completed at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the financial performance of Kellanova through the completion of the Merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that the Merger disrupts Kellanova&#146;s current operations and plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks related to the disruption of management&#146;s attention from ongoing operations due to the Merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of the costs, fees, expenses and charges related to the Merger Agreement; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations placed on Kellanova&#146;s ability to operate its business under the Merger Agreement, which may
impact the Company&#146;s ability to pursue certain business opportunities or strategic transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competitive responses to the Merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the occurrence of any event that could give rise to the termination of the Merger Agreement, including under
circumstances that require Kellanova to pay Acquiror the Termination Fee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that shareowner litigation in connection with the Merger may affect the timing or occurrence of the
Merger or result in significant costs of defense, indemnification and liability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of the announcement or pendency of the Merger on Kellanova&#146;s ability to retain and hire key
personnel and other employees or Kellanova&#146;s business relationships (including customers and suppliers), operating results and business generally; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that any announcements relating to the Merger could have adverse effects on the market price of the
Company&#146;s Common Stock, credit ratings or operating results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">risks related to our indebtedness and continued availability of capital and financing and rating agency actions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general macroeconomic conditions and further deterioration or a protracted extension of current macroeconomic
challenges; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other business effects, including the effects of industry, market, economic or regulatory conditions; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the other factors that are described from time to time in Kellanova&#146;s periodic filings with the SEC,
including its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;30, 2023. See the section entitled &#147;Where You Can Find More Information&#148; for documents incorporated by reference into
this proxy statement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4"></A>THE PARTIES TO THE MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_5"></A>Kellanova </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova is a leader in global snacking, international cereal and noodles, and North America frozen foods with a legacy stretching back more
than 100 years. Powered by differentiated brands including Pringles<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, <FONT STYLE="white-space:nowrap">Cheez-It</FONT><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, <FONT
STYLE="white-space:nowrap">Pop-Tarts</FONT><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Kellogg&#146;s Rice Krispies Treats<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>,
RXBAR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Eggo<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, MorningStar Farms<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Special K<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Coco Pops<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, and more, Kellanova&#146;s vision is to become the world&#146;s best-performing
<FONT STYLE="white-space:nowrap">snacks-led</FONT> company, unleashing the full potential of our differentiated brands and our passionate people. Our net sales for 2023 were $13&nbsp;billion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A detailed description of Kellanova&#146;s business is contained in Kellanova&#146;s Annual Report filed on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;30, 2023, which is incorporated by reference into this proxy statement. See the section entitled &#147;Where You Can Find More Information&#148; beginning on page 122.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Common Stock is listed and traded on the NYSE under the ticker symbol &#147;K.&#148; Kellanova has its executive offices located at
412 N. Wells Street, Chicago, IL 60654. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_6"></A>Mars, Incorporated </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mars, Incorporated, a Delaware corporation, which we refer to as &#147;Mars,&#148; is a global, family-owned business, Mars employs over
150,000 associates. With more than $50&nbsp;billion in annual sales, Mars produces some of the most well-known brands including Ben&#146;s Original<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, CESAR<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Cocoavia<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, DOVE<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>,
EXTRA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, KIND<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, M&amp;M&#146;s<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, SNICKERS<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, PEDIGREE<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, ROYAL CANIN<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, and WHISKAS<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>. Mars has a global network of pet hospitals and diagnostic services &#150; including AniCura, BANFIELD<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, BLUEPEARL<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, Linnaeus and VCA<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> &#150; and it develops programs in genetic health screening and DNA testing. Mars has its executive offices located
at 1676 International Drive, Suite 1000, McLean, Virginia 22102. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_7"></A>Acquiror 10VB8, LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Acquiror 10VB8, LLC, which we refer to as Acquiror, is a Delaware limited liability company and a subsidiary of Mars. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_8"></A>Merger Sub 10VB8, LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Merger Sub 10VB8, LLC, which we refer to as Merger Sub, is a Delaware limited liability company and a wholly owned subsidiary of Acquiror that
was formed solely for the purpose of entering into the Merger Agreement and consummating the transactions contemplated by the Merger Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_9"></A>THE SPECIAL MEETING OF KELLANOVA&#146;S SHAREOWNERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_10"></A>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This
proxy statement is first being mailed on or about [&#9679;], 2024 and constitutes notice of the Special Meeting in conformity with the requirements of the DGCL and the Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This proxy statement is being provided to Kellanova shareowners as part of a solicitation of proxies by the Board for use at the Special
Meeting and at any adjournment or postponement of the Special Meeting. Kellanova shareowners are encouraged to read the entire document carefully, including the annexes to this document, for more detailed information regarding the Merger Agreement
and the transactions contemplated by the Merger Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_11"></A>Date, Time and Place </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Special Meeting will be held virtually on [&#9679;], 2024, at [&#9679;] [a.m./p.m.] Central Time. The Special Meeting can be accessed by
visiting www.virtualshareholdermeeting.com/K2024SM, where Kellanova shareowners will be able to participate and vote online. This proxy statement is first being furnished to Kellanova shareowners on or about [&#9679;], 2024. For purposes of
attendance at the Special Meeting, all references in the accompanying proxy statement to &#147;present in person,&#148; &#147;in person&#148; or &#147;attend&#148; will mean virtually present at or to attend virtually the Special Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_12"></A>Purpose of the Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Special Meeting, Kellanova shareowners will be asked to consider and vote on the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Merger Proposal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Advisory Compensation Proposal; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Adjournment Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova will transact no other business at the Special Meeting except such business as may properly be brought before the Special Meeting or
any adjournment or postponement thereof. This proxy statement, including the Merger Agreement attached hereto as Annex A, contains further information with respect to these matters. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_13"></A>Recommendation of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board has unanimously (i)&nbsp;determined that the Merger Agreement, the Merger and the other transactions contemplated by the Merger
Agreement are advisable and fair to, and in the best interests of, Kellanova and the Kellanova shareowners, (ii)&nbsp;approved, authorized, adopted and declared advisable the Merger Agreement, the Merger and the other transactions contemplated by
the Merger Agreement and (iii)&nbsp;resolved to recommend that the Kellanova shareowners vote in favor of the adoption of the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement. A description of factors
considered by the Board in reaching its decision to approve and declare advisable the foregoing proposals can be found in the section entitled &#147;The Merger&#151;Recommendation of the Board and Its Reasons for the Merger&#148; beginning on
page&nbsp;46. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>The Board unanimously recommends that Kellanova shareowners vote &#147;FOR&#148; the Merger Proposal, &#147;FOR&#148;
the Advisory Compensation Proposal and &#147;FOR&#148; the Adjournment Proposal at the Special Meeting.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova shareowners&#146; approval of Merger Proposal is a condition for the Merger to
occur. If Kellanova shareowners fail to approve the Merger Proposal by the requisite vote, the Merger will not occur. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_14"></A>Record Date; Shareowners Entitled to Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Only holders of record of outstanding shares of Common Stock as of the close of business on [&#9679;], 2024, the Record Date for the Special
Meeting, will be entitled to notice of, and to virtually vote at, the Special Meeting and any adjournment or postponement of the Special Meeting unless a new record date is fixed in connection with any adjournment or postponement of the Special
Meeting. At the close of business on the Record Date, [&#9679;] shares of Common Stock were issued and outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Holders of Common
Stock are entitled to one vote for each share of Common Stock they own at the close of business on the Record Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A list of the names
of shareowners entitled to vote at the Special Meeting will be available for a period of at least ten days prior to the Special Meeting. To arrange review of the list of shareowners for any purpose relevant to the Special Meeting, please contact
Investor Relations at (269) <FONT STYLE="white-space:nowrap">961-2800.</FONT> The shareowner list will also be available during the virtual Special Meeting for examination by shareowners at www.virtualshareholdermeeting.com/K2024SM. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_15"></A>Quorum; Adjournment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The presence at the Special Meeting of the holders of a majority of the outstanding shares of Common Stock entitled to vote thereon and present
in person or represented by proxy will constitute a quorum with respect to a proposal. As a result, with respect to any proposal, there must be a majority of all of our outstanding shares of Common Stock represented by proxy or by shareowners
present at the Special Meeting in order to have a quorum with respect to such proposal. Virtual attendance by Kellanova shareowners of record at the Special Meeting will constitute presence in person for the purpose of determining the presence of a
quorum for the transaction of business at the Special Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Abstentions are counted as present at the Special Meeting for purposes of
determining whether a quorum exists. If you provide voting instructions to your broker, bank, trust or other nominee on one or more of the proposals but not on one or more of the other proposals, then your shares will not be treated as present or
entitled to vote for the purposes of determining a quorum on any proposal for which you fail to provide instructions, and will not be voted on any such proposal, but will be treated as present and entitled to vote for the purposes of determining a
quorum, and will be voted on any proposal for which you provide instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Failure of a quorum to be represented at the Special
Meeting may result in an adjournment of the Special Meeting and may subject Kellanova to additional expense. Even if a quorum is present, the Special Meeting may also be adjourned one or more times in order to provide more time to solicit additional
proxies in favor of approval of the Merger Proposal if sufficient votes are cast in favor of the Adjournment Proposal. In addition, the Special Meeting may be postponed by the presiding chairman. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notice need not be given of any adjourned meeting if the time and place, if any, thereof and the means of remote communications, if any, by
which shareowners and proxy holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken unless the adjournment is for more than 30 days, in which case a notice of
the adjourned meeting will be given to each shareowner of record entitled to vote at the meeting. If, after any adjournment, a new record date for Kellanova shareowners entitled to vote is fixed for any adjourned meeting, the Board must fix a record
date for notice of any adjourned meeting in accordance with the DGCL and provide a new notice of any adjourned meeting to each shareowner of record entitled to vote at the meeting. In addition, the Special Meeting could be postponed before it
commences. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Special Meeting is adjourned or postponed one or more times for the purpose of
soliciting additional votes, Kellanova shareowners who have already submitted their proxies will be able to revoke them at any time prior to the final vote on the proposals. If you submit your proxy over the Internet or by telephone or submit a
properly executed proxy card, even if you abstain from voting, your shares will be counted as present for purposes of determining whether a quorum exists at the Special Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_16"></A>Required Vote </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Approval of
Merger Proposal </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The approval of the Merger Proposal requires the affirmative vote of the holders of a majority of the outstanding
shares of Common Stock entitled to vote as of the close of business on the Record Date. Accordingly, if a quorum is present in person or represented by proxy at the Special Meeting, shares deemed not in attendance at the Special Meeting (whether due
to a record holder&#146;s failure to vote or a &#147;street name&#148; holder&#146;s failure to provide any voting instructions to such holder&#146;s bank, broker or other nominee) and abstentions will have the same effect as a vote
&#147;<B>AGAINST</B>&#148; the Merger Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the Voting Agreements, each Voting Agreement Shareowner agreed, upon the
terms and subject to the conditions of its respective Voting Agreement, among other things, to vote all of the shares of Common Stock held by it in favor of the Merger Proposal at the Special Meeting. For more information, please see the section
entitled &#147;Voting Agreements.&#148; For more information regarding the security ownership of the Kellogg Foundation Trust, G. Zachary Gund Entities and Gund Trusts, please see the section entitled &#147;Certain Beneficial Owners of Common
Stock.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Approval of Advisory Compensation Proposal </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If a quorum is present at the Special Meeting, the approval of the Advisory Compensation Proposal, on an advisory, <FONT
STYLE="white-space:nowrap">non-binding</FONT> basis, requires the affirmative vote of a majority of shares of Common Stock present, in person or represented by proxy. Accordingly, shares deemed not in attendance at the Special Meeting (whether due
to a record holder&#146;s failure to vote or a &#147;street name&#148; holder&#146;s failure to provide any voting instructions to such holder&#146;s bank, broker or other nominee) will have no effect on the outcome of the Advisory Compensation
Proposal. Abstentions will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Advisory Compensation Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Approval of Adjournment
Proposal </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If a quorum is present at the Special Meeting, the approval of the Adjournment Proposal requires the affirmative vote of a
majority of shares of Common Stock present, in person or represented by proxy. Accordingly, shares deemed not in attendance at the Special Meeting (whether due to a record holder&#146;s failure to vote or a &#147;street name&#148; holder&#146;s
failure to provide any voting instructions to such holder&#146;s bank, broker or other nominee) will have no effect on the outcome of the Adjournment Proposal. Abstentions will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the
Adjournment Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger is conditioned on, among other things, the approval of the Merger Proposal at the Special Meeting. The
Advisory Compensation Proposal and the Adjournment Proposal are not conditioned on the approval of any other proposal set forth in this proxy statement and are not conditions to the consummation of the Merger. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_17"></A>Abstentions and Broker <FONT STYLE="white-space:nowrap">Non-Votes</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">An abstention occurs when a shareowner attends a meeting, either in person or by proxy, but abstains from voting. Abstentions will be treated
as present for purposes of determining the presence of a quorum. Abstaining from voting will have the same effect as voting &#147;<B>AGAINST</B>&#148; the Merger Proposal, the Advisory Compensation Proposal and the Adjournment Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If no instruction as to how to vote is given (including no instruction to abstain from
voting) in an executed, duly returned and not revoked proxy, the proxy will be voted in accordance with the Board&#146;s recommendation with respect to each proposal and consequently will be voted &#147;<B>FOR</B>&#148; each of (i)&nbsp;the Merger
Proposal, (ii)&nbsp;the Advisory Compensation Proposal, and (iii)&nbsp;the Adjournment Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Broker
<FONT STYLE="white-space:nowrap">non-votes</FONT> are shares held by a broker, bank, trust or other nominee that are present in person or represented by proxy and entitled to vote at the Special Meeting, but with respect to which the broker, bank or
other nominee is not instructed by the beneficial owner of such shares on how to vote on a particular proposal and the broker does not have discretionary voting power on such proposal. Because brokers, banks and other nominee holders of record do
not have discretionary voting authority with respect to any of the three proposals to be presented at the Special Meeting, if a beneficial owner of shares of the Company&#146;s Common Stock held in &#147;street name&#148; does not give voting
instructions to the broker, bank, trust or other nominee with respect to any of the proposals, then those shares will not be present in person or represented by proxy and entitled to vote at the Special Meeting. If you provide voting instructions to
your broker, bank, trust or other nominee on one or more of the proposals but not on one or more of the other proposals, then your shares will not be treated as present or entitled to vote for the purposes of determining a quorum on any proposal for
which you fail to provide instructions, and will not be voted on any such proposal, but will be treated as present and entitled to vote for the purposes of determining a quorum and will be voted on any proposal for which you provide instructions.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_18"></A>Failure to Vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If you are a Kellanova shareowner of record and you do not sign and return your proxy card or submit your proxy over the Internet, by telephone
or at the Special Meeting, your shares will not be voted at the Special Meeting, will not be counted as present in person or by proxy at the Special Meeting, and will not be counted as present for purposes of determining whether a quorum exists.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of the Merger Proposal, a failure of record owners to vote, or a failure of beneficial owners to instruct their bank,
broker, trust or other nominee to vote, will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Merger Proposal. A failure of record owners who are not present in person or represented by proxy at the Special Meeting to vote, or a failure
of beneficial owners to instruct their bank, broker, trust or other nominee to vote, will have no effect on the outcome of either of the Advisory Compensation Proposal or the Adjournment Proposal. All abstentions from voting will have the same
effect as a vote &#147;<B>AGAINST</B>&#148; the Merger Proposal, the Advisory Compensation Proposal and the Adjournment Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If you
are a Kellanova shareowner of record and you sign, date and return your proxy card and do not indicate how you want your shares of Common Stock to be voted, then your shares of Common Stock will be voted &#147;<B>FOR</B>&#148; the Merger Proposal,
&#147;<B>FOR</B>&#148; the Advisory Compensation Proposal, and &#147;<B>FOR</B>&#148; the Adjournment Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_19"></A>Voting by
Kellanova&#146;s Directors and Executive Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the close of business on September&nbsp;3, 2024, Kellanova&#146;s directors and
current executive officers and their affiliates, as a group, beneficially owned and were entitled to vote approximately 4,745,073 shares of Common Stock, collectively representing approximately 1.4% of the shares of Common Stock outstanding on that
date. Directors and executive officers of Kellanova have informed Kellanova that they intend to vote their shares in favor of the Merger Proposal, the Advisory Compensation Proposal and the Adjournment Proposal, although none of the directors and
executive officers are obligated to do so, except as noted below. As noted above, pursuant to the Voting Agreements, and subject to the terms and conditions thereof, each Voting Agreement Shareowner agreed, among other things, subject to the terms
and conditions of its respective Voting Agreement, to vote all of the shares of Common Stock held by it in favor of the Merger Proposal at the Special Meeting. For more information, please see the section entitled &#147;Voting Agreements.&#148; For
more information regarding the security ownership of the Kellogg Foundation Trust, G. Zachary Gund Entities and Gund Trusts, please see the section entitled &#147;Certain Beneficial Owners of Common Stock.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_20"></A>Voting at the Special Meeting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Special Meeting will be a completely virtual meeting. There will be no physical meeting location and the meeting will only be conducted via
live webcast. The virtual Special Meeting will be held on [&#9679;] at [&#9679;] [a.m./p.m.] Central Time. To participate in the Special Meeting and submit questions during the Special Meeting, visit www.virtualshareholdermeeting.com/K2024SM and
enter the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number on the proxy card, voting instruction form or notice you received. Online <FONT STYLE="white-space:nowrap">check-in</FONT> will begin at [&#9679;] [a.m./p.m.] Central Time.
Please allow time for online <FONT STYLE="white-space:nowrap">check-in</FONT> procedures. The virtual shareowner meeting format uses technology designed to increase shareowner access, save Kellanova and Kellanova shareowners time and money, and
provide Kellanova shareowners rights and opportunities to participate in the meeting similar to what they would have at an <FONT STYLE="white-space:nowrap">in-person</FONT> meeting. In addition to online attendance, Kellanova provides shareowners
with an opportunity to hear all portions of the official meeting, submit written questions and comments during the meeting, and vote online during the open poll portion of the meeting. Although Kellanova offers four different voting methods,
Kellanova encourages you to submit a proxy to vote either over the Internet or by telephone to ensure that your shares are represented and voted at the Special Meeting. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>To Submit a Proxy to Vote over the Internet or by Telephone:</I></B> You may submit your proxy by following
the instructions provided with your proxy materials and on your proxy card or voting instruction card. The telephone and Internet voting procedures have been set up for your convenience and have been designed to authenticate your identity, to allow
you to give voting instructions, and to confirm that those instructions have been recorded properly. If you choose to submit your vote via proxy over the Internet or by telephone, you must do so prior to 11:59 p.m. Eastern Time on [&#9679;],
[&#9679;]. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>To Submit a Proxy by Mail:</I></B> To submit a proxy to vote by mail, complete, sign and date the proxy
card and return it promptly to the address indicated on the proxy card in the postage-paid envelope provided. If you sign and return your proxy card without indicating how you want your shares of Common Stock to be voted with regard to a particular
proposal, your shares of Common Stock will be voted in favor of such proposal. If you return your proxy card without a signature, your shares will not be counted as present at the Special Meeting and cannot be voted. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>To Vote Virtually at the Special Meeting:</I></B> To vote virtually at the Special Meeting to be held on
[&#9679;] at [&#9679;] [a.m./p.m.] Central Time, visit www.virtualshareholdermeeting.com/K2024SM and enter the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number on the proxy card, voting instruction form or notice you received. Online <FONT
STYLE="white-space:nowrap">check-in</FONT> will begin at [&#9679;] [a.m./p.m.] Central Time, on [&#9679;]. If your shares are held by your bank, broker, trust or other nominee, you are considered the beneficial owner of shares held in &#147;street
name&#148; and you will receive a vote instruction form from your bank, broker, trust or other nominee seeking instruction from you as to how your shares should be voted. If you are a Kellanova shareowner of record and you sign your proxy, but do
not indicate how you wish to vote, your shares will be voted &#147;<B>FOR</B>&#148; the Merger Proposal, &#147;<B>FOR</B>&#148; the Advisory Compensation Proposal, and &#147;<B>FOR</B>&#148; the Adjournment Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_21"></A>Revocation of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">You can change or revoke your proxy at any time before the final vote at the Special Meeting. If you are the shareowner of record of your
shares, you may revoke your proxy by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submitting another proxy over the Internet or by telephone prior to the start of the Special Meeting or otherwise
timely delivering a valid, later-dated proxy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">timely delivering a written notice that you are revoking your proxy to Kellanova&#146;s Secretary; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">attending the Special Meeting and voting. Your virtual attendance at the Special Meeting will not revoke your
proxy unless you give written notice of revocation to Kellanova&#146;s Secretary before your proxy is exercised or unless you vote your shares in person at the Special Meeting. If you are the beneficial owner of shares held in &#147;street
name,&#148; you should contact your bank, broker, trust or other nominee with questions about how to change or revoke your voting instructions. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_22"></A>Solicitation of Proxies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board is soliciting your proxy in connection with the Special Meeting, and Kellanova will bear the cost of soliciting such proxies,
including the costs of printing and filing this proxy statement. Kellanova has retained D.F. King&nbsp;&amp; Co., Inc. as proxy solicitor to assist with the solicitation of proxies in connection with the Special Meeting. Kellanova estimates it will
pay D.F. King&nbsp;&amp; Co., Inc. a fee of approximately $25,000, in addition to the reimbursement of expenses, for these services. Solicitation initially will be made by mail. Forms of proxies and proxy materials may also be distributed through
banks, brokers and other nominees to the beneficial owners of shares of Common Stock, in which case these parties will be reimbursed for their reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses. Proxies may also be solicited in person or by telephone, facsimile, electronic mail, or other electronic medium by certain of Kellanova&#146;s directors, officers and employees, without additional compensation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_23"></A>Tabulation of Votes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Broadridge Financial Solutions, Inc. will tabulate the votes at the Special Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_24"></A>Householding of Special Meeting Materials </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each registered Kellanova shareowner will receive one copy of this proxy statement per account, regardless of whether you have the same address
as another shareowner of record. SEC rules permit companies and intermediaries such as brokers to satisfy delivery requirements for proxy statements and notices with respect to two or more shareowners sharing the same address by delivering a single
proxy statement or a single notice addressed to those shareowners. This process, commonly called &#147;householding,&#148; provides cost savings for companies. If you hold shares through a broker, some brokers household proxy materials, delivering a
single proxy statement or notice to multiple shareowners sharing an address unless contrary instructions have been received from the affected shareowners. Once you have received notice from your broker that it will be householding materials to your
address, householding will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement or notice, or if your
household is receiving multiple copies of these documents and you wish to request that future deliveries be limited to a single copy, please notify your broker. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova will promptly deliver, upon oral or written request, a separate copy of this proxy statement to any Kellanova shareowner residing at
an address to which only one copy was mailed. Requests for additional copies should be directed to the Investor Relations Department, Kellanova, P.O. Box 3599, Battle Creek, MI 49016-3599, or contact Investor Relations by telephone at (269) <FONT
STYLE="white-space:nowrap">961-2800</FONT> or by email at investor.relations@kellanova.com. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_25"></A>Questions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If you have more questions about the Merger or how to submit your proxy, or if you need additional copies of this proxy statement or the
enclosed proxy card or voting instructions, please contact the Investor Relations Department, Kellanova, P.O. Box 3599, Battle Creek, MI 49016-3599 or by email at investor.relations@kellanova.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_26"></A>Assistance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If
you need assistance voting or in completing your proxy card or have questions regarding the Special Meeting, please contact Kellanova&#146;s proxy solicitation agent: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D.F. King&nbsp;&amp; Co., Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48
Wall Street, 22nd Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">New York, NY 10005 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free: (800) <FONT STYLE="white-space:nowrap">791-3319</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: K@dfking.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_27"></A>THE MERGER (PROPOSAL 1) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>The discussion of the Merger and the Merger Agreement in this proxy statement is qualified in its entirety by reference to the complete
text of the Merger Agreement, which is attached to this proxy statement as Annex A. You should read the Merger Agreement carefully in its entirety. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_28"></A>Background of the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>The following chronology summarizes the key meetings and events that led to the signing of the Merger Agreement. The following chronology
does not purport to catalogue every conversation of, or among, the Board, representatives of Kellanova, Mars or their respective advisors and other parties. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board, together with Kellanova senior management, regularly reviews and assesses Kellanova&#146;s financial performance and long-term
strategic plans and objectives in light of developments in Kellanova&#146;s business, the industry in which it operates, and economic, market and industry conditions generally. These reviews and assessments have included, among other things,
consideration of various potential opportunities for dispositions, acquisitions, business combinations and separations with the goal of enhancing shareowner value. In June 2022, as a result of these regular reviews, Kellanova announced a plan to
separate its North American cereal business, via a <FONT STYLE="white-space:nowrap">tax-free</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> resulting in the creation of a new independent public company, which
<FONT STYLE="white-space:nowrap">spin-off</FONT> was completed in October 2023 (the &#147;Spin Transaction&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On May&nbsp;31, 2024,
at the unsolicited request of Mr.&nbsp;Poul Weihrauch, Chief Executive Officer of Mars, Mr.&nbsp;Steven Cahillane, Chairman, President and Chief Executive Officer of Kellanova, and Mr.&nbsp;Weihrauch met for lunch at the Chicago office of Skadden,
Arps, Slate, Meagher&nbsp;&amp; Flom LLP (&#147;Skadden&#148;), legal counsel to Mars. During this lunch, Mr.&nbsp;Weihrauch expressed Mars&#146; interest in a combination transaction with Kellanova and indicated that he would be sending a letter
shortly detailing Mars&#146; interest in Kellanova. Also on May&nbsp;31, 2024, following this meeting, Mr.&nbsp;Weihrauch, on behalf of Mars, sent Mr.&nbsp;Cahillane an unsolicited, <FONT STYLE="white-space:nowrap">non-binding</FONT> offer letter to
acquire all of the issued and outstanding shares of Common Stock for $77.00 per share in cash (the &#147;May Offer&#148;). The May Offer included a priority due diligence request list, requested a four-week timeline for Mars to complete its due
diligence review of Kellanova and indicated that certain banks had already reviewed Mars&#146; proposed acquisition and were prepared to provide fully committed financing for the proposed acquisition, subject to finalization of Mars&#146; due
diligence and other transaction terms. Mr.&nbsp;Cahillane indicated to Mr.&nbsp;Weihrauch that he would share the May Offer with the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&nbsp;5, 2024, the Board held a special meeting by videoconference. Members of Kellanova&#146;s senior management and representatives
of each of Goldman Sachs and Kirkland&nbsp;&amp; Ellis LLP (&#147;Kirkland&#148;), outside legal counsel to Kellanova, were also in attendance. At that meeting, Mr.&nbsp;Cahillane discussed with the Board the May Offer, which had been provided to
the Board in advance of the meeting. Also at that meeting, representatives of Goldman Sachs delivered a presentation that outlined the financial profile of Kellanova and Goldman Sachs&#146; preliminary financial analysis with respect to the May
Offer. Representatives of Kirkland then reviewed with the Board its fiduciary duties under Delaware law and discussed certain legal considerations for the Board in connection with a potential acquisition transaction, including, among other things,
the importance of confidentiality, guidance in responding to unsolicited acquisition inquiries and potential approaches to conducting a market check. Following discussion at the meeting, the Board determined to decline the May Offer because the
Board believed that it undervalued Kellanova and the Board believed that management of Kellanova would deliver on its strategic plan for fiscal years 2025 through 2027 (the &#147;Strategic Plan&#148;), which contained financial projections prepared
by Kellanova management which reflected the actual results of the first quarter of fiscal year 2024 and projections for the remainder of fiscal year 2024 and fiscal years 2025 through 2027 and was reviewed during the meeting, which would result in
greater value to Kellanova shareowners than the May Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&nbsp;6, 2024, Mr.&nbsp;Cahillane sent Mr.&nbsp;Weihrauch a letter
which indicated that the Board did not support the May Offer. This letter noted that the Board was confident in its ability to deliver results consistent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with Kellanova management&#146;s strategic plan and that doing so would result in a valuation for Kellanova in excess of the May Offer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&nbsp;10, 2024, Mr.&nbsp;Cahillane and Mr.&nbsp;Weihrauch met <FONT STYLE="white-space:nowrap">in-person</FONT> at the Chicago office
of Skadden to discuss the May Offer. Mr.&nbsp;Cahillane informed Mr.&nbsp;Weihrauch that the Board believed the May Offer undervalued Kellanova, that the Board was confident in Kellanova&#146;s future prospects as a standalone public company and
that the Board had decided to decline the May Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&nbsp;14, 2024, representatives of Citigroup Global Markets Inc.
(&#147;Citi&#148;), Mars&#146; financial advisor, and Goldman Sachs connected to discuss the May Offer. Goldman Sachs reiterated Kellanova&#146;s confidence in executing its strategic plan and indicated that the Company was not willing to provide
access to diligence based on the May Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&nbsp;21, 2024, Mr.&nbsp;Weihrauch sent Mr.&nbsp;Cahillane a revised <FONT
STYLE="white-space:nowrap">non-binding</FONT> offer letter (the &#147;June Offer&#148;). The June Offer reiterated Mars&#146; interest in acquiring Kellanova and increased Mars&#146; proposal to acquire Kellanova from $77.00 per share of Common
Stock in cash to $80.00 per share of Common Stock in cash. The June Offer did not include any new terms from the May Offer and again requested information regarding Kellanova for purposes of Mars&#146; due diligence. Mr.&nbsp;Cahillane indicated to
Mr.&nbsp;Weihrauch that he would share the June Offer with the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&nbsp;26, 2024, the Board held a special meeting by
videoconference. Members of Kellanova&#146;s senior management and representatives of each of Goldman Sachs and Kirkland were also in attendance. At that meeting, Mr.&nbsp;Cahillane discussed with the Board the June Offer, a copy of which had been
provided to the Board in advance of the meeting, and the increased valuation of $80.00 per share of Common Stock in cash. Also at that meeting, representatives from Goldman Sachs delivered a presentation that outlined, among other things, Goldman
Sachs&#146; preliminary financial analysis of the June Offer. After discussion at that meeting, the Board determined that the June Offer&#146;s increased valuation of $80.00 per share of Common Stock in cash still undervalued Kellanova. The Board
reaffirmed its confidence that Kellanova&#146;s management would be able to deliver business results consistent with the Strategic Plan and that the value created on a standalone basis would exceed the proposal in the June Offer. However, the Board
authorized Kellanova&#146;s management to provide Mars with limited financial due diligence information in order to enable Mars to increase its proposal to acquire Kellanova, including the Strategic Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On June&nbsp;28, 2024, Mr.&nbsp;Cahillane sent Mr.&nbsp;Weihrauch a letter which indicated that the Board did not support the June Offer. This
letter also informed Mr.&nbsp;Weihrauch of the Board&#146;s decision to provide Mars with limited financial due diligence information and provided further detail on the reasons the Board did not support the June Offer, which related in part to
Mars&#146; valuation methodology and related use of certain financial metrics in arriving at the June Offer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on June&nbsp;28, 2024,
representatives of Citi and Goldman Sachs connected to discuss Kellanova&#146;s response to the June Offer and next steps, including access to diligence and potential management discussions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on June&nbsp;28, 2024, at the direction of Kellanova management, representatives of Goldman Sachs sent representatives of Citi a draft
confidentiality agreement. On July&nbsp;4, 2024, Kellanova entered into the confidentiality agreement with Mars, which contained customary nondisclosure and nonuse provisions, as well as a customary standstill provision containing standard fall-away
rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On July&nbsp;6, 2024, Mars and its advisors were provided with access to a virtual data room containing limited financial due
diligence information regarding Kellanova, including the Strategic Plan. Thereafter and through the date of the Merger Agreement, Mars engaged in an extensive review of the virtual data room. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On July&nbsp;16, 2024, Kellanova management contacted representatives of Lazard and informed Lazard of Mars&#146; interest in a strategic
transaction with Kellanova. Kellanova management requested that representatives of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Lazard attend the next regularly scheduled board meeting, during which the Board, Kellanova management and representatives of each of Goldman Sachs and Kirkland intended to discuss the potential
transaction with Mars. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On July&nbsp;17, 2024, the Board formally engaged Goldman Sachs as Kellanova&#146;s financial advisor in
connection with a potential acquisition transaction. The Board selected Goldman Sachs as its financial advisor based on Goldman Sachs&#146; qualifications, expertise and reputation and its familiarity and knowledge of Kellanova&#146;s business and
affairs, including acting as financial advisor in connection with the Spin Transaction, and the industries in which it operates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On
July&nbsp;22, 2024, representatives of each of Goldman Sachs and Citi and members of Kellanova&#146;s senior management and Mars&#146; senior management held a meeting at the New York offices of Skadden to discuss Kellanova&#146;s business,
financials and performance and various aspects of Kellanova&#146;s Strategic Plan, including, among other topics, the growth drivers for Kellanova&#146;s businesses by region, the key levers of margin expansion by region and the components of gross
margin expansion, Kellanova&#146;s capital investment plans and other diligence topics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On July&nbsp;23, 2024, Mr.&nbsp;Weihrauch sent
Mr.&nbsp;Cahillane a revised <FONT STYLE="white-space:nowrap">non-binding</FONT> offer letter (the &#147;July 23 Offer&#148;). The July&nbsp;23 Offer reiterated Mars&#146; interest in acquiring Kellanova and increased Mars&#146; proposal to acquire
Kellanova from $80.00 per share of Common Stock in cash to $82.00 per share of Common Stock in cash. Attached to the July&nbsp;23 Offer was an initial draft of the Merger Agreement. The initial draft of the Merger Agreement contemplated, among other
things, that the Gund family and the Kellogg Foundation Trust would enter into voting agreements concurrently with Kellanova&#146;s and Mars&#146; entry into the Merger Agreement, a reverse termination fee in an amount to be determined, payable by
Mars in certain circumstances, a termination fee in an amount to be determined, payable by Kellanova in certain circumstances, an outside date of 12 months from signing, subject to one automatic <FONT STYLE="white-space:nowrap">six-month</FONT>
extension to obtain required regulatory approvals, a regulatory efforts covenant requiring both Kellanova and Mars to use their reasonable best efforts to obtain required regulatory approvals, subject to a &#147;Burdensome Condition&#148; standard
(which, among other things, would not require Mars to divest Kellanova assets that generated more than a to be determined amount of revenue in the <FONT STYLE="white-space:nowrap">12-month</FONT> period ending as of December&nbsp;31, 2023,
applicable to such regulatory efforts), that Kellanova would be restricted from declaring or paying any dividend on its Common Stock and a <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision that prohibited Kellanova from soliciting
or participating in discussions with third parties regarding takeover proposals, subject to certain customary exceptions for potential superior proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On July&nbsp;24, 2024, Goldman Sachs delivered a relationship disclosure letter, which was dated as of July&nbsp;24, 2024, to members of
Kellanova&#146;s senior management, who then submitted the relationship disclosure letter to the Board on July&nbsp;25, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On
July&nbsp;25, 2024, the Board held a regularly scheduled Board meeting, with members of Kellanova&#146;s senior management and representatives of each of Goldman Sachs, Kirkland and Lazard in attendance. At that meeting, representatives from Goldman
Sachs delivered a presentation to the Board that, among other things, summarized the offer history in selected precedent transactions, provided an illustrative analysis of the ability of other potential strategic acquirors to provide Kellanova with
an offer exceeding the July&nbsp;23 Offer, and outlined Goldman Sachs&#146; preliminary financial analysis of the July&nbsp;23 Offer based on the financial projections contained in the Strategic Plan, which had been updated by Kellanova management
to reflect the actual results of the first and second quarters of fiscal year 2024 and projections for the remainder of fiscal year 2024 and fiscal years 2025 through 2027 (the &#147;Financial Projections&#148;). The Strategic Plan was provided to
the Board in advance of the meeting. The Board, Kellanova management and representatives of Goldman Sachs discussed in detail the Financial Projections in the Strategic Plan (for additional information with respect to the financial projections, see
the section of this proxy statement entitled &#147;The Merger&#151;Certain Unaudited Forecasted Financial Information&#148;). Also at that meeting, representatives of Kirkland provided an overview of potential approaches to a market check, as well
as a detailed discussion of key terms and conditions in the initial draft of the Merger Agreement provided by Mars, including the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision, efforts to obtain regulatory approvals, the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
circumstances in which Kellanova would be required to pay a termination fee to Mars, the circumstances in which Mars would be required to pay a reverse termination fee to Kellanova, the treatment
of Kellanova&#146;s employees, including with respect to outstanding Kellanova equity awards and covenants regarding employee benefits, and the voting agreements contemplated in the initial draft of the Merger Agreement that the Gund family and the
Kellogg Foundation Trust would enter into concurrently with Kellanova&#146;s and Mars&#146; entry into the Merger Agreement. Following discussion at that meeting, the Board determined that it did not support the July&nbsp;23 Offer because it still
undervalued Kellanova, but that the Board may be receptive to discussing a potential transaction at an increased valuation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On
July&nbsp;26, 2024, the Board continued its regularly scheduled meeting. Members of Kellanova&#146;s senior management and representatives of each of Goldman Sachs, Kirkland and Lazard were also in attendance. At that meeting, the Board further
discussed the July&nbsp;23 Offer, potential responses to Mars and the potential timeline for the proposed transaction. Also at that meeting, the Board discussed with Kellanova&#146;s senior management and representatives of each of Goldman Sachs,
Kirkland and Lazard the other potential counterparties that may be interested in pursuing a transaction to acquire Kellanova, the risks and benefits of conducting an outreach to potential counterparties, the likelihood that other potential
counterparties could provide an offer that would be superior to the value likely to be obtained from Mars and the risks and uncertainties that each of those potential counterparties might face in pursuing an acquisition of Kellanova, including,
among other things, in seeking regulatory approvals. The representatives of each of Kirkland and Goldman Sachs and the Board also discussed the possibility of an interloper emerging following execution of a transaction with Mars, the ability of the
Board to engage with such an interloper if Kellanova were to pursue an acquisition transaction with Mars and the risk of Mars terminating its offer and discussions with Kellanova if Kellanova were to engage in discussions with other potential
acquirors. Following discussion at that meeting, the Board determined that Kellanova should not contact other potential counterparties at such time and authorized Mr.&nbsp;Cahillane to convey the Board&#146;s determination not to support the
July&nbsp;23 Offer to Mr.&nbsp;Weihrauch and to make a request to Mr.&nbsp;Weihrauch that Mars increase the valuation of Kellanova from its July&nbsp;23 Offer, and to indicate that, if Mars provided a valuation closer to $85.00, Kellanova would be
willing to engage in negotiations with Mars for an acquisition transaction reflecting such increased valuation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Later on July&nbsp;26,
2024, Mr.&nbsp;Cahillane called Mr.&nbsp;Weihrauch to convey that the Board did not support the July&nbsp;23 Offer, but that the Board would be willing to consider pursuing an acquisition transaction at a valuation closer to $85.00 per share of
Common Stock in cash. Mr.&nbsp;Weihrauch told Mr.&nbsp;Cahillane that Mars would not provide an offer at $85.00 per share, and that Mars would terminate its discussions with Kellanova regarding the potential acquisition transaction and pursue other
strategic alternatives that Mars had already identified rather than transact at that valuation. Mr.&nbsp;Weihrauch indicated that he would discuss this matter further with the broader Mars team. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On July&nbsp;30, 2024, Mr.&nbsp;Weihrauch called Mr.&nbsp;Cahillane and verbally offered, on behalf of Mars, to acquire all of the issued and
outstanding shares of Kellanova for $83.50 per share in cash (the &#147;July 30 Offer&#148;). Also on July&nbsp;30, 2024, Mr.&nbsp;Cahillane called Mr.&nbsp;Weihrauch and confirmed that the Board would proceed on the basis of the July&nbsp;30 Offer,
subject to negotiation of a definitive agreement and final approval by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Later on July&nbsp;30, 2024, representatives of
Kirkland sent Skadden an initial draft of a separate &#147;clean team&#148; agreement, pursuant to which it was agreed that certain information of Kellanova would only be shared with a specified subset of the representatives of Mars and under
supervision of outside legal counsel. Kellanova and Mars executed the clean team agreement on August&nbsp;3, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On July&nbsp;31, 2024,
representatives of each of Kirkland and Skadden held a virtual meeting to discuss, among other things, the scope and requirements of Mars&#146; remaining due diligence investigation. Representatives of Citi sent Goldman Sachs a list of due diligence
information requests. From July&nbsp;31, 2024 through the date of the Merger Agreement, Mars and its advisors were provided with additional due diligence information regarding Kellanova in the virtual data room. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on July&nbsp;31, 2024, representatives of Skadden sent Kirkland an initial draft of the
voting agreement to be entered into by the Gund family and the Kellogg Foundation Trust concurrently with Kellanova&#146;s and Mars&#146; entry into the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;2, 2024, following discussions with Kellanova&#146;s management, as authorized by Mr.&nbsp;Cahillane, on key provisions and
issues in the initial draft Merger Agreement, representatives of Kirkland sent Skadden a revised draft of the Merger Agreement which, among other things, contemplated that a monthly ticking fee would be payable by Mars in the event that the proposed
transaction did not close by the end of 2024, that Kellanova would be permitted to declare and pay regular quarterly cash dividends on its Common Stock, that a lower termination fee would be payable by Kellanova if Kellanova were to terminate the
Merger Agreement to accept a superior proposal within thirty days of the execution of the Merger Agreement, provided specific deadlines by which both Mars and Kellanova would need to make any regulatory filings and proposed that Mars and Kellanova
would jointly control the strategy and decision making with respect to obtaining required regulatory approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;3, 2024,
representatives of Lazard submitted a relationship disclosure letter, which was dated as of August&nbsp;3, 2024, to representatives of Kirkland, who shared the relationship disclosure letter with Kellanova on August&nbsp;3, 2024, who then
subsequently submitted the relationship disclosure letter to the Board on August&nbsp;13, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;4, 2024, the Board
formally engaged Lazard as Kellanova&#146;s financial advisor, in addition to Goldman Sachs, in connection with a potential acquisition transaction. The Board selected Lazard as its financial advisor based on Lazard&#146;s qualifications, expertise
and reputation and its familiarity with and knowledge of the industries in which Kellanova operates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;4, 2024, Reuters
published an article reporting that Mars was exploring a potential acquisition of Kellanova (the &#147;August 4 Reuters Article&#148;). The August&nbsp;4 Reuters Article did not speculate on the consideration to be paid to holders of Common Stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;5, 2024, representatives of Skadden sent Kirkland a revised draft of the Merger Agreement which, among other things,
removed each of the monthly ticking fee, the <FONT STYLE="white-space:nowrap">two-tier</FONT> termination fee, the specific deadlines by which filings would need to be made for required regulatory approvals and the joint control over strategy and
decision making with respect to obtaining required regulatory approval proposed in Kirkland&#146;s August&nbsp;2 draft, and proposed that Mars would have sole control over the strategy and decision making with respect to obtaining required
regulatory approvals and a $900&nbsp;million termination fee payable by Kellanova in certain circumstances and a $900&nbsp;million termination fee payable by Mars in certain circumstances if regulatory approvals for the transaction are not received.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Between August&nbsp;5, 2024 and August&nbsp;9, 2024, a representative of Mars conducted <FONT STYLE="white-space:nowrap">in-person</FONT>
site visits at Kellanova&#146;s facilities in Battle Creek, Michigan, Wyoming, Michigan, Grand Rapids, Michigan, Jackson, Tennessee, Kutno, Poland, and Wrexham, United Kingdom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Between August&nbsp;6, 2024 and August&nbsp;8, 2024, representatives of Mars and its advisors participated in numerous diligence calls with
members of Kellanova&#146;s management and its advisors regarding business, tax, intellectual property, labor and employee and general legal matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;6, 2024, the members of the Board&#146;s Compensation and Talent Management Committee (the &#147;Compensation and Talent
Management Committee&#148;) held a special meeting by videoconference to discuss compensation related matters in connection with the potential transaction with Mars, with members of Kellanova senior management and representatives of Kirkland in
attendance. The Compensation and Talent Management Committee provided guidance to the representatives of Kirkland on the various employee matters issues in the draft Merger Agreement and instructed Kellanova&#146;s management and Kirkland to
continue negotiating such terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;7, 2024, representatives of Kirkland sent Cleary Gottlieb Steen&nbsp;&amp;
Hamilton LLP, counsel to the Kellogg Foundation Trust, the initial draft of the voting agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;8, 2024, following
discussions with Kellanova&#146;s management on key issues raised in Skadden&#146;s August&nbsp;5 draft of the Merger Agreement, representatives of Kirkland sent Skadden a revised draft of the Merger Agreement which, among other things, reinserted
each of the monthly ticking fee, the specific deadlines by which filings would need to be made for required regulatory approvals, and joint control over strategy and decision making with respect to obtaining required regulatory approvals and
proposed a $600&nbsp;million termination fee payable by Kellanova in certain circumstances and a $1.5&nbsp;billion reverse termination fee payable by Mars in certain circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;8, 2024, Mr.&nbsp;Cahillane received an unsolicited call from the Chief Executive Officer of Party A, informing
Mr.&nbsp;Cahillane that Party A was interested in pursuing an acquisition transaction with Kellanova. Mr.&nbsp;Cahillane informed the Chief Executive Officer of Party A that Party A should submit any offer it proposed to make to the Board as soon as
possible. The Chief Executive Officer of Party A informed Mr.&nbsp;Cahillane that he would need to convene the board of directors of Party A and that he understood the timing. The Chief Executive Officer of Party A did not provide any further
details on the potential acquisition transaction between Party A and Kellanova at that time and did not provide any indication of Party A&#146;s views as to the value of Kellanova. On the same date, Mr.&nbsp;Cahillane informed the Board of the
unsolicited call from Party A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;8, 2024, representatives of Goldman Sachs received an unsolicited call from a member
of senior management of Party B. The member of senior management of Party B indicated that Party B was interested in pursuing a strategic transaction with respect to certain parts of Kellanova&#146;s business, but that it would not be interested in
pursuing a transaction to acquire Kellanova at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;8, 2024, representatives of Goldman Sachs received an
unsolicited call from the President and Chief Executive Officer of Party C. The President and Chief Executive Officer of Party C expressed interest in Party C pursuing a strategic transaction with Kellanova, but that Party C would not be interested
in pursuing an acquisition of the entirety of Kellanova. The President and Chief Executive Officer of Party C expressed interest in acquiring portions of Kellanova&#146;s business in the event that Kellanova needed to divest assets in order to
complete an acquisition transaction for the entirety of Kellanova&#146;s business with another counterparty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On the same date,
representatives of Goldman Sachs informed the Board of the unsolicited calls from Party B and Party C. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;9, 2024,
Mr.&nbsp;Cahillane and Mr.&nbsp;Weihrauch had a telephone conversation regarding the status of negotiations between the parties. In the course of this conversation, Mr.&nbsp;Cahillane informed Mr.&nbsp;Weihrauch that Kellanova had received inbound
interest from another party potentially interested in exploring an acquisition of Kellanova. Later that day, representatives of Citi called representatives of Goldman Sachs and further discussed the inbound interest received by Kellanova regarding
an acquisition transaction following the August&nbsp;4 Reuters Article. The representatives of Citi indicated to representatives of Goldman Sachs that Mars would terminate negotiations of the potential transaction with Kellanova if Mars determined
that such negotiations had slowed down as a result of Kellanova engaging with other potential acquirors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;9, 2024,
representatives of Skadden sent Kirkland a revised draft of the Merger Agreement. The draft, among other things, removed the monthly ticking fee, included a proposal that Mars would not be required to undertake divestitures of Kellanova assets that
generated more than $500&nbsp;million of revenue in the <FONT STYLE="white-space:nowrap">12-month</FONT> period ending as of December&nbsp;31, 2023, provided that Mars would have sole control over strategy and decision making with respect to
obtaining required regulatory approvals, and did not provide a proposal on the amount of the termination fee to be paid by Kellanova in certain circumstances or the reverse termination to be paid by Mars in certain circumstances. On August&nbsp;10,
2024, representatives of Skadden conveyed that Mars&#146; position </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
was that the termination fee to be paid by Kellanova in certain circumstances would be $900&nbsp;million and that the reverse termination fee to be paid by Mars in certain circumstances would be
$1.1&nbsp;billion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;9, 2024, representatives of Kirkland sent Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.,
counsel to certain entities and trusts affiliated with the Gund family, the initial draft of the voting agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August 9,
2024, representatives of Simpson Thacher &amp; Bartlett LLP (&#147;Simpson Thacher&#148;), debt financing counsel to Mars, sent Kirkland an initial draft of the Debt Commitment Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;10, 2024, the Board held a special meeting by videoconference to discuss the status of negotiations with Mars. Representatives
of each of Goldman Sachs, Kirkland and Lazard were also in attendance. At that meeting, the Board discussed the unsolicited outreach from Party A, Party B and Party C and determined that none of Party A, Party B or Party C would be reasonably likely
or able to pursue an acquisition transaction with Kellanova at a valuation greater than the valuation offered by Mars and that any such acquisition transaction would likely involve greater regulatory uncertainty than an acquisition transaction with
Mars. Also at that meeting, representatives of Kirkland delivered a presentation reviewing the Board&#146;s duties and responsibilities in connection with the potential transaction with Mars, including, among other things, the fiduciary duties owed
by the Board under Delaware law and other legal considerations and obligations applicable in acquisition transactions involving public companies. Also at that meeting, representatives of Kirkland delivered a comprehensive presentation on the status
of the draft Merger Agreement, including on key provisions such as the regulatory efforts covenant and the details of the &#147;Burdensome Condition&#148; standard applicable to such regulatory efforts, the proposed outside date for the potential
transaction, the termination fees payable by Mars or Kellanova in the various circumstances in which the Merger Agreement could be terminated, the instances in which Kellanova could terminate the Merger Agreement in response to an unsolicited
superior proposal from another potential acquiror, the conditions to closing of the Merger, and employee matters, including the treatment of Kellanova&#146;s equity awards and retention of key Kellanova employees. Following discussion regarding the
open points in the Merger Agreement, the Board instructed management and Kellanova&#146;s advisors to convey to Mars and its advisors the Board&#146;s positions on these remaining issues, including that the Board believed a ticking fee was
appropriate if closing did not occur in 2024, that Mars&#146; obligation to divest Kellanova assets should be subject to a $750&nbsp;million cap, that the termination fee to be paid by Kellanova in certain circumstances should be $750&nbsp;million
and that the reverse termination fee to be paid by Mars in certain circumstances should be $1.3&nbsp;billion. Also at that meeting, representatives of Goldman Sachs reviewed with the Board Goldman Sachs&#146;s preliminary financial analysis of
Kellanova. Also at that meeting, representatives of Lazard reviewed with the Board Lazard&#146;s preliminary financial analysis of Kellanova. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Between August&nbsp;10, 2024 and August&nbsp;11, 2024, representatives of Kirkland and members of Kellanova&#146;s management held several
calls to discuss key open issues in Skadden&#146;s August&nbsp;9 draft of the Merger Agreement and Kellanova&#146;s responses to such key issues. Following such discussions, on August&nbsp;11, 2024, representatives of Kirkland sent representatives
of Skadden a revised draft of the Merger Agreement. The revised draft of the Merger Agreement contemplated, among other things, (i)&nbsp;a monthly ticking fee payable in addition to the $83.50 per share of Common Stock for each month that elapsed
after December&nbsp;31, 2024 in which the closing of the Merger had not occurred, (ii)&nbsp;specific deadlines by which any required filings for any required regulatory approvals must be made, (iii)&nbsp;with respect to the &#147;Burdensome
Condition&#148; standard, that Mars would not be required to divest Kellanova assets that generated more than $750&nbsp;million of revenue in <FONT STYLE="white-space:nowrap">12-month</FONT> period ending as of December&nbsp;31, 2023, (iv) a
$750&nbsp;million termination fee payable by Kellanova upon termination of the Merger Agreement in certain circumstances and a $1.3&nbsp;billion reverse termination fee payable by Mars upon termination of the Merger Agreement in certain
circumstances and (v)&nbsp;the treatment of Kellanova&#146;s existing equity awards and changes to covenants providing for the maintenance of Kellanova employee benefits following the closing of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;11, 2024, the Chief Executive Officer of Party A sent an <FONT STYLE="white-space:nowrap">e-mail</FONT> to
Mr.&nbsp;Cahillane indicating that Party A would not be able to meet the timeline that Mr.&nbsp;Cahillane expressed during the August&nbsp;8 call. The Chief Executive Officer of Party A indicated that Party A would be able to offer a compelling
proposal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and requested access to due diligence information and additional time to convene Party A&#146;s board of directors in order to submit a formal proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;11, 2024, Mr.&nbsp;Weihrauch called Mr.&nbsp;Cahillane and inquired about Mr.&nbsp;Cahillane&#146;s discussions with Party
A with respect to a potential acquisition transaction. Mr.&nbsp;Cahillane informed Mr.&nbsp;Weihrauch that the Chief Executive Officer of Party A asked for additional time to submit a formal proposal and that in response to this request,
Mr.&nbsp;Cahillane told the Chief Executive Officer of Party A that it would need to proceed on an expedited timeline if Party A desired to pursue an acquisition transaction with Kellanova. Mr.&nbsp;Cahillane reiterated Kellanova&#146;s interest in
pursuing an acquisition transaction with Mars and indicated that Kellanova&#146;s advisors had relayed all of the Board&#146;s key issues with the Merger Agreement to Mars&#146; advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;11, 2024, representatives of Skadden sent Kirkland a revised draft of the Merger Agreement. Among other things, the
revised draft of the Merger Agreement (i)&nbsp;removed the monthly ticking fee proposed in Kirkland&#146;s August&nbsp;11 draft of the Merger Agreement, (ii)&nbsp;removed the specific deadlines by which any required filings for any required
regulatory approvals must be made as proposed in Kirkland&#146;s August&nbsp;11 draft, (iii)&nbsp;accepted the &#147;Burdensome Condition&#148; divestiture cap proposed in Kirkland&#146;s August&nbsp;11 draft, (iv)&nbsp;proposed an $850&nbsp;million
termination fee payable by Kellanova upon termination of the Merger Agreement in certain circumstances and a $1.2&nbsp;billion reverse termination fee payable by Mars upon termination of the Merger Agreement in certain circumstances,
(v)&nbsp;rejected the treatment of certain Kellanova equity awards as set forth in Kirkland&#146;s August&nbsp;11 draft and (vi)&nbsp;accepted most of the changes to certain covenants relating to employee benefits and compensation following the
closing of the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;11, 2024, representatives of Simpson Thacher sent Kirkland a revised draft of the Debt
Commitment Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;12, 2024, representatives of each of Goldman Sachs and Kirkland and members of senior management of
Kellanova held a virtual meeting to discuss Skadden&#146;s August&nbsp;11 draft of the Merger Agreement and the key open items in the draft Merger Agreement as well as Kellanova&#146;s responses to the key open items. Following this discussion, on
August&nbsp;12, 2024, representatives of Kirkland sent Skadden an <FONT STYLE="white-space:nowrap">e-mail</FONT> outlining Kellanova&#146;s proposals on the remaining key open items in the Merger Agreement. This proposal (i)&nbsp;included a monthly
ticking fee of $0.14 payable in addition to the $83.50 per share of Common Stock for each month that elapses after March&nbsp;31, 2025 in which the closing of the Merger has not occurred, (ii)&nbsp;included an $800&nbsp;million termination fee
payable by Kellanova upon termination of the Merger Agreement in certain circumstances, (iii)&nbsp;included a $1.25&nbsp;billion reverse termination fee payable by Mars upon termination of the Merger Agreement in certain circumstances,
(iv)&nbsp;accepted Mars&#146; proposed treatment of certain Kellanova equity awards as set forth in Skadden&#146;s August&nbsp;11 draft of the Merger Agreement and (v)&nbsp;proposed the changes to covenants relating to employee benefits and
compensation following the closing of the Merger that Skadden did not accept in Skadden&#146;s August&nbsp;11 draft of the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;12, 2024, representatives of Goldman Sachs communicated Kellanova&#146;s proposal to Citi by <FONT
STYLE="white-space:nowrap">e-mail.</FONT> Representatives of Citi indicated to Goldman Sachs that Kellanova&#146;s proposal had been conveyed to Mars&#146; board of directors during a meeting of Mars&#146; board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;12, 2024, representatives of Skadden sent Kirkland a counterproposal on the key open items in the draft Merger Agreement.
This proposal, among other things, (i)&nbsp;rejected the monthly ticking fee proposed in Kellanova&#146;s August&nbsp;12 proposal, (ii)&nbsp;accepted the $800&nbsp;million termination fee payable by Kellanova upon termination of the Merger Agreement
in certain circumstances, and (iii)&nbsp;accepted the $1.25&nbsp;billion reverse termination fee payable by Mars upon termination of the Merger Agreement in certain circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;12, 2024, Mr.&nbsp;Cahillane called Mr.&nbsp;Weihrauch to discuss the remaining open points in the draft Merger Agreement.
Mr.&nbsp;Weihrauch indicated to Mr.&nbsp;Cahillane that Mars would not accept any form of a ticking fee. Thereafter, on August&nbsp;12, 2024, Mr.&nbsp;Cahillane, representatives of each of Goldman Sachs and Kirkland and members of the senior
management of Kellanova held a virtual meeting to discuss Mr.&nbsp;Cahillane&#146;s earlier call with Mr.&nbsp;Weihrauch on the key open points in the draft Merger Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;12, 2024, representatives of Skadden sent Kirkland a revised
counterproposal. The counterproposal continued to reject the monthly ticking fee and accepted several of the remaining open employee-related matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August 12, 2024, representatives of Simpson Thacher sent Kirkland a revised draft of the Debt Commitment Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On August&nbsp;13, 2024, Mr.&nbsp;Cahillane, representatives of each of Goldman Sachs and Kirkland, and members of the senior management of
Kellanova held a virtual meeting to discuss Mars&#146; August&nbsp;12 revised counterproposal on the key open points in the draft Merger Agreement. Mr.&nbsp;Cahillane noted that, based on his discussion with Mr.&nbsp;Weihrauch, Mars would not be
willing to accept any form of a ticking fee and that Mr.&nbsp;Cahillane believed that the terms of Mars&#146; August&nbsp;12 revised counterproposal were &#147;best and final&#148;. Following discussion, Mr.&nbsp;Cahillane authorized Kirkland to
finalize the Merger Agreement with Skadden. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;13, 2024, representatives of Skadden and representatives of Kirkland held
a virtual meeting to negotiate and finalize the open points in the draft Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August 13, 2024, representatives of
Simpson Thacher sent Kirkland a revised draft of the Debt Commitment Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on August&nbsp;13, 2024, representatives of Kirkland
sent representatives of Skadden a revised draft of the Merger Agreement following Kirkland&#146;s discussions with Mr.&nbsp;Cahillane and members of senior management of Kellanova. The revised draft of the Merger Agreement removed the ticking fee
and accepted the remaining open employee-related matters as contemplated in Mars&#146; August&nbsp;12 revised counterproposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also on
August&nbsp;13, 2024, the Board held a special meeting by videoconference. Members of Kellanova&#146;s senior management and representatives of each of Goldman Sachs, Kirkland and Lazard were also in attendance. The proposed final form of the Merger
Agreement was provided to the Board in advance of the meeting. At that meeting, Mr.&nbsp;Cahillane provided an update to the Board on his discussions with the Chief Executive Officer of Party A, and discussed, among other things, the risk of waiting
for Party A to submit a proposal to acquire Kellanova given the message relayed by representatives of Citi to Goldman Sachs that Mars would terminate negotiations if Mars determined that Kellanova had slowed negotiations to engage other potential
acquirors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also at that meeting, representatives of Kirkland provided an update on the final terms of the Merger Agreement, including a
comprehensive review of the resolution of key open items, including, among other things, the removal of the proposed monthly ticking fee, the $800&nbsp;million termination fee payable by Kellanova in certain circumstances, the $1.25&nbsp;billion
reverse termination fee payable by Mars in certain circumstances, the conditions to closing, and various employee matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also at that
meeting, representatives of Goldman Sachs reviewed with the Board its financial analysis of the Merger Consideration, and rendered its opinion to the Board to the effect that, as of August&nbsp;13, 2024, and based upon and subject to the
assumptions, limitations, qualifications and other matters considered as described in its opinion, the Merger Consideration to be paid to the holders of shares of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned
by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects with,
Section&nbsp;262 of the DGCL) pursuant to the Merger Agreement was fair from a financial point of view to such holders. Goldman Sachs&#146; opinion is more fully described in the section of this proxy statement entitled &#147;The
Merger&#151;Opinions of Financial Advisors to Kellanova&#151;Opinion of Goldman Sachs&nbsp;&amp; Co. LLC.&#148; Also at that meeting, representatives of Lazard reviewed with the Board its financial analysis of the Merger Consideration, and rendered
its opinion to the Board to the effect that, as of August&nbsp;13, 2024, and based on and subject to the various assumptions made, procedures followed, matters considered and qualifications and limitations on the review undertaken by Lazard in
connection with its opinion, the Merger Consideration to be paid to the holders of shares of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects
with, Section 262 of the DGCL) in the Merger was fair, from a financial point of view, to such holders. Lazard&#146;s opinion is more fully described in the section of this proxy statement entitled &#147;The Merger&#151;Opinions of Financial
Advisors to Kellanova&#151;Opinion of Lazard Fr&egrave;res&nbsp;&amp; Co. LLC.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Also at that meeting, following discussion and
consideration of the Merger Agreement and the other transactions contemplated by the Merger Agreement (including the factors described in the section entitled &#147;The Merger<I>&#151;</I>Recommendation of the Board and Its Reasons for the
Merger&#148;), the members of the Board unanimously: (i)&nbsp;determined that the terms of the Merger Agreement and the transactions contemplated thereby, including the Merger, are fair to, and in the best interests of, Kellanova and Kellanova
shareowners; (ii)&nbsp;determined that it is in the best interests of Kellanova and Kellanova shareowners, and declared it advisable, to enter into the Merger Agreement providing for the Merger, upon the terms and subject to the conditions set forth
therein and in accordance with the applicable provisions of the DGCL; (iii)&nbsp;approved the execution and delivery of the Merger Agreement, the performance of Kellanova&#146;s covenants and other obligations thereunder and the consummation of the
Merger upon the terms and subject to the conditions set forth in the Merger Agreement; (iv)&nbsp;resolved to recommend that Kellanova shareowners adopt the Merger Agreement in accordance with the DGCL; and (v)&nbsp;directed that the adoption of the
Merger Agreement be submitted for consideration by Kellanova shareowners at a meeting thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Later that same night on August 13, 2024,
Kellanova and Mars executed the Merger Agreement and Mars delivered an executed Debt Commitment Letter. Also that same night on August 13, 2024, Mars executed and delivered voting agreements with each of the Kellogg Foundation Trust and certain
entities and trusts affiliated with the Gund family. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On the morning of August&nbsp;14, 2024, prior to the commencement of trading of
Common Stock on the NYSE, Kellanova and Mars issued a joint press release announcing the Merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_29"></A>Recommendation of the
Board and Its Reasons for the Merger </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In considering the recommendation of the Board with respect to the Merger Proposal, you should be
aware that our directors and executive officers have interests in the Merger that may be different from, or in addition to, yours. The Board was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger
Agreement and the Merger, and in recommending that the Merger Proposal be approved by the Kellanova shareowners. See the section entitled &#147;The Merger&#151;Interests of Kellanova&#146;s Directors and Executive Officers in the Merger&#148;
beginning on page 71. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">By unanimous vote, the Board, at a special meeting held on August&nbsp;13, 2024 and after careful consideration at
this and prior Board meetings, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determined that the terms of the Merger Agreement and the transactions contemplated thereby, including the
Merger, are fair to, and in the best interests of, Kellanova and Kellanova shareowners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determined that it is in the best interests of Kellanova and Kellanova shareowners, and declared it advisable, to
enter into the Merger Agreement providing for the Merger, upon the terms and subject to the conditions set forth therein and in accordance with the applicable provisions of the DGCL; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approved the execution and delivery of the Merger Agreement, the performance of Kellanova&#146;s covenants and
other obligations thereunder and the consummation of the Merger upon the terms and subject to the conditions set forth in the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">resolved to recommend that Kellanova shareowners adopt the Merger Agreement in accordance with the DGCL; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directed that the adoption of the Merger Agreement be submitted for consideration by Kellanova shareowners at a
meeting thereof. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>Accordingly, the Board unanimously recommends that Kellanova shareowners vote
&#147;FOR&#148; the Merger Proposal at the Special Meeting.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In reaching its determination and recommendation, the Board consulted
with representatives of Kellanova management, its legal advisor, Kirkland, and its financial advisors, Goldman Sachs and Lazard, as further described in the section entitled &#147;The Mergers&#151;Background of the Merger&#148;. The Board considered
a number of factors when evaluating the Merger Agreement. The Board considered these factors as a whole and without assigning relative weights to each such factor, and overall considered the relevant factors to be favorable to, and in support of,
its determinations and recommendations with respect to the Merger Agreement. The factors supporting the Board&#146;s determination and recommendation included (which factors are not necessarily presented in order of relative importance): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the current and historical market prices, volatility and trading information with respect to shares of Common
Stock, including the fact that the Merger Consideration of $83.50 per share to be received by Kellanova shareowners in the Merger represents a premium of: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately 33% over the closing price per share as of August&nbsp;2, 2024, the last full trading day prior to
Reuters&#146; published article reporting that Mars was exploring an acquisition of Kellanova (the &#147;Unaffected Date&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately 33% over the highest closing per share price for
<FONT STYLE="white-space:nowrap">the&nbsp;52-week&nbsp;trading</FONT> period prior to the Unaffected Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately 44% over <FONT STYLE="white-space:nowrap">the&nbsp;30-day&nbsp;trading</FONT> period volume
weighted average price (&#147;VWAP&#148;) prior to the Unaffected Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately 42% over <FONT STYLE="white-space:nowrap">the&nbsp;90-day&nbsp;trading</FONT> period VWAP prior to
the Unaffected Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the current and prospective business environment in which Kellanova operates, including economic, market and
industry conditions generally, the current competitive environment in the snack food industry, and the likely effect of these factors on Kellanova and the execution of Kellanova&#146;s plans as a standalone public company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the price of $83.50 per share in cash payable in the Merger provides certainty, immediate value and
liquidity to Kellanova shareowners at a compelling value, while eliminating the risks, uncertainties and potentially longer timeline for realizing equivalent value from Kellanova continuing as a standalone company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the belief that, if Kellanova did not enter into the Merger Agreement, there could be a considerable period of
time before the trading price per share of Common Stock would reach and sustain the per share Merger Consideration of $83.50 (even assuming full realization of the management projections); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the belief that the potential values, benefits, risks and uncertainties facing Kellanova shareowners associated
with possible strategic alternatives to the Merger (including possible alternative business combinations and scenarios involving the possibility of remaining a standalone publicly traded company), and the timing, risks and likelihood of
accomplishing such alternatives, taking into account the Board&#146;s belief that there were likely no other potential strategic acquirors or other parties that would be reasonably likely to engage in a transaction in the near term at a price
greater than the price being offered by Mars and that potential transactions with such other potential strategic acquirors or other parties would likely involve greater regulatory uncertainty than the Merger (including based on the inquiries from
potential acquirors following the release of the Reuters article on August&nbsp;4, 2024 speculating about a potential strategic transaction involving Kellanova, as more fully described under the section of this proxy statement entitled &#147;The
Merger&#151;Background of the Merger<I>&#148;</I>); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential risk of losing the favorable opportunity with Mars in the event Kellanova pursued a higher price or
in the event Kellanova sought to pursue discussions with other third parties who may be interested in pursuing a strategic transaction with Kellanova prior to entry into the Merger Agreement and the potential negative effect that such a process
might have on Kellanova&#146;s business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, the Board and Kellanova&#146;s senior management, in coordination with Kellanova&#146;s outside
legal and financial advisors, vigorously negotiated on an arms-length basis with Mars with respect to price and other terms and conditions in the Merger Agreement, resulting in an increase in Mars&#146; offer price per share from the beginning of
the process to the end of the negotiations, and the belief that, after these negotiations, $83.50 per share of Common Stock was the highest price that Mars was willing to pay as of the date of execution of the Merger Agreement and the terms of the
Merger Agreement include the most favorable terms to Kellanova, in the aggregate, to which Mars would be willing to agree and taken as a whole, and the fact that, the comprehensive terms of the Merger Agreement, including the respective
representations, warranties, covenants and termination rights and fees of the parties, as finally negotiated, are reasonable and customary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the financial analysis of the Merger Consideration reviewed by representatives of Goldman Sachs with the Board as
well as the oral opinion of Goldman Sachs rendered to the Board on August&nbsp;13, 2024, which was subsequently confirmed by delivery of a written opinion dated August&nbsp;13, 2024, that, as of such date and based upon and subject to the
assumptions, limitations, qualifications and other matters considered as described in its opinion, the Merger Consideration to be paid to the holders of shares of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned
by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects with,
Section&nbsp;262 of the DGCL) pursuant to the Merger Agreement was fair from a financial point of view to such holders, as more fully described under &#147;The Merger&#151;Opinions of Financial Advisors to Kellanova&#151;Opinion of Goldman
Sachs&nbsp;&amp; Co. LLC&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the financial analysis of the Merger Consideration reviewed by representatives of Lazard with the Board as well
as the oral opinion of Lazard rendered to the Board on August&nbsp;13, 2024, which was subsequently confirmed by delivery of a written opinion dated August&nbsp;13, 2024, that, as of such date and based on and subject to the various assumptions
made, procedures followed, matters considered and qualifications and limitations on the review undertaken by Lazard in connection with its opinion, the Merger Consideration to be paid to the holders of Common Stock (other than shares owned (or held
in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who
complies in all respects with, Section&nbsp;262 of the DGCL) in the Merger was fair, from a financial point of view, to such holders, as more fully described under &#147;The Merger&#151;Opinions of Financial Advisors to Kellanova&#151;Opinion of
Lazard Fr&egrave;res&nbsp;&amp; Co. LLC&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Kellanova has sufficient operating flexibility under the terms of the Merger Agreement to conduct
its business in the ordinary course prior to the consummation of the Merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Merger Agreement permits Kellanova to continue to pay to its shareowners regular quarterly
dividends during the pendency of the Merger, subject to certain maximum amounts per quarter; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the high degree of certainty that the Merger would close in a timely manner in light of the conditions and other
terms set forth in the Merger Agreement, including the fact that the definition of &#147;Company Material Adverse Effect&#148; has a number of customary exceptions, Mars&#146; strong commitment to use its reasonable best efforts to promptly take all
actions and do all things </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
necessary to obtain all clearances, authorizations, consents, orders and approvals of all governmental entities necessary for the performance of its obligations pursuant to the Merger Agreement
(subject to a Burdensome Condition standard, as more fully described under &#147;The Merger Agreement&#151;Other Covenants and Agreements&#151;Efforts to Complete the Merger; Regulatory Approvals&#148;), and the absence of a requirement for approval
by Mars&#146; stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commitment made by Mars to use its reasonable best efforts to avoid or eliminate impediments under any
Antitrust Law or trade regulation law that may be asserted by any governmental entity so as to enable the parties to the Merger Agreement to close the Merger as promptly as practicable (subject to the specified thresholds and limitations of the
Burdensome Condition standard set forth in the Merger Agreement), including a commitment to contest and defend through litigation any claim asserted in court by any governmental entity in order to avoid entry of, or have vacated or terminated, any
decree, order or judgment that would prevent closing of the Merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the conditions to closing contained in the Merger Agreement, which are limited in number and scope, and which, in
the case of the condition related to the accuracy of Kellanova&#146;s representations and warranties, is generally subject to a Company Material Adverse Effect (as defined in the section of this proxy statement entitled &#147;The Merger
Agreement&#151;Representations and Warranties&#148;) qualification; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of the Board to furnish information to, and conduct negotiations with, third parties in certain
circumstances, and to terminate the Merger Agreement to accept a superior proposal upon payment of a termination fee of $800&nbsp;million (which the Board believed was reasonable and customary under the circumstances and would not unduly deter any
other party that might be interested in acquiring Kellanova); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, in the event the Merger Agreement is terminated prior to the consummation of the Merger in certain
circumstances relating to (i)&nbsp;the failure to obtain required regulatory approvals and clearances, or (ii)&nbsp;the entry of, and continued effectiveness of, an order by a governmental entity or adoption or effectiveness of a law (in each case
solely in respect of the HSR Act or any foreign investment law) that prohibits, enjoins or makes illegal the consummation of the Merger, or (iii)&nbsp;a Burdensome Condition that is a condition to receipt of any regulatory approval, or a regulatory
approval containing, including or imposing a Burdensome Condition, or a law or order in effect at closing of the Merger resulting in a Burdensome Condition, Mars will be required to pay Kellanova a termination fee of $1.25&nbsp;billion (which the
Board believed was reasonable under the circumstances); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Outside Date of August&nbsp;13, 2025 (subject to two automatic
<FONT STYLE="white-space:nowrap">6-month</FONT> extensions under certain circumstances), which the Board believed to be sufficient time to complete the Merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of statutory appraisal rights to Kellanova shareowners who do not vote in favor of the adoption
of the Merger Agreement and otherwise comply with all required procedures under Section&nbsp;262 of the DGCL; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the consummation of the Merger is subject to the approval of Kellanova shareowners, who will have
the opportunity to adopt or reject the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Merger Agreement was unanimously approved by the Board, which is comprised of a majority of
independent directors who are not employees of Kellanova or any of its subsidiaries, and which received advice from the Company&#146;s outside financial and legal advisors in evaluating, negotiating and recommending the terms of the Merger
Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Merger is not subject to a financing condition and that Mars has represented that it or
Acquiror will, as of the closing of the Merger, have available sufficient funds sufficient to pay the amounts required to be paid under the Merger Agreement; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the guaranty of Acquiror&#146;s and Merger Sub&#146;s obligations under the Merger Agreement by Mars pursuant to
the Merger Agreement, which provides substantial assurance that Acquiror and Merger Sub will perform their obligations under the Merger Agreement and increases closing certainty for Kellanova; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Kellogg Foundation Trust, certain entities affiliated with G. Zachary Gund and certain trusts
affiliated with the Gund family, who collectively held approximately 20.66% of the total outstanding shares of Common Stock as of August&nbsp;13, 2024, agreed to enter into voting agreements to vote their shares in favor of the Merger;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Merger does not require the approval of Mars&#146; stockholders, with the attendant risks
associated with such vote; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kellanova&#146;s rights to seek specific performance of Mars&#146;, Acquiror&#146;s and Merger Sub&#146;s
obligations to cause the Merger to occur and to prevent other breaches of the Merger Agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the likelihood that the Merger would be consummated, in light of the experience, reputation and financial
capabilities of Mars, including Mars&#146; prior track record of completing large and complex acquisitions. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the
course of its deliberations, the Board also considered and balanced against the potentially positive factors, a number of uncertainties, risks and other potentially negative factors, including, among other things, the following (which factors are
not necessarily presented in order of relative importance): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that Kellanova shareowners will not have the ability to participate in any future growth potential or
benefit from any future increase in the value of Kellanova as, following the consummation of the Merger and the other transactions contemplated by the Merger Agreement, Kellanova will be a private company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possibility that all conditions to the Merger will not be timely satisfied or waived and that the Merger will
not be consummated, and the potential negative effects on Kellanova&#146;s business, operations, financial results and stock price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential negative effects of the public announcement of the Merger on Kellanova&#146;s sales, operating
results, and stock price, its ability to retain key personnel, and its relationships with vendors, customers, and employees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the restrictions on the conduct of Kellanova&#146;s business prior to the completion of the Merger, requiring
Kellanova to conduct its business in the ordinary course and preventing Kellanova from taking certain specified actions, subject to specific limitations, all of which may delay or prevent Kellanova from undertaking business opportunities pending
completion of the Merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, subject to certain limited exceptions, during the term of the Merger Agreement, Kellanova is
prohibited from soliciting any inquiry or proposal with respect to a competing proposal for Kellanova; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs involved in connection with entering into the Merger Agreement and completing the Merger (many of which
are payable whether or not the Merger is consummated) and the time and effort of Kellanova management required to complete the Merger, which may disrupt its business operations and may have a negative effect on its financial results;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the conditions to the obligations of Acquiror to complete the Merger and the right of Acquiror to terminate the
Merger Agreement under certain circumstances; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that Kellanova shareowners may not approve the Merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that completion of the Merger requires regulatory approvals, which could subject the Merger to delays
and the risk that the required regulatory approvals may not be obtained at all; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that, in the event the Merger Agreement is terminated prior to the consummation of the Merger in certain
circumstances relating to the failure of antitrust clearance to be obtained, Mars will be required to pay Kellanova a termination fee of $1.25&nbsp;billion, which may not be sufficient to compensate Kellanova for losses suffered as a result of the
termination of the Merger Agreement under such circumstances; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk of litigation arising from Kellanova shareowners in respect of the Merger Agreement or transactions
contemplated by the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that the Merger Consideration consists of cash and will generally be taxable for U.S. federal income tax
purposes, as more fully described in the section entitled &#147;The Merger&#151;U.S. Federal Income Tax Considerations&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interests that certain Kellanova directors and executive officers may have with respect to the Merger, which
interests may be different from, or in addition to their interests as Kellanova shareowners generally, as described in the section of this proxy statement entitled &#147;The Merger&#151;Interests of Kellanova&#146;s Directors and Executive Officers
in the Merger&#148;; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks and uncertainties of the nature identified in the section of this proxy statement captioned
&#147;Forward-Looking Statements&#148; and in Kellanova&#146;s filings with the SEC, including the risks set forth in &#147;Item 1A. Risk Factors&#148; in Kellanova&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
year ended December&nbsp;30, 2023. For more information, see the section of this proxy statement captioned &#147;Where You Can Find More Information.&#148; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">After taking into account all of the factors set forth above, as well as others, the Board concluded that the risks, uncertainties,
restrictions and potentially negative factors associated with the Merger Agreement and the transactions contemplated thereby were outweighed by the positive factors and potential benefits associated with the Merger Agreement and the transactions
contemplated thereby that supported its determination and recommendation. Accordingly, the Board unanimously determined that it was fair to, and in the best interests of Kellanova and its shareowners to enter into the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The foregoing discussion of factors considered by the Board is not intended to be exhaustive, but is meant to include material factors
considered by the Board. The Board collectively reached the conclusion to approve the Merger Agreement in light of the various factors described above and other factors that the members of the Board believed were appropriate. In light of the variety
of factors considered in connection with its evaluation of the Merger, the Board did not find it practicable to, and did not, quantify or otherwise assign relative weights to the specific factors considered in reaching its determinations and
recommendations. Moreover, each member of the Board applied his or her own personal business judgment to the process and may have given different weight to different factors. The Board did not undertake to make any specific determination as to
whether any factor, or any particular aspect of any factor, supported or did not support its ultimate determination. The Board based its recommendation on the totality of the information available to it, including discussions with Kellanova&#146;s
senior management and outside legal and financial advisors. It should be noted that this explanation of the reasoning of the Board and certain information presented in this section is forward-looking in nature and should be read in light of the
factors set forth in the section entitled &#147;Cautionary Statement Concerning Forward-Looking Information&#148; beginning on page 28. Accordingly, the Board unanimously recommends that Kellanova shareowners vote &#147;FOR&#148; the Merger
Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_30"></A>Certain Unaudited Forecasted Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Although Kellanova historically has provided guidance as to its projected financial and operational results for its then-current fiscal year,
Kellanova does not otherwise, as a matter of course, make long-term projections as to future performance available to the public, given, among other things, the inherent difficulty of predicting financial performance for future periods and the
likelihood that the underlying assumptions and estimates may not be realized. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As part of the Board&#146;s regular process for evaluating Kellanova&#146;s business,
strategic and financial position, Kellanova management prepared a customary <FONT STYLE="white-space:nowrap">long-range</FONT> plan that was presented to the Board. The <FONT STYLE="white-space:nowrap">long-range</FONT> plan contains certain
non-public, unaudited, <FONT STYLE="white-space:nowrap">stand-alone</FONT> financial projections for Kellanova (the &#147;Financial Projections&#148;). The Financial Projections were authorized for use by Kellanova&#146;s financial advisors for
purposes of their financial analyses and opinions summarized under the sections of this proxy statement titled &#147;The Merger&#151;Opinion of Financial Advisors to Kellanova&#151;Opinion of Goldman Sachs&nbsp;&amp; Co. LLC&#148; and &#147;The
Merger&#151;Opinion of Financial Advisors to Kellanova&#151;Opinion of Lazard Freres&nbsp;&amp; Co. LLC.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Financial Projections
were not prepared with a view toward public disclosure, and accordingly, do not necessarily comply with published guidelines of the SEC or the guidelines established by the American Institute of Certified Public Accountants for preparation and
presentation of prospective financial information or generally accepted accounting principles (&#147;GAAP&#148;), and may not be prepared on a basis consistent with projections the Company has otherwise disclosed publicly. The Financial Projections
included in this document have been prepared by, and are the responsibility of, Kellanova&#146;s management. Kellanova&#146;s independent auditor has not audited, reviewed, examined, compiled nor applied agreed-upon procedures with respect to the
accompanying Financial Projections, and, accordingly, Kellanova&#146;s independent auditor does not express an opinion or any other form of assurance with respect thereto. The PricewaterhouseCoopers LLP report incorporated by reference in this
document relates to Kellanova&#146;s previously issued financial statements. It does not extend to the Financial Projections and should not be read to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Financial Projections summarized below are included solely to provide Kellanova shareowners access to financial projections that were made
available to the Board, Goldman Sachs and Lazard in connection with the proposed Merger, and are not included in this proxy statement to influence a Kellanova shareowner&#146;s decision as to whether to vote to adopt the Merger Agreement or for any
other purpose. None of Kellanova, the Board, Goldman Sachs, Lazard, Mars or any of their respective affiliates, advisors or other representatives makes any representation to any stockholder regarding the validity, reasonableness, accuracy or
completeness of the Financial Projections or the ultimate performance of Kellanova relative to the Financial Projections. The inclusion of the summary of the Financial Projections in this proxy statement does not constitute an admission or
representation of Kellanova, the Board, Goldman Sachs, Lazard, Mars or any of their respective affiliates, advisors or other representatives that the Financial Projections or the information contained therein are material. The inclusion of the
summary of the Financial Projections in this proxy statement should not be regarded as an indication that Kellanova or anyone who receives the Financial Projections then considered, or now considers, the Financial Projections to be necessarily
predictive of actual future events, and this information should not be relied upon as such. In the view of Kellanova&#146;s management, the Financial Projections were prepared on a reasonable basis, reflected the best estimates and judgments
available to Kellanova&#146;s management at the time and presented, to the best of Kellanova&#146;s management&#146;s knowledge and belief, the expected course of action and Kellanova&#146;s expected future financial performance as of the date such
information was prepared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Financial Projections summarized below, while presented with numerical specificity, were based on numerous
variables and assumptions that necessarily involve judgments with respect to, among other things, future economic, competitive, regulatory, financial market conditions, as well as matters specific to Kellanova&#146;s business, in each case as of the
date the Financial Projections were prepared, all of which are difficult or impossible to predict and many of which are beyond Kellanova&#146;s control. In addition, the Financial Projections reflect assumptions that are subject to change and are
susceptible to multiple interpretations based on actual results, revised prospects for Kellanova&#146;s business, changes in general business or economic conditions, or any other transaction or event that has occurred or that may occur and that was
not anticipated when the Financial Projections were prepared. Accordingly, actual results will differ, and may differ materially, from those contained in the Financial Projections, and therefore, the Financial Projections cannot be considered a
guarantee of future operating results and should not be relied upon as such. The Financial Projections cover multiple years, and thus, by their nature, they become subject to greater uncertainty with each successive year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Financial Projections include the following assumptions and estimates, and reflect the
53<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP> week in Kellanova&#146;s fiscal year 2025: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">organic-basis net sales growth rates of nearly 4% in each fiscal year from 2025 through 2027;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adjusted operating profit growth rates of 8% in fiscal year 2025 (aided by the 53<SUP
STYLE="font-size:75%; vertical-align:top">rd</SUP> week), 5% in fiscal year 2026 and 7% in fiscal year 2027; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adjusted operating margins ranging from 15% in fiscal year 2025 to 16% in fiscal year 2027;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adjusted EBITDA margins ranging from 18% in fiscal year 2025 to 19% in fiscal year 2027; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adjusted earnings per share growth of 8% in fiscal year 2025, 7% in fiscal year 2026 and 9% in fiscal year 2027;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">free cash flow growth rates of 7% in fiscal year 2025, 8% in fiscal year 2026 and 7% in fiscal year 2027.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Financial Projections assume no business expansions from mergers and acquisitions or alternative business models.
In addition, the Financial Projections do not take into account any circumstances, transactions or events occurring after the date on which the Financial Projections were prepared and do not give effect to any changes or expenses incurred after the
date on which they were made, including as a result of the Merger or any effects of the Merger (including any failure of the Merger to be completed). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as required by applicable securities laws, Kellanova does not intend to update or otherwise revise the Financial Projections to reflect
circumstances existing after the date on which the Financial Projections were prepared or to reflect the occurrence of future events, even in the event that any or all of the underlying assumptions are shown to be in error. There can be no assurance
that the financial results in the Financial Projections will be realized, or that future actual financial results will not materially vary from those estimated in the Financial Projections. In light of the foregoing, and the uncertainties inherent
in the Financial Projections, Kellanova shareowners are cautioned not to place undue, if any, reliance on the Financial Projections. The Financial Projections should be evaluated, if at all, in conjunction with the historical financial statements
and other information regarding Kellanova in its public filings with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Important factors that may affect actual results and the
achievability of the Financial Projections include, but are not limited to: regulatory actions at the federal, state and local level, changes in consumer food preferences or purchasing behaviors, general economic conditions, including&nbsp;foreign
exchange rates, input cost inflation and disruptions in the financial, debt, capital, credit or securities markets; industry and market dynamics; competition; and those risks and uncertainties described in Kellanova&#146;s Annual Report on <FONT
STYLE="white-space:nowrap">Form&nbsp;10-K&nbsp;for</FONT> the fiscal year ended December&nbsp;30, 2023 and subsequent quarterly reports on <FONT STYLE="white-space:nowrap">Form&nbsp;10-Q&nbsp;and</FONT> current reports on <FONT
STYLE="white-space:nowrap">Form&nbsp;8-K.&nbsp;See</FONT> also the section entitled &#147;Cautionary Statement Concerning Forward-Looking Information&#148; in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Certain of the measures included in the Financial Projections are financial measures that are not calculated in accordance with GAAP. <FONT
STYLE="white-space:nowrap">Such&nbsp;non-GAAP&nbsp;financial</FONT> measures should not be viewed as a substitute for GAAP financial measures, and may be different <FONT STYLE="white-space:nowrap">from&nbsp;non-GAAP&nbsp;financial</FONT> measures
used by other companies. Furthermore, there are limitations inherent <FONT STYLE="white-space:nowrap">in&nbsp;non-GAAP&nbsp;financial</FONT> measures, because they exclude charges and credits that are required to be included in a GAAP presentation. <FONT
STYLE="white-space:nowrap">Accordingly,&nbsp;non-GAAP&nbsp;financial</FONT> measures should be considered together with, and not as an alternative to, financial measures prepared in accordance with GAAP. Financial measures provided to a financial
advisor are excluded from the SEC&#146;s rules <FONT STYLE="white-space:nowrap">concerning&nbsp;non-GAAP&nbsp;financial</FONT> measures and, therefore, are not subject to SEC rules regarding disclosures
<FONT STYLE="white-space:nowrap">of&nbsp;non-GAAP&nbsp;financial</FONT> measures in disclosures relating to a proposed business combination such as the Merger if the disclosure is included in a document such as this proxy statement, which would
otherwise require a reconciliation of <FONT STYLE="white-space:nowrap">a&nbsp;non-GAAP&nbsp;financial</FONT> measure to a GAAP financial measure. Reconciliations <FONT STYLE="white-space:nowrap">of&nbsp;non-GAAP&nbsp;financial</FONT> measures were
not prepared or relied upon by the Board in connection with its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consideration of the Merger Agreement or by Goldman Sachs or Lazard for purposes of their financial analyses. Accordingly, Kellanova has not provided a reconciliation of any financial measures
included in the Financial Projections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table is a summary of the Financial Projections: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>($ in millions other than per share amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2025E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2026E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2027E</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,782</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted Operating Profit<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted EBITDA<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted Net Income<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net Operating Profit After Tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Free Cash Flow<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unlevered Free Cash Flow<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjusted Earnings Per Share<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted Operating Profit, Adjusted Net Income and Adjusted Earnings Per Share are <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> financial measures, each calculated in accordance with GAAP and adjusted to exclude the effect of restructuring programs, costs of the Spin Transaction, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">mark-to-market</FONT></FONT> adjustments for pension plans (service cost, interest cost, expected return on plan assets, and other net periodic pension costs are not excluded), commodity contracts, certain equity
investments and certain foreign currency contracts, a gain on interest rate swaps and other costs impacting comparability. Adjusted EBITDA is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure which represents earnings before
interest, taxes and depreciation and amortization and adjusted in the same manner described in the foregoing sentence. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Free Cash Flow is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure, defined as net cash
provided by operating activities reduced by expenditures for property additions. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unlevered Free Cash Flow is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure equal to Net
Operating Profit After Tax plus depreciation&nbsp;&amp; amortization, less capital expenditures, plus/minus the change in working capital and other balance sheet items, plus/minus other <FONT STYLE="white-space:nowrap">non-cash</FONT> items.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_31"></A>Opinions of Financial Advisors to Kellanova </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company engaged each of Goldman Sachs and Lazard to act as its financial advisors in connection with the Merger. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Opinion of Goldman Sachs&nbsp;&amp; Co. LLC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At a special meeting of the Board held to evaluate the Merger, Goldman Sachs rendered its oral opinion, subsequently confirmed in writing by
delivery of a written opinion dated August&nbsp;13, 2024, that, as of such date and based upon and subject to the assumptions, limitations, qualifications and conditions described in Goldman Sachs&#146; written opinion, the Merger Consideration to
be paid to the holders of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for
which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL) pursuant to the Merger Agreement was fair from a financial point of view to such holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>The full text of the written opinion of Goldman Sachs to the Board, which sets forth assumptions made, procedures followed, matters
considered and limitations on the review undertaken by Goldman Sachs in rendering its opinion, is attached as Annex E to this proxy statement. The summary of Goldman Sachs&#146; opinion contained in this proxy statement is qualified in its entirety
by reference to the full text of Goldman Sachs&#146; written opinion. Goldman Sachs&#146; advisory services and its opinion were provided for the </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
information and assistance of the Board in connection with its consideration of the Merger and such opinion does not constitute a recommendation as to how any holder of Common Stock should vote
with respect to the Merger, or any other matter. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with rendering the opinion described above and performing its related
financial analyses, Goldman Sachs reviewed, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">annual reports to shareowners and Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of
Kellanova for the fiscal&nbsp;year ended December&nbsp;30, 2023, December&nbsp;31, 2022 and January&nbsp;1, 2022, respectively; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the registration statement on Form 10, as amended, of WK Kellogg Co in connection with its <FONT
STYLE="white-space:nowrap">spin-off</FONT> from Kellanova; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain interim reports to shareowners and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT>
of Kellanova; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain other communications from Kellanova to its shareowners; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain publicly available research analyst reports for Kellanova; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain internal financial analyses and forecasts for Kellanova prepared by its management (referred to as the
&#147;Financial Projections&#148; and which are summarized in the section entitled &#147;Certain Unaudited Forecasted Financial Information&#148; beginning on page&nbsp;51), as approved for Goldman Sachs&#146; use by Kellanova.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs also held discussions with members of the senior management of Kellanova regarding their assessment of
the past and current business operations, financial condition and future prospects of Kellanova; reviewed the reported price and trading activity for Common Stock; compared certain financial and stock market information for Kellanova with similar
information for certain other companies, the securities of which are publicly traded; reviewed the financial terms of certain recent business combinations in the food industry and in other industries; and performed such other studies and analyses,
and considered such other factors, as it deemed appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of rendering its opinion, Goldman Sachs, with the consent of
the Board, relied upon and assumed the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, it, without assuming any responsibility for independent
verification thereof. In that regard, Goldman Sachs assumed with the consent of the Board that the Projections were reasonably prepared on a basis reflecting the best then available estimates and judgments of the management of Kellanova. Goldman
Sachs did not make an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other <FONT STYLE="white-space:nowrap">off-balance-sheet</FONT> assets and liabilities) of Kellanova or any of its
subsidiaries and it was not furnished with any such evaluation or appraisal. Goldman Sachs assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the Merger will be obtained without any adverse
effect on the expected benefits of the Merger in any way meaningful to its analysis. Goldman Sachs also assumed that the Merger will be consummated on the terms set forth in the Merger Agreement, without the waiver or modification of any term or
condition the effect of which would be in any way meaningful to its analysis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs&#146; opinion did not address the underlying
business decision of Kellanova to engage in the Merger or the relative merits of the Merger as compared to any strategic alternatives that may be available to Kellanova; nor did it address any legal, regulatory, tax or accounting matters. Goldman
Sachs&#146; opinion addressed only the fairness from a financial point of view to the holders of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars,
Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL), as of the date of its opinion, of the
Merger Consideration to be paid to such holders pursuant to the Merger Agreement. Goldman </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sachs did not express any view on, and its opinion did not address, any other term or aspect of the Merger Agreement or the Merger or any term or aspect of any other agreement or instrument
contemplated by the Merger Agreement or entered into or amended in connection with the Merger, including the fairness of the Merger to, or any Merger Consideration received in connection therewith by, the holders of any other class of securities,
creditors, or other constituencies of Kellanova; nor as to the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of Kellanova, or class of such persons, in connection with the
Merger, whether relative to the Merger Consideration to be paid to the holders of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger
Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL) pursuant to the Merger Agreement or otherwise. Goldman
Sachs did not express any opinion as to the prices at which Common Stock will trade at any time or as to the potential effects of volatility in the credit, financial and stock markets on Kellanova, Acquiror, Mars or the Merger, or as to the impact
of the Merger on the solvency or viability of Kellanova, Acquiror or Mars or the ability of Kellanova, Acquiror or Mars to pay their respective obligations when they come due. Goldman Sachs&#146; opinion was necessarily based on economic, monetary,
market and other conditions as in effect on, and the information made available to Goldman Sachs as of, the date of its opinion and Goldman Sachs assumed no responsibility for updating, revising or reaffirming its opinion based on circumstances,
developments or events occurring after the date of its opinion. Goldman Sachs&#146; opinion was approved by a fairness committee of Goldman Sachs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Summary of Financial Analysis </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The
following is a summary of the material financial analyses delivered by Goldman Sachs to the Board in connection with rendering the opinion described above. The following summary, however, does not purport to be a complete description of the
financial analyses performed by Goldman Sachs, nor does the order of analyses described represent relative importance or weight given to those analyses by Goldman Sachs. Some of the summaries of the financial analyses include information presented
in tabular format. The tables must be read together with the full text of each summary and are alone not a complete description of Goldman Sachs&#146; financial analyses. Except as otherwise noted, the following quantitative information, to the
extent that it is based on market data, is based on market data as it existed on or before August&nbsp;12, 2024, the last trading day before the date on which the Board approved the Merger, and is not necessarily indicative of current market
conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B><I>Implied Premia and Multiple Analyses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs calculated the $83.50 in cash per share to be paid to the holders of shares of Common Stock pursuant to the Merger Agreement in
relation to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the closing price per share of Common Stock of $62.98 on August&nbsp;2, 2024, the last trading day before media
reports of a potential transaction with Mars became public; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the highest trading price for the shares of Common Stock of $62.98 over the
<FONT STYLE="white-space:nowrap">52-week</FONT> period ended August&nbsp;2, 2024 (the <FONT STYLE="white-space:nowrap">&#147;52-week</FONT> high&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the volume weighted average price for the shares of Common Stock of $58.09 over the <FONT
STYLE="white-space:nowrap">thirty-day</FONT> period ended August&nbsp;2, 2024 (the <FONT STYLE="white-space:nowrap">&#147;30-day</FONT> VWAP&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the volume weighted average price for the shares of Common Stock of $58.69 over the <FONT
STYLE="white-space:nowrap">ninety-day</FONT> period ended August&nbsp;2, 2024 (the <FONT STYLE="white-space:nowrap">&#147;90-day</FONT> VWAP&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The results of these calculations are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="23%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Reference Price Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Implied&nbsp;Premium</B><br><B>Represented by</B><br><B>$83.50 Per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Price as of August&nbsp;2, 2024 of $62.98</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">52-week&nbsp;high</FONT> of $62.98 (undisturbed)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">30-day&nbsp;VWAP</FONT> of $58.09 (undisturbed)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">90-day&nbsp;VWAP</FONT> of $58.69 (undisturbed)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs calculated the implied equity value of Kellanova by multiplying the $83.50 per share of Merger
Consideration to be paid pursuant to the Merger Agreement by the number of fully diluted outstanding shares of Common Stock as of August&nbsp;12, 2024, as provided by the management of Kellanova and approved for Goldman Sachs&#146; use by Kellanova,
using the treasury stock method. Goldman Sachs then calculated the implied enterprise value for Kellanova by adding to Kellanova&#146;s implied equity value the amount of Kellanova&#146;s adjusted net debt (including financial net debt and
adjustments for noncontrolling interest, investments in unconsolidated entities and factored receivables) as of June&nbsp;30, 2024, as provided by the management of Kellanova and approved for Goldman Sachs&#146; use by Kellanova. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Using that information, Goldman Sachs calculated the following with respect to Kellanova: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kellanova&#146;s implied enterprise value as a multiple of the EBITDA of Kellanova for the twelve month period
ended June&nbsp;30, 2024, as provided by Kellanova&#146;s management; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kellanova&#146;s implied enterprise value as a multiple of the EBITDA of Kellanova for fiscal years 2024, 2025,
and 2026, in each case as reflected in the Projections. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The results of these calculations were as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Multiples</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Implied Enterprise Value as a Multiple of:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Q2 2024 LTM EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.4x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FY2024E EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FY2025E EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FY2026E EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.0x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>Illustrative Discounted Cash Flow Analysis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Using the Projections, Goldman Sachs performed an illustrative discounted cash flow analysis on Kellanova to derive a range of illustrative
equity values per share of Common Stock. Using the <FONT STYLE="white-space:nowrap">mid-year</FONT> convention for discounting cash flows and discount rates ranging from 6.00% to 7.00%, reflecting estimates of Kellanova&#146;s weighted average cost
of capital, Goldman Sachs discounted to present value, as of June&nbsp;30, 2024, (i)&nbsp;estimates of unlevered free cash flow for Kellanova for the period from July&nbsp;1, 2024 to December&nbsp;31, 2027, as reflected in the Projections, and
(ii)&nbsp;a range of illustrative terminal values for Kellanova, which were calculated by applying a range of EV/LTM EBITDA multiples ranging from 12.0x to 14.0x, to an estimate of adjusted EBITDA to be generated by Kellanova in calendar year 2027,
as reflected in the Projections (which analysis implied perpetuity growth rates ranging from 1.0% to 2.6%). The range of EV/LTM EBITDA multiples was estimated by Goldman Sachs utilizing its professional judgment and experience, taking into account
historical trading multiples of Kellanova and certain publicly traded companies, as described below in the section captioned &#147;Selected Publicly Traded Companies Trading Multiples.&#148; Goldman Sachs derived such discount rates by application
of the Capital Asset Pricing Model (&#147;CAPM&#148;), which requires certain company-specific inputs, including Kellanova&#146;s target capital structure weightings, the cost of long-term debt, <FONT STYLE="white-space:nowrap">after-tax</FONT>
yield on permanent excess cash, if any, future applicable marginal cash tax rate and a beta for Kellanova, as well as certain financial metrics for the United States financial markets generally. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs derived a range of illustrative enterprise values for Kellanova by adding the
ranges of present values it derived above. Goldman Sachs then subtracted from the range of illustrative enterprise values it derived for Kellanova the amount of Kellanova&#146;s adjusted net debt (including financial net debt and adjustments for
noncontrolling interest, investments in unconsolidated entities and factored receivables) as of June&nbsp;30, 2024, as provided by the management of Kellanova and approved for Goldman Sachs&#146; use by Kellanova, to derive a range of illustrative
equity values for Kellanova. Goldman Sachs then divided the range of illustrative equity values it derived by the number of fully diluted outstanding shares of Common Stock as of August&nbsp;12, 2024, as provided by the management of Kellanova and
approved for Goldman Sachs&#146; use by Kellanova, using the treasury stock method, to derive a range of illustrative equity values per share of Common Stock of $68.42 to $83.82. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>Illustrative Present Value of Future Share Price Analysis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Using the Projections, Goldman Sachs performed an illustrative analysis of the implied present value of an illustrative future value per share
of Common Stock. For this analysis, Goldman Sachs first calculated the implied enterprise value of Kellanova as of December&nbsp;31 for each of the calendar&nbsp;years 2024 through 2026, by applying a range of illustrative EV/NTM EBITDA multiples of
11.5x to 14.5x to estimates of Kellanova&#146;s <FONT STYLE="white-space:nowrap">one-year</FONT> forward adjusted EBITDA as of December&nbsp;31 for each of the calendar&nbsp;years 2024 through 2026, respectively. This illustrative range of EV/NTM
EBITDA multiple estimates was derived by Goldman Sachs utilizing its professional judgment and experience, taking into account current and historical EV/NTM EBITDA multiples for Kellanova and certain publicly traded companies, as described below in
the section captioned &#147;Selected Publicly Traded Companies Trading Multiples.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs then subtracted the amount of
Kellanova&#146;s adjusted net debt (including financial net debt and adjustments for noncontrolling interest, investments in unconsolidated entities and factored receivables) as of June&nbsp;30, 2024, as provided by the management of Kellanova and
approved for Goldman Sachs&#146; use by Kellanova, from the respective implied enterprise values in order to derive a range of illustrative equity values for Kellanova as of December&nbsp;31 for each of the calendar&nbsp;years 2024 through 2026.
Goldman Sachs then divided these implied equity values by the projected <FONT STYLE="white-space:nowrap">year-end</FONT> number of fully diluted outstanding shares of Common Stock for each of the calendar&nbsp;years 2024 through 2026, calculated
using information provided by the management of Kellanova and approved for Goldman Sachs&#146; use by Kellanova, to derive a range of implied future values per share of Common Stock (excluding dividends). Goldman Sachs then added the cumulative
dividends per Common Stock expected to be paid to holders of Common Stock through the end of each of calendar&nbsp;years 2024 through 2026, using the Projections, to derive a range of implied future values per share of Common Stock (including
dividends). By applying an illustrative discount rate of 6.9%, reflecting an estimate of Kellanova&#146;s cost of equity, and using a <FONT STYLE="white-space:nowrap">mid-year</FONT> convention, Goldman Sachs discounted to present value as of
June&nbsp;30, 2024 both the theoretical future values per share of Common Stock it derived for Kellanova and the estimated dividends to be paid per share of Common Stock through the end of each of calendar&nbsp;years 2024 through 2026. Goldman Sachs
derived such discount rate by application of the CAPM, which requires certain company-specific inputs, including a beta for Kellanova, as well as certain financial metrics for the United States financial markets generally. This analysis resulted in
a range of implied equity values per share of Common Stock of $60.93 to $90.01. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>Premia Paid Analysis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs reviewed and analyzed, using publicly available information, the acquisition premia paid in selected <FONT
STYLE="white-space:nowrap">all-cash</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cash-and-stock</FONT></FONT> acquisition transaction announced during the period from January&nbsp;1, 2008 through August&nbsp;12, 2024
involving U.S. publicly traded target companies with a transaction value equal to or greater than $20&nbsp;billion where the buyer is not a financial buyer. Using publicly available information, Goldman Sachs calculated the median, 25<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;percentile and 75<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;percentile average premia of the price paid in the observed transactions relative to the target&#146;s last
undisturbed closing share price prior to announcement of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective transaction and the target&#146;s <FONT STYLE="white-space:nowrap">52-week</FONT> high closing share price. The following table presents the results of this analysis: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Precedent Premia Paid</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Undisturbed&nbsp;Share<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">52-Week&nbsp;High</FONT><BR>Share Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Median</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;Percentile</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">75<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>&nbsp;Percentile</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based on Goldman Sachs&#146; review of the foregoing data and its professional judgment and experience,
Goldman Sachs applied (i)&nbsp;with respect to the precedent premia paid relative to undisturbed share price, a reference range of illustrative premia of 14% to 32%, and (ii)&nbsp;with respect to the precedent premia paid relative to <FONT
STYLE="white-space:nowrap">52-week</FONT> high share price, a reference range of illustrative premia of 7% to 23%, in each case to the undisturbed and <FONT STYLE="white-space:nowrap">52-week</FONT> high closing price of Common Stock on
August&nbsp;2, 2024 of $62.98. This analysis resulted in a range of implied equity values per share of Common Stock of (i)&nbsp;with respect to the precedent premia paid relative to undisturbed share price, $71.80 to $83.13, and (ii)&nbsp;with
respect to the precedent premia paid relative to <FONT STYLE="white-space:nowrap">52-week</FONT> high share price, $67.39 to $77.47. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>Precedent Transaction Multiples </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs analyzed certain publicly available information relating to the following selected transactions in the food industry since 2008.
For each of the selected transactions where information was publicly available, Goldman Sachs calculated and compared the implied EV/FY1 (or next fiscal year) EBITDA of the applicable target company based on the total Merger Consideration paid in
the transaction as a multiple of the target company&#146;s FY1 EBITDA based on the closest available broker estimate at the time each such selected transaction was announced. While none of the companies that participated in the selected transactions
are directly comparable to Kellanova, the companies that participated in the selected transactions are companies with operations that, for the purposes of analysis, may be considered similar to certain of Kellanova&#146;s results, industry size and
product profile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table presents the results of this analysis: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Food Selected Precedent
Transactions</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Announcement</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Target</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acquiror</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EV/FY1<BR>EBITDA</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sept 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hostess Brands, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J. M. Smucker Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">17.2x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pinnacle Foods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conagra Brands, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">15.9x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dec 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Snyder&#146;s-Lance,</FONT> Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Campbell Soup Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">19.6x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sept 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bob Evans Farms, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Post Holdings, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">15.1x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Feb 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mead Johnson Nutrition Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reckitt Benckiser Group plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">18.9x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The WhiteWave Foods Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Danone S.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">21.5x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mar 2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kraft Foods Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H.J. Heinz Holding Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">15.5x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July 2014</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Hillshire Brands Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tyson Foods, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">16.2x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Feb 2013</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">H.J. Heinz Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Berkshire Hathaway and 3G Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">13.4x</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Food Selected Precedent
Transactions</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Announcement</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Target</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acquiror</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EV/FY1<BR>EBITDA</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jan 2010</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cadbury plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kraft Foods Group</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12.1x</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Apr 2008</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wm. Wrigley Jr. Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mars, Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">17.6x</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Median</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>16.2x</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based on the results of the foregoing calculations and Goldman Sachs&#146; analyses of the various
transactions and its professional judgment and experience, Goldman Sachs selected a reference range of EV/FY1 EBITDA multiples of 12.1x to 21.5x and applied such range to Kellanova&#146;s FY1 EBITDA, as provided by the management of Kellanova, to
derive a range of implied enterprise values for Kellanova. Goldman Sachs then subtracted from the range of implied enterprise values the amount of Kellanova&#146;s adjusted net debt (including financial net debt and adjustments for noncontrolling
interest, investments in unconsolidated entities and factored receivables) as of June&nbsp;30, 2024, as provided by the management of Kellanova and approved for Goldman Sachs&#146; use by Kellanova, to derive a range of illustrative equity values
for Kellanova. Goldman Sachs divided the results by the number of fully diluted outstanding shares of Common Stock as of August&nbsp;12, 2024, as provided by the management of Kellanova and approved for Goldman Sachs&#146; use by Kellanova, using
the treasury stock method, to derive a range of implied equity values per share of Common Stock of $58.81 to $118.63. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>Selected
Publicly Traded Companies Trading Multiples </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For reference purposes only, Goldman Sachs reviewed and compared certain financial
information of Kellanova to corresponding publicly available financial information and valuation multiples for the following publicly traded companies in the food industry, which are referred to in this section as the &#147;selected companies&#148;:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>Snacking</U> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Hershey Company </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mondel&#275;z International, Inc. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">PepsiCo, Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>Center of Store</U> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Campbell Soup Company </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Conagra Brands, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">General Mills, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The J.M. Smucker Company </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Kraft Heinz Company </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Although none of the selected companies are directly comparable to Kellanova, the selected companies were chosen because they are publicly
traded companies in the food industry with certain operations or financial characteristics that, for purposes of analysis, may be considered similar to certain operations or financial characteristics of Kellanova. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs also calculated and compared various financial multiples and ratios based on financial and trading data as of August&nbsp;12,
2024, using information Goldman Sachs obtained from public filings. With respect to the selected companies, Goldman Sachs calculated among other metrics, EV/NTM EBITDA multiples. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The results of these calculations are summarized as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Selected Companies</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>EV&nbsp;/NTM&nbsp;EBITDA<BR>Multiple</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Median&#8201;&#150;&#8201;Snacking</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.8x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Median&#8201;&#150;&#8201;Center of Store</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.9x</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>General </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description.
Selecting portions of the analyses or of the summary set forth above, without considering the analyses as a whole, could create an incomplete view of the processes underlying Goldman Sachs&#146; opinion. In arriving at its fairness determination,
Goldman Sachs considered the results of all of its analyses and did not attribute any particular weight to any factor or analysis considered by it. Rather, Goldman Sachs made its determination as to fairness on the basis of its experience and
professional judgment after considering the results of all of its analyses. No company or transaction used in the above analyses as a comparison is directly comparable to Kellanova or the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs prepared these analyses for purposes of providing its opinion to the Board as to the fairness from a financial point of view of
the Merger Consideration to be paid to the holders of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary
of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL). These analyses do not purport to be appraisals nor do they necessarily reflect the
prices at which businesses or securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these
analyses. Because these analyses are inherently subject to uncertainty, being based upon numerous factors or events beyond the control of the parties or their respective advisors, none of Kellanova, Mars, Acquiror, Goldman Sachs or any other person
assumes responsibility if future results are materially different from those forecast. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Consideration was determined through <FONT
STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations between Kellanova and Mars and was approved by the Board. Goldman Sachs provided advice to Kellanova during these negotiations. Goldman Sachs did not, however, recommend any specific
amount of consideration to Kellanova or the Board or that any specific amount of consideration constituted the only appropriate consideration for the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As described above, Goldman Sachs&#146; opinion to the Board was one of many factors taken into consideration by the Board in making its
determination to approve the Merger Agreement. The foregoing summary does not purport to be a complete description of the analyses performed by Goldman Sachs in connection with the fairness opinion and is qualified in its entirety by reference to
the written opinion of Goldman Sachs attached as Annex E. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Goldman Sachs and its affiliates are engaged in advisory, underwriting, lending
and financing, principal investing, sales and trading, research, investment management and other financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> activities and services for various persons and entities. Goldman Sachs and its
affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they <FONT STYLE="white-space:nowrap">co-invest,</FONT> may at any time purchase, sell, hold or vote long or
short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of Kellanova, Mars, affiliates of the Kellogg Foundation Trust, a significant shareowner of the
Kellanova, any of their respective affiliates and third parties or any currency or commodity that may be involved in the Merger. Goldman Sachs acted as a financial advisor to Kellanova in connection with, and participated in certain of the
negotiations leading to, the Merger. Goldman Sachs has provided certain financial advisory and/or underwriting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
services to Kellanova and its affiliates from time to time for which Goldman Sachs Investment Banking has received, and may receive, compensation, including having acted as financial advisor to
Kellanova in the <FONT STYLE="white-space:nowrap">spin-off</FONT> of WK Kellogg Co from Kellanova completed on October&nbsp;2, 2023. During the <FONT STYLE="white-space:nowrap">two-year</FONT> period ended August&nbsp;13, 2024, Goldman Sachs
Investment Banking had not been engaged by Mars, Acquiror or their respective affiliates to provide financial advisory or underwriting services for which Goldman Sachs has recognized compensation. Goldman Sachs may also in the future provide
financial advisory and/or underwriting services to Kellanova, Mars, the Kellogg Foundation Trust and their respective affiliates for which Goldman Sachs Investment Banking may receive compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board selected Goldman Sachs as a financial advisor because it is an internationally recognized investment banking firm that has
substantial experience in transactions similar to the Merger. Pursuant to a letter agreement dated July&nbsp;17, 2024, Kellanova engaged Goldman Sachs to act as a financial advisor in connection with its review of strategic alternatives, including
with respect to the Merger. The engagement letter between Kellanova and Goldman Sachs provides for a transaction fee of approximately $93.2&nbsp;million upon the completion of the Merger, $5&nbsp;million of which was payable upon the announcement of
the Merger. In addition, Kellanova has agreed to reimburse Goldman Sachs for certain of its expenses, including attorneys&#146; fees and disbursements, and to indemnify Goldman Sachs and related persons against various liabilities, including certain
liabilities under the federal securities laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Opinion of Lazard Fr&egrave;res&nbsp;&amp; Co. LLC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova retained Lazard as its financial advisor in connection with the Merger. In connection with Lazard&#146;s engagement, Kellanova
requested that Lazard evaluate the fairness, from a financial point of view, to holders of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or
Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL), of the Merger Consideration to be paid to such
holders in the Merger. On August&nbsp;13, 2024, at a meeting of the Board, Lazard rendered to the Board its oral opinion, which opinion was subsequently confirmed by delivery of a written opinion, dated August&nbsp;13, 2024, to the effect that, as
of such date, and based upon and subject to the various assumptions made, procedures followed, matters considered and qualifications and limitations on the review undertaken by Lazard in connection with its opinion, the Merger Consideration to be
paid to holders of Common Stock (other than shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a
holder properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL) in the Merger was fair, from a financial point of view, to such holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The full text of Lazard&#146;s written opinion, dated August&nbsp;13, 2024, which describes the various assumptions made, procedures followed,
matters considered, and qualifications and limitations on the review undertaken by Lazard in connection with its opinion, is attached as Annex F to this proxy statement and is incorporated herein by reference in its entirety. <B>The summary of the
written opinion of Lazard, dated August</B><B></B><B>&nbsp;13, 2024, set forth in this proxy statement is qualified in its entirety by reference to the full text of Lazard&#146;s written opinion attached as Annex F. You are encouraged to read
Lazard&#146;s opinion and the summary contained in this proxy statement carefully and in their entirety.</B> Lazard&#146;s engagement and its opinion were for the benefit of the Board (in its capacity as such) and Lazard&#146;s opinion was rendered
to the Board in connection with its evaluation of the Merger and addressed only the fairness, as of the date of the opinion, from a financial point of view, to holders of Common Stock (other than shares owned (or held in treasury) by Kellanova,
shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such shares pursuant to, and who complies in all respects
with, Section&nbsp;262 of the DGCL) of the Merger Consideration to be paid to such holders in the Merger. Lazard&#146;s opinion did not address the relative merits of the Merger as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compared to any other transaction or business strategy in which Kellanova might engage or the merits of the underlying decision by Kellanova to engage in the Merger. Lazard&#146;s opinion is not
intended to and does not constitute a recommendation to any shareowner as to how such shareowner should vote or act with respect to the Merger or any matter relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with its opinion, Lazard: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed the financial terms and conditions of a draft, dated August&nbsp;13, 2024, of the Merger Agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed certain publicly available historical business and financial information relating to Kellanova;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed various financial forecasts and other data provided to Lazard by Kellanova relating to the business of
Kellanova; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">held discussions with members of the senior management of Kellanova with respect to the business and prospects of
Kellanova; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed public information with respect to certain other companies in lines of business Lazard believed to be
generally relevant in evaluating the business of Kellanova; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed the financial terms of certain business combinations involving companies in lines of business Lazard
believed to be generally relevant in evaluating the business of Kellanova; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewed historical stock prices and trading volumes of Common Stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conducted such other financial studies, analyses and investigations as Lazard deemed appropriate.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Lazard assumed and relied upon the accuracy and completeness of the foregoing information, without independent
verification of such information. Lazard did not conduct any independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of Kellanova or concerning the solvency or fair value of Kellanova, and Lazard was not
furnished with any such valuation or appraisal. With respect to the financial forecasts utilized in Lazard&#146;s analyses, Lazard assumed, with the consent of Kellanova, that they had been reasonably prepared on bases reflecting the best currently
available estimates and judgments as to the future financial performance of Kellanova. Lazard assumed no responsibility for and expressed no view as to any such forecasts or the assumptions on which they are based. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Further, Lazard&#146;s opinion was necessarily based on economic, monetary, market and other conditions as in effect on, and the information
made available to Lazard as of, the date of its opinion. Lazard assumed no responsibility for updating or revising its opinion based on circumstances or events occurring after the date thereof. Lazard further noted that volatility in the credit,
commodities and financial markets may have an effect on Kellanova or the Merger and Lazard did not express an opinion as to the effects of such volatility on Kellanova or the Merger. Lazard did not express any opinion as to the price at which shares
of Common Stock may trade at any time subsequent to the announcement of the Merger. In connection with its engagement, Lazard was not authorized to, and did not, solicit indications of interest from third parties regarding a potential transaction
with Kellanova. In addition, Lazard&#146;s opinion did not address the relative merits of the Merger as compared to any other transaction or business strategy in which Kellanova might engage or the merits of the underlying decision by Kellanova to
engage in the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In rendering its opinion, Lazard assumed, with the consent of Kellanova, that the Merger would be consummated on
the terms described in the Merger Agreement, without any waiver or modification of any material terms or conditions. Representatives of Kellanova advised Lazard, and Lazard assumed, that the Merger Agreement, when executed, would conform to the
draft reviewed by Lazard in all material respects. Lazard also assumed, with the consent of Kellanova, that obtaining the necessary governmental, regulatory or third party approvals and consents for the Merger would not have an adverse effect on
Kellanova or the Merger. Lazard did </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not express any opinion as to any tax or other consequences that might result from the Merger, nor does Lazard&#146;s opinion address any legal, tax, regulatory or accounting matters, as to which
Lazard understood that Kellanova obtained such advice as it deemed necessary from qualified professionals. Lazard expressed no view or opinion as to any terms or other aspects (other than the Merger Consideration to the extent expressly specified in
the opinion) of the Merger, including, without limitation, the form or structure of the Merger or any agreements or arrangements entered into in connection with, or contemplated by the Merger, including, without limitation, the Voting Agreements. In
addition, Lazard expressed no view or opinion as to the fairness of the amount or nature of, or any other aspects relating to, the compensation to any officers, directors or employees of any parties to the Merger, or class of such persons, relative
to the Merger Consideration or otherwise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Summary of Lazard Financial Analysis </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following is a brief summary of the material financial analyses and reviews that Lazard deemed appropriate in connection with rendering its
opinion. The summary of Lazard&#146;s financial analyses and reviews provided below is not a complete description of the financial analyses and reviews underlying Lazard&#146;s opinion. The preparation of a fairness opinion is a complex process
involving various determinations as to the most appropriate and relevant methods of analysis and review and the application of those methods to particular circumstances, and, therefore, is not readily susceptible to summary description. Selecting
portions of the financial analyses described below, without considering the financial analyses described below as a whole, could create an incomplete view of the financial analyses and reviews underlying Lazard&#146;s opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In arriving at its opinion, Lazard considered the results of its financial analyses and did not attribute any particular weight to any factor
or financial analysis considered by it; rather, Lazard made its determination as to fairness on the basis of its experience and professional judgment after considering the results of all of its financial analyses. For purposes of its financial
analyses and reviews, Lazard considered industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond the control of Kellanova. No company, business or transaction used in Lazard&#146;s
financial analyses and reviewed as a comparison is identical to Kellanova, or the Merger and related transactions contemplated by the Merger Agreement, and an evaluation of the results of those financial analyses and reviews is not entirely
mathematical. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Rather, the financial analyses and reviews involve complex considerations and judgments concerning financial and operating
characteristics and other factors that could affect the Merger, public trading or other values of the companies, businesses or transactions used in Lazard&#146;s financial analyses and reviews. The estimates contained in Lazard&#146;s financial
analyses and reviews and the ranges of values resulting from any particular financial analysis or review are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable
than those suggested by Lazard&#146;s financial analyses and reviews. In addition, financial analyses and reviews relating to the value of companies, businesses or securities do not purport to be appraisals or to reflect the prices at which
companies, businesses or securities actually may be sold. Accordingly, the estimates used in, and the results derived from, Lazard&#146;s financial analyses and reviews are inherently subject to substantial uncertainty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The summary of the financial analyses and reviews provided below includes information presented in tabular format. In order to fully
understand Lazard&#146;s financial analyses and reviews, the tables must be read together with the full text of each summary. The tables alone do not constitute a complete description of Lazard&#146;s financial analyses and reviews. Considering the
data in the tables below without considering the full narrative description of the financial analyses and reviews, including the methodologies and assumptions underlying the financial analyses and reviews, could create a misleading or incomplete
view of Lazard&#146;s financial analyses and reviews. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as otherwise noted, the following quantitative information, to the extent
that it is based on market data, is based on market data as it existed on or before August&nbsp;12, 2024, the last trading day before the date of Lazard&#146;s opinion, and is not necessarily indicative of current market conditions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Discounted Cash Flow Analysis </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Using the Financial Projections, Lazard performed a discounted cash flow analysis of Kellanova. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A discounted cash flow analysis is a valuation methodology used to derive a valuation of a company by calculating the present value of the
company&#146;s estimated future cash flows. A company&#146;s &#147;estimated future cash flows&#148; are its projected unlevered free cash flows, and &#147;present value&#148; refers to the value today or as of an assumed date of the future cash
flows or amounts and is obtained by discounting the estimated future cash flows or amounts by a discount rate that takes into account macroeconomic assumptions and estimates of risk, the opportunity cost of capital, capital structure, income taxes,
expected returns and other appropriate factors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of this analysis, Lazard calculated a range of enterprise values for
Kellanova by discounting to present value, utilizing discount rates ranging from 6.25% to 6.75%, chosen by Lazard based upon its analysis of the weighted average cost of capital of Kellanova (determined using the capital asset pricing model and
based on considerations that Lazard deemed relevant in its professional judgment and experience, taking into account certain financial metrics, including capital structure, betas for a comparable group of companies and market risk) and using the <FONT
STYLE="white-space:nowrap">mid-year</FONT> convention, (i)&nbsp;the estimated <FONT STYLE="white-space:nowrap">after-tax</FONT> unlevered free cash flows to be generated by Kellanova from June&nbsp;30, 2024 through end of calendar year 2027; and
(ii)&nbsp;a range of terminal values for Kellanova. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The terminal values were derived by applying a perpetuity growth rate range of 1.50%
to 2.00% to the estimated unlevered free cash flow to be generated by Kellanova. The perpetuity growth rates were estimated by Lazard based on its professional judgment and experience, taking into account the Financial Projections. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Lazard then subtracted Kellanova&#146;s net debt, factored accounts receivable, and noncontrolling interests, and added Kellanova&#146;s
investments in unconsolidated entities, in each case as of June&nbsp;29, 2024 and based on information provided by Kellanova, to the range of enterprise values, to derive a range of total equity values for Kellanova. Lazard then calculated a range
of implied equity values per share of Common Stock by dividing such total equity values of Kellanova by the number of fully diluted shares of Common Stock (determined using the treasury stock method), as calculated based on information provided by
Kellanova with respect to dilutive securities outstanding as of August&nbsp;12, 2024. The results of this analysis implied an equity value per share range of $69.60 to $79.10, rounded to the nearest $0.10. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Selected Publicly Traded Companies Analysis </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Using public filings and data sources, Lazard reviewed and analyzed certain financial information, valuation multiple and market trading data
related to selected publicly traded snacking and diversified grocery companies (referred to in this section as the &#147;selected companies&#148;), the operations of which Lazard believed, based on its professional judgment and experience, to be
generally relevant for purposes of this analysis. Lazard compared such information for the selected companies to the corresponding information for Kellanova. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The selected companies for this analysis were as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>Snacking</U> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">PepsiCo, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mondel&#275;z International, Inc. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Hershey Company </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>Diversified Grocery </U> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Kraft Heinz Company </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">General Mills, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Conagra Brands, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Campbell Soup Company </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The J.M. Smucker Company </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Post Holdings, Inc </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">None of the selected companies is directly comparable to Kellanova and certain of these companies may have characteristics that are materially
different from those of Kellanova. Based on its professional judgment and experience, Lazard believes that purely quantitative analyses are not, in isolation, determinative in the context of the Merger and that qualitative judgments concerning
differences between the business, financial and operating characteristics and prospects of Kellanova and the selected companies that could affect the public trading values of each company are also relevant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For each of the selected companies, Lazard reviewed and compared, among other things, (i)&nbsp;the enterprise value of the selected company
(defined as equity market capitalization plus total debt and factored accounts receivable, plus preferred equity and noncontrolling interest, less investments in unconsolidated entities, less cash and cash equivalents) as of August&nbsp;12, 2024, as
a multiple of such selected company&#146;s estimated Adjusted EBITDA (defined as estimated earnings before interest, taxes, depreciation and amortization, adjusted, as applicable, for <FONT STYLE="white-space:nowrap">non-recurring</FONT> items and
any other adjustments, as appropriate, prepared by equity research analysts and compiled by FactSet, for calendar year 2025 and (ii)&nbsp;price per share as of August&nbsp;12, 2024 as a multiple of Adjusted EPS (defined as diluted earnings per
share, adjusted, as applicable, for <FONT STYLE="white-space:nowrap">non-recurring</FONT> items and any other adjustments, as appropriate), prepared by equity research analysts and compiled by FactSet for calendar year 2025. The results of this
analysis are summarized in the following table: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Benchmark</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>High</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Low</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Mean</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Median</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="9"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="9"><U>Snacking</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025E Adjusted EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">14.9x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">14.3x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">14.5x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">14.5x</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025E Adjusted EPS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">21.1x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">19.2x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">19.9x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">19.6x</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="9"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="9"><U>Diversified Grocery</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025E Adjusted EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12.1x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">9.1x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">10.0x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">9.4x</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025E Adjusted EPS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">17.1x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">10.8x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">13.2x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">12.9x</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based on its experience and professional judgment, after taking into account, among other things, such
observed multiples, Lazard selected and applied a range of multiples of enterprise value / Adjusted EBITDA of 11.00x &#150; 13.50x to Kellanova&#146;s estimated Adjusted EBITDA for 2025, based on the Financial Projections. Based on this range of
implied enterprise values and Kellanova&#146;s net debt, factored accounts receivable, investments in unconsolidated entities and noncontrolling interests, in each case as of June&nbsp;29, 2024 and based on information provided by Kellanova, and the
number of fully diluted outstanding shares of Common Stock (determined using the treasury stock method), based on information provided by Kellanova with respect to dilutive securities outstanding as of August&nbsp;12, 2024,this analysis indicated an
equity value reference range per share of $57.20 to $73.80, rounded to the nearest $0.10. In addition, based on its experience and professional judgment, after taking into account, among other things, such observed multiples, Lazard selected and
applied a range of multiples of price / Adjusted EPS of 14.00x &#150; 19.00x to Kellanova&#146;s estimated Adjusted EPS for fiscal year 2025, based on the Financial Projections. This analysis indicated an equity value reference range per share of
$55.90 to $75.70, rounded to the nearest $0.10. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Selected Precedent Transactions Analysis </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Using public filings and other publicly available information, Lazard reviewed and analyzed selected precedent transactions that Lazard viewed
as generally relevant in evaluating the Merger. In performing these analyses, Lazard analyzed certain financial information and transaction multiples relating to companies in the selected transactions and compared such information to the
corresponding information for the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Specifically, Lazard reviewed eleven acquisition transactions in the food industry announced
since July 2014, that Lazard believed, based on its experience and its professional judgment, to be generally relevant for the purpose of this analysis. These transactions are listed below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Announcement Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Acquiror</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Target</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">September 2023</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The J.M. Smucker Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Hostess Brands, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">August 2023</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Campbell Soup Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Sovos Brands, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">April 2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Nestl&eacute; S.A.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Bountiful Company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">February 2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Hormel Foods Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Planters<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (snacking portfolio of The Kraft Heinz Company)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">June 2018</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conagra Brands, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Pinnacle Foods Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">December 2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Campbell Soup Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Snyder&#146;s-Lance,</FONT> Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">December 2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>KKR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Unilever Spreads business</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">July 2017</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">McCormick&nbsp;&amp; Company Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Reckitt Benckiser Group plc&#146;s Food Division</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">December 2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>JAB Holding Company / Mondel&#275;z International, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Keurig Green Mountain</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">March 2015</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>H.J. Heinz Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Kraft Foods Group, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">July 2014</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tyson Foods, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>The Hillshire Brands Company</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">None of the target companies in the selected transactions is directly comparable to Kellanova and none of the
selected transactions is directly comparable to the Merger, and certain of these selected transactions and target companies may have characteristics that are materially different from those of the Merger and Kellanova. Based on its professional
judgment and experience, Lazard believes that purely quantitative analyses are not, in isolation, determinative in the context of the transaction and that qualitative judgments concerning differences between the terms of the Merger and the business,
financial and operating characteristics and prospects of Kellanova and the selected transactions and target companies that could affect the transaction multiples and transaction values of each selected transaction and target company are also
relevant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For each of the selected transactions, Lazard calculated the transaction value (defined as the target company&#146;s implied
equity value based on the consideration paid in the applicable transaction plus total debt and factored accounts receivable, plus preferred equity and noncontrolling interest, less investments in unconsolidated entities, less cash and cash
equivalents), based on information in public filings, press releases and investor relations documents, as a multiple of the last twelve-month Adjusted EBITDA for the target company at the time of the announcement of the applicable transaction, which
Lazard refers to as &#147;LTM Adjusted EBITDA&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The financial data for the selected transactions and target companies were based on public filings and other publicly available information. The results of this analysis are summarized in the
following table: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Benchmark</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>25<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>
Percentile</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Median</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Mean</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>75<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>
Percentile</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EV / LTM Adjusted EBITDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">15.1x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">16.7x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">16.5x</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">18.9x</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based on its professional judgment after taking into account, among other things, such observed multiples for
each of the selected transactions, Lazard selected an enterprise value / Adjusted LTM EBITDA multiple reference range of 15.50x &#150; 17.50x and applied this multiple reference range to Kellanova&#146;s estimated LTM Adjusted EBITDA as of
June&nbsp;29, 2024 and subtracted from it Kellanova&#146;s net debt, factored accounts receivable, and noncontrolling interests, and added to it Kellanova&#146;s investments in unconsolidated entities, in each case on June&nbsp;29, 2024 and based on
information provided by Kellanova, and divided by the number of fully diluted outstanding shares of Common Stock (determined using the treasury stock method), based on information provided by Kellanova with respect to dilutive securities outstanding
as of August&nbsp;12, 2024. The results of this analysis implied an equity value per share range of $78.10 to $90.20, rounded to the nearest $0.10. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Analysis </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The analyses and data
described below were presented to the Board for informational purposes only and did not provide the basis for, and were not otherwise material to, the rendering of Lazard&#146;s opinion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Premia Paid Analysis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Using information from public filings and other publicly available information, Lazard analyzed the premia paid for <FONT
STYLE="white-space:nowrap">all-cash</FONT> selected acquisitions of publicly-traded companies in the food industry announced since January&nbsp;1, 2009 with a total enterprise value over $20&nbsp;billion involving a U.S. target. For each of the
precedent transactions, Lazard calculated the implied premia as a percentage based on the amount by which the per share consideration in each transaction exceeded the target company&#146;s <FONT STYLE="white-space:nowrap">20-day</FONT>
volume-weighted average price prior to the relevant transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based on its professional judgment and experience, Lazard then applied a
range of per share price premia of approximately 20.00% to 35.00%, respectively, to the closing share price of Common Stock on August&nbsp;2, 2024, the last trading day before press rumors of a potential transaction, of $62.98, to calculate an
implied equity value per share range of $75.60 to $85.10, rounded to the nearest $0.10. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Research Analyst Price
Targets </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Lazard reviewed selected equity research analyst price targets based on published, publicly available Wall Street equity
research reports. Lazard observed that such price targets ranged from $56.07 per share to $68.22 per share, discounted one year at Kellanova&#146;s cost of equity of 7.0%. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; text-indent:7%; font-size:10pt; font-family:Times New Roman"><B><I>Post-Separation High/Low Trading Prices </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Lazard reviewed the range of trading prices of shares of Common Stock for the period since the completion of the separation of Kellanova&#146;s
North American cereal business, WK Kellogg Co, on October&nbsp;2, 2023. Lazard observed that, during such period, the closing prices of the shares of Common Stock ranged from $48.62 per share to $62.98 per share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Miscellaneous </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with Lazard&#146;s services as financial advisor to Kellanova in connection with the Merger, Kellanova agreed to pay Lazard a fee
for such services of $10&nbsp;million, payable upon the consummation of the Merger, of which $2&nbsp;million became payable upon delivery of the fairness opinion. In addition, Kellanova has agreed to reimburse certain of Lazard&#146;s expenses
arising, and to indemnify Lazard against certain liabilities that may arise, out of Lazard&#146;s engagement. In the <FONT STYLE="white-space:nowrap">two-year</FONT> period prior to the date of Lazard&#146;s opinion, other than this engagement,
Lazard has not been engaged to provide financial advisory services to Kellanova. Lazard in the past has provided certain investment banking services to Mars, including, during in the two-year period prior to the date of Lazard&#146;s opinion, having
advised Mars with respect to certain acquisitions by Mars, for which Lazard has received compensation of approximately $17 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Lazard, as part of its investment banking business, is continually engaged in the valuation of businesses and their securities in connection
with mergers and acquisitions, negotiated underwritings, secondary distributions of listed and unlisted securities, private placements, leveraged buyouts, and valuations for corporate and other purposes. In addition, in the ordinary course, Lazard
and its affiliates and employees may trade securities of Kellanova, Mars and certain of their respective affiliates for their own accounts and for the accounts of their customers, may at any time hold a long or short position in such securities, and
may also trade and hold securities on behalf of Kellanova, Mars and certain of their respective affiliates. The issuance of Lazard&#146;s opinion was approved by the opinion committee of Lazard. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova and Mars determined the Merger Consideration through <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations, and the
Board approved such Merger Consideration. Lazard conducted the analyses and reviews summarized above for the purpose of providing an opinion to the Board as to the fairness, from a financial point of view, to holders of Common Stock (other than
shares owned (or held in treasury) by Kellanova, shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and shares for which a holder properly demands appraisal of such
shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL), of the Merger Consideration to be paid to such holders. Lazard did not recommend any specific consideration to the Board or any other person or indicate that
any given consideration constituted the only appropriate consideration for the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Lazard&#146;s opinion was one of many factors
considered by the Board, as discussed further in &#147;&#151;Recommendation of the Board and Its Reasons for the Merger.&#148; Consequently, the summary of the analyses and reviews provided above should not be viewed as determinative of the opinion
of the Board with respect to the Merger Consideration or of whether the Board would have been willing to recommend a different transaction or determine that a different consideration was fair. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Lazard is an internationally recognized investment banking firm providing a full range of financial advisory and other services. Lazard was
selected to act as a financial advisor to the Board after considering Lazard&#146;s qualifications, independence, expertise, international reputation, knowledge of the snacking and diversified grocery industries and experience acting as financial
advisor in connection with similar partnership and strategic transactions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_32"></A>Financing of the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement does not contain any financing-related closing condition. However, the Merger Agreement does require Acquiror and Mars to
undertake to obtain financing on or prior to the Closing in an amount, when taken together with available cash on hand and other sources of funds available to Mars and Acquiror, to consummate the transactions. Acquiror obtained debt financing
commitments for the Merger consisting of a bridge loan facility in an aggregate principal amount equal to $29,000,000,000, subject to certain customary mandatory commitment reductions, which will be available to Acquiror on the terms and subject to
the conditions set forth in the Debt Commitment Letter. The obligations of the lenders to provide the Debt Financing under the Debt Commitment Letter are subject to a number of customary conditions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement further provides that Kellanova will provide customary cooperation that
may be reasonably requested for arranging, obtaining, syndicating and consummating the debt financing for the transaction (or any issuance, sale or offering of debt securities and/or delayed draw term loans, in each case, in lieu thereof as
contemplated by the Debt Commitment Letter) or any exchange offer to exchange all or a portion of Kellanova&#146;s outstanding notes for securities of Mars. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_33"></A>Certain Effects of the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger Proposal receives the required approvals of Kellanova shareowners described elsewhere in this proxy statement and the other
conditions to the Closing of the Merger are either satisfied or waived and the Merger Agreement is not otherwise terminated in accordance with its terms, Merger Sub will be merged with and into Kellanova upon the terms set forth in the Merger
Agreement. As the Surviving Corporation in the Merger, Kellanova will continue to exist following the Merger as a wholly owned subsidiary of Acquiror. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova&#146;s Restated Certificate of Incorporation, dated September&nbsp;29, 2023, and as amended on April&nbsp;29, 2024 (the
&#147;Certificate of Incorporation&#148;) and the Bylaws will be amended and restated as a result of the Merger to the forms attached as Exhibit A and Exhibit B to Annex A to this proxy statement, respectively (collectively, the &#147;Surviving
Corporation Organizational Documents&#148;), which include provisions with respect to exculpation, indemnification and advancement of expenses that are no less favorable to the Company Indemnified Parties (as defined in the section entitled
&#147;The Merger Agreement&#151;Structure of the Merger; Certificate of Incorporation, Bylaws and Directors and Officers of the Surviving Corporation&#148; beginning on page&nbsp;82 with respect to acts or omissions occurring at or prior to the
Effective Time as those contained in the Certificate of Incorporation and the Bylaws as of August&nbsp;13, 2024). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Following the Merger,
all Common Stock will be beneficially owned by Mars, and none of the holders of Common Stock as of immediately prior to the Merger will, by virtue of the Merger, have any ownership interest in, or be a shareowner of, Kellanova, the Surviving
Corporation, Acquiror or Mars. As a result, the holders of Common Stock as of immediately prior to the Merger will no longer benefit from any increase in the value, nor will they bear the risk of any decrease in the value, of Common Stock. Following
the Merger, Mars will benefit from any increase in Kellanova&#146;s value and also will bear the risk of any decrease in Kellanova&#146;s value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each share of Common Stock issued and outstanding immediately prior to the Effective Time (other than shares of Common
Stock owned (or held in treasury) by Kellanova, shares held, directly or indirectly, by Mars or any of its subsidiaries (including Acquiror and its subsidiaries) or any wholly owned subsidiary of Kellanova, immediately prior to the Effective Time,
or shares held by a holder who properly demands appraisal of such shares pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL), will be converted into the right to receive the Merger Consideration. Any shares of Common
Stock held by Kellanova as treasury stock immediately prior to the Effective Time will automatically be cancelled and retired and not be entitled to receive the Merger Consideration, and any shares of Common Stock held, directly or indirectly, by
Mars or any of its subsidiaries (including Acquiror and its subsidiaries), or any wholly owned subsidiary of Kellanova, immediately prior to the Effective Time will remain outstanding and will not be converted into the right to receive the Merger
Consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For information regarding the effects of the Merger on Kellanova&#146;s outstanding equity awards and the ESPP, please see
the sections entitled &#147;The Merger Agreement&#8201;&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of Company Options,&#148; &#147;The Merger Agreement&#8201;&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of Company
Restricted Stock Units,&#148; &#147;The Merger Agreement&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of Company Performance Stock Units,&#148; &#147;The Merger Agreement&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of
Company Deferred Stock Units,&#148; and &#147;The Merger&#151;Treatment of Kellanova Incentive Awards&#151;Treatment of Employee Stock Purchase Plan.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>The Common Stock is currently registered under the Exchange Act and trades on the NYSE
under the symbol &#147;K.&#148; Following the consummation of the Merger, shares of Common Stock will no longer be traded on the NYSE or any other public market. In addition, the registration of the Common Stock under the Exchange Act will be
terminated. Following termination of registration of the Common Stock under the Exchange Act, Kellanova will no longer be required to furnish information to the Kellanova shareowners and the SEC, and the provisions of the Exchange Act, such as the
requirement to file annual and quarterly reports pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act, the short-swing trading provisions of Section&nbsp;16(b) of the Exchange Act and the requirement to furnish a proxy statement in connection
with shareowners&#146; meetings pursuant to Section&nbsp;14(a) of the Exchange Act, will become inapplicable to Kellanova. Mars will become the beneficiary of the cost savings associated with Kellanova no longer being subject to the reporting
requirements under the federal securities laws.</B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_34"></A>Effects on Kellanova if the Merger Is Not Completed </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In the event that the Merger Proposal does not receive the required approvals of Kellanova shareowners described elsewhere in this proxy
statement, or if the Merger is not completed for any other reason, Kellanova&#146;s shareowners will not receive any Merger Consideration or other payment for their shares of Common Stock in connection with the Merger. Instead, Kellanova expects
that its management will operate Kellanova&#146;s business in a manner similar to that in which it is being operated today and Kellanova will remain an independent public company, the Common Stock will continue to be listed and traded on the NYSE,
Common Stock will continue to be registered under the Exchange Act and Kellanova shareowners will continue to own their shares of Common Stock and will continue to be subject to the same general risks and opportunities as they currently are with
respect to ownership of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger is not completed, there can be no assurances as to the effect of these risks and
opportunities on the future value of your shares of Common Stock, including the risk that the market price of Common Stock may decline to the extent that the current market price of Common Stock reflects a market assumption that the Merger will be
completed. If the Merger is not completed, there can be no assurances that any other transaction acceptable to Kellanova will be offered or that the business, operations, financial condition, earnings or prospects of Kellanova will not be adversely
impacted or that Kellanova shareowners will ever receive a control premium for their shares. Pursuant to the Merger Agreement, under certain circumstances Kellanova is permitted to terminate the Merger Agreement in order to enter into an alternative
transaction. Please see the section entitled &#147;The Merger Agreement&#151;Termination.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under certain circumstances, if the
Merger is not completed, Kellanova may be obligated to pay to Acquiror the Termination Fee. Please see the section entitled &#147;The Merger Agreement&#151;Termination Fee.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_35"></A>Interests of Kellanova&#146;s Directors and Executive Officers in the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova&#146;s directors and executive officers may have interests in the Merger that are in addition to, or different from, the interests of
other shareowners, including the treatment of Options, RSUs, PSUs and DSUs, participation in the ESPP, certain severance benefits pursuant to the COC Severance Policy, potential <FONT STYLE="white-space:nowrap">gross-up</FONT> payments to mitigate
the impact of excise taxes imposed under Section&nbsp;4999 of the Code, annual bonus payments under Kellanova&#146;s Annual Incentive Plan (the &#147;AIP&#148;) and continued indemnification coverage. The Board was aware of these interests and
considered them, among other matters, in evaluating and approving the Merger Agreement and the Merger, and in recommending the approval of the Merger Proposal and the Advisory Compensation Proposal to Kellanova shareowners. These interests are
described in further detail below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with the completion of the Merger and subject to the terms of the Merger Agreement, at the Effective Time, each Option that is
outstanding and unexercised as of immediately prior to the Effective </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Time, by virtue of the Merger, will cease to be outstanding and will be converted into the right to receive, in accordance with the terms of the Merger Agreement, an amount in cash, without
interest, equal to the product of the total number of shares of Common Stock subject to such Option and the excess, if any, of the per share Merger Consideration over the per share exercise price of the Option. Any Option with a per share exercise
price equal to or greater than the per share Merger Consideration will be cancelled as of the Effective Time without payment. All Options are currently fully vested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of RSUs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection
with the completion of the Merger and subject to the terms of the Merger Agreement, at the Effective Time, each RSU that is outstanding immediately prior to the Effective Time and that was granted prior to August&nbsp;13, 2024 will be deemed fully
vested and cancelled in exchange for a cash payment, without interest, equal to the sum of the product of such number of shares of Common Stock issuable pursuant to the RSU and the per share Merger Consideration, plus all dividend equivalents
accrued or credited with respect to such RSU. At the Effective Time, each RSU that is outstanding immediately prior to the Effective Time and that was granted on or after August&nbsp;13, 2024 will be cancelled and converted into a Converted RSU Cash
Award equal to the per share Merger Consideration with respect to such RSU plus all dividend equivalents accrued or credited with respect to such RSU, which will otherwise remain subject to the same terms and conditions, including vesting
provisions, that applied immediately prior to the Effective Time. If any holder of a Converted RSU Cash Award experiences a qualifying termination of employment or service on or following the Effective Time (other than a resignation by our executive
officers for &#147;good reason&#148; (as defined in the COC Severance Policy)), the Converted RSU Cash Award will vest in full and be paid shortly following the holder&#146;s termination date, provided that the holder executes and does not revoke a
release of claims in favor of the surviving corporation and its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Additionally, in accordance with the terms of the Merger
Agreement and the COC Severance Policy, if our current executive officers resign for good reason following the Effective Time, their Converted RSU Cash Award (if any) will vest pro rata based on the number of days the executive officer was employed
during the original vesting period, provided that the executive officer executes and does not revoke a release of claims in favor of the surviving corporation and its affiliates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of PSUs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection
with the completion of the Merger and subject to the terms of the Merger Agreement, at the Effective Time, each PSU that is outstanding as of immediately prior to the Effective Time will be deemed vested (i)&nbsp;if the applicable performance period
has ended prior to the Effective Time, assuming maximum level of performance, or (ii)&nbsp;if the applicable performance period has not ended prior to the Effective Time, based on the greater of target and actual performance, and cancelled in
exchange for a cash payment, without interest, equal to the sum of (A)&nbsp;the product of (1)&nbsp;the total number of shares of Common Stock subject to such PSU (as determined in accordance with clause (i)&nbsp;or (ii) above, as applicable) and
(2)&nbsp;the per share Merger Consideration and (B)&nbsp;all dividend equivalents accrued or credited with respect to such PSU (such total cash amount, the &#147;PSU Cash Payment&#148;). Additionally, each holder of a PSU that does not pay out in
full at maximum level of performance upon the Effective Time will receive an additional cash retention payment equal to the difference of the value of their PSUs at maximum level of performance (inclusive of all accrued or credited dividend
equivalents with respect to such PSUs) and the payment received by such holder at the Effective Time (such difference, the &#147;Converted PSU Cash Award&#148;), which will be paid on the last day of the performance period applicable to the
corresponding PSU, subject to the holder&#146;s continued employment or, if earlier, upon the holder&#146;s termination of employment without cause or, with respect to any individual who is a participant in the COC Severance Policy (including our
executive officers), resignation for good reason, provided that the holder executes and does not revoke a release of claims in favor of the surviving corporation and its affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of DSUs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each DSU that is outstanding as of immediately prior to the Effective Time will be converted into the right of the
holder thereof to receive, at the time specified in the applicable company benefit plan and in accordance with Section&nbsp;409A of the Code, an amount in cash, without interest, equal to the per share Merger Consideration and all dividend
equivalents accrued or credited with respect to such DSU. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Value of Unvested Equity Awards Held by Executive Officers and <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Directors </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The estimated aggregate value of unvested equity awards held by our
executive officers, including our named executive officers and including such persons who have served as an executive officer since January&nbsp;1, 2023, that would become vested in connection with the Merger, assuming the Merger closed on
September&nbsp;3, 2024 (the &#147;Equity Awards Cutoff Date&#148;) or, immediately thereafter, the executive officer&#146;s termination of employment by Kellanova without cause (as defined in the COC Severance Policy) or a resignation by the
executive officer for good reason, is approximately $160,430,179. This value does not include any additional equity awards that may be granted after the Equity Awards Cutoff Date. This value is calculated by multiplying the number of shares
underlying such awards by the per share Merger Consideration (assuming maximum performance for PSUs, other than for Mr.&nbsp;Hood&#146;s PSUs, which remained eligible to vest on a pro rata basis following his retirement and are assumed to pro rata
vest at target upon the Effective Time for purposes of this disclosure) and include all dividend equivalents accrued or credited with respect to such awards. Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors (including such persons
who have served in such capacity since January&nbsp;1, 2023) do not hold any unvested equity awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the estimated value of unvested
equity awards for each of our named executive officers individually, see the section entitled &#147;The Merger&#151;Summary of Potential Transaction Payments to Named Executive Officers&#148; below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Prior to the Effective Time, Kellanova may amend the ESPP to freeze all participant payroll deduction elections in effect as of August&nbsp;13,
2024. In addition, Kellanova has taken or will take all actions necessary to provide that, contingent on the Effective Time, (i)&nbsp;no new purchasing period under the ESPP will commence following August&nbsp;13, 2024, (ii) there will be no
increase in the amount of participants&#146; payroll deduction elections under the ESPP and no contributions other than previously elected payroll deductions during the current offering period from those in effect as of August&nbsp;13, 2024, (iii)
no individual will commence participation in the ESPP after August&nbsp;13, 2024 and prior to the Effective Time and (iv)&nbsp;each outstanding purchase right issued pursuant to the ESPP will be fully exercised on the earlier of the scheduled
purchase date for such purchasing period (September 30, 2024) and the date immediately prior to the Effective Time (with any participant payroll deductions not applied to the purchase of Common Stock returned to the participant) (the &#147;Final
Purchase Date&#148;). Kellanova will notify each participant at least 10 days before the Final Purchase Date and terminate the ESPP effective as of immediately prior to the Effective Time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>COC Severance Policy </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All of our
executive officers participate in the COC Severance Policy. The COC Severance Policy provides for enhanced severance benefits in the event that a participant&#146;s employment is terminated without &#147;cause&#148; (other than due to death or
disability) or the participant resigns for &#147;good reason&#148;, in each case, within two years following a &#147;change of control&#148; of Kellanova (each as defined in the COC Severance Policy), or if the participant demonstrates that such
termination is initiated by a third party that has taken steps reasonably calculated to effect a change of control or is in connection with or in anticipation of a change of control (each such termination, a &#147;COC Termination&#148;). In the
event of a COC Termination, our executive officers will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entitled to receive the following severance payments and benefits, subject to their execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of a release of claims and compliance with
certain restrictive covenants: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a lump sum payment equal to two times the sum of the executive officer&#146;s (i) &#147;Annual Base Salary&#148;
(calculated as the annualized amount of the executive officer&#146;s highest monthly salary during the <FONT STYLE="white-space:nowrap">one-year</FONT> period prior to the change of control, or any time after the change of control) and (ii)
&#147;Target Annual Bonus&#148; (calculated by multiplying the executive officer&#146;s target annual bonus percentage under the Kellanova Annual Incentive Plan by the Annual Base Salary); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prorated Target Annual Bonus for the year in which the termination date occurs (the &#147;COC Severance Policy
Prorated Bonus&#148;) (unless a greater amount is due under the terms of the Merger Agreement, as described below in the section entitled &#147;The Merger&#151;Interests of Kellanova&#146;s Directors and Executive Officers in the Merger&#151;Annual
Bonuses&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any compensation previously deferred by the executive officer (together with any accrued interest or earnings
thereon), accrued but unpaid vacation pay and the excess of the actuarial equivalent of the benefits under any qualified defined benefit or other retirement plans and any excess or supplemental retirement plans that the executive officer would have
received if the executive officer remained employed with Kellanova for an additional two years post-termination <I>over </I>the actuarial equivalent of the actual benefits paid or payable to the executive officer under such plans on the actual
termination date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continued welfare benefit plan coverage for the executive officer and/or the executive officer&#146;s family for
up to the greater of two years and such longer period as may be provided under the applicable Kellanova plan, which coverage shall be no less favorable, in the aggregate, than the more favorable of (i)&nbsp;the most favorable applicable plans in
effect at any time during the <FONT STYLE="white-space:nowrap">120-day</FONT> period prior to the change of control and (ii)&nbsp;the applicable plans as in effect generally at any time after the change of control for peer executives of Kellanova,
with such two years to count as service credit for eligibility purposes of the executive officer&#146;s retiree benefits (if any) under such health any welfare plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">two years&#146; continued employment credit for purposes of vesting and exercisability of equity awards, which
provision will be superseded by the terms and conditions of the Merger Agreement that apply to outstanding equity awards; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">outplacement services until the second taxable year following the taxable year in which the termination occurred,
with the scope and provider to be selected the executive officer. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The COC Severance Policy conditions the above
severance payments and benefits on the executive officer&#146;s compliance with an employee <FONT STYLE="white-space:nowrap">non-solicitation</FONT> covenant (for up to one year following termination) and a perpetual mutual <FONT
STYLE="white-space:nowrap">non-disparagement</FONT> covenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The COC Severance Policy also contains a &#147;best net&#148; cutback
provision, pursuant to which any of the severance benefits under the COC Severance Policy that constitute &#147;parachute payments&#148; within the meaning of Section&nbsp;280G of the Code and would be subject to the excise tax imposed by
Section&nbsp;4999 of the Code (the &#147;Excise Tax&#148;) will either be (i)&nbsp;provided in full or (ii)&nbsp;reduced to $1.00 less than the amount that would result in no portion of such benefits being subject to the Excise Tax, whichever of the
foregoing amounts results in the greater amount of benefits to the executive officer on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis, notwithstanding that all or some portion of such benefits may be subject to the Excise Tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger will constitute a &#147;change of control&#148; under the COC Severance Policy. For the quantification of the estimated value of
the severance payments and benefits described above that would be payable to Kellanova&#146;s named executive officers, see the table below entitled &#147;Named Executive Officer Merger-Related Compensation.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;280G <FONT STYLE="white-space:nowrap">Gross-Ups</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with the Merger, if Kellanova, after consultation with Acquiror, reasonably believes that any executive officer (and any other
&#147;disqualified individual&#148; within the meaning of Section&nbsp;280G of the Code) may receive or be entitled to receive excess parachute payments after taking certain actions to mitigate the impact of Section&nbsp;4999 of the Code, Kellanova
may indemnify such individual on an <FONT STYLE="white-space:nowrap">after-tax</FONT> basis for any Excise Tax, up to an aggregate limit of $50,000,000 if the Effective Time occurs in 2024 or $25,000,000 if the Effective Time occurs after 2024. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Bonuses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the
Merger Agreement, either Acquiror or the surviving corporation will pay to each executive officer, consistent with the payment for employees who are not executive officers, a prorated annual bonus in respect of the year in which the Effective Time
occurs (such bonus, the &#147;Closing Year Bonus&#148;), at the greater of (i)&nbsp;target performance and (ii)&nbsp;actual performance extrapolated through the end of the applicable calendar year based on actual performance through the Effective
Time, as determined in good faith by the Compensation and Talent Management Committee (the &#147;C&amp;T Committee&#148;) of the Board prior to the Effective Time in accordance with the terms of the Merger Agreement. The Closing Year Bonus will be
paid at the same time that annual bonuses would have been paid absent the Merger, subject to the applicable executive officer&#146;s continued employment with the successor corporation or its affiliates though the applicable payment date, or, if
earlier, the executive officer&#146;s termination (i)&nbsp;by the surviving corporation without &#147;cause&#148;, (ii) due to death or disability or (iii)&nbsp;by such executive officer for &#147;good reason&#148; (as defined in the COC Severance
Policy) (each such termination, a &#147;Qualifying Termination&#148;), provided that the terminated executive officer executes and does not revoke a release of claims in favor of the surviving corporation and its affiliates. If an executive officer
experiences a Qualifying Termination, the executive officer will be entitled to receive the greater of (A)&nbsp;the Closing Year Bonus, payable at the same time that the annual bonus would have been paid absent the Merger, and (B)&nbsp;the COC
Severance Policy Prorated Bonus (as defined in the section entitled &#147;The Merger&#151;Interests of Kellanova&#146;s Directors and Executive Officers in the Merger&#151;COC Severance Policy&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_36"></A>Agreements with Acquiror Following the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement, none of Kellanova&#146;s executive officers has entered into any new agreement, arrangement or
understanding with Acquiror or any of its affiliates regarding the terms and conditions of compensation, incentive pay or employment with the Company after the Merger. Although no agreements have been entered into at this time with any of
Kellanova&#146;s executive officers, prior to or following the completion of the Merger, they may enter into new agreements and/or amendments to existing employment or compensation arrangements with Acquiror or one of its affiliates regarding their
employment with the surviving corporation after the Merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_37"></A>Summary of Potential Transaction Payments to Named Executive
Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information set forth below is required by Item 402(t) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT>
regarding compensation that is based on or otherwise relates to the Merger that Kellanova&#146;s named executive officers could receive in connection with the Merger, as described more fully above in the section entitled &#147;The
Merger&#151;Interests of Kellanova&#146;s Directors and Executive Officers in the Merger.&#148; Such amounts have been calculated assuming (i)&nbsp;the Effective Time occurs on the Equity Awards Cutoff Date, which is the assumed date of Closing of
the Merger solely for purposes of the disclosures in this section, (ii)&nbsp;a per share Merger Consideration amount equal to $83.50 per share of Common Stock, (iii)&nbsp;none of the named executive officers receives any additional equity awards
following the Equity Awards Cutoff Date, (iv)&nbsp;the PSU Cash Payment is made upon the Effective Time at the target level of performance, (v)&nbsp;each named executive officer experiences a COC Termination or a Qualifying Termination at or
immediately following the Effective Time (assuming that the Effective Time occurs on the Equity Awards Cutoff Date) in a manner that entitles them to the maximum benefit available under the COC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Severance Policy and/or the Merger Agreement, (vi)&nbsp;the Annual Base Salary and Target Annual Bonus for purposes of the COC Severance Policy are equal to the then-current annual base salary
rate and target annual bonus amount, respectively, for each named executive officer as of the Equity Awards Cutoff Date, (vii)&nbsp;the golden parachute rules under Section&nbsp;280G of the Code do not limit the payments to the named executive
officer pursuant to the &#147;best net&#148; provision described above and (viii)&nbsp;each of the named executive officers has properly executed any required releases and complied with all requirements (including any applicable restrictive
covenants) necessary in order to receive all payments and benefits. Some of the assumptions used in the table below are based upon information not currently available and, as a result, the actual amounts to be received by any of the named executive
officers, if any, may materially differ from the amounts set forth below. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Named Executive Officer Merger-Related Compensation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash</B><br><B>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity</B><br><B>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Perquisites/<BR>Benefits</B><br><B>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Tax<BR>Reimbursement</B><br><B>($)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven A. Cahillane</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,513,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66,164,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,218,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,987,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amit Banati</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,111,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,660,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,093,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,957,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lawlor(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,843,692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,324,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,290,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shumit Kapoor(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,991,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,732,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,814,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher M. Hood(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,335,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,335,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gary Pilnick(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,872,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,872,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown reflect the estimated lump sum cash severance payments pursuant to the COC Severance Policy and
the Merger Agreement, payable in the event the named executive officer experiences a COC Termination as described above. These amounts are &#147;double-trigger&#148; benefits and include: (i)&nbsp;two times the sum of each named executive
officer&#146;s Annual Base Salary (defined as the annualized amount of the such named executive officer&#146;s highest monthly salary during one year prior to the change of control, or any time after the change of control) and such named executive
officer&#146;s Target Annual Bonus (calculated based on the Annual Base Salary); and (ii)&nbsp;the greater of the COC Severance Policy Prorated Bonus and the Closing Year Bonus, which, for purposes of this disclosure, has been assumed to be equal to
the prorated target annual bonus based on the named executive officer&#146;s annual base salary rate in effect as of the Equity Awards Cutoff Date; and (iii)&nbsp;any accrued but unpaid vacation pay, as set forth below: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cash&nbsp;Severance</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Prorated&nbsp;Target<BR>Annual Bonus</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accrued&nbsp;but<BR>Unpaid&nbsp;Vacation</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven A. Cahillane</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,020,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,467,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amit Banati</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">594,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,827</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lawlor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,451,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">382,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shumit Kapoor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,559,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">399,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown reflect the potential value that each named executive officer could receive in connection with
accelerated vesting and cancellation and <FONT STYLE="white-space:nowrap">cash-out</FONT> of unvested RSUs and PSUs (including both the PSU Cash Payments and the Converted PSU Cash Awards), including all dividend equivalents accrued or credited with
respect thereto, as a result of the Merger. All Options held by the named executive officers are fully vested, and, accordingly, no amounts are reflected for vested Options. No DSUs are subject to vesting, and, accordingly the payout of
Mr.&nbsp;Cahillane&#146;s DSUs of $1,295,570 upon his termination of employment is not reflected in the table. These amounts are &#147;single-trigger&#148; benefits, except for the Converted PSU Cash Awards which are &#147;double-trigger&#148;
benefits and become accelerated in full upon a termination without cause or resignation for good reason occurring between the Effective Time and the original payment date. The PSU Cash Payment amount set forth below for Mr.&nbsp;Hood reflects a
prorated PSU amount assumed at target, with the proration calculated based on his May&nbsp;1, 2024 retirement date. The table below does not </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
include outstanding RSUs held by Mr.&nbsp;Hood that are currently vested but have not yet settled in accordance with their terms. The estimated amount of each such payment is set forth in the
table below: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>RSUs</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>PSU Cash<BR>Payments</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Converted&nbsp;PSU<BR>Cash Awards</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven A. Cahillane</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,301,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,931,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,931,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amit Banati</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,229,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,215,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,215,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lawlor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,588,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,367,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,367,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shumit Kapoor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,983,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,874,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,874,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christopher M. Hood</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,335,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gary Pilnick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,872,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown reflect (i)&nbsp;the estimated cost of continued health benefit plan coverage provided pursuant
to the COC Severance Policy (ii)&nbsp;the estimated cost of outplacement services provided pursuant to the COC Severance Policy, and (iii)&nbsp;the estimated cost of other continued benefits for the named executive officer under the COC Severance
Policy, including the annual cost for Kellanova-paid death benefits, financial planning and physical exams. These amounts are &#147;double-trigger&#148; benefits, as set forth below: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Continued&nbsp;Health<BR>Benefit Coverage</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Outplacement</B><br><B>Services</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Other&nbsp;Benefits</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven A. Cahillane</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amit Banati</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lawlor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shumit Kapoor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts shown reflect the estimated <FONT STYLE="white-space:nowrap">gross-up</FONT> payments in respect of any
Excise Tax for each named executive officer following a resignation from employment for &#147;good reason&#148; upon the Closing, which are reduced based on a reasonable estimated value for the named executive officer to not compete for the <FONT
STYLE="white-space:nowrap">one-year</FONT> period following the Closing. The portion of these amounts that relates to the amounts set forth in the &#147;Equity&#148; column (except for such amounts relating to Converted PSU Cash Awards) is a
&#147;single-trigger&#148; benefit and the portion of these amounts that relates to the amounts set forth in the &#147;Cash&#148; column, the &#147;Perquisites/Benefits&#148; column and Converted PSU Cash Awards is a &#147;double-trigger&#148;
benefit. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Lawlor is employed in Ireland and is paid in Euro. In calculating the U.S. dollar equivalent, we used
a conversion rate of 1.1043 based on the exchange rate as of the Equity Awards Cutoff Date. We have not included in the table a negative change of approximately -$20,000, which is an estimated amount reflecting the change to Mr.&nbsp;Lawlor&#146;s
retirement benefit and is negative because the present value reflects mortality between September&nbsp;3, 2024, and his unreduced retirement age. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Kapoor is employed in Singapore and is paid in Singapore dollars. In calculating the U.S. dollar
equivalent, we used a conversion rate of 0.7651 based on the exchange rate as of the Equity Awards Cutoff Date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Hood retired from Kellanova on May&nbsp;1, 2024 and is no longer actively employed with Kellanova.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with the completion of the <FONT STYLE="white-space:nowrap">spin-off</FONT> of WK Kellogg Co on
October&nbsp;2, 2023, Mr.&nbsp;Pilnick ceased serving as Kellanova&#146;s Vice Chairman and Chief Legal Officer and became the Chief Executive Officer of WK Kellogg Co. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_38"></A>Indemnification, Exculpation and Insurance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All rights to indemnification and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time, and any
rights to advancement of expenses in favor of the Company Indemnified Parties, as provided in the organizational documents of Kellanova or its subsidiaries existing as of the date of the Merger </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement or any indemnification agreements existing as of such date will survive the Merger and will not be amended, repealed or otherwise modified for a period of six years from and after the
Effective Time in any manner that would adversely affect the rights thereunder with respect to acts or omissions occurring at or prior to the Effective Time of the Company Indemnified Parties except to the extent required by applicable law. From and
after the Effective Time, Acquiror will cause the Surviving Corporation and its subsidiaries to honor these obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For more
information, see section entitled &#147;The Merger Agreement&#151;Indemnification, Exculpation and Insurance.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_39"></A>U.S.
Federal Income Tax Considerations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following discussion summarizes the U.S. federal income tax considerations generally applicable
to U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined below) who exchange Common Stock for cash pursuant to the Merger. This discussion applies only to holders of Common Stock who hold their stock as a capital asset within
the meaning of section 1221 of the Internal Revenue Code of 1986, which we refer to as the &#147;Code&#148; (generally, an asset held for investment). This summary is based on the Code, the U.S. Treasury Department regulations issued under the Code,
which we refer to as the &#147;Treasury Regulations,&#148; and administrative rulings and court decisions in effect as of the date of this proxy statement, all of which are subject to change at any time, possibly with retroactive effect. Any such
changes could affect the accuracy of the statements and conclusions set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This summary is not binding on the Internal Revenue
Service, which we refer to as the &#147;IRS,&#148; or a court, and there can be no assurance that the tax consequences described in this summary will not be challenged by the IRS or that they would be sustained by a court if so challenged. No ruling
has been or will be sought from the IRS, and no opinion of counsel has been or will be rendered, as to the U.S. federal income tax consequences of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, the term &#147;U.S. holder&#148; means a beneficial owner of Common Stock that is for U.S. federal income tax
purposes (i)&nbsp;a citizen or an individual who is a resident of the United States, (ii)&nbsp;a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States,
any state thereof, or the District of Columbia, (iii)&nbsp;an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source or (iv)&nbsp;a trust if (A)&nbsp;a court within the United States is
able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or (B)&nbsp;the trust has a valid election in effect under applicable
Treasury Regulations to be treated as a U.S. person for U.S. federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As used herein, the term <FONT
STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; means a beneficial owner of Common Stock that is neither a U.S. holder nor an entity or arrangement treated as a partnership for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This summary is not a complete description of all of the U.S. federal income tax considerations relating to the Merger and, in particular, may
not address U.S. federal income tax considerations applicable to holders of Common Stock who are subject to special treatment under U.S. federal income tax law including, for example, partnerships (or an entity or arrangement treated as a
partnership for U.S. federal income tax purposes) and partners therein, &#147;controlled foreign corporations&#148; or &#147;passive foreign investment companies,&#148; financial institutions, dealers in securities, insurance companies, <FONT
STYLE="white-space:nowrap">tax-exempt</FONT> entities (including private foundations), mutual funds, real estate investment trusts, personal holding companies, regulated investment companies, securities or currency dealers, traders in securities who
elect to use the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> method of accounting, <FONT STYLE="white-space:nowrap">tax-exempt</FONT> investors, S corporations, holders whose functional currency is
not the U.S. dollar, <FONT STYLE="white-space:nowrap">tax-deferred</FONT> or other retirement accounts, U.S. expatriates, former citizens or long-term residents of the United States, holders who acquired Common Stock pursuant to the exercise of an
employee stock Option or right or otherwise as compensation, holders who hold Common Stock as part of a hedge, straddle, constructive sale, conversion </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transaction, or other integrated investment, and holders that hold or have held, directly, indirectly or constructively pursuant to attribution rules, more than 5% of the shares of Common Stock
at any time during the five-year period ending on the date of the consummation of the Merger. Also, this summary does not address U.S. federal income tax considerations applicable to a holder of Common Stock who exercises appraisal rights under
DGCL. In addition, no information is provided with respect to the tax consequences of the Merger under any U.S. federal law other than income tax laws (including, for example the U.S. federal estate, gift, Medicare, and alternative minimum tax
laws), or any state, local, or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws that may be applicable to a holder. This summary does not address the tax consequences of any transaction other than the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If an entity or arrangement treated as a partnership for U.S. federal income tax purposes holds Common Stock, the tax treatment of a partner
in such a partnership generally will depend on the status of the partner and the activities of the partnership. Any entity or arrangement treated as a partnership for U.S. federal income tax purposes that holds Common Stock, and any partners in such
partnership, should consult their tax advisors regarding the tax consequences of the Merger to them in their specific circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>The tax consequences of the Merger will depend on a holder&#146;s specific situation. Holders of Common Stock should consult their tax
advisor as to the tax consequences of the Merger relevant to their particular circumstances, including the applicability and effect of the alternative minimum tax and any state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> or other tax
laws and of changes in those laws. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Consequences to U.S. holders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The receipt of cash by U.S. holders in exchange for shares of Common Stock pursuant to the Merger will generally be a taxable transaction for
U.S. federal income tax purposes. In general, for U.S. federal income tax purposes, a U.S. holder who receives cash in exchange for shares of Common Stock pursuant to the Merger will recognize capital gain or loss in an amount equal to the
difference, if any, between (i)&nbsp;the amount of cash received in the Merger and (ii)&nbsp;the U.S. holder&#146;s adjusted tax basis in its Common Stock exchanged therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If a U.S. holder acquired shares of Common Stock by purchasing them, the U.S. holder&#146;s adjusted tax basis in its shares will generally
equal the amount the U.S. holder paid for the relevant shares. If a U.S. holder&#146;s holding period in the shares of Common Stock surrendered in the Merger is greater than one year as of the date of the Merger, the gain or loss will be long-term
capital gain or loss. Long-term capital gains of certain <FONT STYLE="white-space:nowrap">non-corporate</FONT> holders, including individuals, are generally subject to U.S. federal income tax at preferential rates. The deductibility of capital
losses is subject to certain limitations. If a U.S. holder acquired different blocks of Common Stock at different times or different prices, such U.S. holder must determine its adjusted tax basis and holding period separately with respect to each
block of Common Stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Information Reporting and Backup Withholding </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Payments of cash to a U.S. holder of Common Stock pursuant to the Merger may, under certain circumstances, be subject to information reporting
and backup withholding, unless the holder provides proof of an applicable exemption or furnishes its taxpayer identification number, and otherwise complies with all applicable requirements of the backup withholding rules. Certain holders (such as
corporations) are exempt from backup withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">To avoid backup withholding, U.S. holders that do not otherwise establish an exemption
should return a properly completed and executed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> included with the letter of transmittal, certifying that such holder is a United States person, that the taxpayer identification number provided in
the IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> is correct, and that such holder is not subject to backup withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Backup
withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be refunded or credited against a holder&#146;s U.S. federal income tax liability, if any, provided that such holder furnishes the required information
to the IRS in a timely manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any gain realized by <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders pursuant to the Merger generally will not be subject to U.S.
federal income tax unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the gain is effectively connected with a trade or business of the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States (and, if required by an applicable income tax treaty, is also attributable to a U.S. permanent establishment of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
or, in the case of an individual, a fixed base in the United States maintained by such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder), in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to
tax on such gain in the same manner as a U.S. holder, and, if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a corporation, such corporation may be subject to a branch profits tax at the rate of 30% (or such lower rate as may be
specified by an applicable income tax treaty); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is an individual who is present in the United
States for 183 days or more in the taxable year of the Merger and certain other conditions are met, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to a 30% tax (or tax at such lower rate as may be
specified under an applicable income tax treaty) on the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s net gain realized in the Merger. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Information Reporting and Backup Withholding </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Payments of cash to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of Common Stock pursuant to the Merger will be subject to
information reporting and, in certain circumstances, backup withholding, unless such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder provides the paying agent with a properly executed applicable IRS Form
<FONT STYLE="white-space:nowrap">W-8</FONT> (or any appropriate successor or replacement forms) certifying under penalties of perjury the holder&#146;s <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status (and the payor or applicable withholding
agent does not have actual knowledge or reason to know that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a United States person as defined under the Code) or otherwise establishes an exemption. Copies of information returns that
are filed with the IRS may be made available under an applicable tax treaty or information exchange agreement to the taxing authorities of the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is established.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be refunded or credited against
a holder&#146;s U.S. federal income tax liability, if any, provided that such holder furnishes the required information to the IRS in a timely manner. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B><I>The discussion set forth above is included for general information purposes only and is not a complete analysis or discussion of all
potential tax consequences relevant to holders of Common Stock. Holders of Common Stock are strongly urged to consult their tax advisors with respect to the tax consequences of the Merger in their particular circumstances, including the
applicability and effect of the alternative minimum tax and any state, local, <FONT STYLE="white-space:nowrap">non-U.S.</FONT> or other tax laws and of changes in those laws. </I></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_40"></A>Litigation Related to the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement, no shareowner litigation related to the Merger Agreement has been brought against Kellanova or any
members of the Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_41"></A>Regulatory Approvals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The completion of the Merger is subject to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any applicable waiting period (and any extension thereof, including under any agreement between a party and a
governmental authority agreeing not to consummate the Merger prior to a certain date) under the HSR Act relating to the consummation of the Merger having expired or been terminated; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each other clearance or approval under any Antitrust Law in the jurisdiction set forth in the specified section
of the Company Disclosure Schedule, which jurisdictions include, in respect of competition and antitrust laws, Brazil, Canada, Chile, the Common Market for Eastern and Southern Africa, Costa Rica, Egypt, the European Union, India, Japan, Kuwait,
Mexico, Nigeria, Saudi Arabia, Serbia, South Africa, South Korea, Turkey and Ukraine and may include others, in respect of foreign investment laws, Austria, Belgium, France, Italy and Romania and may include others and, in respect of trade
regulation laws, the European Union under the Foreign Subsidies Regulation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) no governmental authority of competent jurisdiction has entered any order that remains in effect and no law
has been adopted or is effective, in each case, that temporarily or permanently prohibits, enjoins or makes illegal the consummation of the Merger or (ii)&nbsp;no legal proceeding has been brought by a governmental authority that remains pending and
that seeks an order that would impose a Legal Restraint. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the HSR Act and related rules, certain transactions,
including the Merger, may not be completed until required information and materials are furnished to the Antitrust Division and the FTC and statutory waiting period requirements have been satisfied. Following the filing by Kellanova and Acquiror of
their respective Notification and Report Forms, the waiting period under the HSR Act is expected to expire thirty days later unless earlier terminated or extended by the issuance of a Second Request. If the Antitrust Division or FTC issue a Second
Request, the waiting period with respect to the Merger will be extended for an additional period of 30&nbsp;calendar days following both parties&#146; substantial compliance with that request unless earlier terminated by the FTC or the Antitrust
Division. After that time, the waiting period may be extended only by court order or with the consent of the parties. At any time before or after the consummation of any such transactions, the FTC or the Antitrust Division could take such action
under the Antitrust Laws of the United States as it deems necessary or desirable in the public interest, including seeking to enjoin the Merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_42"></A>Required Vote of Shareowners </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Approval of the Merger Proposal is a condition to completion of the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The vote on the Merger Proposal is a vote separate and apart from the vote to approve either the Advisory Compensation Proposal or the
Adjournment Proposal. Accordingly, a Kellanova shareowner may vote to approve the Merger Proposal and vote not to approve the Advisory Compensation Proposal or the Adjournment Proposal, and vice versa. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Approval of the Merger Proposal requires the affirmative vote of holders of a majority of the outstanding shares of Common Stock entitled to
vote thereon. A failure to vote (including a failure to instruct your bank, broker, trust or other nominee to vote) or an abstention will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Merger Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the Voting Agreement and subject to the terms and conditions thereof, each Voting Agreement Shareowner agreed, among other things,
subject to the terms and conditions of its respective Voting Agreement, to vote all of the shares of Common Stock held by it in favor of the Merger Proposal at the Special Meeting. For more information, please see the section entitled &#147;The
Merger Agreement&#151;Voting Agreements.&#148; For more information regarding the security ownership of the Kellogg Foundation Trust, G. Zachary Gund Entities and Gund Trusts, please see the section entitled &#147;Certain Beneficial Owners of Common
Stock.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board, after due and careful discussion and consideration, unanimously (i)&nbsp;determined that the Merger Agreement,
the Merger and the other transactions contemplated by the Merger Agreement are advisable and fair to, and in the best interests of, Kellanova and the Kellanova shareowners, (ii)&nbsp;approved, authorized,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
adopted and declared advisable the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement and (iii)&nbsp;resolved to recommend that the Kellanova shareowners
vote in favor of the adoption of the Merger Agreement, the Merger and the other transactions contemplated by the Merger Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE
BOARD ACCORDINGLY UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#147;FOR&#148; THE MERGER PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_43"></A>THE MERGER AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>Below is a summary of the material provisions of the Merger Agreement, a copy of which is attached to this proxy statement as Annex&nbsp;A
and which is incorporated by reference into this proxy statement. This summary does not purport to be complete, may not contain all of the information about the Merger Agreement that is important to you, and is subject to, and qualified in its
entirety by, the full text of the Merger Agreement. We encourage you to read carefully the Merger Agreement in its entirety, as the rights and obligations of the parties thereto are governed by the express terms of the Merger Agreement and not by
this summary or any other information contained in this proxy statement. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_44"></A>Explanatory Note Regarding the Merger
Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following summary of the Merger Agreement, and the copy of the Merger Agreement attached as Annex&nbsp;A to this proxy
statement, are intended to provide information regarding the terms of the Merger Agreement and are not intended to provide any factual information about Kellanova or modify or supplement any factual disclosures about Kellanova in its public reports
filed with the SEC. In particular, the Merger Agreement and the related summary are not intended to be disclosures regarding any facts and circumstances relating to Kellanova. The Merger Agreement contains representations and warranties by, and
covenants of, Kellanova, Acquiror and Merger Sub (and solely in connection with (i)&nbsp;providing a guaranty of Acquiror&#146;s and Merger Sub&#146;s obligations under the Merger Agreement and (ii)&nbsp;undertakings with respect to compliance with
the confidentiality agreement and to obtain financing and regulatory approvals, Mars) that were made only for purposes of the Merger Agreement and as of specified dates. The representations, warranties and covenants in the Merger Agreement were made
solely for the benefit of the parties to the Merger Agreement, may be subject to limitations agreed upon by the contracting parties, including being modified and qualified by confidential disclosures made for the purposes of allocating contractual
risk between the parties to the Merger Agreement instead of establishing these matters as facts and may be subject to contractual standards of materiality or material adverse effect applicable to the contracting parties that generally differ from
those applicable to investors. In addition, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected
in Kellanova&#146;s public disclosures. Investors are not third-party beneficiaries under the Merger Agreement. Accordingly, you should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the
actual state of facts or condition of Kellanova, Acquiror, Merger Sub or Mars. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Additional information about Kellanova may be found
elsewhere in this proxy statement and Kellanova&#146;s other public filings. See the section entitled &#147;Where You Can Find More Information&#148; beginning on page 122. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_451"></A>Structure of the Merger; Certificate of Incorporation, Bylaws and Directors and Officers of the Surviving Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, Merger Sub will merge with and into Kellanova and the separate corporate existence of Merger Sub will cease. Kellanova
will be the Surviving Corporation in the Merger and will continue its corporate existence as a wholly owned subsidiary of Acquiror. At the Effective Time, all of the property, rights, privileges, powers and franchises of Kellanova and Merger Sub
will vest in the Surviving Corporation, and all debts, liabilities and duties of Kellanova and Merger Sub will become the debts, liabilities and duties of the Surviving Corporation, all as provided under the DGCL and the Delaware Limited Liability
Company Act (the &#147;DLLCA&#148;). At the Effective Time, the Certificate of Incorporation and Bylaws of Kellanova will be amended and restated as a result of the Merger in the forms attached as Exhibit A and Exhibit B to Annex A to this proxy
statement, respectively. The Surviving Corporation Organizational Documents include provisions with respect to exculpation, indemnification and advancement of expenses that are no less favorable to any person who is or prior to the Effective Time
becomes, or has been at any time prior to the date of the Merger Agreement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a director or officer of Kellanova (in each case, when acting in such capacity), which we collectively refer to as the &#147;Company Indemnified Parties,&#148; with respect to actions or
omissions occurring at or prior to the Effective Time as those contained in the Certificate of Incorporation and Bylaws of Kellanova as of immediately prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to applicable law, the managers of Merger Sub immediately prior to the Effective Time will be the initial directors of the Surviving
Corporation and will hold office until their respective successors are duly elected and qualified, or their earlier death, resignation or removal. The officers of Kellanova immediately prior to the Effective Time, or such other individuals
designated by Acquiror as of the Effective Time, will be the initial officers of the Surviving Corporation and will hold office until their respective successors are duly elected and qualified, or their earlier death, resignation or removal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_452"></A>When the Merger Becomes Effective; Closing and Effective Time </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Closing of the Merger will take place at the offices of Skadden at One Manhattan West, New York, New York 10001 at 10:00 a.m., New York
City time, on the third business day (or other date agreed upon in writing by the parties) after the satisfaction or, if permissible, waiver of the last of the closing conditions set forth in the Merger Agreement (other than any such conditions that
by their nature are to be satisfied by action taken at or immediately prior to the Closing of the Merger, but subject to the satisfaction or waiver of such conditions at or immediately prior to the Closing of the Merger), unless another time, date
or place is agreed to in writing by Kellanova and Acquiror (such date, the &#147;Closing Date&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">On the Closing Date, the parties
will cause a certificate of merger with regard to the Merger to be duly executed and filed with the Secretary of State of the State of Delaware as provided under the DGCL and DLLCA. The Merger will become effective at such time as such certificate
of merger is duly filed with the Secretary of State of the State of Delaware or on such later date and time as will be agreed upon by Kellanova and Acquiror and specified in such certificate of merger. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_453"></A>Effect of the Merger on the Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the Effective Time, each share of Common Stock issued and outstanding immediately prior to the Effective Time (other than (a)&nbsp;shares
owned (or held in treasury) by Kellanova, (b)&nbsp;shares owned by any of Kellanova&#146;s wholly owned subsidiaries, Mars, Acquiror or Merger Sub (or any other subsidiary of Mars) and (c)&nbsp;shares for which a holder properly perfects its
appraisal rights under the DGCL) will be canceled and automatically converted into the right to receive the Merger Consideration, without interest, and subject to any applicable withholding taxes. In addition, in respect of each such share of Common
Stock, if Kellanova declares and sets a record date for a dividend as permitted under the Merger Agreement (as further described in the section entitled &#147;The Merger Agreement&#151;Conduct of Business Pending the Merger&#148; beginning on page
88), and the Effective Time occurs after the record date for such dividend and prior to the payment date for such dividend, such dividend (and any applicable dividend equivalent rights to the extent any holder of a Kellanova equity award is entitled
to such rights under the terms of such equity awards as in effect on the date Kellanova declares the applicable dividend) will be paid to the holders of record as of such record date on the scheduled payment date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the Effective Time, each share of Common Stock owned or held in treasury by Kellanova immediately prior to the Effective Time will be
automatically canceled and no consideration will be delivered in exchange thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the Effective Time, each share of Common
Stock that is owned by any direct or indirect wholly owned subsidiary of Kellanova or by Mars or any of its subsidiaries (including Acquiror and its subsidiaries) immediately prior to the Effective Time will remain outstanding at the Effective Time
and will not be converted into the right to receive the Merger Consideration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Shares of Common Stock issued and outstanding immediately prior to the Effective Time with
respect to which a Kellanova shareowner did not vote in favor of the adoption of the Merger Agreement (or consent thereto in writing) and is entitled to demand and has properly made a demand for appraisal and who does not thereafter fail to perfect
or otherwise effectively waive, withdraw or otherwise lose such shareowner&#146;s right to appraisal in accordance with Section&nbsp;262, will not be converted into the right to receive the Merger Consideration, but instead at the Effective Time
will be automatically canceled and converted into the right to receive payment of such amounts as are payable in accordance with Section&nbsp;262. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the Effective Time, each common interest issued by Merger Sub and outstanding will be automatically converted into and become one fully
paid and nonassessable share of common stock of the Surviving Corporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_454"></A>Withholding Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each of Kellanova, Acquiror, Merger Sub, the Surviving Corporation and the payment agent for the Merger Consideration will be entitled to
deduct and withhold from the amounts that would otherwise be payable under the terms of the Merger Agreement any amounts that may be required to be deducted or withheld with respect to the making of such payment under any applicable tax law, and any
amounts so deducted or withheld and that, if required, are paid over to the applicable governmental entity will be treated as having been paid to the person in respect of which such deduction or withholding was made. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_455"></A>Treatment of Kellanova Incentive Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of Options </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective
Time, each Option that is outstanding and unexercised as of immediately prior to the Effective Time, by virtue of the Merger, will cease to be outstanding and will be converted into the right to receive an amount in cash, without interest, equal to
the product of the total number of shares of Common Stock subject to such Option and the excess, if any, of the per share Merger Consideration over the exercise price per share of Common Stock underlying the Option, subject to tax withholding. Any
Option with a per share exercise price equal to or greater than the per share Merger Consideration will be canceled as of the Effective Time without payment. All Options are currently fully vested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of RSUs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time,
each RSU that was granted prior to the date of the Merger Agreement and that is outstanding immediately prior to the Effective Time (including any restricted stock unit granted in 2022 that was originally subject to vesting based on service and
performance goals), by virtue of the Merger, will be deemed fully vested as to the number of shares of Common Stock issuable pursuant to such RSU, will cease to be outstanding and will be converted into the right to receive an amount in cash,
without interest, equal to the sum of the product of such number of shares of Common Stock issuable pursuant to the RSU and the per share Merger Consideration, plus all dividend equivalents accrued or credited with respect to such RSU, subject to
tax withholding. Each RSU granted on or after the date of the Merger Agreement that is outstanding and unvested immediately prior to the Effective Time will automatically be cancelled and converted into the contractual right to receive a payment in
an amount of cash (without interest and subject to applicable tax withholdings) equal to a Converted RSU Cash Award. Each Converted RSU Cash Award will generally be subject to the same terms and conditions as applied to such RSU immediately prior to
the Effective Time and will become payable in accordance with the original vesting schedule applicable to the corresponding RSU or, if earlier, upon a qualifying termination of employment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of PSUs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each PSU that is outstanding immediately prior to the Effective Time, by virtue of the Merger, will be deemed fully
vested as to the number of shares of Common Stock (i)&nbsp;if the performance period applicable to such PSU ends prior to the Effective Time, issuable pursuant to such PSU assuming maximum level of performance, and (ii)&nbsp;if the performance
period applicable to such PSU does not end prior to the Effective Time, issuable pursuant to such PSU at the greater of target or actual level of performance, as determined by Kellanova in good faith . All PSUs will cease to be outstanding and will
be converted into the right to receive an amount in cash, without interest, equal to the sum of the product of such number of shares of Common Stock issuable pursuant to the PSU (based on the level of vesting as described above) and the per share
Merger Consideration, plus all dividend equivalents accrued or credited with respect to such PSU, subject to tax withholding. Holders of PSUs that do not pay out in full at maximum level of performance at the Effective Time will also be entitled to
a cash retention payment based on the difference between the value of their PSUs at maximum level of performance and the payment received by such holder at the Effective Time, which will be payable on the last day of the performance period
applicable to the corresponding PSU, subject to the holder&#146;s continued employment through such date or, if earlier, upon a qualifying termination of employment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of DSUs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time,
each DSU that is outstanding immediately prior to the Effective Time, by virtue of the Merger, will cease to be outstanding and will be converted into the right to receive, at the time specified in the applicable company benefit plan and in
accordance with Section&nbsp;409A of the Code, an amount in cash, without interest, equal to the sum of the product of such number of shares of Common Stock underlying the DSU and the per share Merger Consideration, plus all dividend equivalents
accrued or credited with respect to such DSU, subject to tax withholding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Treatment of Employee Stock Purchase Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Prior to the Effective Time, Kellanova may, in its discretion, amend the ESPP to freeze all participant payroll deduction elections in effect
as of the date of the Merger Agreement under the ESPP, and is required to take all actions necessary to (i)&nbsp;provide that, contingent on the Effective Time: (1)&nbsp;no new purchasing period under the ESPP will commence following the date of the
Merger Agreement; (2)&nbsp;there will be no increase in the amount of participants&#146; payroll deduction elections under the ESPP and no contributions other than previously elected payroll deductions during the current offering period from those
in effect as of the date of the Merger Agreement; (3)&nbsp;no individual will commence participation in the ESPP during the period from the date of the Merger Agreement through the Effective Time; (4)&nbsp;each purchase right issued pursuant to the
ESPP will be fully exercised on the earlier of the scheduled purchase date for such purchasing period and the date that is immediately prior to the Effective Time, (ii)&nbsp;notify each participant that the purchase date for his or her purchase
right issued pursuant to the ESPP has been changed and (iii)&nbsp;
terminate the ESPP effective as of immediately prior to the Effective Time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_456"></A>Payment for Common Stock in the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Prior to the Effective Time, Acquiror will appoint a payment agent reasonably acceptable to Kellanova. At or prior to the Effective Time,
Acquiror will deposit with, or will make or cause to be made available to, the payment agent cash sufficient to pay the aggregate Merger Consideration payable pursuant to the Merger Agreement. As promptly as reasonably practicable after the
Effective Time (and in any event within three business days of the Closing Date), Acquiror will cause the payment agent to send to each holder of a certificate that immediately prior to the Effective Time represented shares of Common Stock (each, a
&#147;Certificate&#148;) that were converted into the right to receive the Merger Consideration a letter of transmittal and instructions for use. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Upon surrender of a Certificate (or effective affidavit of loss in lieu thereof) to the payment agent together with the letter of transmittal,
duly completed and validly executed, the holder of such Certificate will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entitled to receive the Merger Consideration (less applicable withholding taxes) in exchange for each share of Common Stock formerly represented by such Certificate. No interest will be paid or
will accrue on the cash payable upon the surrender or transfer of such Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As promptly as practicable following the Effective
Time, the payment agent will issue and deliver the Merger Consideration to each holder of book-entry shares that immediately prior to the Effective Time represented shares of Common Stock that were converted pursuant to the Merger Agreement into the
right to receive the Merger Consideration, and the book-entry shares will be canceled, and unless reasonably requested by the payment agent, without such holder being required to deliver a Certificate or any letter of transmittal, &#147;agent&#146;s
message&#148; or other documents to the payment agent. No interest will be paid or accrue on the cash payable in respect of any book-entry share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_457"></A>Representations and Warranties </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement contains representations and warranties of Kellanova, Acquiror, Merger Sub
and, solely in connection with providing a guaranty of Acquiror&#146;s and Merger Sub&#146;s obligations under the Merger Agreement, Mars. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Some of the representations and warranties in the Merger Agreement are qualified by materiality qualifications or a &#147;Company Material
Adverse Effect&#148; qualification with respect to Kellanova or an &#147;Acquiror Material Adverse Effect&#148; qualification with respect to Acquiror and Merger Sub. For purposes of the Merger Agreement, a &#147;Company Material Adverse
Effect&#148; with respect to Kellanova means any fact, change, circumstance, event, occurrence, condition, development or combination of the foregoing that is materially adverse to the business, properties, results of operations or condition
(financial or otherwise) of Kellanova and its subsidiaries, taken as a whole; provided, however, that a &#147;Company Material Adverse Effect&#148; will not be deemed to include the impact of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes in GAAP (or authoritative interpretation or enforcement thereof) after the date of the Merger
Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes in laws (or authoritative interpretation or enforcement thereof) after the date of the Merger
Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes in global, national or regional political conditions (including cyber-attacks, acts of terrorism or
sabotage, the outbreak of war or other armed hostilities or the escalation of any of the foregoing) after the date of the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any epidemics or pandemics (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> and any hurricane,
flood, tornado, earthquake or other natural disaster; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">actions or omissions required of Kellanova or any of its subsidiaries by the Merger Agreement or any action or
omission taken at the written request of Acquiror; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(A) the negotiation, execution, announcement or existence of the Merger Agreement or the Merger, including the
announcement of the identity of Acquiror (provided that the forgoing will not apply to certain representations or warranties related to (x)&nbsp;required governmental filings, consents and approvals, (y)&nbsp;conflicts or violations under contracts,
organizational documents and laws and (z)&nbsp;acceleration or triggering of certain employee benefits, in each case, to the extent the purpose of such representation or warranty is to address the consequences resulting from the execution and
delivery of the Merger Agreement or the consummation of the transactions), or (B)&nbsp;any communication by Acquiror or any of its affiliates regarding plans or proposals, with respect to Kellanova and its subsidiaries, in the case of each of the
foregoing clauses (A)&nbsp;and (B), including the impact thereof on the relationships, contractual or otherwise, of Kellanova and its subsidiaries with customers, suppliers, lenders, lessors, business partners and employees (including any employee
attrition); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any breach of the Merger Agreement by Acquiror or Merger Sub; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any change, in and of itself, in the trading price or volume of Common Stock or the failure, in and of itself,
to meet internal or external budgets, forecasts, projections or predictions or analysts&#146; expectations or projections for any future period (provided, that the underlying causes of such change or failure may be taken into account in determining
the existence of a &#147;Company Material Adverse Effect&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes in the global securities, credit or other financial markets, or in general economic, business or market
conditions, including any disruptions thereof or any change in prevailing interest rates, after the date of the Merger Agreement; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">conditions generally affecting the U.S. or any foreign economy (in which Kellanova and its subsidiaries
operate) or the industries in which Kellanova and its subsidiaries operate (including changes to commodity prices). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">However, with respect to the matters described in (i), (ii), (iii), (iv), (ix)&nbsp;and (x)&nbsp;above, such impact will be taken into account
to the extent that the effects of the change are disproportionately adverse to the business, properties, results of operations or condition (financial or otherwise) of Kellanova and its subsidiaries, taken as a whole, as compared to other companies
in the industries in which Kellanova and its subsidiaries operate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For the purpose of the Merger Agreement, an &#147;Acquiror Material
Adverse Effect&#148; with respect to Acquiror and Merger Sub means any fact, change, circumstance, event, occurrence, condition, development or combination of the foregoing that prevents, materially delays or materially impairs the ability of
Acquiror or Merger Sub to consummate the transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions in the Merger Agreement, Company Disclosure Schedule
and certain of Kellanova&#146;s public filings with the SEC filed after January&nbsp;1, 2021 and made publicly available prior to the date of the Merger Agreement, the Merger Agreement contains representations and warranties of Kellanova as to,
among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">organization, good standing and qualification to do business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">capital stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">corporate authority, and consents and approvals relating to the execution, delivery and performance of the Merger
Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reports, forms, documents and financial statements of Kellanova required by the SEC; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishment and maintenance of certain disclosure controls and procedures and internal control over financial
reporting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of undisclosed liabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with applicable laws and possession of permits necessary for the lawful operation of Kellanova and its
subsidiaries&#146; businesses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with sanctions and export control laws; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of investigations or reviews pending or threatened by any governmental entity and orders of or before any
governmental entity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details with respect to litigation against Kellanova or its subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">compliance with applicable environmental laws and certain details with respect to other environmental matters;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details with respect to Kellanova&#146;s employee benefit plans, employee relations and labor matters;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of certain events or changes in the businesses of Kellanova and its subsidiaries, including that there
has not been a &#147;Company Material Adverse Effect,&#148; from December&nbsp;31, 2023 through the date of the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accuracy and completion of the information supplied by Kellanova for inclusion in this proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details pertaining to Kellanova&#146;s and its subsidiaries&#146; tax returns, filings and other tax
matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details pertaining to Kellanova&#146;s and its subsidiaries&#146; intellectual property;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details pertaining to Kellanova&#146;s and its subsidiaries&#146; privacy and data protection practices;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details pertaining to the real estate owned and leased by Kellanova or its subsidiaries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details pertaining to Kellanova&#146;s and its subsidiaries&#146; material contracts;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain details pertaining to Kellanova&#146;s top suppliers and customers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">opinions of Kellanova&#146;s financial advisors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of broker&#146;s and finder&#146;s fees other than those described in the Merger Agreement; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain actions in respect of potentially applicable state anti-takeover statutes or regulations and any similar
provisions in the Certificate of Incorporation or Bylaws. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to certain exceptions in the Merger Agreement, the
Merger Agreement also contains representations and warranties of Acquiror and Merger Sub as to, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">organization and good standing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">corporate authority, and consents and approvals relating to the execution, delivery and performance of the Merger
Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accuracy and completion of the information supplied by Acquiror and Merger Sub for inclusion in this proxy
statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">availability of financing necessary to consummate the transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ownership, business and operations of Merger Sub; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of litigation in connection with the Merger Agreement or the Merger; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">absence of ownership of Common Stock by Mars, Acquiror, Merger Sub and certain related parties as of the date of
the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">solvency of the Surviving Corporation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ability to deliver, and the accuracy of, an opinion of counsel as to certain tax matters. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_458"></A>Conduct of Business Pending the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement provides that, during the period commencing on the signing of the Merger Agreement and ending on the earlier of the
termination of the Merger Agreement in accordance with its terms and the Effective Time, except (i)&nbsp;as required by applicable law, (ii)&nbsp;as expressly required by the Merger Agreement, (iii)&nbsp;as set forth in the Company Disclosure
Schedule, (iv)&nbsp;any action taken reasonably and in good faith in response to <FONT STYLE="white-space:nowrap">COVID-19</FONT> or <FONT STYLE="white-space:nowrap">COVID-19</FONT> measures or any other similar public health outbreak or
(v)&nbsp;with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prior written consent of Acquiror (which will not be unreasonably withheld, conditioned or delayed), Kellanova will, and will cause each of its subsidiaries to, (x)&nbsp;use commercially
reasonable efforts to conduct its business in the ordinary course consistent with past practice, and (y)&nbsp;use commercially reasonable efforts to maintain and preserve substantially intact its business organization, and preserve existing
relationships with key employees, persons having significant business dealings with Kellanova or any of its subsidiaries and any governmental entity that has jurisdiction over Kellanova or its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Further, the Merger Agreement also provides that, from the signing date of the Merger Agreement through the earlier of the termination of the
Merger Agreement in accordance with its terms and the Effective Time, except (i)&nbsp;as required by applicable law, (ii)&nbsp;as expressly required by the Merger Agreement, (iii)&nbsp;as set forth in the Company Disclosure Schedule or
(iv)&nbsp;with the prior written consent of Acquiror (which consent will not be unreasonably withheld, conditioned or delayed; provided, that Acquiror will be permitted, in its sole discretion, to withhold, condition or delay its consent with
respect to the matters described in (xi)&nbsp;below), Kellanova will not, and will cause its subsidiaries not to, among other things (and no action by Kellanova or its subsidiaries with respect to the following matters would constitute a breach of
the preceding paragraph unless it would be a breach of this paragraph): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amend Kellanova&#146;s or its subsidiaries&#146; organizational documents except for amendments to its
subsidiaries&#146; organizational documents that would not reasonably be expected to materially and adversely affect Acquiror or any of its subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">split, combine or reclassify any of its capital stock, repurchase (or redeem, purchase or otherwise acquire)
any shares of capital stock or make, declare or pay dividends or distributions thereon, subject to limited exceptions including payment of regular quarterly cash dividends declared and paid as set forth in the Company Disclosure Schedule;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">issue, sell or grant any right to acquire additional shares of capital stock, subject to limited exceptions
including in connection with (i)&nbsp;the settlement or exercise, as applicable, of equity awards, (ii)&nbsp;purchases pursuant to the ESPP and (iii)&nbsp;benefit plans in effect as of the date of the Merger Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">enter into a voting agreement or adopt a shareholder rights plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring,
recapitalization or other reorganization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">incur or guarantee indebtedness, subject to limited exceptions including (i)&nbsp;borrowings under any credit
facility in place as of the date of the Merger Agreement or replacements thereof up to $200&nbsp;million in the aggregate, (ii)&nbsp;issuances of letters of credit under any credit facility in place as of the date of the Merger Agreement or
replacements thereof up to $100&nbsp;million in the aggregate, (iii)&nbsp;borrowings under any commercial paper program up to $600&nbsp;million and (iv)&nbsp;indebtedness for borrowed money incurred in the ordinary course consistent with past
practice among Kellanova and its subsidiaries or among Kellanova&#146;s subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">incur any liens, except for permitted liens; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">redeem, repurchase or prepay indebtedness (except for (I)&nbsp;any repayments and prepayments under
Kellanova&#146;s credit facilities or (II)&nbsp;working capital lines of credit in the ordinary course of business consistent with past practice); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">dispose of material intellectual property rights, properties or assets, subject to limited exceptions, other
than in the ordinary course of business consistent with past practice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">cancel, release or assign any indebtedness owed to it or material claims held by it against any other person in
excess of $10&nbsp;million in the aggregate, other than in the ordinary course of business consistent with past practice; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Acquire any person or business (excluding any acquisitions of supplies and inventory in the ordinary course of
business consistent with past practice), make any material investment in any other person (other than ordinary course investments in subsidiaries of Kellanova), make any loans or advances to any other person (subject to limited ordinary course
exceptions) or enter into any new material line of business, other than in the ordinary course of business consistent with past practice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make any capital expenditures in excess of the aggregate amounts set forth in the Company Disclosure Schedule;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xiii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">other than in the ordinary course of business consistent with past practice, enter into a new material contract
or any other contract with consideration paid or payable by Kellanova or any of its subsidiaries of more than $25&nbsp;million in fiscal year 2023 or any fiscal year thereafter or terminate, amend (other than by renewing on terms not materially
different) or waive a right in a manner material and adverse to Kellanova and its subsidiaries under an existing material contract (or amend any contract such that it would constitute a material contract); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xiv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">enter into any contract that contains, or amend an existing contract such that it would contain, terms that
would be binding on Acquiror and its affiliates (other than Kellanova and its subsidiaries) after giving effect to the Merger and that would materially restrict their ability to compete in any business or with any person or in any geographic area or
buy and sell products and services from or to any person, which restrictions in each case would, to Kellanova&#146;s knowledge, be material and adverse to Mars and its subsidiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except as required by applicable law or pursuant to the requirements of any written agreements or benefit plans
in existence as of the date of the Merger Agreement or as set forth in the Company Disclosure Schedule, (i)&nbsp;increase the compensation or benefits payable or that become payable to any current or former employee or other service provider,
(ii)&nbsp;grant any increase in severance or termination pay to any current or former employee or other service provider or pay or award, or commit to pay or award, any bonuses or incentive compensation (including equity and equity-based awards) to
any current or former employee or other service provider, (iii)&nbsp;grant or award, or commit to grant or award, any equity or equity-based awards or incentives (including any Options, RSUs, DSUs or PSUs) to any current or former employee or other
service provider, (iv)&nbsp;amend any existing written employment agreement or offer letter with any current or former employee or other service provider, (v)&nbsp;amend or enter into any employment agreement or offer letter, (vi)&nbsp;establish,
adopt, enter into, amend, renew or terminate any collective bargaining agreement or benefit plan, (vii)&nbsp;take any action to accelerate any payment or benefit, or the funding of any payment or benefit, payable or to become payable to any current
or former employee or other service provider, (viii)&nbsp;amend the funding policy or contribution rate of any benefit plan or change any underlying actuarial assumptions used to calculate accrued benefit liabilities or benefits payable under any
benefit plan, except as may be required by GAAP or applicable law, (ix)&nbsp;waive or amend any restrictive covenant, (x)&nbsp;terminate the employment or service of any employee or other service provider other than for cause or (xi)&nbsp;hire any
person who would be an employee or other service provider. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xvi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">materially change its financial accounting principles, practices or methods, other than as required by GAAP or
applicable law; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xvii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">settle litigation subject to limited exceptions, including in the ordinary course consistent with past practice
or involving amounts to be paid by Kellanova (net of insurance proceeds and indemnity or similar payments) in settlement of $10&nbsp;million or less; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xviii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">engage in certain <FONT STYLE="white-space:nowrap">tax-related</FONT> actions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">other than in the ordinary course of business consistent with past practice, abandon or fail to take any
actions necessary to maintain any of its rights in any of Kellanova&#146;s material intellectual property; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xx)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">other than in the ordinary course of business consistent with past practice, make or forgive any loans to any
employees, officers or directors of Kellanova or any of its subsidiaries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xxi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">close any plant or facility; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xxii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">take any action or cause any registration statement to be declared effective by the SEC or issue, sell,
transfer or offer to sell or transfer any securities pursuant to a registration statement (other than pursuant to any registration statement on form <FONT STYLE="white-space:nowrap">S-8</FONT> or pursuant to the Kellanova Direct Stock Purchase and
Dividend Reinvestment Plan pursuant to the registration statement on form <FONT STYLE="white-space:nowrap">S-3);</FONT> or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(xxiii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">authorize, offer to any third party, agree or commit to take any of the above actions. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_459"></A>Other Covenants and Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Solicitation;</FONT> Takeover Proposals </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as expressly permitted by the Merger Agreement, Kellanova will, and will cause each of its subsidiaries, and will use its reasonable
best efforts to cause its and its subsidiaries&#146; representatives (i)&nbsp;to&nbsp;immediately cease and terminate any ongoing solicitation, encouragement, discussions or negotiations with any person (other than Mars and its subsidiaries,
including Acquiror and their respective representatives) with respect to a Company Takeover Proposal (as defined below) and (ii)&nbsp;not, directly or indirectly: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">solicit, initiate, knowingly encourage or knowingly facilitate any inquiries regarding, or the making of any
proposal or offer that constitutes, or would reasonably be expected to lead to, a Company Takeover Proposal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any
other person any <FONT STYLE="white-space:nowrap">non-public</FONT> information with the intent of inducing the making of, or knowingly encouraging or knowingly facilitating, a Company Takeover Proposal, other than (A)&nbsp;solely in response to an
unsolicited inquiry to refer the inquiring person to the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement and to limit its communication exclusively to such referral or (B)&nbsp;upon receipt of a bona fide,
unsolicited written Company Takeover Proposal that did not result from a material breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement solely to the extent necessary to ascertain facts or clarify
terms in order for the Board to have sufficient information to determine whether such Company Takeover Proposal is or could reasonably be expected to lead to a Company Superior Proposal (as defined below); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approve, adopt, publicly recommend or enter into, or publicly propose to approve, adopt, recommend or enter into,
any letter of intent or similar document, agreement, commitment, or agreement in principle (whether written or oral, binding or nonbinding) with respect to a Company Takeover Proposal (other than to enter into a confidentiality agreement in
accordance with the terms of the Merger Agreement); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">take any action to make the provisions of any &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control share
acquisition,&#148; &#147;business combination&#148; or other similar anti-takeover statute or regulation (including any transaction under, or a third party becoming an &#147;interested stockholder&#148; under, Section&nbsp;203 of the DGCL)
inapplicable to any person (other than Acquiror and its affiliates) or to any transactions constituting or contemplated by a Company Takeover Proposal; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">resolve or agree to do any of the foregoing. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the Merger Agreement, a &#147;Company Takeover Proposal&#148; means any proposal or offer from any person (other than Mars or any of its
subsidiaries) with respect to, or that would reasonably be expected to lead to, in a single transaction or a series of related transactions, (i)&nbsp;a merger, consolidation, business combination, recapitalization, binding share exchange,
liquidation, dissolution, joint venture or other similar transaction involving Kellanova or any of its subsidiaries that if consummated would result in any person (or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders of such person) beneficially owning 20% or more of the outstanding Common Stock or securities representing 20% or more of the voting power of Kellanova, (ii)&nbsp;any acquisition of
20% or more of the outstanding Common Stock (or securities representing 20% or more of the voting power of Kellanova), (iii)&nbsp;any acquisition (including the acquisition of stock of any subsidiary of Kellanova) of assets or businesses of
Kellanova or its subsidiaries, including pursuant to a joint venture, representing 20% or more of the consolidated assets, revenues or net income of Kellanova, (iv)&nbsp;any tender offer or exchange offer that if consummated would result in any
person beneficially owning 20% or more of the outstanding Common Stock (or securities representing 20% or more of the voting power of Kellanova) or (v)&nbsp;any combination of the foregoing types of transactions if the sum of the percentage of
consolidated assets, consolidated revenues or earnings and Common Stock (or voting power of securities of Kellanova other than Common Stock) involved is 20%&nbsp;or more. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Receipt of Company Takeover Proposal </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If
(i)&nbsp;at any time after the date of the Merger Agreement and prior to the receipt of approval of the transactions by Kellanova&#146;s shareowners (but not after), Kellanova or any of its representatives receives a bona fide,<I> </I>unsolicited
written Company Takeover Proposal that did not result from a material breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement and (ii)&nbsp;the Board determines, in good faith, after consultation
with its outside financial advisors and outside legal counsel, that such Company Takeover Proposal constitutes or could reasonably be expected to result in a Company Superior Proposal (as defined below), then Kellanova and its representatives may,
prior to the time of receipt of approval of the transactions by Kellanova&#146;s shareowners, but not after: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">furnish, pursuant to a confidentiality agreement that contains provisions that are no less favorable to Kellanova
than the confidentiality agreement between Kellanova and Mars, information with respect to Kellanova to the party making such Company Takeover Proposal and its representatives; provided, that, to the extent permitted by law, Kellanova must
substantially concurrently provide to Acquiror any such information that is <FONT STYLE="white-space:nowrap">non-public;</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engage in discussions or negotiations with such party regarding such Company Takeover Proposal.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the Merger Agreement, a &#147;Company Superior Proposal&#148; means a bona fide, unsolicited written Company
Takeover Proposal (i)&nbsp;that if consummated would result in a third party (or the stockholders of such third party) acquiring, directly or indirectly, more than 50% of the outstanding Common Stock or more than 50% of the assets of Kellanova and
its subsidiaries, taken as a whole, and (ii)&nbsp;that the Board determines in good faith (in accordance with the Merger Agreement), after consultation with its outside financial advisors and outside legal counsel, taking into account the timing and
likelihood of consummation relative to the transactions, and after giving effect to any changes to the Merger Agreement proposed by Acquiror in response to such Company Takeover Proposal (in accordance with the Merger Agreement) and all other
financial, legal, regulatory, tax and other aspects of such Company Takeover Proposal, including all conditions contained therein and the person making such Company Takeover Proposal, as the Board deems relevant, is more favorable from a financial
standpoint to Kellanova shareowners than the Merger. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Notice of Company Takeover Proposal </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the terms of the Merger Agreement, Kellanova must (i)&nbsp;as promptly as practicable (and in any event within 48 hours after receipt)
notify Acquiror of the receipt of any Company Takeover Proposal or a request for information relating to Kellanova or its subsidiaries that constitutes or contemplates a Company Takeover Proposal, including the identity of the person making such
Company Takeover Proposal and a description of the material terms and conditions thereof and (ii)&nbsp;keep Acquiror reasonably informed, on a reasonably current basis, as to the status of the Company Takeover Proposal including any developments,
discussions or negotiations and providing to Acquiror a description of any changes to the material terms and conditions in respect thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Company Recommendation; Adverse Recommendation Change; Fiduciary Exception </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As described above in the section of this proxy statement entitled &#147;The Merger&#8201;&#151;Recommendation of the Board and Its Reasons for
the Merger,&#148; and subject to the provisions described below, the Board has unanimously made the recommendation that Kellanova shareowners vote &#147;<B>FOR</B>&#148; the proposal to approve the adoption of the Merger Agreement and the
transactions contemplated thereby, including, without limitation, the Merger, which unanimous recommendation we refer to as the &#147;Company Recommendation.&#148; The Merger Agreement provides that the Board will not effect an &#147;Adverse
Recommendation Change&#148; (as described below) except as defined below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the Merger Agreement, generally, the Board may not:
(i)&nbsp;(A) fail to include the Company Recommendation in this proxy statement; (B)&nbsp;change, qualify, withhold, withdraw or modify, or authorize or publicly propose to change, qualify, withhold, withdraw or modify, in a manner adverse to
Acquiror, the Company Recommendation; or (C)&nbsp;adopt, approve or recommend to Kellanova shareowners, or resolve to or publicly propose or announce its intention to adopt, approve or recommend to Kellanova shareowners, a Company Takeover Proposal
(any action described in (i)&nbsp;being referred to as an &#147;Adverse Recommendation Change&#148;) or (ii)&nbsp;authorize, cause or permit Kellanova or any of its subsidiaries to enter into any letter of intent, memorandum of understanding,
agreement (including an acquisition agreement, merger agreement, joint venture agreement or other agreement), commitment or agreement in principle with respect to any such Company Takeover Proposal (other than a confidentiality agreement entered
into in accordance with the Merger Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may, prior to receipt of approval of the transactions by Kellanova&#146;s
shareowners (but not after): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">with respect to a bona fide, unsolicited Company Takeover Proposal that did not result from a breach of the <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement, make an Adverse Recommendation Change or cause Kellanova to terminate the Merger Agreement in order to substantially concurrently with such termination enter into
a definitive agreement relating to such Company Takeover Proposal if and only if, prior to taking either such action, (i)&nbsp;Kellanova has complied, in all material respects, with its obligations under the
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision of the Merger Agreement (including the notice obligations to Acquiror described below), (ii)&nbsp;the Board has determined in good faith, after consultation with its outside
financial advisors and outside legal counsel, that the Company Takeover Proposal constitutes a Company Superior Proposal and (iii)&nbsp;the Board determines in good faith (after consultation with its outside financial advisors and outside legal
counsel) that the failure to do so would reasonably be expected to be inconsistent with its fiduciary duties under applicable law; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make an Adverse Recommendation Change in response to a &#147;Company Intervening Event&#148; which is defined as
any fact, circumstance, occurrence, event, development, change or condition or combination thereof (other than (x)&nbsp;the fact that Kellanova meets or exceeds any internal or published projections, forecasts, estimates or predictions of revenue,
earnings or other financial or operating metrics for any period, any changes after the date of the Merger Agreement in the market price or trading volume of Common Stock (provided that the underlying causes of such fact, to the extent not otherwise
excluded from this definition of &#147;Company Intervening Event,&#148; may be taken into account in determining the existence of a Company Intervening Event), or (y)&nbsp;any reasonably foreseeable consequence of the announcement of the Merger
Agreement) that was not known to or reasonably expected by the Board as of or prior to the date of the Merger Agreement (or if known or reasonably expected, the consequences of which were not reasonably foreseeable as of or prior to the date of the
Merger Agreement) and is unrelated to any Company Takeover Proposal or expected receipt of a Company Takeover Proposal, which we refer to as an &#147;Intervening Event Recommendation Change,&#148; if (i)&nbsp;Kellanova has complied, in all material
respects, with its obligations under the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement (including the notice obligations to Acquiror described below) and (ii)&nbsp;the Board has determined, in good
faith, after consultation with its outside financial advisors and outside legal counsel, that the failure to take such action would reasonably be expected to be inconsistent with its fiduciary duties under applicable law. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Prior to making any such Adverse Recommendation Change, effecting any such termination or
making any such Intervening Event Recommendation Change, (i)&nbsp;Kellanova must give Acquiror at least five business days&#146; prior notice of its intention to do so, the reasons therefor, and certain information related thereto,
(ii)&nbsp;Kellanova must negotiate in good faith with Acquiror and its representatives to enable Acquiror to propose revisions to the terms of the Merger Agreement, and (iii)&nbsp;the Board must consider in good faith any revisions to the terms of
the Merger Agreement proposed in writing by Acquiror (and not revoked) and determine in good faith after consultation with its outside financial advisors and outside legal counsel, either that the Company Takeover Proposal continues to constitute a
Company Takeover Proposal if the revisions proposed by Acquiror were to be given effect, or that the failure to make an Intervening Event Recommendation Change would reasonably be expected to be inconsistent with the Board&#146;s fiduciary duties
under applicable law, as the case may be. Further, in the event of any change to the financial terms or other material terms of such Company Takeover Proposal, Kellanova must give a new notice to Acquiror consistent with that described in clause
(i)&nbsp;above and a new notice period under clause (i)&nbsp;above will commence, except that the five business day notice period will instead be the longer of three business days and the period remaining under the original notice period immediately
prior to the delivery of such additional notice. Kellanova is not permitted to terminate the Merger Agreement under these provisions with respect to a Company Superior Proposal unless Kellanova pays Acquiror the Termination Fee (which is described
in more detail in the section entitled &#147;&#151;Termination Fee&#148; beginning on page 103) prior to or concurrently with such termination. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Access to Information </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to
certain exceptions and limitations, Kellanova will, and will cause its subsidiaries to (i)&nbsp;afford Acquiror and its representatives reasonable access during normal business hours, upon reasonable advance notice, to Kellanova&#146;s and its
subsidiaries&#146; personnel, properties, contracts, commitments, books and records (including tax returns), and (ii)&nbsp;make available to Acquiror such other available information concerning its business, properties and personnel as Acquiror may
reasonably request for the purpose of consummating the transactions, reasonable integration planning or filing any tax return required to be filed in connection with or the result of the transactions and will instruct Kellanova&#146;s (and its
subsidiaries&#146;) independent accountants to provide access to their work papers and such other information (including tax returns and drafts of any U.S. federal income tax returns or other material state or
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> income tax returns) as Acquiror may reasonably request. Kellanova will not be required to provide access to or make available, in each case of (i)&nbsp;and (ii) above, to any person any information if
(x)&nbsp;doing so would, in Kellanova&#146;s and its outside counsel&#146;s reasonable judgment, violate any law or contract or give rise to a material risk of jeopardizing the attorney-client privilege, or result in the disclosure of any trade
secrets; provided, that Kellanova informs Acquiror of the general nature of such information and reasonably cooperates with Acquiror to share the information in such a manner that would not result in the violation of law or contract or loss or
waiver of such privilege or the disclosure of any trade secret, or (y)&nbsp;such documents or information are reasonably pertinent to any adverse legal proceeding between Kellanova and its affiliates, on the one hand, and Mars and its affiliate, on
the other hand. Any access or investigation must be conducted so as not to interfere unreasonably with the business and operations of Kellanova or any of its subsidiaries and will not extend to or include any sampling or testing of environmental
media. No investigation by Acquiror or its representatives will affect or be deemed to modify or waive the representations and warranties of Kellanova set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as prohibited by law, prior to the Closing Kellanova will, and will cause its subsidiaries and their respective representatives to, use
commercially reasonable efforts to (i)&nbsp;as promptly as reasonably practicable after the date of the Merger Agreement provide to Acquiror any contract of Kellanova and its subsidiaries for the procurement of goods and services with consideration
payable by Kellanova or any its subsidiaries of more than $25&nbsp;million in the twelve months ended August&nbsp;1, 2024 or in any single fiscal year thereafter as may be reasonably requested by Acquiror, (ii)&nbsp;as promptly as reasonably
practicable after the date of the Merger Agreement, provide to Acquiror a copy of the primary loan agreement, credit agreement, note, debenture, bond or indenture, in each case, as in effect on the date of the Merger Agreement, pursuant to which any
indebtedness for borrowed money of Kellanova or any of its subsidiaries may be incurred or is outstanding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with a principal amount then-outstanding or commitments thereunder that is individually greater than $100&nbsp;million as of the date of the Merger Agreement, in each case, to the extent not
previously provided to Acquiror prior to the date of the Merger Agreement and (iii)&nbsp;cooperate with any reasonable due diligence request and process regarding such contracts as reasonably requested by Acquiror as contemplated by the previous
paragraph. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification, Exculpation and Insurance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All rights to indemnification and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time, and any
rights to advancement of expenses in favor of the Company Indemnified Parties, as provided in the organizational documents of Kellanova or its subsidiaries existing as of the date of the Merger Agreement or any indemnification agreements existing as
of such date will survive the Merger and will not be amended, repealed or otherwise modified for a period of six years from and after the Effective Time in any manner that would adversely affect the rights thereunder with respect to acts or
omissions occurring at or prior to the Effective Time of the Company Indemnified Parties except to the extent required by applicable law. From and after the Effective Time, Acquiror will cause the Surviving Corporation and its subsidiaries to honor
these obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Prior to the Effective Time, at Kellanova&#146;s option, Kellanova will, or, if Kellanova does not, Acquiror will
cause the Surviving Corporation to, obtain and fully pay the premium for the <FONT STYLE="white-space:nowrap">non-cancelable</FONT> extension of the Kellanova&#146;s existing directors&#146; and officers&#146; insurance policies and Kellanova&#146;s
existing fiduciary liability insurance policies with respect to acts or omissions occurring at or prior to the Effective Time and for a claims reporting or discovery period of at least six years from and after the Effective Time; provided that
Kellanova (or the Surviving Corporation) will not pay an amount for such new insurance in excess of 300% of the aggregate annual premium currently paid by Kellanova for such policies. If such policies have been obtained by either Kellanova or the
Surviving Corporation prior to or as of the Effective Time, Acquiror will cause such policies to be maintained in full force and effect, for their full term, and cause all obligations thereunder to be honored by the Surviving Corporation. If such
policies are not obtained as of the Effective Time, then the Surviving Corporation is required to maintain in effect, for a period of not less than six years, Kellanova&#146;s current directors&#146; and officers&#146; fiduciary liability insurance
policies or a comparable policy, subject to certain limitations and minimum standards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Efforts to Complete the Merger; Regulatory Approvals
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement provides that Kellanova, Acquiror and Merger Sub will (and will cause their respective affiliates to, if
applicable) each use their respective reasonable best efforts to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">promptly submit all notifications to and obtain all clearances, authorizations, consents, orders and approvals of
all governmental entities that may be, or become necessary for execution and delivery of, and the performance of obligations pursuant to, the Merger Agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cooperate fully in promptly submitting all notifications and seeking to obtain all such clearances,
authorizations, consents, orders and approvals; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide any other information any governmental entity may reasonably request in connection with the Merger
Agreement (including requests for additional information or materials under the Antitrust Laws) as promptly as reasonably practicable. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the Merger Agreement, each party is required to (i)&nbsp;promptly, and in no event later than the date that is 10 business days after
the date of the Merger Agreement (or such other date determined by Acquiror reasonably and in good faith), make its respective filings pursuant to the HSR Act and (ii)&nbsp;as promptly as practicable, make its respective filings and notifications
(initially in draft form where customary), if any, under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any other applicable Antitrust Law, and, in each case, to supply to the appropriate governmental entities as promptly as practicable any additional information and documentary materials as may be
requested. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Acquiror and Kellanova (if requested by Acquiror) have agreed to use their respective reasonable best efforts to avoid or
eliminate any impediment under any Antitrust Law that may be asserted by any antitrust or competition governmental entity, so as to enable the parties to close the Merger as promptly as practicable, including (subject to the next paragraph): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">proposing, negotiating, committing to and effecting, the sale, divestiture or disposition of such of its assets,
properties or businesses or of the assets, properties or businesses to be acquired by it pursuant to the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">entering into such other arrangements as are necessary or advisable to avoid the entry of, or to have vacated,
lifted, reversed or overturned any decree, judgment, injunction or other order, that would prevent the consummation of the Merger; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">contesting and defending on the merits any claim asserted by a governmental entity in order to avoid the entry
of, or to have vacated or terminated, any decree, order or judgment that would prevent the Closing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the HSR Act
and related rules, certain transactions, including the Merger, may not be completed until required information and materials are furnished to the Antitrust Division and the FTC and statutory waiting period requirements have been satisfied. Following
the filing by Kellanova and Acquiror of their respective Notification and Report Forms, the waiting period under the HSR Act is expected to expire on thirty days later unless earlier terminated or extended by the issuance of a Second Request to the
parties by the FTC or the Antitrust Division prior to that time. If the FTC or the Antitrust Division issues a Second Request, the waiting period with respect to the Merger will be extended for an additional period of 30&nbsp;calendar days following
both parties&#146; substantial compliance with that request unless earlier terminated by the FTC or the Antitrust Division. After that time, the waiting period may be extended only by court order or with the consent of the parties. At any time
before or after the consummation of any such transactions, the FTC or the Antitrust Division could take such action under the Antitrust Laws of the United States as it deems necessary or desirable in the public interest, including seeking to enjoin
the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Acquiror and Kellanova have agreed that Acquiror will control and direct the parties&#146; filings (including filing timing),
strategies, processes, negotiation of settlements (if any) and related proceedings to obtain regulatory approvals (and Acquiror shall consult with and consider in good faith Kellanova&#146;s views with regard thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">However, none of Mars, Acquiror, Merger Sub or any other subsidiary of Mars will be required to, and Kellanova and its subsidiaries will not
without the prior written consent of Mars, take any action, or commit to take any action, or agree to any condition or limitation contemplated in the antitrust covenant of the Merger Agreement (i)&nbsp;that is not conditioned upon the consummation
of the Merger, (ii)&nbsp;with respect to any of Mars&#146;, Acquiror&#146;s or their respective subsidiaries operations, divisions, businesses, product lines, contracts, licenses, relationships, contractual rights or obligations, customers or assets
or (iii)&nbsp;that would result in, or would be reasonably likely to result in, the sale, divestiture or disposition of assets, properties or businesses of Kellanova or any of its subsidiaries and/or the termination of any business (in any
jurisdictions(s)) of Kellanova or any of its subsidiaries that generated more than $750&nbsp;million of annual consolidated revenues of Kellanova and its subsidiaries during the <FONT STYLE="white-space:nowrap">12-month</FONT> period ending as of
December&nbsp;31, 2023 (each of (i), (ii)&nbsp;or (iii), a &#147;Burdensome Condition&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mars, Kellanova and their respective
subsidiaries (including Acquiror and Merger Sub) have agreed not to, prior to the Closing, acquire, or agree to acquire, any businesses, assets or securities of a third party if such acquisition would, or would reasonably be expected to, prevent or
materially delay the obtaining of necessary regulatory approvals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employee Matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For a period of at least 12 months following the Effective Time (or, if earlier, the date of termination of the applicable continuing
employee), Acquiror or the Surviving Corporation must provide each employee of Kellanova or any of its subsidiaries who continues as of the Effective Time to be employed by Acquiror, the Surviving Corporation or any affiliate (which we refer to
herein as &#147;continuing employees&#148;) with (i)&nbsp;at least the same level of base salary or hourly wage rate and target annual short-term cash incentive opportunities at rates that, in each case, were provided to such continuing employee
immediately prior to the Effective Time, (ii)&nbsp;employee benefits (including employee car, transit and housing allowances provided in the ordinary course of business consistent with past practice, employee leave policies and arrangements,
post-retirement medical benefits and 401(k) matching and contribution levels, but excluding all cash and equity incentive compensation, benefits under an ESPP, executive corporate aircraft policy, severance, defined benefit pension plans and change
in control, retention or other similar <FONT STYLE="white-space:nowrap">non-reoccurring</FONT> compensation arrangements) that are substantially comparable in the aggregate to those provided to such continuing employee by Kellanova and any of its
subsidiaries immediately prior to the Effective Time (subject to the exclusions described above), (iii) no less favorable severance payments and benefits and garden leave and/or notice requirements (excluding any treatment in respect of equity
awards granted after the Closing) to those that would have been provided to such continuing employee prior to the Effective Time consistent with the terms of the applicable benefit plan (provided that the calculation of such severance benefits
including certain employee allowances is taken into account in a manner that is consistent with past practices prior to the Closing) and (iv)&nbsp;no less favorable target long-term incentive opportunities to those provided to such continuing
employee by Kellanova or any of its subsidiaries immediately prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">To the extent unpaid as of the Closing Date, in
respect of each Kellanova employee&#146;s annual bonus for the calendar year prior to the calendar year in which the Closing occurs (referred to herein as the &#147;prior year annual bonus&#148;), Acquiror will, or will cause the Surviving
Corporation to, pay to each continuing employee such prior year annual bonus in the ordinary course consistent with past practice for paying prior year annual bonuses (including for employees who experience an involuntary termination without
&#147;cause&#148; following the end of the applicable calendar year but prior to the applicable payment date). In respect of each continuing employee&#146;s annual bonus for the calendar year in which the Closing occurs (referred to herein as the
&#147;closing year annual bonus&#148;), Acquiror will, or will cause the Surviving Corporation to, pay to each continuing employee such closing year annual bonus in an amount no less than the product obtained by multiplying (1)&nbsp;such continuing
employee&#146;s full bonus entitlement under the applicable benefit plan, assuming the greater of (A)&nbsp;target performance for all company performance goals, and (B)&nbsp;actual performance, extrapolated through the end of the applicable calendar
year based on actual performance through the Closing Date, as determined in good faith by the Compensation and Talent Management Committee of the Board prior to the Closing Date, by (2)&nbsp;a fraction, the numerator of which equals the number of
days that have elapsed from the first day of the calendar year in which the Closing occurs through the Closing Date and the denominator of which equals the total number of calendar days in such calendar year. The closing year annual bonus payment
will be payable at the same time that annual bonuses would have been paid absent the Merger, subject to the continuing employee&#146;s continued employment with Kellanova or its affiliates though the applicable payment date, unless the continuing
employee&#146;s employment is terminated due to an early qualifying termination. If any continuing employee experiences a qualifying termination of employment prior to the payment of his or her closing year annual bonus, such terminated continuing
employee will be entitled to receive his or her closing year annual bonus, payable at the same time that the annual bonus would have been paid absent the qualifying termination of employment or, if greater, the payment that such continuing employee
would otherwise be entitled in respect of the closing year annual bonus under the severance benefits protections described in the first paragraph of this section, subject to execution of a general release of claims. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Effective Time, each continuing employee will be given service credit for all purposes, including for eligibility to participate,
benefit levels and eligibility for vesting under Acquiror employee benefit plans with respect to his or her length of service with Kellanova (and its subsidiaries and predecessors) prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Closing, provided that in no event will any continuing employee be given service credit that would result in the duplication of benefits and no service credit will be recognized with respect
to benefit accruals under any defined benefit pension plan or for any purpose under any post-employment health or welfare benefit plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">After the Effective Time, Acquiror will use its reasonable best efforts to cause each continuing employee to be immediately eligible to
participate in all Acquiror benefit plans to the extent coverage under such benefit plans replaces coverage under a comparable benefit plan of Kellanova in which such continuing employee participated immediately before the Effective Time and, for
purposes of each Acquiror benefit plan providing medical, dental, pharmaceutical and/or vision benefits to any continuing employee and his or her covered dependents, cause all <FONT STYLE="white-space:nowrap">pre-existing</FONT> condition
limitations, exclusions, waiting periods and actively at work requirements of such Acquiror benefit plan to be waived to the extent such limitations, exclusions, waiting periods and actively at work requirements were waived or satisfied under the
comparable benefit plan of Kellanova and recognize any eligible expenses incurred under a benefit plan of Kellanova during the portion of the plan year prior to the date such continuing employee becomes eligible to participate in such
Acquiror&#146;s benefit plan to be taken into account under such Acquiror benefit plan for purposes of satisfying all deductible, <FONT STYLE="white-space:nowrap">co-insurance,</FONT> <FONT STYLE="white-space:nowrap">co-payment</FONT> and maximum
out of pocket requirements for the applicable plan year as if such amounts had been paid in accordance with such benefit plan of Kellanova. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">With respect to continuing employees covered by a collective bargaining agreement, the terms and conditions of employment for those continuing
employees will be governed by the applicable collective bargaining agreement until the expiration, modification or termination of such collective bargaining agreement in accordance with its terms or applicable law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Company Special Meeting </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova
has agreed to duly give notice of, convene and hold a meeting of Kellanova shareowners for the purpose of voting upon the Merger Proposal as promptly as practicable following resolution of any SEC comments with respect to this proxy statement (which
Kellanova was required to use its reasonable best efforts to file within 30 days of the date of the Merger Agreement). Subject to certain exceptions permitting a delay, Kellanova must hold a meeting of Kellanova shareowners for the purpose of voting
on the Merger Proposal on or around the 20th business day following the commencement of the mailing of this proxy statement to Kellanova shareowners. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Matters </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At the Closing,
Kellanova and Acquiror will each use their respective reasonable best efforts to obtain an opinion of Acquiror Tax Counsel (as defined in the section entitled &#147;The Merger Agreement&#151;Conditions to Consummation of the Merger&#148;) addressed
to Acquiror to the effect that, based upon certain facts, assumptions and representations, and subject to certain qualifications and limitations, for U.S. federal income tax purposes, the Merger will not affect the qualification of (i)&nbsp;the
Contribution and Distribution, each as defined in the Separation and Distribution Agreement, dated as of September&nbsp;29, 2023, by and between Kellanova and WK Kellogg Co (the &#147;Separation and Distribution Agreement&#148;), as qualifying for <FONT
STYLE="white-space:nowrap">non-recognition</FONT> of gain or loss to Kellanova pursuant to Sections 368, 355 and 361 of the Code, and (ii)&nbsp;the Distribution (as defined in the Separation and Distribution Agreement) as qualifying for <FONT
STYLE="white-space:nowrap">non-recognition</FONT> of income, gain, or loss to Kellanova&#146;s shareowners pursuant to Section&nbsp;355 of the Code, except to the extent of cash received in lieu of fractional shares (referred to as the &#147;Closing
Tax Opinion&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatment of Certain Indebtedness </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova will, and will cause its subsidiaries to, deliver all notices and take all other actions reasonably requested by Acquiror that are
required to, in accordance with the terms thereof, terminate all commitments outstanding under the Credit Agreements, repay in full all obligations, if any, outstanding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereunder, and facilitate the release of all liens, if any, securing such obligations, and the release of all guarantees, if any, in connection therewith, in each case, as of the Effective Time.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mars, Acquiror or any of their affiliates may, or may request Kellanova to, in which case Kellanova will use its reasonable best efforts,
commence as promptly as practicable following receipt of such request, one or more consent solicitations regarding certain proposed amendments to the Indentures as reasonably requested by Mars, including to eliminate, waive or amend the change of
control provisions and to amend the reporting covenants in the Indentures. Upon receipt of the requisite consents, Kellanova will execute a supplemental indenture to each applicable Indenture reflecting the terms of such consent solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova will, and will cause its subsidiaries to, and will use reasonable best efforts to cause its and its subsidiaries&#146; respective
representatives to, use its and their respective reasonable best efforts to provide all cooperation reasonably requested by Mars or Acquiror in connection with the commencement and conduct of any consent solicitation described in the preceding
paragraph, or any exchange offer to exchange all or a portion of Kellanova&#146;s outstanding notes for securities of Mars, including assistance with the preparation of one or more offering memorandums, offers to purchase and consent solicitation
statements, letters of transmittal and consents (if required) and press releases. Any documents (including all amendments or supplements thereto) and all mailings to the holders of Kellanova&#146;s notes in connection with any such consent
solicitation conducted by Kellanova will be subject to the prior review of, and comment by, Kellanova and Acquiror and shall be reasonably acceptable in form and substance to each of them. If at any time prior to the completion of any such exchange
offer, any information should be discovered by Acquiror or Kellanova that Acquiror or Kellanova reasonably believes should be set forth in an amendment or supplement to the documentation relating thereto, so that such documentation shall not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of circumstances under which they are made, not misleading, the party that
discovers such information will promptly notify the other parties, and an appropriate amendment or supplement prepared by Acquiror (or at the reasonable request of Acquiror, prepared by Kellanova) describing such information (which amendment or
supplement shall be reasonably satisfactory in form and substance to Acquiror) will be disseminated to the holders of the applicable Kellanova notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At or prior to the Effective Time, Acquiror will provide (or cause to be provided) to Kellanova funds in an amount equal to the consent fee
payable in connection with any consent solicitation pursuant to the foregoing. Acquiror will, promptly upon written request by Kellanova, (i)&nbsp;reimburse Kellanova for all reasonable and documented <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by Kellanova or any of its subsidiaries in connection with the cooperation of Kellanova and its subsidiaries and (ii)&nbsp;indemnify, defend and hold harmless
Kellanova and its subsidiaries and their respective representatives from any liability arising out of the contemplated financing transactions and any information used in connection therewith (subject to certain customary exceptions). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Financing Covenants and Obligations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova will use its reasonable best efforts, and will cause its subsidiaries to use their respective reasonable best efforts, to provide,
and Kellanova and its subsidiaries will use their respective reasonable best efforts to cause each of their respective representatives to provide, at Acquiror&#146;s sole cost and expense, to Mars, Acquiror and its affiliates all customary
cooperation that may be reasonably requested by Mars or Acquiror (including reasonable requests of the debt financing sources) to assist Mars, Acquiror and its affiliates in arranging, obtaining, syndicating and consummating debt financing for the
transaction (or any issuance, sale or offering of debt securities and/or delayed draw term loans, in each case, in lieu thereof) or any exchange offer to exchange all or a portion of Kellanova&#146;s outstanding notes for securities of Mars. Mars
and Acquiror may share confidential information with respect to the businesses of Kellanova and its subsidiaries with the debt financing sources in connection with any marketing efforts for the financing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Acquiror will, promptly upon written request by Kellanova, (i)&nbsp;reimburse Kellanova for
all reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by Kellanova and its subsidiaries and its and their respective representatives in connection with
the foregoing paragraph and (ii)&nbsp;indemnify, defend and hold harmless Kellanova and its subsidiaries and their respective representatives against any liability or arising out of the arrangement of such financing or providing any of the
information utilized in connection therewith (subject to certain customary exceptions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each of Acquiror and Mars will, and will cause
their applicable subsidiaries to, use reasonable best efforts to obtain financing on or prior to the Closing in an amount, when taken together with available cash on hand and other sources of funds available to Mars and Acquiror, to consummate the
transactions. Acquiror will keep Kellanova informed on a reasonably current basis and in reasonable detail of the status of its efforts to arrange such financing. If all or any portion of such financing becomes unavailable, Acquiror shall
(i)&nbsp;notify as soon as reasonably practicable (and in any event within three business days) to Kellanova of such event and (ii)&nbsp;use its reasonable best efforts to obtain, on or prior to the Closing, the alternative financing from the same
or alternative sources, which may include one or more of a loan financing, an offering and sale of notes, or any other financing or offer and sale of other debt securities, or any combination thereof, in an amount sufficient when taken together with
available cash on hand and other sources of funds available to Mars and Acquiror, to consummate the transactions; provided that in no event will the &#147;reasonable best efforts&#148; of Mars, Acquiror or any of their subsidiaries be deemed or
construed to require, Mars, Acquiror or any such subsidiary to seek or accept such alternative financing on terms materially less favorable in the aggregate than the terms and conditions described in the Debt Commitment Letter, as determined in the
reasonable judgement of Acquiror. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Certain Additional Covenants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement also contains additional covenants, including, among others, covenants relating to the filing of this proxy statement,
covenants relating to regulatory filings and approvals (which are described in the section entitled &#147;The Merger (Proposal 1)&#151;Regulatory Approvals&#148; beginning on page 80), reporting requirements under Section&nbsp;16 of the Exchange
Act, certain takeover matters, coordination with respect to litigation relating to the Merger, public announcements with respect to the transactions and notification regarding certain matters. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4510"></A>Conditions to Consummation of the Merger </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Each party&#146;s obligation to effect the Merger is subject to the fulfillment on or prior to the Closing Date, or waiver (to the extent not
prohibited under applicable law) at Closing, of each of the following conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the adoption of the Merger Agreement by the affirmative vote of the holders of a majority of the issued and
outstanding shares of Common Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the absence of any Legal Restraint; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expiration or termination of the applicable waiting period under the HSR Act, and receipt of all other
clearances or approvals under other applicable Antitrust Laws. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The obligations of Acquiror and Merger Sub to consummate
the Merger are also subject to the fulfillment at or prior to the Closing Date or waiver (to the extent not prohibited under applicable law) at Closing, of each of the following conditions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations and warranties of Kellanova: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regarding the capital structure of Kellanova being true and correct at and as of the date of the Merger Agreement
and at and as of the Closing Date as though made at and as of the Closing Date (except that representations and warranties made as of a particular date or period need to be true and correct only as of such date or period), except for any de minimis
inaccuracies; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regarding certain aspects of Kellanova&#146;s organization, good standing and qualification to do business,
capital stock, corporate authority relative to the Merger Agreement and no violation thereof (with limited exceptions), opinions of Kellanova&#146;s financial advisors, absence of broker&#146;s and finder&#146;s fees other than those described in
the Merger Agreement and certain actions in respect of potentially applicable state anti-takeover statutes or regulations and any similar provisions in the Certificate of Incorporation or Bylaws shall be true and correct in all material respects
both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regarding the absence of a &#147;Company Material Adverse Effect&#148; and certain other changes or events, being
true and correct at and as of the date of the Merger Agreement; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other than the representations and warranties described in the bullets above, being true and correct at and as of
the date of the Merger Agreement and at and as of the Closing Date as though made at and as of the Closing Date (except that representations and warranties made as of a particular date or period need to be true and correct only as of such date or
period), other than for failures to be so true and correct (without regard to materiality, &#147;Company Material Adverse Effect&#148; and similar qualifiers contained in such representations and warranties) that would not, individually or in the
aggregate, have or reasonably be expected to have a &#147;Company Material Adverse Effect.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kellanova having performed or complied with in all material respects all covenants required by the Merger
Agreement to be performed or complied with by it prior to the Closing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no &#147;Company Material Adverse Effect&#148; having arisen or occurred following the date of the Merger
Agreement that is continuing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Acquiror&#146;s receipt of a certificate of Kellanova, dated as of the Closing Date, signed by its chief
executive officer or another senior officer certifying the satisfaction of the foregoing three conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i) no Burdensome Condition has been a condition to receipt of any regulatory approval, (ii)&nbsp;there is not in
effect at or upon the Closing any order or law resulting, individually or in the aggregate, in a Burdensome Condition and (iii)&nbsp;no regulatory approval contains, includes or imposes any Burdensome Condition; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Acquiror&#146;s receipt of the Closing Tax Opinion from Skadden, or, if Skadden is unable, or declines, to
deliver the Closing Tax Opinion, from Kirkland&nbsp;&amp; Ellis LLP (either, the &#147;Acquiror Tax Counsel&#148;), provided that Acquiror&#146;s receipt of the Closing Tax Opinion from Acquiror Tax Counsel is not a condition to the consummation of
the Merger to the extent that Acquiror Tax Counsel determines that it cannot render the Closing Tax Opinion for reasons other than as a result of material changes in law or facts prior to the Closing Date. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova&#146;s obligation to effect the Merger is subject to the fulfillment at or prior to the Closing Date or waiver (to the extent not
prohibited under applicable law) at Closing, of each of the following additional conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the representations and warranties of Acquiror and Merger Sub: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regarding corporate existence and good standing, corporate authority relative to the Merger Agreement, and no
violation thereof (with limited exceptions), being true and correct in all material respects at and as of the date of the Merger Agreement and at and as of the Closing Date as though made at and as of the Closing Date (except that representations
and warranties made as of a particular date or period need to be true and correct only as of such date or period); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other than the representations and warranties described in the bullet above, being true and correct at and as of
the date of the Merger Agreement and at and as of the Closing Date as though made at and as of the Closing Date, other than for failures to be so true and correct (without regard to materiality, &#147;Acquiror Material Adverse Effect&#148; and
similar qualifiers contained in such </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
representations and warranties) that would not, individually or in the aggregate, reasonably be expected to have an &#147;Acquiror Material Adverse Effect&#148;; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Acquiror and Merger Sub having performed or complied with in all material respects all covenants required by the
Merger Agreement to be performed or complied with by it prior to the Closing Date; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Kellanova&#146;s receipt of a certificate of Acquiror, dated as of the Closing Date, signed by its chief
executive officer or another senior officer certifying the satisfaction of the foregoing two conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4511"></A>Termination </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by mutual written agreement of Kellanova and Acquiror; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by either Kellanova or Acquiror: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the Merger is not consummated on or before the Outside Date; provided that if, on the Outside Date, the
conditions to the Closing set forth in the Merger Agreement relating to (i)&nbsp;the absence of a Legal Restraint, (ii)&nbsp;the expiration of the waiting period applicable to the Merger under the HSR Act and the receipt of the clearances or
approvals under applicable Antitrust Laws in the jurisdictions set forth on the specified Company Disclosure Schedule and (iii)&nbsp;the absence of a Burdensome Condition (in the case of each of clauses (i)&nbsp;through (iii), as it relates to an
Antitrust Law) are not fulfilled but all other conditions to the Closing set forth in the Merger Agreement have been waived or fulfilled (other than those conditions that by their terms cannot be satisfied prior to the Closing, but which conditions
would be satisfied if the Closing occurred on such date), then the Outside Date will be automatically extended by six months to February&nbsp;13, 2026; provided, further, that if, on February&nbsp;13, 2026, the conditions to the Closing set forth in
the Merger Agreement relating to (i)&nbsp;the absence of a Legal Restraint, (ii)&nbsp;the expiration of the waiting period applicable to the Merger under the HSR Act and the receipt of the clearances or approvals under applicable Antitrust Laws in
the jurisdictions set forth on the specified section of the Company Disclosure Schedule and (iii)&nbsp;the absence of a Burdensome Condition (in the case of each of clauses (i)&nbsp;through (iii), as it relates to an Antitrust Law) are not fulfilled
but all other conditions to the Closing set forth in the Merger Agreement have been waived or fulfilled (other than those conditions that by their terms cannot be satisfied prior to the Closing, but which conditions would be satisfied if the Closing
occurred on such date), then the Outside Date will again be extended by six months to August&nbsp;13, 2026. However, the right to terminate the Merger Agreement pursuant to this bullet will not be available to any party if the failure of the Closing
to have occurred on or before the Outside Date was primarily due to the failure of such party to perform any of its obligations under the Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if any Legal Restraint that has become final and <FONT STYLE="white-space:nowrap">non-appealable</FONT>
permanently restrains, enjoins or otherwise prohibits or makes illegal the consummation of the Merger. However, the party seeking to terminate the Merger Agreement pursuant to this bullet must comply in all material respects with its obligations
under the Merger Agreement to contest, appeal and remove such Legal Restraint and the right to terminate the Merger Agreement pursuant to this bullet will not be available to any party&nbsp;if the issuance of the Legal Restraint or the occurrence of
any such other action was primarily due to the failure of such party to perform any of its obligations under the Merger Agreement (which failure constitutes a material breach of the Merger Agreement); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the required approval of the Merger Proposal at the Special Meeting (or any adjournment or postponement
thereof) is not obtained at which a vote was taken on the matter. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Acquiror: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if Kellanova has (i)&nbsp;breached any representation, warranty, covenant or other agreement contained in the
Merger Agreement (other than an intentional and material breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement), which breach would result in the failure to satisfy the closing conditions relating
to Kellanova&#146;s representations and warranties or covenants and (ii)&nbsp;such breach is not curable or, if curable, is not cured before the earlier of (A)&nbsp;the Outside Date or any extension thereof as applicable, and (B) 20 business days
following Acquiror&#146;s written notice to Kellanova. However, Acquiror will not have the right to terminate the Merger Agreement pursuant to this bullet if Acquiror is in breach of any representation, warranty, covenant or other agreement
contained in the Merger Agreement (which breach would result in the failure to satisfy the closing conditions relating to Acquiror&#146;s or Merger Sub&#146;s representations and warranties or covenants); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i)&nbsp;at any time following an Adverse Recommendation Change; or (ii)&nbsp;if Kellanova has intentionally and
materially breached the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement. However, in each case, Acquiror&#146;s right to terminate the Merger Agreement pursuant to this bullet will expire upon receipt of
approval of the transactions by Kellanova&#146;s shareowners. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Kellanova: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if Acquiror or Merger Sub has (i)&nbsp;breached any representation, warranty, covenant or other agreement
contained in the Merger Agreement, which breach would result in the failure to satisfy the closing conditions relating to Acquiror&#146;s and Merger Sub&#146;s representations and warranties or covenants and (ii)&nbsp;such breach is not curable or,
if curable, is not cured by the earlier of (A)&nbsp;the Outside Date, or any extension thereof as applicable, and (B)&nbsp;20&nbsp;business days following Kellanova&#146;s written notice to Acquiror. However, Kellanova will not have the right to
terminate the Merger Agreement pursuant to this bullet if Kellanova is in breach of any representation, warranty, covenant or other agreement contained in the Merger Agreement (which breach would result in the failure to meet the closing conditions
relating to Kellanova&#146;s representations, warranties and covenants); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the receipt of approval of the transactions by Kellanova&#146;s shareowners, in order to substantially
concurrently with such termination enter into a definitive agreement relating to a Company Superior Proposal to the extent permitted by and subject to the terms of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provision in the Merger
Agreement, subject to the prior or concurrent payment of the Termination Fee to Acquiror. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4512"></A>Termination
Fee </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger Agreement is terminated in specified circumstances, Kellanova will be required to pay or cause to be paid to
Acquiror a Termination Fee of $800,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Acquiror would be entitled to receive the Termination Fee from Kellanova if the Merger
Agreement is terminated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(i)&nbsp;(A) by either Acquiror or Kellanova because (1)&nbsp;the Closing has not occurred by the Outside Date or
any extension thereof as applicable, and approval of the transactions by Kellanova&#146;s shareowners has not been obtained, (B)&nbsp;Acquiror or Kellanova terminates the Merger Agreement as a result of a failure to obtain approval of the
transactions by Kellanova&#146;s shareowners at the Special Meeting (or any adjournment or postponement thereof) at which a vote was taken on the matter or (C)&nbsp;Acquiror terminates the Merger Agreement because (1)&nbsp;Kellanova has breached a
representation, warranty, covenant or other agreement in the Merger Agreement (other than an intentional and material breach of the <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement), which breach would
result in the failure to </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
satisfy the closing conditions relating to Kellanova&#146;s representations and warranties or covenants and (ii)&nbsp;such breach is not curable or, if curable, is not cured by the earlier of
(A)&nbsp;the Outside Date or any extension thereof as applicable, and (B) 20 business days following Acquiror&#146;s written notice to Kellanova, (iii)&nbsp;any person has made or publicly made known (since the date of the Merger Agreement) a
Company Takeover Proposal and not (A)&nbsp;if publicly made, publicly withdrawn such proposal or (B)&nbsp;if made privately, withdrawn such proposal in writing and in good faith, in either case, prior to the date of the Merger Agreement or the
Special Meeting, as applicable, and (iv)&nbsp;at any time on or prior to the first anniversary of such termination, Kellanova or any of its subsidiaries enters into a definitive agreement with respect to, or consummates, any Company Takeover
Proposal (provided, that references in the definition of a &#147;Company Takeover Proposal&#148; as defined in the section entitled &#147;The Merger Agreement&#151;Other Covenants and
<FONT STYLE="white-space:nowrap">Agreements&#151;Non-Solicitation;</FONT> Takeover Proposals&#148; beginning on page 91 to 20% are deemed to be 50%); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Acquiror, because Kellanova has made an Adverse Recommendation Change or is in material breach of the <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement giving rise to Acquiror&#146;s right to terminate the Merger Agreement; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by Kellanova, prior to the receipt of approval of the transactions by Kellanova&#146;s shareowners, subject to
compliance with certain <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions of the Merger Agreement, in order to substantially concurrently with such termination enter into a definitive agreement relating to a Company Superior
Proposal. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4513"></A>Reverse Termination Fee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger Agreement is terminated in specified circumstances, Acquiror will be required to pay or cause to be paid to Kellanova a Reverse
Termination Fee of $1,250,000,000. Kellanova would be entitled to receive the Reverse Termination Fee from Acquiror if the Merger Agreement is terminated by either Acquiror or Kellanova: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">because of a failure of the Closing to occur by the Outside Date or any extension thereof as applicable, and at
such time any of the closing conditions related to (i)&nbsp;the absence of a Legal Restraint (solely as a result of a Legal Restraint in respect of an Antitrust Law issued or entered after the date of the Merger Agreement), (ii) the expiration of
the waiting period applicable to the Merger under the HSR Act and the receipt of the clearances or approvals under applicable Antitrust Laws in the jurisdictions set forth on the specified section of the Company Disclosure Schedule and
(iii)&nbsp;the absence of a Burdensome Condition have not been fulfilled (or waived to the extent permissible under applicable law), but all other closing conditions either have been waived or fulfilled or would be fulfilled if the closing of the
Merger were to occur on such date; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">because any Legal Restraint in respect of an Antitrust Law issued or entered after the date of the Merger
Agreement has become final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> that permanently restrains, enjoins or otherwise prohibits or makes illegal the consummation of the Merger. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4514"></A>Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in the Merger Agreement, whether or not the Merger is consummated, all costs and expenses incurred in connection
with the transactions will be paid by the party incurring or required to incur such expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4515"></A>Specific Performance;
Remedies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition to any other remedy that may be available to any of the parties, including monetary damages, each of Kellanova,
Acquiror and Merger Sub is generally entitled to an injunction or injunctions to prevent breaches of the Merger Agreement and to enforce specifically the terms and provisions of the Merger Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4516"></A>Amendment; Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At any time prior to the Effective Time, any provision of the Merger Agreement may be amended or waived only if such amendment or waiver is in
writing and signed, in the case of an amendment, by Kellanova, Acquiror and Merger Sub; provided, that, without the further approval of Kellanova shareowners and the sole member of Merger Sub, no amendment or waiver will be made or given after the
receipt of approval of the transactions by Kellanova&#146;s shareowners that requires the approval of Kellanova shareowners or the sole member of Merger Sub under Delaware law unless such required further approval is obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At any time prior to the Effective Time, either Kellanova, on the one hand, or Acquiror and Merger Sub, on the other hand, may, to the extent
not prohibited by applicable law and except as otherwise set forth in the Merger Agreement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">extend the time for performance of any of the obligations or other acts of Acquiror or Merger Sub (in the case of
an extension by Kellanova) or of Kellanova (in the case of an extension by Acquiror and Merger Sub); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive any inaccuracies in the representations and warranties made to such party; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive compliance with any of the agreements or conditions for such party&#146;s benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4517"></A>Governing Law and Jurisdiction </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Merger Agreement is governed by Delaware law. Kellanova, Acquiror and Merger Sub have agreed (i)&nbsp;to the exclusive jurisdiction of the
Court of Chancery of the State of Delaware or, solely if such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware, with respect to any dispute arising out of, relating to or
in connection with the Merger Agreement or the transactions, (ii)&nbsp;not to attempt to deny or defeat personal jurisdiction in any such court, (iii)&nbsp;not to bring any such action in any other court and (iv)&nbsp;not to plead or claim such
courts are an inconvenient forum. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4518"></A>Guarantee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Mars, in order to induce Kellanova to execute and deliver the Merger Agreement, has absolutely, unconditionally and irrevocably guaranteed the
covenants, agreements and other obligations of Acquiror and Merger Sub, including the due, punctual and full payment and performance of Acquiror&#146;s and Merger Sub&#146;s obligations under the Merger Agreement, subject to limitations on
Acquiror&#146;s and Merger Sub&#146;s obligations provided in the Merger Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4519"></A>THE VOTING AGREEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><I>The following description sets forth the material provisions of the Voting Agreements, but it does not purport to describe all of the terms
of the Voting Agreements. The full texts of the Voting Agreements are attached to this proxy statement as Annexes B, C and D and incorporated herein by reference. You are urged to read the Voting Agreements in their entirety. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the Merger Agreement on August&nbsp;13, 2024 Acquiror entered into a Voting Agreement with the Kellogg
Foundation Trust pursuant to which the Kellogg Foundation Trust, among other things, is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">required to vote or cause to be voted: (1)&nbsp;in favor of the Merger Proposal and in favor of any other
transactions or matters expressly contemplated by the Merger Agreement; (2)&nbsp;against approval of any proposal, including any Company Takeover Proposal, made in opposition to, or in competition or inconsistent with, consummation of the Merger or
any other transactions contemplated by the Merger Agreement; (3)&nbsp;against any other action, agreement or transaction that is intended, or that would reasonably be expected, to materially impede, interfere with, delay, postpose, discourage or
adversely affect the Merger or any of the other transactions expressly contemplated by the Merger Agreement or performance of his, her or its obligations under the Voting Agreement; and (4)&nbsp;against any action, proposal, transaction or agreement
that would, or would reasonably be expected to, result in a breach in any material respect of any covenant, representation or warranty of any other obligation or agreement of Kellanova contained in the Merger Agreement or of himself, herself or
itself contained in the Voting Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibited from transferring his, her or its shares of Common Stock, subject to limited exceptions described in
the Voting Agreements, including sales pursuant to the Kellogg Foundation Trust&#146;s existing <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibited from (1)&nbsp;soliciting proxies or becoming a participant in a solicitation in connection with either
any proposal to approve the Merger Agreement and the Merger or any Company Takeover Proposal, (2)&nbsp;initiating a shareowners&#146; vote with respect to a Company Takeover Proposal or (3)&nbsp;becoming a member of a &#147;group&#148; (as such term
is used in Section&nbsp;13(d) of the Exchange Act) with respect to any voting securities of Kellanova with respect to a Company Takeover Proposal; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibited from exercising any appraisal or dissent rights in connection with the Merger. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the Voting Agreement, the Kellogg Foundation Trust revoked all previous proxies granted and agreed, under certain
circumstances, to grant an irrevocable proxy to Acquiror and appoint Acquiror or its designee as its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> and proxy, with full power of substitution and
resubstitution, to vote or cause to be voted (including by proxy or written consent) with respect to all of its shares of Common Stock on the matters and in the manner specified above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Voting Agreement with the Kellogg Foundation Trust will terminate upon the earliest to occur of (i)&nbsp;a termination of the Merger
Agreement, (ii)&nbsp;any amendment of the Merger Agreement that has certain adverse effects to the Kellogg Foundation Trust (including a reduction in the per share consideration), (iii) the mutual written consent of Acquiror and the Kellogg
Foundation Trust and (iv)&nbsp;the receipt of approval of the transactions by the Kellanova shareowners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Concurrently with the execution
of the Merger Agreement on August&nbsp;13, 2024 Acquiror also entered into Voting Agreements with the G. Zachary Gund Entities and Gund Trusts, pursuant to which the G. Zachary Gund Entities and Gund Trusts, among other things, are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">required to vote or cause to be voted: (1)&nbsp;in favor of the Merger Proposal and in favor of any other
transactions or matters expressly contemplated by the Merger Agreement; (2)&nbsp;against approval of any </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
proposal, including any Company Takeover Proposal, made in opposition to, or in competition or inconsistent with, consummation of the Merger or any other transactions contemplated by the Merger
Agreement; (3)&nbsp;against any other action, agreement or transaction that is intended, or that would reasonably be expected, to materially impede, interfere with, delay, postpose, discourage or adversely affect the Merger or any of the other
transactions expressly contemplated by the Merger Agreement or performance of his, her or its obligations under the Voting Agreement; (4)&nbsp;against any action, proposal, transaction or agreement that would, or would reasonably be expected to,
result in a breach in any material respect of any covenant, representation or warranty of any other obligation or agreement of Kellanova contained in the Merger Agreement or of himself, herself or itself contained in the Voting Agreement; and
(5)&nbsp;in favor of any other matter necessary to the consummation of the transactions contemplated by the Merger Agreement, including the Merger; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibited from transferring his, her or its shares of Common Stock, subject to limited exceptions described in
the Voting Agreements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibited from (1)&nbsp;soliciting proxies or becoming a participant in a solicitation in connection with either
any proposal to approve the Merger Agreement and the Merger or any Company Takeover Proposal, (2)&nbsp;initiating a shareowners&#146; vote with respect to a Company Takeover Proposal or (3)&nbsp;becoming a member of a &#147;group&#148; (as such term
is used in Section&nbsp;13(d) of the Exchange Act) with respect to any voting securities of Kellanova with respect to a Company Takeover Proposal; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prohibited from exercising any appraisal or dissent rights in connection with the Merger. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the Voting Agreements, the G. Zachary Gund Entities and Gund Trusts each irrevocably granted a proxy appointing
Acquiror or its designee as its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> and proxy, with full power of substitution and resubstitution, to vote or cause to be voted (including by proxy or
written consent) with respect to all of its shares of Common Stock on the matters and in the manner specified above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Voting
Agreements with the G. Zachary Gund Entities and Gund Trusts will terminate upon the earliest to occur of (i)&nbsp;a termination of the Merger Agreement, (ii)&nbsp;any amendment of the Merger Agreement that has the effect of reducing the per share
Merger Consideration, (iii)&nbsp;an Adverse Recommendation Change, (iv)&nbsp;the mutual written consent of Acquiror and the applicable Voting Agreement Shareowner and (v)&nbsp;the receipt of approval of the transactions by the Kellanova shareowners.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the Voting Agreements and subject to the terms and conditions thereof, (1)&nbsp;the Kellogg Foundation Trust has agreed to
vote 50,830,838 shares of Common Stock, representing 14.78% of the issued and outstanding Common Stock as of August 9, 2024 (less any shares of Common Stock sold pursuant to the Kellogg Foundation Trust&#146;s existing
<FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan), and any shares of Common Stock acquired by the Kellogg Foundation Trust thereafter, (2)&nbsp;the G. Zachary Gund Entities have agreed to vote 1,644,365 shares of Common Stock,
representing 0.48% of the issued and outstanding Common Stock as of August&nbsp;9, 2024, and any shares of Common Stock acquired by the G. Zachary Gund Entities thereafter and (3)&nbsp;the Gund Trusts have agreed to vote 18,327,318 shares of Common
Stock, representing 5.40% of the issued and outstanding Common Stock as of August&nbsp;9, 2024, and any shares of Common Stock acquired by the Gund Trusts thereafter, in each case, in favor of the Merger Proposal at the Special Meeting. In the
aggregate, pursuant to the Voting Agreements, holders of at least 20.66% of the issued and outstanding Common Stock as of August&nbsp;9, 2024 have agreed to vote in favor of the Merger Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4520"></A>CERTAIN BENEFICIAL OWNERS OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table sets forth information known to Kellanova regarding the beneficial ownership of Common Stock as of September&nbsp;3, 2024:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person who is the beneficial owner of more than 5% of the outstanding shares of Common Stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of Kellanova&#146;s current named executive officers and directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all officers and directors of Kellanova, as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a
security if he, she or it possesses sole or shared voting or investment power over that security, including securities that such he, she or it has the right to acquire within 60 days of a specified date through (i)&nbsp;the exercise of any option,
warrant or right, (ii)&nbsp;the conversion of a security, (iii)&nbsp;the power to revoke a trust, discretionary account or similar arrangement or (iv)&nbsp;the automatic termination of a trust, discretionary account or similar arrangement. Except as
described in the footnotes below and subject to applicable community property laws and similar laws, Kellanova believes that each person listed above has sole voting and investment power with respect to such shares of Common Stock or Common Stock
beneficially owned by them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The beneficial ownership of Common Stock is based on 344,667,063 shares of Common Stock issued and
outstanding as of September&nbsp;3, 2024. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4521"></A>Five Percent Holders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows each person who, based upon their most recent filings or correspondence with the SEC, beneficially owns more than 5%
of our Common Stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares<BR>Beneficially&nbsp;Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of&nbsp;Shares<BR>Beneficially&nbsp;Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">W.K. Kellogg Foundation Trust<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP><BR>c/o
Northern Trust Corporation<BR>50 South LaSalle Street<BR>Chicago, IL 60603</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,375,129</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Vanguard Group<BR>100 Vanguard Blvd.<BR>Malvern, PA 19355</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,150,331</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc.<BR>55 East 52nd Street<BR>New York, NY 10055</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,982,413</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyCorp<BR>127 Public Square<BR>Cleveland, OH 44114-1306</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,027,982</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gordon Gund<BR>14 Nassau Street<BR>Princeton, NJ 08542-4523</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,737,958</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to a Schedule 13G/A filed with the SEC on February&nbsp;8, 2024, as modified by a Form 4 filed on
August 28, 2024, Kellogg Foundation Trust shares voting and investment power with the W.K. Kellogg Foundation with respect to 50,597,438 shares of Kellanova, or 14.7% of our outstanding shares on September&nbsp;3, 2024. As of December 30, 2023, the
trustees of Kellogg Foundation Trust were Steve Cahillane, Richard Tsoumas, La June Montgomery Tabron and Northern Trust Company. The W.K.&nbsp;Kellogg </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Foundation, a Michigan charitable corporation, is the sole beneficiary of Kellogg Foundation Trust. Under the agreement governing Kellogg Foundation Trust (the &#147;Foundation Agreement&#148;),
at least one trustee of Kellogg Foundation Trust must be a member of the W.K. Kellogg Foundation&#146;s Board, and one member of our Board must be a trustee of Kellogg Foundation Trust. The Foundation Agreement provides if a majority of the trustees
of Kellogg Foundation Trust (which majority must include the corporate trustee) cannot agree on how to vote the Kellanova stock, the Kellogg Foundation Trust has the power to direct the voting of such stock. With certain limitations, the Foundation
Agreement also provides that the Kellogg Foundation Trust has the power to approve successor trustees, and to remove any trustee of Kellogg Foundation Trust. The shares of Kellanova owned directly by Mr.&nbsp;Cahillane and Ms.&nbsp;Montgomery Tabron
are disclosed in the table below. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to a Schedule 13G/A filed with the SEC on February&nbsp;13, 2024, Northern Trust Corporation has sole
voting power for 607,451 shares, shared voting power for 56,754,641 shares (including those shares beneficially owned by Kellogg Foundation Trust), sole investment power for 2,669,193 shares and shared investment power for 54,223,992 shares
(including those shares beneficially owned by Kellogg Foundation Trust). Northern Trust Corporation, as parent holding company for The Northern Trust Company, as trustee of Kellogg Foundation Trust, shares voting and investment power with respect to
the shares owned by the Kellogg Foundation Trust, which shares are reflected in Northern Trust Corporation&#146;s totals above. Each of Mr.&nbsp;Cahillane, Ms.&nbsp;Montgomery Tabron and Mr.&nbsp;Tsoumas disclaims beneficial ownership over Kellanova
stock owned by the Kellogg Foundation Trust. The remaining shares not owned by the Kellogg Foundation Trust that are disclosed in the table above represent shares beneficially owned by Northern Trust Corporation and The Northern Trust Company
unrelated to the Kellogg Foundation Trust. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to a Schedule 13G/A filed with the SEC on February&nbsp;13, 2024, The Vanguard Group has sole voting
power for 0 shares, shared voting power for 345,062 shares, sole investment power for 30,969,415 shares and shared investment power for 1,180,916 shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to a Schedule 13G/A filed with the SEC on January&nbsp;25, 2024, BlackRock, Inc. has sole voting
power for 27,510,611 shares and sole investment power for 29,982,413 shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to a Schedule 13G/A filed with the SEC on January&nbsp;8, 2024, KeyCorp, as trustee for certain Gund
family trusts, including the trusts discussed under (6)&nbsp;below, as well as other trusts, has sole voting power for 70,955 shares, shared voting power for 5,417 shares, sole investment power for 19,994,948 shares and shared investment power for
29,964 shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">According to a Schedule 13D filed with the SEC on August&nbsp;20, 2024, Gordon Gund has sole voting power for
19,546,089 shares, shared voting power for 191,869 shares, sole investment power for 0 shares and shared investment power for 191,869 shares. The shares over which Gordon Gund has sole voting power are held by various trusts for the benefit of
certain members of the Gund family, as to which shares Gordon Gund disclaims beneficial ownership. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4522"></A>Officer and Director Stock Ownership </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following table shows the number of shares of our Common Stock beneficially owned as of September&nbsp;3, 2024, by each director, each
named executive officer and all directors and executive officers as a group. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Options<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deferred<BR>Stock<BR>Units<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of<BR>Shares<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-NEO</FONT> Directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephanie Burns</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carter Cast</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rod Gillum</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Zack Gund<SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,481,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,502,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald Knauss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Laschinger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Options<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Deferred<BR>Stock<BR>Units<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent of<BR>Shares<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Erica Mann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">La June Montgomery Tabron<SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mike Schlotman</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carolyn Tastad</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steve Cahillane<SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">359,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,155,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,786</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,529,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amit Banati</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">111,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">277,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">389,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chris Hood<SUP STYLE="font-size:75%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">408,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">531,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gary Pilnick<SUP STYLE="font-size:75%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">379,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">379,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Lawlor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">136,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">187,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shumit Kapoor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>All Directors and current executive officers as a group (22 persons)<SUP
STYLE="font-size:75%; vertical-align:top">(9)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,498,581</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,171,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75,080</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,745,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Less than 1% </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the number of shares beneficially owned, excluding shares which may be acquired through exercise of
stock options and units held under our deferred compensation plans. Includes (i)&nbsp;restricted stock units that vested within 60 days of September&nbsp;3, 2024; and (ii)&nbsp;the following number of shares held in the Kellanova Grantor Trust for
directors and executives related to the annual grants of deferred shares for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, which shares are subject to restrictions on voting and investment: Dr.&nbsp;Burns, 31,876 shares;
Mr.&nbsp;Cast, 21,716 shares; Mr.&nbsp;Gillum, 16,728 shares; Mr.&nbsp;Zack Gund, 29,292&nbsp;shares; Mr.&nbsp;Knauss, 57,209 shares; Ms.&nbsp;Laschinger, 36,790 shares; Ms.&nbsp;Mann, 16,728 shares; Ms.&nbsp;Montgomery Tabron, 31,876 shares;
Mr.&nbsp;Schlotman 11,486 shares; Ms.&nbsp;Tastad 26,103 shares; and all directors as a group, 279,805 shares </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents options that were exercisable on September&nbsp;3, 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the number of common stock units held under our deferred compensation plans as of September&nbsp;3,
2024. For additional information, refer to &#147;2023 Director Compensation and Benefits &#151; Elective Deferral&#148; and &#147;Retirement and <FONT STYLE="white-space:nowrap">Non-Qualified</FONT> Defined Contribution and Deferred Compensation
Plans &#151; Discontinued / Frozen Plans &#151; Executive Deferral Program&#148; of our Definitive Proxy Statement on Schedule 14A, filed with the SEC on March&nbsp;4, 2024. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">None of the shares listed have been pledged as collateral. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes: (i) 34,296 shares held by a trust for the benefit of Mr.&nbsp;Gund and certain members of his family,
of which Mr.&nbsp;Gund is one of several trustees; (ii) 9,200 shares held by a limited liability company that is owned by a trust for the benefit of certain members of Mr.&nbsp;Gund&#146;s family, of which a family member of Mr.&nbsp;Gund&#146;s is
the trustee of the trust and Mr.&nbsp;Gund is the manager of the limited liability company; and (iii) 1,409,000 shares held in family partnerships, the partners of which include a trust for the benefit of Mr.&nbsp;Gund and he serves as a manager of
these partnerships. As a result of these relationships, Mr.&nbsp;Gund may have voting and dispositive power over all such shares. Mr.&nbsp;Gund disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Does not include shares owned by Kellogg Foundation Trust, as to which Mr.&nbsp;Cahillane and
Ms.&nbsp;Montgomery Tabron, as trustees of Kellogg Foundation Trust as of the date of this table disclaim beneficial ownership, or shares as to which Kellogg Foundation Trust or Kellogg Foundation have a current beneficial interest.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Hood retired from Kellanova on May&nbsp;1, 2024. Accordingly, the number of shares reported as
beneficially owned by Mr.&nbsp;Hood is based solely on Kellanova&#146;s records and information provided to Kellanova by Mr.&nbsp;Hood. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with the completion of the <FONT STYLE="white-space:nowrap">spin-off</FONT> of WK Kellogg Co on
October&nbsp;2, 2023, Mr.&nbsp;Pilnick ceased serving as Kellanova&#146;s Vice Chairman and Chief Legal Officer and became the Chief Executive Officer of WK Kellogg Co. Accordingly, the number of shares reported as beneficially owned by
Mr.&nbsp;Pilnick is based solely on Kellanova&#146;s records information provided to Kellanova by Mr.&nbsp;Pilnick. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 34,296 shares held by a trust for the benefit of the applicable Director and certain family members,
of which the applicable Director disclaims beneficial ownership except to the extent of the applicable Director&#146;s pecuniary interest; 9,200 shares held by a limited liability company that is owned by a trust for the benefit of certain family
members of the applicable Director, of which the applicable Director disclaims beneficial ownership except to the extent of the applicable Director&#146;s pecuniary interest; 1,409,000 shares held in family partnerships, of which the applicable
Director disclaims beneficial ownership except to the extent of the applicable Director&#146;s pecuniary interest; 359,834 shares held jointly with spouse, of which the applicable Director and his wife share voting and investment power; 277,774
Options held through a trust in which an officer or a family member are beneficiary; 1,206 shares held in our Savings&nbsp;&amp; Investment Plans; and 111,796 shares held through a trust in which the officer or a family member are a beneficiary.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4523"></A>THE ADVISORY COMPENSATION PROPOSAL (PROPOSAL 2) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;14A of the Exchange Act, Kellanova is asking Kellanova shareowners to approve, on an advisory <FONT
STYLE="white-space:nowrap">(non-binding)</FONT> basis, the compensation that will or may be paid to Kellanova&#146;s named executive officers in connection with the Merger as described in the section entitled &#147;The Merger&#151;Summary of
Potential Transaction Payments to Named Executive Officers&#148; beginning on page <U></U>75 of this proxy statement. Because the vote on the Advisory Compensation Proposal is advisory only, it will not be binding on Kellanova, Mars, Acquiror or
Merger Sub. Accordingly, if the Merger Proposal is approved and the Merger is completed, the Merger-related compensation will be payable to Kellanova&#146;s named executive officers, subject only to the conditions applicable thereto, regardless of
the outcome of the approval of the Advisory Compensation Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4524"></A>Required Vote of Shareowners </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board unanimously recommends that Kellanova shareowners vote &#147;FOR&#148; the Advisory Compensation Proposal. Under the Bylaws, if a
quorum is present, approval of the Advisory Compensation Proposal requires the affirmative vote of the holders of a majority of the Common Stock present in person or represented by proxy at the Special Meeting and entitled to vote thereon.
Accordingly, for shareowners of record who are not present in person or represented by proxy at the Special Meeting and for beneficial owners who fail to instruct their bank, broker, trust or other nominee to vote on any proposal, a failure to vote
will have no effect on the outcome of the Advisory Compensation Proposal. Abstentions will have the same effect as a vote &#147;<B>AGAINST</B>&#148; the Advisory Compensation Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The vote on the Advisory Compensation Proposal is a vote separate and apart from the vote to approve either the Merger Proposal or the
Adjournment Proposal. Accordingly, a Kellanova shareowner may vote to approve the Advisory Compensation Proposal and vote not to approve the Merger Proposal or the Adjournment Proposal, and vice versa. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD ACCORDINGLY UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#147;FOR&#148; THE ADVISORY COMPENSATION PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4525"></A>ADJOURNMENT PROPOSAL (PROPOSAL 3) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Special Meeting may be adjourned one or more times to another time and place, if any, including if necessary, to permit solicitation of
additional proxies if there are not sufficient votes to approve the Merger Proposal or to ensure that any supplement or amendment to this proxy statement is timely provided to Kellanova shareowners. Kellanova is asking its shareowners to authorize
the holder of any proxy solicited by the Board to vote in favor of any adjournment of the Special Meeting to solicit additional proxies if a quorum is not present, there are not sufficient votes to approve the Merger Proposal, or to ensure that any
supplement or amendment to this proxy statement is timely provided to Kellanova shareowners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="rom893453_4526"></A>Required Vote of Shareowners
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Board unanimously recommends that Kellanova shareowners vote &#147;<B>FOR</B>&#148; the Adjournment Proposal, if necessary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under the Bylaws, if a quorum is present, approval of the Adjournment Proposal requires the affirmative vote of the holders of a majority of
the Common Stock present in person or represented by proxy at the Special Meeting and entitled to vote thereon. Accordingly, for shareowners of record who are not present in person or represented by proxy at the Special Meeting and for beneficial
owners who fail to instruct their bank, broker, trust or other nominee to vote on any proposal, a failure to vote will have no effect on the outcome of the Adjournment Proposal. Abstentions will have the same effect as a vote
&#147;<B>AGAINST</B>&#148; the Adjournment Proposal. The vote on the Adjournment Proposal is a vote separate and apart from the vote to approve the Merger Proposal. Accordingly, a Kellanova shareowner may vote to approve the Merger Proposal and vote
not to approve the Adjournment Proposal, and vice versa. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD ACCORDINGLY UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#147;FOR&#148; THE
ADJOURNMENT PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4527"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy statement, the Board knows of no matters that will be presented for consideration at the Special Meeting other
than as described in this proxy statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4528"></A>APPRAISAL RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger is consummated, a holder of Common Stock who does not vote in favor of the Merger Proposal and who properly demands appraisal of
its shares of Common Stock, who does not effectively withdraw its demand or waive or lose the right to appraisal, and who otherwise complies with the requirements for perfecting and preserving appraisal rights, will be entitled to seek appraisal of
his, her or its shares in connection with the Merger under Section&nbsp;262. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The following discussion is not a complete statement of the
law pertaining to appraisal rights under the DGCL and is qualified in its entirety by the full text of Section&nbsp;262, a copy of which may be accessed without subscription or cost at the following publicly available website:
<I>https://delcode.delaware.gov/title8/c001/sc09/index.html#262</I> and is incorporated herein by reference. The following summary does not constitute any legal or other advice and does not constitute a recommendation that a holder of Common Stock
exercise its appraisal rights under Section&nbsp;262. Only a holder of record of shares of Common Stock is entitled to demand appraisal rights for the shares registered in that holder&#146;s name. A person having a beneficial interest in shares of
Common Stock held of record in the name of another person, such as a bank, broker, trust or other nominee, must act promptly to cause the record holder to follow the steps summarized below properly and in a timely manner to perfect appraisal rights.
<B>If you hold your shares of Common Stock through a bank, broker, trust or other nominee and you wish to exercise appraisal rights, you should consult with your bank, broker, trust or the other nominee.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;262, a holder of shares of Common Stock who (1)&nbsp;does not vote in favor of the Merger Proposal; (2)&nbsp;continuously
is the record holder of such shares from the date of the making of the demand through the effective date of the Merger; and (3)&nbsp;otherwise follows the procedures set forth in Section&nbsp;262, may be entitled to have its shares of Common Stock
appraised by the Delaware Court of Chancery and to receive payment in cash of the &#147;fair value&#148; of the shares of Common Stock, exclusive of any element of value arising from the accomplishment or expectation of the Merger, together with
interest to be paid, if any, on the amount determined to be fair value, as determined by the Delaware Court of Chancery. The &#147;fair value&#148; of the shares of Common Stock as determined by the Delaware Court of Chancery may be more than, the
same as, or less than the per share consideration that the shareowners are otherwise entitled to receive under the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;262, where a merger agreement is to be submitted for adoption and approval at a meeting of shareowners, the corporation,
not less than 20 days prior to the meeting, must notify each of its shareowners entitled to appraisal rights that appraisal rights are available and include in the notice a copy of Section&nbsp;262. <B>This proxy statement constitutes notice to
holders of Common Stock that appraisal rights are available in connection with the Merger, and the full text of Section</B><B></B><B>&nbsp;262 a copy of which may be accessed without subscription or cost at the following publicly available
website:</B><B><I></I></B><B><I> https://delcode.delaware.gov/title8/c001/sc09/index.html#262</I></B><B></B><B>&nbsp;and is incorporated herein by reference. </B>In connection with the Merger, any holder of shares of Common Stock who wishes to
exercise appraisal rights, or who wishes to preserve such holder&#146;s right to do so, should review Section&nbsp;262 carefully and consult with legal advisors. Failure to strictly comply with the requirements of Section&nbsp;262 in a timely and
proper manner will result in the loss of appraisal rights under the DGCL. A holder of Common Stock who loses his, her or its appraisal rights will be entitled to receive the Merger Consideration described in the Merger Agreement. Moreover, because
of the complexity of the procedures for exercising the right to seek appraisal of shares of Common Stock, the Company encourages a shareowner considering exercising such rights to seek the advice of legal counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A shareowner wishing to exercise the right to seek an appraisal of its shares of Common Stock must do <B>ALL</B> of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the shareowner must not vote or submit a proxy in favor of the Merger Proposal; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the shareowner must deliver to Kellanova a written demand for appraisal before the vote on the Merger Proposal at
the Special Meeting and be a shareowner of record at the time of the making of such demand; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the shareowner must continuously hold the shares of Common Stock from the date of making the demand through the
effective date of the Merger (a shareowner will lose appraisal rights if the shareowner transfers the shares before the effective date of the Merger); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a shareowner of record, a beneficial owner of shares as to which the record holder has duly demanded appraisal or
the surviving company must file a petition in the Delaware Court of Chancery requesting a determination of the fair value of the shares of Common Stock within 120 days after the effective date of the Merger. The surviving company is under no
obligation to file any such petition and has no intention of doing so. Accordingly, it is the shareowner&#146;s obligation to initiate all necessary action to perfect his, her or its appraisal rights in respect of his, her or its shares of Common
Stock within the time prescribed in Section&nbsp;262. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Because a proxy that does not contain voting instructions will,
unless revoked, be voted in favor of the Merger Proposal, a shareowner who votes by proxy and who wishes to exercise appraisal rights must vote against or abstain from voting on the Merger Proposal or not vote their shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Filing Written Demand </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any holder
of shares of Common Stock wishing to exercise appraisal rights must deliver to Kellanova, before the vote on the Merger Proposal at the Special Meeting at which the Merger Proposal will be submitted to the shareowners, a written demand for the
appraisal of the shareowner&#146;s shares of Common Stock. A holder of shares of Common Stock exercising appraisal rights must hold of record the shares on the date the written demand for appraisal is made and must continue to hold the shares of
record through the effective date of the Merger. A proxy that is submitted and does not contain voting instructions will, unless revoked, be voted in favor of the Merger Proposal, and it will result in the shareowner&#146;s loss of appraisal rights
and will nullify any previously delivered written demand for appraisal. Therefore, a shareowner who submits a proxy and who wishes to exercise appraisal rights must submit a proxy containing instructions to vote against or abstain from voting on the
Merger Proposal. Neither voting against the Merger Proposal nor abstaining from voting or failing to vote on the Merger Proposal will, in and of itself, constitute a written demand for appraisal satisfying the requirements of Section&nbsp;262. The
written demand for appraisal must be in addition to and separate from any proxy or vote on the Merger Proposal. A shareowner&#146;s failure to make the written demand prior to the taking of the vote on the Merger Proposal at the Special Meeting will
result in a loss of appraisal rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Only a holder of record of shares of Common Stock is entitled to demand appraisal rights for the
shares registered in that holder&#146;s name on the date the written demand is made. A demand for appraisal in respect of shares of Common Stock should be executed by or on behalf of the holder of record and must reasonably inform Kellanova of the
identity of the holder and state that the person intends thereby to demand appraisal of the holder&#146;s shares of Common Stock in connection with the Merger. If the shares of Common Stock are owned of record in a fiduciary capacity, such as by a
trustee, guardian or custodian, such demand must be executed by or on behalf of the record owner, and if the shares are owned of record by more than one person, as in a joint tenancy or tenancy in common, the demand should be executed by or on
behalf of all joint owners. An authorized agent, including an authorized agent for two or more joint owners, may execute a demand for appraisal on behalf of a holder of record; however, the agent must identify the record owner or owners and
expressly disclose that, in executing the demand, the agent is acting as agent for the record owner or owners. In addition, in the case of a demand for appraisal of a beneficial owner, the demand must also (1)&nbsp;reasonably identify the holder of
record of the shares for which the demand is made, (2)&nbsp;be accompanied by documentary evidence of the beneficial owner&#146;s ownership of stock (such as a brokerage or securities account statement containing such information or a letter from
the broker or other record holder of such shares confirming such information) and a statement that such documentary evidence is a true and correct copy of what it purports to be and (3)&nbsp;provide an address at which
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such beneficial owner consents to receive notices given by the Surviving Corporation under Section&nbsp;262 and the verified list required by subsection (f)&nbsp;of Section&nbsp;262. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A SHAREOWNER WHO HOLDS ITS SHARES IN BROKERAGE OR BANK ACCOUNTS, TRUST OR OTHER NOMINEE FORMS AND WHO WISHES TO EXERCISE APPRAISAL RIGHTS
SHOULD CONSULT WITH ITS BANK, BROKER, TRUST OR OTHER NOMINEES, AS APPLICABLE, TO DETERMINE THE APPROPRIATE PROCEDURES FOR THE BANK, BROKER, TRUST OR OTHER NOMINEE TO MAKE A DEMAND FOR APPRAISAL OF THOSE SHARES. A PERSON HAVING A BENEFICIAL INTEREST
IN SHARES HELD OF RECORD IN THE NAME OF ANOTHER PERSON, SUCH AS A BANK, BROKER, TRUST OR OTHER NOMINEE, MUST ACT PROMPTLY TO CAUSE THE RECORD HOLDER TO FOLLOW PROPERLY AND IN A TIMELY MANNER THE STEPS NECESSARY TO PERFECT APPRAISAL RIGHTS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A record owner, such as a bank, brokerage firm, trust or other nominee, who holds shares of Common Stock as a nominee for others may exercise
his, her or its right of appraisal with respect to shares of Common Stock held for one or more beneficial owners, while not exercising this right for other beneficial owners. In that case, the written demand should state the number of shares of
Common Stock as to which appraisal is sought. Where no number of shares of Common Stock is expressly mentioned, the demand will be presumed to cover all shares of Common Stock held in the name of the record owner. If a shareowner holds shares of
Common Stock through a broker who in turn holds the shares through a central securities depository nominee such as Cede&nbsp;&amp; Co., a demand for appraisal of such shares must be made by or on behalf of the depository nominee and must identify
the depository nominee as record owner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All written demands for appraisal pursuant to Section&nbsp;262 should be mailed or delivered to:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">412 N. Wells
Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Chicago, Illinois 60654 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn: Office of the Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">At
any time within 60 days of the effective date of the Merger, any holder of shares of Common Stock who has demanded appraisal but has not commenced an appraisal proceeding or joined a proceeding as a named party may withdraw his, her or its demand
for appraisal and accept the consideration offered pursuant to the Merger Agreement by delivering to Kellanova a written withdrawal of the demand for appraisal. However, any such attempt to withdraw the demand made more than 60 days after the
effective date of the Merger will require written approval of the Surviving Corporation. No appraisal proceeding in the Delaware Court of Chancery will be dismissed without the approval of the Delaware Court of Chancery, and such approval may be
conditioned upon such terms as the Delaware Court of Chancery deems just. If the Surviving Corporation does not approve a request to withdraw a demand for appraisal when that approval is required or if the Delaware Court of Chancery does not approve
the dismissal of an appraisal proceeding, the shareowner will be entitled to receive only the appraised value of his, her or its shares of Common Stock determined in any such appraisal proceeding, which value may be more than, the same as, or less
than the Merger Consideration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice by the Surviving Corporation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the Merger is completed, within 10 days after the effective date of the Merger, the Surviving Corporation will notify each holder of shares
of Common Stock who has made a written demand for appraisal pursuant to Section&nbsp;262, and who has not voted in favor of the Merger Proposal, that the Merger has become effective and the effective date thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Filing a Petition for Appraisal </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Within 120 days after the effective date of the Merger, but not thereafter, the Surviving Corporation, a beneficial owner of shares as to which
the record holder has duly demanded appraisal or any record holder of shares of Common Stock who has complied with Section&nbsp;262 and is entitled to appraisal rights under Section&nbsp;262 may commence an appraisal proceeding by filing a petition
in the Delaware Court of Chancery, with a copy served on the Surviving Corporation in the case of a petition filed by a shareowner, demanding a determination of the fair value of the shares of Common Stock held by all shareowners entitled to
appraisal. The Surviving Corporation is under no obligation, and has no present intention, to file a petition, and holders should not assume that the Surviving Corporation will file a petition or initiate any negotiations with respect to the fair
value of the shares of Common Stock. Accordingly, any holder of shares of Common Stock who desires to have its shares appraised should initiate all necessary action to perfect its appraisal rights in respect of its shares of Common Stock within the
time and in the manner prescribed in Section&nbsp;262. The failure of a holder of Common Stock to file such a petition within the period specified in Section&nbsp;262 could nullify the holder&#146;s previous written demand for appraisal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Within 120 days after the effective date of the Merger, any holder of shares of Common Stock who has complied with the requirements for
exercise of appraisal rights will be entitled, upon request given in writing, to receive from the Surviving Corporation a statement setting forth the aggregate number of shares not voted in favor of the adoption and approval of the Merger Proposal
and with respect to which Kellanova has received demands for appraisal, and the aggregate number of holders of such shares. The Surviving Corporation must give this statement to the requesting shareowner within 10 days after receipt of the request
for such a statement or within 10 days after the expiration of the period for delivery of demands for appraisal, whichever is later. A beneficial owner of shares of Common Stock held either in a voting trust or by a nominee on behalf of such person
may, in such person&#146;s own name, file a petition seeking appraisal or request from the Surviving Corporation the foregoing statements. As noted above, however, the demand for appraisal can only be made by a shareowner of record. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If a petition for an appraisal is duly filed by a holder of shares of Common Stock and a copy thereof is served upon the Surviving
Corporation, the Surviving Corporation will then be obligated within 20 days after such service to file with the Delaware Register in Chancery a duly verified list containing the names and addresses of all shareowners who have demanded payment for
their shares and with whom agreements as to the value of their shares have not been reached. After notice to the shareowners who have demanded appraisal and the Surviving Corporation, if such notice is ordered by the Delaware Court of Chancery, the
Delaware Court of Chancery is empowered to conduct a hearing on the petition to determine those shareowners who have complied with Section&nbsp;262 and who have become entitled to appraisal rights thereunder. The Delaware Court of Chancery may
require the shareowners who demanded payment for their shares to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings, and if any shareowner fails to comply with the direction,
the Delaware Court of Chancery may dismiss that shareowner from the proceedings. In addition, because the Common Stock is publicly listed on the NYSE (and we do not expect this to change prior to the Merger), the Delaware Court of Chancery will
dismiss appraisal proceedings as to all holders of shares of Common Stock who are otherwise entitled to appraisal rights unless (x)&nbsp;the total number of such shares entitled to appraisal rights exceeds 1% of the outstanding shares of Common
Stock or (y)&nbsp;the value of consideration provided in the merger for such total number of shares exceeds $1&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Determination of Fair
Value </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">After determining the holders of Common Stock entitled to appraisal, the Delaware Court of Chancery will appraise the shares
of Common Stock in accordance with the rules of the Delaware Court of Chancery, including any rules specifically governing appraisal proceedings. Through the proceeding, the Delaware Court of Chancery will determine the &#147;fair value&#148; of the
Common Stock as of the effective date of the Merger after taking into account all relevant factors exclusive of any element of value arising from the accomplishment or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expectation of the Merger, together with interest, if any, to be paid upon the amount determined to be the fair value. When the fair value has been determined, the Delaware Court of Chancery will
direct the payment of such value, with interest thereon accrued during the pendency of the proceeding, if the Delaware Court of Chancery so determines, by the Surviving Corporation to the shareowners entitled to receive the same, upon surrender by
those shareowners of the Certificates representing their shares of Common Stock or, in the case of holders of uncertificated shares of Common Stock, forthwith. Unless the court in its discretion determines otherwise for good cause shown, interest
from the effective date of the Merger through the date of payment of the judgment will be compounded quarterly and will accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period
between the effective date of the Merger and the date of payment of the judgment. At any time before the entry of judgment in the appraisal proceeding, the Surviving Corporation may pay to each shareowner entitled to appraisal an amount in cash, in
which case interest will accrue thereafter as provided in the preceding sentence only upon the sum of (1)&nbsp;the difference, if any, between the amount so paid and the fair value of shares as determined by the Delaware Court of Chancery and
(2)&nbsp;interest theretofore accrued, unless paid at that time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In determining fair value, the Delaware Court of Chancery will take into
account all relevant factors. In <I>Weinberger v. UOP, Inc.</I>, the Supreme Court of Delaware discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that &#147;proof of value by any techniques
or methods which are generally considered acceptable in the financial community and otherwise admissible in court&#148; should be considered, and that &#147;[f]air price obviously requires consideration of all relevant factors involving the value of
a company.&#148; The Delaware Supreme Court stated that, in making this determination of fair value, the court must consider market value, asset value, dividends, earnings prospects, the nature of the enterprise and any other facts that could be
ascertained as of the date of the merger that throw any light on future prospects of the merged corporation. Section&nbsp;262 provides that fair value is to be &#147;exclusive of any element of value arising from the accomplishment or expectation of
the merger.&#148; In <I>Cede</I><I></I><I>&nbsp;&amp; Co. v. Technicolor, Inc.</I>, the Delaware Supreme Court stated that such exclusion is a &#147;narrow exclusion [that] does not encompass known elements of value,&#148; but which rather applies
only to the speculative elements of value arising from such accomplishment or expectation. In <I>Weinberger</I>, the Supreme Court of Delaware also stated that &#147;elements of future value, including the nature of the enterprise, which are known
or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A shareowner
considering seeking appraisal should be aware that the fair value of its shares of Common Stock as so determined by the Delaware Court of Chancery could be more than, the same as, or less than the consideration it would receive pursuant to the
Merger if it did not seek appraisal of its shares and that an opinion of an investment banking firm as to the fairness, from a financial point of view, of the Merger Consideration payable in a Merger is not an opinion as to, and does not in any
manner address, fair value under Section&nbsp;262. <B>Although Kellanova believes that the Merger Consideration is fair, no representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court of Chancery, and
shareowners should recognize that such an appraisal could result in a determination of a value higher or lower than, or the same as, the Merger Consideration</B>. Neither Kellanova nor Mars anticipate offering more than the Merger Consideration to
any shareowner exercising appraisal rights, and each of Kellanova and Mars reserve the right to assert, in any appraisal proceeding, that for purposes of Section&nbsp;262, the &#147;fair value&#148; of a share of Common Stock is less than the Merger
Consideration. If a petition for appraisal is not timely filed, then the right to an appraisal will cease. The costs of the appraisal proceedings (which do not include attorneys&#146; fees or the fees and expenses of experts) may be determined by
the Delaware Court of Chancery and taxed upon the parties as the Delaware Court of Chancery deems equitable under the circumstances. Each shareowner seeking appraisal is responsible for his, her or its attorneys&#146; fees and expert witness
expenses, although, upon application of a shareowner, the Delaware Court of Chancery may also order that all or a portion of the expenses incurred by a shareowner in connection with an appraisal, including, without limitation, reasonable
attorneys&#146; fees and the fees and expenses of experts, be charged pro rata against the value of all the shares entitled to be appraised. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If any shareowner who demands appraisal of his, her or its shares of Common Stock under
Section&nbsp;262 fails to perfect, or loses or successfully withdraws, such holder&#146;s right to appraisal, the shareowner&#146;s shares of Common Stock will be deemed to have been converted at the effective date of the Merger into the right to
receive the Merger Consideration. A shareowner will fail to perfect, or effectively lose or withdraw, the holder&#146;s right to appraisal if, among other things, no petition for appraisal is filed within 120 days after the effective date of the
Merger or if the shareowner delivers to the Surviving Corporation a written withdrawal of the holder&#146;s demand for appraisal and an acceptance of the Merger Consideration in accordance with Section&nbsp;262 within 60 days of the effective date
of the Merger or thereafter with the written approval of Kellanova. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">From and after the effective date of the Merger, no shareowner who
has demanded appraisal rights will be entitled to vote such shares of Common Stock for any purpose or to receive payment of dividends or other distributions on the stock, except dividends or other distributions on the holder&#146;s shares of Common
Stock, if any, payable to shareowners as of a time prior to the effective date of the Merger. If no petition for an appraisal is filed, or if the shareowner delivers to the Surviving Corporation a written withdrawal of the demand for an appraisal
and an acceptance of the Merger, either within 60 days after the effective date of the Merger or thereafter with the written approval of the Surviving Corporation, then the right of such shareowner to an appraisal will cease. Once a petition for
appraisal is filed with the Delaware Court of Chancery, however, the appraisal proceeding may not be dismissed as to any shareowner who commenced the proceeding or joined that proceeding as a named party without the approval of the court. Failure to
comply strictly with all of the procedures set forth in Section&nbsp;262 may result in the loss of a shareowner&#146;s statutory appraisal rights. In view of the complexity of Section&nbsp;262, any shareowner wishing to exercise appraisal rights is
encouraged to consult legal counsel before attempting to exercise those rights. To the extent there are any inconsistencies between the foregoing summary and Section&nbsp;262, Section&nbsp;262 will govern. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4529"></A>DEADLINE FOR RECEIPT OF SHAREOWNER PROPOSALS FOR FUTURE
ANNUAL MEETING </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova held its 2024 annual meeting of shareowners (the &#147;2024 Annual Meeting&#148;) on April&nbsp;26, 2024.
Kellanova will only hold an annual meeting of shareowners in 2025 if the Merger is not completed before such meeting. If the Merger is not completed, Kellanova shareowners may submit proposals for consideration at the Kellanova 2025 annual meeting
of shareowners (the &#147;2025 Annual Meeting&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Shareowner Proposals or Director Nominees for the 2025 Annual Meeting </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If Kellanova holds the 2025 Annual Meeting, shareowner proposals submitted for inclusion in our Proxy Statement for the 2025 Annual Meeting
must be received by us no later than November&nbsp;4, 2024. Other Shareowner proposals or Director nominations to be submitted from the floor must be received by us not earlier than November&nbsp;4, 2024 and not later than December&nbsp;4, 2024, and
must meet certain other requirements specified in our Bylaws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Shareowner Nomination of Director Candidates for Inclusion in Proxy Statement for 2025
Annual Meeting </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If Kellanova holds the 2025 Annual Meeting, shareowner nominations of director candidates for inclusion in our proxy
materials for the 2025 Annual Meeting must be received by us not earlier than October&nbsp;5, 2024 and not later than November&nbsp;4, 2024. Any such nomination must meet the other requirements set forth in our Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In addition to satisfying the requirements of our Bylaws, including the notice deadlines set out above and therein, to comply with the
universal proxy rules, Shareowners who intend to solicit proxies in support of director nominees, other than Kellanova&#146;s nominees, must also comply with the additional requirements of Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> under
the Exchange Act, which notice must be postmarked or transmitted electronically to the Office of the Secretary at our principal executive offices no later than February&nbsp;25, 2025. However, if the date of the 2025 Annual Meeting is changed by
more than 30 days from April&nbsp;26, 2025, then written notice must be provided by the later of the 60th day prior to the date of the 2025 Annual Meeting and the 10th day following the day on which public announcement of the date of the 2025 Annual
Meeting is first made by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A copy of the provisions of our Bylaws governing the notice requirements set forth above may be obtained by
contacting the Investor Relations Department at Kellanova, P.O. Box 3599, Battle Creek, MI 49016-3599 (phone: (269) <FONT STYLE="white-space:nowrap">961-2800),</FONT> or investor.relations@kellanova.com.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>FOR MORE INFORMATION REGARDING SHAREOWNER PROPOSALS FOR THE 2025 ANNUAL MEETING, SEE SECTIONS &#147;SHAREOWNER PROPOSALS OR DIRECTOR
NOMINEES FOR THE 2025 ANNUAL MEETING&#148; AND &#147;SHAREOWNER NOMINATION OF DIRECTOR CANDIDATES FOR INCLUSION IN PROXY STATEMENT FOR 2025 ANNUAL MEETING&#148; OF KELLANOVA&#146;S DEFINITIVE PROXY STATEMENT ON SCHEDULE 14A FILED WITH THE SEC ON
MARCH&nbsp;4, 2024. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom893453_4530"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova files annual, quarterly and current reports, proxy statements and any amendments or supplements thereto and other information with
the SEC. Kellanova&#146;s public filings are available to the public free of charge on the website maintained by the SEC at www.sec.gov and may also be obtained through other document retrieval services. Information contained on Kellanova&#146;s
website or connected thereto does not constitute a part of this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The SEC allows Kellanova to &#147;incorporate by
reference&#148; information into this proxy statement. This means that Kellanova can disclose important information by referring to another document filed separately with the SEC. The information incorporated by reference is considered to be part of
this proxy statement. This proxy statement may update and supersede the information incorporated by reference. Similarly, the information that Kellanova later files with the SEC may update and supersede the information in this proxy statement.
Statements contained in this proxy statement, or in any document incorporated in this proxy statement by reference, regarding the contents of any contract or other document, are not necessarily complete and each such statement is qualified in its
entirety by reference to the complete text of that contract or other document filed as an exhibit with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Kellanova also
incorporates by reference into this proxy statement the following documents filed by it with the SEC under the Exchange Act: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000162828024005583/k-20231230.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal years ended December&nbsp;30, 2023, filed with the SEC on February&nbsp;
20, 2023 (including the portions of our Definitive Proxy Statement on Schedule 14A, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000005506724000010/k-20240303.htm">March&nbsp;4,
2024</A>, incorporated by reference therein). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended
March&nbsp;30, 2024, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000162828024020015/k-20240330.htm">May&nbsp;2, 2024</A>, and Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for
the quarterly period ended June&nbsp;29, 2024, filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000162828024034156/k-20240629.htm">August&nbsp;1, 2024</A>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000005506724000002/k-20240109.htm">January&nbsp;12,
 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000162828024003791/k-20240205.htm">February&nbsp;
8, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000005506724000005/k-20240216.htm">February&nbsp;
22, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000005506724000025/k-20240426.htm">May&nbsp;
1, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000119312524135360/d804742d8k.htm">May&nbsp;
9, 2024</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000119312524140619/d814518d8k.htm">May&nbsp;
16, 2024</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/55067/000119312524200233/d884455d8k.htm">August&nbsp;14, 2024</A> (other than the portions of those documents not deemed to be filed pursuant to the
rules promulgated under the Exchange Act). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">You can obtain any of the documents listed above from the SEC, through the
SEC&#146;s website at the address indicated above or from Kellanova by requesting them in writing or by telephone at the following address and telephone number: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">P.O. Box 3599 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Battle Creek, MI 49016-3599 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(269) <FONT
STYLE="white-space:nowrap">961-2800</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attn: Investor Relations Department </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">These documents are available from Kellanova without charge, excluding any exhibits to them, and the proxy materials will also be posted at
https://materials.proxyvote.com/487836. You can also find information about Kellanova at its Internet website at www.kellanova.com. Information contained on this website does not constitute a part of this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The information contained in this proxy statement speaks only as of the date indicated on the cover of this proxy statement unless the
information specifically indicates that another date applies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>No persons have been authorized to give any information or to make any representations
other than those contained, or incorporated by reference, in this proxy statement and, if given or made, such information or representations must not be relied upon as having been authorized by Kellanova or any other person. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom893453_4531"></A>Annex A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by and among </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KELLANOVA, </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACQUIROR
10VB8, LLC, </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MERGER SUB 10VB8, LLC </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and (solely for the purposes of <U>Section</U><U></U><U>&nbsp;6.2(b)</U>, <U>Section</U><U></U><U>&nbsp;6.5</U>,
<U>Section</U><U></U><U>&nbsp;6.18</U> and <U>Section</U><U></U><U>&nbsp;9.15</U>) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MARS, INCORPORATED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dated as of August&nbsp;13, 2024 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">DEFINITIONS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_1">Certain Specified Definitions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_2">Defined Terms</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-12</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">THE MERGER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_3">The Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-14</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_4">Closing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_5">Effective Time</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_6">Effects of the Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_7">Organizational Documents of the Surviving Corporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_8">Officers and Directors of the Surviving Corporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_9">Effect on Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-16</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_10">Exchange of Certificates</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-17</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_11">Company Incentive Awards</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-19</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_12">Further Assurances</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-21</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_13">Withholding Rights</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-21</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;IV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_14">Organization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_15">Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-22</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_16">Corporate Authority Relative to this Agreement; No Violation</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-24</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_17">Reports and Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-25</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_18">Internal Controls and Procedures</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_19">No Undisclosed Liabilities</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_20">Compliance with Law; Permits</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-27</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_21">Sanctions and Export Control Laws</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-27</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_22">Investigations; Litigation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-28</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.10</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_23">Environmental Laws and Regulations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-28</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.11</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_24">Employee Benefit Plans; Employment Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-28</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_25">Absence of Certain Changes or Events</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-32</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.13</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_26">Information Supplied; Proxy Statement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-32</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.14</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_27">Tax Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-32</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.15</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_28">Intellectual Property</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-34</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_29">Property</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-35</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.17</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_30">Insurance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-36</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.18</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_31">Suppliers and Customers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-36</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.19</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_32">Material Contracts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-36</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.20</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_33">Opinion of Financial Advisor</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-38</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.21</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_34">Finders or Brokers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-38</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.22</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_35">State Takeover Statutes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-38</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.23</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_36">No Additional Representations or Warranties; Acknowledgment of
Disclaimer</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-38</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">REPRESENTATIONS AND WARRANTIES OF ACQUIROR AND MERGER SUB</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_37">Organization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-38</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_38">Corporate Authority Relative to this Agreement; No Violation</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_39">Information Supplied</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_40">Financing</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_41">Merger Sub</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-40</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_42">Litigation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-40</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_43">Stock Ownership</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-41</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_44">Solvency</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-41</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_45">Tax Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-41</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.10</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_46">No Additional Representations or Warranties; Acknowledgment of
Disclaimer</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-41</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;VI</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">COVENANTS AND AGREEMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_47">Conduct of Business of the Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-42</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_48">Access; Integration Planning</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-46</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_49">No Solicitation by the Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-47</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_50">Employee Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-51</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_51">Regulatory Approvals; Efforts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-53</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_52">Preparation of the Proxy Statement; Company Special Meeting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-55</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_53">Takeover Statutes</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-57</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_54">Public Announcements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-57</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_55">Indemnification and Insurance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-57</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.10</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_56">Control of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-59</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.11</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_57">Section&nbsp;16 Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-60</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_58">Tax Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-60</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.13</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_59">Financing Cooperation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-60</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.14</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_60">Treatment of Certain Company Indebtedness</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-63</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.15</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_61">Transaction Litigation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-64</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_62">Obligations of Merger Sub and Surviving Corporation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-65</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.17</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_63">Notification of Certain Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-65</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.18</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_64">Financing Obligation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-65</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;VII</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">CONDITIONS TO CONSUMMATION OF THE MERGER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_64a">Conditions to Each Party&#146;s Obligation to Effect the
Merger</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-67</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_65">Conditions to Obligations of Acquiror and Merger Sub</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-68</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_66">Conditions to Obligations of the Company</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-69</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;VIII</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">TERMINATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;8.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_67">Termination or Abandonment</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-69</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;8.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_68">Effect of Termination</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-70</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;8.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_69">Termination Fees and Remedies</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-71</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Article&nbsp;IX</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">MISCELLANEOUS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_70">No Survival</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-72</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_71">Expenses</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-72</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_72">Counterparts; Effectiveness</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-72</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_73">Governing Law</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-73</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_74">Jurisdiction; Specific Enforcement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-73</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_75">WAIVER OF JURY TRIAL</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-73</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_76">Notices</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-74</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_77">Assignment; Binding Effect</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_78">Severability</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.10</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_79">Entire Agreement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.11</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_80">Amendments; Waivers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_81">Headings</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.13</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_82">No Third-Party Beneficiaries</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-76</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.14</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_83">Interpretation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-76</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.15</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_84">Guaranty</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-77</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.16</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#atoc893453_85">Financing Parties</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">A-79</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">EXHIBITS AND SCHEDULES </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate of Incorporation of the Surviving Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Bylaws of the Surviving Corporation</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AGREEMENT AND PLAN OF MERGER (this &#147;<U>Agreement</U>&#148;), dated as of August&nbsp;13, 2024, is by and among Kellanova, a Delaware
corporation (the &#147;<U>Company</U>&#148;), Acquiror 10VB8, LLC, a Delaware limited liability company (&#147;<U>Acquiror</U>&#148;), Merger Sub 10VB8, LLC, a Delaware limited liability company and direct or indirect wholly owned Subsidiary of
Acquiror (&#147;<U>Merger Sub</U>&#148;), and, solely for the purposes of <U>Section</U><U></U><U>&nbsp;6.2(b)</U>, <U>Section</U><U></U><U>&nbsp;6.5</U>,<U> Section</U><U></U><U>&nbsp;6.18</U> and <U>Section</U><U></U><U>&nbsp;9.15</U>, Mars,
Incorporated, a Delaware corporation (&#147;<U>Parent</U>&#148;). Parent (solely for the purposes of <U>Section</U><U></U><U>&nbsp;6.2(b)</U>, <U>Section</U><U></U><U>&nbsp;6.5</U>, <U>Section</U><U></U><U>&nbsp;6.18</U> and
<U>Section</U><U></U><U>&nbsp;9.15)</U>, Acquiror, Merger Sub and the Company are each sometimes referred to herein as a &#147;<U>Party</U>&#148; and, collectively, as the &#147;<U>Parties</U>.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WITNESSETH: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
upon the terms and subject to the conditions contained herein, the Parties wish to effect a business combination through the merger of Merger Sub with and into the Company, with the Company being the surviving corporation; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with the Merger (as defined below), each outstanding share of common stock, par value $0.25 per share, of the Company
(the &#147;<U>Company Common Stock</U>&#148; or &#147;<U>Company Shares</U>&#148;) issued and outstanding immediately prior to the Effective Time (as defined below) (other than any Canceled Shares, any Dissenting Shares and any Remainder Shares
(each as defined below)) will be automatically converted into the right to receive the Merger Consideration (as defined below) upon the terms and conditions set forth in this Agreement and in accordance with the General Corporation Law of the State
of Delaware (the &#147;<U>DGCL</U>&#148;) and Limited Liability Company Act of the State of Delaware (the &#147;<U>DLLCA</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors of the Company (the &#147;<U>Company Board of Directors</U>&#148;), after due and careful consideration, and
in consultation with the Company&#146;s legal and financial advisors, has unanimously (a)&nbsp;determined that this Agreement, the Merger and the other transactions contemplated hereby are fair to, and in the best interests of, the Company and its
stockholders, (b)&nbsp;approved, authorized, adopted and declared advisable this Agreement, the Merger and other transactions contemplated hereby and (c)&nbsp;resolved to recommend that the stockholders of the Company vote in favor of the adoption
of this Agreement and the transactions contemplated hereby, including the Merger (the &#147;<U>Company Recommendation</U>&#148;) and to include such recommendation in the Proxy Statement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of managers of Acquiror (the &#147;<U>Acquiror Board of Managers</U>&#148;) has unanimously approved the Merger and
authorized (a)&nbsp;the execution and delivery by Acquiror of this Agreement, (b)&nbsp;the performance by Acquiror of its covenants and agreements contained herein and (c)&nbsp;the consummation of the Merger upon the terms and subject to the
conditions contained herein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of managers of Merger Sub has unanimously (a)&nbsp;approved and declared advisable this
Agreement and the transactions contemplated hereby, including the Merger, the performance by Merger Sub of its covenants and agreements contained herein and the consummation of the Merger upon the terms and subject to the conditions contained
herein; (b)&nbsp;determined that this Agreement and the Merger are fair to, advisable and in the best interests of Merger Sub and its sole member; (c)&nbsp;resolved to submit this Agreement to the sole member of Merger Sub for its approval of the
adoption hereof; and (d)&nbsp;resolved to recommend the adoption of this Agreement by the sole member of Merger Sub; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
concurrently with the execution and delivery of this Agreement, and as a condition to the willingness of Parent, Acquiror and Merger Sub to enter into this Agreement, each of the W.K. Kellogg Foundation Trust, Gordon Gund and Zachary Gund (and
certain family members and other affiliated entities of such persons that are stockholders of the Company) is entering into a voting agreement with Acquiror (each, a &#147;<U>Voting Agreement</U>&#148;), pursuant to which such person is agreeing to
vote all of the shares of Company Common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock beneficially owned by it in favor of the adoption of this Agreement and the transactions contemplated hereby, including the Merger, at the Company Special Meeting (as defined below); and
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties desire to make certain representations, warranties, covenants and agreements in connection with the Merger and also
prescribe various conditions to the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this
Agreement and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;I </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_1"></A>Section&nbsp;1.1 <U>Certain Specified Definitions</U>. As used in this Agreement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2025 Notes</U>&#148; means the 1.250% Euro
Notes due 2025 issued by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2026 Notes</U>&#148; means the 3.250% U.S.&nbsp;Dollar Notes due 2026 issued by the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2027 Notes</U>&#148; means the 3.400% U.S.&nbsp;Dollar Notes due 2027 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2028 Notes</U>&#148; means the 4.300% U.S.&nbsp;Dollar Notes due 2028 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2029 Notes</U>&#148; means the 0.500% Euro Notes due 2029 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2030 Notes</U>&#148; means the 2.100% U.S.&nbsp;Dollar Notes due 2030 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2031 Debentures</U>&#148; means the 7.450% U.S.&nbsp;Dollar Debentures due 2031 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2033 Notes</U>&#148; means the 5.250% U.S.&nbsp;Dollar Notes due 2033 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2034 Notes</U>&#148; means the 3.750% Euro Notes due 2034 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2046 Debentures</U>&#148; means the 4.500% U.S.&nbsp;Dollar Debentures due 2046 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>2054 Notes</U>&#148; means the 5.750% U.S.&nbsp;Dollar Notes due 2054 issued by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Facility</U>&#148; means that certain
<FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Agreement, dated as of December&nbsp;19, 2023, by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders and other parties from time to time party thereto, as
amended, restated, amended and restated, refinanced, supplemented or otherwise modified, replaced or refinanced from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acceptable Confidentiality Agreement</U>&#148; means any confidentiality agreement that contains provisions that are no less
favorable (other than in any immaterial and <FONT STYLE="white-space:nowrap">non-substantive</FONT> respect) to the Company than those that are contained in the Confidentiality Agreement (including standstill restrictions, except that such agreement
need not contain any restriction that would prohibit the counterparty from making a Company Takeover Proposal or acquiring the Company pursuant to such Company Takeover Proposal as contemplated by this Agreement) and that does not prohibit the
Company from providing to Acquiror the information required to be provided pursuant to <U>Section</U><U></U><U>&nbsp;6.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquiror Closing Tax Opinion Representation Letter</U>&#148; means a representation letter substantially in the form of the Acquiror
Signing Tax Opinion Representation Letter with such changes, updates or refinements, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
agreed to by Acquiror and Acquiror Tax Counsel, as may be necessary to reflect any changes in, or clarifications of, facts prior to the Closing, to be executed by Acquiror, dated and effective as
of the Closing Date, delivered to Acquiror Tax Counsel as a condition to, and in connection with, the issuance of the Closing Tax Opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquiror</U><U> Material Adverse Effect</U>&#148; means any fact, change, circumstance, event, occurrence, condition, development or
combination of the foregoing that prevents, materially delays or materially impairs the ability of Acquiror or Merger Sub to consummate the Merger or the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquiror Signing Tax Opinion Representation Letter</U>&#148; means the representation letter executed by Acquiror prior to the
execution of this Agreement, dated and effective as of the date hereof, and delivered to Acquiror Tax Counsel as a condition to, and in connection with, the issuance of the Signing Tax Opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Acquiror Tax Counsel</U>&#148; means Skadden, Arps, Slate, Meagher and Flom LLP (or, if Skadden, Arps, Slate, Meagher and Flom LLP is
unable, or declines, to deliver the Closing Tax Opinion, Kirkland&nbsp;&amp; Ellis LLP). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliates</U>&#148; means, as to any
person, any other person which, directly or indirectly, controls, or is controlled by, or is under common control with, such person. As used in this definition, &#147;control&#148; (including, with its correlative meanings, &#147;controlled by&#148;
and &#147;under common control with&#148;) means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a person, whether through the ownership of securities or partnership interests or
other ownership interests, by Contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Antitrust Laws</U>&#148; means (i)&nbsp;any antitrust, competition or trade
regulation Laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening competition through merger or acquisition, including the HSR Act and Council
Regulation (EC) No&nbsp;139/2004 of 20&nbsp;January 2004 on the control of concentrations between undertakings in the European Union; and (ii)&nbsp;any Foreign Investment Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day other than a Saturday, Sunday or any other day on which commercial banks in New York, New York,
or Governmental Entities in the State of Delaware are authorized or required by Law to close. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CARES Act</U>&#148; means the
Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) and any similar or successor legislation in any applicable jurisdiction, and any subsequent legislation, regulation, memorandum or executive order relating to <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> including the Health and Economic Recovery Omnibus Emergency Solutions Act and the Health, Economic Assistance, Liability, and Schools Act and including the Memorandum for the Secretary of the Treasury
signed by President Trump on August&nbsp;8, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Tax Opinion Representation Letters</U>&#148; means the Company Closing
Tax Opinion Representation Letter and the Acquiror Closing Tax Opinion Representation Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the U.S.
Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commercially Available Software</U>&#148; shall mean any computer software which is <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf,</FONT></FONT> generally commercially available pursuant to shrink wrap, click through or other <FONT STYLE="white-space:nowrap">non-negotiable</FONT> licensing terms, used by
the Company or any of its Subsidiaries with little or no configuration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Associate</U>&#148; means each Named Executive
Officer and any other employee of the Company or its Subsidiaries with a title of vice president or above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Benefit
Plan</U>&#148; means each compensation and/or employee benefit plan, program, scheme, policy, practice, agreement or other arrangement, including any pension, retirement, supplemental retirement, profit-sharing, deferred compensation, stock option,
change in control, retention, employment, equity or equity-based </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compensation, stock purchase, employee stock ownership, severance pay, vacation, bonus or other incentive plan, medical, retiree medical, vision, dental or other health plan, life insurance plan,
and each other compensatory or employee benefit plan or fringe benefit plan, including any &#147;employee benefit plan&#148; as that term is defined in Section&nbsp;3(3) of ERISA (whether or not subject to ERISA), in each case, whether oral or
written, funded or unfunded, or insured or self-insured, maintained by the Company or any Subsidiary, or to which the Company or any of its ERISA Affiliates contributes or is obligated to contribute on behalf of any current or former officer,
employee, director or individual consultant (or their respective beneficiaries) of the Company or any Subsidiary or with respect to which the Company or any Subsidiary has any current or contingent Liability; <I>provided</I> that in no event shall a
Company Benefit Plan include any arrangement operated by a Governmental Entity to which the Company or any Subsidiary is required to contribute under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Closing Tax Opinion Representation Letter</U>&#148; means a representation letter substantially in the form of the Company
Signing Tax Opinion Representation Letter, with such changes, updates or refinements, agreed to by the Company and Acquiror Tax Counsel, as may be necessary to reflect any changes in, or clarifications of, facts prior to the Closing, to be executed
by the Company, dated and effective as of the Closing Date, delivered to Acquiror Tax Counsel as a condition to, and in connection with, the issuance of the Closing Tax Opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Credit Agreements</U>&#148; means (a)&nbsp;the <FONT STYLE="white-space:nowrap">364-Day</FONT> Credit Facility and
(b)&nbsp;the Five-Year Credit Facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Deferred Stock Unit</U>&#148; means any deferred share of Company Common Stock
(whether or not vested) under any Company Benefit Plan that is outstanding as of immediately prior to the Effective Time and is credited in the form of units representing the fair market value of shares of Company Common Stock and is ultimately paid
in shares of Company Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company ESPP</U>&#148; means the Amended and Restated 2002 Employee Stock Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Fundamental Representations</U>&#148; means the representations and warranties made pursuant to
<U>Section</U><U></U><U>&nbsp;4.1(a)</U> (<I>Organization</I>) (first sentence only), <U>Section</U><U></U><U>&nbsp;4.1(b)</U> (<I>Organization</I>) (with respect to the Company Organizational Documents only), <U>Section</U><U></U><U>&nbsp;4.2</U>
(<I>Capital Stock</I>) (other than <U>Section</U><U></U><U>&nbsp;4.2(a)</U> and, in the case of <U>Section</U><U></U><U>&nbsp;4.2(d)</U>, with respect to Subsidiaries that are not material to the Company), <U>Section</U><U></U><U>&nbsp;4.3</U>
(<I>Corporate Authority Relative to this Agreement; No Violation</I>) (other than <U>Section</U><U></U><U>&nbsp;4.3(d)(</U><U>i</U><U>)</U> and <U>Section</U><U></U><U>&nbsp;4.3(d)(iii)</U>), <U>Section</U><U></U><U>&nbsp;4.20</U> (<I>Opinion of
Financial Advisor</I>), <U>Section</U><U></U><U>&nbsp;4.21</U> (<I>Finders or Brokers</I>) and <U>Section</U><U></U><U>&nbsp;4.22</U> (<I>State Takeover Statutes</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Indentures</U>&#148; means (i)&nbsp;the Indenture, dated as of March&nbsp;15, 2001, between the Company and BNY Midwest Trust
Company, as trustee, as supplemented by the Supplemental Indenture, dated as of March&nbsp;29, 2001, between the Company and BNY Midwest Trust Company, as trustee, (ii)&nbsp;the Indenture, dated as of May&nbsp;21, 2009, between the Company and The
Bank of New York Mellon Trust Company, N.A., as trustee and (iii)&nbsp;the Indenture, dated as of May&nbsp;6, 2024, between the Company and U.S. Bank Trust Company, National Association, as trustee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Intellectual Property</U>&#148; means all Intellectual Property that is owned or purported to be owned by the Company or any
of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Intervening Event</U>&#148; means any fact, circumstance, occurrence, event, development, change or
condition or combination thereof that (a)&nbsp;was not known to or reasonably expected by the Company Board of Directors as of or prior to the date of this Agreement (or if known or reasonably expected, the consequences of which were not reasonably
foreseeable as of or prior to the date of this Agreement) and (b)&nbsp;does not relate to any Company Takeover Proposal or expected receipt of a Company Takeover Proposal; <I>provided, however</I>, that in no event shall any of the following
constitute, or be taken into account in determining the existence of, a Company Intervening Event: (x)&nbsp;the fact that the Company meets or exceeds any internal or published projections, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forecasts, estimates or predictions of revenue, earnings or other financial or operating metrics for any period, or changes after the date of this Agreement in the market price or trading volume
of the Company Common Stock (<I>provided</I> that the underlying causes of such fact, to the extent not otherwise excluded from this definition of &#147;Company Intervening Event,&#148; may be taken into account in determining the existence of a
Company Intervening Event) or (y)&nbsp;the reasonably foreseeable consequences of the announcement of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company
Material Adverse Effect</U>&#148; means any fact, change, circumstance, event, occurrence, condition, development or combination of the foregoing&nbsp;that is materially adverse to the business, properties, results of operations or condition
(financial or otherwise) of the Company and its Subsidiaries, taken as a whole; <I>provided</I> that &#147;Company Material Adverse Effect&#148; shall not be deemed to include any fact, change, circumstance, event, occurrence, condition or
development (in each case, by itself or when aggregated) relating to, resulting from or arising out of (i)&nbsp;changes after the date hereof in GAAP (or authoritative interpretation or enforcement thereof), (ii)&nbsp;changes after the date hereof
in Laws (or authoritative interpretation or enforcement thereof), (iii)&nbsp;changes after the date hereof in global, national or regional political conditions (including cyber-attacks, acts of terrorism or sabotage, the outbreak of war or other
armed hostilities or the escalation of any of the foregoing), (iv)&nbsp;any epidemics or pandemics (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> and any hurricane, flood, tornado, earthquake or other natural disaster, (v)&nbsp;actions
or omissions required of the Company or any of the Company&#146;s Subsidiaries by this Agreement or any action or omission taken at the written request of Acquiror, (vi) (A)&nbsp;the negotiation, execution, announcement or existence of this
Agreement or the Merger, including the announcement of the identity of Acquiror (<I>provided</I>, that this clause&nbsp;(vi)(A) shall not apply to any representation or warranty in <U>Section</U><U></U><U>&nbsp;4.3(c)</U>,
<U>Section</U><U></U><U>&nbsp;4.3(d)</U> or <U>Section</U><U></U><U>&nbsp;4.11(j)</U> to the extent the purpose of such representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or the
consummation of the transactions contemplated hereby), or (B)&nbsp;any communication by Acquiror or any of its Affiliates regarding plans or proposals with respect to the Company and its Subsidiaries, in the case of each of foregoing clauses
(A)&nbsp;and (B), including the impact thereof on the relationships, contractual or otherwise, of the Company and its Subsidiaries with customers, suppliers, lenders, lessors, business partners, employees (including any employee attrition),
(vii)&nbsp;any breach of this Agreement by Acquiror or Merger Sub, (viii)&nbsp;any change, in and of itself, in the trading price or volume of the Company Common Stock or the failure, in and of itself, to meet internal or external budgets,
forecasts, projections or predictions or analysts&#146; expectations or projections for any future period (<I>provided</I>, that the underlying causes of such change or failure may be taken into account in determining the existence of a Company
Material Adverse Effect), (ix) changes after the date hereof in the global securities, credit or other financial markets or in general economic, business or market conditions, including any disruption thereof or any change in prevailing interest
rates, or (x)&nbsp;conditions generally affecting the U.S. or any foreign economy (in which the Company and its Subsidiaries operate) or the industries in which the Company and its Subsidiaries operate (including changes to commodity prices);
except, with respect to clauses&nbsp;(i), (ii), (iii), (iv), (ix) and (x)&nbsp;of this definition, to the extent that the effects of such change are disproportionately adverse to the business, properties, results of operations or condition
(financial or otherwise) of the Company and its Subsidiaries, taken as a whole, as compared to other companies in the industries in which the Company and its Subsidiaries operate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Notes</U>&#148; means, collectively, (i)&nbsp;the 2025 Notes, (ii)&nbsp;the 2026 Notes, (iii)&nbsp;the 2027 Notes,
(iv)&nbsp;the 2028 Notes, (v)&nbsp;the 2029 Notes, (vi)&nbsp;the 2030 Notes, (vii)&nbsp;the 2031 Debentures, (viii)&nbsp;the 2033 Notes, (ix)&nbsp;the 2034 Notes, (x)&nbsp;the 2046 Debentures, and (xi)&nbsp;the 2054 Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Option</U>&#148; means any option to purchase Company Common Stock granted under any Company Stock Plan that is not a Company
Stock Purchase Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Performance Stock Unit</U>&#148; means any restricted stock unit subject to vesting based on
service and performance goals granted under any Company Stock Plan, payable in shares of Company Common Stock or whose value is determined with reference to the value of shares of Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Registrations</U>&#148; means all Patent Rights and all registrations and applications for Trademarks, Copyrights, Internet
domain names and social media addresses that constitute Company Intellectual Property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Restricted Stock Unit</U>&#148; means any restricted stock unit subject to
vesting solely based on service (and not on performance) granted under any Company Stock Plan other than a Company Deferred Stock Unit, payable in shares of Company Common Stock, or whose value is determined with reference to the value of shares of
Company Common Stock, including any restricted stock unit granted in 2022 that was originally subject to vesting based on service and performance goals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Signing Tax Opinion Representation Letter</U>&#148; means the representation letter executed by the Company prior to the
execution of this Agreement, dated and effective as of the date hereof, and delivered to Acquiror Tax Counsel as a condition to, and in connection with, the issuance of the Signing Tax Opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Stock Plans</U>&#148; means, collectively, the Company Stock Purchase Plans, the Company&#146;s 2009 <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director Stock Plan, the Company&#146;s 2013 Long-Term Incentive Plan, the Company&#146;s 2017 Long-Term Incentive Plan and the Company&#146;s 2022 Long-Term Incentive Plan, in each case, as amended.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Stock Purchase Plans</U>&#148; means, collectively, the Company ESPP, the Company&#146;s Share Incentive Plan, the
Company&#146;s Employee Share Ownership Plan, the Company&#146;s discounted share purchase plan maintained for the benefit of service providers in Belgium and a share purchase plan maintained for the benefit of service providers in France, in each
case, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Superior Proposal</U>&#148; means a bona fide, unsolicited written Company Takeover Proposal
(a)&nbsp;that if consummated would result in a third party (or in the case of a direct merger between such third party and the Company, the stockholders of such third party) acquiring, directly or indirectly, more than fifty percent (50%) of the
outstanding Company Common Stock or more than fifty percent (50%) of the assets of the Company and its Subsidiaries, taken as a whole, and (b)&nbsp;that the Company Board of Directors determines in good faith (in accordance with
<U>Section</U><U></U><U>&nbsp;6.3(f)</U>), after consultation with its outside financial advisor and outside legal counsel, taking into account the timing and likelihood of consummation relative to the transactions contemplated by this Agreement,
and after giving effect to any changes to this Agreement proposed by Acquiror in response to such Company Takeover Proposal (in accordance with <U>Section</U><U></U><U>&nbsp;6.3(f)</U>) and all other financial, legal, regulatory, Tax and other
aspects of such proposal, including all conditions contained therein and the person making such Company Takeover Proposal, as the Company Board of Directors deems relevant, is more favorable from a financial standpoint to the stockholders of the
Company than the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Takeover Proposal</U>&#148; means any proposal or offer from any person (other than Parent or
any of its direct or indirect Subsidiaries), with respect to, or that would reasonably be expected to lead to, in a single transaction or a series of related transactions, (a)&nbsp;a merger, consolidation, business combination, recapitalization,
binding share exchange, liquidation, dissolution, joint venture or other similar transaction involving the Company or any of its Subsidiaries that if consummated would result in any person (or the stockholders of such person) beneficially owning
twenty percent (20%) or more of the outstanding Company Common Stock or securities of the Company representing twenty percent (20%) or more of the voting power of the Company, (b)&nbsp;any acquisition of twenty percent (20%) or more of the
outstanding Company Common Stock or securities of the Company representing twenty percent (20%) or more of the voting power of the Company, (c)&nbsp;any acquisition (including the acquisition of stock in any Subsidiary of the Company) of assets or
businesses of the Company or its Subsidiaries, including pursuant to a joint venture, representing twenty percent (20%) or more of the consolidated assets, revenues or net income of the Company, (d)&nbsp;any tender offer or exchange offer that if
consummated would result in any person beneficially owning twenty percent (20%) or more of the outstanding Company Common Stock or securities of the Company representing twenty percent (20%) or more of the voting power of the Company or (e)&nbsp;any
combination of the foregoing types of transactions if the sum of the percentage of consolidated assets, consolidated revenues or earnings and Company Common Stock (or voting power of securities of the Company other than the Company Common Stock)
involved is twenty percent (20%) or more. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contract</U>&#148; (including, its correlative meaning,
&#147;<U>Contractual</U>&#148;) means any contract, note, bond, mortgage, indenture, deed of trust, license, lease, agreement, arrangement, commitment or other instrument or obligation that is legally binding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contribution</U>&#148; has the meaning specified in the Separation and Distribution
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT></U>&#148; means <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> or <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and any evolutions or mutations thereof or related or associated epidemics, pandemics, public health emergencies or disease outbreaks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT></U><U></U><U>&nbsp;Measures</U>&#148; means quarantine, &#147;shelter in
place,&#148; &#147;stay at home,&#148; workforce reduction, social distancing, shut down, closure, sequester, safety or similar laws, directives, restrictions, guidelines, responses, or recommendations of, or promulgated by, any Governmental Entity,
including the Centers for Disease Control and Prevention and the World Health Organization, or other reasonable actions taken, in each case, in connection with or in response <FONT STYLE="white-space:nowrap">to&nbsp;COVID-19.</FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Financing Sources</U>&#148; means the entities that are party to the Debt Financing Commitment Letter and any other entity
(other than, in each case, Acquiror or any of its Affiliates) that has committed to provide, underwrite or arrange or act as an administrative or facility agent in respect of all or any part of the Financing (or any credit facilities or debt
securities being issued in lieu of any portion of the Financing) in connection with the Merger or other transactions contemplated by this Agreement, including any arranger, agent, lender, initial purchaser, underwriter or investor that is a party to
any commitment letter, engagement letter, joinder agreement, purchase agreement, indenture, credit agreement or other definitive agreement entered into pursuant thereto or relating thereto, together with its Affiliates, and its and their respective
officers, directors, employees, agents, Representatives, members, managers, general or limited partners, shareholders, controlling persons, and their respective successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Distribution</U>&#148; has the meaning specified in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Law</U>&#148; means any Law relating to the protection, preservation or restoration of the environment (including air,
surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource), or any exposure to or Release of, or the management of (including the use, storage, recycling, treatment,
generation, transportation, processing, handling, labeling, production or disposal of any Hazardous Materials). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148;
means the Employee Retirement Income and Security Act of 1974, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means, with respect to any
entity, trade or business, any other entity, trade or business that is, or was at the relevant time, a member of a group described in Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA that includes or included
the first entity, trade or business, or that is, or was at the relevant time, a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to Section&nbsp;4001(a)(14) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Five-Year Credit Facility</U>&#148; means that certain Five-Year Credit Agreement, dated as of December&nbsp;21, 2021, by and among
the Company (as successor in interest to Kellogg Company), JPMorgan Chase Bank, N.A., as administrative agent, and the lenders and other parties from time to time party thereto, as amended, restated, amended and restated, refinanced, supplemented or
otherwise modified, replaced or refinanced from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Foreign Investment Law</U>&#148; means any applicable Law that
provides for the review, clearance or notification of transactions on grounds of national security or other national or public interest, including any state, national or multi-jurisdictional applicable Law that is designed or intended to prohibit,
restrict or regulate actions by foreigners to acquire interests in or control over domestic equities, securities, entities, assets, land or interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Entity</U>&#148; means any U.S. federal, state, local or foreign government, any transnational governmental organization
or any court of competent jurisdiction, arbitral, regulatory authority, administrative agency or commission or other governmental authority or instrumentality, domestic or foreign, or any national securities exchange or national quotation system or
any SRO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous Materials</U>&#148; means (i)&nbsp;any material, substance, chemical, or
waste (or combination thereof) that (A)&nbsp;is listed, defined, designated, regulated or classified as hazardous, toxic, radioactive, dangerous, a pollutant, a contaminant, petroleum, oil, or words of similar meaning or effect under any
Environmental Law or (B)&nbsp;can form the basis of any liability under any Environmental Law relating to pollution, waste, or the environment, in each case due to its hazardous, toxic, dangerous or deleterious properties or characteristics; and
(ii)&nbsp;any petroleum, petroleum products, <FONT STYLE="white-space:nowrap">per-</FONT> and polyfluoroalkyl substances (including PFAs, PFOA, PFOS, Gen X, and PFBs), polychlorinated biphenyls (PCBs), asbestos and asbestos-containing materials,
radon, and toxic mold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means, with respect to any person, without duplication, as of the date of
determination, (a)&nbsp;all obligations of such person for borrowed money, (b)&nbsp;all obligations of such person evidenced by bonds, debentures, notes or similar instruments, (c)&nbsp;all obligations of such person issued or assumed as the
deferred purchase price of property (including any potential future <FONT STYLE="white-space:nowrap">earn-out,</FONT> purchase price adjustment, release of &#147;holdback&#148; or similar payment, but excluding obligations of such person incurred in
the ordinary course of business consistent with past practice), (d)&nbsp;all lease obligations of such person that are required to be capitalized in accordance with GAAP as in effect on the date hereof on the books and records of such person,
(e)&nbsp;all Indebtedness of others (excluding the Company and any of its Subsidiaries) secured by a Lien on property or assets owned or acquired by such person, whether or not the Indebtedness secured thereby has been assumed, (f)&nbsp;all
obligations of such person under interest rate, currency or commodity derivatives or hedging transactions or similar arrangements (valued at the termination value thereof), (g)&nbsp;all letters of credit or performance bonds issued for the account
of such person, to the extent drawn upon and not repaid or reimbursed, and (h)&nbsp;all guarantees and keepwell arrangements of such person of any Indebtedness of any other person other than the Company and any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means all forms of intellectual property and intellectual property rights subsisting anywhere in the
world, whether registered or unregistered, including the following: (a)&nbsp;patents, patent applications (including provisional patent applications), utility models, design registrations and certificates of invention and other governmental grants
for the protection of inventions or industrial designs (including all related continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, reissues and reexaminations)
(&#147;<U>Patent Rights</U>&#148;); (b)&nbsp;trademarks and service marks, logos, trade dress, corporate names and doing business designations, including all goodwill therein, and all registrations and applications for registration of the foregoing
(&#147;<U>Trademarks</U>&#148;); (c)&nbsp;copyrights, designs, data and database rights and registrations and applications for registration thereof, including moral rights of authors, and all works of authorship (&#147;<U>Copyrights</U>&#148;);
(d)&nbsp;Internet domain names and social media addresses; (e)&nbsp;inventions, invention disclosures, statutory invention registrations, trade secrets and confidential business information, formulas,
<FONT STYLE="white-space:nowrap">know-how,</FONT> manufacturing and product processes and techniques, research and development information, financial, marketing and business data, pricing and cost information, business and marketing plans and
customer and supplier lists and information, whether patentable or nonpatentable, whether copyrightable or noncopyrightable and whether or not reduced to practice; and (f)&nbsp;other proprietary rights relating to any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Inventory</U>&#148; shall mean, collectively, all finished goods, raw materials, packaging supplies and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-process</FONT></FONT> owned by the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>IRS Ruling</U>&#148; has the meaning specified in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>knowledge</U>&#148; means, (i)&nbsp;with respect to the Company and its Subsidiaries, the actual knowledge, after reasonable due
inquiry, of the individuals listed on <U>Section</U><U></U><U>&nbsp;1.1(A)(</U><U>i</U><U>)</U> of the Company Disclosure Schedule and (ii)&nbsp;with respect to Acquiror and Merger Sub, the actual knowledge, after reasonable due inquiry, of the
individuals listed on <U>Section</U><U></U><U>&nbsp;1.1(A)(ii)</U> of the Company Disclosure Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Laws</U>&#148; means all
federal, state, local and foreign laws, statutes, ordinances, rules, regulations, judgments, Orders, injunctions, decrees or agency requirements of Governmental Entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Legal Proceeding</U>&#148; means any claim, action, suit, litigation, arbitration,
proceeding or governmental or administrative investigation, inquiry or action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liability</U>&#148; means any and all debts,
liabilities and obligations, whether fixed, contingent or absolute, matured or unmatured, accrued or not accrued, determined or determinable, secured or unsecured, disputed or undisputed, subordinated or unsubordinated, or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Licensed IP</U>&#148; means Intellectual Property licensed or otherwise granted to the Company or any of its Subsidiaries by any
third party, other than licenses in or to Commercially Available Software. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means all liens, claims, mortgages,
encumbrances, pledges, security interests or charges of any kind. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>made available</U>&#148; means, with respect to any
information, document or material, that such information, document or material was (a)&nbsp;publicly filed on the SEC EDGAR database as part of a Company SEC Document (or expressly incorporated by reference into a Company SEC Document) after
January&nbsp;1, 2021, and prior to the date hereof or (b)&nbsp;made available on or prior to 12:00&nbsp;p.m. New York time on August&nbsp;13, 2024 for review by Acquiror or its Representatives in the electronic data site established on behalf of the
Company and to which Acquiror and certain of its Representatives have been given access in connection with the transactions contemplated by this Agreement or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Named Executive Officers</U>&#148; means the principal executive officer, the principal financial officer and the next three most
highly paid executive officers of the Company as of the end of the most recently completed fiscal year, based on total compensation as determined under Rule&nbsp;402 of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> under the Securities
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>NYSE</U>&#148; means the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any charge, order, writ, injunction, judgment, decree, ruling, determination, directive, award or settlement
of, with or by a Governmental Entity, whether civil, criminal or administrative and whether formal or informal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted
Lien</U>&#148; means (a)&nbsp;any Lien for Taxes not yet due and payable or delinquent or which are being contested in good faith by appropriate proceedings and for which adequate reserves have been established in the applicable financial statements
in accordance with GAAP, (b)&nbsp;vendors&#146;, mechanics&#146;, materialmen&#146;s, carriers&#146;, workers&#146;, landlords&#146;, repairmen&#146;s, warehousemen&#146;s, construction and other similar Liens arising or incurred in the ordinary
course of business or with respect to Liabilities that are not yet due and payable or, if due, are not delinquent for greater than thirty (30)&nbsp;days or are being contested in good faith by appropriate proceedings and for which adequate reserves
(based on good faith estimates of management) have been set aside for the payment thereof, (c)&nbsp;Liens imposed or promulgated by applicable Law or any Governmental Entity with respect to real property, including zoning, building, fire, health and
Environmental Laws and similar regulations, which do not materially affect the use of the properties or the assets subject thereto or affected thereby or otherwise materially impair business operations at such properties, (d)&nbsp;pledges or
deposits in connection with workers&#146; compensation, unemployment insurance, social security and other similar legislation, (e)&nbsp;Liens relating to intercompany borrowings among a person and its direct or indirect Subsidiaries,
(f)&nbsp;purchase money Liens securing payments under capital lease arrangements, (g)&nbsp;other than with respect to Company Owned Real Property or Company Leased Real Property, Liens arising under, and the other terms and conditions set forth in,
original purchase price conditional sales contracts and equipment leases with third parties entered into in the ordinary course of business and containing terms consistent with arm&#146;s length transactions of a similar type, <FONT
STYLE="white-space:nowrap">(h)&nbsp;non-exclusive</FONT> licenses to Intellectual Property granted in the ordinary course of business consistent with past practice, (i)&nbsp;Liens specifically identified, reflected in, reserved against or otherwise
disclosed in the Company Financial Statements, (j)&nbsp;any right, interest, title or Lien of a landlord or sublandlord of any Company Leased Real Property or in the property being leased, <I>provided</I> any such Lien relates to the fee interest
(and not the leasehold interest) of a Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Leased Real Property, (k)&nbsp;easements, covenants, conditions, restrictions and other similar matters of record affecting title to any Company Owned Real Property or Company Leased Real
Property which do not materially impair the use of the properties or the assets subject thereto or affected thereby or otherwise materially impair business operations at such properties and (l)&nbsp;Liens securing Indebtedness that is secured as of
the date of this Agreement (and any refinancing Indebtedness thereof incurred in accordance with this Agreement) and Liens securing any working capital lines of credit and cash pooling arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>person</U>&#148; means an individual, a corporation, a partnership, a limited liability company, an association, a trust or any other
entity, group (as such term is used in Section&nbsp;13 of the Exchange Act) or organization, including a Governmental Entity, and any permitted successors and assigns of such person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proxy Statement</U>&#148; means the proxy statement of the Company related to the solicitation of votes in favor of the adoption of
this Agreement and the transactions contemplated hereby, including the Merger, at the Company Special Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Release</U>&#148;
means any release, spill, emission, discharge, leaking, pumping, injection, deposit, disposal, dispersal, leaching or migration into the indoor or outdoor environment (including ambient air, surface water, groundwater and surface or subsurface
strata) or into or out of any property, including the migration of Hazardous Materials through or in the air, soil, surface water, groundwater or property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148; means, with respect to any person, such person&#146;s Subsidiaries and such person&#146;s and its
Subsidiaries&#146; respective directors, officers, employees, agents, attorneys, accountants, financial advisors, investment bankers and other representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Request for Additional Information or Documentary Material</U>&#148; means any request or demand for the production, delivery or
disclosure of documents, information or other evidence, or any request or demand for the production of witnesses for interviews or depositions or other oral or written testimony, by any Governmental Entity under any applicable Antitrust Law relating
to the transactions contemplated hereby or by any third party challenging the transactions contemplated hereby, including any <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;second request&#148; for additional information or documentary
material or any civil investigative demand made or issued by the Antitrust Division of the Department of Justice or the United States Federal Trade Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Reserved Terms</U>&#148; means the following terms related to any Consent Solicitation: the choice of one or more series of Company
Notes to be made subject to such Consent Solicitation, the price and conditionality of such Consent Solicitation, all timing elements of such Consent Solicitation, the proposed amendments to the applicable Company Indentures in such Consent
Solicitation, the choice of the solicitation agents or other agents to be retained in connection with such Consent Solicitation and their compensation arrangements, any termination of such Consent Solicitation and all amendments and modifications
with respect to the foregoing from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Person</U>&#148; means any person identified on the U.S. Department
of Commerce&#146;s Entity List, Denied Persons List, Unverified List or Military End User List, or the U.S. Department of State&#146;s Debarred List. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restrictive Covenant</U>&#148; means any agreement or obligation restricting or limiting the ability of a Company Associate to
solicit or hire any employee of the Company or its Subsidiaries, solicit or conduct business with any business counterparty of the Company or its Subsidiaries or compete with the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctioned Jurisdiction</U>&#148; means a country or territory that is itself the subject or target of any Sanctions (at the time of
this Agreement, Cuba, Iran, North Korea, Syria, and the Crimea, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#146;s Republic, and the <FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk People&#146;s Republic regions of
Ukraine, and the <FONT STYLE="white-space:nowrap">non-government</FONT> controlled areas of Ukraine in the oblasts of Kherson and Zaporizhzhia). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctioned Person</U>&#148; means any person subject to Sanctions, including as a
result of being (a)&nbsp;listed in any list of sanctioned persons, including those maintained by the United States (including the Department of the Treasury&#146;s Office of Foreign Assets Control and the Department of State), the United Nations
Security Council, the United Kingdom, or the European Union; (b)&nbsp;located, organized, or resident in a Sanctioned Jurisdiction; or (c)&nbsp;directly or indirectly owned fifty percent (50%) or more or controlled, individually or in the aggregate,
by one or more persons described in the foregoing clauses&nbsp;(a) and/or (b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctions</U>&#148; means the economic, trade or
financial sanctions laws, regulations, embargoes or restrictive measures administered, enacted or enforced from time to time by any Sanctions Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctions and Export Control Laws</U>&#148; means any applicable Law related to (a)&nbsp;import and export controls, including the
U.S. Export Administration Regulations, (b)&nbsp;economic or financial sanctions and trade embargoes, including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of State, the
United Nations Security Council, the European Union, and the United Kingdom or (c)&nbsp;anti-boycott measures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Sanctions
Authority</U>&#148; means the United States government (including the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control and the U.S. Department of State); the Government of Canada (including Global Affairs Canada, the Minister
of Foreign Affairs, Public Safety Canada and the Department of Justice Canada), the United Nations Security Council; the European Union, any European Union member state; and the United Kingdom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; means the U.S. Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Section</U><U></U><U>&nbsp;336(e) Election</U>&#148; has the meaning specified in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Separation and Distribution Agreement</U>&#148; means that certain Separation and Distribution Agreement, dated as of
September&nbsp;29, 2023, by and between the Company and SpinCo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Separation Transactions</U>&#148; means the Contribution, the
Distribution, and all other transactions listed on Schedule A to the Tax Matters Agreement to the extent intended to be treated as transactions qualifying in whole or in part under Section&nbsp;355 and/or Section&nbsp;368(a)(1)(D) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Signing Tax Opinion Representation Letters</U>&#148; means the Company Signing Tax Opinion Representation Letter and the Acquiror
Signing Tax Opinion Representation Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SpinCo</U>&#148; means WK Kellogg Co. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SRO</U>&#148; means any self-regulatory organization of any nature, including any United States or foreign securities exchange,
futures exchange, commodities exchange or contract market and any advertising or industry self-regulatory organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiaries</U>&#148; means, with respect to any Party, any corporation, partnership, joint venture or other legal entity of which
such Party (either alone or through or together with any other Subsidiary), owns, directly or indirectly, fifty percent (50%) or more of the capital stock or other equity interests the holders of which are generally entitled to vote for the election
of the board of directors or other governing body of such corporation, limited liability company, partnership, joint venture or other legal entity, or otherwise owns, directly or indirectly, such capital stock or other equity interests that would
confer control of any such corporation, limited liability company, partnership, joint venture or other legal entity, or any person that would otherwise be deemed a &#147;subsidiary&#148; under <FONT STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT>
promulgated under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax</U>&#148; (including, its correlative meaning &#147;<U>Taxes</U>&#148;) means all
federal, state, local or foreign tax, custom, impost, levy, duty, fee or other assessment or charge of any nature whatsoever imposed by any Governmental </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Entity (including any income, gross receipts, capital, sales, use, ad valorem, value added, transfer, franchise, profits, inventory, capital stock, withholding, payroll, employment, social
security, unemployment, excise, severance, stamp, premium, license, recording, occupation, environmental, abandoned or unclaimed property, real or personal property and estimated tax, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT>
minimum tax, customs duty or other tax), together with any interest, penalties, fines or additions imposed with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions</U>&#148; has the meaning specified in the Tax Matters
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Materials</U>&#148; has the meaning specified in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Matters Agreement</U>&#148; means that certain Tax Matters Agreement, dated as of September&nbsp;29, 2023, by and between the
Company and SpinCo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Return</U>&#148; means any return, report, information return, claim for refund, election, estimated tax
filing or declaration or similar filing (including any attached schedules, supplements and additional or supporting material) filed or required to be filed, or supplied or required to be supplied, with respect to Taxes, including any amendments
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Top Customers</U>&#148; means the largest ten (10)&nbsp;customers of the Company and its Subsidiaries, taken as a
whole, based on dollar value of sales to such customers by the Company and its Subsidiaries, taken as a whole, during the fiscal year ended December&nbsp;30, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Top Suppliers</U>&#148; means the largest ten (10)&nbsp;suppliers of products or services to the Company and its Subsidiaries, taken
as a whole, based on expenditures of the Company and its Subsidiaries, taken as a whole, during the twelve (12)&nbsp;month period ended March&nbsp;30, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Treasury Regulations</U>&#148; means the regulations promulgated under the Code by the U.S. Department of the Treasury. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Willful Breach</U>&#148; means a breach that is the result of a willful or intentional act or failure to act by a person that would,
or reasonably would be expected to, result in a material breach of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_2"></A>Section&nbsp;1.2 <U>Defined
Terms</U>. The following terms are defined in this Agreement in the sections indicated below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquiror</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquiror 401(k) Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(f)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquiror Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;5.2(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquiror Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquiror Board of Managers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adverse Recommendation Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.3(e)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Book-Entry Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(a)(i)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Broker Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Burdensome Condition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.5(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Canceled Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(a)(ii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalization Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.2(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(a)(i)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 2.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chosen Courts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;9.5(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clean Room Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.2(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clearance Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.6(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 2.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 2.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Tax Opinion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.2(f)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Year Annual Bonus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Year Annual Bonus Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collective Bargaining Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.11(n)</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Acquisition Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.3(e)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.3(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Bylaws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Certificate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Disclosure Schedule</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Article IV</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.4(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Indemnified Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.9(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Intervening Event Recommendation Change</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.3(g)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Leased Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 4.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Material Contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.19(a)(viii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Non-Union 401(k) Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(f)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Organizational Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Owned Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.16</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.7(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Real Property Leases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 4.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Recommendation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.4(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.2(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Special Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.6(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Stockholder Approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.3(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Subsidiary Organizational Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Company Takeover Transaction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;8.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Confidentiality Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.2(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consent Solicitation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.14(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Continuing Employee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">D&amp;O Insurance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.9(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 5.4</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing Commitment Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 5.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Financing Letters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 5.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definitive Agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.18(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Delaware Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 2.3</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DGCL 262</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dispositions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.1(a)(vi)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dissenting Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DLLCA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DSU Cash Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.3(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Early Good Leaver Termination</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 2.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Allowances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.3(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange Offer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.14(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fee Letter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 5.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Final Purchase Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.3(f)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.13(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GAAP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.4(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guaranteed Obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;9.15(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guaranty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;9.15(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSR Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.3(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IRS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.11(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal Restraint</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Letter of Transmittal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.2(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 2.1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(a)(i)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merger Sub Common Interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(a)(iv)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Multiemployer Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.11(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Option Cash Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.3(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside Date</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;8.1(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Preamble</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment Agent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.2(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment Fund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.2(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payoff Letters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.14(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PBGC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.11(e)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prior Year Annual Bonus</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.4(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prohibited Modifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;6.18(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSU Cash Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.3(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Qualified Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.11(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;7.1(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regulatory Filings and Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.3(c)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remainder Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.1(a)(iii)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Required Amount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 5.4</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reverse Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;8.3(e)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RSU Cash Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;3.3(b)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sarbanes-Oxley Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.4(a)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securities Act</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.3(c)</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signing Tax Opinion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;5.9(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Surviving Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section 2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination Fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;8.3(d)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title IV Plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Section&nbsp;4.11(e)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting Agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Recitals</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;II </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE MERGER</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_3"></A>Section&nbsp;2.1 <U>The Merger</U>. Upon the terms and subject to the satisfaction or valid waiver of the conditions set forth in this Agreement, and in accordance with the DGCL and DLLCA, at the Effective Time, Merger Sub shall be merged with
and into the Company (the &#147;<U>Merger</U>&#148;), whereupon the separate existence of Merger Sub will cease, with the Company surviving the Merger (the Company, as the surviving entity in the Merger, sometimes
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
being referred to herein as the &#147;<U>Surviving Corporation</U>&#148;), such that following the Merger, the Surviving Corporation will be a wholly owned direct or indirect Subsidiary of
Acquiror. The Merger shall have the effects provided in this Agreement and as specified in the DGCL and DLLCA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_4"></A>Section&nbsp;2.2 <U>Closing</U>. The closing of the Merger (the &#147;<U>Closing</U>&#148;) shall take place at the
offices of Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP, One Manhattan West, New York, New York 10018 at 10:00&nbsp;a.m., New York City time, on the third (3<SUP STYLE="font-size:75%; vertical-align:top">rd</SUP>) Business Day (or other date
agreed in writing by the Parties) after the satisfaction or waiver of the last of the conditions set forth in <U>Article</U><U></U><U>&nbsp;VII</U> to be satisfied or, if permissible, waived (other than any such conditions that by their nature are
to be satisfied by action taken at or immediately prior to the Closing, but subject to the satisfaction or waiver of such conditions at or immediately prior to the Closing), unless another time, date or place is agreed upon in writing by the Company
and Acquiror. The date on which the Closing actually occurs is referred to as the &#147;<U>Closing Date</U>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_5"></A>Section&nbsp;2.3 <U>Effective Time</U>. On the Closing Date, the Parties shall cause a certificate of merger with respect to the Merger (the &#147;<U>Certificate of Merger</U>&#148;) to be duly executed and filed with the Secretary of State of
the State of Delaware (the &#147;<U>Delaware Secretary</U>&#148;) as provided under the DGCL and DLLCA and make any other filings, recordings or publications required to be made by the Company, Merger Sub or Acquiror under the DGCL and DLLCA in
connection with the Merger. The Merger shall become effective at such time as the Certificate of Merger is duly filed with the Delaware Secretary or on such later date and time as shall be agreed upon by the Company and Acquiror and specified in the
Certificate of Merger (such date and time being hereinafter referred to as the &#147;<U>Effective Time</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_6"></A>Section&nbsp;2.4 <U>Effects of the Merger</U>. The effects of the Merger shall be as provided in this Agreement and in the applicable provisions of the DGCL and DLLCA. Without limiting the generality of the foregoing, and subject thereto, at the
Effective Time all of the property, rights, privileges, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all debts, Liabilities and duties of the Company and Merger Sub shall become the debts,
Liabilities and duties of the Surviving Corporation, all as provided under the DGCL and DLLCA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_7"></A>Section&nbsp;2.5 <U>Organizational Documents of the Surviving Corporation</U>. Subject to
<U>Section</U><U></U><U>&nbsp;6.9</U>, at the Effective Time: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the certificate of incorporation of the Surviving
Corporation shall be amended and restated to conform to <U>Exhibit</U><U></U><U>&nbsp;A</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the bylaws of the
Surviving Corporation shall be amended and restated to conform to <U>Exhibit</U><U></U><U>&nbsp;B</U>; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the name of
the Surviving Corporation shall be &#147;Kellanova&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_8"></A>Section&nbsp;2.6 <U>Officers and Directors of the
Surviving Corporation</U>. Subject to applicable Law, the managers of Merger Sub immediately prior to the Effective Time shall be the initial directors of the Surviving Corporation and shall hold office until their respective successors are duly
elected and qualified, or their earlier death, resignation or removal. The officers of the Company immediately prior to the Effective Time, or such other individuals designated by Acquiror as of the Effective Time, shall be the initial officers of
the Surviving Corporation and shall hold office until their respective successors are duly elected and qualified, or their earlier death, resignation or removal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;III </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_9"></A>Section&nbsp;3.1 <U>Effect on Capital Stock</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Effective Time, by virtue of the Merger and without any action on the part of any of the Parties or the holder of
any shares of Company Common Stock or Merger Sub Common Interests (as defined below): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Conversion of Company Common
Stock</U>. Subject to <U>Section</U><U></U><U>&nbsp;3.1(b)</U>, each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares, Dissenting Shares, and Remainder Shares) shall be
automatically converted into the right to receive $83.50, in cash, without interest (the &#147;<U>Merger Consideration</U>&#148;). From and after the Effective Time, all such shares of Company Common Stock (including all uncertificated shares of
Company Common Stock represented by book-entry form (&#147;<U>Book-Entry Shares</U>&#148;) and each certificate that, immediately prior to the Effective Time, represented any such shares of Company Common Stock (each, a
&#147;<U>Certificate</U>&#148;)) shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each applicable holder of such shares of Company Common Stock shall cease to have any rights with respect thereto,
except the right to receive the Merger Consideration and any dividends or other distributions declared in accordance with the terms of <U>Section</U><U></U><U>&nbsp;6.1</U> with a record date prior to the Effective Time to which holders of Company
Common Stock as of such record date become entitled and that remain unpaid as of the Effective Time upon the surrender or conversion of such shares of Company Common Stock in accordance with <U>Section</U><U></U><U>&nbsp;3.2</U>, without interest.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Cancellation of Company Common Stock</U>. Each share of Company Common Stock issued and outstanding immediately
prior to the Effective Time that is owned or held in treasury by the Company shall no longer be outstanding and shall automatically be canceled and shall cease to exist (the &#147;<U>Canceled Shares</U>&#148;), and no consideration shall be
delivered in exchange therefor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Certain Parent and Subsidiary Owned Shares</U>. Each share of Company Common
Stock issued and outstanding immediately prior to the Effective Time that is owned by any direct or indirect wholly owned Subsidiary of the Company or by Parent or any of its Subsidiaries (including Acquiror and its Subsidiaries) shall remain
outstanding at the Effective Time (&#147;<U>Remainder Shares</U>&#148;) and shall not be converted into the right to receive the Merger Consideration as provided in <U>Section</U><U></U><U>&nbsp;3.1(a)(</U><U>i</U><U>)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Treatment of Merger Sub Common Interests</U>. At the Effective Time, each common interest issued by Merger Sub and
outstanding (&#147;<U>Merger Sub Common Interests</U>&#148;) shall be automatically converted into and become one (1)&nbsp;fully paid and nonassessable share of common stock of the Surviving Corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Shares of Dissenting Stockholders</U>. Anything in this Agreement to the contrary notwithstanding, shares of Company
Common Stock issued and outstanding immediately prior to the Effective Time and held by a holder of record or beneficial owner who did not vote in favor of the adoption of this Agreement (or consent thereto in writing) and is entitled to demand and
properly demands appraisal of such shares of Company Common Stock pursuant to, and who complies in all respects with, Section&nbsp;262 of the DGCL (&#147;<U>DGCL 262</U>&#148;, and any such shares meeting the requirement of this sentence,
&#147;<U>Dissenting Shares</U>&#148;) shall not be converted into the right to receive the Merger Consideration, but instead at the Effective Time shall be converted into the right to receive payment of such amounts as are payable in accordance with
DGCL 262 (it being understood and acknowledged that, at the Effective Time, such Dissenting Shares shall no longer be outstanding, shall automatically be canceled and shall cease to exist, and such holder shall cease to have any rights with respect
thereto other than the right to receive the fair value of such Dissenting Shares to the extent afforded by DGCL 262); <I>provided</I> that if any such holder or beneficial owner shall fail to perfect or otherwise shall effectively waive, withdraw or
otherwise lose the right to payment of the fair value of such Dissenting Shares under DGCL 262, then the right of such holder to be paid the fair value of such holder&#146;s Dissenting Shares shall cease and such Dissenting Shares shall be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
deemed to have been converted as of the Effective Time into, and to have become exchangeable solely for the right to receive, without interest or duplication, the Merger Consideration as provided
in <U>Section</U><U></U><U>&nbsp;3.1(a)(i)</U>. The Company shall give prompt written notice to Acquiror of any demands received by the Company for fair value of any Company Shares, of any withdrawals of such demands and of any other instruments
served pursuant to the DGCL and received by the Company relating to DGCL 262 and any alleged appraisal rights, and Acquiror shall have the opportunity to participate in, and direct all negotiations and proceedings with respect to, such demands.
Prior to the Effective Time, the Company shall not, without the prior written consent of Acquiror, make any payment with respect to, or settle or compromise or offer to settle or compromise, any such demand, or agree to do any of the foregoing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Certain Adjustments</U>. If, between the date of this Agreement and the Effective Time, the outstanding shares of
Company Common Stock shall have been changed into a different number of shares or a different class of shares by reason of any stock dividend, subdivision, reclassification, stock split, reverse stock split, combination or exchange of shares, or any
similar event shall have occurred, then the Merger Consideration shall be equitably adjusted, without duplication, to proportionally reflect such change; <I>provided</I> that nothing in this <U>Section</U><U></U><U>&nbsp;3.1(c)</U> shall be
construed to permit the Company to take any action with respect to its securities that is prohibited by the terms of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Dividends Declared Prior to Closing</U>. Acquiror acknowledges and agrees on its behalf and on behalf of the Surviving
Corporation that if prior to the Closing Date, the Company has declared and set a record date for a dividend permitted by this Agreement, and the Effective Time occurs after the record date for such dividend and prior to the payment date for such
dividend, that such dividend (and any applicable dividend equivalent rights to the extent any holder of a Company equity award was entitled to such rights under the terms of a Company equity award as in effect on the date the Company declared the
applicable dividend) shall be paid to holders of record as of such record date on the scheduled payment date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_10"></A>Section&nbsp;3.2 <U>Exchange of Certificates</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Appointment of Payment Agent</U>. Prior to the Effective Time, Acquiror shall appoint a bank or trust company to act as
payment agent (the &#147;<U>Payment Agent</U>&#148;), the identity and terms of appointment of which to be reasonably acceptable to the Company for the payment of the Merger Consideration in the Merger and shall enter into an agreement relating to
the Payment Agent&#146;s responsibilities under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Deposit of Merger Consideration</U>. At or prior to
the Effective Time, Acquiror shall make or cause to be made available to the Payment Agent cash sufficient to pay the aggregate Merger Consideration payable in the Merger at such time as is necessary for the payment to holders of Company Common
Stock (the &#147;<U>Payment Fund</U>&#148;). The Payment Agent shall invest any cash included in the Payment Fund as directed by Acquiror; <I>provided, however</I>, that (i)&nbsp;no such investment or loss thereon shall affect the amounts payable to
holders of Certificates or Book-Entry Shares pursuant to this <U>Article</U><U></U><U>&nbsp;III</U>, and following any losses from any such investment, Acquiror shall promptly provide, or cause to be provided, additional funds to the Payment Agent
for the benefit of the holders of the Company Common Stock at the Effective Time in the amount of such losses, which additional funds will be deemed to be part of the Payment Fund and (ii)&nbsp;such investments shall be in short-term obligations of
the United States of America with maturities of no more than thirty (30)&nbsp;days or guaranteed by the United States of America and backed by the full faith and credit of the United States of America or in commercial paper obligations rated <FONT
STYLE="white-space:nowrap">A-1</FONT> or <FONT STYLE="white-space:nowrap">P-1</FONT> or better by Moody&#146;s Investors Services, Inc. or Standard&nbsp;&amp; Poor&#146;s Corporation, respectively. Any interest or other income resulting from such
investments shall be paid to Acquiror or its designee, upon demand. Acquiror shall cause the Payment Fund to be (i)&nbsp;held for the benefit of the holders of the Company Common Stock and (ii)&nbsp;applied promptly to making the payments pursuant
to <U>Section</U><U></U><U>&nbsp;3.1</U>. The Payment Fund shall not be used for any purpose other than to fund payments pursuant to <U>Section</U><U></U><U>&nbsp;3.1</U>, except as expressly provided for in this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Exchange Procedures</U>. As promptly as reasonably practicable after the Effective Time and in any event within three
(3)&nbsp;Business Days of the Closing Date, Acquiror shall cause the Payment Agent to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
mail to each holder of a Certificate that immediately prior to the Effective Time represented shares of Company Common Stock that were converted pursuant to
<U>Section</U><U></U><U>&nbsp;3.1(a)(</U><U>i</U><U>)</U> into the right to receive the Merger Consideration (i)&nbsp;a letter of transmittal (which shall specify that delivery shall be effected, and risk of loss and title to the Certificates shall
pass, only upon delivery of the Certificates (or effective affidavits of loss in lieu thereof as provided in <U>Section</U><U></U><U>&nbsp;3.2(d)</U>) to the Payment Agent and shall be in customary form and have such other provisions as Acquiror and
the Company shall reasonably agree) (the &#147;<U>Letter of Transmittal</U>&#148;) and (ii)&nbsp;instructions for use in effecting the surrender of Certificates in exchange for the Merger Consideration. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Surrender of Certificates</U>. Upon surrender of Certificates (or effective affidavits of loss in lieu thereof as
provided in this <U>Section</U><U></U><U>&nbsp;3.2(d)</U> or <U>Section</U><U></U><U>&nbsp;3.2(</U><U>i</U><U>)</U>) to the Payment Agent together with the Letter of Transmittal, duly completed and validly executed in accordance with the
instructions thereto, and such other documents as may customarily be required by the Payment Agent, the holder of such Certificates shall be entitled to receive in exchange therefor the Merger Consideration into which the shares represented by such
Certificates have been converted pursuant to this Agreement promptly following the later to occur of (i)&nbsp;the Effective Time or (ii)&nbsp;the Payment Agent&#146;s receipt of such Certificate (or affidavit of loss in lieu thereof), and the
Certificate (or affidavit of loss in lieu thereof) so surrendered shall be forthwith canceled. In the event of a transfer of ownership of shares of Company Common Stock that is not registered in the transfer or stock records of the Company, any cash
to be paid upon due surrender of the Certificate formerly representing such shares of Company Common Stock may be paid to such a transferee if such Certificate is presented to the Payment Agent, accompanied by all documents required to evidence and
effect such transfer and to evidence to the satisfaction of the Payment Agent that any applicable stock transfer or other similar Taxes have been paid or are not applicable. No interest shall be paid or shall accrue on the cash payable upon
surrender of any Certificate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Book-Entry Shares</U>. As promptly as practicable following the Effective Time, the
Payment Agent shall issue and deliver the Merger Consideration to each holder of Book-Entry Shares that immediately prior to the Effective Time represented shares of Company Common Stock that were converted pursuant to
<U>Section</U><U></U><U>&nbsp;3.1(a)(</U><U>i</U><U>)</U> into the right to receive the Merger Consideration, and the Book-Entry Shares shall be canceled, and unless reasonably requested by the Payment Agent, without such holder being required to
deliver a Certificate or any letter of transmittal, &#147;agent&#146;s message&#148; or other documents to the Payment Agent. No interest shall be paid or shall accrue on the cash payable in respect of any Book-Entry Share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>No Further Ownership Rights in Company Common Stock</U>. The cash paid in accordance with the terms of this
<U>Article</U><U></U><U>&nbsp;III</U> in respect of any shares of Company Common Stock shall be deemed to have been delivered and paid in full satisfaction of all rights pertaining to such shares of Company Common Stock (subject to DGCL 262). From
and after the Effective Time, all holders of Certificates and Book-Entry Shares shall cease to have any rights as stockholders of the Company other than the right to receive the Merger Consideration (subject to DGCL 262) and any dividends or other
distributions declared in accordance with the terms of <U>Section</U><U></U><U>&nbsp;6.1</U> with a record date prior to the Effective Time to which holders of shares of Company Common Stock as of such record date become entitled and that remain
unpaid as of the Effective Time into which the shares represented by such Certificates or Book-Entry Shares have been converted pursuant to this Agreement upon the surrender of such Certificate or Book-Entry Share in accordance with
<U>Section</U><U></U><U>&nbsp;3.1(b)</U> or <U>3.2(d)</U>, as applicable, in each case without interest or duplication. From and after the Effective Time, the stock transfer books of the Company shall be closed with respect to all shares of Company
Common Stock outstanding immediately prior to the Effective Time, and there shall be no further registration of transfers on the stock transfer books of the Surviving Corporation of shares of Company Common Stock that were outstanding immediately
prior to the Effective Time. If, after the Effective Time, any Certificates or Book-Entry Shares formerly representing shares of Company Common Stock converted pursuant to this Agreement are presented to the Surviving Corporation, Acquiror or the
Payment Agent for any reason, such Certificates or Book-Entry Shares shall be canceled and exchanged as provided in this <U>Article</U><U></U><U>&nbsp;III</U>, subject to DGCL 262 in the case of Dissenting Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination of Payment Fund</U>. Any portion of the Payment Fund
(including any interest or other amounts received with respect thereto) that remains unclaimed by, or otherwise undistributed to, the holders of Certificates and Book-Entry Shares for one (1)&nbsp;year after the Effective Time shall be delivered to
Acquiror or a Subsidiary of Acquiror designated by Acquiror, upon written demand, and any holder of Certificates or Book-Entry Shares who has not theretofore complied with this <U>Article</U><U></U><U>&nbsp;III</U> shall thereafter look only to the
Surviving Corporation (subject to abandoned property, escheat or other similar Laws), as general creditors thereof, for satisfaction of its claim for Merger Consideration without any interest thereon. Any portion of the aggregate Merger
Consideration made available to the Payment Agent pursuant to <U>Section</U><U></U><U>&nbsp;3.2(b)</U> to pay for Company Shares for which appraisal rights have been perfected shall be delivered to Acquiror promptly (and in any event within two
(2)&nbsp;Business Days) following Acquiror&#146;s demand to the Payment Agent therefor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>No Liability</U>. None of
Acquiror, the Company, Merger Sub, the Payment Agent or any of their respective Affiliates shall be liable to any person in respect of any portion of the Payment Fund or portion of the aggregate Merger Consideration delivered to a public official
pursuant to any applicable abandoned property, escheat or similar Law. Any other provision of this Agreement notwithstanding, any portion of the aggregate Merger Consideration that remains undistributed to the holders of Certificates and Book-Entry
Shares as of the second anniversary of the Effective Time (or immediately prior to such earlier date on which the aggregate Merger Consideration or such cash would otherwise escheat to or become the property of any Governmental Entity), shall, to
the extent permitted by applicable Law, become the property of the Surviving Corporation, free and clear of all claims or interest of any person previously entitled thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Lost Certificates</U>. If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of
that fact by the person claiming such Certificate to be lost, stolen or destroyed and, if required by Acquiror or the Payment Agent, the making by such person of an indemnity in such amount as Acquiror or the Payment Agent may determine is
reasonably necessary as indemnity against any claim that may be made against it or the Surviving Corporation with respect to such Certificate, the Payment Agent (or, if subsequent to the termination of the Payment Fund and subject to
<U>Section</U><U></U><U>&nbsp;3.2(g)</U>, Acquiror) shall deliver or cause to be delivered, in exchange for such lost, stolen or destroyed Certificate, the Merger Consideration with respect to such shares of Company Common Stock represented by such
Certificate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_11"></A>Section&nbsp;3.3 <U>Company Incentive Awards</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall take all action necessary so that, at the Effective Time, each Company Option that is outstanding and
unexercised as of immediately prior to the Effective Time (whether vested or unvested and whether subject to service-based or performance-based vesting conditions), by virtue of the Merger and without any action on the part of the Company, Acquiror,
Parent, Merger Sub, the holders of such Company Option or any other person, (i)&nbsp;shall be deemed to be fully vested (including with respect to any performance-based vesting requirements), (ii)&nbsp;shall be converted into the right of the holder
to receive from Acquiror or its applicable Affiliate an amount, in cash, without interest, equal to the product of (A)&nbsp;the total number of shares of Company Common Stock subject to such Company Option after giving effect to
<U>clause</U><U></U><U>&nbsp;(</U><U>i</U><U>)</U> of this <U>Section</U><U></U><U>&nbsp;3.3(a)</U> and (B)&nbsp;the excess, if any, of the Merger Consideration over the exercise price per share of Company Common Stock of such Company Option (the
&#147;<U>Option Cash Payment</U>&#148;) and (iii)&nbsp;from and after the Effective Time, shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each applicable holder of such Company Options shall cease to
have any rights with respect thereto, except the right to receive the Option Cash Payment in accordance with this <U>Section</U><U></U><U>&nbsp;3.3(a)</U>. For the avoidance of doubt, in the event that the per share exercise price of any Company
Option is equal to or greater than the Merger Consideration, such Company Option shall be canceled as of the Effective Time without payment therefor and shall have no further force or effect and the applicable holder shall cease to have any rights
with respect thereto, and the Company shall take all such action necessary to effect such treatment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as
otherwise provided in <U>Section</U><U></U><U>&nbsp;3.3(b)</U> of the Company Disclosure Schedule, the Company shall take all action necessary so that, at the Effective Time, each Company Restricted Stock Unit
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
that is outstanding as of immediately prior to the Effective Time, by virtue of the Merger and without any action on the part of the Company, Acquiror, Parent, Merger Sub, the holders of such
Company Restricted Stock Unit or any other person, (i)&nbsp;shall be deemed to be fully vested as to the number of shares of Company Common Stock issuable pursuant to such Company Restricted Stock Unit, (ii)&nbsp;shall be converted into the right of
the holder thereof to receive from Acquiror or its applicable Affiliate an amount, in cash, without interest, equal to the sum of (A)&nbsp;the product of (I)&nbsp;such number of shares of Company Common Stock referenced in
<U>clause</U><U></U><U>&nbsp;(i)</U> of this <U>Section</U><U></U><U>&nbsp;3.3(b)</U> and (II)&nbsp;the Merger Consideration and (B)&nbsp;all dividend equivalents accrued or credited with respect to such Company Restricted Stock Units (collectively,
the&nbsp;&#147;<U>RSU Cash Payment</U>&#148;) and (iii)&nbsp;from and after the Effective Time, shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each applicable holder of such Company Restricted Stock
Unit shall cease to have any rights with respect thereto, except the right to receive the RSU Cash Payment in accordance with this <U>Section</U><U></U><U>&nbsp;3.3(b)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall take all action necessary so that, at the Effective Time, each Company Performance Stock Unit that is
outstanding as of immediately prior to the Effective Time, by virtue of the Merger and without any action on the part of the Company, Acquiror, Parent, Merger Sub, the holders of such Company Performance Stock Unit or any other person,
(i)&nbsp;shall be deemed vested with the number of shares of Company Common Stock issuable pursuant to such Company Performance Stock Unit determined in accordance with <U>Section</U><U></U><U>&nbsp;3.3(c)</U> of the Company Disclosure Schedule,
(ii)&nbsp;shall be converted into the right of the holder thereof to receive from Acquiror or its applicable Affiliate in accordance with <U>Section</U><U></U><U>&nbsp;3.3(c)</U> of the Company Disclosure Schedule an amount, in cash, without
interest, equal to the sum of (A)&nbsp;the product of (I)&nbsp;such number of shares of Company Common Stock referenced in <U>clause</U><U></U><U>&nbsp;(</U><U>i</U><U>)</U> of this <U>Section</U><U></U><U>&nbsp;3.3(c)</U> and (II)&nbsp;the Merger
Consideration and (B)&nbsp;all dividend equivalents accrued or credited with respect to such Company Performance Stock Units (collectively, the&nbsp;&#147;<U>PSU Cash Payment</U>&#148;) and (iii)&nbsp;from and after the Effective Time, shall no
longer be outstanding and shall automatically be canceled and shall cease to exist, and each applicable holder of such Company Performance Stock Unit shall cease to have any rights with respect thereto, except the right to receive the PSU Cash
Payment in accordance with this <U>Section</U><U></U><U>&nbsp;3.3(c)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company shall take all action necessary
so that, at the Effective Time, all Company Deferred Stock Units, by virtue of the Merger and without any action on the part of the Company, Acquiror, Parent, Merger Sub, the holders of such Company Deferred Stock Unit or any other person,
(i)&nbsp;shall be converted into the right of the holder thereof to receive from Acquiror or its applicable Affiliate at the time specified in the applicable Company Benefit Plan and in accordance with Section&nbsp;409A of the Code, an amount, in
cash, without interest, equal to the sum of (X)&nbsp;the product of (A)&nbsp;such number of shares of Company Common Stock underlying the Deferred Stock Units and (B)&nbsp;the Merger Consideration and (Y)&nbsp;all dividend equivalents accrued or
credited with respect to such Company Deferred Stock Units (collectively, the&nbsp;&#147;<U>DSU Cash Payment</U>&#148;) and (ii)&nbsp;from and after the Effective Time, shall no longer be outstanding and shall automatically be canceled and shall
cease to exist, and each applicable holder of such Company Deferred Stock Units shall cease to have any rights with respect thereto, except the right to receive the DSU Cash Payment in accordance with this <U>Section</U><U></U><U>&nbsp;3.3(d)</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as otherwise required under the terms of the applicable award agreement or as necessary to avoid the imposition
of any additional Taxes or penalties with respect to awards under the Company Stock Plans pursuant to Section&nbsp;409A of the Code, Acquiror or its applicable Affiliates shall cause the Company to make all payments, subject to
<U>Section</U><U></U><U>&nbsp;3.5</U>, required to be made by Acquiror or its applicable Affiliates under this <U>Section</U><U></U><U>&nbsp;3.3</U> as soon as reasonably practicable following the Effective Time, but no later than the first
regularly scheduled payroll date that is at least five (5)&nbsp;Business Days after the Effective Time; <I>provided</I> that any such amounts shall be paid without interest. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Prior to the Effective Time, the Company (1)&nbsp;may, in its discretion, amend the Company ESPP to freeze all participant
payroll deduction elections in effect as of the date of this Agreement under the Company ESPP, and (2)&nbsp;shall take all actions necessary pursuant to the terms of the Company ESPP and applicable Law to, contingent on the Effective Time,
(i)&nbsp;provide that (A)&nbsp;no new Purchasing Period (as defined in the Company ESPP) will be commenced following the date of this Agreement under the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Company ESPP, (B)&nbsp;there will be no increase in the amount of participants&#146; payroll deduction elections under the Company ESPP or any contributions other than previously elected payroll
deductions during the current Purchasing Period from those in effect as of the date of this Agreement, (C)&nbsp;no individuals shall commence participation in the Company ESPP during the period from the date of this Agreement through the Effective
Time and (D)&nbsp;each purchase right issued pursuant to the Company ESPP shall be fully exercised on the &#147;<U>Final Purchase Date</U>,&#148; which shall be the earlier of (x)&nbsp;the scheduled purchase date for such Purchasing Period and
(y)&nbsp;the date immediately prior to the Effective Time (with any participant payroll deductions not applied to the purchase of Company Common Stock returned to the participant), (ii)&nbsp;notify each participant in writing, at least ten
(10)&nbsp;days before the Final Purchase Date, that the purchase date for his or her purchase right issued pursuant to the Company ESPP has been changed to the Final Purchase Date and (iii)&nbsp;terminate the Company ESPP effective as of immediately
prior to the Effective Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Prior to the Effective Time, the Company Board of Directors (or, if appropriate, any duly
authorized committee thereof administering the Company Stock Plans) shall adopt such resolutions, provide any required notice, obtain any required holder written consents and take such other actions as may be required to provide for the treatment
set forth in this <U>Section</U><U></U><U>&nbsp;3.3</U> in respect of the Company Options, the Company Restricted Stock Units, the Company Performance Stock Units, the Company Deferred Stock Units and the Company ESPP, in each case, effective upon
the Effective Time; <I>provided</I> that the foregoing actions shall be subject to Acquiror&#146;s prior review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_12"></A>Section&nbsp;3.4 <U>Further Assurances</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If at any time before or after the Effective Time, Acquiror or the Company reasonably believes or is advised that any
further instruments, deeds, assignments or assurances are reasonably necessary or desirable to consummate the Merger or to carry out the purposes and intent of this Agreement at or after the Effective Time, then Acquiror, Merger Sub, the Company and
the Surviving Corporation and their respective officers and directors or managers shall execute and deliver all such proper instruments, deeds, assignments or assurances and do all other things reasonably necessary or desirable to consummate the
Merger and to carry out the purposes and intent of this Agreement; <I>provided, however</I>, that this <U>Section</U><U></U><U>&nbsp;3.4(a)</U> shall not be interpreted to require any person to take any action or omit from taking any action that it
is not required to take pursuant to the terms of <U>Section</U><U></U><U>&nbsp;6.5</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In case at any time after the
Effective Time any further action is necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full title to all properties, assets, rights, approvals, immunities and franchises of any of the
Parties to the Merger, the officers of the Surviving Corporation shall be authorized to, in the name and on behalf of the Company, execute and deliver such deeds, bills of sale, assignment or assurances and take all such other action as may be
necessary in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_13"></A>Section&nbsp;3.5 <U>Withholding Rights</U>. Each of the Company, Acquiror,
Merger Sub, the Surviving Corporation and the Payment Agent shall be entitled to deduct and withhold or cause to be deducted and withheld from any amounts otherwise payable pursuant to this <U>Article</U><U></U><U>&nbsp;III</U>, such amounts as may
be required to be deducted or withheld with respect to the making of such payment under any applicable Tax Law. Any amounts so deducted or withheld, and, if required, paid over to the applicable Governmental Entity, shall be treated for all purposes
of this Agreement as having been paid to the person in respect of which such deduction or withholding was made. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IV
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as disclosed in (a)&nbsp;the Company SEC Documents filed after January&nbsp;1, 2021, and publicly available prior to
the date hereof where the relevance of the information to a particular representation is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
reasonably apparent on its face (excluding any disclosures contained under the captions &#147;Risk Factors&#148; or &#147;Forward Looking Statements&#148; or any similarly titled captions and any
other disclosures contained therein that are cautionary or forward looking in nature) or (b)&nbsp;the disclosure schedule delivered by the Company to Acquiror immediately prior to the execution of this Agreement (the &#147;<U>Company Disclosure
Schedule</U>&#148;) (<I>provided</I>, that disclosure in any section or subsection of the Company Disclosure Schedule shall apply only to the corresponding section or subsection of this Agreement except to the extent that the relevance of such
disclosure to another section or subsection of this Agreement is reasonably apparent on the face of such disclosure; <I>provided, further</I>, that any listing of any fact, item or exception disclosed in any section of the Company Disclosure
Schedule shall not be construed as an admission of liability under any applicable Law or for any other purpose and shall not be construed as an admission that such fact, item or exception is in fact material or creates a measure of materiality for
purpose of this Agreement or otherwise), the Company represents and warrants to Acquiror and Merger Sub as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_14"></A>Section&nbsp;4.1 <U>Organization</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is a corporation duly incorporated, validly existing and in
good standing under the Laws of the State of Delaware and has all requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted in all material respects. Each of the
Company&#146;s Subsidiaries is a legal entity duly organized, validly existing and in good standing under the Laws of its respective jurisdiction of organization and has all requisite corporate or similar power and authority to own, lease and
operate its properties and assets and to carry on its business as presently conducted, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Each of the Company and
its Subsidiaries is duly qualified or licensed, and has all necessary governmental approvals, to do business and is in good standing (with respect to jurisdictions that recognize such concept) in each jurisdiction in which the property owned, leased
or operated by it or the nature of the business conducted by it makes such approvals, qualification or licensing necessary, except where the failure to be so duly qualified or licensed, have such approvals and be in good standing (with respect to
jurisdictions that recognize such concept) has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company has made available to Acquiror prior to the date of this Agreement a true and complete copy of the
Company&#146;s Restated Certificate of Incorporation, dated September&nbsp;29, 2023, and as amended on April&nbsp;29, 2024 (as so amended, the &#147;<U>Company Certificate</U>&#148;) and Bylaws (the &#147;<U>Company Bylaws</U>&#148;) (together, the
&#147;<U>Company Organizational Documents</U>&#148;), in each case, as amended and in effect through the date hereof. The Company Organizational Documents and the certificate of incorporation, bylaws, limited partnership agreement, limited liability
company agreement or comparable constituent or organizational documents for each Subsidiary of the Company that would be required to be identified in the Company&#146;s Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> pursuant
to Section&nbsp;601(b)(21) of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> of the SEC (collectively, the &#147;<U>Company Subsidiary Organizational Documents</U>&#148;) are in full force and effect, and neither the Company nor any of
its Subsidiaries is in violation of any of their respective provisions, except, in the case of the Company&#146;s Subsidiaries, as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_15"></A>Section&nbsp;4.2 <U>Capital Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of the Company consists of 1,000,000,000 shares of Company Common Stock. At the close of
business on August&nbsp;9, 2024 (the&nbsp;&#147;<U>Capitalization Date</U>&#148;): (i) 343,946,955 shares of Company Common Stock were issued and outstanding; (ii)&nbsp;77,576,516 shares of Company Common Stock were held by the Company or any of its
Subsidiaries in its or their treasury; (iii) 7,614,029 shares of Company Common Stock were underlying outstanding and unexercised Company Options; (iv)&nbsp;3,051,168 shares of Company Common Stock were underlying Company Restricted Stock Units;
(v)&nbsp;3,263,867 shares of Company Common Stock were underlying Company Performance Stock Units </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
(assuming performance is calculated at the maximum level of performance); (vi) 354,852 shares of Company Common Stock were underlying Company Deferred Stock Units; and (vii) 1,087,726 shares of
Company Common Stock remain available for future issuance under the Company ESPP. Except as set forth in the preceding sentence, at the close of business on the Capitalization Date, no shares of capital stock or other voting securities of or equity
interests in the Company were issued, reserved for issuance or outstanding. From and after the Capitalization Date until and including the date hereof the Company (A)&nbsp;has not issued any shares of its capital stock (other than pursuant to the
Company ESPP or in respect of the valid exercise of Company Options or upon the valid settlement of Company Restricted Stock Units, Company Performance Stock Units or Company Deferred Stock Units), (B)&nbsp;has not granted any options, warrants,
restricted stock, restricted stock units or stock appreciation rights or entered into any other agreements or commitments to issue any shares of its capital stock or (C)&nbsp;granted any other awards in respect of any shares of its capital stock and
has not split, combined or reclassified any of its shares of capital stock. All of the outstanding Company Shares are, and all Company Shares that may be issued prior to the Effective Time will be, when issued, duly authorized, validly issued, fully
paid and nonassessable and not subject to preemptive rights. There are no bonds, debentures, notes or other Indebtedness of the Company having the right to vote (or convertible into, or exchangeable for, securities having the right to vote) on any
matters on which holders of Company Common Stock may vote. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company will make available to Acquiror, within fifteen
(15)&nbsp;Business Days of this Agreement, a true, correct and complete list, as of the Capitalization Date, of (i)&nbsp;the name or employee identification number of each holder of Company Options, Company Restricted Stock Units, Company
Performance Stock Units and Company Deferred Stock Units, (ii)&nbsp;the Company Stock Plan under which such Company Option, Company Restricted Stock Unit, Company Performance Stock Unit or Company Deferred Stock Unit was granted, (iii)&nbsp;the
number of outstanding Company Options, Company Restricted Stock Units, Company Performance Stock Units and Company Deferred Stock Units held by such holder (at maximum levels of performance), (iv)&nbsp;the grant date of each such Company Option,
Company Restricted Stock Unit, Company Performance Stock Unit and Company Deferred Stock Unit, (v)&nbsp;the number of Company Shares such holder is entitled to receive upon the exercise of each Company Option and the corresponding exercise price and
(vi)&nbsp;the expiration date of each Company Option. Each Company Option has been granted with an exercise price no less than the fair market value of the underlying Company Shares as of the date of such grant. Except for the Company Options,
Company Restricted Stock Units, Company Performance Stock Units, Company Deferred Stock Units and the Company Stock Purchase Plans, and except for changes since the Capitalization Date resulting from (x)&nbsp;the exercise of Company Options
outstanding on such date, (y)&nbsp;the vesting and settlement of the Company Restricted Stock Units or Company Performance Stock Units outstanding on such date and (z)&nbsp;the issuance of shares under the Company Stock Purchase Plans, there are no
outstanding (A)&nbsp;shares of capital stock, voting securities, other ownership interests or other securities of the Company or any of its Subsidiaries, in each case, convertible into or exchangeable for shares of capital stock or voting securities
or ownership interests in the Company or any of its Subsidiaries, (B)&nbsp;options, warrants, rights or other agreements, obligations or commitments requiring the Company or any of its Subsidiaries to issue any capital stock, voting securities or
other ownership interests in (or securities convertible into or exchangeable for capital stock or voting securities or other ownership interests in) the Company or any of its Subsidiaries (or, in each case, the economic equivalent thereof),
(C)&nbsp;obligations of the Company or any of its Subsidiaries to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable security or other similar agreement or commitment relating to any capital stock, voting
securities or other ownership interests in the Company or any of its Subsidiaries or (D)&nbsp;restricted shares, stock appreciation rights, performance shares or units, contingent value rights, &#147;phantom&#148; stock or similar securities or
rights issued by the Company or any of its Subsidiaries that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any shares of capital stock or voting securities of, or other ownership interests
in, the Company (the items in clauses&nbsp;(A), (B), (C) and (D), collectively with the capital stock of the Company or any of its Subsidiaries, being referred to collectively as &#147;<U>Company Securities</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except pursuant this Agreement, there are no outstanding obligations of
the Company or any of its Subsidiaries to purchase, redeem or otherwise acquire any Company Securities. There are no voting trusts or other agreements or understandings to which the Company or any of its Subsidiaries is a party with respect to the
voting of capital stock of the Company. All outstanding securities of the Company and its Subsidiaries have been offered and issued in compliance in all material respects with all applicable securities Laws, including the Securities Act and
&#147;blue sky&#148; laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) All of the outstanding shares of capital stock of, or other equity interests in, each
Subsidiary of the Company have been duly authorized, and to the extent the following concepts are applicable thereto, validly issued, fully paid and nonassessable and are owned, directly or indirectly, by the Company free and clear of any Liens
(other than Permitted Liens and any Liens arising under applicable federal and state securities Laws). None of the Company or any of its Subsidiaries, directly or indirectly, owns any interest in any other person other than the Company&#146;s
Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_16"></A>Section&nbsp;4.3 <U>Corporate Authority Relative to this Agreement; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has the requisite corporate power and authority to enter into this Agreement and, subject to the receipt of the
Company Stockholder Approval, to consummate the transactions contemplated by this Agreement, including the Merger. The execution, delivery and performance of this Agreement by the Company and the consummation of the Merger have been duly and validly
authorized by the Company Board of Directors and, other than the Company Stockholder Approval and the filing of the Certificate of Merger with the Delaware Secretary, no other corporate proceedings on the part of the Company or vote of the
Company&#146;s stockholders are necessary to authorize the execution and delivery by the Company of this Agreement and the consummation of the Merger. The Company Board of Directors has unanimously (i)&nbsp;determined that this Agreement, the Merger
and the other transactions contemplated hereby are fair to, and in the best interests of, the Company and its stockholders, (ii)&nbsp;approved, authorized, adopted and declared advisable this Agreement, the Merger and other transactions contemplated
hereby, including the Merger and (iii)&nbsp;resolved to recommend that the stockholders of the Company vote in favor of the adoption of this Agreement and the transactions contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The affirmative vote of the holders of a majority of the issued and outstanding shares of Company Common Stock in favor of
the adoption of this Agreement and the transactions contemplated hereby, including the Merger (the &#147;<U>Company Stockholder Approval</U>&#148;) is the only vote of the holders of any class or series of Company capital stock that is necessary
under applicable Law and the Company Organizational Documents to approve the adoption of this Agreement and the transactions contemplated hereby, including the Merger, for the Company to engage in the transactions contemplated by this Agreement and
to consummate the Merger. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Other than in connection with or in compliance with (i)&nbsp;the filing of the Certificate
of Merger with the Delaware Secretary, (ii)&nbsp;the filing of the Proxy Statement and any amendments or supplements thereto with the SEC, (iii)&nbsp;the U.S. Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder (the
&#147;<U>Exchange Act</U>&#148;), (iv)&nbsp;the U.S. Securities Act of 1933, as amended, and the rules promulgated thereunder (the &#147;<U>Securities Act</U>&#148;), (v)&nbsp;applicable state securities and &#147;blue sky&#148; laws, (vi)&nbsp;the
rules and regulations of NYSE, (vii)&nbsp;the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the &#147;<U>HSR Act</U>&#148;) and any other requisite clearances or approvals
under any other applicable Antitrust Laws, (viii)&nbsp;the Company Stockholder Approval and (ix)&nbsp;the approvals set forth in <U>Section</U><U></U><U>&nbsp;4.3(c)</U> of the Company Disclosure Schedule (collectively, the &#147;<U>Company
Approvals</U>&#148;), no authorization, consent, Order, license, permit or approval of, or registration, declaration, notice or filing with, any Governmental Entity (the &#147;<U>Regulatory Filings and Consents</U>&#148;) is necessary, under
applicable Law, for the consummation by the Company of the Merger, except for such Regulatory Filings and Consents that are not required to be obtained or made prior to consummation of the Merger or that, if not obtained or made, have not had and
would not reasonably be expected to (x)&nbsp;have, individually or in the aggregate, a Company Material Adverse Effect or (y)&nbsp;prevent, materially delay or materially impair the ability of the Company to consummate the Merger or the other
transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The execution and delivery by the Company of this Agreement does not,
and (assuming the Company Approvals are obtained) the consummation of the Merger and compliance with the provisions of this Agreement will not (i)&nbsp;result in any loss, suspension, limitation or impairment of any right of the Company or any of
its Subsidiaries to own or use any assets required for the conduct of their business or result in any violation of, or default (with or without notice or lapse of time or both) under, or give rise to a right of termination, cancellation, first
offer, first refusal, adverse modification or acceleration of any obligation or to the loss of a benefit under any Company Material Contract, (ii)&nbsp;conflict with or result in any violation of any provision of the Company Organizational Documents
or Company Subsidiary Organizational Documents or (iii)&nbsp;conflict with or violate any applicable Laws except, in the case of clauses&nbsp;(i) and (iii), for such losses, suspensions, limitations, impairments, conflicts, violations, defaults,
terminations, cancellation, accelerations or Liens as has not had and would not reasonably be expected to (x)&nbsp;have, individually or in the aggregate, a Company Material Adverse Effect or (y)&nbsp;prevent, materially delay or materially impair
the ability of the Company to consummate the Merger or the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_17"></A>Section&nbsp;4.4 <U>Reports and Financial Statements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has timely filed or otherwise transmitted all forms, documents and reports required to be filed or otherwise
so transmitted, as applicable, by it with the SEC (including under the Securities Act and the Exchange Act) since January&nbsp;1, 2021 (all such documents and reports filed or furnished by the Company or any of its Subsidiaries, the &#147;<U>Company
SEC Documents</U>&#148;) and has timely paid all fees due in connection therewith. As of their respective dates or, if amended, as of the date of the last such amendment (and, in the case of registration statements and proxy statements, on the dates
of effectiveness and the dates of the relevant meetings, respectively), (i)&nbsp;the Company SEC Documents complied in all material respects with the requirements (A)&nbsp;of the Securities Act, (B)&nbsp;the Exchange Act and (C)&nbsp;the
Sarbanes-Oxley Act of 2002 (the &#147;<U>Sarbanes-Oxley Act</U>&#148;), as the case may be, and, in each case, the applicable rules and regulations promulgated thereunder and (ii)&nbsp;none of the Company SEC Documents contained any untrue statement
of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. None of the Company&#146;s Subsidiaries is,
or at any time since January&nbsp;1, 2021, has been, required to file any forms, reports or other documents with the SEC. No executive officer of the Company has failed in any respect to make the certifications required of him or her under
Section&nbsp;302 or 906 of the Sarbanes-Oxley Act. As of the date of this Agreement, there are no outstanding or unresolved comments in any comment letters of the staff of the SEC received by the Company relating to the Company SEC Documents. To the
knowledge of the Company, as of the date of this Agreement, none of the Company SEC Documents is the subject of ongoing SEC review or outstanding SEC investigation. The Company is in compliance in all material respects with the applicable listing
and corporate governance rules of NYSE. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The consolidated financial statements (including all related notes and
schedules) of the Company and its Subsidiaries included in or incorporated by reference into the Company SEC Documents (the &#147;<U>Company Financial Statements</U>&#148;) (i)&nbsp;fairly present in all material respects the consolidated financial
position of the Company and its Subsidiaries, as at the respective dates thereof, and their consolidated income, results of operations, changes in financial position and cash flows and stockholders&#146; equity for the respective periods then ended,
all in accordance with U.S. generally accepted accounting principles (&#147;<U>GAAP</U>&#148;), (ii)&nbsp;were prepared in conformity with GAAP (except, in the case of the unaudited statements, as permitted by
<FONT STYLE="white-space:nowrap">Form&nbsp;10-Q</FONT> and subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments and the absence of footnote disclosure) applied on a consistent basis during the periods involved (except
as may be indicated therein or in the notes thereto), (iii)&nbsp;have been prepared from, and are in accordance with, the books and records of the Company and its Subsidiaries and (iv)&nbsp;comply in all material respects with the applicable
accounting requirements and with the rules and regulations of the SEC, the Exchange Act and the Securities Act, as applicable. No financial statements of any person other than the Company and its consolidated Subsidiaries are required by GAAP to be
included in the consolidated financial statements of the Company. The books </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
and records of the Company and its Subsidiaries have been, and are being, maintained in all material respects in accordance with GAAP and any other applicable legal and accounting requirements.
Since January&nbsp;1, 2021, and to the date of this Agreement, the Company has not made any material change in the accounting practices or policies applied in the preparation of its financial statements, except as required by GAAP, SEC rule or
policy, promulgations by the Financial Accounting Standards Board or applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Neither the Company nor any of
its Subsidiaries is a party to, nor does it have any commitment to become a party to, any <FONT STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangements&#148; (as defined in Item&nbsp;303(b) of
<FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> of the SEC). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_18"></A>Section&nbsp;4.5 <U>Internal
Controls and Procedures</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has established and maintains disclosure controls and procedures and internal
control over financial reporting (as such terms are defined in paragraphs&nbsp;(e) and (f), respectively, of <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act) as required by
<FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act. The Company&#146;s disclosure controls and procedures are reasonably designed, and since January&nbsp;1, 2021, have been reasonably designed, to ensure that all
material information required to be disclosed by the Company in the reports that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and
that all such material information is accumulated and communicated to the Company&#146;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections&nbsp;302 and 906
of the Sarbanes-Oxley Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2021, the Company&#146;s principal executive officer and principal
financial officer have disclosed to the Company&#146;s auditors and the audit committee of the Company Board of Directors (i)&nbsp;all known significant deficiencies and material weaknesses in the design or operation of internal controls over
financial reporting that are reasonably likely to adversely affect in any material respect the Company&#146;s ability to record, process, summarize and report financial information and (ii)&nbsp;any known fraud, whether or not material, that
involves management or other employees who have a significant role in the Company&#146;s internal control over financial reporting (as such term is defined in paragraph&nbsp;(f) of <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the
Exchange Act). The Company has made available to Acquiror all disclosures described in this <U>Section</U><U></U><U>&nbsp;4.5(b)</U> made by management to the Company&#146;s auditors and audit committee from January&nbsp;1, 2021, to the date hereof.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2021, neither the Company nor any of its Subsidiaries has received, in writing, any material
complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or any of its Subsidiaries or their respective internal accounting controls. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_19"></A>Section&nbsp;4.6 <U>No Undisclosed Liabilities</U>. There are no Liabilities of the Company or any of its
Subsidiaries of any nature whatsoever (whether accrued, absolute, determined, contingent or otherwise and whether due or to become due) of the type required to be (x)&nbsp;disclosed in the liabilities column of a consolidated balance sheet of the
Company and its Subsidiaries prepared in accordance with GAAP or (y)&nbsp;reflected, reserved against or expressly disclosed in any notes or schedules thereto prepared in accordance with GAAP, except for (a)&nbsp;Liabilities that are reflected or
reserved against on the audited consolidated balance sheet of the Company and its Subsidiaries included in its Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;30, 2023 (including
Liabilities reflected, reserved against or expressly disclosed in any notes or schedules thereto), (b)&nbsp;Liabilities that are reflected or reserved against on the unaudited consolidated balance sheet of the Company and its Subsidiaries included
in its Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended June&nbsp;29, 2024 (including Liabilities reflected, reserved against or expressly disclosed in any notes or schedules thereto), (c)
Liabilities incurred in the ordinary course of business consistent with past practice since June&nbsp;29, 2024, (d)&nbsp;Liabilities incurred in connection with this Agreement and the transactions contemplated hereby and (e)&nbsp;Liabilities that
have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_20"></A>Section&nbsp;4.7 <U>Compliance with Law; Permits</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries are, and since January&nbsp;1, 2021, have been, in compliance with all applicable Laws,
except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> has not had and would not reasonably be expected to (x)&nbsp;have, individually or in the aggregate, a Company Material Adverse Effect or (y)&nbsp;prevent, materially delay or
materially impair the ability of the Company to consummate the Merger or the other transactions contemplated by this Agreement. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, since January&nbsp;1, 2021, neither the Company nor any of its Subsidiaries has (i)&nbsp;received any written notice or, to the knowledge of the Company, oral notice from any Governmental Entity regarding any actual or alleged
failure by the Company, any Company Benefit Plan or any fiduciary of any Company Benefit Plan to comply with any Law or (ii)&nbsp;provided any notice to any Governmental Entity regarding any violation by the Company or any of its Subsidiaries of any
Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect, the Company and its Subsidiaries (i)&nbsp;hold, and have at all times since January&nbsp;1, 2021, held, all franchises, grants, authorizations, licenses, permits, easements, variances, exceptions, consents, certificates,
approvals, clearances, permissions, qualifications and registrations and Orders of, or issued by, all applicable Governmental Entities necessary for the lawful operation of the businesses of the Company and its Subsidiaries as is currently being
conducted, including the research, development, manufacture, distribution, marketing, storage, transportation, use or sale of the products of the Company or its Subsidiaries (the &#147;<U>Company Permits</U>&#148;), (ii)&nbsp;have paid all fees and
assessments due and payable in connection therewith, (iii)&nbsp;are in compliance in all respects with the terms and requirements of all Company Permits and (iv)&nbsp;the consummation of the Merger and compliance with the provisions of this
Agreement will not result in any loss, suspension, limitation or impairment of any right of the Company or its Subsidiaries with respect to any Company Permit. Except as has not had and would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect, all Company Permits are valid and in full force and effect and are not subject to any administrative or judicial proceeding that would reasonably be expected to result in any adverse modification,
termination or revocation thereof and, to the knowledge of the Company, no suspension or cancellation of any such Company Permit is threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Since January&nbsp;1, 2021, none of the Company, its Subsidiaries or, to the knowledge of the Company, any of their
respective directors or officers or employees, agents or other persons acting on behalf of the Company or any of its Subsidiaries has, directly or indirectly, except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect, (i)&nbsp;used any funds of the Company or any of its Subsidiaries for unlawful contributions, unlawful gifts, unlawful entertainment or other unlawful expenses relating to political activity,
(ii)&nbsp;made any unlawful payment to governmental officials or employees or to political parties or campaigns from funds of the Company or any of its Subsidiaries or (iii)&nbsp;made any unlawful bribe, unlawful rebate, unlawful payoff, unlawful
influence payment, unlawful kickback or other unlawful payment to any person, private or public, regardless of form, whether in money, property or services, to obtain favorable treatment in securing business to obtain special concessions for the
Company or any of its Subsidiaries or to influence any act or decision of a government official or other person, in each case of (i) &#150; (iii) in violation of any applicable anti-corruption or anti-bribery Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_21"></A>Section&nbsp;4.8 <U>Sanctions and Export Control Laws</U>. Since January&nbsp;1, 2020: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Neither the Company nor any of its Subsidiaries, directors, officers, employees or agents is or has been, a Sanctioned
Person or a Restricted Person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company nor any of its Subsidiaries has materially violated any Sanctions
and Export Control Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and its Subsidiaries have in place written policies,
controls, and systems reasonably designed to ensure material compliance with applicable Sanctions and Export Control Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither the Company nor any of its Subsidiaries has (i)&nbsp;made any voluntary, directed or involuntary disclosure to any
Governmental Entity with respect to any alleged act or omission arising under or relating to any material <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Sanctions and Export Control Laws, (ii)&nbsp;to the knowledge of the Company,
been the subject of an investigation, inquiry or enforcement proceeding for a material violation of Sanctions and Export Control Laws, or (iii)&nbsp;received any notice, request, penalty or citation for any actual or potential material <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with Sanctions and Export Control Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_22"></A>Section&nbsp;4.9
<U>Investigations; Litigation</U>. Except as has not had and would not reasonably be expected to (x)&nbsp;have, individually or in the aggregate, a Company Material Adverse Effect or (y)&nbsp;prevent, materially delay or materially impair the
ability of the Company to consummate the Merger or the other transactions contemplated by this Agreement: (a)&nbsp;there is no investigation or review pending or, to the knowledge of the Company, threatened by any Governmental Entity with respect to
the Company or any of its Subsidiaries and (b)&nbsp;there are no Orders of, or before, any Governmental Entity against the Company or any of its Subsidiaries or under which the Company or any of its Subsidiaries is subject to ongoing obligations. As
of the date hereof, there are not any (x)&nbsp;Legal Proceedings or (y)&nbsp;subpoenas, civil investigative demands or other written requests for information relating to potential violations of Law, in each case ((x) and (y)), that are pending or,
to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries or any of their respective properties that have had or would reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_23"></A>Section&nbsp;4.10 <U>Environmental Laws and Regulations</U>. Except as has not had and would
not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: (a)&nbsp;the Company and its Subsidiaries are, and since January&nbsp;1, 2021, have been, in compliance with all applicable Environmental Laws
(which compliance includes the possession by the Company and each of its Subsidiaries of all Company Permits required under applicable Environmental Laws to conduct their respective business and operations and compliance with the terms and
conditions thereof), (b)&nbsp;there have been no Releases of Hazardous Materials for which the Company or any of its Subsidiaries (or to the knowledge of the Company, their predecessors) is liable that have given rise to or would reasonably be
expected to give rise to any unresolved or outstanding Liability under applicable Environmental Laws to the Company or its Subsidiaries, (c)&nbsp;none of the Company or its Subsidiaries is subject to any outstanding Order that would reasonably be
expected to result in Liabilities to the Company and its Subsidiaries under applicable Environmental Laws or concerning Hazardous Materials or Releases and (d)&nbsp;since January&nbsp;1, 2021, neither the Company nor any of its Subsidiaries has
received any unresolved written claim, notice, complaint or request for information from a Governmental Entity or any other person relating to actual or alleged material noncompliance with or material Liability under applicable Environmental Laws or
otherwise relating to Hazardous Materials (including any such Liability or obligation arising under, retained or assumed by Contract or by operation of law). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_24"></A>Section&nbsp;4.11 <U>Employee Benefit Plans; Employment Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;4.11(a)</U> of the Company Disclosure Schedule sets forth a correct and complete list of each
material Company Benefit Plan for Company employees who are located within the United States, and, within thirty (30)&nbsp;Business Days after the date of this Agreement, the Company will update <U>Section</U><U></U><U>&nbsp;4.11(a)</U> of the
Company Disclosure Schedule to set forth a correct and complete list of all remaining material Company Benefit Plans. With respect to each material Company Benefit Plan, to the extent applicable, correct and complete copies of the following have
been, or within thirty (30)&nbsp;Business Days after the date of this Agreement will be, delivered or made available to Acquiror by the Company: (i)&nbsp;the Company Benefit Plan document, if written (including all amendments and attachments
thereto), (ii)&nbsp;a written summary of the material terms thereof, if the Company Benefit Plan is not in writing, (iii)&nbsp;all related trust documents, (iv)&nbsp;all insurance Contracts or other funding arrangements, (v)&nbsp;the two
(2)&nbsp;most recent annual reports (Form&nbsp;5500) filed with the Internal Revenue Service (the &#147;<U>IRS</U>&#148;), (vi)&nbsp;the most recent determination, opinion or advisory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
letter from the IRS, (vii)&nbsp;the most recent summary plan description and any summary of material modifications thereto, (viii)&nbsp;all related,
<FONT STYLE="white-space:nowrap">non-routine</FONT> material filings and communications received from or sent to any Governmental Entity since January&nbsp;1, 2021 and (ix)&nbsp;the most recent audited financial statement and/or actuarial valuation
report. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, each Company Benefit Plan has been established, operated and administered in accordance with its terms and the requirements of all applicable Laws, including ERISA and the Code. Except as has not had and would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;all contributions required to be made to any Company Benefit Plan by applicable Law or by any plan document or other contractual
undertaking, and all premiums due or payable with respect to insurance policies funding any Company Benefit Plan, have been timely made or paid in full, (ii)&nbsp;all reports, returns, notices and similar documents required to be filed with any
Governmental Entity or distributed to any Company Benefit Plan participant have been timely filed or distributed and (iii)&nbsp;there are no pending, anticipated or, to the knowledge of the Company and its Subsidiaries, threatened actions, disputes,
suits, hearings or claims (other than routine claims for benefits) by, on behalf of or against any of the Company Benefit Plans or any trusts related thereto. Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect, no Company Benefit Plan is, or since January&nbsp;1, 2021, has been, the subject of an examination, investigation or audit by a Governmental Entity, or is the subject of an application or filing under,
or a participant in, a government-sponsored amnesty, voluntary compliance, self-correction or similar program. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The IRS
has issued a favorable determination, opinion or advisory letter with respect to each Company Benefit Plan that is intended to be qualified under Section&nbsp;401(a) of the Code (each, a &#147;<U>Qualified Plan</U>&#148;), and such determination,
advisory or opinion letter has not been revoked (nor has revocation been threatened), and, to the knowledge of the Company and its Subsidiaries, there are no existing circumstances and no events have occurred that would or would reasonably be
expected to, individually or in the aggregate, adversely affect the qualified status of any Qualified Plan or its related trust. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, neither the Company nor any ERISA Affiliate, currently has, or has had during any period within the preceding six (6)&nbsp;years during which any such ERISA Affiliate has been a member of the same &#147;controlled group&#148; (within
the meaning of Section&nbsp;4001(a)(14) of ERISA) with the Company, an obligation to contribute to a &#147;defined benefit plan&#148; as defined in Section&nbsp;3(35) of ERISA, a pension plan subject to the funding standards of Section&nbsp;302 of
ERISA or Section&nbsp;412 of the Code or a &#147;multiemployer plan&#148; as defined in Section&nbsp;3(37) of ERISA or Section&nbsp;414(f) of the Code (a &#147;<U>Multiemployer Plan</U>&#148;). Except as has not had and would not reasonably be
expected to have, individually or in the aggregate, a Company Material Adverse Effect, no Company Benefit Plan is a &#147;multiple employer plan&#148; that is subject to Section&nbsp;413(c) of the Code or Sections&nbsp;4063 or 4064 of ERISA, or a
&#147;multiple employer welfare arrangement,&#148; as defined in Section&nbsp;3(40) of ERISA. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had
and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, with respect to each Company Benefit Plan that is subject to Title&nbsp;IV of ERISA (each, a &#147;<U>Title</U><U></U><U>&nbsp;IV
Plan</U>&#148;), (i)&nbsp;no liability under Title&nbsp;IV or Section&nbsp;302 of ERISA has been incurred by the Company or any ERISA Affiliate that has not been satisfied in full and, to the knowledge of the Company, no condition exists that,
individually or in the aggregate, presents or would reasonably be expected to present a risk to the Company or any ERISA Affiliate of incurring any liability under Title&nbsp;IV or Section&nbsp;302 of ERISA other than any liability for premiums due
the Pension Benefit Guaranty Corporation (&#147;<U>PBGC</U>&#148;) (which premiums have been paid when due), (ii)&nbsp;the minimum funding standards under Section&nbsp;302 of ERISA and Section&nbsp;412 of the Code have been satisfied in all material
respects and no waiver of any minimum funding standard or extension of any amortization period has been requested or granted and (iii)&nbsp;no proceedings have been commenced or threatened by the PBGC to terminate any Title&nbsp;IV Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) With respect to each Multiemployer Plan, (i)&nbsp;neither the Company
nor any ERISA Affiliate has made or suffered a &#147;complete withdrawal&#148; or a &#147;partial withdrawal&#148; as such terms are respectively defined in sections&nbsp;4203 and 4205 of ERISA, from a Multiemployer Plan (or any liability resulting
therefrom has been satisfied in full) except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (ii)&nbsp;neither the Company nor any ERISA Affiliate has any contingent liability under
Section&nbsp;4204 of ERISA except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, and (iii)&nbsp;the withdrawal liability of the Company and its ERISA Affiliates under Subtitle E of
Title&nbsp;IV of ERISA, computed as if a complete withdrawal by the Company and the ERISA Affiliates had occurred under each Multiemployer Plan on the date hereof, would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as has not had and would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries or sponsors has sponsored or has any obligation with respect to any employee benefit plan that provides for any post-employment or post-retirement medical
or death benefits (whether or not insured) with respect to former or current directors or employees, or their respective beneficiaries or dependents, beyond their retirement or other separation from service, except as required by Section&nbsp;4980B
of the Code or comparable U.S. state Laws or applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) With
respect to each Company Benefit Plan, (i)&nbsp;neither the Company nor its Subsidiaries have engaged in, and, to the knowledge of the Company, no other person has engaged in, any nonexempt &#147;prohibited transaction&#148; (as defined in
Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code) and (ii)&nbsp;none of the Company or any of its Subsidiaries or, to the knowledge of the Company, any other &#147;fiduciary&#148; (as defined in Section&nbsp;3(21) of ERISA) has any
Liability for breach of fiduciary duty or any other failure to act or comply in connection with the administration or investment of the assets of such Company Benefit Plan that, in the case of (i)&nbsp;or (ii) above, either individually or in the
aggregate, could reasonably be expected to have a Company Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except as has not had and would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries have incurred any material liability for any Tax or civil penalty imposed under Chapter&nbsp;43 of
the Code or Sections&nbsp;409 or 502 of ERISA that has not been satisfied in full. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Except as set forth in
<U>Section</U><U></U><U>&nbsp;4.11(j)</U> of the Company Disclosure Schedule (or as made available by the Company to Acquiror within fifteen (15)&nbsp;Business Days of this Agreement) or as otherwise expressly provided in this Agreement or as is not
and would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole, the execution of this Agreement and the consummation of the Merger will not, either alone or in combination
with another event, (i)&nbsp;entitle any current or former officer, employee, director or individual consultant of the Company or any of its Subsidiaries to severance pay, unemployment compensation or accrued pension benefit or any other payment or
benefit, (ii)&nbsp;accelerate the time of payment or vesting, or increase the amount of compensation or benefits due or payable to any current or former officer, employee, director or individual consultant of the Company or any of its Subsidiaries,
(iii)&nbsp;trigger any funding obligation under any Company Benefit Plan, (iv)&nbsp;result in the forgiveness of Indebtedness for the benefit of any such Company Associate or (v)&nbsp;result in any payment (whether in cash or property or the vesting
of property) to any &#147;disqualified individual&#148; (as such term is defined in Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.280G-1)</FONT> that would, or would reasonably be expected to, individually or in combination
with any other such payment or benefit, constitute an &#147;excess parachute payment&#148; (as defined in Section&nbsp;280G(b)(1) of the Code). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) Except as set forth in <U>Section</U><U></U><U>&nbsp;4.11(k)</U> of the Company Disclosure Schedule, no Company Benefit
Plan provides for, and neither the Company nor any of its Subsidiaries otherwise has any obligation to provide, a <FONT STYLE="white-space:nowrap">gross-up,</FONT> or reimbursement of Taxes imposed under Sections&nbsp;4999, 409A(a)(1)(B) or 457A of
the Code, or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Except as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, each Company Benefit Plan which is a &#147;nonqualified deferred compensation plan&#148; subject to Section&nbsp;409A of the Code has been established, operated and maintained in
compliance with Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Except as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, each Company Benefit Plan subject to the Laws of any jurisdiction outside of the United States: (i)&nbsp;has been maintained in all respects in accordance with all applicable
requirements; (ii)&nbsp;that is intended to qualify for special Tax treatment meets all requirements for such treatment; (iii)&nbsp;that is intended to be funded and/or book-reserved is fully funded and/or book reserved, as appropriate, based upon
reasonable actuarial assumptions; and (iv)&nbsp;if required to be registered or approved by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> governmental entity, has been registered or approved and has been maintained in good standing with the
applicable regulatory authorities, and, to the knowledge of the Company, there are no existing circumstances or any events that have occurred since the date of the most recent approval or application therefor relating to any such plan that would
reasonably be likely to adversely affect any such approval or good standing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The Company will make available to
Acquiror, within fifteen (15)&nbsp;Business Days of this Agreement, a correct and complete list (for U.S. arrangements) and/or description (for <FONT STYLE="white-space:nowrap">non-U.S.</FONT> arrangements) of each Contract that is a collective
bargaining agreement, labor union contract, trade union agreement or works council agreement (each, a &#147;<U>Collective Bargaining Agreement</U><U>&#148;</U><U>)</U> to which the Company or any of its Subsidiaries are a party to and/or bound by.
Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, since January&nbsp;1, 2021, (i) to the knowledge of the Company, there have been no labor union organizing
activities with respect to any employees of the Company or any of its Subsidiaries, (ii)&nbsp;there have been no representation or certification proceedings or petitions seeking a representation proceeding presently pending or, to the knowledge of
the Company, threatened to be brought or filed with the National Labor Relations Board or any other labor relations tribunal or authority (iii)&nbsp;there has been no pending, or to the knowledge of the Company, threatened, strikes, lockouts,
slowdowns, work stoppages, grievances, arbitrations, labor disputes or unfair labor practice complaints against the Company or any of its Subsidiaries, and (iv)&nbsp;no employees of the Company or any of its Subsidiaries are represented by any labor
union, labor organization or works council with respect to such employment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) Except as has not had and would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and its Subsidiaries are in compliance in all respects with and have since January&nbsp;1, 2021 complied in all respects with all Laws
regarding employment and employment practices (including anti-discrimination), terms and conditions of employment and wages and hours (including classification of employees and independent contractors, and equitable pay practices) and other Laws in
respect of any reduction in force (including notice, information and consultation requirements), and no claims, grievances or charges or complaints by the National Labor Relations Board or any comparable Governmental Entity relating to such <FONT
STYLE="white-space:nowrap">non-compliance</FONT> with the foregoing are pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, to the knowledge of the Company or its Subsidiaries, no employee of the Company or its Subsidiaries is in any respect in violation of any term of any employment agreement, nondisclosure agreement, common law nondisclosure obligation,
fiduciary duty, noncompetition agreement, restrictive covenant or other obligation: (i)&nbsp;to the Company or its Subsidiaries or (ii)&nbsp;to a former employer of any such employee relating (A)&nbsp;to the right of any such employee to be employed
by the Company or its Subsidiaries or (B)&nbsp;to the knowledge or use of trade secrets or proprietary information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q)
Within fifteen (15)&nbsp;Business Days following the date of this Agreement, the Company will provide Acquiror with a correct and complete list of any settlement agreements entered into by the Company or any of its Subsidiaries with a current or
former officer, employee or independent contractor of the Company or its Subsidiaries since January&nbsp;1, 2021 that involves allegations relating to sexual </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
harassment or sexual misconduct by either (i)&nbsp;an officer of the Company or its Subsidiaries or (ii)&nbsp;a Company Associate. Since January&nbsp;1, 2021, to the knowledge of the Company, no
material allegations of sexual harassment or sexual misconduct have been made to the Company or its Subsidiaries against (i)&nbsp;any officer of the Company or its Subsidiaries or (ii)&nbsp;any Company Associate, in each case, that the Company has
failed to reasonably investigate and adequately address. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_25"></A>Section&nbsp;4.12 <U>Absence of Certain Changes or
Events</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since December&nbsp;31, 2023, through the date of this Agreement, except as expressly contemplated by this
Agreement or as set forth on <U>Section</U><U></U><U>&nbsp;4.12</U> of the Company Disclosure Schedule, the businesses of the Company and its Subsidiaries have been conducted in all material respects in the ordinary course of business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since December&nbsp;31, 2023, through the date of this Agreement, there has not been any fact, change, circumstance, event,
occurrence, condition or development that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_26"></A>Section&nbsp;4.13 <U>Information Supplied; Proxy Statement</U>. The information supplied or to be supplied by the
Company for inclusion in the Proxy Statement will not, on the date that the Proxy Statement is first mailed to the stockholders of the Company, or on the date of the Company Special Meeting, contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading, except that no representation or warranty is made by the Company
with respect to statements made therein based on information supplied by Acquiror or any of its respective Affiliates or Representatives in writing expressly for inclusion (whether directly or incorporated by reference) therein. The Proxy Statement
will comply as to form in all material respects with the requirements of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_27"></A>Section&nbsp;4.14
<U>Tax Matters</U><SUP STYLE="font-size:75%; vertical-align:top">.</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Each of the
Company and its Subsidiaries has prepared and timely filed (taking into account any valid extension of time within which to file) all Tax Returns required to be filed by it, and all such Tax Returns are true, complete and accurate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Each of the Company and its Subsidiaries has timely paid in full all Taxes required to be paid by it (whether or not shown
on any Tax Return). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The U.S. federal income Tax Returns of the Company and its Subsidiaries have been examined (or
the applicable statute of limitations has expired) through the Tax year ending on or before December&nbsp;31, 2022, and neither the Company nor any of its Subsidiaries has waived or extended, or requested any waiver or extension for, any statute of
limitations with respect to Taxes or agreed to any extensions of time with respect to a Tax assessment or deficiency. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv)
All assessments for Taxes due by the Company or any of its Subsidiaries with respect to completed and settled audits or examinations or any concluded litigation have been timely paid in full. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) No deficiencies for Taxes have been claimed, proposed or assessed by any Governmental Entity in writing against or with
respect to the income or assets of the Company or any of its Subsidiaries except for deficiencies which have been fully satisfied by payment, settled or withdrawn. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) There are no audits, examinations, investigations or other proceedings ongoing, pending or threatened in writing in
respect of any Taxes or Tax matters (including Tax Returns) of the Company or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) There are no Liens for Taxes on any of the assets of the Company or
any of its Subsidiaries other than Permitted Liens. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) Each of the Company and its Subsidiaries has complied with all
applicable Laws relating to the payment, collection, withholding and remittance of Taxes (including information reporting requirements) with respect to payments made to or received from any employee, independent contractor, creditor, stockholder,
customer or other third party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) During the five (5)&nbsp;year period ending on the date of this Agreement, no written
claim has been made by any Governmental Entity in a jurisdiction where the Company or its Subsidiaries does not file Tax Returns or pay Taxes of a particular type claiming that any such entity is or may be subject to taxation by that jurisdiction,
required to file such Tax Returns, or required to pay Taxes of such type. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) Neither the Company nor any of its
Subsidiaries (A)&nbsp;is or has been a member of any affiliated, consolidated, combined, unitary, group relief or similar group for purposes of filing Tax Returns or paying Taxes (other than a group the common parent of which is the Company),
(B)&nbsp;is a party to, bound by or has any obligation under any Tax sharing or Tax indemnity agreement or similar Contract or arrangement relating to the apportionment, sharing, assignment, indemnification or allocation of any Tax or Tax asset
(other than an agreement or arrangement solely between or among the Company and/or its Subsidiaries) or (C)&nbsp;has any Liability for Taxes of any person (other than the Company or any of its Subsidiaries) under Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any analogous or similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law), as transferee, successor, by Contract or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) Neither the Company nor any of its Subsidiaries will be required to include any item of income in, or exclude any item of
deduction from, taxable income for any taxable period (or portion thereof) beginning after the Closing Date, as a result of any (A)&nbsp;change in or incorrect method of accounting pursuant to Section&nbsp;481(c) of the Code (or any analogous or
similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) prior to the Closing, (B)&nbsp;installment sale, intercompany transaction, or open transaction made or entered into prior to the Closing, or any &#147;excess
loss account,&#148; existing as of immediately prior to the Closing, (C)&nbsp;prepaid amount received on or prior to the Closing, (D)&nbsp;&#147;closing agreement&#148; within the meaning of Section&nbsp;7121 of the Code (or any similar or analogous
provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) entered into prior to the Closing or (E)&nbsp;election pursuant to Section&nbsp;965(h) of the Code (or any analogous or similar provision of state, local or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> Law). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) During the five (5)&nbsp;year period ending on the date of this
Agreement, neither the Company nor any of its Subsidiaries has or has ever had a permanent establishment and otherwise has not had an office or fixed place of business in a jurisdiction outside of the jurisdiction in which the Company or its
Subsidiaries, respectively, are organized. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than with respect to the Separation Transactions, none of the Company
or any of its Subsidiaries has been a &#147;controlled corporation&#148; or a &#147;distributing corporation&#148; (within the meaning of Section&nbsp;355(a)(1)(A) of the Code) in any distribution that was purported or intended to qualify for <FONT
STYLE="white-space:nowrap">tax-free</FONT> treatment under Section&nbsp;355 of the Code (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law) occurring during the two (2)&nbsp;year period ending on the
date of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) None of the Company or any of its Subsidiaries has participated in any &#147;listed
transaction&#148; within the meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)(2)</FONT> (or any analogous or similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as set forth on <U>Section</U><U></U><U>&nbsp;4.14(d)</U> of the Company Disclosure Schedule, neither the Company
nor any of its Subsidiaries has (i)&nbsp;deferred the employer&#146;s share of any &#147;applicable employment taxes&#148; under Section&nbsp;2302 of the CARES Act, (ii)&nbsp;claimed any Tax credits under Sections&nbsp;7001 through 7005 of the
Families First Coronavirus Response Act and Section&nbsp;2301 of the CARES Act, (iii)&nbsp;sought a covered loan under paragraph&nbsp;(36) of Section&nbsp;7(a) of the Small Business Act (15 U.S.C. 636(a)), as added by Section&nbsp;1102 of the CARES
Act or (iv)&nbsp;elected to defer any payroll, employment or similar Taxes pursuant to any payroll tax Executive Order. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Neither the Company nor any of its Subsidiaries knows of any fact,
agreement, plan or other circumstance that would reasonably be expected to cause the Separation Transactions to fail to qualify for the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions to the Company and the holders of
Company Common Stock that received SpinCo common stock in the Separation Transactions (except with respect to any cash received in lieu of fractional shares). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) As of the date hereof, the representations set forth in the Company Signing Tax Opinion Representation Letter are true,
complete and accurate in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company and its Subsidiaries are not aware of any fact, agreement,
plan or other circumstance that would reasonably be expected to prevent or preclude the Company from delivering the Company Closing Tax Opinion Representation Letter immediately prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To the knowledge of the Company, all statements of fact contained in the Tax Matters Agreement and the Tax Materials are
true, complete and accurate in all material respects. To the knowledge of the Company, (i)&nbsp;the Tax Matters Agreement has not been amended or modified as of the date hereof, and (ii)&nbsp;neither the Company nor SpinCo has submitted any
supplemental requests relating to the IRS Ruling or any other ruling or determination from any Governmental Entity relating to the Separation Transactions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) There has been no indemnification claim and, to the knowledge of the Company, there is no pending indemnification claim,
and the Company is not aware of any fact which the Company believes will give rise to an indemnification obligation of the Company, in each case, relating to the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions, the basis
for which claim exists or will exist prior to the Closing (it being agreed and understood that any fact related to the Company Organizational Documents, the Merger and the transactions contemplated by this Agreement shall not constitute a fact that
violates this <U>Section</U><U></U><U>&nbsp;4.14(</U><U>i</U><U>)</U>). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company is not and, to the knowledge of
the Company, SpinCo is not in breach of the Tax Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_28"></A>Section&nbsp;4.15 <U>Intellectual
Property</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;4.15(a)</U> of the Company Disclosure Schedule sets forth a complete and
accurate list of all material Company Registrations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company and its Subsidiaries solely and
exclusively own the Company Registrations free and clear of all Liens other than Permitted Liens, and the Company Registrations are, to the knowledge of the Company, valid and enforceable (and there currently is no written complaint, claim or
notice, or, to the knowledge of the Company, threat, and since January&nbsp;1, 2021, there has been no written complaint, claim or notice, or, to the knowledge of the Company, threat challenging the ownership, validity or enforceability of the
Company Registrations, in each case, other than ordinary course proceedings related to Company Registrations, none of which would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) each item of Company Intellectual Property will be owned (free and clear of all Liens other than Permitted Liens), and
each item of Licensed IP and material Commercially Available Software will be available for use, by the Surviving Corporation and its Subsidiaries immediately following the Closing on substantially identical terms and conditions as it was owned or
available for use by the Company and its Subsidiaries immediately prior to the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) SpinCo and its Subsidiaries
do not own any Intellectual Property used in the business of the Company and its Subsidiaries as currently conducted, other than the Intellectual Property expressly licensed to the Company and its Subsidiaries pursuant to (A)&nbsp;that certain
Master Ownership and License Agreement Regarding Trademarks and Certain Related Intellectual Property, dated as of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
September&nbsp;29, 2023, by and between the Company and SpinCo and (B)&nbsp;that certain Master Ownership and License Agreement Regarding Patents, Trade Secrets and Certain Related Intellectual
Property, dated as of September&nbsp;29, 2023, by and between the Company and SpinCo; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) the Company and its
Subsidiaries have taken reasonable measures to maintain the confidentiality of trade secrets and other material proprietary or confidential information included in the Company Intellectual Property; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) except as set forth on <U>Section</U><U></U><U>&nbsp;4.15(b)(v)</U> of the Company Disclosure Schedule, (x)&nbsp;the
conduct of the business of the Company and its Subsidiaries does not infringe or violate, or constitute a misappropriation of, any Intellectual Property rights of any third party, and (y)&nbsp;since January&nbsp;1, 2021, the Company and its
Subsidiaries have not received in writing any complaint, claim or notice, or threat of any of the foregoing (including any notification that a license under any patent is or may be required) alleging any such infringement, violation or
misappropriation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) each of the Company and its Subsidiaries complies in all material respects with (A)&nbsp;the
Company&#146;s or such Subsidiary&#146;s applicable written privacy policies, if any, and (B)&nbsp;all applicable Laws relating to privacy, data protection and the collection, compilation, sharing, use, storage, transfer or security from
unauthorized disclosure of personally identifiable information (including name, address, telephone number or email address) of its customers collected, used or held for use by the Company or the relevant Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) except as set forth on <U>Section</U><U></U><U>&nbsp;4.15(b)(vii)</U> of the Company Disclosure Schedule, to the
knowledge of the Company, no person (including any current or former employee or consultant of the Company or any of its Subsidiaries) is infringing, violating or misappropriating any of the Company Intellectual Property, and, since January&nbsp;1,
2021, the Company and its Subsidiaries have not sent to or made against any third party in writing any complaint, claim or notice, or threat of any of the foregoing (including any notification that a license under any patent is or may be required);
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) no Company Intellectual Property is subject to any Legal Proceeding, nor is the Company Intellectual Property
subject to any Order or Contract limiting, restricting, or affecting the use, exploitation, registration, attempted registration, enforceability, transfer, or licensing of the Company Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_29"></A>Section&nbsp;4.16 <U>Property</U>. With respect to the real property owned by the Company or any Subsidiary of the
Company (the &#147;<U>Company Owned Real Property</U>&#148;), except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (a)&nbsp;either the Company or a Subsidiary of the
Company has good, marketable and valid title to such Company Owned Real Property, free and clear of all Liens other than any Permitted Liens and (b)&nbsp;neither the Company nor any Subsidiary of the Company has received written notice of any
pending condemnation proceeding with respect to any Company Owned Real Property, and, to the knowledge of the Company, no such proceeding is threatened. Either the Company or a Subsidiary of the Company has a good, subsisting and valid leasehold
interest in each lease, sublease and other agreement under which the Company or any of its Subsidiaries uses or occupies or has the right to use or occupy any real property (such property subject to a lease, sublease or other agreement, the
&#147;<U>Company Leased Real Property</U>&#148; and such leases, subleases and other agreements are, collectively, the &#147;<U>Company Real Property Leases</U>&#148;), in each case, free and clear of all Liens other than any Permitted Liens, except
as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect, each Company Real Property Lease (a)&nbsp;is a valid and binding obligation of the Company or the Subsidiary of the Company that is party thereto and, to the knowledge of the Company, of each other party thereto, and is in
full force and effect, (b)&nbsp;no uncured default on the part of the Company or, if applicable, its Subsidiary or, to the knowledge of the Company, the landlord thereunder, exists under any such Company Real Property Lease and (c)&nbsp;no event has
occurred or circumstance exists which, with the giving of notice, the passage of time, or both, would constitute a breach or default under any such Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Real Property Lease. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its
Subsidiaries is subleasing, licensing or otherwise granting any person any right to use or occupy a Company Owned Real Property or a Company Leased Real Property. No damage or destruction has occurred with respect to any of the Company Owned Real
Property or the Company Leased Real Property that has not been repaired, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_30"></A>Section&nbsp;4.17 <U>Insurance</U>. The Company and its Subsidiaries maintain insurance with reputable insurers in
such amounts and against such risks reasonably consistent with customary and prudent industry practice for similar businesses. Except as is not and would not reasonably be expected to be, individually or in the aggregate, material to the Company and
its Subsidiaries, taken as a whole, all material insurance policies maintained by or on behalf of the Company or any of its Subsidiaries as of the date of this Agreement are in full force and effect, the Company and its Subsidiaries are in
compliance with the terms and provisions of all such insurance policies, and neither the Company nor any of its Subsidiaries is in breach or default under, has received any written notice of, or has taken any action or failed to take action that
would, or would reasonably be expected to, individually or in the aggregate, permit cancellation, termination or modification of, any such material insurance policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_31"></A>Section&nbsp;4.18 <U>Suppliers and Customers</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;4.18(a)</U> of the Company Disclosure Schedule sets forth a true and complete list, as of the
date of this Agreement, of the Top Suppliers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;4.18(b)</U> of the Company Disclosure
Schedule sets forth a true and complete list, as of the date of this Agreement, of the Top Customers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_32"></A>Section&nbsp;4.19 <U>Material Contracts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;4.19(a)</U> of the Company Disclosure Schedule sets forth a true and complete list, as of the
date of this Agreement, of the following Contracts to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries (or any of their respective properties or assets) is bound (other than any Company
Benefit Plan): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any &#147;material contract&#148; (as such term is defined in Item&nbsp;601(b)(10) of <FONT
STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> of the SEC) or any Contract that would be required to be disclosed under Item&nbsp;404(a) of <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> promulgated under the Exchange Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Contract that provides for or governs the formation, creation, operation, management or control of any partnership,
strategic alliance, joint venture or similar arrangement involving the sharing of profits or losses, in each case, that is material to the business of the Company and its Subsidiaries, taken as a whole; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any Contract that provides for the license or other grant of rights by or to the Company or any of its Subsidiaries of
any Intellectual Property that is material to the business of the Company and its Subsidiaries, taken as a whole, other than <FONT STYLE="white-space:nowrap">(a)&nbsp;non-exclusive</FONT> licenses or sublicenses of Intellectual Property entered into
in the ordinary course of business consistent with past practice, including those entered into with customers, contractors, vendors, service providers, suppliers, resellers and distributors, (b)&nbsp;Contracts in which the licenses or grants of
rights to use Intellectual Property are ancillary and incidental to the transaction contemplated in such Contract (including a sale of products or services to customers in the ordinary course of business), (c) licenses granted by the Company or any
of its Subsidiaries to another Subsidiary, (d)&nbsp;licenses granted to the Company or any of its Subsidiaries of Commercially Available Software, (e)&nbsp;Contracts with officers, employees, or contractors of the Company or any of its Subsidiaries
that assign to the Company or any of its Subsidiaries the rights in Intellectual Property developed by any such person in the scope of their employment or engagement with the Company or any of its Subsidiaries, and (f)&nbsp;nondisclosure agreements
and confidentiality agreements, in each case of clause (a)-(f), that are entered into in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any Contract that involves any settlement, conciliation or similar
agreement (A)&nbsp;that is with any Governmental Entity or (B)&nbsp;pursuant to which the Company or any of its Subsidiaries is obligated after the date of this Agreement to pay consideration in excess of ten million dollars ($10,000,000); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) any loan agreement, credit agreement, note, debenture, bond, indenture, security agreement, guarantee or other Contract, in
each case, pursuant to which any Indebtedness for borrowed money of the Company or any of its Subsidiaries may be incurred or is outstanding, or any guarantees by the Company or any of its Subsidiaries of any Indebtedness for borrowed money, in each
case, that constitutes an Indebtedness obligation of the Company or any Company Subsidiary with a principal amount as of the date hereof greater than fifty million dollars ($50,000,000); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) any Contract with respect to an acquisition by the Company of a third party or business that provides for payment of
material &#147;earn outs&#148; by the Company or any of its Subsidiaries, other than those (A)&nbsp;with respect to which there are no outstanding obligations under such provisions or (B)&nbsp;involving total consideration less than ten million
dollars ($10,000,000); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) any Contract that (A)&nbsp;was entered into on or after January&nbsp;1, 2021, and/or
(B)&nbsp;has not yet been consummated, and involves the acquisition or Disposition, directly or indirectly (by merger or otherwise), of a business or all, or substantially all, of the capital stock or other equity interests of a person or all, or
substantially all, of the material assets or properties of a person, other than any such acquisition for consideration (including any &#147;earnouts&#148; and contingent payments) that does not exceed twenty million dollars ($20,000,000); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) any Contract that expressly prohibits the payment of dividends or distributions in respect of, or the pledging of, any
equity interest of, or the issuance of guarantees by, the Company or any of its Subsidiaries, in each case, that is material to the business of the Company and its Subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Contract of the type described in clauses&nbsp;(i) through (viii)&nbsp;above (or set forth in
<U>Section</U><U></U><U>&nbsp;4.19(a)</U> of the Company Disclosure Schedule or filed as an exhibit to the Company SEC Documents (other than any such Contract filed as an exhibit to the Company SEC Documents that, as of the date hereof, has expired
pursuant to its terms or has been disclosed prior to the date hereof in the Company SEC Documents (without giving effect to the date limitation in the definition thereof) as having been terminated)), other than a Company Stock Plan, is referred to
herein as a &#147;<U>Company Material Contract</U>.&#148; The Company has made available to Acquiror prior to the date of this Agreement, a complete and correct copy of each Company Material Contract as in effect on the date of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, (i)&nbsp;neither the Company nor any Subsidiary of the Company is in breach of or default under the terms of any Company Material Contract and, to the knowledge of the Company, no other party to any Company Material Contract is in
breach of or default under the terms of any Company Material Contract, (ii)&nbsp;no event has occurred or not occurred through the Company&#146;s or any of its Subsidiaries&#146; action or inaction or, to the knowledge of the Company, through the
action or inaction of any third party, that with or without notice or lapse of time or both would constitute a breach of or default under the terms of any Company Material Contract, (iii)&nbsp;each Company Material Contract is a valid and binding
obligation of the Company or the Subsidiary of the Company that is party thereto and, to the knowledge of the Company, of each other party thereto, and is in full force and effect (in each case, subject to the effects of bankruptcy, insolvency,
reorganization, moratorium or similar Laws affecting creditors&#146; rights generally and by general principles of equity, regardless of whether enforcement is sought in a proceeding at law or in equity) and (iv)&nbsp;neither the Company nor any of
its Subsidiaries has received any written notice of the intention of any other party to any Company Material Contract to terminate for default, convenience or otherwise any Company Material Contract, nor to the knowledge of the Company, is any such
party threatening to do so. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_33"></A>Section&nbsp;4.20 <U>Opinion of Financial Advisor</U>. The
Company Board of Directors has received the opinions of Goldman Sachs&nbsp;&amp; Co. LLC and Lazard Fr&egrave;res&nbsp;&amp; Co. LLC, each to the effect that, as of the date thereof and subject to the assumptions, limitations, qualifications and
other matters considered in the preparation thereof, the $83.50 per share of Company Common Stock to be paid to the holders of Company Common Stock (other than Parent, Acquiror and their respective Affiliates) pursuant to this Agreement is fair from
a financial point of view to such holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_34"></A>Section&nbsp;4.21 <U>Finders or Brokers</U>. Except for Goldman
Sachs&nbsp;&amp; Co. LLC and Lazard Fr&egrave;res&nbsp;&amp; Co. LLC, neither the Company nor any of its Subsidiaries has employed any investment banker, broker or finder in connection with the Merger who would be entitled to any fee or any
commission in connection with or upon consummation of the Merger. <U>Section</U><U></U><U>&nbsp;4.21</U> of the Company Disclosure Schedule sets forth a good faith estimated calculation, based on the Company&#146;s fully diluted equity
capitalization as of the Capitalization Date, of the aggregate amount of fees and commissions that are or would be payable to Goldman Sachs&nbsp;&amp; Co. LLC and Lazard Fr&egrave;res&nbsp;&amp; Co. LLC in connection with the consummation of the
Merger (assuming the capitalization of the Company at the Closing is as set forth in <U>Section</U><U></U><U>&nbsp;4.2(a)</U>) (the &#147;<U>Broker Fees</U>&#148;). The Company has made available to Acquiror complete and correct copies of all
agreements under which the Broker Fees are payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_35"></A>Section&nbsp;4.22 <U>State Takeover Statutes</U>.
Assuming the accuracy of the representation in the second sentence of <U>Section</U><U></U><U>&nbsp;5.7</U>, the Company Board of Directors has taken all action necessary to render inapplicable to this Agreement, the Voting Agreements and the
transactions contemplated hereby (including the Merger) all potentially applicable state anti-takeover statutes or regulations (including Section&nbsp;203 of the DGCL) and any similar provisions in the Company Certificate or Company Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_36"></A>Section&nbsp;4.23 <U>No Additional Representations or Warranties; Acknowledgment of Disclaimer</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except for the representations and warranties expressly set forth in this <U>Article</U><U></U><U>&nbsp;IV</U> or in a
certificate delivered pursuant to this Agreement, neither the Company nor any other person on behalf of the Company or its Subsidiaries makes any express or implied representation or warranty with respect to the Company or its Subsidiaries or with
respect to any other information provided to Parent, Acquiror, Merger Sub or any of their Affiliates or Representatives, including its business, operations, assets, Liabilities, conditions (financial or otherwise) or prospects, in connection with
the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company acknowledges and agrees that, except for the representations and
warranties of Acquiror and Merger Sub expressly set forth in <U>Article</U><U></U><U>&nbsp;V</U> and of Parent expressly set forth in <U>Section</U><U></U><U>&nbsp;9.15(c)</U>, or in a certificate delivered pursuant to this Agreement, (a)&nbsp;none
of Acquiror, Merger Sub or any of their Affiliates is making and none of them has made any representations or warranties (express or implied) relating to itself or its business, operations, assets, Liabilities, conditions (financial or otherwise) or
prospects or otherwise in connection with the transactions contemplated by this Agreement, including the Merger, and none of the Company or its Representatives is relying on any representation or warranty of Acquiror, Merger Sub or any of their
Affiliates except for those expressly set forth in <U>Article</U><U></U><U>&nbsp;V</U> and <U>Section</U><U></U><U>&nbsp;9.15</U>, and (b)&nbsp;no person has been authorized by Parent, Acquiror, Merger Sub or any of their Affiliates to make any
representation or warranty relating to Parent, Acquiror, Merger Sub or any of their Affiliates or their respective businesses or otherwise in connection with the transactions contemplated by this Agreement, including the Merger, and if made, such
representation or warranty has not been and shall not be relied upon by the Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;V </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>REPRESENTATIONS AND WARRANTIES OF ACQUIROR AND MERGER SUB</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acquiror and Merger Sub jointly and severally represent and warrant to the Company as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_37"></A>Section&nbsp;5.1 <U>Organization</U>. Acquiror is a Delaware limited liability company and Merger Sub is a Delaware
limited liability company. Acquiror is duly formed, validly existing and in good standing under the Laws of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
State of Delaware. Merger Sub is duly formed, validly existing and in good standing under the Laws of the State of Delaware. Each of Acquiror and Merger Sub has all requisite corporate or similar
power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted except as has not had and would not reasonably be expected to have, individually or in the aggregate, an Acquiror Material
Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_38"></A>Section&nbsp;5.2 <U>Corporate Authority Relative to this Agreement; No Violation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Acquiror and Merger Sub has the requisite corporate or similar power and authority to enter into this Agreement and
to consummate the transactions contemplated by this Agreement, including the Merger. The execution, delivery and performance of this Agreement by Acquiror and Merger Sub and the consummation by each of them of the Merger have been duly and validly
authorized by the Acquiror Board of Managers and the board of managers of Merger Sub, and, subject to the approval of the adoption of this Agreement by the sole member of Merger Sub, no other corporate or similar proceedings on the part of either
Acquiror or Merger Sub or vote of Acquiror&#146;s members is necessary to authorize the execution and delivery by Acquiror and Merger Sub of this Agreement and the consummation of the Merger. The board of managers of Merger Sub has unanimously
(i)&nbsp;approved and declared advisable this Agreement and the transactions contemplated hereby, including the Merger, the performance by Merger Sub of its covenants and agreements contained herein and the consummation of the Merger upon the terms
and subject to the conditions contained herein; (ii)&nbsp;determined that this Agreement and the Merger are advisable and in the best interests of Merger Sub and its sole member; (iii)&nbsp;resolved to submit this Agreement to the sole member of
Merger Sub for its approval of the adoption hereof; and (iv)&nbsp;resolved to recommend the adoption of this Agreement by the sole member of Merger Sub. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than in connection with or in compliance with (i)&nbsp;the filing of the Certificate of Merger with the Delaware
Secretary, (ii)&nbsp;the Exchange Act, (iii)&nbsp;the Securities Act, (iv)&nbsp;applicable state securities and &#147;blue sky&#148; laws, (v)&nbsp;the HSR Act and any other requisite or advisable clearances or approvals under any other applicable
Antitrust Laws, and (vi)&nbsp;the adoption of this Agreement by the sole member of Merger Sub, which will occur immediately following the execution of this Agreement (collectively, the &#147;<U>Acquiror</U><U> Approvals</U>&#148;), no Regulatory
Filing or Consent is necessary, under applicable Law, for the consummation by Acquiror or Merger Sub of the Merger, except for such Regulatory Filings and Consents that are not required to be obtained or made prior to consummation of the Merger or
that, if not obtained or made, have not had and would not reasonably be expected to have, individually or in the aggregate, an Acquiror Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The execution and delivery by Acquiror and Merger Sub of this Agreement does not, and (assuming the Acquiror Approvals are
obtained) the consummation of the Merger and compliance with the provisions of this Agreement will not (i)&nbsp;conflict with or result in any violation of any provision of the Acquiror&#146;s constituent documents or (ii)&nbsp;conflict with or
violate any applicable Laws, except, in the case of clause&nbsp;(ii), for such conflicts or violations as have not had and would not reasonably be expected to have, individually or in the aggregate, an Acquiror Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_39"></A>Section&nbsp;5.3 <U>Information Supplied</U>. The information supplied or to be supplied by or on behalf of
Acquiror and Merger Sub in writing expressly for inclusion in the Proxy Statement will not, at the time the Proxy Statement is first mailed to the stockholders of the Company and on the date of the Company Special Meeting, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading, except that no
representation or warranty is made by Acquiror or Merger Sub with respect to statements made therein based on information supplied by the Company in writing expressly for inclusion therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_40"></A>Section&nbsp;5.4 <U>Financing</U>. Acquiror has delivered to the Company a true and complete copy of (x)&nbsp;the
executed commitment letter (including all attachments thereto), dated as of the date hereof, from the Debt Financing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sources party thereto (the &#147;<U>Debt Financing Commitment Letter</U>&#148;), pursuant to which and subject to the terms and conditions thereof such Debt Financing Sources have agreed to lend
the amounts set forth therein (the &#147;<U>Debt Financing</U>&#148;) for the purpose of funding the transactions contemplated by this Agreement and the related fees and expenses and (y)&nbsp;the fee letter, redacted to remove fee amounts, pricing
terms, pricing caps, &#147;market flex&#148; provisions and other economic terms, related thereto (collectively, the &#147;<U>Fee Letter</U>&#148; and together with the Debt Financing Commitment Letter, the &#147;<U>Debt Financing
Letters</U>&#148;); <I>provided</I> that, in each case, such redactions would not reasonably be expected to adversely affect the conditionality, enforceability or termination provisions of, or to reduce the aggregate principal amount of, the Debt
Financing. As of the date hereof, the Debt Financing Letters have not been amended, restated, amended and restated, supplemented or otherwise modified, and the commitments contained in the Debt Financing Commitment Letter have not been withdrawn,
modified or rescinded in any respect. As of the date hereof, each Debt Financing Letter is in full force and effect and constitutes the legal, valid and binding obligations of Parent and, to the knowledge of Acquiror, the other parties thereto,
subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar Laws of general applicability relating to or affecting creditors&#146; rights and to general equity principles. Except as expressly set forth in the Debt
Financing Commitment Letter delivered to the Company pursuant to this Section&nbsp;5.4, there are no side letters or other contracts, agreements, arrangements or understandings (written or oral) directly or indirectly related to the Debt Financing,
which could affect the conditionality, enforceability or termination provisions of, or reduce the aggregate principal amount of, the Debt Financing. There are no conditions precedent (including pursuant to any &#147;market flex&#148; provisions)
related to the funding of the Debt Financing, other than as expressly set forth in the Debt Financing Commitment Letter. Subject to the terms and conditions of the Debt Financing Letters, assuming satisfaction of the conditions in
<U>Sections</U><U></U><U>&nbsp;7.1</U> and <U>7.2</U>, Acquiror and the Surviving Corporation will have, as of the Closing Date, sufficient funds to pay the aggregate Merger Consideration and all fees and expenses and other amounts payable by
Acquiror in connection with the Merger and the other transactions contemplated by this Agreement (collectively, the &#147;<U>Required Amount</U>&#148;). As of the date of this Agreement, assuming the accuracy of the representations and warranties
contained in <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, no event has occurred which, with or without notice, lapse of time or both, would reasonably be expected to (x)&nbsp;constitute a breach or default (or an event which with notice or lapse of
time or both would constitute a default), in each case, on the part of Parent under the Debt Financing Letters or, to the knowledge of the Acquiror, any other party thereto under any term or condition of the Debt Financing Letters, (y)&nbsp;result
in any of the conditions to the funding of the Debt Financing not being satisfied on a timely basis or (z)&nbsp;otherwise result in the Debt Financing not being available in accordance with the terms of the Debt Financing Letters on the Closing
Date, and subject to the satisfaction of the conditions contained in <U>Sections</U><U></U><U>&nbsp;7.1</U> and <U>7.2</U> herein, Acquiror does not have any reason to believe that Parent will be unable to satisfy any of the conditions to the Debt
Financing to be satisfied by it on a timely basis with respect to the Debt Financing Commitment Letter or that the Debt Financing will not be available to Parent on the Closing Date. As of the date of this Agreement, no Debt Financing Source party
to the Debt Financing Commitment Letter has notified Parent or the Acquiror of its intention to terminate any of the commitments in respect of the Debt Financing or not to provide all or any portion of the Debt Financing. As of the date hereof,
Parent has fully paid (or caused to be paid) all commitment fees or other fees required to be paid prior to the date of this Agreement pursuant to the Debt Financing Letters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_41"></A>Section&nbsp;5.5 <U>Merger Sub</U>. Merger Sub is a wholly owned direct or indirect Subsidiary of Acquiror. Since
its date of formation, Merger Sub has not carried on any business nor conducted any operations other than the execution of this Agreement, the performance of its obligations hereunder and matters ancillary thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_42"></A>Section&nbsp;5.6 <U>Litigation</U>. As of the date hereof, there are no (x)&nbsp;Legal Proceedings of any nature
or (y)&nbsp;subpoenas, civil investigative demands or other requests for information relating to potential violations of Law, in each case ((x) and (y)) pending or, to the knowledge of Acquiror, threatened against or relating to Acquiror, Merger Sub
or any of their Affiliates, that challenge or seek to prevent, enjoin, alter or materially delay, or recover any damages or obtain any other remedy in connection with, this Agreement or the Merger in each case threatened against or relating to
Acquiror, Merger Sub or any of their Affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_43"></A>Section&nbsp;5.7 <U>Stock Ownership</U>. As of the date hereof,
none of Parent, Acquiror, Merger Sub or any of their respective controlled Affiliates (other than pursuant to an employee benefit, pension or similar plan) owns any shares of Company Common Stock. Each of Parent, Acquiror, Merger Sub and any of
their respective &#147;Affiliates&#148; or &#147;Associates&#148; (as such terms are defined in Section&nbsp;203 of the DGCL) is not, and at no time during the last three (3)&nbsp;years has been, an &#147;interested stockholder&#148; of the Company
as defined in Section&nbsp;203 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_44"></A>Section&nbsp;5.8 <U>Solvency</U>. None of Acquiror, Parent or
Merger Sub is entering into this Agreement with the intent to hinder, delay or defraud either present or future creditors, and immediately after giving effect to the Merger and the other transactions contemplated by this Agreement, including the
payment of the Merger Consideration, then assuming (a)&nbsp;satisfaction of the conditions to Acquiror&#146;s and Merger Sub&#146;s obligation to consummate the Merger as set forth herein; (b)&nbsp;the accuracy of the representations and warranties
of the Company set forth in <U>Article</U><U></U><U>&nbsp;IV</U> hereof (for such purposes, such representations and warranties shall be true and correct in all material respects without giving effect to (x)&nbsp;any &#147;Company Material Adverse
Effect,&#148; &#147;materiality&#148; or similar qualifiers and (y)&nbsp;the exclusion contained in clause&nbsp;(b) of <U>Section</U><U></U><U>&nbsp;4.6</U>); and (c)&nbsp;the preparation in good faith based upon assumptions that were and continue
to be reasonable of any estimates, projections or forecasts of the Company and its Subsidiaries, (i)&nbsp;the Surviving Corporation will not have incurred debts beyond its ability to pay such debts as they become due, (ii)&nbsp;the then-present fair
value of the assets of the Surviving Corporation and its Subsidiaries will exceed the amount that will be required to pay their existing debts (including the probable amount of all contingent liabilities) as such debts become due, (iii)&nbsp;the
assets of the Surviving Corporation and its Subsidiaries shall have a fair value in excess of their debts (including the probable amount of all contingent liabilities) and (iv)&nbsp;the Surviving Corporation will not have unreasonably small capital
to carry on its business as proposed to be conducted following the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_45"></A>Section&nbsp;5.9 <U>Tax
Matters</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date hereof, the representations set forth in the Acquiror Signing Tax Opinion Representation
Letter are true, complete and accurate in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Acquiror is not aware of any fact, agreement, plan or
other circumstance that would reasonably be expected to prevent or preclude Acquiror from delivering the Acquiror Closing Tax Opinion Representation Letter immediately prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Acquiror is not aware of any fact, agreement, plan or other circumstance that would reasonably be expected to prevent or
preclude Acquiror Tax Counsel from delivering the Closing Tax Opinion, assuming delivery to Acquiror Tax Counsel of the Closing Tax Opinion Representation Letters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Acquiror has received the opinion of Acquiror Tax Counsel, addressed to Acquiror and dated as of the date hereof, in form
and substance reasonably satisfactory to Acquiror, to the effect that, based upon the Signing Tax Opinion Representation Letters and any other facts, assumptions and representations set forth or referred to in such opinion, and subject to such
qualifications and limitations as may be set forth in such opinion, for U.S. federal income Tax purposes, the Merger contemplated by this Agreement will not affect the qualification of (i)&nbsp;the Contribution and Distribution as a transaction
qualifying for <FONT STYLE="white-space:nowrap">non-recognition</FONT> of gain or loss to the Company pursuant to Sections 368, 355 and 361 of the Code, and (ii)&nbsp;the Distribution as a transaction qualifying for
<FONT STYLE="white-space:nowrap">non-recognition</FONT> of income, gain, or loss to the Company&#146;s stockholders pursuant to Section&nbsp;355 of the Code, except to the extent of cash received in lieu of fractional shares (the &#147;<U>Signing
Tax Opinion</U>&#148;). Acquiror has delivered to the Company a copy of the Signing Tax Opinion and the Acquiror Signing Tax Opinion Representation Letter on the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_46"></A>Section&nbsp;5.10 <U>No Additional Representations or Warranties; Acknowledgment of Disclaimer</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except for the representations and warranties of Acquiror and Merger Sub expressly set forth in this
<U>Article</U><U></U><U>&nbsp;V</U> and of Parent expressly set forth in <U>Section</U><U></U><U>&nbsp;9.15(c)</U>, or in a certificate delivered pursuant to this Agreement, none of Parent, Acquiror, Merger Sub or any other person on behalf of
Parent, Acquiror or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Merger Sub makes any express or implied representation or warranty with respect to Parent, Acquiror or Merger Sub or with respect to any other information provided to the Company or any of its
Subsidiaries or Representatives in connection with the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Acquiror and Merger Sub
acknowledge and agree that, except for the representations and warranties expressly set forth in <U>Article</U><U></U><U>&nbsp;IV</U> or in a certificate delivered pursuant to this Agreement, (a)&nbsp;none of the Company or any of its Affiliates is
making and none of them has made any representations or warranties (express or implied) relating to itself (other than those made by the parties to the Voting Agreements solely with respect to themselves and their ownership of certain equity
interests in the Company and not with respect to the Company or any other Affiliate of the Company) or its business, operations, assets, Liabilities, conditions (financial or otherwise) or prospects or otherwise in connection with the transactions
contemplated by this Agreement, including the Merger, and none of Parent, Acquiror, Merger Sub or their respective Affiliates or Representatives is relying on any representation or warranty of the Company or any of its Affiliates except for those
expressly set forth in <U>Article</U><U></U><U>&nbsp;IV</U> and (b)&nbsp;no person has been authorized by the Company or any of its Affiliates to make any representation or warranty relating to the Company or any of its Affiliates or their
respective businesses or otherwise in connection with the transactions contemplated by this Agreement, including the Merger, and if made, such representation or warranty has not been and shall not be relied upon by Parent, Acquiror or Merger Sub.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VI </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COVENANTS AND AGREEMENTS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_47"></A>Section&nbsp;6.1 <U>Conduct of Business of the Company</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the period from the date hereof through the earlier of the termination of this Agreement in accordance with
<U>Article</U><U></U><U>&nbsp;VIII</U> and the Effective Time, except as required by applicable Law or as expressly required by this Agreement or as set forth in <U>Section</U><U></U><U>&nbsp;6.1</U> of the Company Disclosure Schedule and for any
action taken reasonably and in good faith in response <FONT STYLE="white-space:nowrap">to&nbsp;COVID-19</FONT> or <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or any other similar public health outbreak, or unless the prior written
consent of Acquiror (which shall not be unreasonably withheld, conditioned or delayed) has been obtained, the Company shall, and shall cause each of its Subsidiaries to, (x)&nbsp;use commercially reasonable efforts to conduct its business in the
ordinary course consistent with past practice and (y)&nbsp;use commercially reasonable efforts to maintain and preserve substantially intact its business organization and preserve existing relationships with key employees, persons having significant
business dealings with the Company or any of its Subsidiaries and any Governmental Entity that has jurisdiction over the Company or its Subsidiaries (it being agreed that no action by the Company or any of its Subsidiaries with respect to the
matters specifically addressed by any provision of the immediately following sentence will be deemed a&nbsp;breach&nbsp;of this sentence unless such action would constitute a breach of such relevant provision of the immediately following sentence).
Without limiting the generality of the foregoing, during the period from the date hereof through the earlier of the termination of this Agreement in accordance with <U>Article</U><U></U><U>&nbsp;VIII</U> and the Effective Time, except as required by
applicable Law or as expressly required by this Agreement or as set forth in the corresponding subsection of <U>Section</U><U></U><U>&nbsp;6.1</U> of the Company Disclosure Schedule, or unless the prior written consent of Acquiror (which consent
shall not be unreasonably withheld, conditioned or delayed; <I>provided</I> that Acquiror shall be permitted, in its sole discretion, to withhold, condition or delay consent with respect to <U>Section</U><U></U><U>&nbsp;6.1(a)(vii)</U>) has been
obtained, the Company shall not, and shall cause its Subsidiaries not to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) amend the Company Organizational Documents
or the Company Subsidiary Organizational Documents (except, in the case of Company Subsidiary Organizational Documents, amendments that would not reasonably be expected to, directly or indirectly, materially and adversely affect Acquiror or any of
its Subsidiaries (after giving effect to the Merger)) or otherwise take any action to exempt any person from any provision of the Company Organizational Documents or, except as would not be material and adverse to the Company, the Company Subsidiary
Organizational Documents; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (i)&nbsp;split, combine or reclassify any of its capital stock or
(ii)&nbsp;make, declare or pay any dividend, or make any other distribution on, or directly or indirectly redeem, purchase or otherwise acquire, any shares of its capital stock, or any other securities or obligations convertible (whether currently
convertible or convertible only after the passage of time or the occurrence of certain events) into or exercisable or exchangeable for any shares of its capital stock except (A)&nbsp;pro rata dividends paid or pro rata<I> </I>distributions made by
any Subsidiaries of the Company to the Company or to other wholly owned Subsidiaries of the Company in accordance with the applicable Company Subsidiary Organizational Documents, (B)&nbsp;(I) the acquisition by the Company of Company Shares in
connection with the surrender of Company Shares by holders of Company Options in order to pay the exercise price of the Company Options, (II)&nbsp;the withholding of Company Shares to satisfy Tax obligations with respect to Company Options, Company
Restricted Stock Units, Company Deferred Stock Units or Company Performance Stock Units in the ordinary course of business consistent with past practice or (III)&nbsp;the acquisition by the Company of Company Options, Company Restricted Stock Units,
Company Deferred Stock Units or Company Performance Stock Units in connection with the forfeiture of such awards or (C)&nbsp;regular quarterly cash dividends on Company Common Stock declared and paid as set forth on
<U>Section</U><U></U><U>&nbsp;6.1(a)(ii)</U> of the Company Disclosure Schedule; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) (i)&nbsp;issue, sell, grant any
right to acquire or otherwise permit to become outstanding any additional shares of its capital stock or securities convertible or exchangeable into, or exercisable for, any shares of its capital stock or any options, warrants, or other rights of
any kind to acquire any shares of its capital stock, except (A)&nbsp;pursuant to the settlement or exercise of Company Options, Company Restricted Stock Units, Company Deferred Stock Units or Company Performance Stock Units in accordance with their
terms, (B)&nbsp;pursuant to any purchases of shares of Company Common Stock pursuant to the Company ESPP in accordance with the terms of such plan and in accordance with <U>Section</U><U></U><U>&nbsp;3.3(f)</U>, (C)&nbsp;as required to comply with
any Company Benefit Plan or other written agreement as in effect on the date of this Agreement that has been made available to Acquiror or (D)&nbsp;as permitted by <U>Section</U><U></U><U>&nbsp;6.1(a)(x)</U> of the Company Disclosure Schedule,
(ii)&nbsp;enter into any agreement, understanding or arrangement with respect to the voting of shares of Company Common Stock, or (iii)&nbsp;adopt or implement a shareholder rights plan or similar arrangement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, recapitalization or
other reorganization of the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) (i)&nbsp;incur, assume, endorse, guarantee or
otherwise become liable for any Indebtedness for borrowed money or issue or sell any debt securities or calls, options, warrants or other rights to acquire any debt securities (directly, contingently or otherwise), except for
(A)&nbsp;(x)&nbsp;borrowings under the Company Credit Agreements or any credit facility (other than the issuance of letters of credit) of the Company or any of its Subsidiaries existing as of the date hereof (and to the extent such Company Credit
Agreements or credit facilities are replaced or refinanced, such replacement credit facility) in an amount, in the aggregate, not to exceed two hundred million dollars ($200,000,000), (y)&nbsp;the issuance of letters of credit under the Company
Credit Agreements or any credit facility of the Company or any of its Subsidiaries existing as of the date hereof (and to the extent such Company Credit Agreements or credit facilities are replaced or refinanced, such replacement credit facility) in
an aggregate face amount not to exceed one hundred million dollars ($100,000,000) or (z)&nbsp;borrowings under any commercial paper program of the Company or any of its Subsidiaries in an amount, in the aggregate, not to exceed six hundred million
dollars ($600,000,000) (the&nbsp;&#147;<U>Commercial Paper Cap</U>&#148;) at any time outstanding (<I>provided</I> that, to the extent the Company decides to replace or refinance any of the Company Notes as they mature with borrowings under the
Company or its Subsidiaries&#146; respective commercial paper programs, the Commercial Paper Cap shall be increased by the amount necessary to replace or refinance such Company Notes, as applicable), (B)&nbsp;any Indebtedness for borrowed money in
the ordinary course of business consistent with past practice (I)&nbsp;among the Company and its Subsidiaries or (II)&nbsp;among Subsidiaries of the Company or (C)&nbsp;guarantees by the Company of Indebtedness for borrowed money of Subsidiaries of
the Company or guarantees by Subsidiaries of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
Company of Indebtedness for borrowed money of the Company or any of its Subsidiaries, in each case (I)&nbsp;in the ordinary course of business consistent with past practice and (II)&nbsp;which
Indebtedness is incurred in accordance with this clause&nbsp;(v); (ii)&nbsp;incur or suffer to exist any Lien on any of its material property or assets (including, for the avoidance of doubt, material Company Intellectual Property), except for
Permitted Liens; (iii)&nbsp;redeem, repurchase, prepay, defease, cancel or otherwise acquire any Indebtedness for borrowed money, any debt securities or any calls, options, warrants or other rights with respect to any debt securities other than
(x)&nbsp;repayments and prepayments under the Company Credit Agreements or (y)&nbsp;in the ordinary course of business consistent with past practice with respect to working capital lines of credit; or (iv)&nbsp;assume, guarantee, endorse or
otherwise become liable or responsible (whether directly, contingently or otherwise) for the obligations of any other person for Indebtedness (other than the Company or any of its Subsidiaries in the ordinary course of business consistent with past
practice) for borrowed money; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) other than in the ordinary course of business consistent with past practice,
(i)&nbsp;sell, transfer, license, mortgage, encumber, abandon or otherwise dispose (collectively, &#147;<U>Dispositions</U>&#148;) of any of its material Intellectual Property rights, properties or assets, other than (x)&nbsp;sales of Inventory or
of obsolete equipment or licenses of Intellectual Property that do not constitute a Company Material Contract under <U>Section</U><U></U><U>&nbsp;4.19(a)(iii)</U>, (y) Dispositions of assets or properties (excluding material Intellectual Property
rights) in an amount not to exceed twenty-five million dollars ($25,000,000) individually or fifty million dollars ($50,000,000) in the aggregate, or (z)&nbsp;under Permitted Liens or (ii)&nbsp;cancel, release or assign any Indebtedness of any
person owed to it or any material claims (for the avoidance of doubt, this <U>Section</U><U></U><U>&nbsp;6.1(a)(vi)</U> shall not limit the ability of the Company or any of its Subsidiaries to compromise or settle any Legal Proceeding in accordance
with <U>Section</U><U></U><U>&nbsp;6.1(a)(xii)</U>) held by it against any person in excess of ten million dollars ($10,000,000) in the aggregate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) (A)&nbsp;acquire (whether by merger or consolidation, acquisition of stock or assets or by formation of a joint venture
or otherwise) any other person or business, excluding any acquisitions of supplies and Inventory in the ordinary course of business consistent with past practice, (B)&nbsp;make any material investment in any other person (other than a Subsidiary of
the Company in the ordinary course of business consistent with past practice), (C)&nbsp;make any loans or advances to any other person, except for (I)&nbsp;loans among the Company and any of its Subsidiaries or among the Company&#146;s Subsidiaries
and other Subsidiaries of the Company, (II)&nbsp;loans or cash advances to employees and (III)&nbsp;extensions of credit to clients, in the case of each of clauses&nbsp;(I), (II) and (III), in the ordinary course of business consistent with past
practice or (D)&nbsp;enter into any new material line of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) make any capital expenditures other
than&nbsp;capital expenditures not to exceed the aggregate amounts set forth in <U>Section</U><U></U><U>&nbsp;6.1(a)(viii)</U> of the Company Disclosure Schedule; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) (A) other than in the ordinary course of business consistent with past practice, (x)&nbsp;terminate, amend (other than by
renewing on terms not otherwise materially different), or waive, release or assign any right under, in a manner material and adverse to the Company and/or any of its Subsidiaries (as applicable), any Company Material Contract or any other Contract
with consideration paid to or payable by the Company or any of the Company&#146;s Subsidiaries of more than twenty-five million dollars ($25,000,000), in the fiscal year ended December&nbsp;30, 2023 or in any single fiscal year thereafter or
(y)&nbsp;enter into (1)&nbsp;any Contract that would constitute a Company Material Contract if it were in effect on the date of this Agreement (or amend any Contract such that it would constitute a Company Material Contract if such Contract were in
effect on the date of this Agreement) or (2)&nbsp;any other Contract with consideration paid to or payable by the Company or any of the Company&#146;s Subsidiaries of more than twenty-five million dollars ($25,000,000), in the fiscal year ending
December&nbsp;28, 2024 or in any single fiscal year thereafter (or amend any such Contract) or (B)&nbsp;enter into any Contract that contains, or amend any Contract such that it would contain, terms that purport to be binding on Acquiror and its
Affiliates (other than the Company and its Subsidiaries) after giving effect to the Merger and materially restrict the ability of Parent and its Affiliates (other than the Company and its Subsidiaries)&nbsp;to (x)&nbsp;compete in any business or
with any person or in any geographic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
area (including any <FONT STYLE="white-space:nowrap">non-compete</FONT> provisions) or (y)&nbsp;purchase or sell products or services from or to any person, which restrictions in each case would
be material and adverse to Parent and its Subsidiaries (<I>provided</I>, however, that the restriction set forth in this clause (B)&nbsp;shall only apply to the extent that the Company &#147;knows&#148; that any such Contract or amendment thereto
would reasonably be expected to result in such material restriction or effect on Parent and its Subsidiaries (where such &#147;knowledge&#148; would be based on the standard of what a reasonable person would know or would reasonably be expected to
know based on information that is publicly available about Parent and its Subsidiaries)); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) other than (i)&nbsp;as
required by applicable Law or (ii)&nbsp;pursuant to the requirements of any written Contract (including any Company Benefit Plan) in existence as of the date hereof, (A)&nbsp;increase the compensation or benefits (including equity and equity-based
awards) payable or that become payable to any current or former employee or other service provider of the Company and/or any of its Subsidiaries, (B)&nbsp;grant any increase in severance or termination pay to any current or former employee or other
service provider of the Company and/or any of its Subsidiaries or pay or award, or commit to pay or award, any bonuses or incentive compensation (including equity and equity-based awards) to any current or former employee or other service provider
of the Company and/or any of its Subsidiaries, (C)&nbsp;grant or award, or commit to grant or award, any equity or equity-based awards or incentives (including any Company Options, Company Restricted Stock Unit, Company Deferred Stock Unit or
Company Performance Stock Unit) to any current or former employee or other service provider of the Company and/or any of its Subsidiaries, (D)&nbsp;amend any existing written employment agreement or offer letter with any current or former employee
or other service provider of the Company and/or any of its Subsidiaries who is a party to a written employment agreement or offer letter as of the date hereof, (E)&nbsp;amend or enter into any employment agreement or offer letter,
(F)&nbsp;establish, adopt, enter into, amend, renew or terminate any Collective Bargaining Agreement or Company Benefit Plan (or any arrangement that would be a Company Benefit Plan if in effect on the date hereof), (G) take any action to accelerate
any payment or benefit, or the funding of any payment or benefit, payable or to become payable to any current or former employee or other service provider of the Company and/or any of its Subsidiaries, other than as expressly provided by this
Agreement, (H)&nbsp;amend the funding policy or contribution rate of any Company Benefit Plan or change any underlying actuarial assumptions used to calculate accrued benefit liabilities or benefits payable under any Company Benefit Plan, except as
may be required by GAAP or applicable Law, (I)&nbsp;waive or modify any Restrictive Covenant, (J)&nbsp;terminate the employment or service of any employee or other service provider of the Company and/or any of its Subsidiaries, other than for cause,
or (K)&nbsp;hire any person who would be an employee or other service provider of the Company and/or any of its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) implement or adopt any material change in its financial accounting principles, practices or methods, other than as may be
required by GAAP or applicable Law; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) settle or compromise any Legal Proceeding, except for settlements or compromises
(x)&nbsp;in the ordinary course consistent with past practice or (y)&nbsp;involving amounts to be paid by the Company (net of insurance proceeds and indemnity or similar payments) in settlement of ten million dollars ($10,000,000) or less, in each
case ((x) and (y)), that&nbsp;(i) do not impose any material restriction on its business or the business of its Subsidiaries or Affiliates, (ii)&nbsp;do not relate to any litigation by any of the Company&#146;s stockholders in connection with this
Agreement or the Merger and (iii)&nbsp;do not include an admission of liability or fault on the part of the Company or any of its Subsidiaries; <I>provided</I> that the foregoing shall not permit the Company or any of its Subsidiaries to settle or
compromise any Legal Proceeding that is not permitted pursuant to <U>Section</U><U></U><U>&nbsp;6.5</U> or <U>Section</U><U></U><U>&nbsp;6.15</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) (i)&nbsp;make, change or revoke any material Tax election, (ii)&nbsp;change any annual Tax accounting period or change
any method of Tax accounting, except as may be required by Law or GAAP, (iii)&nbsp;file any material amended Tax Return, (iv)&nbsp;enter into any material &#147;closing agreement&#148; within the meaning of Section&nbsp;7121 of the Code (or any
analogous or similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law), (v)&nbsp;request any Tax ruling from any Governmental Entity or submit any supplemental </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
requests relating to the IRS Ruling or any other ruling or determination from any Governmental Entity relating to the Separation Transactions, (vi)&nbsp;settle or compromise any material Tax
liability or any audit, examination or other proceeding relating to a material amount of Taxes or surrender any claim for a material refund of Taxes, (vii)&nbsp;file any material Tax Returns inconsistent with past practice, (viii)&nbsp;except in the
ordinary course of business consistent with past practice, agree to an extension or waiver of the statute of limitations with respect to a material amount of Taxes, (ix)&nbsp;change or amend the Tax Matters Agreement or (x)&nbsp;take any action, or
cause or otherwise permit any other person to take any action, outside the ordinary course of business which would reasonably be expected to (A)&nbsp;materially increase the Company&#146;s or any of its Affiliates&#146; (which following the Closing
shall include Acquiror and its Subsidiaries) liability for Taxes or (B)&nbsp;result in, or change the character of, any material amounts of income or gain (including any &#147;subpart&nbsp;F income&#148; as defined in Section&nbsp;952 of the Code or
&#147;global intangible <FONT STYLE="white-space:nowrap">low-taxed</FONT> income&#148; as defined in Section&nbsp;951A of the Code) that the Company or any of its Affiliates (which following the Closing shall include Acquiror and its Subsidiaries)
must report on any Tax Return; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiv) other than in the ordinary course of business consistent with past practice,
relinquish, abandon or permit to lapse, or fail to take any action necessary to maintain, any of its rights in any material Company Registrations; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xv) except in the ordinary course of business consistent with past practice, make or forgive any loans to any employees,
officers or directors of the Company or any of its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xvi) close any plant or facility; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xvii) take any action to cause any registration statement (other than a registration statement on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> that solely registers Company Common Stock) to be declared effective by the SEC or otherwise deemed to be effective (including by way of a Section&nbsp;10(a)(3) update), or to issue, sell, transfer or offer to
sell or transfer any securities pursuant to a registration statement other than pursuant to any registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> or pursuant to the Company Direct Stock Purchase and Dividend Reinvestment
Plan pursuant to the registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-277884);</FONT> or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xviii) authorize, offer to any third party, agree or commit (in writing or otherwise) to take any of the foregoing actions
prohibited by this <U>Section</U><U></U><U>&nbsp;6.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_48"></A>Section&nbsp;6.2 <U>Access; Integration
Planning</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall, and shall cause its Subsidiaries to, afford Acquiror and its employees, accountants,
consultants, internal and external legal counsel, financial advisors, tax advisors and other Representatives reasonable access during normal business hours, upon reasonable advance notice, throughout the period prior to the earlier of the valid
termination of this Agreement in accordance with <U>Article</U><U></U><U>&nbsp;VIII</U> and the Effective Time, to its and its Subsidiaries&#146; personnel, properties, Contracts, commitments, books and records (including Tax Returns) and, during
such period, the Company shall, and shall cause its Subsidiaries to, make available to Acquiror such other available information concerning its business, properties and personnel as Acquiror may reasonably request for the purpose of consummating the
Merger and the other transactions contemplated hereby, for reasonable integration planning purposes, or for purposes of filing any Tax Returns required to be filed in connection with or as a result of the Merger and the other transactions
contemplated hereby and shall instruct the Company&#146;s (and its Subsidiaries&#146;) independent accountants to provide access to their work papers and such other information (including Tax Returns and drafts of any U.S. federal income Tax Returns
or other material state or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> income Tax Returns) as Acquiror may reasonably request. The foregoing notwithstanding, the Company shall not be required to provide access to or make available to any person
any document or information if (i)&nbsp;doing so would, in the reasonable judgment of the Company and its outside counsel, violate any Law or the provisions of any Contract to which the Company or any of its Subsidiaries is a party, give rise to a
material risk of jeopardizing the attorney-client privilege of the Company or any of its Subsidiaries, or result in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
disclosure of any trade secrets of the Company or any of its Subsidiaries; <I>provided</I> that the Company will inform Acquiror of the general nature of the document or information being
withheld and reasonably cooperate with Acquiror to provide such document or information in a manner that would not result in violation of Law or Contract, the loss or waiver of such privilege or the disclosure of any trade secret, or (ii)&nbsp;such
documents or information are reasonably pertinent to any adverse Legal Proceeding between the Company and its Affiliates, on the one hand, and Parent and its Affiliates, on the other hand; <I>provided, further</I>, that any access or investigation
pursuant to this <U>Section</U><U></U><U>&nbsp;6.2(a)</U> shall be conducted in such a manner as not to interfere unreasonably with the business and operations of the Company or any of the Company&#146;s Subsidiaries and shall not extend to or
include any sampling or testing of environmental media. No investigation by Acquiror or its Representatives shall affect or be deemed to modify or waive the representations and warranties of the Company set forth in this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting <U>Section</U><U></U><U>&nbsp;6.2(a)</U>, prior to the Closing, and except as prohibited by Law, the
Company shall, and shall cause each Company Subsidiary and their respective Representatives to, use commercially reasonable efforts to (x)&nbsp;as promptly as reasonably practicable after the date hereof provide to Acquiror any Contract of the
Company and its Subsidiaries for the procurement of goods and services with consideration payable by the Company or any of the Company&#146;s Subsidiaries of more than twenty-five million dollars ($25,000,000) in the twelve months ended
August&nbsp;1, 2024 or in any single fiscal year thereafter as may be reasonably requested by Acquiror; (y)&nbsp;as promptly as reasonably practicable after the date hereof, provide to Acquiror a copy of the primary loan agreement, credit agreement,
note, debenture, bond or indenture, in each case, as in effect on the date of this Agreement, pursuant to which any Indebtedness for borrowed money of the Company or any of its Subsidiaries may be incurred or is outstanding with a principal amount
then-outstanding or commitments thereunder that is individually greater than one hundred million dollars ($100,000,000) as of the date of this Agreement, in each case, to the extent not previously provided to Acquiror prior to the date of this
Agreement; and (z)&nbsp;cooperate with any reasonable due diligence requests and process regarding such Contracts as reasonably requested by Acquiror as contemplated by <U>Section</U><U></U><U>&nbsp;6.2(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties agree to the covenants set forth on Section&nbsp;6.2(c) of the Company Disclosure Schedule with respect to
certain contracting policies of the Company and its Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties hereto hereby agree that all information
provided to them or their respective officers, directors, employees or Representatives in connection with this Agreement and the consummation of the Merger shall be governed in accordance with the confidentiality agreement, dated as of July&nbsp;4,
2024, between the Company and Parent (as may be amended or supplemented, the &#147;<U>Confidentiality Agreement</U>&#148;), and the clean room agreement, dated as of August&nbsp;3, 2024, between the Company and Parent (as may be amended or
supplemented, the &#147;<U>Clean Room Agreement</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) From and after the date hereof until the Effective Time,
the Company and Acquiror shall, and shall cause their Subsidiaries and Representatives to, use their commercially reasonable efforts, subject to applicable Law, to cooperate with the other Party in connection with planning the integration of the
business operations of the Surviving Corporation and Acquiror and their respective Subsidiaries following the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_49"></A>Section&nbsp;6.3 <U>No Solicitation by the Company</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as expressly permitted by this
<U>Section</U><U></U><U>&nbsp;6.3</U>, the Company shall, and shall cause each of its Subsidiaries, and shall use its reasonable best efforts to cause its and its Subsidiaries&#146; Representatives: (i)&nbsp;to immediately cease and cause to be
terminated any solicitation, encouragement, discussions or negotiations with any persons (other than Parent and its Subsidiaries (including Acquiror) and their respective Representatives) that may be ongoing with respect to a Company Takeover
Proposal and (ii)&nbsp;not to, directly or indirectly, (A)&nbsp;solicit, initiate, knowingly encourage or knowingly facilitate any inquiries regarding, or the making of any proposal or offer that constitutes, or would reasonably be expected to lead
to, a Company Takeover Proposal, (B)&nbsp;engage in, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any other person any <FONT STYLE="white-space:nowrap">non-public</FONT> information with the intent of
inducing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the making of, or knowingly encouraging or knowingly facilitating, a Company Takeover Proposal (other than (x)&nbsp;solely in response to an unsolicited inquiry, to refer the inquiring person to
the terms of this <U>Section</U><U></U><U>&nbsp;6.3</U> and to limit its communication exclusively to such referral or (y)&nbsp;upon receipt of a bona fide, unsolicited written Company Takeover Proposal from any person that did not result from a
material breach of this <U>Section</U><U></U><U>&nbsp;6.3</U>, solely to the extent necessary to ascertain facts or clarify terms with respect to a Company Takeover Proposal for the Company Board of Directors to be able to have sufficient
information to make the determination described in <U>Section</U><U></U><U>&nbsp;6.3(c)</U>), (C)&nbsp;approve, adopt, publicly recommend or enter into, or publicly propose to approve, adopt, recommend or enter into, any letter of intent or similar
document, agreement, commitment, or agreement in principle (whether written or oral, binding or nonbinding) with respect to a Company Takeover Proposal (other than an Acceptable Confidentiality Agreement entered into in accordance with
<U>Section</U><U></U><U>&nbsp;6.3(c)</U>), (D)&nbsp;take any action to make the provisions of any &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control share acquisition,&#148; &#147;business combination&#148; or other similar anti-takeover
statute or regulation (including any transaction under, or a third-party becoming an &#147;interested stockholder&#148; under, Section&nbsp;203 of the DGCL) inapplicable to any person (other than Acquiror and its Affiliates) or to any transactions
constituting or contemplated by a Company Takeover Proposal or (E)&nbsp;resolve or agree to do any of the foregoing. Notwithstanding anything to the contrary herein, prior to the time the Company Stockholder Approval is obtained, but not after, the
Company and its Subsidiaries shall be permitted to waive any rights under any &#147;standstill&#148; or similar covenants in confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements entered into in connection with or
applicable to a Company Takeover Proposal to which the Company or any of its Subsidiaries is a party to allow a person to make, or to amend, a Company Takeover Proposal or make any related communications; <I>provided</I>, that the Company may only
take such action if the Company Board of Directors determines in good faith (after consultation with its outside financial advisor and outside legal counsel) that the failure of the Company Board of Directors to take such action would reasonably be
expected to be inconsistent with its fiduciary duties under applicable Law. None of the Company or its Subsidiaries shall enter into any confidentiality agreement or other agreement subsequent to the date hereof which prohibits the Company or any of
its Subsidiaries from (x)&nbsp;providing to Acquiror or any of its Affiliates or Representatives the information required to be provided pursuant to this <U>Section</U><U></U><U>&nbsp;6.3</U> or (y)&nbsp;otherwise complying with this
<U>Section</U><U></U><U>&nbsp;6.3</U>. The Company and Acquiror hereby agree that all standstill or similar provisions in the Confidentiality Agreement shall, as of the date of this Agreement, terminate and be of no further force and effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall, and shall cause its Subsidiaries to, promptly after the date hereof, request any person that has
executed a currently <FONT STYLE="white-space:nowrap">in-effect</FONT> confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreement after January&nbsp;1, 2021, and in connection with any actual or potential Company Takeover
Proposal, to promptly after the date of such request return or destroy all confidential information in the possession of such person or its Representatives (other than from any person with which the Company has entered into an Acceptable
Confidentiality Agreement and, prior to the date of the earlier of (x)&nbsp;the receipt of the Company Stockholder Approval and (y)&nbsp;the return or destruction of such information, enters into negotiations or discussions regarding any Company
Takeover Proposal in accordance with this <U>Section</U><U></U><U>&nbsp;6.3</U> other than as a result of any material breach of this <U>Section</U><U></U><U>&nbsp;6.3</U> by the Company). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Anything to the contrary contained in <U>Section</U><U></U><U>&nbsp;6.3(a)</U> notwithstanding, if at any time after the
date of this Agreement and prior to the time that the Company Stockholder Approval is obtained, but not after, the Company or any of its Representatives receives a bona fide, unsolicited written Company Takeover Proposal from any person that did not
result from a material breach of this <U>Section</U><U></U><U>&nbsp;6.3</U> and if the Company Board of Directors determines, in good faith, after consultation with its outside financial advisor and outside legal counsel, that such Company Takeover
Proposal constitutes or could reasonably be expected to result in a Company Superior Proposal, then the Company and its Representatives may, prior to the time the Company Stockholder Approval is obtained, but not after, (i)&nbsp;furnish, pursuant to
an Acceptable Confidentiality Agreement, information with respect to the Company and its Subsidiaries to the person who has made such Company Takeover Proposal and its Representatives; <I>provided</I> that the Company, to the extent permitted under
applicable Law (including any applicable Antitrust Law), shall substantially concurrently with the delivery to such person provide to Acquiror any <FONT STYLE="white-space:nowrap">non-public</FONT> information concerning
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Company or any of its Subsidiaries that is provided or made available to such person or its Representatives unless such <FONT STYLE="white-space:nowrap">non-public</FONT> information has been
previously provided or made available to Acquiror (which <FONT STYLE="white-space:nowrap">non-public</FONT> information, for the avoidance of doubt, shall be subject to the Confidentiality Agreement and the Clean Room Agreement, and may, in order to
comply with applicable Law, be restricted to certain designated Representatives of Acquiror) and (ii)&nbsp;engage in or otherwise participate in discussions or negotiations with the person making such Company Takeover Proposal and its
Representatives regarding such Company Takeover Proposal. The Company shall as promptly as practicable (and in any event within twenty-four (24)&nbsp;hours) notify Acquiror if the Company Board of Directors makes a determination that a Company
Takeover Proposal constitutes or could reasonably be expected to result in a Company Superior Proposal or if the Company furnishes information or enters into discussions or negotiations as provided in this <U>Section</U><U></U><U>&nbsp;6.3(c)</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Without limiting the foregoing, the Company shall as promptly as practicable (and in any event within forty-eight
(48)&nbsp;hours after receipt) notify Acquiror in the event that the Company or any of its Representatives receives a Company Takeover Proposal or a request for information relating to the Company or its Subsidiaries that constitutes or contemplates
a Company Takeover Proposal, including the identity of the person making the Company Takeover Proposal and a description of the material terms and conditions thereof. The Company shall keep Acquiror reasonably informed, on a reasonably current
basis, as to the status of (including any developments, discussions or negotiations) such Company Takeover Proposal (including by as promptly as practicable (and in any event within forty-eight (48)&nbsp;hours after receipt) providing to Acquiror a
description of any changes to the material terms and conditions of such Company Takeover Proposal). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as
expressly permitted by <U>Section</U><U></U><U>&nbsp;6.3(f)</U> or <U>Section</U><U></U><U>&nbsp;6.3(g)</U>, the Company Board of Directors shall not (i) (A)&nbsp;fail to include the Company Recommendation in the Proxy Statement, (B)&nbsp;change,
qualify, withhold, withdraw or modify, or authorize or publicly propose to change, qualify, withhold, withdraw or modify, in a manner adverse to Acquiror, the Company Recommendation or (C)&nbsp;adopt, approve or recommend to stockholders of the
Company, or resolve to or publicly propose or announce its intention to adopt, approve or recommend to stockholders of the Company a Company Takeover Proposal (any action described in this clause&nbsp;(i) being referred to as an &#147;<U>Adverse
Recommendation Change</U>&#148;) or (ii)&nbsp;authorize, cause or permit the Company or any of its Subsidiaries to enter into any letter of intent, memorandum of understanding, agreement (including an acquisition agreement, merger agreement, joint
venture agreement or other agreement), commitment or agreement in principle with respect to any Company Takeover Proposal (other than an Acceptable Confidentiality Agreement entered into in accordance with <U>Section</U><U></U><U>&nbsp;6.3(c)</U>)
(a &#147;<U>Company Acquisition Agreement</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Anything to the contrary set forth in this Agreement
notwithstanding, prior to the time that the Company Stockholder Approval is obtained, but not after, the Company Board of Directors may, with respect to a bona fide, unsolicited Company Takeover Proposal that did not result from a material breach of
this <U>Section</U><U></U><U>&nbsp;6.3</U>, make an Adverse Recommendation Change or cause the Company to terminate this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;8.1(g)</U> in order to substantially concurrently with such
termination enter into a definitive agreement relating to such Company Takeover Proposal if and only if, prior to taking either such action, (i)&nbsp;the Company has complied, in all material respects, with its obligations under this
<U>Section</U><U></U><U>&nbsp;6.3</U>, (ii)&nbsp;the Company Board of Directors has determined, in good faith, after consultation with its outside financial advisor and outside legal counsel, that such Company Takeover Proposal constitutes a Company
Superior Proposal and (iii)&nbsp;the Company Board of Directors determines, in good faith, after consultation with its outside financial advisor and outside legal counsel, that the failure to do so would reasonably be expected to be inconsistent
with its fiduciary duties under applicable Law; <I>provided</I> that prior to making such Adverse Recommendation Change or effecting such termination (and prior to making the determination set forth in clause&nbsp;(iii)), (A)&nbsp;the Company has
given Acquiror at least five (5)&nbsp;Business Days&#146; prior notice of its intention to take such action, specifying the reasons therefor, including the terms and conditions of, and the identity of the person making, any such Company Takeover
Proposal and has contemporaneously provided to Acquiror a copy of the Company Takeover Proposal and a copy of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
proposed Company Acquisition Agreements and a copy of any financing commitments relating thereto (or, in each case, if not provided in writing to the Company, a written summary of the material
terms and conditions thereof), (B)&nbsp;the Company shall have negotiated, in good faith, with Acquiror and its Representatives during such notice period (if, and to the extent, Acquiror has indicated its desire to negotiate to the Company) to
enable Acquiror to propose revisions to the terms of this Agreement such that it would cause such Company Takeover Proposal to no longer constitute a Company Superior Proposal, (C)&nbsp;following the end of such notice period, the Company Board of
Directors shall have considered, in good faith, any revisions to the terms of this Agreement proposed in writing by Acquiror (and not revoked), and shall have determined, in good faith, after consultation with its outside financial advisor and
outside legal counsel, that the Company Takeover Proposal would nevertheless continue to constitute a Company Superior Proposal if the revisions proposed in writing by Acquiror (and not revoked) were to be given effect and (D)&nbsp;in the event of
any change to any of the financial terms (including the form, amount, mix and timing of payment of consideration) or any other material terms of such Company Takeover Proposal, the Company shall, in each case, have delivered to Acquiror an
additional notice consistent with that described in clause&nbsp;(A) above of this proviso and a new notice period under clause&nbsp;(A) of this proviso shall commence (except that the five (5)&nbsp;Business Day notice period referred to in
clause&nbsp;(A) above of this proviso shall instead be equal to the longer of (x)&nbsp;three (3)&nbsp;Business Days and (y)&nbsp;the period remaining under the notice period under clause&nbsp;(A) of this proviso immediately prior to the delivery of
such additional notice under this clause&nbsp;(D)) during which time the Company shall be required to comply with the requirements of this <U>Section</U><U></U><U>&nbsp;6.3(f)</U> anew with respect to such additional notice, including
clauses&nbsp;(A) through (D)&nbsp;above of this proviso; <I>provided, however</I>, that the Company shall not terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;6.3(f)</U> and <U>Section</U><U></U><U>&nbsp;8.1(g)</U> unless the
Company pays, or causes to be paid, to Acquiror the Termination Fee pursuant to <U>Section</U><U></U><U>&nbsp;8.3(c)</U> prior to or concurrently with such termination. Anything to the contrary contained herein notwithstanding, neither the Company
nor any of its Subsidiaries shall enter into any Company Acquisition Agreement unless this Agreement has been, or is substantially concurrently, terminated in accordance with its terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Other than in connection with a Company Takeover Proposal, the Company Board of Directors may, at any time after the date
of this Agreement and prior to the time the Company Stockholder Approval has been obtained, but not after, make an Adverse Recommendation Change in response to a Company Intervening Event (a &#147;<U>Company Intervening Event Recommendation
Change</U>&#148;) if (i)&nbsp;the Company has complied, in all material respects, with its obligations under this <U>Section</U><U></U><U>&nbsp;6.3</U> and (ii)&nbsp;prior to taking such action, the Company Board of Directors has determined, in good
faith, after consultation with its outside financial advisor and outside legal counsel, that the failure to take such action would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law; <I>provided</I> that prior
to making such Company Intervening Event Recommendation Change, (A)&nbsp;the Company has given Acquiror at least five (5)&nbsp;Business Days&#146; prior written notice of its intention to take such action, and specifying the reasons therefor,
including specifying in reasonable detail the facts and circumstances relating to such Company Intervening Event that render a Company Intervening Event Recommendation Change necessary, (B)&nbsp;the Company shall have negotiated, in good faith, with
Acquiror and its Representatives during such notice period to enable Acquiror to propose revisions to the terms of this Agreement (if, and to the extent, Acquiror has indicated its desire to negotiate to the Company) and (C)&nbsp;following the end
of such notice period, the Company Board of Directors shall have considered, in good faith, any revisions to the terms of this Agreement proposed in writing by Acquiror (and not revoked), and shall have determined, in good faith, after consultation
with its outside financial advisor and outside legal counsel, that the failure to make a Company Intervening Event Recommendation Change would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Nothing contained in this <U>Section</U><U></U><U>&nbsp;6.3</U> shall prohibit the Company or the Company Board of
Directors from&nbsp;complying with its disclosure obligations under United States federal or state Law with regard to a Company Takeover Proposal, including (i)&nbsp;taking and disclosing to the stockholders of the Company a position contemplated by
<FONT STYLE="white-space:nowrap">Rule&nbsp;14e-2(a)(2)-(3)</FONT> or <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9</FONT> promulgated under the Exchange </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Act (or any similar communication to stockholders in connection with the making or amendment of a tender offer or exchange offer), (ii)&nbsp;making any legally required (based upon the advice of
outside counsel) disclosure to stockholders with regard to the transactions contemplated by this Agreement or a Company Takeover Proposal, or (iii)&nbsp;making any &#147;stop, look and listen&#148; communication to the stockholders of the Company
pursuant to <FONT STYLE="white-space:nowrap">Rule&nbsp;14d-9(f)</FONT> under the Exchange Act pending disclosure of its position thereunder; <I>provided</I> that, in the case of <U>clauses</U><U></U><U>&nbsp;(</U><U>i</U><U>)</U>, <U>(ii)</U> and
<U>(iii)</U>&nbsp;of this <U>Section</U><U></U><U>&nbsp;6.3(h)</U>, no such action or disclosure that would amount to an Adverse Recommendation Change shall be permitted, made or taken other than in compliance with this
<U>Section</U><U></U><U>&nbsp;6.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_50"></A>Section&nbsp;6.4 <U>Employee Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For a period of at least twelve (12)&nbsp;months following the Effective Time (or, if earlier, the date of termination of
the applicable Continuing Employee), Acquiror shall, or shall cause the Surviving Corporation to, provide each employee of the Company or any of its Subsidiaries who continues as of the Effective Time to be employed by Acquiror, the Surviving
Corporation or any Affiliate of Acquiror (each, a &#147;<U>Continuing Employee</U>&#148;) with (i)&nbsp;at least the same level of base salary or hourly wage rate, as the case may be, and target annual short-term cash incentive opportunities at
rates that, in each case, were provided to such Continuing Employee immediately prior to the Effective Time, (ii)&nbsp;employee benefits (including employee car, transit and housing allowances provided in the ordinary course of business consistent
with past practice (collectively, the &#147;<U>Employee Allowances</U>&#148;), employee leave policies and arrangements, post-retirement medical benefits and 401(k) matching and contribution levels, but excluding all cash and equity incentive
compensation, Company ESPP, the Company&#146;s executive corporate aircraft policy, severance, defined benefit pension plans and change in control, retention or other similar <FONT STYLE="white-space:nowrap">non-reoccurring</FONT> compensation
arrangements) that are substantially comparable in the aggregate to those provided to such Continuing Employee by the Company and any of its Subsidiaries immediately prior to the Effective Time (subject to the foregoing exclusions), (iii) no less
favorable severance payments and benefits and garden leave and/or notice requirements (excluding any treatment in respect of equity awards granted after the Closing) to those that would have been provided to such Continuing Employee prior to the
Effective Time consistent with the terms of the applicable Company Benefit Plan (<I>provided</I> that the calculation of such severance benefits, including with respect to including Employee Allowances, is taken into account in a manner that is
consistent with past practice prior to the Closing) and (iv)&nbsp;no less favorable target long-term incentive opportunities to those provided to such Continuing Employee by the Company or any of its Subsidiaries immediately prior to the Effective
Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties (i)&nbsp;acknowledge that the transactions contemplated by this Agreement constitute a &#147;change
in control&#148; or &#147;change of control&#148; or such other similar term for purposes of all Company Benefit Plans that contain a definition of &#147;change in control&#148; or &#147;change of control&#148; or such other similar term, as
applicable, and (ii)&nbsp;agree to take all actions set forth on <U>Section</U><U></U><U>&nbsp;6.4(b)</U> of the Company Disclosure Schedule. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent unpaid as of the Closing Date, in respect of each Company Employee&#146;s annual bonus for the calendar year
prior to the calendar year to which the Closing Date occurs (the &#147;<U>Prior Year Annual Bonus</U>&#148;), Acquiror shall, or shall cause the Surviving Corporation to, pay to each Continuing Employee the Prior Year Annual Bonus in the ordinary
course consistent with the Company&#146;s past practice for paying Prior Year Annual Bonuses (including, for the avoidance of doubt, paying a Prior Year Annual Bonus to an employee who experiences an involuntary termination without &#147;cause&#148;
following the end of the calendar year in which the Prior Year Annual Bonus relates but prior to the applicable payment date). For the avoidance of doubt, nothing in this <U>Section</U><U></U><U>&nbsp;6.4(c)</U> will impact the Company&#146;s
ability to make determinations in respect of Prior Year Annual Bonuses in accordance with <U>Section</U><U></U><U>&nbsp;6.1(a)(x)</U> of the Company Disclosure Schedule. In respect of each Continuing Employee&#146;s annual bonus for the calendar
year in which the Closing Date occurs (the &#147;<U>Closing Year Annual Bonus</U>&#148;), Acquiror shall, or shall cause the Surviving Corporation to, pay to each Continuing Employee the Closing Year Annual Bonus in an amount no less than the
product obtained by multiplying (1)&nbsp;such Continuing Employee&#146;s full bonus entitlement under the applicable Company Benefit Plan, assuming the greater of (A)&nbsp;target performance for all company
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
performance goals, and (B)&nbsp;actual performance, extrapolated through the end of the applicable calendar year based on actual performance through the Closing Date, as determined in good faith
by the Compensation and Talent Management Committee of the Board of Directors of the Company prior to the Closing Date; <I>provided</I>, that, in each case, individual performance adjustments shall be determined in accordance with the terms set
forth in <U>Section</U><U></U><U>&nbsp;6.4(c)(</U><U>i</U><U>)</U> of the Company Disclosure Schedule, by (2)&nbsp;a fraction, the numerator of which equals the number of days that have elapsed from the first day of the calendar year in which the
Closing Date occurs through the Closing Date and the denominator of which equals the total number of calendar days in such calendar year (the &#147;<U>Closing Year Annual Bonus</U><U> Payment</U>&#148;); <I>provided</I>, that, notwithstanding the
terms of any applicable Company Benefit Plan, the Closing Year Annual Bonus Payment will be payable at the same time that annual bonuses would have been paid absent the Merger, subject to the Continuing Employee&#146;s continued employment with the
Company or its Affiliates though the applicable payment date, unless the Continuing Employee&#146;s employment is terminated due to an Early Good Leaver Termination (as defined below). If any Continuing Employee (x)&nbsp;experiences a termination of
employment by the Surviving Corporation without Cause, due to the Continuing Employee&#146;s death or disability, or, solely for Continuing Employees who are participants in the Company&#146;s Change in Control Severance Policy for Key Executives as
of the date of this Agreement, by the Continuing Employee for Good Reason (as each such term is defined in <U>Section</U><U></U><U>&nbsp;6.4(c)(ii)</U> of the Company Disclosure Schedule) prior to the payment of his or her Closing Year Annual Bonus
and (y)&nbsp;executes and does not revoke a customary general release of claims in favor of the Surviving Corporation and its Affiliates pursuant to a form with substantially similar terms as the Release (as defined in
<U>Section</U><U></U><U>&nbsp;6.4(c)(iii)</U> of the Company Disclosure Schedule) (each an &#147;<U>Early Good Leaver Termination</U>&#148;), such terminated Continuing Employee shall be entitled to receive (I)&nbsp;such Closing Year Annual Bonus,
payable at the same time that the annual bonus would have been paid absent the Early Good Leaver Termination or, (II)&nbsp;if greater, the payment that such Continuing Employee would otherwise be entitled in respect of the Closing Year Annual Bonus
under the severance benefits protections set forth in <U>Section</U><U></U><U>&nbsp;6.4(a)</U> above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At the Effective
Time, each Continuing Employee shall be given service credit for all purposes, including for eligibility to participate, benefit levels and eligibility for vesting under Acquiror employee benefit plans and arrangements (collectively, the
&#147;<U>Acquiror Benefit Plans</U>&#148;) with respect to his or her length of service with the Company (and its Subsidiaries and predecessors) prior to the Closing Date; <I>provided</I> that the foregoing shall not result in the duplication of
benefits; <I>provided, further</I>, that the foregoing shall not be recognized with respect to benefit accruals under any defined benefit pension plan or for any purpose under any post-employment health or welfare benefit plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In addition, and without limiting the generality of the foregoing, after the Effective Time, Acquiror shall use its
reasonable best efforts to (i)&nbsp;cause each Continuing Employee to be immediately eligible to participate, without any waiting time, in any and all Acquiror Benefit Plans to the extent coverage under such Acquiror Benefit Plan replaces coverage
under a comparable Company Benefit Plan in which such Continuing Employee participated immediately before the Effective Time; and (ii)&nbsp;for purposes of each Acquiror Benefit Plan providing medical, dental, pharmaceutical and/or vision benefits
to any Continuing Employee from and after the Effective Time, (A)&nbsp;cause all <FONT STYLE="white-space:nowrap">pre-existing</FONT> condition limitations, exclusions, waiting periods and actively at work requirements of such Acquiror Benefit Plan
to be waived for such Continuing Employee and his or her covered dependents to the extent such <FONT STYLE="white-space:nowrap">pre-existing</FONT> condition limitations, exclusions, waiting periods or actively at work requirements were waived or
satisfied under the comparable Company Benefit Plan and (B)&nbsp;recognize, or cause to be recognized, any eligible expenses incurred by such Continuing Employee and his or her covered dependents under a Company Benefit Plan during the portion of
the plan year prior to the date such Continuing Employee becomes eligible to participate in such Acquiror Benefit Plan to be taken into account under such Acquiror Benefit Plan for purposes of satisfying all deductible, <FONT
STYLE="white-space:nowrap">co-insurance,</FONT> <FONT STYLE="white-space:nowrap">co-payment</FONT> and maximum out of pocket requirements applicable to such Continuing Employee and his or her covered dependents for the applicable plan year as if
such amounts had been paid in accordance with such Acquiror Benefit Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Unless otherwise directed by Acquiror at least ten (10)&nbsp;Business
Days prior to the Closing Date,&nbsp;the Company&nbsp;shall take all actions necessary to terminate each of the Company&#146;s <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution 401(k) retirement plans that exclusively cover <FONT
STYLE="white-space:nowrap">non-union</FONT> employees (the &#147;<U>Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans</U>&#148;), or cause such plan to be terminated, effective as of no later than the day immediately preceding
the Closing Date, and contingent upon the occurrence of the Closing, and provide that participants in the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans shall become fully vested in any unvested portion of their Company <FONT
STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plan accounts as of the date such plan is terminated. If the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans are terminated, the Company shall provide Acquiror&nbsp;with
evidence that the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans have been terminated (effective no later than immediately prior to the Closing Date and contingent on the Closing) pursuant to resolutions of the Company, which
such resolutions shall be provided to Acquiror at least three (3)&nbsp;Business Days prior to the Closing Date and shall be subject to Acquiror&#146;s review and comment. If the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans
are terminated, Acquiror shall designate a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> defined contribution retirement plan with a cash or deferred arrangement that is sponsored by Acquiror or one of its Subsidiaries (the &#147;<U>Acquiror
401(k) Plan</U>&#148;) that will cover such eligible Continuing Employees who had participated in a Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plan effective as of the Closing Date, <I>provided</I> that the Company reasonably
cooperates in facilitating administrative payroll and recordkeeping matters. In connection with the termination of the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans, Acquiror shall cause the Acquiror 401(k) Plan to accept
from the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans the &#147;direct rollover&#148; of the account balance (including, subject to the next sentence, the <FONT STYLE="white-space:nowrap">in-kind</FONT> rollover of
promissory notes evidencing all outstanding loans) of each Continuing Employee who participated in a Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plan as of the date such plans are terminated and who elects such direct rollover
in accordance with the terms of the applicable Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plan and the Code. The Parties shall cooperate in good faith to work with the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT>
401(k) Plans and Acquiror 401(k) Plan recordkeepers to develop a process and procedure for effecting the <FONT STYLE="white-space:nowrap">in-kind</FONT> direct rollover of promissory notes evidencing participant loans from the Company <FONT
STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans to the Acquiror 401(k) Plan. In the event that a process and procedure acceptable to the Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plans and Acquiror 401(k) Plan
recordkeepers for effecting the <FONT STYLE="white-space:nowrap">in-kind</FONT> rollover of loan promissory notes is agreed upon, the Parties shall take any and all commercially reasonable actions needed to permit each Continuing Employee with an
outstanding loan balance under a Company <FONT STYLE="white-space:nowrap">Non-Union</FONT> 401(k) Plan as of the Closing Date to continue to make scheduled loan payments to the applicable Company <FONT STYLE="white-space:nowrap">Non-Union</FONT>
401(k) Plan after the Closing, pending the distribution and <FONT STYLE="white-space:nowrap">in-kind</FONT> rollover of such promissory notes evidencing such loans, so as to prevent, to the extent reasonably possible, a deemed distribution or loan
offset with respect to such outstanding loans. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything in this Agreement to the contrary, the terms
and conditions of employment for any Continuing Employees covered by a Collective Bargaining Agreement shall be governed by the applicable Collective Bargaining Agreement until the expiration, modification or termination of such Collective
Bargaining Agreement in accordance with its terms or applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Parties hereto acknowledge and agree that all
provisions contained in this <U>Section</U><U></U><U>&nbsp;6.4</U> are included for the sole benefit of the Parties hereto, and that nothing in this <U>Section</U><U></U><U>&nbsp;6.4</U>, whether express or implied, (i)&nbsp;shall create any
third-party beneficiary or other rights (A)&nbsp;in any other person, including any current or former employees or other service providers of the Company or any Affiliate of the Company, any Continuing Employee, or any dependent or beneficiary
thereof, or (B)&nbsp;to continued employment with Acquiror or any of its Affiliates (including, following the Effective Time, the Surviving Corporation), (ii)&nbsp;shall be treated as an amendment or other modification of any Company Benefit Plan or
Acquiror Benefit Plan, or (iii)&nbsp;shall limit the right of Acquiror or its Affiliates (including, following the Effective Time, the Surviving Corporation) to amend, terminate or otherwise modify any Company Benefit Plan or Acquiror Benefit Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_51"></A>Section&nbsp;6.5 <U>Regulatory Approvals; Efforts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the other terms of this Agreement, including <U>Section</U><U></U><U>&nbsp;6.5(b)</U> and
<U>Section</U><U></U><U>&nbsp;6.5(d)</U>, Parent, Acquiror, Merger Sub and the Company shall (and shall cause their respective Affiliates to, if </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
applicable) use their respective reasonable best efforts to (i)&nbsp;promptly take, or cause to be taken, all action and to do, or cause to be done, all things necessary, proper or advisable
under this Agreement and applicable Laws to submit all notifications to and obtain all clearances, authorizations, consents, Orders and approvals of all Governmental Entities that may be or become necessary for its execution and delivery of, and the
performance of its obligations pursuant to, this Agreement, (ii)&nbsp;cooperate fully in promptly submitting all notifications and seeking to obtain all such clearances, authorizations, consents, Orders and approvals, and (iii)&nbsp;provide such
other information to any Governmental Entity as such Governmental Entity may reasonably request in connection herewith including responding to any Request for Additional Information or Documentary Material under the Antitrust Laws as promptly as
reasonably practicable. Each Party agrees to (i)&nbsp;make promptly its respective filings, if necessary, pursuant to the HSR Act with respect to the transactions contemplated by this Agreement no later than the date which is ten (10)&nbsp;Business
Days after the execution of this Agreement, or such other later date determined by Acquiror reasonably and in good faith (consistent with its obligations in this <U>Section</U><U></U><U>&nbsp;6.5</U> to use reasonable best efforts to promptly obtain
the required approvals of Governmental Entities) and (ii)&nbsp;supply as promptly as practicable to the appropriate Governmental Entities any additional information and documentary material that may be requested pursuant to the HSR Act. Each Party
agrees to make as promptly as practicable its respective filings and notifications (initially in draft form where customary), if any, under any other applicable Antitrust Law and to supply as promptly as practicable to the appropriate Governmental
Entities any additional information and documentary material that may be requested pursuant to such applicable Antitrust Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the generality of Parent, Acquiror, Merger Sub and the Company&#146;s undertakings pursuant to
<U>Section</U><U></U><U>&nbsp;6.5(a)</U> but subject to <U>Section</U><U></U><U>&nbsp;6.5(c)</U>, <U>Section</U><U></U><U>&nbsp;6.5(d)</U> and the proviso below, Parent, Acquiror and the Company (if requested by Acquiror or Parent) shall use their
respective reasonable best efforts to avoid or eliminate each and every impediment under any Antitrust Law or trade regulation Law that may be asserted by any Governmental Entity so as to enable the Parties hereto to close the Merger as promptly as
practicable including proposing, negotiating, committing to and effecting, by consent decree, hold separate orders, or otherwise, the sale, divestiture or disposition of such of its assets, properties or businesses or of the assets, properties or
businesses to be acquired by it pursuant hereto, and the entrance into such other arrangements, as are necessary or advisable in order to avoid the entry of, or to have vacated, lifted, reversed or overturned any decree, judgment, injunction or
other Order, whether temporary, preliminary or permanent, that would prevent the consummation of the transactions contemplated hereby as soon as practicable; <I>provided</I> that, notwithstanding anything in this Agreement to the contrary, none of
Parent, Acquiror, Merger Sub or any other Subsidiary of Parent shall be required to, and the Company and its Subsidiaries shall not without the prior written consent of Parent, take any action, or commit to take any action, or agree to any condition
or limitation contemplated in <U>Section</U><U></U><U>&nbsp;6.5(a)</U> (to the extent relating to the obligations in this <U>Section</U><U></U><U>&nbsp;6.5(b)</U>) or this <U>Section</U><U></U><U>&nbsp;6.5(b)</U> (A)&nbsp;that is not conditioned
upon the consummation of the Merger, (B)&nbsp;with respect to any of Parent&#146;s, Acquiror&#146;s or their respective Subsidiaries operations, divisions, businesses, product lines, contracts, licenses, relationships, contractual rights or
obligations, customers or assets or (C)&nbsp;that would result in, or would be reasonably likely to result in, the sale, divestiture or disposition of assets, properties or businesses of the Company or any of its Subsidiaries and/or the termination
of any business (in any jurisdictions(s)) of the Company or any of its Subsidiaries that generated more than seven hundred fifty million dollars ($750,000,000) of annual consolidated revenues of the Company and its Subsidiaries during the twelve
(12)-month period ending as of December&nbsp;31, 2023 (each of clause&nbsp;(A), (B) or (C), a &#147;<U>Burdensome Condition</U>&#148;). In addition, in the event that any administrative or judicial action or proceeding is instituted (or threatened
to be instituted) by any Governmental Entity challenging the transactions contemplated by this Agreement, each of the Parties shall, and shall cause its respective Affiliates to, in each case in accordance with and subject to
<U>Section</U><U></U><U>&nbsp;6.5(c)</U> and <U>Section</U><U></U><U>&nbsp;6.5(d)</U>, cooperate with each other in all respects and to use their respective reasonable best efforts to contest and defend on the merits any claim asserted in court by
any Governmental Entity in order to avoid entry of, or to have vacated or terminated, any decree, Order or judgment (whether temporary, preliminary or permanent) that would prevent the Closing. Acquiror shall be responsible for all filing fees and
other similar fees required to be paid in connection with obtaining any consent, approval, order or authorization of, or making </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
any declaration or filing with, any Governmental Entity in connection with the discharge of the Parties&#146; obligations under this <U>Section</U><U></U><U>&nbsp;6.5</U>; <I>provided</I> that
none of Parent, Acquiror, Merger Sub or any other Subsidiary of Parent shall be required to, and the Company and its Subsidiaries shall not, without the prior written consent of Acquiror, take any action under this
<U>Section</U><U></U><U>&nbsp;6.5</U> that would result in, or would be reasonably likely to result in, individually or in the aggregate, a Burdensome Condition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Party shall promptly notify the other Party of any substantive communication received from, or given by such Party or
any of its Affiliates to, any Governmental Entity or person relating to the matters that are the subject of this <U>Section</U><U></U><U>&nbsp;6.5</U> and shall permit the other Party (and its advisors) to review in advance any proposed substantive
communication by such Party (and its advisors or Affiliates) to any Governmental Entity and shall consider in good faith the views of the other Party in connection with any such proposed communication. None of the Parties shall, and each Party shall
cause its Affiliates not to, participate in any substantive meeting or conference, whether in person or by telephone, with any Governmental Entity in respect of any filings, investigation (including any settlement of the investigation), litigation
or other inquiry unless it consults with the other Party in advance and, to the extent permitted by such Governmental Entity, gives the other Party the opportunity to attend and participate at such meeting. The Parties shall, and shall cause their
Affiliates to, coordinate and cooperate fully with each other in exchanging such information and providing such assistance as the other Party may reasonably request in connection with the foregoing. The Parties shall provide each other with copies
of all substantive correspondence, filings or communications between them or any of their Representatives or Affiliates, on the one hand, and any Governmental Entity or members of its staff, on the other hand, with respect to this Agreement and the
transactions contemplated by this Agreement. Acquiror and the Company may, as each deems advisable and necessary, (i)&nbsp;redact or remove references concerning the valuation of the businesses of the Company and its Subsidiaries and
(ii)&nbsp;reasonably designate any competitively sensitive or any confidential business material provided to the other under this <U>Section</U><U></U><U>&nbsp;6.5(c)</U> as &#147;counsel only&#148; or, as appropriate, as &#147;outside counsel
only.&#148; This <U>Section</U><U></U><U>&nbsp;6.5(c)</U> shall not apply with regard to Tax matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties
acknowledge and agree that Acquiror shall control and direct, and the Company will cooperate reasonably, subject to applicable Law, with such direction and control, all strategy and decisions with respect to obtaining all Regulatory Approvals,
including all filings (including where to file and the timing of such filings) and any withdrawals and/or refiling thereof, strategies, processes, negotiation of settlements (if any), and related proceedings contemplated by this
<U>Section</U><U></U><U>&nbsp;6.5</U>, including for the avoidance of doubt the marketing or sale of any part of the Company&#146;s, the Acquiror&#146;s or any of their respective Affiliates&#146; businesses or assets; <I>provided</I> that Acquiror
shall consult with and consider in good faith the views of the Company regarding the form and content of any such filings, withdrawals, refilings, strategies, processes, negotiations and related proceedings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Prior to the Closing, none of Parent, Acquiror, the Company or any of their respective Subsidiaries shall acquire, or agree
to acquire, any businesses, assets or securities of a third party if such acquisition would, or would reasonably be expected to, prevent or materially delay satisfaction of the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1(b)</U> or
<U>Section</U><U></U><U>&nbsp;7.1(c)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Prior to the Effective Time, the Company shall, and shall cause its
Subsidiaries to, reasonably cooperate with Acquiror and use reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under applicable Laws and
rules and policies of NYSE to cause the delisting of the Company Shares, the 1.250% Senior Notes due 2025, the 0.500% Senior Notes due 2029 and the 3.750% Senior Notes due 2034 from NYSE by the Surviving Corporation as promptly as practicable after
the Effective Time and the deregistration of the Company Shares and the Company Notes under the Exchange Act as promptly as practicable after such delisting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_52"></A>Section&nbsp;6.6 <U>Preparation of the Proxy Statement; Company Special Meeting</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As promptly as reasonably practicable following the date of this Agreement, the Company shall prepare and file with the SEC
the Proxy Statement in preliminary form (and shall use its reasonable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
best efforts to do so within thirty (30)&nbsp;days of the date of this Agreement). Acquiror shall cooperate with the Company in the preparation of the Proxy Statement and furnish all information
concerning Parent, Acquiror and Merger Sub that is required in connection with the preparation of the Proxy Statement. The Company will respond as promptly as practicable to any comments from the SEC or the staff of the SEC. No filing of, or
amendment or supplement to, the Proxy Statement, will be made by the Company without providing Acquiror and its counsel a reasonable opportunity to review and comment thereon, and the Company shall reasonably consider all such comments in good
faith. The Company shall notify Acquiror as promptly as practicable of the receipt of any comments (whether written or oral) from the SEC or the staff of the SEC and of any request by the SEC or the staff of the SEC for amendments or supplements to
the Proxy Statement or for additional information and shall supply Acquiror with copies of all correspondence between the Company and any of its Representatives, on the one hand, and the SEC or the staff of the SEC, on the other hand, with respect
to the Proxy Statement or the transactions contemplated by this Agreement. If, at any time prior to the Company Special Meeting (or any adjournment or postponement thereof), any information relating to Acquiror or the Company, or any of their
respective Affiliates, officers or directors, is discovered by Acquiror or the Company that should be set forth in an amendment or supplement to the Proxy Statement, so that the Proxy Statement would not include a misstatement of a material fact or
omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Party that discovers such information shall promptly notify the other Parties hereto and an
appropriate amendment or supplement describing such information shall be promptly filed by the Company with the SEC and, to the extent required by applicable Law, disseminated to the stockholders of the Company. The Company will cause the Proxy
Statement to be mailed to the Company&#146;s stockholders as promptly as reasonably practicable after the resolution of any comments of the SEC or the staff of the SEC with respect to the preliminary Proxy Statement (or confirmation of no comments
to, or further review of, the preliminary Proxy Statement by the SEC or the staff of the SEC) (such date, the &#147;<U>Clearance Date</U>&#148;) (and in any event no later than five (5)&nbsp;Business Days following the Clearance Date). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to <U>Section</U><U></U><U>&nbsp;6.3(f)</U>, the Company shall take all action necessary in accordance with
applicable Laws and the Company Organizational Documents to set a record date for, duly give notice of, convene and hold a meeting of its stockholders for the purpose of obtaining the Company Stockholder Approval (the &#147;<U>Company Special
Meeting</U>&#148;) as promptly as practicable following the Clearance Date. The Company shall, subject to <U>Section</U><U></U><U>&nbsp;6.6(c)</U>, convene the Company Special Meeting on or around the twentieth (20th) Business Day following the
commencement of the mailing of the Proxy Statement to its stockholders. Except as expressly permitted by <U>Section</U><U></U><U>&nbsp;6.3</U>, the Company Board of Directors (or any committee thereof) shall not make any Adverse Recommendation
Change and, unless the Company shall have made an Adverse Recommendation Change if, and to the extent, permitted by this Agreement, shall include the Company Recommendation in the Proxy Statement and shall solicit, and use its reasonable best
efforts to obtain, the Company Stockholder Approval at the Company Special Meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall cooperate with
and keep Acquiror informed on a reasonably current basis regarding its solicitation efforts and voting results following the dissemination of the Proxy Statement to its stockholders. The Company may adjourn or postpone the Company Special Meeting
only (i)&nbsp;if, as of the time which the Company Special Meeting is originally scheduled (as set forth in the Proxy Statement), there are insufficient shares of Company Common Stock represented (either in person or by proxy) to constitute a quorum
necessary to conduct the business of the Company Special Meeting or to the extent that at such time the Company has not received proxies sufficient to allow receipt of the Company Stockholder Approval, (ii)&nbsp;to allow time for the filing and
dissemination of any supplemental or amended disclosure document that the Company Board of Directors has determined, in good faith, after consultation with the Company&#146;s outside legal counsel, is necessary or required to be filed and
disseminated under applicable Law, the Company Certificate or the Company Bylaws or (iii)&nbsp;with the prior written consent of Acquiror; <I>provided, however</I>, that any such adjournment or postponement shall be for not more than the amount of
time that, in the reasonable judgment of the Company (after consultation with its outside legal counsel and after reasonably consulting with Acquiror and its outside legal counsel), is necessary to comply with applicable Law or the Company
Certificate or the Company Bylaws, and, in any event, without the prior written </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
consent of Acquiror (which shall not be unreasonably withheld, conditioned or delayed), shall not be to a date that is later than fifteen (15)&nbsp;Business Days after the date for which the
Company Special Meeting was originally scheduled. Any additional postponements or adjournments shall be by mutual agreement of Acquiror and the Company. In no event will the record date of the Company Special Meeting be changed without
Acquiror&#146;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed), unless required by applicable Law. The Company shall, at the reasonable request of Acquiror, postpone or adjourn the Company Special Meeting if
there are not sufficient affirmative votes in person or by proxy at such meeting to adopt this Agreement to allow reasonable time for the solicitation of proxies for the purposes of obtaining the Company Stockholder Approval. During any such period
of adjournment or postponement, the Company and Acquiror shall each continue to comply with their respective obligations under <U>Section</U><U></U><U>&nbsp;6.3</U> and this <U>Section</U><U></U><U>&nbsp;6.6</U>. Without the prior written consent of
Acquiror, the adoption of this Agreement shall be the only matter (other than matters of procedure and matters required by applicable Law to be voted on by the Company&#146;s stockholders in connection with the adoption of this Agreement) that the
Company shall propose to be acted on by the stockholders of the Company at the Company Special Meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company
shall cooperate with and keep Acquiror informed on a reasonably current basis regarding its solicitation efforts and voting results following dissemination of the definitive Proxy Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_53"></A>Section&nbsp;6.7 <U>Takeover Statutes</U>. The Company shall not take any action that would cause the Merger to be
subject to requirements imposed by any takeover statute. If any &#147;moratorium,&#148; &#147;control share acquisition,&#148; &#147;fair price,&#148; &#147;supermajority,&#148; &#147;affiliate transactions&#148; or &#147;business combination
statute or regulation&#148; or other similar state anti-takeover Laws and regulations may become, or may purport to be, applicable to the Merger, the Company shall grant such approvals and take such actions as are reasonably necessary so that the
transactions contemplated by this Agreement may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise act to eliminate or minimize the effects of such statute or regulation on the transactions
contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_54"></A>Section&nbsp;6.8 <U>Public Announcements</U>. The initial press release with
respect to the execution of this Agreement shall be a joint press release to be reasonably agreed upon by Acquiror and the Company. The Parties shall consult with one another prior to issuing, and provide each other with the opportunity to review
and comment upon, any public announcement, statement or other disclosure with respect to this Agreement or the Merger and Acquiror and the Company shall not, and shall cause their respective Affiliates not to, issue any such public announcement,
statement or disclosure prior to such consultation, except as may be required by Law, by the rules and regulations of NYSE or in connection with a Company Superior Proposal or Company Takeover Proposal or Adverse Recommendation Change or any action
taken pursuant thereto. Anything in this Agreement to the contrary notwithstanding, (w)&nbsp;each of the Company and Acquiror may make any public statements in response to questions by the press, analysts, investors or analyst or investor calls, so
long as such statements are not inconsistent with previous statements made jointly by the Company and Acquiror (or made by one Party after having consulted with the other Party), (x)&nbsp;no public announcement or statement or other disclosure shall
be made in connection with a Company Superior Proposal, a Company Takeover Proposal or an Adverse Recommendation Change or any action taken pursuant thereto unless it is made in compliance with <U>Section</U><U></U><U>&nbsp;6.3</U>, (y) the Company
may make any communication to employees of the Company and its Subsidiaries, so long as such statements are not inconsistent with previous statements made jointly by the Company and Acquiror and (z)&nbsp;this <U>Section</U><U></U><U>&nbsp;6.8</U>
shall not apply to any disclosure of information concerning this Agreement in connection with any dispute between the Parties regarding this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_55"></A>Section&nbsp;6.9 <U>Indemnification and Insurance</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All rights to indemnification and exculpation from Liabilities for acts or omissions occurring at or prior to the Effective
Time, and any rights to advancement of expenses, existing as of the date hereof in favor of any person who is or prior to the Effective Time becomes, or has been at any time prior to the date of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
this Agreement, a director or officer of the Company or any of the Company&#146;s Subsidiaries or any of their respective predecessors (in each case, when acting in such capacity) (collectively,
the &#147;<U>Company Indemnified Parties</U>&#148;) as provided in the Company Organizational Documents (or Company Subsidiary Organizational Documents) in effect as of the date hereof or any indemnification agreements in existence as of the date
hereof (and provided to Acquiror as of the date hereof), shall survive the Merger and continue in full force and effect in accordance with their terms, and the Company Organizational Documents and the Company Subsidiary Organizational Documents
shall not be amended, repealed or otherwise modified for a period of six (6)&nbsp;years from and after the Effective Time in any manner that would adversely affect the rights thereunder with respect to acts or omissions occurring at or prior to the
Effective Time of such Company Indemnified Parties except to the extent required by applicable Law. From and after the Effective Time, Acquiror shall cause the Surviving Corporation and its Subsidiaries to comply with and honor the foregoing
obligations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For a period of six (6)&nbsp;years from and after the Effective Time, the Surviving Corporation shall,
and Acquiror shall cause the Surviving Corporation to, indemnify and hold harmless each Company Indemnified Party against any costs or expenses (including reasonable and reasonably documented attorneys&#146; fees), judgments, fines, losses, damages
or Liabilities incurred in connection with any threatened or actual claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of the fact that such person is or was a director or officer
of the Company, any of the Company&#146;s Subsidiaries or any of their respective predecessors or, while serving as a director or officer, and pertaining to matters existing or occurring or actions or omissions taken at or prior to the Effective
Time, including with respect to this Agreement and the Merger, in each case, to the fullest extent permitted by the Company Organizational Documents (or Company Subsidiary Organizational Documents) in effect as of the date hereof, and the Surviving
Corporation shall, and Acquiror shall cause the Surviving Corporation to, also advance reasonable and reasonably documented expenses to the Company Indemnified Parties as incurred to the fullest extent permitted by the Company Organizational
Documents (or Company Subsidiary Organizational Documents, as applicable) in effect as of the date hereof; <I>provided</I> that the Company Indemnified Party to whom expenses are advanced provides an undertaking to repay such advances if it is
ultimately determined by a final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> judicial determination that such Company Indemnified Party is not entitled to indemnification under this <U>Section</U><U></U><U>&nbsp;6.9</U> or otherwise.
The Surviving Corporation shall not, and Acquiror shall cause the Surviving Corporation not to, without the prior written consent of the applicable Company Indemnified Party (which shall not be unreasonably withheld, conditioned or delayed), settle,
compromise or consent to the entry of any judgment in any threatened or actual claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, for which such Company Indemnified Party would reasonably be
expected to be entitled to and sought indemnification hereunder, unless such settlement, compromise or consent (i)&nbsp;does not require such Company Indemnified Party to perform any covenant or refrain from engaging in any activity and
(ii)&nbsp;does not include any statement as to, or an admission of, fault, violation, culpability, malfeasance or nonfeasance by, or on behalf of, such Company Indemnified Party. The Surviving Corporation shall provide the applicable Company
Indemnified Party with the opportunity to reasonably participate in (but not control) the defense of any matter for which such Company Indemnified Party would reasonably be expected to be entitled to and sought indemnification hereunder.
Acquiror&#146;s and the Surviving Corporation&#146;s obligations under this <U>Section</U><U></U><U>&nbsp;6.9(b)</U> shall continue in full force and effect for the period beginning upon the Effective Time and ending six (6)&nbsp;years from the
Effective Time; <I>provided</I> that all rights to indemnification in respect of any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, asserted or made within such period shall continue until
the final disposition of such claim, action, suit, proceeding or investigation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Prior to the Effective Time, at the
Company&#146;s option, the Company shall, or, if the Company does not, Acquiror shall, cause the Surviving Corporation as of the Effective Time to, obtain and fully pay the premium for the <FONT STYLE="white-space:nowrap">non-cancelable</FONT>
extension of the Company&#146;s existing directors&#146; and officers&#146; insurance policies and the Company&#146;s existing fiduciary liability insurance policies (collectively, the &#147;<U>D&amp;O Insurance</U>&#148;), with respect to acts or
omissions occurring at or prior to the Effective Time and for a claims reporting or discovery period of at least six (6)&nbsp;years from and after the Effective Time; <I>provided</I>, <I>however</I>,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
that the Company (or the Surviving Corporation, as applicable) shall not pay an amount for the D&amp;O Insurance in excess of three hundred percent (300%) of the aggregate annual premium
currently paid by the Company for such insurance for the policy period that includes the date of this Agreement. If the D&amp;O Insurance has been obtained by either the Company or the Surviving Corporation prior to or as of the Effective Time,
Acquiror shall cause the D&amp;O Insurance to be maintained in full force and effect, for its full term, and cause all obligations thereunder to be honored by the Surviving Corporation. If the Company or the Surviving Corporation for any reason
fails to obtain the D&amp;O Insurance as of the Effective Time, (i)&nbsp;the Surviving Corporation shall continue to maintain in effect, for a period of at least six (6)&nbsp;years from and after the Effective Time, the directors&#146; and
officers&#146; insurance and fiduciary liability insurance of the Company in place as of the date of this Agreement with the Company&#146;s current insurance carrier(s) or with an insurance carrier(s) with the same or better credit rating as the
Company&#146;s current insurance carrier(s) with respect to such insurance and with terms, conditions, retentions and limits of liability that are no less favorable than the coverage provided under the Company&#146;s existing such insurance as of
the date of this Agreement, or (ii)&nbsp;Acquiror will provide, or cause the Surviving Corporation to provide, for a period of not less than six (6)&nbsp;years after the Effective Time, the Company Indemnified Parties who are insured under the
Company&#146;s directors&#146; and officers&#146; insurance and fiduciary liability insurance with comparable such insurance that provides coverage for acts, omissions or events occurring at or prior to the Effective Time (including in connection
with the approval of this Agreement and the consummation of the Merger) from an insurance carrier(s) with the same or better credit rating as the Company&#146;s current insurance carrier(s) for such insurance, that is no less favorable than the
existing insurance of the Company as of the date of this Agreement or, if substantially equivalent insurance coverage is unavailable, the best available coverage; <I>provided</I>, <I>however</I>, that Acquiror and the Surviving Corporation shall not
be required to pay an aggregate annual premium for such insurance in excess of three hundred percent (300%) of the aggregate annual premium currently paid by the Company for such insurance for the policy period that includes the date of this
Agreement; <I>provided</I>, <I>further</I>, that if the aggregate annual premium of such insurance coverage exceeds such amount, Acquiror or the Surviving Corporation shall be obligated to obtain insurance with the greatest coverage available, with
respect to matters occurring at or prior to the Effective Time (including in connection with the approval of this Agreement and the consummation of the Merger), for a cost not exceeding such amount. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The provisions of this <U>Section</U><U></U><U>&nbsp;6.9</U> are (i)&nbsp;intended to be for the benefit of, and shall be
enforceable by, each of the Company Indemnified Parties, his or her heirs and his or her representatives and (ii)&nbsp;in addition to, and not in substitution for, any other rights to indemnification or contribution that any such individual may have
under the Company Organizational Documents (or Company Subsidiary Organizational Documents), by Contract or otherwise. Notwithstanding anything in this Agreement to the contrary, following the Effective Time, no Party shall amend, or seek to amend,
this <U>Section</U><U></U><U>&nbsp;6.9</U> (except to the extent such amendment permits the Company to provide broader indemnification rights on a retroactive basis to the Company Indemnified Parties). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In the event that the Surviving Corporation or Acquiror or any of their respective successors or assigns
(i)&nbsp;consolidates with or merges into any other person and shall not be the continuing or surviving person of such consolidation or merger or (ii)&nbsp;transfers or conveys all or substantially all of its properties and assets to any person,
then, and in each such case, Acquiror and/or the Surviving Corporation, as applicable, shall cause proper provision to be made so that the successors and assigns or transferees of the Surviving Corporation or Acquiror, as the case may be, expressly
assume or succeed to their respective obligations set forth in this <U>Section</U><U></U><U>&nbsp;6.9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_56"></A>Section&nbsp;6.10 <U>Control of Operations</U>. Without in any way limiting any Party&#146;s rights or obligations
under this Agreement, the Parties understand and agree that (a)&nbsp;nothing contained in this Agreement shall give Acquiror or the Company, directly or indirectly, the right to control or direct the other Party&#146;s operations prior to the
Effective Time and (b)&nbsp;prior to the Effective Time, each of the Company and Acquiror shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its respective operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_57"></A>Section&nbsp;6.11 <U>Section</U><U></U><U>&nbsp;16 Matters</U>.
Prior to the Effective Time, the Company shall take all such steps as may be required to cause any dispositions of Company Common Stock (including derivative securities with respect to Company Common Stock) resulting from the Merger by each
individual who is subject to the reporting requirements of Section&nbsp;16(a) of the Exchange Act with respect to the Company (including each director and officer of the Company) to be exempt under
<FONT STYLE="white-space:nowrap">Rule&nbsp;16b-3</FONT> promulgated under the Exchange Act, to the extent permitted by applicable Law. The Company shall provide Acquiror with a reasonable opportunity to review any resolutions or other documents in
respect of the actions described in this <U>Section</U><U></U><U>&nbsp;6.11</U> and will implement any reasonable comments that are timely provided by Acquiror in respect thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_58"></A>Section&nbsp;6.12 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Company and Acquiror shall use its reasonable best efforts to obtain the Closing Tax Opinion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Immediately prior to the Closing, the Company shall execute and deliver the Company Closing Tax Opinion Representation
Letter to Acquiror Tax Counsel. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Immediately prior to the Closing, Acquiror shall execute and deliver the Acquiror
Closing Tax Opinion Representation Letter to Acquiror Tax Counsel and, to the extent reasonably requested by the Company, Kirkland&nbsp;&amp; Ellis LLP in connection with any other Tax opinion received by the Company with respect to the matters
addressed in the Signing Tax Opinion and Closing Tax Opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company shall make the Section&nbsp;336(e) Election
prior to the due date (including extensions) for filing such election and provide Acquiror with a copy of such timely filed Section&nbsp;336(e) Election; <I>provided, however</I>, that if the Company determines prior to filing such election that it
is not beneficial to do so, the Company shall consult with Acquiror as to whether or not such election should be filed and making any determinations with respect thereto under the Tax Matters Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company shall keep Acquiror reasonably apprised regarding any significant developments, discussions or communications
(whether written or otherwise), to the extent practical, in advance of such developments, discussions or communications related to the Separation Transactions, in connection with or as part of, any Tax compliance program, audit, examination or other
proceeding that could be expected to relate to a substantial amount of Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_59"></A>Section&nbsp;6.13 <U>Financing
Cooperation</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall use its reasonable best efforts, and shall cause its Subsidiaries to use their
respective reasonable best efforts, to provide, and the Company and its Subsidiaries shall use their respective reasonable best efforts to cause each of their respective Representatives to provide, at Acquiror&#146;s sole cost and expense, to
Parent, Acquiror and its Affiliates all customary cooperation that may be reasonably requested by Parent or Acquiror (including reasonable requests of the Debt Financing Sources) to assist Parent, Acquiror and its Affiliates in arranging, obtaining,
syndicating and consummating the Debt Financing (or any issuance, sale or offering of debt securities and/or delayed draw term loans, in each case, in lieu thereof as contemplated in the Debt Financing Commitment Letter) or any Exchange Offer
(collectively, the &#147;<U>Financing</U>&#148;) (it being understood that the arrangement or receipt of any such financing is not a condition to the Merger), including: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) furnishing Parent, Acquiror and its Affiliates with (A)&nbsp;the financial statements required by paragraph&nbsp;2 of
Annex&nbsp;II to Exhibit&nbsp;B to the Debt Financing Commitment Letter and (B)&nbsp;such other customary financial and other customary information regarding the Company and its Subsidiaries as Parent, Acquiror or its Affiliates may reasonably
request in connection with any Financing, including customary historical financial and other information regarding the Company reasonably necessary to permit Parent or Acquiror to prepare pro forma financial statements customary for the Financing;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) reasonably assisting Parent, Acquiror, its Affiliates and the Debt
Financing Sources in the preparation of customary offering and syndication materials for any Financing, including by providing customary information for due diligence purposes (including records, data or other information reasonably necessary to
support any statements or statistical information relating to the Company that are included in such materials) and customary letters authorizing the distribution of information relating to the Company and its Subsidiaries to the Debt Financing
Sources (it being agreed that any such authorization letter shall not include any representation, warranty or certification as to projections, pro forma statements or similar information); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) reasonably cooperating with the marketing efforts for any portion of the Financing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) reasonably cooperating with legal counsel to Parent, Acquiror, its Affiliates or any Debt Financing Sources; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) providing customary information with respect to the Company to assist Parent or Acquiror in obtaining any corporate,
securities or facility ratings from any ratings agencies, in each case, to the extent reasonably requested in writing by the Acquiror or Parent in connection with the Financing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) furnishing any documentation and other information regarding the Company and its Subsidiaries that the Debt Financing
Sources reasonably determine is required under applicable &#147;know your customer&#148; and anti-money laundering rules and regulations, including the PATRIOT Act, in each case, at least four (4)&nbsp;Business Days prior to the Closing Date if
requested by Acquiror in writing at least ten (10)&nbsp;Business Days prior to the Closing Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) causing members of
senior management of the Company to participate in a reasonable number of rating agency presentations, due diligence sessions, lender meetings, &#147;road shows&#148; and similar sessions and meetings or conference calls with prospective lenders,
financing sources, investors, rating agencies and other Debt Financing Sources, in each case, that may be reasonably requested in writing by Parent, Acquiror or its Affiliates in connection with the arrangement of the Financing during normal
business hours and with reasonable advance written notice to the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) using reasonable best efforts to cause
the Company&#146;s independent accountants to provide reasonable and customary assistance and cooperation to Parent, Acquiror and its Affiliates in connection with any Financing, including by obtaining customary &#147;comfort letters&#148; in
connection with any Financing and participating in a reasonable number of accounting due diligence sessions during normal business hours; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) provide or cause to be provided any customary certificates, or other customary closing documents as may reasonably be
requested by Parent, Acquiror or its Affiliates in connection with the Financing (<I>provided</I> that no obligation under any document or agreement with respect thereto will take effect until the Closing); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) facilitate the execution and delivery of definitive financing documentation as may be reasonably requested by Parent,
Acquiror or its Affiliates in connection with the Financing (<I>provided</I> that no obligation under any document or agreement with respect thereto will take effect until the Closing). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any other provision set forth herein or in any other agreement between Acquiror or Parent, on the one
hand, and the Company, on the other hand (or their respective Affiliates), the Company agrees that Acquiror and Parent may share confidential information with respect to the businesses of the Company and its Subsidiaries with the Debt Financing
Sources, and that Parent, Acquiror and such Debt Financing Sources may share such information with potential financing sources in connection with any marketing efforts for the Financing; <I>provided, however</I>, that the recipients of such
information and any other information contemplated to be provided by Parent, Acquiror or any of its Affiliates pursuant to this <U>Section</U><U></U><U>&nbsp;6.13(b)</U> agree to customary confidentiality arrangements, including confidentiality
provisions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
contained in customary bank books and offering memoranda. The Company, on behalf of itself and its Subsidiaries, hereby consents to the use of their logos in connection with the Financing;
<I>provided, however</I>, that logos are used solely in a manner that is not intended to or reasonably likely to harm or disparage the Company, its Subsidiaries or the reputation or goodwill of the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For the avoidance of doubt, the Company shall not be required to provide, or to cause its Subsidiaries or its or their
respective Representatives to provide, cooperation under this <U>Section</U><U></U><U>&nbsp;6.13</U> that unreasonably interferes with the ongoing business of the Company or any of its Subsidiaries or provide any information that the Company does
not otherwise already prepare in the ordinary course of its business that would be burdensome in any material respect for the Company to prepare. Nothing in this <U>Section</U><U></U><U>&nbsp;6.13</U> shall require the Company or its Subsidiaries to
(i)&nbsp;bear any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> cost or expense or pay any fee in connection with the Financing, other than to the extent contingent upon the Closing or for which the
Company shall be reimbursed by Parent, Acquiror or its Affiliates, (ii)&nbsp;incur any liability in connection with the Financing prior to the Effective Time, (iii)&nbsp;enter into any binding agreement or commitment that would be effective prior to
the Effective Time (other than customary authorization and representation letters or auditor engagement letters for purposes of effecting the cooperation envisioned hereunder) and that does not terminate without liability to the Company and its
Subsidiaries upon termination of this Agreement, (iv)&nbsp;provide or prepare any financial statements (x)&nbsp;not contemplated by <U>Section</U><U></U><U>&nbsp;4.4(b)</U> or (y)&nbsp;that the Company does not otherwise prepare in the ordinary
course of its business, (v)&nbsp;pass resolutions or consents (except those that are subject to the occurrence of the Closing passed by directors or officers continuing in their positions following the Closing) to approve or authorize the execution
of the Debt Financing or any definitive documentation related thereto that would be effective prior to the Closing Date, (vi)&nbsp;conflict with the Company Organizational Documents or any of the Company Subsidiary Organizational Documents,
(vii)&nbsp;take any action that would result in the contravention of, or that could result in a violation or breach of, or a default (with or without notice, lapse of time or both) under, any material Contract to which the Company or any of its
Subsidiaries is party or by which it is bound or applicable Law, (viii)&nbsp;provide any solvency or other similar certificate of its chief financial officer or similar representative prior to the Closing Date, (ix)&nbsp;provide or prepare any
projections or pro forma financial statements, (x)&nbsp;deliver or cause to be delivered any opinion of counsel in connection with the Financing or (xi)&nbsp;take any action that would (A)&nbsp;reasonably be expected to cause any natural person
serving as a director, manager, partner, officer, employee, accountant, advisor, consultant, auditor, agent or other representative of the Company or any of its Subsidiaries to incur any personal liability or (B)&nbsp;require the Company or any of
its Subsidiaries to provide access to, or disclose, information that reasonably would be expected to result in the waiver of, or otherwise jeopardize, any attorney-client, work product or other applicable privilege or protection. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Acquiror shall, promptly upon written request by the Company, (i)&nbsp;reimburse the Company for all reasonable and
documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred by the Company and its Subsidiaries and its and their respective Representatives in connection with their respective
obligations under this <U>Section</U><U></U><U>&nbsp;6.13</U> and (ii)&nbsp;indemnify, defend and hold harmless the Company and its Subsidiaries and their respective Representatives to the fullest extent permitted by applicable Law from and against
any and all Liability suffered, sustained or incurred by, or asserted against, any of them, directly or indirectly relating to, or arising out of, this <U>Section</U><U></U><U>&nbsp;6.13</U>, the arrangement of the Financing or providing any of the
information utilized in connection therewith, whether in respect of direct claims, third-party claims or otherwise, other than to the extent any of the foregoing are determined by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT>
judgment of a court of competent jurisdiction to have arisen from (A)&nbsp;the Willful Breach of the obligations of the Company, its Subsidiaries and their respective Representatives under this <U>Section</U><U></U><U>&nbsp;6.13</U> or any fraud,
intentional misrepresentation, willful misconduct, bad faith or gross negligence of the Company, its Subsidiaries or their respective Representatives or (B)&nbsp;material misstatements or omissions in information provided by the Company, its
Subsidiaries or their respective Representatives in connection with the Financing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_60"></A>Section&nbsp;6.14 <U>Treatment of Certain Company
Indebtedness</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall, and shall cause the Company&#146;s Subsidiaries to, deliver all notices and take
all other actions reasonably requested by Acquiror that are required to, in accordance with the terms thereof, terminate all commitments outstanding under the Company Credit Agreements, repay in full all obligations, if any, outstanding thereunder,
and facilitate the release of all Liens, if any, securing such obligations, and the release of all guarantees, if any, in connection therewith, in each case, on the Closing Date as of the Effective Time. In furtherance and not in limitation of the
foregoing, the Company shall, and shall cause the Company&#146;s Subsidiaries to, use reasonable best efforts to deliver to Acquiror at least three (3)&nbsp;Business Days prior to the Closing Date, and shall deliver to Acquiror on or prior to the
Closing Date, a customary executed payoff letter with respect to each Company Credit Agreement (the &#147;<U>Payoff Letters</U>&#148;) (and drafts reasonably in advance thereof), from the applicable agent on behalf of the persons to whom such
Indebtedness is owed, which Payoff Letters together with any related release documentation shall, among other things, include the payoff amount and provide that all Liens (and guarantees), if any, granted in connection therewith relating to the
assets, rights and properties of the Company and the Company&#146;s Subsidiaries securing such Indebtedness and any other obligations secured thereby, shall, upon the payment of the amount set forth in the applicable Payoff Letter on the Closing
Date, be automatically released and terminated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent, Acquiror or any of their Affiliates may, or may request the
Company to, in which case the Company shall use its reasonable best efforts to, commence as promptly as practicable following receipt of such request, one or more consent solicitations regarding certain proposed amendments to the Company Indentures
(any such consent solicitation, a &#147;<U>Consent Solicitation</U>&#148;) as reasonably requested by Parent, including to eliminate, waive or amend the change of control provisions and to amend the reporting covenants in such Company Indentures.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Any Consent Solicitation shall be made on such terms and conditions as determined by Acquiror subject to the
reasonable approval of the Company (other than with respect to the Reserved Terms of any such Consent Solicitation which shall be determined by Acquiror in its sole discretion) and subject to the proviso to this sentence, and the Company shall waive
any of the conditions relating to any Consent Solicitation to be made by the Company (other than the terms and conditions set forth in the proviso to this sentence), as applicable, as may be reasonably requested by Acquiror in writing and shall not,
without the written consent of Acquiror, waive any condition to any such Consent Solicitation or make any changes to any such Consent Solicitation other than as consented to or approved by Acquiror; <I>provided</I> that, each such Consent
Solicitation shall include the following conditions: (x)&nbsp;such Consent Solicitation shall not conflict with or violate any applicable Laws, (y)&nbsp;the proposed amendments that are the subject of such Consent Solicitation shall only become
operative substantially concurrently with the Effective Time (including the obtaining by Acquiror of financing or otherwise having cash sufficient, and providing such amount to the Company, to fund any consent fees and other related fees and
expenses) and (z)&nbsp;receipt of the requisite consents in respect of any Consent Solicitation. Subject to the foregoing, the Company shall use its reasonable best efforts to promptly make any change to the terms and conditions of any Consent
Solicitation reasonably requested by Acquiror. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Provided that the requisite consents in respect of any Consent
Solicitation have been received with respect to the applicable Company Notes (which may be prior to the Effective Time), the Company shall execute (or cause to be executed) a supplemental indenture to the applicable Company Indenture reflecting the
terms of such Consent Solicitation, and shall use commercially reasonable efforts to cause the trustee under such Company Indenture to enter into such supplemental indenture, as the case may be; <I>provided</I> that the proposed amendments therein
shall only become operative substantially concurrently with the Effective Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall, and shall cause its
Subsidiaries to, and shall use reasonable best efforts to cause its and its Subsidiaries&#146; respective Representatives to, use its and their respective reasonable best </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
efforts to provide all cooperation reasonably requested by Parent or Acquiror in connection with the commencement and conduct of any Consent Solicitation, or any exchange offer to exchange all or
a portion of the Company Notes for securities of Parent (any exchange offer, together with any Consent Solicitation, an &#147;<U>Exchange Offer</U>&#148;), including assistance with the preparation of one or more offering memorandums, offers to
purchase and consent solicitation statements, letters of transmittal and consents (if required) and press releases. Any documents (including all amendments or supplements thereto) and all mailings to the holders of the Company Notes in connection
with any Consent Solicitation conducted by the Company shall be subject to the prior review of, and comment by, the Company and Acquiror and shall be reasonably acceptable in form and substance to each of them; <I>provided</I> that, for the
avoidance of doubt, the terms and conditions of any Consent Solicitation shall be subject to <U>Section</U><U></U><U>&nbsp;6.14(b)</U> above. If at any time prior to the completion of any Exchange Offer, any information should be discovered by
Acquiror or the Company that Acquiror or the Company reasonably believes should be set forth in an amendment or supplement to the documentation relating thereto, so that such documentation shall not contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of circumstances under which they are made, not misleading, the Party that discovers such information shall promptly notify
the other Parties hereto, and an appropriate amendment or supplement prepared by Acquiror (or at the reasonable request of Acquiror, prepared by the Company) describing such information (which amendment or supplement shall be reasonably satisfactory
in form and substance to Acquiror) shall be disseminated to the holders of the applicable Company Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At or prior
to the Effective Time, Acquiror shall provide (or cause to be provided) to the Company funds in an amount equal to the consent fee payable in connection with any Consent Solicitation pursuant to this <U>Section</U><U></U><U>&nbsp;6.14</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Acquiror shall, promptly upon written request by the Company, (i)&nbsp;reimburse the Company for all reasonable and
documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including attorneys&#146; and accountants&#146; fees, fees of the trustees for the Company Notes and their counsel, and fees
of any exchange agents, solicitation agents and other agents and their counsel) incurred by the Company or any of its Subsidiaries in connection with the cooperation of the Company and its Subsidiaries contemplated by this
<U>Section</U><U></U><U>&nbsp;6.14</U> and (ii)&nbsp;indemnify, defend and hold harmless the Company and its Subsidiaries and their respective Representatives to the fullest extent permitted by applicable Law from and against any and all Liability
suffered, sustained or incurred by, or asserted against, any of them, directly or indirectly relating to, or arising out of, the transactions contemplated by this <U>Section</U><U></U><U>&nbsp;6.14</U> and any information used in connection
therewith (other than (A)&nbsp;information furnished by or on behalf of the Company or its Subsidiaries expressly for use in connection with any Exchange Offer contemplated by this <U>Section</U><U></U><U>&nbsp;6.14</U> or (B)&nbsp;the Willful
Breach of the obligations of the Company, its Subsidiaries and their respective Representatives under this <U>Section</U><U></U><U>&nbsp;6.14</U> or any fraud, intentional misrepresentation, willful misconduct, bad faith or gross negligence of the
Company, its Subsidiaries or their respective Representatives (to the extent determined by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment of a court of competent jurisdiction)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_61"></A>Section&nbsp;6.15 <U>Transaction Litigation</U>. In the event that any litigation related to this Agreement, the
Merger or the other transactions contemplated hereby is brought by any stockholder or other holder of any Company Securities (whether directly or on behalf of the Company or otherwise) against the Company and/or its directors or officers, the
Company shall (i)&nbsp;promptly notify Acquiror of such litigation, (ii)&nbsp;keep Acquiror reasonably informed with respect to the status thereof and (iii)&nbsp;give Acquiror the opportunity to participate, subject to a customary joint defense
agreement, in the defense or settlement of any such litigation. Notwithstanding anything to the contrary contained herein, the Company shall not settle or enter into any negotiations for full or partial settlement of any such litigation, including,
in each case, any payment of fees, without the prior written consent of Acquiror (which consent shall not be unreasonably conditioned, withheld or delayed); <I>provided, however</I>, that Acquiror shall not be obligated to consent to any settlement
that does not include a full release of Acquiror and its Affiliates or that imposes equitable relief upon Acquiror or its Affiliates (including, after the Effective Time, the Company and its Subsidiaries). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_62"></A>Section&nbsp;6.16 <U>Obligations of Merger Sub and
Survi</U><U>ving Corporation</U>. Acquiror shall cause Merger Sub or the Surviving Corporation, as applicable, to perform its obligations under this Agreement, and, prior to the Effective Time, Merger Sub shall not engage in any activities of any
nature except as provided in, or contemplated by, this Agreement. Acquiror shall, immediately following the execution and delivery of this Agreement, deliver or cause to be delivered the irrevocable written consent of the sole member of Merger Sub
approving and adopting this Agreement in accordance with the DLLCA and the organizational documents of Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_63"></A>Section&nbsp;6.17 <U>Notification of Certain Matters</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Company and Acquiror shall promptly notify
the other of (i)&nbsp;any written notice or other communication received by such Party (or any of its controlled Affiliates or, to such Party&#146;s knowledge, any of its other Affiliates or Representatives) from any person alleging that the consent
of such person is or may be required in connection with the Merger, if the failure to obtain such consent would reasonably be expected to materially affect, impede or impair the consummation of the Merger and (ii)&nbsp;any Legal Proceedings
commenced or, to such Party&#146;s knowledge, threatened against, the Company or Acquiror or any of their respective Affiliates, that seek to materially impede or delay the consummation of the Merger, or that make allegations that, if true, would
reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or an Acquiror Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company shall promptly notify Acquiror of (i)&nbsp;any inaccuracy of any representation or warranty of the Company
contained herein in any material respect at any time during the term hereof and (ii)&nbsp;any failure of the Company (or its Subsidiaries) to comply with or satisfy in any material respect any covenant or agreement to be complied with or satisfied
by it hereunder, in each case, if and only to the extent that such inaccuracy, or such failure, would reasonably be expected to cause either of the conditions to the obligations of Acquiror and Merger Sub to consummate the transactions contemplated
hereby set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U> to fail to be satisfied. For the avoidance of doubt, the delivery of any notice pursuant to this <U>Section</U><U></U><U>&nbsp;6.17(a)</U> shall
not affect or be deemed to modify any representation or warranty (or cure any inaccuracy thereof) of the Company set forth in this Agreement or the conditions to the obligations of Acquiror and Merger Sub to consummate the transactions contemplated
by this Agreement or the remedies available to the Parties hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Acquiror shall promptly notify the Company of
(i)&nbsp;any inaccuracy of any representation or warranty of Acquiror or Merger Sub contained herein in any material respect at any time during the term hereof and (ii)&nbsp;any failure of Acquiror or Merger Sub to comply with or satisfy in any
material respect any covenant or agreement to be complied with or satisfied by it hereunder, in each case, if and only to the extent that such inaccuracy, or such failure, would reasonably be expected to cause either of the conditions to the
obligations of Acquiror and Merger Sub to consummate the transactions contemplated hereby set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> to fail to be satisfied. For the avoidance of doubt, the
delivery of any notice pursuant to this <U>Section</U><U></U><U>&nbsp;6.17(c)</U> shall not affect or be deemed to modify any representation or warranty (or cure any inaccuracy thereof) of Acquiror or Merger Sub set forth in this Agreement or the
conditions to the obligations of the Company to consummate the transactions contemplated by this Agreement or the remedies available to the Parties hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_64"></A>Section&nbsp;6.18 <U>Financing Obligation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Acquiror and Parent shall, and shall cause their applicable Subsidiaries to, use reasonable best efforts to obtain
the Financing on or prior to the Closing Date in an amount, when taken together with available cash on hand and other sources of funds available to Parent and Acquiror to consummate the Merger and the other transactions contemplated by this
Agreement, sufficient to pay the Required Amount, including by (i)&nbsp;complying with its obligations under the Debt Financing Commitment Letter, (ii)&nbsp;maintaining in effect the Debt Financing Commitment Letter or the definitive financing
agreements related to the Financing (the &#147;<U>Definitive Agreements</U>&#148;) in accordance with the terms and conditions thereof, (iii)&nbsp;negotiating and entering into Definitive Agreements on a timely basis on terms and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
conditions (including any &#147;market flex&#148; provisions) contained in the Debt Financing Commitment Letter or such other terms and conditions as Parent may determine, so long as such other
terms and conditions would not constitute a Prohibited Modification, (iv)&nbsp;enforcing its rights under the Debt Financing Letters or the Definitive Agreements, (v)&nbsp;satisfying, or causing to be satisfied (or, if applicable, obtaining waivers
of), on or prior to the Closing Date all conditions applicable to Acquiror, Parent and/or their Subsidiaries contained in the Debt Financing Commitment Letter (or any Definitive Agreements), including the payment of any commitment, engagement or
placement fees required as a condition to the initial funding of the Financing and (vi)&nbsp;otherwise taking, or causing to be taken, all actions and to do, or cause to be done, all things reasonably necessary, proper and advisable to arrange and
obtain the Financing; <I>provided</I> that, notwithstanding anything herein to the contrary, the documentation related to the bridge loan facility contemplated by the Debt Financing Commitment Letter and the funding thereunder shall not be required
unless and until necessary to obtain funds sufficient to pay the Required Amount on the Closing Date. Acquiror shall keep the Company informed on a reasonably current basis and in reasonable detail of the status of its efforts to arrange the
Financing, including, for the avoidance of doubt, notifying the Company of any reduction in the aggregate principal amount of the Debt Financing in connection with Acquiror or Parent obtaining other Financing in lieu thereof as contemplated by the
Debt Financing Commitment Letter and permitted hereby and thereby. Acquiror shall give the Company prompt written notice (A)&nbsp;upon having knowledge of any material violation, material breach or material default (or any event or circumstance
that, with or without notice, lapse of time or both, would reasonably be expected to give rise to any material violation, material breach or material default) by any party to the Debt Financing Commitment Letter or the Definitive Agreements or any
early termination of the commitments thereunder (other than any termination in accordance with the terms thereof), (B)&nbsp;of any written notice or other written communication from any Debt Financing Source with respect to any actual or threatened
breach, default, termination or repudiation by any party to the Debt Financing Commitment Letter or the Definitive Agreements of any provision thereof or (C)&nbsp;if for any reason Acquiror has determined in good faith that it will not be able to
obtain all or any portion of the Debt Financing on the terms contemplated by the Debt Financing Commitment Letter or the Definitive Agreements in an amount sufficient, when taken together with available cash on hand and other sources of funds
available to Parent and Acquiror to consummate the Merger and the other transactions contemplated by this Agreement, to pay the Required Amount. As soon as reasonably practicable, Acquiror shall provide any information reasonably requested by the
Company relating to any circumstance referred to in clauses&nbsp;(A) through (C)&nbsp;of the immediately preceding sentence. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither of Parent nor Acquiror shall, without the prior written consent of the Company, amend, modify, supplement, waive
(or otherwise grant consent under) the Debt Financing Commitment Letter (or any Definitive Agreement) or replace (including via the issuance of New Company Notes (as defined in the Debt Financing Commitment Letter as in effect on the date hereof) or
the incurrence of a Qualifying Loan Facility (as defined in the Debt Financing Commitment Letter as in effect on the date hereof)) all or any portion of the commitments in respect of the Debt Financing or, if applicable, provided under the
Definitive Agreements, in each case, to the extent such amendment, modification, supplement, replacement or waiver would reasonably be expected to (u)&nbsp;reduce the amount of the Debt Financing to an amount that would result in Acquiror having
insufficient funds, when taken together with available cash on hand and other sources of funds available to Parent and Acquiror to consummate the Merger or the other transactions contemplated by this Agreement, to pay the Required Amount,
(v)&nbsp;otherwise adversely affect the ability of Acquiror to consummate the transactions contemplated by this Agreement on the Closing Date, including the ability to pay the Required Amount in full, (w)(i)&nbsp;impose new or additional conditions
precedent to the initial funding of the Debt Financing other than as contemplated by the Debt Financing Commitment Letter (as in effect on the date hereof) (or the Definitive Agreements, as applicable) or (ii)&nbsp;otherwise modify the conditions
precedent to the initial funding of the Debt Financing (as in effect on the date hereof) in a manner reasonably expected to delay, prevent or impede the funding of the Debt Financing (or satisfaction of the conditions precedent to the Debt
Financing) on the Closing Date or make such funding materially less likely to occur, (x)&nbsp;delay in any material respect the Closing, (y)&nbsp;adversely affect the termination provisions of the Debt Financing Commitment Letter (or the Definitive
Agreements, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
as applicable) or (z)&nbsp;adversely affect the ability of Acquiror to enforce its rights against the other parties to the Debt Financing Commitment Letter (or the Definitive Agreements, as
applicable) (clauses&nbsp;(u) through (z), &#147;<U>Prohibited Modifications</U>&#148;); <I>provided, however</I>, subject to compliance with the other provisions of <U>Section</U><U></U><U>&nbsp;6.18</U>, Parent and Acquiror may amend, modify,
supplement or waive any provision of the Debt Financing Commitment Letter to add lenders, lead arrangers, bookrunners, syndication agents or similar entities that have not executed the Debt Financing Commitment Letter as of the date hereof, in each
case, as contemplated by the Debt Financing Commitment Letter on the date hereof. As soon as reasonably practicable, Acquiror will provide the Company with true, correct and complete executed copies of any amendment or supplement to, or modification
of or waiver under, the Debt Financing Letters (it being agreed that copies of any fee letters may be delivered in redacted form removing only the fee amounts, pricing terms, pricing caps, &#147;market flex&#148; provisions and other economic terms
therein). Notwithstanding anything to the contrary in the foregoing, to the extent that the Debt Financing contemplated by the Debt Financing Commitment Letter is replaced in whole or in part by the incurrence of a Qualifying Loan Facility (as
defined in the Debt Financing Commitment Letter as in effect on the date hereof), the parties hereto acknowledge and agree that the definitive documentation with respect to such Qualifying Loan Facility shall constitute Definitive Agreements and
such Qualifying Loan Facility shall constitute a Debt Financing for purposes of, and shall be subject to the provisions of, this <U>Section</U><U></U><U>&nbsp;6.18(b)</U> and <U>Section</U><U></U><U>&nbsp;6.18(c)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If all or any portion of the Debt Financing becomes unavailable on the terms and conditions of the Debt Financing
Commitment Letter (except in accordance with its terms) (including the &#147;market flex&#148; provisions thereof), Acquiror shall (i)&nbsp;notify as soon as reasonably practicable (and in any event within three (3)&nbsp;Business Days) the Company
of such event and (ii)&nbsp;use its reasonable best efforts to obtain, on or prior to the Closing Date, the alternative financing from the same or alternative sources, which may include one or more of a loan financing, an offering and sale of notes,
or any other financing or offer and sale of other debt securities, or any combination thereof, in an amount sufficient, when added to any portion of the Debt Financing that is and will be available and cash on hand and other sources of available
funds, to pay in cash the Required Amount on terms and conditions that would not constitute a Prohibited Modification; <I>provided</I> that nothing contained in this <U>Section</U><U></U><U>&nbsp;6.18</U> shall require, and in no event shall the
&#147;reasonable best efforts&#148; of Parent, Acquiror or any of their Subsidiaries be deemed or construed to require, Parent, Acquiror or any such Subsidiary to seek or accept such alternative financing on terms materially less favorable in the
aggregate than the terms and conditions described in the Debt Financing Commitment Letter (including the exercise of &#147;market flex&#148; provisions) as in effect on the date of this Agreement, as determined in the reasonable judgment of
Acquiror. In such event, the term &#147;Debt Financing&#148; as used in this Agreement shall be deemed to include any such alternative debt financing, and the term &#147;Debt Financing Commitment Letter&#148; as used in this Agreement shall be
deemed to include any commitment letter entered into in respect of any such alternative debt financing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Acquiror
expressly acknowledges and agrees that (i)&nbsp;obtaining the Debt Financing is not a condition to the Closing and (ii)&nbsp;notwithstanding anything contained in this Agreement to the contrary, Acquiror&#146;s obligations hereunder are not
conditioned in any manner upon Acquiror obtaining the Debt Financing, or any other financing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONDITIONS TO CONSUMMATION OF THE MERGER</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_64a"></A>Section&nbsp;7.1 <U>Conditions to Each Party</U><U>&#146;</U><U>s Obligation to Effect the Merger</U>. The
respective obligations of each Party to effect the Merger shall be subject to the fulfillment (or waiver by each of the Company and Acquiror, to the extent not prohibited under applicable Law) on or prior to the Closing Date of the following
conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Stockholder Approval</U>. The Company Stockholder Approval shall have been obtained. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Legal Prohibition</U>. No Order by any Governmental Entity of competent jurisdiction shall have been entered and
shall continue to be in effect, and no Law shall have been adopted or be effective, in each case that temporarily or permanently prohibits, enjoins or makes illegal the consummation of the Merger (any of the foregoing, a &#147;<U>Legal
Restraint</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Regulatory Approval</U>. (i)&nbsp;The waiting period (and any
extension thereof, including any timing agreement entered into with the relevant Governmental Entity) applicable to the Merger under the HSR Act shall have expired or been terminated; and (ii)&nbsp;all other clearances or approvals under applicable
Antitrust Laws in the jurisdictions set forth on <U>Section</U><U></U><U>&nbsp;7.1(c)</U> of the Company Disclosure Schedule (collectively, &#147;<U>Regulatory Approvals</U>&#148;), shall have been obtained, or are deemed obtained, or the respective
authority concluded in writing that the transactions contemplated hereby are not subject to its jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_65"></A>Section&nbsp;7.2 <U>Conditions to Obligations of </U><U>Acquiror</U><U> and Merger Sub</U>. The respective
obligations of Acquiror and Merger Sub to effect the Merger shall be subject to the fulfillment (or waiver by Acquiror, to the extent not prohibited under applicable Law) on or prior to the Closing Date of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. The representations and warranties of the Company set forth in
(i)<U>&nbsp;Article</U><U></U><U>&nbsp;IV</U> (other than in the Company Fundamental Representations, <U>Section</U><U></U><U>&nbsp;4.2(a)</U> (<I>Capital Stock</I>) and <U>Section</U><U></U><U>&nbsp;4.12(b)</U> (<I>Absence of Certain Changes or
Events</I>)) shall be true and correct both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date, other than for failures to be so true and correct (without regard to materiality,
Company Material Adverse Effect and similar qualifiers contained in such representations and warranties) that would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect; (ii)&nbsp;the Company
Fundamental Representations shall be true and correct in all material respects both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date;
(iii)<U>&nbsp;Section</U><U></U><U>&nbsp;4.2(a)</U> (<I>Capital Stock</I>) shall be true and correct both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date, except for any de
minimis inaccuracies and (iv)<U>&nbsp;Section</U><U></U><U>&nbsp;4.12(b)</U> (<I>Absence of Certain Changes or Events</I>) shall be true and correct at and as of the date of this Agreement; <I>provided</I> that, in the case of clauses&nbsp;(i), (ii)
and (iii)&nbsp;above, representations and warranties that are made as of a particular date or period need be true and correct (in the manner set forth in clauses&nbsp;(i), (ii) and (iii)&nbsp;above, as applicable) only as of such date or period.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance of Obligations of the Company</U>. The Company shall have performed or complied with in all material
respects all covenants required by the Agreement to be performed or complied with by it prior to the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No
Company Material Adverse Effect</U>. No Company Material Adverse Effect shall have arisen or occurred following the date of this Agreement that is continuing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Closing Certificate</U>. The Company shall have delivered to Acquiror a certificate, dated as of the Closing Date and
signed by its Chief Executive Officer or another senior officer, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U>, <U>Section</U><U></U><U>&nbsp;7.2(b)</U> and <U>Section</U><U></U><U>&nbsp;7.2(c)</U> have been
satisfied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Burdensome Condition</U>. (i)&nbsp;No Burdensome Condition shall be a condition to receipt of any
Regulatory Approval, (ii)&nbsp;there shall not be in effect at or upon the Closing any Order or Law resulting, individually or in the aggregate, in a Burdensome Condition and (iii)&nbsp;no Regulatory Approval shall contain, include or impose any
Burdensome Condition. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Closing Tax Opinion</U>. Acquiror shall have received the opinion of Acquiror Tax Counsel,
addressed to Acquiror and dated as of the Closing Date, in form and substance reasonably satisfactory to Acquiror, to the effect that, based upon the Closing Tax Opinion Representation Letters and any other facts, assumptions and representations set
forth or referred to in such opinion, and subject to such qualifications and limitations as may be set forth in such opinion, for U.S. federal income Tax purposes, the Merger contemplated by this Agreement will not affect the qualification of
(i)&nbsp;the Contribution and Distribution as a transaction qualifying for <FONT STYLE="white-space:nowrap">non-recognition</FONT> of gain or loss to the Company pursuant to Sections 368, 355 and 361 of the Code, and (ii)&nbsp;the Distribution as a
transaction qualifying for <FONT STYLE="white-space:nowrap">non-recognition</FONT> of income, gain, or loss to the Company&#146;s stockholders pursuant to Section&nbsp;355 of the Code, except to the extent of cash received in lieu of fractional
shares (the &#147;<U>Closing Tax Opinion</U>&#148;). Notwithstanding the foregoing, this Section&nbsp;7.2(f) shall not apply (and will not be a condition to the obligations of Acquiror and Merger Sub to effect the Merger) if Acquiror Tax Counsel
determines that it cannot render the Closing Tax Opinion, for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
reasons other than as a result of material changes in (x)&nbsp;Law or (y)&nbsp;facts, as set forth in either the Company Signing Tax Opinion Representation Letter or the Acquiror Signing Tax
Opinion Representation Letter, since the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_66"></A>Section&nbsp;7.3 <U>Conditions to Obligations of the
Company</U>. The obligations of the Company to effect the Merger shall be subject to the fulfillment (or waiver by the Company, to the extent permissible under applicable Law) on or prior to the Closing Date of the following additional conditions:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. The representations and warranties of Acquiror set forth in
(i)<U>&nbsp;Article</U><U></U><U>&nbsp;V</U> (other than in <U>Section</U><U></U><U>&nbsp;5.1</U> (<I>Organization</I>) and <U>Section</U><U></U><U>&nbsp;5.2</U> (<I>Corporate Authority Relative to this Agreement; No Violation</I>)<I> </I>(other
than<U>&nbsp;Section</U><U></U><U>&nbsp;5.2(c)(ii)</U>)) shall be true and correct both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date, other than for failures to be so true and
correct (without regard to materiality, Acquiror Material Adverse Effect and similar qualifiers contained in such representations and warranties) that would not, individually or in the aggregate, reasonably be expected to have an Acquiror Material
Adverse Effect and (ii)<U>&nbsp;Section</U><U></U><U>&nbsp;5.1</U> (<I>Organization</I>) and <U>Section</U><U></U><U>&nbsp;5.2 </U>(<I>Corporate Authority Relative to this Agreement; No Violation</I>) (other than
<U>Section</U><U></U><U>&nbsp;5.2(c)(ii)</U>) shall be true and correct in all material respects both at and as of the date of this Agreement and at and as of the Closing Date as though made at and as of the Closing Date; <I>provided</I> that
representations and warranties that are made as of a particular date or period need be true and correct (in the manner set forth in clauses&nbsp;(i) and (ii), as applicable) only as of such date or period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Performance of Obligations of </U><U>Acquiror</U><U> and Merger Sub</U>. Each of Acquiror and Merger Sub shall have
performed or complied with in all material respects all covenants required by the Agreement to be performed or complied with by it prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Closing Certificate</U>. Acquiror shall have delivered to the Company a certificate, dated as of the Closing Date and
signed by its Chief Executive Officer or another senior officer, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> and <U>Section</U><U></U><U>&nbsp;7.3(b)</U> have been satisfied. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;VIII </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERMINATION</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_67"></A>Section&nbsp;8.1 <U>Termination or Abandonment</U>. Anything in this Agreement to the contrary notwithstanding, this Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by the mutual written consent of the Company and Acquiror; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by either the Company or Acquiror, if the Effective Time shall not have occurred on or prior to August&nbsp;13, 2025 (the
&#147;<U>Outside Date</U>&#148;); <I>provided</I> that if on August&nbsp;13, 2025 all of the conditions to Closing, other than the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1(b)</U>, <U>Section</U><U></U><U>&nbsp;7.1(c)</U> and
<U>Section</U><U></U><U>&nbsp;7.2(e)</U> (in each case, as it relates to an Antitrust Law), shall have been satisfied or shall be capable of being satisfied at such time, the Outside Date shall be automatically extended by six (6)&nbsp;months (and
all references to the Outside Date herein shall be as so extended); <I>provided, further</I>, that if on such extended Outside Date all of the conditions to Closing, other than the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.1(b)</U>,
<U>Section</U><U></U><U>&nbsp;7.1(c)</U> and <U>Section</U><U></U><U>&nbsp;7.2(e)</U> (in each case, as it relates to an Antitrust Law), shall have been satisfied or shall be capable of being satisfied at such time, the Outside Date will again be
extended by six (6)&nbsp;months (and all references to the Outside Date herein shall be as so extended); <I>provided, further</I>, that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(b)</U> shall not be
available to a Party if the failure of the Closing to have occurred on or before the Outside Date was primarily due to the failure of such Party to perform any of its obligations under this Agreement (which failure constitutes a material breach of
this Agreement); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by either the Company or Acquiror if, prior to the Effective Time, any Legal Restraint permanently
restraining, enjoining or otherwise prohibiting or making illegal the Merger or otherwise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
prohibiting the consummation of the Merger shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> <I>provided</I> that the Party seeking to terminate this Agreement
pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(c)</U> shall have complied in all material respects with its obligations under <U>Section</U><U></U><U>&nbsp;6.5</U> to contest, appeal and remove such Legal Restraint; <I>provided, further</I>,
that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(c)</U> shall not be available to a Party if the issuance of the Legal Restraint or the occurrence of any such other action was primarily due to the failure
of such Party to perform any of its obligations under this Agreement (which failure constitutes a material breach of this Agreement); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by either the Company or Acquiror, if the Company Stockholder Approval shall not have been obtained at the Company Special
Meeting (or any adjournment or postponement thereof) at which a vote was taken on the matter; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by the Company if
(i)&nbsp;Acquiror or Merger Sub has breached any representation, warranty, covenant or other agreement contained in this Agreement, which breach would result in the conditions in <U>Section</U><U></U><U>&nbsp;7.3(a)</U> or
<U>Section</U><U></U><U>&nbsp;7.3(b)</U> not being satisfied and (ii)&nbsp;which breach, failure to perform or inaccuracy (A)&nbsp;is either not curable or (B)&nbsp;if capable of being cured, is not cured by the earlier of (I)&nbsp;the Outside Date
and (II)&nbsp;the date that is twenty (20)&nbsp;Business Days following written notice from the Company to Acquiror; <I>provided, however</I>, that the right to terminate the Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(e)</U> shall
not be available to the Company if it is then in breach of any representations, warranties, covenants or agreements under this Agreement (which breach would result in the conditions set forth in <U>Section</U><U></U><U>&nbsp;7.2(a)</U> or
<U>Section</U><U></U><U>&nbsp;7.2(b)</U> not being satisfied); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by Acquiror (i)&nbsp;if the Company has breached any
representation, warranty, covenant or other agreement contained in this Agreement (other than an intentional and material breach of <U>Section</U><U></U><U>&nbsp;6.3</U>), which breach would result in the conditions in
<U>Section</U><U></U><U>&nbsp;7.2(a)</U> or <U>Section</U><U></U><U>&nbsp;7.2(b)</U> not being satisfied and (ii)&nbsp;which breach, failure to perform or inaccuracy (A)&nbsp;is either not curable or (B)&nbsp;if capable of being cured, is not cured
by the earlier of (I)&nbsp;the Outside Date and (II)&nbsp;the date that is twenty (20)&nbsp;Business Days following written notice from Acquiror to the Company; <I>provided, however</I>, that the right to terminate the Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1(f)</U> shall not be available to the Acquiror if it is then in breach of any representations, warranties, covenants or agreements under this Agreement (which breach would result in the conditions set forth in
<U>Section</U><U></U><U>&nbsp;7.3(a)</U> or <U>Section</U><U></U><U>&nbsp;7.3(b)</U> not being satisfied); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by the
Company, prior to receipt of the Company Stockholder Approval, in order to substantially concurrently with such termination enter into a definitive agreement relating to a Company Superior Proposal to the extent permitted by and subject to the terms
of <U>Section</U><U></U><U>&nbsp;6.3(f)</U> so long as the Company pays, or causes to be paid, to Acquiror the Termination Fee pursuant to <U>Section</U><U></U><U>&nbsp;8.3(c)</U> prior to or concurrently with, and as a condition to the
effectiveness of, such termination; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by Acquiror, (i)&nbsp;at any time following an Adverse Recommendation Change or
(ii)&nbsp;if the Company shall have intentionally and materially breached <U>Section</U><U></U><U>&nbsp;6.3</U>; <I>provided</I> that Acquiror&#146;s right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;8.1(h)</U> shall
expire upon receipt of the Company Stockholder Approval. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Party seeking to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1</U> shall give written notice of such termination to the other Parties in accordance with <U>Section</U><U></U><U>&nbsp;9.7</U>, specifying the provision of this Agreement pursuant to which such termination is
effected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_68"></A>Section&nbsp;8.2 <U>Effect of Termination</U>. In the event of termination of this Agreement
pursuant to <U>Section</U><U></U><U>&nbsp;8.1</U>, this Agreement shall terminate (except that the Confidentiality Agreement, the Clean Room Agreement and the provisions of this <U>Section</U><U></U><U>&nbsp;8.2</U>,
<U>Section</U><U></U><U>&nbsp;8.3</U> and <U>Article</U><U></U><U>&nbsp;IX</U> shall survive any termination), and there shall be no other Liability on the part of the Company, on the one hand, or Acquiror or Merger Sub, on the other hand, to the
other except (a)&nbsp;as provided in <U>Section</U><U></U><U>&nbsp;8.3</U> or (b)&nbsp;Liability arising out of or resulting from fraud or any Willful Breach of any provision of this Agreement occurring prior to termination (in which case the
aggrieved Party shall be entitled to all rights and remedies available at law or in equity, including for the avoidance of doubt, in the case of the Company, damages based on the loss of premium offered to each holder of Company Common Stock, which
the Company shall be entitled to retain). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_69"></A>Section&nbsp;8.3 <U>Termination Fees and Remedies</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If (i)&nbsp;(A) Acquiror or the Company terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(b)</U> and
the Company Stockholder Approval shall not have been obtained, (B) Acquiror or the Company terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U> or (C)&nbsp;Acquiror terminates this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;8.1(f)</U> (or this Agreement is terminated under any other provision of <U>Section</U><U></U><U>&nbsp;8.1</U>, and at such time could have been terminated as described in clause (A), (B) or (C)), (ii)&nbsp;a Company
Takeover Proposal shall have been made or publicly made known after the date of this Agreement and not, as applicable, (x)&nbsp;in the case of a Company Takeover Proposal that has not been publicly made known after the date of this Agreement,
withdrawn in writing in good faith (with a copy of such written withdrawal having been delivered to Acquiror), or (y)&nbsp;in the case of a proposal made known publicly, publicly withdrawn, in each case ((x) and (y)), prior to such termination (in
the case of a termination pursuant to <U>Section</U><U></U><U>&nbsp;8.1(b)</U> or <U>Section</U><U></U><U>&nbsp;8.1(f)</U>) or the later of the Company Special Meeting and any postponement or adjournment thereof (in the case of a termination
pursuant to <U>Section</U><U></U><U>&nbsp;8.1(d)</U>) and (iii)&nbsp;at any time on or prior to the first (1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) anniversary of such termination, the Company or any of its Subsidiaries enters into
a definitive agreement with respect to, or consummates, any Company Takeover Proposal (<I>provided</I> that references in the definition of &#147;Company Takeover Proposal&#148; to twenty percent (20%) shall be deemed to be fifty percent (50%)) with
any person (a &#147;<U>Company Takeover Transaction</U>&#148;), the Company shall pay or cause to be paid to Acquiror or its designee the Termination Fee, by wire transfer (to an account designated by Acquiror) in immediately available funds, upon
the earlier of entering into such definitive agreement with respect to any Company Takeover Transaction and the consummation of any Company Takeover Transaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If Acquiror terminates this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;8.1(h)</U>, the Company shall pay or cause
to be paid to Acquiror or its designee the Termination Fee, by wire transfer (to an account designated by Acquiror) in immediately available funds, within three (3)&nbsp;Business Days after such termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If this Agreement is terminated by the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(g)</U>, the Company shall pay
or cause to be paid to Acquiror or its designee the Termination Fee, by wire transfer (to an account designated by Acquiror) in immediately available funds, prior to or concurrently with, and as a condition to the effectiveness of, such termination.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Termination Fee</U>&#148; shall mean a cash amount equal to eight hundred million dollars ($800,000,000).
Anything to the contrary in this Agreement notwithstanding, if the Termination Fee shall become due and payable in accordance with this <U>Section</U><U></U><U>&nbsp;8.3</U>, from and after such termination and payment of the Termination Fee in full
pursuant to and in accordance with this <U>Section</U><U></U><U>&nbsp;8.3</U>, the Company shall have no further Liability of any kind for any reason in connection with this Agreement or the termination contemplated hereby other than as provided
under this <U>Section</U><U></U><U>&nbsp;8.3</U> except in the case of fraud or Willful Breach and Acquiror agrees, on behalf of itself and its Affiliates and their respective Representatives, that, following payment by the Company to Acquiror of
the Termination Fee, no person shall be entitled to bring or maintain any Legal Proceeding against the Company or any of its Affiliates or any of their respective Representatives relating to, or arising out of, this Agreement, any of the
transactions contemplated hereby or any matter forming the basis of this Agreement&#146;s termination, except in each case for fraud or Willful Breach. In no event shall Acquiror or its designee be entitled to more than one (1)&nbsp;payment of the
Termination Fee in connection with a termination of this Agreement pursuant to which such Termination Fee is payable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)
If this Agreement is terminated by (i)&nbsp;either Acquiror or the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(b)</U> and at the time of such termination any of the conditions to the Closing set forth in
<U>Section</U><U></U><U>&nbsp;7.1(c)</U>, <U>Section</U><U></U><U>&nbsp;7.1(b)</U> (solely as a result of a Legal Restraint in respect of an Antitrust Law issued or entered after the date of this Agreement) or
<U>Section</U><U></U><U>&nbsp;7.2(e)</U> shall not have been fulfilled (or waived to the extent permissible under applicable Law) but all other conditions to the Closing set forth in <U>Article</U><U></U><U>&nbsp;VII</U> either have been waived or
fulfilled or would be fulfilled if the Closing were to occur on such date or (ii)&nbsp;either Acquiror or the Company pursuant to <U>Section</U><U></U><U>&nbsp;8.1(c)</U> (solely as a result of a final and
<FONT STYLE="white-space:nowrap">non-appealable</FONT> Legal Restraint in respect of an Antitrust Law issued or entered after the date of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Agreement), the Company shall become entitled to a cash amount equal to one billion two hundred fifty million dollars ($1,250,000,000), which shall be paid, or caused to be paid, by Acquiror to
the Company or its designee, by wire transfer (to an account designated by the Company) in immediately available funds, within three (3)&nbsp;Business Days after the applicable termination (&#147;<U>Reverse Termination Fee</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Anything to the contrary in this Agreement notwithstanding, if the Reverse Termination Fee shall become due in accordance
with this <U>Section</U><U></U><U>&nbsp;8.3</U>, from and after such termination and payment of the Reverse Termination Fee in full pursuant to and in accordance with this <U>Section</U><U></U><U>&nbsp;8.3</U>, none of Parent, Acquiror or Merger Sub
shall have any further Liability of any kind for any reason in connection with this Agreement or the termination contemplated hereby other than as provided under this <U>Section</U><U></U><U>&nbsp;8.3</U>, except in the case of fraud or Willful
Breach and the Company agrees, on behalf of itself and its Affiliates and their respective Representatives, that, following payment by Acquiror to the Company of the Reverse Termination Fee, no person shall be entitled to bring or maintain any Legal
Proceeding against Acquiror or any of its Affiliates or any of their respective Representatives relating to, or arising out of, this Agreement, any of the transactions contemplated hereby or any matter forming the basis of this Agreement&#146;s
termination, except in each case for fraud or Willful Breach. In no event shall the Company or its designee be entitled to more than one (1)&nbsp;payment of the Reverse Termination Fee in connection with a termination of this Agreement pursuant to
which such Reverse Termination Fee is payable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Each of the Parties hereto acknowledges that the payment of the
Termination Fee or the Reverse Termination Fee, as applicable, is not intended to be a penalty, but rather is a reasonable amount that will compensate the other Party in the circumstances in which the Termination Fee or Reverse Termination Fee, as
applicable, is due and payable, and which do not involve fraud or Willful Breach of this Agreement, for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the
expectation of the consummation of the Merger, which amount would otherwise be impossible to calculate with precision. Each of the Company and Acquiror acknowledges that the agreements contained in this <U>Section</U><U></U><U>&nbsp;8.3</U> are an
integral part of the Merger, and that, without these agreements, the other Party would not enter into this Agreement. Accordingly, if a Party fails to pay in a timely manner any amount due pursuant to this <U>Section</U><U></U><U>&nbsp;8.3</U>, then
(i)&nbsp;such Party shall reimburse the payee Party or its designee for all reasonable costs and expenses (including reasonable disbursements and fees of outside legal counsel) incurred in the collection of such overdue amount, including in
connection with any related claims, actions or proceedings commenced with respect thereto and (ii)&nbsp;such Party shall pay to the payee Party or its designee interest on such amount from and including the date payment of such amount was due but
excluding the date of actual payment at the prime rate set forth in <U>The Wall Street Journal</U> in effect on the date such payment was required to be made plus two percent (2.00%). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE&nbsp;IX </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_70"></A>Section&nbsp;9.1 <U>No Survival</U>. None of the representations, warranties, covenants and agreements in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Merger, except for covenants and agreements
which contemplate performance after the Effective Time or otherwise expressly by their terms survive the Effective Time (including, for the avoidance of doubt, <U>Section</U><U></U><U>&nbsp;6.9</U> (<I>Indemnification and Insurance</I>)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_71"></A>Section&nbsp;9.2 <U>Expenses</U>. Except as set forth in <U>Section</U><U></U><U>&nbsp;6.5(b)</U>,
<U>Section</U><U></U><U>&nbsp;6.13</U>, <U>Section</U><U></U><U>&nbsp;6.14 </U>and <U>Section</U><U></U><U>&nbsp;8.3</U>, whether or not the Merger is consummated, all costs and expenses incurred in connection with the Merger, this Agreement and the
other transactions contemplated by this Agreement shall be paid by the Party incurring or required to incur such expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_72"></A>Section&nbsp;9.3 <U>Counterparts; Effectiveness</U>. This Agreement may be executed in two (2)&nbsp;or more counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
instrument, and shall become effective when one or more counterparts have been signed by each of the Parties and delivered (by telecopy, electronic delivery or otherwise) to the other Parties.
Signatures to this Agreement transmitted by electronic mail in &#147;portable document format&#148; form, or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document, will have the same effect as
physical delivery of the paper document bearing the original signature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_73"></A>Section&nbsp;9.4 <U>Governing
Law</U>. This Agreement, and all claims or causes of action (whether at law, in Contract or in tort or otherwise) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance hereof, shall be governed
by and construed in accordance with the Laws of the State of Delaware, without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws
of any jurisdiction other than the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_74"></A>Section&nbsp;9.5 <U>Jurisdiction; Specific
Enforcement</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of the Parties hereto (i)&nbsp;consents to submit itself to the exclusive jurisdiction of the
Court of Chancery of the State of Delaware or, solely if such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware (the &#147;<U>Chosen Courts</U>&#148;), with respect to any
dispute arising out of, relating to or in connection with this Agreement or any transaction contemplated hereby, including the Merger, (ii)&nbsp;agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request
for leave from any such Chosen Court, and (iii)&nbsp;agrees that it will not bring any action arising out of, relating to or in connection with this Agreement or any transaction contemplated by this Agreement, including the Merger, in any court
other than any such Chosen Court. The Parties irrevocably and unconditionally waive any objection to the laying of venue of any Legal Proceeding arising out of this Agreement or the transactions contemplated hereby in the Chosen Courts, and hereby
further irrevocably and unconditionally waive and agree not to plead or claim in any such Chosen Court that any such Legal Proceeding brought in any such Chosen Court has been brought in an inconvenient forum. Each of the Parties hereto hereby
agrees that service of any process, summons, notice or document by U.S. registered mail to the respective addresses set forth in <U>Section</U><U></U><U>&nbsp;9.7</U> shall be effective service of process for any proceeding arising out of, relating
to or in connection with this Agreement or the transactions contemplated hereby, including the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties
agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed, or were threatened to be not performed, in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that, in addition to any other remedy that may be available to it, including monetary damages, each of the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms
and provisions of this Agreement exclusively in the courts designated in <U>Section</U><U></U><U>&nbsp;9.5(a)</U> without proof of actual damages, and all such rights and remedies at law or in equity shall be cumulative, except as may be limited by
<U>Section</U><U></U><U>&nbsp;8.3</U>. Nothing contained in this <U>Section</U><U></U><U>&nbsp;9.5(b)</U> shall be deemed to be an election of remedies. The Parties further agree that no Party to this Agreement shall be required to obtain, furnish
or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this <U>Section</U><U></U><U>&nbsp;9.5</U>; and each Party waives any objection to the imposition of such relief or any right it may
have to require the obtaining, furnishing or posting of any such bond or similar instrument. Each Party hereby agrees not to raise any objections to the availability of the equitable remedy of specific performance to prevent or restrain breaches or
threatened breaches of this Agreement by any other Party and to specifically enforce the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the terms, provisions, covenants and
obligations of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_75"></A>Section&nbsp;9.6 <U>WAIVER OF JURY TRIAL</U>. EACH PARTY ACKNOWLEDGES AND
AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN ANY LITIGATION ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREBY, INCLUDING THE MERGER. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (III)&nbsp;EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (IV)&nbsp;EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_76"></A>Section&nbsp;9.7
<U>Notices</U>. All notices and other communications hereunder shall be in writing in one of the following formats and shall be deemed given (a)&nbsp;upon actual delivery if personally delivered to the Party to be notified; (b)&nbsp;when sent if
sent by email to the Party to be notified (with notice deemed given upon transmission; <I>provided</I> that no &#147;bounceback&#148; or notice of <FONT STYLE="white-space:nowrap">non-delivery</FONT> is received); or (c)&nbsp;when delivered if sent
by a courier (with confirmation of delivery); in each case to the Party to be notified at the following address: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">If to Acquiror, Parent
or Merger Sub, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">c/o Mars, Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">6885 Elm Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">McLean, VA,
22101 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:&#8195;Peter Seka, General Counsel, Corporate Development </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email:&#8195;&#8194;&#8199;&#8196;[***] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">One Manhattan West </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York,
NY 10001 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">(212) <FONT STYLE="white-space:nowrap">735-3000</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:&#8195;Howard Ellin </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:23%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neil Stronski </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:23%; text-indent:4%; font-size:10pt; font-family:Times New Roman">June Dipchand </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email:&#8195;&#8194;&#8199;&#8196;[***] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">If to the Company, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">One Kellogg Square
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Battle Creek, MI 49017 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:&#8195;Todd Haigh, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:23%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Senior Vice President, Chief </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:23%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Legal Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email:&#8195;&#8194;&#8199;&#8196;[***] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York,
NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:&#8195;Eric Schiele </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:23%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Allison Wein </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:23%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emily Lichtenheld </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email:&#8195;&#8194;&#8199;&#8196;[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">or to such other address as any Party shall specify by written notice so given. Any Party to
this Agreement may notify any other Party of any changes to the address or any of the other details specified in this paragraph; <I>provided</I> that such notification shall only be effective on the date specified in such notice or three
(3)&nbsp;Business Days after the notice is given, whichever is later. Rejection or other refusal to accept or the inability to deliver because of changed address of which no notice was given shall be deemed to be receipt of the notice as of the date
of such rejection, refusal or inability to deliver. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_77"></A>Section&nbsp;9.8 <U>Assignment; Binding Effect</U>.
Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned or delegated by any of the Parties hereto without the prior written consent of the other Parties; <I>provided</I> that each of Merger Sub and Acquiror
may assign any of their rights hereunder to a wholly owned direct or indirect Subsidiary of Parent upon prior written notice to the Company, but no such assignment shall relieve Parent, Acquiror or Merger Sub of any of its obligations hereunder.
Subject to the first sentence of this <U>Section</U><U></U><U>&nbsp;9.8</U>, this Agreement shall be binding upon and shall inure to the benefit of the Parties hereto and their respective successors and assigns. Any purported assignment not
permitted under this <U>Section</U><U></U><U>&nbsp;9.8</U> shall be null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_78"></A>Section&nbsp;9.9
<U>Severability</U>. Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or
unenforceable the remaining terms and provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, such provision shall be interpreted to be only so broad as is enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_79"></A>Section&nbsp;9.10 <U>Entire Agreement</U>. This Agreement together with the exhibits hereto, schedules hereto, the
Confidentiality Agreement and the Clean Room Agreement constitute the entire agreement, and supersede all other prior agreements and understandings, both written and oral, between the Parties, or any of them, with respect to the subject matter
hereof and thereof, and this Agreement is not intended to grant standing to any person other than the Parties hereto. Notwithstanding anything in this Agreement to the contrary, the Parties hereto acknowledge and agree that the Company Disclosure
Schedule is not incorporated by reference into, and shall not be deemed to constitute a part of, this Agreement or the &#147;agreement of merger&#148; for purposes of Section&nbsp;251 of the DGCL, but shall have the effects provided in this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_80"></A>Section&nbsp;9.11 <U>Amendments; Waivers</U>. At any time prior to the Effective Time, any
provision of this Agreement may be amended or waived if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by the Company, Acquiror, and Merger Sub; <I>provided</I> that, without the further approval of the
stockholders of the Company and the sole member of Merger Sub, no such amendment or waiver shall be made or given after the Company Stockholder Approval that requires the approval of the stockholders of the Company or the sole member of Merger Sub
under the DGCL or DLLCA, as applicable, unless the required further approval is obtained. At any time and from time to time prior to the Effective Time, either the Company, on the one hand, or Acquiror and Merger Sub, on the other hand, may, to the
extent not prohibited by applicable Law and except as otherwise set forth herein, (a)&nbsp;extend the time for the performance of any of the obligations or other acts of Acquiror or Merger Sub, in the case of an extension by the Company, or of the
Company, in the case of an extension by Acquiror and Merger Sub, as applicable, (b)&nbsp;waive any inaccuracies in the representations and warranties made to such Party contained herein or in any document delivered pursuant hereto and (c)&nbsp;waive
compliance with any of the agreements or conditions for the benefit of any such Party contained herein. The foregoing notwithstanding, no failure or delay by any Party hereto in exercising any right hereunder shall operate as a waiver thereof nor
shall any single or partial exercise thereof preclude any other or further exercise of any other right hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_81"></A>Section&nbsp;9.12 <U>Headings</U>. Headings of the Articles and Sections of this Agreement are for convenience of the Parties only and shall be given no substantive or interpretive effect whatsoever. The table of contents to this Agreement is
for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_82"></A>Section&nbsp;9.13 <U>No Third-Party Beneficiaries</U>. Except
for (a)&nbsp;the right of the Company Indemnified Parties to enforce the provisions of <U>Section</U><U></U><U>&nbsp;6.9</U> (<I>Indemnification and Insurance</I>), (b)&nbsp;at and after the Effective Time, the rights of the holders of shares of
Company Common Stock to receive the Merger Consideration in accordance with the terms and conditions of this Agreement and any dividends or other distributions declared in accordance with the terms of <U>Section</U><U></U><U>&nbsp;6.1</U> with a
record date prior to the Effective Time to which holders of shares of Company Common Stock as of such record date become entitled and that remain unpaid as of the Effective Time, (c)&nbsp;at and after the Effective Time, the rights of the holders of
Company Options, Company Restricted Stock Units, Company Deferred Stock Units and Company Performance Stock Units to receive the payments contemplated by the applicable provisions of <U>Section</U><U></U><U>&nbsp;3.3</U>, in each case in accordance
with the terms and conditions of this Agreement and (d)&nbsp;the rights of the Debt Financing Sources contemplated by <U>Section</U><U></U><U>&nbsp;9.16</U>, each of Acquiror, Merger Sub and the Company agrees that (i)&nbsp;their respective
representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other Party hereto, in accordance with and subject to the terms of this Agreement, and (ii)&nbsp;this Agreement is not intended to, and does
not, confer upon any person other than the Parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_83"></A>Section&nbsp;9.14 <U>Interpretation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) It is understood and agreed that the specification of any dollar amount in the representations and warranties contained in
this Agreement or the inclusion of any specific item in the Company Disclosure Schedule is not intended to imply that such amounts or higher or lower amounts, or the items so included or other items, are or are not material, and no Party shall use
the fact of the setting of such amounts or the fact of the inclusion of any such item in the Company Disclosure Schedule in any dispute or controversy between the Parties as to whether any obligation, item or matter not described in this Agreement
or included in the Company Disclosure Schedule is or is not material for purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For the purposes
of this Agreement, (i)&nbsp;the definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term; (ii)&nbsp;references to
the terms Article, Section, paragraph, Exhibit&nbsp;and Schedule are references to the Articles, Sections, paragraphs, Exhibits and Schedules to this Agreement unless otherwise specified; (iii)&nbsp;the words &#147;hereof,&#148; &#147;herein&#148;
and &#147;hereunder&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement, unless the context otherwise requires; (iv)&nbsp;the word
&#147;extent&#148; in the phrase &#147;to the extent&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#147;if&#148;; (v)&nbsp;whenever the words &#147;include,&#148; &#147;includes&#148;
or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation&#148;; (vi)&nbsp;unless otherwise specifically provided for herein, the term &#147;or&#148; shall not be deemed to be
exclusive; (vii)&nbsp;the word &#147;since&#148; when used in this Agreement in reference to a date shall be deemed to be inclusive of such date; (viii)&nbsp;references to &#147;written&#148; or &#147;in<B> </B>writing&#148; include in electronic
form; (ix)&nbsp;provisions shall apply, when appropriate, to successive events and transactions; (x)&nbsp;a reference to any person includes such person&#146;s successors and permitted assigns; (xi)&nbsp;references to &#147;$&#148; shall mean U.S.
dollars; (xii)&nbsp;any reference to &#147;days&#148; means calendar days unless Business Days are expressly specified; (xiii)&nbsp;when calculating the period of time before which, within which or following which any act is to be done or step taken
pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded; if the day at the end of the period is not a Business Day, then such period shall end on the close of the next immediately following
Business Day; (xiv)&nbsp;references in this Agreement to specific Laws or to specific provisions of Laws shall include all rules and regulations promulgated thereunder, and any statute defined or referred to herein or in any agreement or instrument
referred to herein shall mean such statute as from time to time amended, modified or supplemented, including by succession of comparable successor statutes; and (xv)&nbsp;all terms defined in this Agreement shall have the defined meanings when used
in any certificate or other document made or delivered pursuant thereto unless otherwise defined therein. Each of the Parties has participated in the negotiation of this Agreement. If an ambiguity or question of intent or interpretation
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
arises, this Agreement must be construed as if it is drafted by all the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of authorship of any
of the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_84"></A>Section&nbsp;9.15 <U>Guaranty</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent, in order to induce the Company to execute and deliver this Agreement, hereby absolutely, unconditionally and
irrevocably guarantees, as principal and not merely as surety (the &#147;<U>Guaranty</U>&#148;), to the Company, the Surviving Corporation and their successors and assigns, with respect to each and every covenant, agreement and other obligation of
Acquiror and Merger Sub, including the due, punctual and full payment and performance of Acquiror&#146;s and Merger Sub&#146;s (including their permitted designees&#146; and assigns&#146;) obligations hereunder when due (and including, for the
avoidance of doubt, in connection with any breach of any of Acquiror&#146;s and Merger Sub&#146;s representations, warranties or covenants herein) (the &#147;<U>Guaranteed Obligations </U>&#148;), subject to any and all limitations on
Acquiror&#146;s and Merger Sub&#146;s covenants, agreements and other obligations hereunder. Any breach or nonperformance of any such obligations of Acquiror or Merger Sub (or any of their successors or assigns) shall also be deemed to be a default
of Parent. So long as this <U>Section</U><U></U><U>&nbsp;9.15</U> is in effect, Parent shall not exercise any right or remedy arising by reason of its performance of the Guaranty (subject to any and all limitations on Acquiror&#146;s and Merger
Sub&#146;s covenants, agreements and other obligations hereunder), whether by subrogation, reimbursement, indemnification, contribution or otherwise, against the Company, the Surviving Corporation or their successors and assigns or any express
intended third party beneficiary described in <U>Section</U><U></U><U>&nbsp;9.13</U> of any Guaranteed Obligations, or any other guarantor of the Guaranteed Obligations or any security therefor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Guaranty is a guarantee of payment and performance, and not of collection, and Parent acknowledges and agrees that
this Guaranty is full and unconditional, and no release or extinguishment of Acquiror&#146;s and/or Merger Sub&#146;s and/or their respective designees&#146; or assigns&#146; Liabilities (other than in accordance with the terms of this Agreement),
whether by decree in any bankruptcy proceeding or otherwise, will affect the continuing validity and enforceability of this Guaranty. Parent hereby waives (i)&nbsp;any right to require the Company, as a condition of payment or performance by Parent
of any obligations of Acquiror or Merger Sub hereunder, to proceed against Acquiror or Merger Sub or pursue any other remedy whatsoever in the event that Acquiror or Merger Sub fails to perform its obligations hereunder or that any other action be
taken or not taken as a condition to Parent&#146;s liability for the Guaranteed Obligations or as a condition to the enforcement of this Agreement or the Guaranteed Obligations against Parent, and (ii)&nbsp;to the fullest extent permitted by
applicable Law, any defenses or benefits that may be derived from or afforded by Law which limit the liability of or exonerate guarantors or sureties. If and whenever Acquiror or Merger Sub defaults for any reason whatsoever in the performance of
any of the Guaranteed Obligations, Parent shall, subject to any and all limitations on Acquiror&#146;s and Merger Sub&#146;s covenants, agreements and other obligations hereunder, as soon as reasonably practicable following demand, unconditionally
perform (or procure the performance of) and satisfy (or procure the satisfaction of) the Guaranteed Obligations in regard to which such default has been made in the manner prescribed by this Agreement and so that the same benefits are conferred on
the Company, the Surviving Corporation, their successors and assigns and any third party beneficiary as such person would have received if the Guaranteed Obligations had been duly performed and satisfied by Acquiror and Merger Sub. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent represents and warrants to the Company that (i)&nbsp;Parent is a Delaware corporation, duly organized, validly
existing and in good standing under the Laws of the State of Delaware, and has all requisite corporate power and authority necessary to execute and deliver this Guaranty and to perform its obligations hereunder<U>,</U> (ii)&nbsp;the execution,
delivery and performance by Parent of this Guaranty have been approved by all requisite corporate action and, assuming the due authorization, execution and delivery of this Agreement by the Company, the execution and delivery of this Guaranty by
Parent constitutes a legal, valid and binding obligation of Parent, enforceable against Parent in accordance with its terms, (iii)&nbsp;no other action on the part of Parent or any holder of capital stock of, or other equity or voting interest in,
Parent is necessary to authorize the execution, delivery and performance by Parent of this Guaranty, (iv)&nbsp;Parent will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
have as of the Closing available funds sufficient to perform its obligations under this <U>Section</U><U></U><U>&nbsp;9.15</U>. Except for the representations and warranties of Parent expressly
set forth in this <U>Section</U><U></U><U>&nbsp;9.15(c)</U> and of Acquiror and Merger Sub expressly set forth in <U>Article</U><U></U><U>&nbsp;V</U>, or in a certificate delivered pursuant to this Agreement, none of Parent, Acquiror, Merger Sub or
any other person on behalf of Parent, Acquiror or Merger Sub makes any express or implied representation or warranty with respect to Parent, Acquiror, Merger Sub or with respect to any other information provided to the Company or any of its
Affiliates in connection with the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Without limiting in any way the foregoing
Guaranty, but subject in all respects to any and all limitations on Acquiror&#146;s and Merger Sub&#146;s covenants, agreements and other obligations hereunder, Parent agrees to cause, and to take all actions to enable, Acquiror and Merger Sub to
adhere to each provision of the Agreement which requires an act or omission on the part of Acquiror or Merger Sub or any of their respective Affiliates to cause or enable Acquiror and Merger Sub to comply with their respective obligations under this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) This Guaranty is to be a continuing guaranty and accordingly is to remain in force until all Guaranteed
Obligations have been performed or satisfied. This Guaranty is in addition to and without prejudice to and not in substitution for any rights that the Company, the Surviving Corporation, their successors and assigns and any third-party beneficiary
may now or in future have or hold for the performance and observance of the Guaranteed Obligations. The Guaranteed Obligations shall be discharged as a result of (i)&nbsp;indefeasible payment and performance in full of the Guaranteed Obligations in
accordance with the terms of this Agreement, or (ii)&nbsp;those defenses to the payment of the Guaranteed Obligations that Acquiror or Merger Sub has under the specific terms of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) As a separate and independent stipulation, Parent acknowledges, confirms and agrees that any of the Guaranteed Obligations
(including any monies payable) that is or becomes unenforceable against, or not capable of recovery from, Acquiror or Merger Sub by reason of any legal limitation, disability or incapacity on or of Acquiror or Merger Sub or any other fact or
circumstances (other than any limitation imposed by this Agreement) shall nevertheless be enforceable against and recoverable from Parent as though the same had been incurred by Parent and Parent was the sole or principal obligor in respect of that
Guaranteed Obligation. Without limiting the generality of the foregoing, (i)&nbsp;Parent hereby waives: (A)&nbsp;notice of acceptance of this Guaranty, and of the creation or existence of any of the Guaranteed Obligations and of any action by the
Company in reliance hereon or in connection herewith; and (B)&nbsp;presentment, demand for payment, notice of dishonor or nonpayment, protest and notice of protest with respect to the Guaranteed Obligations; and (ii)&nbsp;the liability of Parent
under this Agreement and the Guaranty shall be irrevocable and enforceable irrespective of (subject to any and all limitations on Acquiror&#146;s and Merger Sub&#146;s covenants, agreements and other obligations hereunder): (A) any change in the
time, manner, terms, place of payment, or in any other term of all or any of the Guaranteed Obligations, or any other document executed in connection therewith; (B)&nbsp;any release, amendment, waiver, or consent to departure from any other
guaranty, for all or any of the Guaranteed Obligations; (C)&nbsp;failure, omission, delay, waiver, or refusal by the Company, the Surviving Corporation, their successors and assigns and any third-party beneficiary to exercise, in whole or in part,
any right or remedy held by such person with respect to the Guaranteed Obligations unless and to the extent Parent is actually and materially prejudiced by such failure, omission, delay, waiver, or refusal; and (D)&nbsp;any change in the existence,
structure, or ownership of Parent, Acquiror or Merger Sub, or any insolvency, bankruptcy, reorganization, or other similar proceeding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything to the contrary set forth herein, the Company hereby acknowledges and agrees that (i)&nbsp;no
recourse hereunder may be had against any Representative or stockholders of Parent, whether by or through attempted piercing of the corporate veil or otherwise, by the enforcement of any judgment or assessment or by any legal or equitable Legal
Proceeding, by virtue of any Law, or otherwise, and (ii)&nbsp;no personal liability whatsoever will attach to, be imposed on or otherwise be incurred by any Representative or stockholders of Parent under this <U>Section</U><U></U><U>&nbsp;9.15</U>
or for any claim based on, in respect of or by reason of the Guaranteed Obligations. The Company acknowledges and agrees that Parent is agreeing to enter into this <U>Section</U><U></U><U>&nbsp;9.15</U> in reliance on the provisions set forth in
this Section 9.15(g) and that this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;9.15(g)</U> shall survive the termination of this Agreement. For the avoidance of doubt, in no event shall the potential liability of Parent in connection with this
Agreement or the transactions contemplated hereby exceed that of Acquiror in connection with this Agreement or the Merger and the transaction contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The provisions of <U>Section</U><U></U><U>&nbsp;9.1</U> (<I>No Survival</I>), <U>Section</U><U></U><U>&nbsp;9.2</U>
(<I>Expenses</I>), <U>Section</U><U></U><U>&nbsp;9.3</U> (<I>Counterparts; Effectiveness</I>), <U>Section</U><U></U><U>&nbsp;9.4</U> (<I>Governing Law</I>), <U>Section</U><U></U><U>&nbsp;9.5</U> (<I>Jurisdiction; Specific Enforcement</I>),
<U>Section</U><U></U><U>&nbsp;9.6</U> (<I>Waiver of Jury Trial</I>), <U>Section</U><U></U><U>&nbsp;9.7</U> (<I>Notices</I>), <U>Section</U><U></U><U>&nbsp;9.8</U> (<I>Assignment; Binding</I> <I>Effect</I>), <U>Section</U><U></U><U>&nbsp;9.9</U>
(<I>Severability</I>), <U>Section</U><U></U><U>&nbsp;9.10</U> (<I>Entire Agreement</I>), <U>Section</U><U></U><U>&nbsp;9.11</U> (<I>Amendments; Waivers</I>), <U>Section</U><U></U><U>&nbsp;9.12</U> (<I>Headings</I>),
<U>Section</U><U></U><U>&nbsp;9.13</U> (<I>No Third-Party Beneficiaries</I>), <U>Section</U><U></U><U>&nbsp;9.14</U> (<I>Interpretation</I>) and <U>Section</U><U></U><U>&nbsp;9.16</U> (<I>Financing Parties</I>) of this Agreement will be deemed to be
applicable to this <U>Section</U><U></U><U>&nbsp;9.15</U>, and for the purposes of such Sections, Parent shall be considered a &#147;Party&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="atoc893453_85"></A>Section&nbsp;9.16 <U>Financing Parties</U>. Notwithstanding anything in this Agreement to the contrary, each of
the Parties to this Agreement, on behalf of itself and each of its Affiliates, hereby (a)&nbsp;agrees that it will not bring or support any action, cause of action, claim, suit, litigation, cross-claim or third-party claim or any proceeding, whether
in law or in equity, whether in contract or in tort or otherwise against any Debt Financing Source, arising out of or relating to, this Agreement, the Financing or any of the agreements (including the Debt Financing Letters and definitive debt
financing agreements) entered into in connection with the Financing or any of the transactions contemplated hereby or thereby or the performance of any services thereunder in any forum other than exclusively in the United States District Court for
the Southern District of New York sitting in the County of New York, New York (and appellate courts thereof) or if such court does not have subject matter jurisdiction, the Supreme Court of the State of New York, County of New York, and irrevocably
submits itself and its property with respect to any such proceeding to the exclusive jurisdiction of such courts, and irrevocably waives, to the fullest extent that it may effectively do so, the defense of an inconvenient forum to the maintenance of
such proceeding in such courts, (b)&nbsp;agrees that any such proceeding shall be governed by the laws of the State of New York (without giving effect to any conflicts of law principles that would result in the application of the laws of another
state), (c)&nbsp;agrees that service of process upon such person in any such proceeding shall be effective if notice is given in accordance with <U>Section</U><U></U><U>&nbsp;9.7</U>, (d)&nbsp;agrees that notwithstanding anything to the contrary
contained herein, none of the Company, any of its Affiliates or any of their respective stockholders, partners, members, officers, directors, employees, controlling persons, agents and Representatives shall have any rights or claims against any Debt
Financing Source relating to or arising out of this Agreement, the Financing, the Debt Financing Letters, any definitive debt financing agreement or any of the transactions contemplated hereby or thereby or the performance of any services
thereunder, whether at law or equity, in contract, in tort or otherwise, (e)&nbsp;KNOWINGLY, INTENTIONALLY AND VOLUNTARILY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW TRIAL BY JURY IN ANY PROCEEDING BROUGHT AGAINST ANY DEBT FINANCING
SOURCE IN ANY WAY ARISING OUT OF OR RELATING TO, THIS AGREEMENT, THE FINANCING, THE DEBT FINANCING LETTERS, ANY DEFINITIVE DEBT FINANCING AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY OR THE PERFORMANCE OF ANY SERVICES
THEREUNDER and (f)&nbsp;agrees that the Debt Financing Sources are express third-party beneficiaries of, and may enforce, any of the provisions herein reflecting the foregoing agreements in this <U>Section</U><U></U><U>&nbsp;9.16</U> (and such
provisions (and the definitions used in such provisions (as used in such provisions)) shall not be amended, modified, waived or terminated in any respect that is adverse in any material respect to the Debt Financing Sources without the prior written
consent of the applicable Debt Financing Sources (and any such amendment, modification, waiver or termination without such prior written consent shall be null and void)). This <U>Section</U><U></U><U>&nbsp;9.16</U> shall not limit the rights of the
parties to the Financing under the Debt Financing Letters or other definitive debt financing agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGES FOLLOW] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed and
delivered as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>KELLANOVA</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steve Cahillane</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Steve Cahillane</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chairman, President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACQUIROR 10VB8, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Peter Seka</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Peter Seka</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jean-Christophe Roux</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Jean-Christophe Roux</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>MERGER SUB 10VB8, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Peter Seka</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Peter Seka</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jean-Christophe Roux</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Jean-Christophe Roux</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>MARS, INCORPORATED</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">(solely for the purposes of <U>Section</U><U></U><U>&nbsp;6.2(b)</U>, <U>Section</U><U></U><U>&nbsp;6.5</U>, <U>Section</U><U></U><U>&nbsp;6.18</U> and <U>Section</U><U></U><U>&nbsp;9.15</U>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Peter Seka</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Peter Seka</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jean-Christophe Roux</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name: Jean-Christophe Roux</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: Authorized Signatory</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Agreement and Plan of Merger</I>] </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND RESTATED </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CERTIFICATE
OF INCORPORATION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">KELLANOVA </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>FIRST</U>: The
name of the Corporation is Kellanova (the &#147;Corporation&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>SECOND</U>: The address of the registered office of the
Corporation in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at that address is The Corporation Trust Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>THIRD</U>: The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the
General Corporation Law of the State of Delaware as set forth in Title 8 of the Delaware Code (as amended from time to time, the &#147;DGCL&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>FOURTH</U>: The total number of shares of stock which the Corporation shall have authority to issue is ten thousand (10,000) shares of
capital stock, consisting of 10,000 shares of common stock, each having a par value of $0.01 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>FIFTH</U>: The following
provisions are inserted for the management of the business and the conduct of the affairs of the Corporation, and for further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors of the Corporation (the
&#147;Board of Directors&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The directors shall have concurrent power with the stockholders to adopt, amend or repeal the bylaws
of the Corporation (the &#147;Bylaws&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The number of directors constituting the Board of Directors shall be as from time to
time fixed by, or in the manner provided in, the Bylaws. Election of directors need not be by written ballot unless the Bylaws so provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>SIXTH</U>: The following provisions of this Article SIXTH shall apply with respect to matters arising prior to or on [&#149;], 2024,
whether asserted or claimed prior to, at or after such date, and shall continue in effect for such matters until [&#149;], 2030: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No
person who is or was at any time a director or officer of the Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, provided, however, that unless
and except to the extent otherwise permitted from time to time by applicable law, the provisions of this Article shall not eliminate or limit the liability of a director or officer (i)&nbsp;for any breach of the director&#146;s or officer&#146;s
duty of loyalty to the Corporation or its stockholders, (ii)&nbsp;for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&nbsp;under Section&nbsp;174 of the DGCL (iv)&nbsp;for any
transaction from which the director or officer derived an improper personal benefit, (v)&nbsp;for any action by or in the right of the Corporation, in the case of officers only, or (vi)&nbsp;for any act or omission occurring prior to the date this
Article becomes effective. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any repeal or modification of the foregoing paragraph by the stockholders of the
Corporation existing at the time of such repeal or modification shall not adversely affect any right or protection of a director or officer of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding,
whether civil, criminal, administrative or investigative (hereinafter a &#147;proceeding&#148;), by reason of the fact that he or she is or was a director or officer of the Corporation, where the basis of such proceeding is an alleged action or
omission in an official capacity as such, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the
extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide prior to amendment), against all expense, liability and loss (including attorneys&#146; fees, judgments,
fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith and such indemnification shall continue as to an indemnitee who has ceased to be a director or officer
and shall inure to the benefit of the indemnitee&#146;s heirs, executors and administrators; provided, however, that except as provided in paragraph (d)&nbsp;hereof with respect to proceedings to enforce rights to indemnification, the Corporation
shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors. The right to indemnification conferred in this
Section shall be a contract right and shall include the right to be paid by the Corporation the expenses incurred in defending any such proceeding in advance of its final disposition (hereinafter an &#147;advancement of expenses&#148;); provided,
however, that, if the DGCL requires, an advancement of expenses incurred by an indemnitee in his or her capacity as a director or officer shall be made only upon delivery to the Corporation of an undertaking, by or on behalf of such indemnitee, to
repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal that such indemnitee is not entitled to be indemnified for such expenses under this Section or otherwise
(hereinafter an &#147;undertaking&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If a claim under paragraph (c)&nbsp;of this Section is not paid in full by the Corporation
within sixty days after a written claim has been received by the Corporation, except in the case of a claim for an advancement of expenses, in which case the applicable period shall be twenty days, the indemnitee may at any time thereafter bring
suit against the Corporation to recover the unpaid amount of the claim. If successful in whole or in part in any suit or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the
indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In (i)&nbsp;any suit brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a
right to an advancement of expenses) it shall be a defense that, and (ii)&nbsp;any suit by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking the Corporation shall be entitled to recover such expenses upon
a final adjudication that, the indemnitee has not met the applicable standard of conduct set forth in the DGCL. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel or its stockholders) to have made a
determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the
Corporation (including its Board of Directors, independent legal counsel or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of
conduct or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a right hereunder, or by the Corporation to recover an advancement of expenses pursuant to the terms of an
undertaking, the burden of proving that the indemnitee is not entitled to be indemnified or to such advancement of expenses under this Section or otherwise shall be on the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The rights to indemnification and to the advancement of expenses conferred in this Section shall not be exclusive of any other right which
any person may have or hereafter acquire under any statute, this Certificate of Incorporation, <FONT STYLE="white-space:nowrap">by-law,</FONT> agreement, vote of stockholders or disinterested directors or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Corporation may maintain insurance, at its expense, to protect itself and any
director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such
person against such expense, liability or loss under the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Corporation may, to the extent authorized from time to time by the
Board of Directors, grant rights to indemnification and to the advancement of expenses to any director, officer, employee or agent of the Corporation, whether or not acting in his or her capacity as such or at the request of the Corporation, to the
fullest extent of the provisions of this Section with respect to the indemnification and advancement of expenses of directors and officers of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>SEVENTH</U>: The following provisions of this Article SEVENTH shall apply with respect to matters arising after [&#149;], 2024: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">No director or officer of the Corporation shall be personally liable to the Corporation or any of its stockholders for monetary damages for
breach of fiduciary duty as a director or officer, except for liability of: (i)&nbsp;a director or officer for any breach of the director&#146;s or officer&#146;s duty of loyalty to the Corporation or its stockholders; (ii)&nbsp;a director or
officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii)&nbsp;a director or officer for any transaction from which the director or officer derived an improper personal benefit;
(iv)&nbsp;a director under Section&nbsp;174 of the DGCL; or (v)&nbsp;an officer in any action by or in the right of the Corporation. Any amendment, repeal or elimination of this Article SEVENTH shall not affect its application with respect to an act
or omission by a director or officer occurring before such amendment, repeal or elimination.<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>All references in this Article SEVENTH to an &#147;officer&#148; shall mean only a person who, at the
time of an act or omission as to which liability is asserted, falls within the meaning of the term &#147;officer,&#148; as defined in Section&nbsp;102(b)(7) of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>EIGHTH</U>: Meetings of stockholders may be held within or without the State of Delaware, as the Bylaws may provide. The books and records
of the Corporation may be kept (subject to any provision contained in the DGCL) outside the State of Delaware at such place or places as may be designated from time to time by the Board of Directors or in the Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>NINTH</U>: The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Amended and Restated
Certificate of Incorporation in the manner now or hereafter prescribed in this Amended and Restated Certificate of Incorporation, the Bylaws or the DGCL, and all rights conferred upon stockholders herein are granted subject to this reservation. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND RESTATED </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BYLAWS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">KELLANOVA </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A Delaware Corporation </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Effective
[&#149;], 2024 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">OFFICES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_1">Registered Office</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-87</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_2">Other Offices</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-87</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">MEETINGS OF STOCKHOLDERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_3">Place of Meetings</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-87</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_4">Annual Meetings</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-87</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_5">Special Meetings</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-87</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_6">Notice</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-87</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_7">Adjournments and Postponements</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-88</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_8">Quorum</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-88</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_9">Voting</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-88</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;8.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_10">Proxies</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-88</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_11">Consent of Stockholders in Lieu of Meeting</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-89</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;10.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_12">List of Stockholders Entitled to Vote</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-90</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;11.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_13">Record Date</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-90</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;12.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_14">Stock Ledger</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-90</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;13.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_15">Conduct of Meetings</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-91</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">DIRECTORS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_16">Number and Election of Directors</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-91</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_17">Vacancies</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-91</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_18">Duties and Powers</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-91</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_19">Meetings</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-91</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_20">Organization</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-92</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_21">Resignations and Removals of Directors</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-92</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_22">Quorum</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-92</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;8.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_23">Actions of the Board by Written Consent</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-92</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_24">Meetings by Means of Conference Telephone</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-92</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;10.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_25">Committees</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-93</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;11.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_26">Subcommittees</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-93</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;12.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_27">Compensation</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-93</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;13.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_28">Interested Directors</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-93</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE IV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">OFFICERS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_29">General</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-94</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_30">Election</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-94</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_31">Voting Securities Owned by the Corporation</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-94</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_32">Chairman of the Board of Directors</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-94</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_33">President</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-94</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_34">Vice Presidents</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-95</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_35">Secretary</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-95</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;8.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_36">Treasurer</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-95</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;9.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_37">Assistant Secretaries</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-95</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;10.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_38">Assistant Treasurers</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-96</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;11.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_39">Other Officers</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-96</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">STOCK</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_37a">Form of Certificates</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-96</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_38a">Signatures</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-96</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_39a">Lost Certificates</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-96</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_40">Transfers</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-96</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;5.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_41">Dividend Record Date</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-97</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;6.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_42">Record Owners</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-97</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;7.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_43">Transfer and Registry Agents</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-97</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE VI</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">NOTICES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_44">Notices</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-97</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_45">Waivers of Notice</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-98</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE VII</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">GENERAL PROVISIONS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_46">Dividends</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-98</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_47">Disbursements</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-98</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;3.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_48">Fiscal Year</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-98</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;4.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_49">Corporate Seal</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-98</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE VIII</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">INDEMNIFICATION</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_50">Indemnification Provisions with Respect to Historic Matters</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">A-98</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_51">Indemnification Provisions with Respect to Future Matters</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">A-100</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE IX</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">FORUM FOR ADJUDICATION OF CERTAIN DISPUTES</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_52">Forum for Adjudication of Certain Disputes </A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">A-103</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">ARTICLE X</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">AMENDMENTS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;1.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_53">Amendments</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">A-103</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Section&nbsp;2.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="#ctoc893453_54">Entire Board of Directors</A></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="white-space:nowrap">A-104</FONT></TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND RESTATED BYLAWS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">KELLANOVA </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(hereinafter called the &#147;Corporation&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OFFICES </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_1"></A>Section&nbsp;1. <U>Registered Office</U>. The registered office of the Corporation in the State of Delaware is
located at 1209 Orange Street, in the City of Wilmington, Count of Newcastle. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_2"></A>Section&nbsp;2. <U>Other
Offices</U>. The Corporation may also have offices at such other places, both within and without the State of Delaware, as the Board of Directors of the Corporation (the &#147;Board of Directors&#148;) may from time to time determine. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MEETINGS OF
STOCKHOLDERS</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_3"></A>Section&nbsp;1. <U>Place of Meetings</U>. Meetings of the stockholders for the election of
directors or for any other purpose shall be held at such time and place, either within or without the State of Delaware, as shall be designated from time to time by the Board of Directors. The Board of Directors may, in its sole discretion,
determine that a meeting of the stockholders shall not be held at any place, but may instead be held solely by means of remote communication in the manner authorized by Section&nbsp;211 of the General Corporation Law of the State of Delaware (the
&#147;DGCL&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_4"></A>Section&nbsp;2. <U>Annual Meetings</U>. The annual meeting of stockholders for the election
of directors shall be held on such date and at such time as shall be designated from time to time by the Board of Directors. Any other proper business may be transacted at the annual meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_5"></A>Section&nbsp;3. <U>Special Meetings</U>. Unless otherwise required by law or by the certificate of incorporation of
the Corporation, as amended and restated from time to time (the &#147;Certificate of Incorporation&#148;), special meetings of stockholders, for any purpose or purposes, may be called by either (i)&nbsp;the Chairman of the Board of Directors, if
there be one, or (ii)&nbsp;the President, (iii)&nbsp;any Vice President, if there be one, (iv)&nbsp;the Secretary or (v)&nbsp;any Assistant Secretary, if there be one, and shall be called by any such officer at the request in writing of (i)&nbsp;the
Board of Directors, (ii)&nbsp;a committee of the Board of Directors that has been duly designated by the Board of Directors and whose powers and authority include the power to call such meetings or (iii)&nbsp;stockholders owning a majority of the
capital stock of the Corporation issued and outstanding and entitled to vote on the matter for which such special meeting of stockholders is called. Such request shall state the purpose or purposes of the proposed meeting. At a special meeting of
stockholders, only such business shall be conducted as shall be specified in the notice of meeting (or any supplement thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_6"></A>Section&nbsp;4. <U>Notice</U>. Whenever stockholders are required or permitted to take any action at a meeting, a notice of the meeting shall be given in accordance with Section&nbsp;232 of the DGCL, and such notice shall state the place, if
any, date and hour of the meeting, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, the record date for determining the stockholders entitled to vote
at such meeting, if such date is different from the record date for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determining stockholders entitled to notice of such meeting and, in the case of a Special Meeting of Stockholders, the purpose or purposes for which the meeting is called. Unless otherwise
required by law, notice of any meeting shall be given not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining
stockholders entitled to notice of such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_7"></A>Section&nbsp;5. <U>Adjournments</U><U> and Postponements</U>.
Any meeting of the stockholders may be adjourned or postponed from time to time by the chairman of such meeting or by the Board of Directors, without the need for approval thereof by stockholders, to reconvene or convene, respectively at the same or
some other place. Notice need not be given of any such adjourned or postponed meeting (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication) if the time and place, if any, thereof,
and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned or postponed meeting are (i)&nbsp;with respect to an adjourned meeting, (a)&nbsp;announced at
the meeting at which the adjournment is taken, (b)&nbsp;displayed during the time scheduled for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication,
or (c)&nbsp;set forth in the notice of meeting given in accordance with Section&nbsp;4 of this Article II, or (ii)&nbsp;with respect to a postponed meeting, are publicly announced. At the adjourned or postponed meeting, the Corporation may transact
any business which might have been transacted at the original meeting. If the adjournment or postponement is for more than thirty (30)&nbsp;days, notice of the adjourned or postponed meeting in accordance with the requirements of Section&nbsp;4 of
this Article II hereof shall be given to each stockholder of record entitled to vote at the meeting. If, after the adjournment or postponement, a new record date for stockholders entitled to vote is fixed for the adjourned or postponed meeting, the
Board of Directors shall fix a new record date for notice of such adjourned or postponed meeting in accordance with Section&nbsp;11 of this Article II, and shall give notice of the adjourned or postponed meeting to each stockholder of record
entitled to vote at such adjourned or postponed meeting as of the record date fixed for notice of such adjourned or postponed meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_8"></A>Section&nbsp;6. <U>Quorum</U>. Unless otherwise required by the DGCL or other applicable law or the Certificate of Incorporation, the holders of a majority of the Corporation&#146;s capital stock issued and outstanding and entitled to vote
thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business. A quorum, once established, shall not be broken by the withdrawal of enough votes to leave less than a
quorum. If, however, such quorum shall not be present or represented at any meeting of the stockholders, the stockholders entitled to vote thereat, present in person or represented by proxy, shall have power to adjourn the meeting from time to time,
in the manner provided in Section&nbsp;5 of this Article II, until a quorum shall be present or represented. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_9"></A>Section&nbsp;7. <U>Voting</U>. Unless otherwise required by law, the Certificate of Incorporation or these Amended
and Restated Bylaws (these &#147;<U>Bylaws</U>&#148;), or permitted by the rules and regulations of any securities exchange or quotation system on which the securities of the Corporation are listed or quoted for trading, any question brought before
any meeting of the stockholders, other than the election of directors, shall be decided by the vote of the holders of a majority of the total number of votes of the Corporation&#146;s capital stock present at the meeting in person or represented by
proxy and entitled to vote on such question, voting as a single class. Unless otherwise provided in the Certificate of Incorporation, and subject to Section&nbsp;11(a) of this Article II, each stockholder represented at a meeting of the stockholders
shall be entitled to cast one (1)&nbsp;vote for each share of the capital stock entitled to vote thereat held by such stockholder. Such votes may be cast in person or by proxy as provided in Section&nbsp;8 of this Article II. The Board of Directors,
in its discretion, or the chairman of a meeting of the stockholders, in his or her discretion, may require that any votes cast at such meeting shall be cast by written ballot. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_10"></A>Section&nbsp;8. <U>Proxies</U>. Each stockholder entitled to vote at a meeting of the stockholders or to express
consent or dissent to corporate action in writing without a meeting may authorize another person or persons to act for such stockholder as proxy, but no such proxy shall be voted upon after three years from its date, unless such
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proxy provides for a longer period. Without limiting the manner in which a stockholder may authorize another person or persons to act for such stockholder as proxy, the following shall constitute
a valid means by which a stockholder may grant such authority: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) A stockholder, or such stockholder&#146;s authorized
officer, director, employee or agent, may execute a document (meaning (a)&nbsp;any tangible medium on which information is inscribed, and includes handwritten, typed, printed or similar instruments, and copies of such instruments; and (b)&nbsp;an
electronic transmission) authorizing another person or persons to act for such stockholder as proxy. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) A stockholder
may authorize another person or persons to act for such stockholder as proxy by transmitting or authorizing the transmission of an electronic transmission to the person who will be the holder of the proxy or to a proxy solicitation firm, proxy
support service organization or like agent duly authorized by the person who will be the holder of the proxy to receive such transmission, provided that any such transmission must either set forth or be submitted with information from which it can
be determined that the transmission was authorized by the stockholder. If it is determined that such transmissions are valid, the inspectors or, if there are no inspectors, such other persons making that determination shall specify the information
on which they relied. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The authorization of a person to act as proxy may be documented, signed and delivered in
accordance with Section&nbsp;116 of the DGCL, provided that such authorization shall set forth, or be delivered with information enabling the Corporation to determine, the identity of the stockholder granting such authorization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any copy, facsimile telecommunication or other reliable reproduction of the document (including any electronic transmission) authorizing another person or
persons to act as proxy for a stockholder may be substituted or used in lieu of the original document for any and all purposes for which the original document could be used; provided, however, that such copy, facsimile telecommunication or other
reproduction shall be a complete reproduction of the entire original document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_11"></A>Section&nbsp;9. <U>Consent of
Stockholders in Lieu of Meeting</U>. Unless otherwise provided in the Certificate of Incorporation, any action required or permitted to be taken at any Annual or Special Meeting of Stockholders of the Corporation may be taken without a meeting,
without prior notice and without a vote, if a consent or consents, setting forth the action so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take
such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the Corporation in accordance with Section&nbsp;228(d) of the DGCL. A consent must be set forth in writing or in an electronic
transmission. No consent shall be effective to take the corporate action referred to therein unless consents signed by a sufficient number of holders to take action are delivered to the Corporation in the manner required by this Section&nbsp;9 of
this Article II within sixty (60)&nbsp;days of the first date on which a consent is so delivered to the Corporation. Any person executing a consent may provide, whether through instruction to an agent or otherwise, that such a consent will be
effective at a future time (including a time determined upon the happening of an event), no later than sixty (60)&nbsp;days after such instruction is given or such provision is made, if evidence of such instruction or provision is provided to the
Corporation. If the person is not a stockholder of record when the consent is executed, the consent shall not be valid unless the person is a stockholder of record as of the record date for determining stockholders entitled to consent to the action.
Unless otherwise provided, any such consent shall be revocable prior to its becoming effective. Any copy, facsimile or other reliable reproduction of a consent in writing may be substituted or used in lieu of the original writing for any and all
purposes for which the original writing could be used, provided that such copy, facsimile or other reproduction shall be a complete reproduction of the entire original writing. Prompt notice of the taking of the corporate action without a meeting by
less than unanimous consent shall be given to those stockholders who have not consented and who, if the action had been taken at a meeting, would have been entitled to notice of the meeting if the record date for notice of such meeting had been the
date that consents signed by a sufficient number of holders to take the action were delivered to the Corporation as provided above in this Section&nbsp;9 of this Article II. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_12"></A>Section&nbsp;10. <U>List of Stockholders Entitled to Vote</U>.
The Corporation shall prepare, not later than the tenth (10th) day before each meeting of the stockholders, a complete list of the stockholders entitled to vote at the meeting; provided, however, if the record date for determining the stockholders
entitled to vote is less than ten (10)&nbsp;days before the meeting date, the list shall reflect the stockholders entitled to vote as of the tenth (10th) day before the meeting date. Such list shall be arranged in alphabetical order, and show the
address of each stockholder and the number of shares registered in the name of each stockholder; <U>provided</U>, that the Corporation shall not be required to include electronic mail addresses or other electronic contact information on such list.
Such list shall be open to the examination of any stockholder for any purpose germane to the meeting for a period of ten (10)&nbsp;days ending on the day before the meeting date (i)&nbsp;on a reasonably accessible electronic network, provided that
the information required to gain access to such list is provided with the notice of the meeting, or (ii)&nbsp;during ordinary business hours, at the principal place of business of the Corporation. In the event that the Corporation determines to make
the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_13"></A>Section&nbsp;11. <U>Record Date</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In order that the Corporation may determine the stockholders entitled to notice of any meeting of the stockholders or any adjournment
thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than sixty
(60)&nbsp;nor less than ten (10)&nbsp;days before the date of such meeting. If the Board of Directors so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board of
Directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the Board of Directors, the record date for
determining stockholders entitled to notice of and to vote at a meeting of the stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day
next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of the stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of
Directors may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix, as the record date for stockholders entitled to notice of such adjourned meeting, the same or an
earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting in accordance with the foregoing provisions of this Section&nbsp;11 of this Article II. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In order that the Corporation may determine the stockholders entitled to consent to corporate action without a meeting, the Board of
Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board of Directors, and which record date shall not be more than ten (10)&nbsp;days after the date upon
which the resolution fixing the record date is adopted by the Board of Directors. If no record date has been fixed by the Board of Directors, the record date for determining stockholders entitled to consent to corporate action without a meeting,
when no prior action by the Board of Directors is required by applicable law, shall be the first date on which a signed consent setting forth the action taken or proposed to be taken is delivered to the Corporation in accordance with
Section&nbsp;228(d) of the DGCL. If no record date has been fixed by the Board of Directors and prior action by the Board of Directors is required by applicable law, the record date for determining stockholders entitled to consent to corporate
action in writing without a meeting shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_14"></A>Section&nbsp;12. <U>Stock Ledger</U>. The stock ledger of the Corporation shall be the only evidence as to who are
the stockholders entitled to examine the list of stockholders required by Section&nbsp;10 of this Article II or the books and records of the Corporation, or to vote in person or by proxy at any meeting of stockholders. As used herein, the stock
ledger of the Corporation shall refer to one (1)&nbsp;or more records administered by or on behalf of the Corporation in which the names of all of the Corporation&#146;s stockholders of record, the address and number of shares registered in the name
of each such stockholder, and all issuances and transfer of stock of the Corporation are recorded in accordance with Section&nbsp;224 of the DGCL. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_15"></A>Section&nbsp;13. <U>Conduct of Meetings</U>. The Board of
Directors of the Corporation may adopt by resolution such rules and regulations for the conduct of any meeting of the stockholders as it shall deem appropriate. Meetings of stockholders shall be presided over by the Chairman of the Board of
Directors, if there shall be one, or in his or her absence, or there shall not be a Chairman of the Board of Directors or in his or her absence, the President. The Board of Directors shall have the authority to appoint a temporary chairman to serve
at any meeting of the stockholders if the Chairman of the Board of Directors or the President is unable to do so for any reason. Except to the extent inconsistent with any rules and regulations adopted by the Board of Directors, the chairman of any
meeting of the stockholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules,
regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following: (i)&nbsp;the establishment of an agenda or order of business for the meeting;
(ii)&nbsp;the determination of when the polls shall open and close for any given matter to be voted on at the meeting; (iii)&nbsp;rules and procedures for maintaining order at the meeting and the safety of those present; (iv)&nbsp;limitations on
attendance at or participation in the meeting to stockholders of record of the Corporation, their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine; (v)&nbsp;restrictions on entry to the
meeting after the time fixed for the commencement thereof; and (vi)&nbsp;limitations on the time allotted to questions or comments by stockholders. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DIRECTORS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_16"></A>Section&nbsp;1. <U>Number and Election of Directors</U>. The Board of Directors shall consist of one or more
members, each of whom shall be a natural person. The number of directors may be determined thereafter from time to time by the Board of Directors. Except as provided in Section&nbsp;2 of this Article III, directors shall be elected by a plurality of
the votes cast at each Annual Meeting of Stockholders and each director so elected shall hold office until the next Annual Meeting of Stockholders and until such director&#146;s successor is duly elected and qualified, or until such director&#146;s
earlier death, resignation or removal. Directors need not be stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_17"></A>Section&nbsp;2. <U>Vacancies</U>.
Unless otherwise required by law or the Certificate of Incorporation, vacancies on the Board of Directors or any committee thereof resulting from the death, resignation or removal of a director, or from an increase in the number of directors
constituting the Board of Directors or such committee or otherwise, may be filled only by a majority of the directors then in office, though less than a quorum, or by a sole remaining director. The directors so chosen shall, in the case of the Board
of Directors, hold office until the next annual election and until their successors are duly elected and qualified, or until their earlier death, resignation or removal and, in the case of any committee of the Board of Directors, shall hold office
until their successors are duly appointed by the Board of Directors or until their earlier death, resignation or removal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_18"></A>Section&nbsp;3. <U>Duties and Powers</U>. The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors which may exercise all such powers of the Corporation except as may be otherwise provided
in the DGCL, the Certificate of Incorporation, or these Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_19"></A>Section&nbsp;4. <U>Meetings</U>. The Board of
Directors and any committee thereof may hold meetings, both regular and special, either within or without the State of Delaware. Regular meetings of the Board of Directors or any committee thereof may be held without notice at such time and at such
place as may from time to time be determined by the Board of Directors or such committee, respectively. Special meetings of the Board of Directors may be called by the Chairman of the Board of Directors, if there be one, the President, or by any
director. Special meetings of any committee of the Board of Directors may be called by the chairman of such committee, if there be one, the President, or any director serving on such committee. Notice of any special meeting stating the place, date
and hour of the meeting shall be given to each director (or, in the case of a committee, to each member of such committee) not less than twenty-four hours before the date of the meeting, by telephone, or in the form of a writing or electronic
transmission, or on such shorter notice as the person or persons calling such meeting may deem necessary or appropriate in the circumstances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_20"></A>Section&nbsp;5. <U>Organization</U>. At each meeting of the
Board of Directors or any committee thereof, the Chairman of the Board of Directors or the chairman of such committee, as the case may be, or, in his or her absence or if there be none, a director chosen by a majority of the directors present, shall
act as chairman of such meeting. Except as provided below, the Secretary of the Corporation shall act as secretary at each meeting of the Board of Directors and of each committee thereof. In case the Secretary shall be absent from any meeting of the
Board of Directors or of any committee thereof, an Assistant Secretary shall perform the duties of secretary at such meeting; and in the absence from any such meeting of the Secretary and all the Assistant Secretaries, the chairman of the meeting
may appoint any person to act as secretary of the meeting. Notwithstanding the foregoing, the members of each committee of the Board of Directors may appoint any person to act as secretary of any meeting of such committee and the Secretary or any
Assistant Secretary of the Corporation may, but need not if such committee so elects, serve in such capacity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_21"></A>Section&nbsp;6. <U>Resignations and Removals of Directors</U>. Any director of the Corporation may resign from the
Board of Directors or any committee thereof at any time, by giving notice in writing or by electronic transmission to the Chairman of the Board of Directors, if there be one, the President or the Secretary of the Corporation and, in the case of a
committee, to the chairman of such committee, if there be one. Such resignation shall take effect when delivered or, if such resignation specifies a later effective time or an effective time, determined upon the happening of an event or events, in
which case, such resignation takes effect upon such effective time. Unless otherwise specified in such resignation, the acceptance of such resignation shall not be necessary to make it effective. A resignation which is conditioned upon the director
failing to receive a specified vote for reelection as a director may provide that it is irrevocable. Except as otherwise required by applicable law and subject to the rights, if any, of the holders of shares of preferred stock then outstanding, any
director or the entire Board of Directors may be removed from office at any time, with or without cause, by the affirmative vote of the holders of at least a majority in voting power of the issued and outstanding capital stock of the Corporation
entitled to vote in the election of directors. Any director serving on a committee of the Board of Directors may be removed from such committee at any time by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_22"></A>Section&nbsp;7. <U>Quorum</U>. Except as otherwise required by law, or the Certificate of Incorporation, at all
meetings of the Board of Directors or any committee thereof, a majority of the entire Board of Directors or a majority of the directors constituting such committee, as the case may be, shall constitute a quorum for the transaction of business and
the vote of a majority of the directors or committee members, as applicable, present at any meeting at which there is a quorum shall be the act of the Board of Directors or such committee, as applicable. If a quorum shall not be present at any
meeting of the Board of Directors or any committee thereof, the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting of the time and place of the adjourned meeting, until a quorum
shall be present. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_23"></A>Section&nbsp;8. <U>Actions of the Board by Written Consent</U>. Unless otherwise provided
in the Certificate of Incorporation or these Bylaws, (a)&nbsp;any action required or permitted to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all the members of the Board of
Directors or such committee, as the case may be, consent thereto in writing or by electronic transmission and (b)&nbsp;a consent may be documented, signed and delivered in any manner permitted by Section&nbsp;116 of the DGCL. Any person, whether or
not then a director, may provide, through instruction to an agent or otherwise, that a consent to action will be effective at a future time (including a time determined upon the happening of an event) no later than sixty (60)&nbsp;days after such
instruction is given or such provision is made and such consent shall be deemed to have been given at such effective time so long as such person is then a director and did not revoke the consent prior to such time. Any such consent shall be
revocable prior to its becoming effective. After an action is taken, the consent or consents relating thereto shall be filed with the minutes of the proceedings of the Board of Directors, or the committee thereof, in the same paper or electronic
form as the minutes are maintained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_24"></A>Section&nbsp;9. <U>Meetings by Means of Conference Telephone</U>. Unless
otherwise provided in the Certificate of Incorporation or these Bylaws, members of the Board of Directors of the Corporation, or any committee thereof, may participate in a meeting of the Board of Directors or such committee by means of a conference
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this Section&nbsp;9 of this
Article III shall constitute presence in person at such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_25"></A>Section&nbsp;10. <U>Committees</U>. The
Board of Directors may designate one or more committees, each committee to consist of one or more of the directors of the Corporation. Each member of a committee must meet the requirements for membership, if any, imposed by applicable law. The Board
of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of any such committee. In the absence of a designation by the Board of Directors of an alternate
member to replace the absent or disqualified member, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another qualified member
of the Board of Directors to act at the meeting in the place of any absent or disqualified member. Any such committee, to the extent permitted by law and provided in the resolution establishing such committee, shall have and may exercise all the
powers and authority of the Board of Directors in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers which may require it; provided, however, that no such
committee shall have the power or authority to (i)&nbsp;approve, adopt, or recommend to the stockholders any action or matter (other than the election or removal of directors) expressly required by the DGCL to be submitted to stockholders for
approval, or (ii)&nbsp;adopt, amend, or repeal any of these Bylaws. Each committee shall keep regular minutes and report to the Board of Directors when required. Notwithstanding anything to the contrary contained in this Article III, the resolution
of the Board of Directors establishing any committee of the Board of Directors and/or the charter of any such committee may establish requirements or procedures relating to the governance and/or operation of such committee that are different from,
or in addition to, those set forth in these Bylaws and, to the extent that there is any inconsistency between these Bylaws and any such resolution or charter, the terms of such resolution or charter shall be controlling. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_26"></A>Section&nbsp;11. <U>Subcommittees</U>. Unless otherwise provided in the Certificate of Incorporation, these
Bylaws, or the resolution of the Board of Directors designating a committee, such committee may create one or more subcommittees, each subcommittee to consist of one or more members of the committee, and delegate to a subcommittee any or all of the
powers and authority of the committee. Except for references to committees and members of committees in Section&nbsp;10 of this Article III, every reference in these Bylaws to a committee of the Board of Directors or a member of a committee shall be
deemed to include a reference to a subcommittee or member of a subcommittee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_27"></A>Section&nbsp;12.
<U>Compensation</U>. The directors may be paid their expenses, if any, of attendance at each meeting of the Board of Directors and may be paid a fixed sum for attendance at each meeting of the Board of Directors or a stated salary for service as
director, payable in cash or securities. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor. Members of special or standing committees may be allowed like compensation
for service as committee members. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_28"></A>Section&nbsp;13. <U>Interested Directors</U>. No contract or transaction
between the Corporation and one or more of its directors or officers, or between the Corporation and any other corporation, partnership, association or other organization in which one or more of its directors or officers are directors or officers or
have a financial interest, shall be void or voidable solely for this reason, or solely because the director or officer is present at or participates in the meeting of the Board of Directors or committee thereof which authorizes the contract or
transaction, or solely because any such director&#146;s or officer&#146;s vote is counted for such purpose if: (i)&nbsp;the material facts as to the director&#146;s or officer&#146;s relationship or interest and as to the contract or transaction are
disclosed or are known to the Board of Directors or the committee, and the Board of Directors or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of the disinterested directors, even though the
disinterested directors be less than a quorum; or (ii)&nbsp;the material facts as to the director&#146;s or officer&#146;s relationship or interest and as to the contract or transaction are disclosed or are known to the stockholders entitled to vote
thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or (iii)&nbsp;the contract or transaction is fair as to the Corporation as of the time it is authorized, approved or ratified by the Board of Directors, a committee thereof or the stockholders.
Common or interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or of a committee which authorizes such contract or transaction. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OFFICERS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_29"></A>Section&nbsp;1. <U>General</U>. The officers of the Corporation shall be chosen by the Board of Directors and
shall be a President, a Treasurer and a Secretary. The Board of Directors, in its discretion, also may choose a Chairman of the Board of Directors (who must be a director) and one or more Vice Presidents, Assistant Secretaries, Assistant Treasurers
and other officers. Any number of offices may be held by the same person, unless otherwise prohibited by law, the Certificate of Incorporation or these Bylaws. The officers of the Corporation need not be stockholders of the Corporation nor, except
in the case of the Chairman of the Board of Directors, need such officers be directors of the Corporation. Any officer may be removed, with or without cause, at any time by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_30"></A>Section&nbsp;2. <U>Election</U>. The Board of Directors, at its first meeting held after each Annual Meeting of
Stockholders (or action by written consent of stockholders in lieu of the Annual Meeting of Stockholders), shall elect the officers of the Corporation who shall hold their offices for such terms and shall exercise such powers and perform such duties
as shall be determined from time to time by the Board of Directors; and each officer of the Corporation shall hold office until such officer&#146;s successor is elected and qualified, or until such officer&#146;s earlier death, resignation or
removal. Any officer elected by the Board of Directors may be removed at any time by the Board of Directors. Any vacancy occurring in any office of the Corporation shall be filled by the Board of Directors. The salaries of all officers of the
Corporation shall be fixed by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_31"></A>Section&nbsp;3. <U>Voting Securities Owned by the
Corporation</U>. Powers of attorney, proxies, waivers of notice of meeting, consents and other instruments relating to securities owned by the Corporation may be executed in the name of and on behalf of the Corporation by the President or any Vice
President or any other officer authorized to do so by the Board of Directors and any such officer may, in the name of and on behalf of the Corporation, take all such action as any such officer may deem advisable to vote in person or by proxy at any
meeting of security holders of any corporation or other entity in which the Corporation may own securities and at any such meeting shall possess and may exercise any and all rights and power incident to the ownership of such securities and which, as
the owner thereof, the Corporation might have exercised and possessed if present. The Board of Directors may, by resolution, from time to time confer like powers upon any other person or persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_32"></A>Section&nbsp;4. <U>Chairman of the Board of Directors</U>. The Chairman of the Board of Directors, if there be
one, shall preside at all meetings of the stockholders and of the Board of Directors. The Chairman of the Board of Directors shall be the Chief Executive Officer of the Corporation, unless the Board of Directors designates the President as the Chief
Executive Officer, and, except where by law the signature of the President is required, the Chairman of the Board of Directors shall possess the same power as the President to sign all contracts, certificates and other instruments of the Corporation
which may be authorized by the Board of Directors. During the absence or disability of the President, the Chairman of the Board of Directors shall exercise all the powers and discharge all the duties of the President. The Chairman of the Board of
Directors shall also perform such other duties and may exercise such other powers as may from time to time be assigned by these Bylaws or by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_33"></A>Section&nbsp;5. <U>President</U>. The President shall, subject to the oversight and control of the Board of
Directors and, if there be one, the Chairman of the Board of Directors, have general supervision of the business of the Corporation and shall see that all orders and resolutions of the Board of Directors are carried into effect. The
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
President shall execute all bonds, mortgages, contracts and other instruments of the Corporation requiring a seal, under the seal of the Corporation, except where required or permitted by law to
be otherwise signed and executed and except that the other officers of the Corporation may sign and execute documents when so authorized by these Bylaws, the Board of Directors or the President. In the absence or disability of the Chairman of the
Board of Directors, or if there be none, the President shall preside at all meetings of the stockholders and, if the President is also a director, the Board of Directors. If there be no Chairman of the Board of Directors, or if the Board of
Directors shall otherwise designate, the President shall be the Chief Executive Officer of the Corporation. The President shall also perform such other duties and may exercise such other powers as may from time to time be assigned to such officer by
these Bylaws or by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_34"></A>Section&nbsp;6. <U>Vice Presidents</U>. At the request of the
President or in the President&#146;s absence or in the event of the President&#146;s inability or refusal to act (and if there be no Chairman of the Board of Directors), the Vice President, or the Vice Presidents if there are more than one (in the
order designated by the Board of Directors), shall perform the duties of the President, and when so acting, shall have all the powers of and be subject to all the restrictions upon the President. Each Vice President shall perform such other duties
and have such other powers as the Board of Directors from time to time may prescribe. If there be no Chairman of the Board of Directors and no Vice President, the Board of Directors shall designate the officer of the Corporation who, in the absence
of the President or in the event of the inability or refusal of the President to act, shall perform the duties of the President, and when so acting, shall have all the powers of and be subject to all the restrictions upon the President. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_35"></A>Section&nbsp;7. <U>Secretary</U>. The Secretary shall attend all meetings of the Board of Directors and all
meetings of the stockholders and record all the proceedings thereat in a book or books to be kept for that purpose; the Secretary shall also perform like duties for committees of the Board of Directors when required. The Secretary shall give, or
cause to be given, notice of all meetings of the stockholders and special meetings of the Board of Directors, and shall perform such other duties as may be prescribed by the Board of Directors, the Chairman of the Board of Directors or the
President, under whose supervision the Secretary shall be. If the Secretary shall be unable or shall refuse to cause to be given notice of all meetings of the stockholders and special meetings of the Board of Directors, and if there be no Assistant
Secretary, then either the Board of Directors or the President may choose another officer to cause such notice to be given. The Secretary shall have custody of the seal of the Corporation and the Secretary or any Assistant Secretary, if there be
one, shall have authority to affix the same to any instrument requiring it and when so affixed, it may be attested by the signature of the Secretary or by the signature of any such Assistant Secretary. The Board of Directors may give general
authority to any other officer to affix the seal of the Corporation and to attest to the affixing by such officer&#146;s signature. The Secretary shall see that all books, reports, statements, certificates and other documents and records required by
law to be kept or filed are properly kept or filed, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_36"></A>Section&nbsp;8. <U>Treasurer</U>. The
Treasurer shall have the custody of the Corporation&#146;s funds and securities and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation and shall deposit all moneys and other valuable effects in
the name and to the credit of the Corporation in such depositories as may be designated by the Board of Directors. The Treasurer shall disburse the funds of the Corporation as may be ordered by the Board of Directors or the President taking proper
vouchers for such disbursements, and shall render to the President and the Board of Directors, at its regular meetings, or when the Board of Directors so requires, an account of all transactions as Treasurer and of the financial condition of the
Corporation. If required by the Board of Directors, the Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall be satisfactory to the Board of Directors for the faithful performance of the duties of the
office of the Treasurer and for the restoration to the Corporation, in case of the Treasurer&#146;s death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind in the
Treasurer&#146;s possession or under the Treasurer&#146;s control belonging to the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_37"></A>Section&nbsp;9. <U>Assistant Secretaries</U>. Assistant Secretaries, if there be any, shall perform such duties
and have such powers as from time to time may be assigned to them by the Board of Directors, the President, any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Vice President, if there be one, or the Secretary, and in the absence of the Secretary or in the event of the Secretary&#146;s inability or refusal to act, shall perform the duties of the
Secretary, and when so acting, shall have all the powers of and be subject to all the restrictions upon the Secretary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_38"></A>Section&nbsp;10. <U>Assistant Treasurers</U>. Assistant Treasurers, if there be any, shall perform such duties and have such powers as from time to time may be assigned to them by the Board of Directors, the President, any Vice President, if
there be one, or the Treasurer, and in the absence of the Treasurer or in the event of the Treasurer&#146;s inability or refusal to act, shall perform the duties of the Treasurer, and when so acting, shall have all the powers of and be subject to
all the restrictions upon the Treasurer. If required by the Board of Directors, an Assistant Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall be satisfactory to the Board of Directors for the faithful
performance of the duties of the office of Assistant Treasurer and for the restoration to the Corporation, in case of the Assistant Treasurer&#146;s death, resignation, retirement or removal from office, of all books, papers, vouchers, money and
other property of whatever kind in the Assistant Treasurer&#146;s possession or under the Assistant Treasurer&#146;s control belonging to the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_39"></A>Section&nbsp;11. <U>Other Officers</U>. Such other officers as the Board of Directors may choose shall perform
such duties and have such powers as from time to time may be assigned to them by the Board of Directors. The Board of Directors may delegate to any other officer of the Corporation the power to choose such other officers and to prescribe their
respective duties and powers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STOCK</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_37a"></A>Section&nbsp;1. <U>Form of Certificates</U>. Every holder of stock in the Corporation shall be entitled to have a certificate signed by, or in the name of, the Corporation by any two authorized officers of the Corporation, certifying the number
of shares owned by such stockholder in the Corporation. The Corporation shall not have power to issue a certificate in bearer form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_38a"></A>Section&nbsp;2. <U>Signatures</U>. Any or all of the signatures on a certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have
ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if such person were such officer, transfer agent or registrar at the date of issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_39a"></A>Section&nbsp;3. <U>Lost Certificates</U>. The Board of Directors may direct a new certificate to be issued in
place of any certificate theretofore issued by the Corporation alleged to have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen or destroyed. When
authorizing such issue of a new certificate, the Board of Directors may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificate, or such owner&#146;s legal
representative, to advertise the same in such manner as the Board of Directors shall require and/or to give the Corporation a bond in such sum as it may direct as indemnity against any claim that may be made against the Corporation on account of the
alleged loss, theft or destruction of such certificate or the issuance of such new certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_40"></A>Section&nbsp;4. <U>Transfers</U>. Stock of the Corporation shall be transferable in the manner prescribed by
applicable law and in these Bylaws. Transfers of stock shall be made on the books of the Corporation only by the person named in the certificate or by such person&#146;s attorney lawfully constituted in writing and upon the surrender of the
certificate therefor, properly endorsed for transfer and payment of all necessary transfer taxes; provided, however, that such surrender and endorsement or payment of taxes shall not be required in any case in which the officers of the Corporation
shall determine to waive such requirement. Every certificate exchanged, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
returned or surrendered to the Corporation shall be marked &#147;Cancelled,&#148; with the date of cancellation, by the Secretary or Assistant Secretary of the Corporation or the transfer agent
thereof. No transfer of stock shall be valid as against the Corporation for any purpose until it shall have been entered in the stock records of the Corporation by an entry showing from and to whom transferred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_41"></A>Section&nbsp;5. <U>Dividend Record Date</U>. In order that the Corporation may determine the stockholders entitled
to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful action, the
Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty (60)&nbsp;days prior to such action. If no record
date is fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_42"></A>Section&nbsp;6. <U>Record Owners</U>. The Corporation shall be entitled to recognize the exclusive right of a
person registered on its books as the owner of shares to receive dividends, and to vote as such owner, and to hold liable for calls and assessments a person registered on its books as the owner of shares, and shall not be bound to recognize any
equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_43"></A>Section&nbsp;7. <U>Transfer and Registry Agents</U>. The Corporation may from time to time maintain one or more
transfer offices or agencies and registry offices or agencies at such place or places as may be determined from time to time by the Board of Directors. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>NOTICES</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_44"></A>Section&nbsp;1. <U>Notices</U>. Whenever written notice is required by law, the Certificate of Incorporation or
these Bylaws, to be given to any director, member of a committee or stockholder, such notice may be given in writing directed to such director&#146;s, committee member&#146;s or stockholder&#146;s mailing address (or by electronic transmission
directed to such director&#146;s, committee member&#146;s or stockholder&#146; electronic mail address, as applicable) as it appears on the records of the Corporation and shall be given: (a)&nbsp;if mailed, when the notice is deposited in the United
States mail, postage prepaid, (b)&nbsp;if delivered by courier service, the earlier of when the notice is received or left at such director&#146;s, committee member&#146;s or stockholder&#146;s address or (c)&nbsp;if given by electronic mail, when
directed to such director&#146;s, committee member&#146;s or stockholder&#146;s electronic mail address unless such director, committee member or stockholder has notified the corporation in writing or by electronic transmission of an objection to
receiving notice by electronic mail or such notice is prohibited by the under applicable law, the Certificate of Incorporation or these Bylaws. Without limiting the manner by which notice otherwise may be given effectively to stockholders, but
subject to Section&nbsp;232(e) of the DGCL, any notice to stockholders given by the Corporation under applicable law, the Certificate of Incorporation or these Bylaws shall be effective if given by a form of electronic transmission consented to by
the stockholder to whom the notice is given. Any such consent shall be revocable by the stockholder by written notice or electronic transmission to the Corporation. The Corporation may give notice by electronic mail in accordance with the first
sentence of this Section&nbsp;1 of this Article VI without obtaining the consent required by the second sentence of this Section&nbsp;1 of this Article VI. Notice given by electronic transmission, as described above, shall be deemed given:
(i)&nbsp;if by facsimile telecommunication, when directed to a number at which the stockholder has consented to receive notice; (ii)&nbsp;if by a posting on an electronic network, together with separate notice to the stockholder of such specific
posting, upon the later of (A)&nbsp;such posting and (B)&nbsp;the giving of such separate notice; and (iii)&nbsp;if by any other form of electronic transmission, when directed to the stockholder. Notwithstanding the foregoing, a notice may not be
given by an electronic transmission from and after the time that (i)&nbsp;the Corporation is unable to deliver by such electronic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transmission two consecutive notices given by the Corporation and (ii)&nbsp;such inability becomes known to the Secretary or an Assistant Secretary of the Corporation or to the transfer agent, or
other person responsible for the giving of notice, provided, however, the inadvertent failure to discover such inability shall not invalidate any meeting or other action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_45"></A>Section&nbsp;2. <U>Waivers of Notice</U>. Whenever any notice is required, by applicable law, the Certificate of
Incorporation or these Bylaws, to be given to any director, member of a committee or stockholder, a waiver thereof in writing, signed by the person or persons entitled to notice, or a waiver by electronic transmission by the person or persons
entitled to notice, whether before or after the time stated therein, shall be deemed equivalent thereto. Attendance of a person at a meeting, present in person or represented by proxy, shall constitute a waiver of notice of such meeting, except
where the person attends the meeting for the express purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the
purpose of, any Annual or Special Meeting of Stockholders or any regular or special meeting of the directors or members of a committee of directors need be specified in any written waiver of notice or any waiver by electronic transmission unless so
required by law, the Certificate of Incorporation or these Bylaws. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VII </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>GENERAL PROVISIONS</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_46"></A>Section&nbsp;1. <U>Dividends</U>. Dividends upon the capital stock of the Corporation, subject to the requirements of the DGCL and the provisions of the Certificate of Incorporation, if any, may be declared by the Board of Directors at any
regular or special meeting of the Board of Directors (or any action by written consent in lieu thereof in accordance with Section&nbsp;8 of Article III hereof), and may be paid in cash, in property, or in shares of the Corporation&#146;s capital
stock. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the Board of Directors from time to time, in its absolute discretion, deems proper as a reserve or reserves
to meet contingencies, or for purchasing any of the shares of capital stock, warrants, rights, options, bonds, debentures, notes, scrip or other securities or evidences of indebtedness of the Corporation, or for equalizing dividends, or for
repairing or maintaining any property of the Corporation, or for any proper purpose, and the Board of Directors may modify or abolish any such reserve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_47"></A>Section&nbsp;2. <U>Disbursements</U>. All checks or demands for money and notes of the Corporation shall be signed
by such officer or officers or such other person or persons as the Board of Directors may from time to time designate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_48"></A>Section&nbsp;
3. <U>Fiscal Year</U>. The fiscal year of the Corporation shall be fixed by resolution of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_49"></A>Section&nbsp;4.
 <U>Corporate Seal</U>. The corporate seal shall have inscribed thereon the name of the Corporation, the year of its organization and the words &#147;Corporate Seal, Delaware&#148;. The seal may be used by causing it or a facsimile thereof to be
impressed or affixed or reproduced or otherwise. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VIII </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>INDEMNIFICATION</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_50"></A>Section&nbsp;1. <U>Indemnification Provisions with Respect to Historic Matters.</U> The following provisions of this Section&nbsp;1 of this Article VIII shall apply with respect to matters arising prior to or on [&#149;], 2024, whether asserted
or claimed prior to, at or after such date, and shall continue in effect for such matters until [&#149;], 2030: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Right to
Indemnification</U>. Each person who was or is made a party, or is threatened to be made a party to, or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
investigative (hereinafter a &#147;Proceeding&#148;), by reason of the fact that he or she or a person of whom he or she is the legal representative (i)&nbsp;is or was a director or officer of
the Corporation or (ii)&nbsp;is or was serving at the request of the Corporation as a director, officer, trustee, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect
to employee benefit plans maintained or sponsored by the Corporation (hereinafter, an &#147;indemnitee&#148;), whether the basis of such Proceeding is an alleged action or omission in an official capacity as a director, officer, trustee, employee or
agent or in any other capacity while serving as a director, officer, trustee, employee or agent, shall be indemnified and held harmless by the Corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended,
against all expense, liability and loss (including attorneys&#146; fees, judgments, fines, ERISA excise taxes, or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such indemnitee in connection therewith, and
such indemnification shall continue as to an indemnitee who has ceased to be a director, officer, trustee, employee or agent, and shall inure to the benefit of the indemnitee&#146;s heirs, executors and administrators; provided, however, that except
as provided in Section&nbsp;1(b) of this Article VIII with respect to proceedings to enforce rights to indemnification, the Corporation shall indemnify any such indemnitee in connection with a Proceeding (or part thereof) initiated by such
indemnitee only if such Proceeding (or part thereof) was authorized by the Board of Directors. The right to indemnification conferred in this Section&nbsp;1(a) shall be a contract right and shall include the right to be paid by the Corporation the
expenses incurred in defending any such Proceeding in advance of its final disposition (hereinafter an &#147;Advancement of Expenses&#148;); provided, however, that if the DGCL requires, an Advancement of Expenses incurred by an indemnitee in his or
her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such person while a director or officer, including, without limitation, service to an employee benefit plan) shall be made only upon delivery
to the Corporation of an undertaking, by or on behalf of such indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision, from which there is no further right to appeal, that such indemnitee is not
entitled to be indemnified for such expenses under this Section&nbsp;1(a) or otherwise (hereinafter an &#147;Undertaking&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Right of Indemnitee to Bring Suit</U>. If a claim under Section&nbsp;1(a) of this Article VIII is not paid in full by the Corporation within sixty days after a written claim has been received by the Corporation, except in the case of a claim for
an Advancement of Expenses, in which case the applicable period shall be twenty days, the indemnitee may, at any time thereafter, bring suit against the Corporation to recover the unpaid amount of the claim. If successful, in whole or in part, in
any suit, or in a suit brought by the Corporation to recover an Advancement of Expenses pursuant to the terms of an Undertaking, the indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit. In (i), any suit
brought by the indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the indemnitee to enforce a right to an Advancement of Expenses), it shall be a defense that, and (ii)&nbsp;any suit by the Corporation to
recover an Advancement of Expenses pursuant to the terms of an Undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that, the indemnitee has not met the applicable standard of conduct set forth in the
DGCL. Neither the failure of the Corporation (including its Board of Directors, independent legal counsel or its stockholders) to have made a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in
the circumstances because the indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the Corporation (including its Board of Directors, independent legal counsel or its stockholders) that the
indemnitee has not met such applicable standard of conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct, or, in the case of such a suit brought by the indemnitee, be a defense to such suit. In any
suit brought by the indemnitee to enforce a right hereunder, or by the Corporation to recover an Advancement of Expenses pursuant to the terms of an Undertaking, the burden of proving that the indemnitee is not entitled to be indemnified or to such
Advancement of Expenses under this Section&nbsp;1(b) or otherwise, shall be on the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights; Reliance</U>. The rights to indemnification and to the Advancement of Expenses conferred in this Section&nbsp;1 (i) shall not be exclusive of any other right which any person may
have or hereafter acquire under any statute, these Bylaws, the Certificate of Incorporation, vote of stockholders or disinterested directors, or otherwise and (ii) cannot be terminated by the Corporation, the Board of Directors or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the stockholders of the Corporation with respect to a person&#146;s service prior to the date of such termination. The rights of an indemnitee to indemnification, advancement of expenses or
otherwise under this Section&nbsp;1 shall vest at the time such person is elected or appointed a director, officer, trustee, employee or agent, and no amendment, modification, alteration or repeal of this Section shall affect the rights of any
indemnitee or his or her successors whose rights previously vested prior to the time of any such amendment modification, alternation or repeal without such person&#146;s written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Insurance</U>. The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent
of the Corporation or another corporation, partnership, joint venture, trustor other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense, liability or
loss under the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Other Indemnification</U>. The Corporation may, to the extent authorized from
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-time</FONT></FONT> by the Board of Directors, grant rights to indemnification and to the Advancement of Expenses to any director, officer, employee or agent of the
Corporation, whether or not acting in his or her capacity as such, or at the request of the Corporation, to the fullest extent of the provisions of this Section&nbsp;1 with respect to the indemnification and Advancement of Expenses of directors and
officers of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_51"></A>Section&nbsp;2. <U>Indemnification Provisions with Respect to Future
Matters</U>. The following provisions of this Section&nbsp;2 of this Article VIII shall apply with respect to matters arising after [&#149;], 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Power to Indemnify in Actions, Suits or Proceedings other than Those by or in the Right of the Corporation</U>. Subject to
Section&nbsp;2(c) of this Article VIII, the Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative (other than an action by or in the right of the Corporation), by reason of the fact that such person is or was a director or officer of the Corporation, or is or was a director or officer of the Corporation serving at the request of
the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and
reasonably incurred by such person in connection with such action, suit or proceeding if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with
respect to any criminal action or proceeding, had no reasonable cause to believe such person&#146;s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere
or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any
criminal action or proceeding, had reasonable cause to believe that such person&#146;s conduct was unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Power to Indemnify in
Actions, Suits or Proceedings by or in the Right of the Corporation</U>. Subject to Section&nbsp;2(c) of this Article VIII, the Corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that such person is or was a director or officer of the Corporation, or is or was a director or officer of the
Corporation serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees) actually and reasonably
incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Corporation; except
that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the Corporation unless and only to the extent that the Court of Chancery of the State of Delaware or the
court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such
expenses which the Court of Chancery or such other court shall deem proper. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorization of Indemnification</U>. Any indemnification under this Section&nbsp;2
of this Article VIII (unless ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification of the present or former director or officer is proper in the circumstances because
such person has met the applicable standard of conduct set forth in Section&nbsp;2(a) of this Article VIII or Section&nbsp;2(b) of this Article VIII, as the case may be. Such determination shall be made, with respect to a person who is a director or
officer of the Corporation at the time of such determination, (i)&nbsp;by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, (ii)&nbsp;by a committee of such directors designated
by a majority vote of such directors, even though less than a quorum, (iii)&nbsp;if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion or (iv)&nbsp;by the stockholders. Such determination
shall be made, with respect to former directors and officers, by any person or persons having the authority to act on the matter on behalf of the Corporation. To the extent, however, that a present or former director or officer of the Corporation
has been successful on the merits or otherwise in defense of any action, suit or proceeding described above, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys&#146; fees)
actually and reasonably incurred by such person in connection therewith, without the necessity of authorization in the specific case. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<U>Good Faith Defined</U>. For purposes of any determination under Section&nbsp;2(c) of this Article VIII, a person shall be deemed to have acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best
interests of the Corporation, or, with respect to any criminal action or proceeding, to have had no reasonable cause to believe such person&#146;s conduct was unlawful, if such person&#146;s action is based on the records or books of account of the
Corporation or another enterprise, or on information supplied to such person by the officers of the Corporation or another enterprise in the course of their duties, or on the advice of legal counsel for the Corporation or another enterprise or on
information or records given or reports made to the Corporation or another enterprise by an independent certified public accountant or by an appraiser or other expert selected with reasonable care by the Corporation or another enterprise. The
provisions of this Section&nbsp;2(d) of this Article VIII shall not be deemed to be exclusive or to limit in any way the circumstances in which a person may be deemed to have met the applicable standard of conduct set forth in Section&nbsp;2(a) of
this Article VIII or Section&nbsp;2(b) of this Article VIII, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Indemnification by a Court</U>. Notwithstanding
any contrary determination in the specific case under Section&nbsp;2(c) of this Article VIII, and notwithstanding the absence of any determination thereunder, any director or officer may apply to the Court of Chancery of the State of Delaware or any
other court of competent jurisdiction in the State of Delaware for indemnification to the extent otherwise permissible under Section&nbsp;2(a) of this Article VIII or Section&nbsp;2(b) of this Article VIII. The basis of such indemnification by a
court shall be a determination by such court that indemnification of the director or officer is proper in the circumstances because such person has met the applicable standard of conduct set forth in Section&nbsp;2(a) of this Article VIII or
Section&nbsp;2(b) of this Article VIII, as the case may be. Neither a contrary determination in the specific case under Section&nbsp;2(c) of this Article VIII nor the absence of any determination thereunder shall be a defense to such application or
create a presumption that the director or officer seeking indemnification has not met any applicable standard of conduct. Notice of any application for indemnification pursuant to this Section&nbsp;2(e) of this Article VIII shall be given to the
Corporation promptly upon the filing of such application. If successful, in whole or in part, the director or officer seeking indemnification shall also be entitled to be paid the expense of prosecuting such application. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Expenses Payable in Advance</U>. Expenses (including attorneys&#146; fees) incurred by a director or officer of the Corporation in
defending any civil, criminal, administrative or investigative action, suit or proceeding shall be paid by the Corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such
director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the Corporation as authorized in this Section&nbsp;2 of this Article VIII. Such expenses (including attorneys&#146;
fees) incurred by former directors and officers or other employees and agents of the Corporation or by persons serving at the request of the Corporation as directors, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
officers, employees or agents of another corporation, partnership, joint venture, trust or other enterprise may be so paid upon such terms and conditions, if any, as the Corporation deems
appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Indemnification and Advancement of Expenses</U>. The
indemnification and advancement of expenses provided by, or granted pursuant to, this Section&nbsp;2 of this Article VIII shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be
entitled under the Certificate of Incorporation, these Bylaws, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#146;s official capacity and as to action in another capacity while holding such
office, it being the policy of the Corporation that indemnification of the persons specified in Section&nbsp;2(a) of this Article VIII and Section&nbsp;2(b) of this Article VIII shall be made to the fullest extent permitted by law. A right to
indemnification or to advancement of expenses arising under a provision of the Certificate of Incorporation or these Bylaws shall not be eliminated or impaired by an amendment to the Certificate of Incorporation or these Bylaws after the occurrence
of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or
omission explicitly authorizes such elimination or impairment after such action or omission has occurred. The provisions of this Section&nbsp;2 of this Article VIII shall not be deemed to preclude the indemnification of any person who is not
specified in Section&nbsp;2(a) of this Article VIII or Section&nbsp;2(b) of this Article VIII but whom the Corporation has the power or obligation to indemnify, under the provisions of the DGCL, or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Insurance</U>. The Corporation may purchase and maintain insurance on behalf of any person who is or was a director or officer of the
Corporation, or is or was a director or officer of the Corporation serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any
liability asserted against such person and incurred by such person in any such capacity, or arising out of such person&#146;s status as such, whether or not the Corporation would have the power or the obligation to indemnify such person against such
liability under the provisions of this Section&nbsp;2 of this Article VIII. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Certain Definitions</U>. For purposes of this
Section&nbsp;2 of this Article VIII, references to &#147;the Corporation&#148; shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger
which, if its separate existence had continued, would have had power and authority to indemnify its directors or officers, so that any person who is or was a director or officer of such constituent corporation, or is or was a director or officer of
such constituent corporation serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under the
provisions of this Section&nbsp;2 of this Article VIII with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate existence had continued. The term &#147;another
enterprise&#148; as used in this Section&nbsp;2 of this Article VIII shall mean any other corporation or any partnership, joint venture, trust, employee benefit plan or other enterprise of which such person is or was serving at the request of the
Corporation as a director, officer, employee or agent. For purposes of this Section&nbsp;2 of this Article VIII, references to &#147;fines&#148; shall include any excise taxes assessed on a person with respect to an employee benefit plan; and
references to &#147;serving at the request of the Corporation&#148; shall include any service as a director, officer, employee or agent of the Corporation which imposes duties on, or involves services by, such director or officer with respect to an
employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to
have acted in a manner &#147;not opposed to the best interests of the Corporation&#148; as referred to in this Section&nbsp;2 of this Article VIII. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Survival of Indemnification and Advancement of Expenses</U>. The indemnification and advancement of expenses provided by, or granted
pursuant to, this Section&nbsp;2 of this Article VIII shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors and
administrators of such a person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Limitation on Indemnification</U>. Notwithstanding anything contained in this
Section&nbsp;2 of this Article VIII to the contrary, except for proceedings to enforce rights to indemnification (which shall be governed by Section&nbsp;2(e) of this Article VIII), the Corporation shall not be obligated to, under this
Section&nbsp;2 of this Article VIII, indemnify any director or officer (or his or her heirs, executors or personal or legal representatives) or advance expenses in connection with a proceeding (or part thereof) initiated by such person unless such
proceeding (or part thereof) was authorized or consented to by the Board of Directors of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Indemnification of
Employees and Agents</U>. The Corporation may, to the extent authorized from time to time by the Board of Directors, provide rights to indemnification and to the advancement of expenses to employees and agents of the Corporation similar to those
conferred in this Section&nbsp;2 of this Article VIII to directors and officers of the Corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IX </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>FORUM FOR ADJUDICATION OF CERTAIN DISPUTES</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_52"></A>Section&nbsp;1. <U>Forum for Adjudication of Certain Disputes</U>. Unless the Corporation consents in writing to
the selection of an alternative forum (an &#147;Alternative Forum Consent&#148;), the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on behalf of the
Corporation, (ii)&nbsp;any action asserting a claim of breach of a duty (including any fiduciary duty) owed by any current or former director, officer, stockholder, employee<B> </B>or agent of the Corporation to the Corporation or the
Corporation&#146;s stockholders, (iii)&nbsp;any action asserting a claim against the Corporation or any current or former director, officer, stockholder, employee or agent of the Corporation arising out of or relating to any provision of the DGCL,
the Certificate of Incorporation or these Bylaws (each, as in effect from time to time), or (iv)&nbsp;any action asserting a claim against the Corporation or any current or former director, officer, stockholder, employee or agent of the Corporation
governed by the internal affairs doctrine of the State of Delaware; provided, however,&nbsp;that, in the event that the Court of Chancery of the State of Delaware lacks subject matter jurisdiction over any such action or proceeding,&nbsp;the sole
and exclusive forum for such action or proceeding shall be another state or federal court located within the State of Delaware, in each such case, unless the Court of Chancery (or such other state or federal court located within the State of
Delaware, as applicable) has dismissed a prior action by the same plaintiff asserting the same claims because such court lacked personal jurisdiction over an indispensable party named as a defendant therein. Unless the Corporation gives an
Alternative Forum Consent, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the
Securities Act of 1933, as amended. Failure to enforce the foregoing provisions would cause the Corporation irreparable harm and the Corporation shall be entitled to equitable relief, including injunctive relief and specific performance, to enforce
the foregoing provisions. Any person or entity purchasing, otherwise acquiring or holding any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of Section&nbsp;1 of this Article
IX. The existence of any prior Alternative Forum Consent shall not act as a waiver of the Corporation&#146;s ongoing consent right as set forth above in Section&nbsp;1 of this Article IX with respect to any current or future actions or claims. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE X </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>AMENDMENTS</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_53"></A>Section&nbsp;1. <U>Amendments</U>. These Bylaws may be altered, amended or repealed, in whole or in part, or new
Bylaws may be adopted by the stockholders or by the Board of Directors; provided, however, that notice of such alteration, amendment, repeal or adoption of new Bylaws be contained in the notice of a meeting of the stockholders or Board of Directors,
as the case may be, called for the purpose of acting upon any proposed alteration, amendment, repeal or adoption of new Bylaws. All such alterations, amendments, repeals or adoptions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of new Bylaws must be approved by either the holders of a majority of the outstanding capital stock entitled to vote thereon or by a majority of the entire Board of Directors then in office. Any
amendment to these Bylaws adopted by stockholders which specifies the votes that shall be necessary for the election of directors shall not be further amended or repealed by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><A NAME="ctoc893453_54"></A>Section&nbsp;2. <U>Entire Board of Directors</U>. As used in this Article X and in these Bylaws generally, the
term &#147;entire Board of Directors&#148; means the total number of directors which the Corporation would have if there were no vacancies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adopted as of: [&#149;], 2024 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom893453_4534"></A>Annex B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VOTING AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">VOTING
AGREEMENT (this &#147;<U>Agreement</U>&#148;), dated as of August&nbsp;13, 2024, among Acquiror 10VB8, LLC, a Delaware limited liability company (&#147;<U>Acquiror</U>&#148;), and the W.K. Kellogg Foundation Trust, a Michigan charitable trust for
the sole benefit of the W.K. Kellogg Foundation (the &#147;Foundation&#148;) (&#147;<U>Stockholder</U>&#148;), a stockholder of Kellanova, a Delaware corporation (the &#147;<U>Company</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as of the date hereof, the Stockholder is the record or &#147;beneficial&#148; owner (as defined in Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> under the U.S. Securities Exchange Act of 1934 (as amended, and the rules promulgated thereunder the &#147;<U>Exchange Act</U>&#148;)) of the number of shares of public common stock of the Company, par value
$0.25 (&#147;<U>Company Shares</U>&#148;), as set forth opposite such Stockholder&#146;s name on <U>Exhibit A</U>;<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution and delivery of this Agreement, Acquiror, Merger Sub 10VB8, LLC, a Delaware limited liability company
and direct or indirect, wholly owned subsidiary of Acquiror (&#147;<U>Merger Sub</U>&#148;), Mars, Incorporated, a Delaware corporation (for the purposes of specific sections only), and the Company, have entered into an Agreement and Plan of Merger,
dated as of the date hereof (as&nbsp;may be amended, supplemented or otherwise modified from time to time, the &#147;<U>Merger Agreement</U>&#148;), pursuant to which, among other things, upon the terms and subject to the conditions thereof, at the
Effective Time, Merger Sub will merge with and into the Company with the Company surviving the merger (the &#147;<U>Merger</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the affirmative vote of the holders of a majority of the issued and outstanding shares of Company Common Stock in favor of the
adoption of the Merger Agreement and the transactions contemplated thereby, including the Merger, is a condition to the consummation of the Merger; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as of the date hereof and subject to the terms and conditions herein, the Stockholder has determined to vote in favor of the Merger
and the other transactions contemplated in the Merger Agreement and in furtherance thereof has agreed to enter into this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to induce Acquiror to enter into the Merger Agreement, Acquiror has requested Stockholder, and Stockholder has agreed, to
enter into this Agreement with respect to all Company Shares, now or hereafter &#147;beneficially owned&#148; by Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, in consideration of the foregoing, the mutual covenants and agreements set forth herein, and other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, intending to be legally bound, the parties
hereto agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 1 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V<SMALL>OTING</SMALL> A<SMALL>GREEMENT</SMALL>; G<SMALL>RANT</SMALL> <SMALL>OF</SMALL> P<SMALL>ROXY</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 <I>Voting Agreement</I>. From the date hereof until the termination of this Agreement in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, Stockholder shall (x)&nbsp;appear at each meeting (whether annual or special and each adjourned or postponed meeting and including the Company Special Meeting) of the stockholders of the Company concerning
proposals related to the Merger, Merger Agreement, any Company Takeover Proposal or any other transaction contemplated by the Merger Agreement or at which any matter set forth in this <U>Section</U><U></U><U>&nbsp;1.01</U> is being considered,
however called, or otherwise cause all of the Company Shares owned (whether beneficially or of record) at such time by Stockholder to be counted as present thereat for purposes of calculating a quorum, and respond to each request by the Company for
written consent, if any, and (y)&nbsp;vote or cause to be voted (including by proxy or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
written consent, if applicable, with respect to) all Company Shares (including any New Company Shares (as defined below), as applicable) owned (whether beneficially or of record) at such time by
Stockholder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) with respect to each meeting at which a vote of Stockholder on the Merger is requested (a &#147;<U>Merger
Proposal</U>&#148;), in favor of such Merger Proposal (and, in the event that such Merger Proposal is presented as more than one proposal, in favor of each proposal that is part of such Merger Proposal), and in favor of any other transactions or
matters expressly contemplated by the Merger Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) against any Company Takeover Proposal, without regard to the terms of such
Company Takeover Proposal, or any other transaction, proposal, agreement or action made in opposition to adoption of the Merger Agreement or in competition or inconsistent with the Merger and the other transactions or matters contemplated by the
Merger Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) against any other action, agreement or transaction that is intended, or that would or would reasonably be expected,
to materially impede, interfere with, delay, postpone, discourage or adversely affect the Merger or any of the other transactions expressly contemplated by the Merger Agreement or the performance by Stockholder of his, her or its obligations under
this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) against any action, proposal, transaction or agreement that would or would reasonably be expected to result in a
breach in any material respect of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Merger Agreement, or of Stockholder contained in this Agreement (clauses&nbsp;(a) through (d)&nbsp;of
this <U>Section</U><U></U><U>&nbsp;1.01</U>, the &#147;<U>Required Votes</U>&#148;); provided that, notwithstanding the foregoing, nothing in this Agreement shall require Stockholder to vote in any manner with respect to any amendment to the Merger
Agreement if such amendment (i)&nbsp;decreases the Merger Consideration, changes the form of the Merger Consideration or otherwise adversely affects the consideration payable to the holders of Company Common Stock, (ii)&nbsp;other than as
contemplated by the Merger Agreement (as it exists on the date of this Agreement) including <U>Section</U><U></U><U>&nbsp;7.1(c)</U> of the Company Disclosure Schedule thereto, imposes any material restrictions or any additional material conditions
on the consummation of the Merger or the payment of the Merger Consideration to the Company&#146;s stockholders or (iii)&nbsp;extends the Outside Date beyond the latest date to which the Merger Agreement (as it exists on the date of this Agreement)
contemplates extension of the Outside Date (each such amendment, an &#147;<U>Adverse Amendment</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) For the avoidance of
doubt, except as expressly set forth in this <U>Section</U><U></U><U>&nbsp;1.01</U>, Stockholder shall not be restricted from voting in any manner with respect to any other matters presented or submitted to the stockholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02 <I>Solicitation</I>. Stockholder further agrees that, until the termination of this Agreement, Stockholder will not
(a)&nbsp;solicit proxies or become a &#147;participant&#148; in a &#147;solicitation&#148; (as such terms are defined in Rule 14A under the Exchange Act) in connection with either any proposal to approve the Merger Agreement and the Merger or any
Company Takeover Proposal, (b)&nbsp;subject to <U>Section</U><U></U><U>&nbsp;5.15</U>, initiate a stockholders&#146; vote with respect to a Company Takeover Proposal or (c)&nbsp;become a member of a &#147;group&#148; (as such term is used in
Section&nbsp;13(d) of the Exchange Act) with respect to any voting securities of the Company with respect to a Company Takeover Proposal; provided that nothing herein (including <U>Section</U><U></U>&nbsp;4.04) shall prohibit Stockholder or any of
its Representatives from participating at the Company&#146;s direction in any discussions or negotiations with respect to a possible stockholders&#146; consent or voting agreement in connection with any Company Takeover Proposal in the event that
the Company becomes, and only while the Company is, permitted to take such actions pursuant to Section&nbsp;6.3(c) or Section&nbsp;6.3(f) of the Merger Agreement with respect to such Company Takeover Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.03 <I>Irrevocable Proxy</I>. Stockholder hereby revokes any and all previous proxies granted by Stockholder with respect to
Company Shares owned (whether beneficially or of record) by it as of the date of this Agreement. In the event, but only in the event, that Stockholder fails to comply with any of its obligations set </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forth in <U>Section</U><U></U><U>&nbsp;1.01 </U>with respect to the Required Votes (and Stockholder shall give prompt written notice of such failure in accordance with
<U>Section</U><U></U><U>&nbsp;5.04</U> and, in any event, before the closing of the voting at the Company Special Meeting with sufficient time to allow Acquiror to exercise its rights under this <U>Section</U><U></U><U>&nbsp;1.03</U>), then
Stockholder hereby irrevocably grants to, and appoints, Acquiror and any designee of Acquiror (determined in Acquiror&#146;s sole discretion) as Stockholder&#146;s
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> and proxy, with full power of substitution and resubstitution, for and in Stockholder&#146;s name, to vote, or cause to be voted (including by proxy or
written consent, if applicable) (until the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>) any Company Shares owned (whether beneficially or of record) by Stockholder solely to the extent, and in the manner,
expressly set forth with respect to the Required Votes in <U>Section</U><U></U><U>&nbsp;1.01</U>. The proxy granted by Stockholder pursuant to this <U>Section</U><U></U><U>&nbsp;1.03</U>, if it becomes effective, and except upon the termination of
this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>, is irrevocable and is granted in consideration of the Acquiror entering into this Agreement and the Merger Agreement and incurring certain related fees and expenses.
Stockholder hereby affirms that such irrevocable proxy, if it becomes effective, is coupled with an interest by reason of the Merger Agreement and, except upon the termination of this Agreement in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, is intended to be irrevocable. Each Stockholder agrees, subject to this <U>Section</U><U></U><U>&nbsp;1.03</U> and unless and until this Agreement is terminated in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, to vote its Company Shares (including any New Company Shares) in accordance with <U>Section</U><U></U><U>&nbsp;1.01(a)</U> through <U>Section</U><U></U><U>&nbsp;1.01(d) </U>above. The parties agree that the
foregoing is a voting agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 2 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDER</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder represents and warrants to Acquiror that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 <I>Authorization</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Stockholder has all requisite power and authority to execute and deliver this Agreement and to consummate the transactions contemplated
hereby and to perform his, her or its covenants and other obligations hereunder. The execution and delivery of this Agreement by Stockholder, the performance by Stockholder of his, her or its covenants and obligations hereunder and the consummation
by Stockholder of the transactions contemplated hereby have been duly authorized by all necessary action on the part of Stockholder (to the extent Stockholder is not a natural person), and no additional proceedings or actions on the part of
Stockholder are necessary to authorize the execution and delivery of this Agreement, the performance by Stockholder of his, her or its covenants or other obligations hereunder, or the consummation of the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement has been duly executed and delivered by Stockholder and, assuming the due authorization, execution and delivery by
Acquiror, constitutes a legal, valid and binding obligation of Stockholder, enforceable against Stockholder in accordance with its terms, except that such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other similar Laws affecting or relating to creditors&#146; rights generally and by general principles of equity. No consent of Stockholder&#146;s spouse (if Stockholder is a natural person) is necessary under any community property or other
applicable Laws for Stockholder to enter into, and perform, his or her obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 <I><FONT
STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution, delivery and performance by Stockholder of this Agreement and the consummation of the transactions contemplated hereby do not and will not (i)&nbsp;violate any Law,
(ii)&nbsp;require any further consent or other action by any person under any provision of any agreement or other instrument binding on Stockholder or (iii)&nbsp;result in the creation of any Lien upon the Company Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03 <I>Actions and Proceedings</I>. As of the date hereof, there are no (a)&nbsp;Legal Proceedings pending or, to the knowledge
of Stockholder, threatened against Stockholder or (b)&nbsp;material orders, writs, judgments, injunctions, decrees or awards of any kind or nature that, in the case of either clause (a)&nbsp;or (b), would prevent,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
seek to prevent or materially delay, hinder or impair the exercise by Acquiror of its rights under this Agreement or the ability of Stockholder to fully perform his, her or its covenants and
obligations pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04 <I>No Inconsistent Agreements</I>. Except for this Agreement, Stockholder has
not: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) granted any proxies or powers of attorney, or any other authorization or consent with respect to any or all of his, her or its
Company Shares with respect to the matters set forth in <U>Section</U><U></U><U>&nbsp;1.01</U>; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) deposited any of his, her or its
Company Shares into a separate voting trust or entered into a voting agreement with respect to any of his, her or its Company Shares (or any other agreement or arrangement with respect to the voting of such Company Shares), other than under the
terms of the trust agreement of Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05 <I>Ownership</I>. As of the date hereof, Stockholder owns (whether
beneficially or of record) those Company Shares set forth opposite Stockholder&#146;s name on <U>Exhibit A</U>. Stockholder is a trust that, together with the Foundation, is the sole beneficial owner and has and, other than in connection with
Transfers (as defined below) to Permitted Transferees (as defined below) in accordance with the terms hereof or as provided in Section&nbsp;4.02(c) (&#147;<U>Exempt Transfers</U>&#148;), will have at all times through the receipt of the Company
Stockholder Approval such beneficial ownership, free and clear of all Liens (other than Permitted Liens (as defined below)). (a) Stockholder has and, other than in connection with Exempt Transfers, will have at all times through the receipt of the
Company Stockholder Approval sole voting power (including the right to control such vote as contemplated herein) and sole power of disposition with respect to such Company Shares (and any New Company Shares), and sole power to issue instructions
with respect to the matters set forth in <U>Article 1</U> hereof and sole power to agree to all of the matters set forth in this Agreement, free and clear of any adverse claim or other Liens (other than such Liens created by this Agreement, Liens
applicable to the Company Shares that may exist pursuant to securities Laws, under the Company&#146;s organizational documents or customary Liens pursuant to the terms of any custody or similar agreement applicable to the Company Shares held in
brokerage accounts, Liens imposed pursuant to any written policies of the Company with respect to the trading of securities in connection with insider trading restrictions, Liens imposed pursuant to the terms of a Rule
<FONT STYLE="white-space:nowrap">10b5-1</FONT> Trading Plan (as defined below) in effect as of the date of this Agreement or Liens imposed under the terms of any trust in effect as of the date of this Agreement (but none of the terms of any such
trust or Lien will impede, restrict, delay or preclude performance by Stockholder of, or compliance by such Stockholder with, its obligations under this Agreement) (collectively, &#147;<U>Permitted Liens</U>&#148;)), (b) no person other than
Stockholder has any right to direct or approve the voting or disposition of any of the Company Shares as it relates to the matters covered by this Agreement, and (c)&nbsp;Stockholder has not entered into any contract, option or other arrangement or
understanding with respect to the direct or indirect Transfer (as defined below) with respect to any of the Company Shares owned (whether beneficially or of record) by Stockholder, other than as provided in Section&nbsp;4.02(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06 <I>Broker Fees</I>. There is no investment banker, broker, finder, agent or other Person that has been retained by or is
authorized to act on behalf of Stockholder who is entitled to any financial advisor&#146;s, brokerage, finder&#146;s or other fee or commission that would be payable by any Person other than Stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07 <I>Acknowledgement</I>. Stockholder understands and acknowledges that Acquiror is entering into the Merger Agreement in
reliance upon Stockholder&#146;s execution, delivery and performance of this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 3 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> A<SMALL>CQUIROR</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acquiror represents and warrants to Stockholder that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 <I>Authorization</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Acquiror has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions
contemplated hereby and to perform its obligations hereunder. The execution and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
delivery of this Agreement by Acquiror has been duly authorized by all necessary corporate action on the part of Acquiror, and no other corporate proceedings on the part of Acquiror are necessary
to authorize this Agreement or the consummation of the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement has been duly executed and
delivered by Acquiror and, assuming the due authorization, execution and delivery by Stockholder, constitutes a legal, valid and binding obligation of Acquiror, enforceable against it in accordance with its terms, except that such enforceability may
be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors&#146; rights generally and by general principles of equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 <I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution, delivery and performance by Acquiror of
this Agreement and the consummation of the transactions contemplated hereby do not and will not (i)&nbsp;violate any Law, (ii)&nbsp;require any consent or other action by any person under any provision of any agreement or other instrument binding on
the Acquiror or (iii)&nbsp;result in the creation of any Lien upon any of the properties or assets of Acquiror. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03
<I>Actions and Proceedings</I>. As of the date hereof, there are no (a)&nbsp;Legal Proceedings pending or, to the knowledge of the Acquiror, threatened against Acquiror or any of its Affiliates or (b)&nbsp;material orders, writs, judgments,
injunctions, decrees or awards of any kind or nature that, in the case of either clause (a)&nbsp;or (b), would prevent, seek to prevent or materially delay, hinder or impair the exercise by Stockholder of its rights under this Agreement or the
ability of Acquiror to fully perform its covenants and obligations pursuant to this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 4 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDER</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder hereby covenants and agrees that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 <I>No Proxies for or Encumbrances on Company Shares</I>. Stockholder shall not, without the prior written consent of
Acquiror, directly or indirectly, (i)&nbsp;grant any proxies, consents or powers of attorney or enter into any voting trust or other agreement or arrangement with respect to the voting of any Company Shares or deposit any Company Shares in a voting
trust, or (ii)&nbsp;create or permit to exist any Lien (other than Permitted Liens), or take or agree to take any other action, that would or would reasonably be expected to prevent Stockholder from voting the Company Shares owned (whether
beneficially or of record) by it in accordance with this Agreement or from complying in all material respects with the other obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 <I>No Transfer of Company Shares</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the period beginning on the date hereof and ending as of the termination of this Agreement in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, except as consented to in advance in writing by Acquiror, Stockholder agrees not to, directly or indirectly, sell, transfer, assign, tender in any tender or exchange offer, pledge, hypothecate, exchange or
otherwise dispose of (including by merger, special purpose business combination, consolidation, testamentary disposition, operation of law or otherwise), either voluntarily or involuntarily (&#147;<U>Transfer</U>&#148;) the Company Shares or any New
Company Shares, other than to a Permitted Transferee (as defined below), or enter into any contract, option or other arrangement or understanding with respect to the direct or indirect Transfer of, any Company Shares or New Company Shares;
<I>provided</I>, that, a Transfer may be made to a Permitted Transferee only if (i)&nbsp;such Permitted Transferee agrees in writing to be bound by the terms of this Agreement as if they were a party hereto; (ii)&nbsp;such written instrument
expressly provides Acquiror with the ability to enforce the obligations of Stockholder and the Permitted Transferee with respect to the Company Shares, including causing such Company Shares to vote in accordance with the Required Votes; and
(iii)&nbsp;prompt notice of such Transfer to such Permitted Transferee is delivered to Acquiror pursuant to <U>Section</U><U></U><U>&nbsp;5.04</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From and after the date of this Agreement through the term of this Agreement,
Stockholder agrees not to request the Company to register or otherwise recognize the transfer (book-entry or otherwise) of any Company Shares or any certificate or uncertificated interest representing any of Stockholder&#146;s Company Shares, except
as permitted by, and in accordance with, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the foregoing, this <U>Section</U><U></U><U>&nbsp;4.02</U>
shall not apply to Transfers of Company Shares by Stockholder executed pursuant to the terms of a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Trading Plan that is in existence as of the date of this Agreement and which has been made
available to Acquiror prior to the date of this Agreement and which is attached hereto as Exhibit B. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Any attempted Transfer of
Company Shares in violation of this <U>Section</U><U></U><U>&nbsp;4.02</U> shall be null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) A &#147;<U>Permitted
Transferee</U>&#148; means, with respect to Stockholder, (i)&nbsp;to any person by will or the laws of intestacy, (ii)&nbsp;a spouse, lineal descendant or antecedent, brother or sister, adopted child or grandchild of the spouse of any child, adopted
child, grandchild or adopted grandchild of Stockholder (if Stockholder is a natural person), (iii) any trust, the beneficiaries of which include only Stockholder and his or her family members (including the persons named in clause (ii)) (if
Stockholder is a natural person), (iv) any partnership or limited liability company, all partners or members of which include only Stockholder and his or her family members (including the persons named in clause (ii)) and any trust named in clause
(iii) (if Stockholder is a natural person), (v) if Stockholder is an entity, any of its partners (including limited or general partners), members, stockholders and affiliates in connection with a pro rata distribution of such Company Shares
(including any New Company Shares), (vi) an entity qualified as a 501(c)(3) charitable organization, in connection with a <I>bona fide</I> gift or gifts thereto, and (vii)&nbsp;in the event that Stockholder is a natural person, to any person by
operation of law pursuant to a qualified domestic order, divorce settlement, divorce decree or similar separation agreement. For the avoidance of doubt, a Permitted Transferee may Transfer Company Shares to its own Permitted Transferees in
accordance with the terms and subject to the conditions of this <U>Section</U><U></U><U>&nbsp;4.02</U>. A &#147;<U>Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Trading Plan</U>&#148; means any written plan that meets the requirements of Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 <I>Additional Company Shares</I>. Stockholder agrees
that any Company Shares (or other voting securities of the Company or any other securities exchangeable for, or convertible into, any voting securities of the Company) that Stockholder purchases or with respect to which Stockholder otherwise
acquires record or beneficial ownership after the date of this Agreement and prior to the termination of this Agreement (&#147;<U>New Company Shares</U>&#148;) shall be subject to the terms and conditions of this Agreement to the same extent as the
Company Shares currently owned by Stockholder (it being understood, for the avoidance of doubt, that any such New Company Shares shall be subject to the terms of this Agreement as though owned by Stockholder on the date hereof, and the
representations and warranties in <U>Article 2</U> above shall be true and correct as of the date that beneficial ownership of such New Company Shares is acquired). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 <I>No Solicitation</I>. Stockholder hereby agrees that, during the term of this Agreement, Stockholder shall not take any
action, in his, her or its capacity as a stockholder of the Company, that the Company otherwise is then-prohibited from taking under Section&nbsp;6.3 of the Merger Agreement. Notwithstanding anything to the contrary in this Agreement, solely to the
extent the Company is permitted to take certain actions set forth in Section&nbsp;6.3 of the Merger Agreement with respect to a Company Takeover Proposal, Stockholder in his or her capacity as an officer or director of the Company, if Stockholder is
an officer or director, will be free to participate in any discussions or negotiations regarding such actions in accordance with and subject to the provisions of the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 <I>Disclosure</I>. Stockholder hereby consents to and authorizes the publication and disclosure by Acquiror and the Company
in the Proxy Statement or other disclosure document required by applicable Law to be filed with the SEC or other Governmental Entity in connection with this Agreement, the Merger Agreement or the transactions contemplated hereby or thereby, of
Stockholder&#146;s identity and ownership, this Agreement and the nature of Stockholder&#146;s commitments, arrangements and understandings pursuant to this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>provided</I>, that Acquiror shall (with respect to any of its disclosures) give Stockholder and its legal counsel a reasonable opportunity to review and comment on such disclosures prior to
any such disclosures being made public (<I>provided</I>, that by executing this Agreement, Stockholder hereby consents to the filing of this Agreement by the Company in the Proxy Statement or other disclosure document required by applicable Law to
be filed with the SEC or other Governmental Entity in connection with this Agreement, the Merger Agreement or the transactions contemplated hereby). As promptly as practicable after obtaining actual knowledge thereof, Stockholder shall notify the
Acquiror and the Company of any required corrections with respect to such information previously supplied by Stockholder to Acquiror or the Company hereunder, if and to the extent that any such information shall have become false or misleading in
any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 <I>Appraisal and Dissenter&#146;s Rights</I>. Stockholder hereby irrevocably waives, and agrees
not to exercise, any rights of appraisal or rights of dissent from the Merger that such Stockholder may have with respect to the Company Shares or New Company Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 <I>Share Dividends, etc</I>. In the event of a stock split, stock dividend or distribution, or any <FONT
STYLE="white-space:nowrap">split-up,</FONT> reverse stock split, recapitalization, combination, reclassification, reincorporation, exchange of shares or the like, in each case affecting the Company Shares, the terms &#147;Company Shares&#148; and
&#147;New Company Shares&#148; shall be deemed to refer to and include such shares as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares may be changed or exchanged or which are
received in such transaction. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 5 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">M<SMALL>ISCELLANEOUS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 <I>Definitional and Interpretative Provisions</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Capitalized terms used but not defined herein shall have the respective meanings set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For the purposes of this Agreement, (i)&nbsp;the definitions contained in this Agreement are applicable to the singular as well as the
plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term; (ii)&nbsp;references to the terms Article, Section, paragraph and Exhibits are references to the Articles, Sections, paragraphs and Exhibits
to this Agreement unless otherwise specified; (iii)&nbsp;the words &#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any
particular provision of this Agreement, unless the context otherwise requires; (iv)&nbsp;the word &#147;extent&#148; in the phrase &#147;to the extent&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not
mean simply &#147;if&#148;; (v)&nbsp;whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation&#148;; (vi)&nbsp;unless
otherwise specifically provided for herein, the term &#147;or&#148; shall not be deemed to be exclusive; (vii)&nbsp;the word &#147;since&#148; when used in this Agreement in reference to a date shall be deemed to be inclusive of such date;
(viii)&nbsp;references to &#147;written&#148; or &#147;in<B> </B>writing&#148; include in electronic form; (ix)&nbsp;provisions shall apply, when appropriate, to successive events and transactions; (x)&nbsp;a reference to any person includes such
person&#146;s successors and permitted assigns; (xi)&nbsp;references to &#147;$&#148; shall mean U.S. dollars; (xii)&nbsp;any reference to &#147;days&#148; means calendar days unless Business Days are expressly specified; (xiii)&nbsp;when
calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded; if the day at the end of
the period is not a Business Day, then such period shall end on the close of the next immediately following Business Day; (xiv)&nbsp;references in this Agreement to specific Laws or to specific provisions of Laws shall include all rules and
regulations promulgated thereunder, and any statute defined or referred to herein or in any agreement or instrument referred to herein shall mean such statute as from time to time amended, modified or supplemented,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including by succession of comparable successor statutes; and (xv)&nbsp;all terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or
delivered pursuant thereto unless otherwise defined therein. Each of the parties hereto has participated in the negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if it
is drafted by all the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party hereto by virtue of authorship of any of the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For purposes of this Agreement, the term &#147;beneficially owned&#148; (and correlative terms) has the meaning ascribed to it in Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> adopted by the SEC under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 <I>Further Assurances</I>. Acquiror
and Stockholder will each execute and deliver, or cause to be executed and delivered, all further documents and instruments and use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things
necessary, proper or advisable under applicable Law, to consummate and make effective the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 <I>Amendments; Termination</I>. Any provision of this Agreement may be amended or waived if, but only if, such amendment or
waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement and by the Company, or in the case of a waiver, by the party against whom the waiver is to be effective. This Agreement shall terminate upon the
earliest to occur of (i)&nbsp;the termination of the Merger Agreement, (ii)&nbsp;the entering into of any Adverse Amendment, (iii)&nbsp;the mutual written consent of Acquiror and Stockholder and (iv)&nbsp;the receipt of the Company Stockholder
Approval; <I>provided, </I>that, notwithstanding anything in this Agreement to the contrary, the termination of this Agreement shall not relieve any party hereto of liability for any Willful Breach (with respect to this Agreement) prior to such
termination. Subject to the foregoing, upon any termination of this Agreement, this Agreement shall thereupon become void and of no further force and effect, and there shall be no liability in respect of this Agreement or of any transactions
contemplated hereby on the part of any party hereto. Notwithstanding the preceding sentence, <U>Article</U><U></U><U>&nbsp;5</U> of this Agreement (except for <U>Section</U><U></U><U>&nbsp;5.02</U>) shall survive any termination of this Agreement.
The representations, warranties and covenants of Stockholder contained herein shall not survive the termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 <I>Notices</I>. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be
deemed given if delivered in accordance with the terms of Section&nbsp;9.7 of the Merger Agreement: to Acquiror or the Company in accordance with Section&nbsp;9.7 of the Merger Agreement or to Stockholder at its address set forth in <U>Exhibit A</U>
attached hereto, with a copy (which shall not constitute notice) to Cleary Gottlieb Steen&nbsp;&amp; Hamilton LLP, One Liberty Plaza, New York, NY 10003, Attn: John A. Kupiec and Kyle A. Harris, Email: [***] and [***] (or at such other address for a
party as shall be specified by like notice). Stockholder shall be required to give Acquiror prompt (and in any event within 24 hours) written notice of any breaches of any representation, warranty, covenant or agreement of Stockholder set forth in
this Agreement that would prevent or delay the performance by Stockholder of its obligations under this Agreement in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 <I>Expenses</I>. All costs and expenses incurred in connection with this Agreement shall be paid by the party incurring such
cost or expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 <I>Successors and Assigns</I>. The provisions of this Agreement shall be binding upon and inure to the
benefit of the parties hereto and their respective successors and assigns; <I>provided</I>, that no party hereto may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other party
hereto, except that Acquiror may transfer or assign its rights and obligations to any Affiliate of Acquiror. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07
<I>Governing Law; Submission to Jurisdiction.</I> This Agreement, and all claims or causes of action (whether at law, in Contract or in tort or otherwise) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution
or performance hereof, shall be governed by and construed in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
accordance with the Laws of the State of Delaware, without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would
cause the application of the Laws of any jurisdiction other than the State of Delaware. Each of Acquiror and Stockholder agrees that a final judgment in any action or proceeding in such courts as provided above shall be conclusive and may be
enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each of the parties hereto (a)&nbsp;consents to submit himself, herself or itself to the exclusive jurisdiction of the Court of Chancery of the State of
Delaware or, solely if such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware (the &#147;<U>Chosen Courts</U>&#148;), with respect to any dispute arising out of, relating
to or in connection with this Agreement or any of the actions contemplated hereby, (b)&nbsp;agrees that he, she or it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such Chosen Court, and
(c)&nbsp;agrees that he, she or it will not bring any action arising out of, relating to or in connection with this Agreement or any actions contemplated by this Agreement in any court other than any such Chosen Court. Each of the parties hereto
irrevocably and unconditionally waives any objection to the laying of venue of any claim, action, suit, litigation, arbitration, proceeding or governmental or administrative investigation, audit, inquiry or action (&#147;<U>Legal
Proceeding</U>&#148;) arising out of this Agreement or the transactions contemplated hereby in the Chosen Courts, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such Chosen Court that any such Legal
Proceeding brought in any such Chosen Court has been brought in an inconvenient forum. Each of the parties hereto hereby agrees that service of any process, summons, notice or document by U.S. registered mail to the respective addresses in
accordance with <U>Section</U><U></U><U>&nbsp;5.04</U> shall be effective service of process for any proceeding arising out of, relating to or in connection with this Agreement or the actions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08 <I>Waiver of Jury Trial</I>. EACH OF THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER
THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF, RELATING TO
OR IN CONNECTION WITH THIS AGREEMENT OR THE ACTIONS CONTEMPLATED HEREBY. EACH OF THE PARTIES HERETO CERTIFIES AND ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (III)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY, AND (IV)&nbsp;EACH PARTY HAS BEEN
INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION AND IN <U>SECTION 5.07</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 <I>Counterparts; Effectiveness</I>. This Agreement may be executed in one or more counterparts, all of which shall be
considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other party hereto, it being understood that all parties hereto need not sign the same
counterpart. Irrespective of negotiations among the parties or the exchanging of drafts of this Agreement, this Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding between the parties unless
and until (a)&nbsp;the Company Board of Directors has approved the transactions contemplated by the Merger Agreement and this Agreement, (b)&nbsp;the Merger Agreement is executed by all parties thereto and (c)&nbsp;this Agreement is executed by all
parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <I>Severability</I>. In the event that any provision of this Agreement, or the application thereof,
becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be
interpreted so as reasonably to effect the intent of the parties hereto. The parties hereto further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent
possible, the economic, business and other purposes of such void or unenforceable provision. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <I>Remedies</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Generally</I>. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party hereto will be deemed
cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party hereto of any one remedy will not preclude the exercise of any other remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Specific Performance</I>. The parties hereto hereby agree that irreparable damage would occur in the event that any provision of this
Agreement were not performed in accordance with its specific terms or were otherwise breached, and that money damages or other legal remedies would not be an adequate remedy for any such damages. Accordingly, the parties hereto acknowledge and
hereby agree that in the event of any breach or threatened breach by Stockholder, on the one hand, or Acquiror, on the other hand, of any of their respective covenants or obligations set forth in this Agreement, Stockholder, on the one hand, and
Acquiror, on the other hand, shall be entitled to an injunction or injunctions to prevent or restrain breaches or threatened breaches of this Agreement by the other (as applicable), and to specifically enforce the terms and provisions of this
Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of the other under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <I>Entire Agreement</I>. <I></I>This Agreement, the documents and&nbsp;instruments and other agreements among the parties
hereto as contemplated by or referred to herein, and to the extent referenced herein, the Merger Agreement, constitute the entire agreement between the parties hereto with respect to the subject matter hereof and supersede all prior agreements and
understandings, both written and oral, between the parties with respect to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <I>No Third-Party
Beneficiaries</I>. Each of Acquiror and Stockholder agrees that (a)&nbsp;his, her or its respective representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other party hereto in accordance with and
subject to the terms of this Agreement and (b)&nbsp;this Agreement is not intended to, and shall not, confer upon any other person any rights or remedies hereunder; <U>provided</U>, <U>however</U>, that the Company is an express third party
beneficiary of this Agreement, and is entitled to directly enforce the provisions hereof (including <U>Section</U><U></U><U>&nbsp;5.03</U>) and to remedies hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <I>Ownership Interest</I>. Nothing contained in this Agreement shall be deemed to vest in Acquiror any direct or indirect
ownership or incidence of ownership of or with respect to any Company Shares beneficially owned by Stockholder. All rights, ownership and economic benefits of and relating to such Company Shares shall remain vested in and belong to Stockholder, and
the Acquiror shall not have any authority to direct Stockholder in the voting or disposition of such Company Shares except as otherwise provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <I>Capacity</I>. Stockholder is entering into this Agreement solely in his, her or its capacity as the record holder or
beneficial owner of the Company Shares and nothing herein shall limit, restrict or otherwise affect any actions taken by Stockholder in his or her capacity as director, officer or employee of the Company (if applicable) (including from acting in
such capacity or voting in such capacity in his or her sole discretion on any matter, including causing the Company or any of its Subsidiaries to exercise rights under the Merger Agreement (in accordance with the terms thereof)), and no such actions
or omissions shall be deemed a breach of this Agreement. Furthermore, nothing in this Agreement shall be construed to prohibit, limit or restrict Stockholder, in his or her capacity as a director or officer of the Company or any of its Subsidiaries
(if applicable), from exercising Stockholder&#146;s fiduciary duties as a director or officer of the Company or any of its Subsidiaries, in each cash, however, in accordance with the applicable terms of the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 <I>No Liability</I>. Stockholder (in its capacity as a stockholder of the Company) shall be not liable for claims, losses,
damages, expenses and other liabilities or obligations resulting from or related to breaches of the Merger Agreement by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 <I>Trust Acknowledgement</I>. The parties hereto acknowledge and agree
that Stockholder owns the Company Shares (and will own any New Company Shares) in trust for the benefit of its sole beneficiary, the Foundation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 <I>No Other Representations</I>. Acquiror and Stockholder acknowledge and agree that, except for the representations and
warranties expressly set forth in Section&nbsp;2 and Section&nbsp;3 of this Agreement, neither Acquiror nor Stockholder makes, has made, or shall be deemed to have made, any representation or warranty in connection with this Agreement. Acquiror and
Stockholder acknowledge and agree that each is not entering into this Agreement in reliance on any representation or warranty, express or implied, except for the representations and warranties expressly set forth in Section&nbsp;2 or Section&nbsp;3,
as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of this page intentionally left blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACQUIROR 10VB8, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Peter Seka</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Peter Seka</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jean-Christophe Roux</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Jean-Christophe Roux</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TRUSTEES OF THE W.K. KELLOGG FOUNDATION TRUST</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: THE NORTHERN TRUST COMPANY, as corporate trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marina Jaudenes</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Marina Jaudenes</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Sr. Vice President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ La June Montgomery Tabron</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: La June Montgomery Tabron, as <FONT STYLE="white-space:nowrap">Co-Trustee</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: <FONT STYLE="white-space:nowrap">Co-Trustee</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven A. Cahillane</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Steven A. Cahillane, as <FONT STYLE="white-space:nowrap">Co-Trustee</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: <FONT STYLE="white-space:nowrap">Co-Trustee</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard M. Tsoumas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Richard M. Tsoumas, as <FONT STYLE="white-space:nowrap">Co-</FONT> Trustee</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: <FONT STYLE="white-space:nowrap">Co-Trustee</FONT></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:160pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Voting
Agreement</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Stockholder Information</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Company</B><br><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Notice&nbsp;Address</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">W.K. Kellogg Foundation Trust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,830,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit B </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U><FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan Information</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom893453_4535"></A>Annex C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VOTING AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">VOTING
AGREEMENT (this &#147;<U>Agreement</U>&#148;), dated as of August&nbsp;13, 2024 (the &#147;<U>Effective Date</U>&#148;), among (i)&nbsp;Acquiror 10VB8, LLC, a Delaware limited liability company (&#147;<U>Acquiror</U>&#148;), (ii) each of
(a)&nbsp;Gund Family Twelfth Investment Partnership, a New Jersey general partnership, (b)&nbsp;Gund Family Thirteenth Investment Partnership, a New Jersey general partnership, (c)&nbsp;G. Zachary Gund Article III, LLC, a Massachusetts limited
liability company, (d)&nbsp;GCG Investments, LLC, a Massachusetts limited liability company, (e)&nbsp;Dionis Trust by and through the trustees of Dionis Trust, solely in their capacities as such, and (f)&nbsp;the Marital Trust for Gordon Gund by and
through the trustees of the Marital Trust for Gordon Gund, solely in their capacities as such (each of (a)&nbsp;through (f), a &#147;<U>Stockholder</U>,&#148; and, collectively, the &#147;<U>Stockholders</U>&#148;), in such Stockholder&#146;s
capacity as a stockholder of Kellanova, a Delaware corporation (the &#147;<U>Company</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as of the date hereof, each
Stockholder is the record or &#147;beneficial&#148; owner (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the U.S. Securities Exchange Act of 1934 (as amended, and the rules promulgated thereunder the &#147;<U>Exchange
Act</U>&#148;)) of the number of shares of public common stock of the Company, par value $0.25 per share (&#147;<U>Company Shares</U>&#148;), as set forth opposite such Stockholder&#146;s name on <U>Exhibit A</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution and delivery of this Agreement, Acquiror, Merger Sub 10VB8, LLC, a Delaware limited liability company
and direct or indirect, wholly owned subsidiary of Acquiror (&#147;<U>Merger Sub</U>&#148;), Mars, Incorporated, a Delaware corporation (for the purposes of specific sections only), and the Company, have entered into an Agreement and Plan of Merger,
dated as of the date hereof (as may be amended, supplemented or otherwise modified from time to time, the &#147;<U>Merger Agreement</U>&#148;), pursuant to which, among other things, upon the terms and subject to the conditions thereof, at the
Effective Time, Merger Sub will merge with and into the Company with the Company surviving the merger (the &#147;<U>Merger</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the affirmative vote of the holders of a majority of the issued and outstanding shares of Company Common Stock in favor of the
adoption of the Merger Agreement and the transactions contemplated thereby, including the Merger, is a condition to the consummation of the Merger; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as of the date hereof and subject to the terms and conditions herein, each Stockholder has determined to vote in favor of the Merger
and the other transactions contemplated in the Merger Agreement and in furtherance thereof has agreed to enter into this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to induce Acquiror to enter into the Merger Agreement, Acquiror has requested each Stockholder, and such Stockholder has
agreed, to enter into this Agreement with respect to all Company Shares, now or hereafter &#147;beneficially owned&#148; by such Stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing, the mutual covenants and agreements set forth herein, and other good and valuable
consideration the receipt and sufficiency of which are hereby acknowledged, intending to be legally bound, the parties hereto agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 1 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V<SMALL>OTING</SMALL>
A<SMALL>GREEMENT</SMALL>; G<SMALL>RANT</SMALL> <SMALL>OF</SMALL> P<SMALL>ROXY</SMALL> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 <I>Voting Agreement</I>. From the
date hereof until the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>, each Stockholder shall (x)&nbsp;appear at each meeting (whether annual or special and each adjourned or postponed meeting and including
the Company Special Meeting) of the stockholders of the Company concerning proposals related to the Merger, Merger Agreement, any Company Takeover Proposal or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any other transaction contemplated by the Merger Agreement or at which any matter set forth in this <U>Section</U><U></U><U>&nbsp;1.01</U> is being considered, however called, or otherwise cause
all of the Company Shares owned (whether beneficially or of record) at such time by such Stockholder to be counted as present thereat for purposes of calculating a quorum, and respond to each request by the Company for written consent, if any, and
(y)&nbsp;vote or cause to be voted (including by proxy or written consent, if applicable, with respect to) all Company Shares (including any New Company Shares (as defined below), as applicable) owned (whether beneficially or of record) at such time
by such Stockholder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) with respect to each meeting at which a vote of such Stockholder on the Merger is requested (a &#147;<U>Merger
Proposal</U>&#148;), in favor of such Merger Proposal (and, in the event that such Merger Proposal is presented as more than one proposal, in favor of each proposal that is part of such Merger Proposal), and in favor of any other transactions or
matters expressly contemplated by the Merger Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) against any Company Takeover Proposal, without regard to the terms of such
Company Takeover Proposal, or any other transaction, proposal, agreement or action made in opposition to adoption of the Merger Agreement or in competition or inconsistent with the Merger and the other transactions or matters contemplated by the
Merger Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) against any other action, agreement or transaction that is intended, or that would or would reasonably be expected,
to materially impede, interfere with, delay, postpone, discourage or adversely affect the Merger or any of the other transactions expressly contemplated by the Merger Agreement or the performance by such Stockholder of his, her or its obligations
under this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) against any action, proposal, transaction or agreement that would or would reasonably be expected to result in
a breach in any material respect of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Merger Agreement, or of such Stockholder contained in this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) in favor of any other matter necessary to the consummation of the transactions contemplated by the Merger Agreement, including the Merger
(clauses&nbsp;(a) through (e)&nbsp;of this <U>Section</U><U></U><U>&nbsp;1.01</U>, the &#147;<U>Required Votes</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02 <I>Solicitation</I>. Without limiting the generality of <U>Section</U><U></U><U>&nbsp;5.15</U>, such Stockholder further
agrees that, until the termination of this Agreement, such Stockholder will not (a)&nbsp;solicit proxies or become a &#147;participant&#148; in a &#147;solicitation&#148; (as such terms are defined in Rule 14A under the Exchange Act) in connection
with either any proposal to approve the Merger Agreement and the Merger or any Company Takeover Proposal, (b)&nbsp;initiate a stockholders&#146; vote with respect to a Company Takeover Proposal or (c)&nbsp;become a member of a &#147;group&#148; (as
such term is used in Section&nbsp;13(d) of the Exchange Act) with respect to any voting securities of the Company with respect to a Company Takeover Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.03 <I>Irrevocable Proxy</I>. Each Stockholder hereby revokes any and all previous proxies granted by such Stockholder with
respect to Company Shares owned (whether beneficially or of record) by it as of the date of this Agreement. By entering into this Agreement, such Stockholder hereby irrevocably grants to, and appoints, Acquiror and any designee of Acquiror
(determined in Acquiror&#146;s sole discretion) as such Stockholder&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> and proxy, with full power of substitution and resubstitution, for and in
such Stockholder&#146;s name, to vote, or cause to be voted (including by proxy or written consent, if applicable) (until the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>) any Company Shares owned (whether
beneficially or of record) by such Stockholder solely to the extent, and in the manner, expressly set forth with respect to the Required Votes in <U>Section</U><U></U><U>&nbsp;1.01</U>. The proxy granted by such Stockholder pursuant to this
<U>Section</U><U></U><U>&nbsp;1.03</U>, except upon the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>, is irrevocable and is granted in consideration of the Acquiror entering into this Agreement and the
Merger Agreement and incurring certain related fees and expenses. Each Stockholder hereby affirms that such irrevocable proxy is coupled with an interest by reason of the Merger Agreement and, except upon the termination of this Agreement in
accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>, is intended to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
irrevocable. Each Stockholder agrees, subject to this <U>Section</U><U></U><U>&nbsp;1.03</U> and unless and until this Agreement is terminated in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, to vote its Company Shares (including any New Company Shares) in accordance with <U>Section</U><U></U><U>&nbsp;1.01(a)</U> through <U>Section</U><U></U><U>&nbsp;1.01(e)</U> above. The parties agree that the
foregoing is a voting agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 2 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDER</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Stockholder, severally and not jointly, represents and warrants to Acquiror that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 <I>Authorization</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Such Stockholder has all requisite power and authority to execute and deliver this Agreement and to consummate the transactions
contemplated hereby and to perform his, her or its covenants and other obligations hereunder. The execution and delivery of this Agreement by Stockholder, the performance by such Stockholder of his, her or its covenants and obligations hereunder and
the consummation by such Stockholder of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of such Stockholder (to the extent such Stockholder is not a natural person), and no additional
proceedings or actions on the part of such Stockholder are necessary to authorize the execution and delivery of this Agreement, the performance by such Stockholder of his, her or its covenants or other obligations hereunder, or the consummation of
the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement has been duly executed and delivered by such Stockholder and, assuming the due
authorization, execution and delivery by Acquiror, constitutes a legal, valid and binding obligation of such Stockholder, enforceable against such Stockholder in accordance with its terms, except that such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors&#146; rights generally and by general principles of equity. No consent of such Stockholder&#146;s spouse (if Stockholder is a natural
person) is necessary under any community property or other applicable Laws for Stockholder to enter into, and perform, his or her obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 <I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution, delivery and performance by such
Stockholder of this Agreement and the consummation of the transactions contemplated hereby do not and will not (i)&nbsp;violate any Law, (ii)&nbsp;require any consent or other action by any person under any provision of any agreement or other
instrument binding on such Stockholder or (iii)&nbsp;result in the creation of any Lien upon the Company Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03
<I>Actions and Proceedings</I>. As of the date hereof, there are no (a)&nbsp;Legal Proceedings pending or, to the knowledge of such Stockholder, threatened against such Stockholder or (b)&nbsp;material orders, writs, judgments, injunctions, decrees
or awards of any kind or nature that, in the case of either clause (a)&nbsp;or (b), would prevent, seek to prevent or materially delay, hinder or impair the exercise by Acquiror of its rights under this Agreement or the ability of such Stockholder
to fully perform his, her or its covenants and obligations pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04 <I>No Inconsistent
Agreements</I>. Except for this Agreement, such Stockholder has not: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) granted any proxies or powers of attorney, or any other
authorization or consent with respect to any or all of his, her or its Company Shares with respect to the matters set forth in <U>Section</U><U></U><U>&nbsp;1.01</U>; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) deposited any of his, her or its Company Shares into a separate voting trust or entered into a voting agreement with respect to any of
his, her or its Company Shares (or any other agreement or arrangement with respect to the voting of such Company Shares). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05 <I>Ownership</I>. As of the date hereof, each Stockholder, severally and
not jointly, represents and warrants as to such Stockholder that (a)&nbsp;such Stockholder owns (whether beneficially or of record) those Company Shares set forth opposite such Stockholder&#146;s name on <U>Exhibit</U><U></U><U>&nbsp;A</U> and
Stockholder is the sole beneficial owner and has (and, other than in connection with Transfers (as defined below) to Permitted Transferees (as defined below) in accordance with the terms hereof), will have at all times through the Closing) sole
beneficial ownership, sole voting power (including the right to control such vote as contemplated herein), sole power of disposition, sole power to issue instructions with respect to the matters set forth in <U>Article 1</U> hereof, and sole power
to agree to all of the matters set forth in this Agreement, free and clear of any adverse claim or other Liens (other than such Liens created by this Agreement, Liens applicable to the Company Shares that may exist pursuant to securities Laws, under
the Company&#146;s organizational documents or customary Liens pursuant to the terms of any custody or similar agreement applicable to the Company Shares held in brokerage accounts (collectively, &#147;<U>Permitted Liens</U>&#148;)), (b) no person
other than such Stockholder has any right to direct or approve the voting or disposition of any of the Company Shares, and (c)&nbsp;such Stockholder has not entered into any contract, option or other arrangement or understanding with respect to the
direct or indirect Transfer (as defined below) with respect to any of the Company Shares owned (whether beneficially or of record) by such Stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06 <I>Broker Fees</I>. There is no investment banker, broker, finder, agent or other Person that has been retained by or is
authorized to act on behalf of such Stockholder who is entitled to any financial advisor&#146;s, brokerage, finder&#146;s or other fee or commission in connection with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07 <I>Acknowledgement</I>. Each Stockholder understands and acknowledges that Acquiror is entering into the Merger Agreement in
reliance upon Stockholder&#146;s execution, delivery and performance of this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 3 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> A<SMALL>CQUIROR</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acquiror represents and warrants to each Stockholder that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 <I>Authorization</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Acquiror has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions
contemplated hereby and to perform its obligations hereunder. The execution and delivery of this Agreement by Acquiror has been duly authorized by all necessary corporate action on the part of Acquiror, and no other corporate proceedings on the part
of Acquiror are necessary to authorize this Agreement or the consummation of the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement has
been duly executed and delivered by Acquiror and, assuming the due authorization, execution and delivery by each Stockholder, constitutes a legal, valid and binding obligation of Acquiror, enforceable against it in accordance with its terms, except
that such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors&#146; rights generally and by general principles of equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 <I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution, delivery and performance by Acquiror of
this Agreement and the consummation of the transactions contemplated hereby do not and will not (i)&nbsp;violate any Law, (ii)&nbsp;require any consent or other action by any person under any provision of any agreement or other instrument binding on
the Acquiror or (iii)&nbsp;result in the creation of any Lien upon any of the properties or assets of Acquiror. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03
<I>Actions and Proceedings</I>. As of the date hereof, there are no (a)&nbsp;Legal Proceedings pending or, to the knowledge of the Acquiror, threatened against Acquiror or any of its Affiliates or (b)&nbsp;material orders,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
writs, judgments, injunctions, decrees or awards of any kind or nature that, in the case of either clause (a)&nbsp;or (b), would prevent, seek to prevent or materially delay, hinder or impair the
exercise by any Stockholder of its rights under this Agreement or the ability of Acquiror to fully perform its covenants and obligations pursuant to this Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 4 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDER</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder hereby covenants and agrees, severally and not jointly, that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 <I>No Proxies for or Encumbrances on Company Shares</I>. Such Stockholder shall not, without the prior written consent of
Acquiror, directly or indirectly, (i)&nbsp;grant any proxies, consents or powers of attorney or enter into any voting trust or other agreement or arrangement with respect to the voting of any Company Shares or deposit any Company Shares in a voting
trust, or (ii)&nbsp;create or permit to exist any Lien (other than Permitted Liens), or take or agree to take any other action, that would or would reasonably be expected to prevent such Stockholder from voting the Company Shares owned (whether
beneficially or of record) by it in accordance with this Agreement or from complying in all material respects with the other obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 <I>No Transfer of Company Shares</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the period beginning on the date hereof and ending as of the termination of this Agreement in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, except as consented to in advance in writing by Acquiror, such Stockholder agrees not to, directly or indirectly, sell, transfer, assign, tender in any tender or exchange offer, pledge, hypothecate, exchange
or otherwise dispose of (including by merger, special purpose business combination, consolidation, testamentary disposition, operation of law or otherwise), either voluntarily or involuntarily (&#147;<U>Transfer</U>&#148;) the Company Shares or any
New Company Shares, other than to a Permitted Transferee (as defined below), or enter into any contract, option or other arrangement or understanding with respect to the direct or indirect Transfer of, any Company Shares or New Company Shares;
<I>provided</I>, that, a Transfer may be made to a Permitted Transferee only if (i)&nbsp;such Permitted Transferee agrees in writing to be bound by the terms of this Agreement as if they were a party hereto; (ii)&nbsp;such written instrument
expressly provides Acquiror with the ability to enforce the obligations of such Stockholder and the Permitted Transferee with respect to the Company Shares, including causing such Company Shares to vote in accordance with the Required Votes; and
(iii)&nbsp;prompt notice of such Transfer to such Permitted Transferee is delivered to Acquiror pursuant to <U>Section</U><U></U><U>&nbsp;5.04</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From and after the date of this Agreement through the term of this Agreement, such Stockholder agrees not to request the Company to
register or otherwise recognize the transfer (book-entry or otherwise) of any Company Shares or any certificate or uncertificated interest representing any of such Stockholder&#146;s Company Shares, except as permitted by, and in accordance with,
this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any attempted Transfer of Company Shares in violation of this <U>Section</U><U></U><U>&nbsp;4.02</U> shall be null
and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) A &#147;<U>Permitted Transferee</U>&#148; means, with respect to any Stockholder, (i)&nbsp;to any person by will or the
laws of intestacy, (ii)&nbsp;a spouse, lineal descendant or antecedent, brother or sister, adopted child or grandchild of the spouse of any child, adopted child, grandchild or adopted grandchild of such Stockholder (if such Stockholder is a natural
person), (iii) any trust, the beneficiaries of which include only such Stockholder and his or her family members (including the persons named in clause (ii)) (if such Stockholder is a natural person), (iv) any partnership or limited liability
company, all partners or members of which include only such Stockholder and his or her family members (including the persons named in clause (ii)) and any trust named in clause (iii) (if such Stockholder is a natural person), (v) if such Stockholder
is an entity, any of its partners (including limited or general partners), members, stockholders and affiliates in connection with a pro rata distribution of such Company Shares (including any New Company Shares), (vi) an entity qualified as a
501(c)(3) charitable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
organization, in connection with a <I>bona fide</I> gift or gifts thereto, and (vii)&nbsp;in the event that such Stockholder is a natural person, to any person by operation of law pursuant to a
qualified domestic order, divorce settlement, divorce decree or similar separation agreement. For the avoidance of doubt, a Permitted Transferee may Transfer Company Shares to its own Permitted Transferees in accordance with the terms and subject to
the conditions of this <U>Section</U><U></U><U>&nbsp;4.02</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 <I>Additional Company Shares</I>. Such Stockholder
agrees that any Company Shares (or other voting securities of the Company or any other securities exchangeable for, or convertible into, any voting securities of the Company) that such Stockholder purchases or with respect to which such Stockholder
otherwise acquires record or beneficial ownership after the date of this Agreement and prior to the termination of this Agreement (&#147;<U>New Company Shares</U>&#148;) shall be subject to the terms and conditions of this Agreement to the same
extent as the Company Shares currently owned by such Stockholder (it being understood, for the avoidance of doubt, that any such New Company Shares shall be subject to the terms of this Agreement as though owned by such Stockholder on the date
hereof, and the representations and warranties in <U>Article 2</U> above shall be true and correct as of the date that beneficial ownership of such New Company Shares is acquired). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 <I>No Solicitation</I>. Such Stockholder hereby agrees that, during the term of this Agreement, such Stockholder shall not
take any action, in his, her or its capacity as a stockholder of the Company, that the Company otherwise is then-prohibited from taking under Section&nbsp;6.3 of the Merger Agreement. Notwithstanding anything to the contrary in this Agreement,
without limiting the generality of Section&nbsp;5.15 hereof, to the extent the Company is permitted to take certain actions set forth in Section&nbsp;6.3 of the Merger Agreement with respect to a Company Takeover Proposal, such Stockholder in his or
her capacity as an officer or director of the Company, if such Stockholder is an officer or director, will be free to participate in any discussions or negotiations regarding such actions in accordance with and subject to the provisions of the
Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 <I>Disclosure</I>. Such Stockholder hereby consents to and authorizes the publication and disclosure
by Acquiror and the Company in the Proxy Statement or other disclosure document required by applicable Law to be filed with the SEC or other Governmental Entity in connection with this Agreement, the Merger Agreement or the transactions contemplated
hereby or thereby, of such Stockholder&#146;s identity and ownership, this Agreement and the nature of such Stockholder&#146;s commitments, arrangements and understandings pursuant to this Agreement and such other information required in connection
with such disclosure; <I>provided</I>, that Acquiror shall (with respect to any of its disclosures) give such Stockholder and his legal counsel a reasonable opportunity to review and comment on such disclosures prior to any such disclosures being
made public (<I>provided</I>, that by executing this Agreement, such Stockholder hereby consents to the filing of this Agreement by the Company in the Proxy Statement or other disclosure document required by applicable Law to be filed with the SEC
or other Governmental Entity in connection with this Agreement, the Merger Agreement or the transactions contemplated hereby). As promptly as practicable after obtaining actual knowledge thereof, such Stockholder shall notify the Acquiror and the
Company of any required corrections with respect to such information previously supplied by Stockholder to Acquiror or the Company hereunder, if and to the extent that any such information shall have become false or misleading in any material
respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 <I>Appraisal and Dissenter&#146;s Rights</I>. Such Stockholder hereby irrevocably waives, and agrees not to
exercise, any rights of appraisal or rights of dissent from the Merger that such Stockholder may have with respect to the Company Shares or New Company Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 <I>Share Dividends, etc</I>. In the event of a stock split, stock dividend or distribution, or any <FONT
STYLE="white-space:nowrap">split-up,</FONT> reverse stock split, recapitalization, combination, reclassification, reincorporation, exchange of shares or the like, in each case affecting the Company Shares, the terms &#147;Company Shares&#148; and
&#147;New Company Shares&#148; shall be deemed to refer to and include such shares as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares may be changed or exchanged or which are
received in such transaction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 5 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">M<SMALL>ISCELLANEOUS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 <I>Definitional and Interpretative Provisions</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Capitalized terms used but not defined herein shall have the respective meanings set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For the purposes of this Agreement, (i)&nbsp;the definitions contained in this Agreement are applicable to the singular as well as the
plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term; (ii)&nbsp;references to the terms Article, Section, paragraph and Exhibits are references to the Articles, Sections, paragraphs and Exhibits
to this Agreement unless otherwise specified; (iii)&nbsp;the words &#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any
particular provision of this Agreement, unless the context otherwise requires; (iv)&nbsp;the word &#147;extent&#148; in the phrase &#147;to the extent&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not
mean simply &#147;if&#148;; (v)&nbsp;whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation&#148;; (vi)&nbsp;unless
otherwise specifically provided for herein, the term &#147;or&#148; shall not be deemed to be exclusive; (vii)&nbsp;the word &#147;since&#148; when used in this Agreement in reference to a date shall be deemed to be inclusive of such date;
(viii)&nbsp;references to &#147;written&#148; or &#147;in<B> </B>writing&#148; include in electronic form; (ix)&nbsp;provisions shall apply, when appropriate, to successive events and transactions; (x)&nbsp;a reference to any person includes such
person&#146;s successors and permitted assigns; (xi)&nbsp;references to &#147;$&#148; shall mean U.S. dollars; (xii)&nbsp;any reference to &#147;days&#148; means calendar days unless Business Days are expressly specified; (xiii)&nbsp;when
calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded; if the day at the end of
the period is not a Business Day, then such period shall end on the close of the next immediately following Business Day; (xiv)&nbsp;references in this Agreement to specific Laws or to specific provisions of Laws shall include all rules and
regulations promulgated thereunder, and any statute defined or referred to herein or in any agreement or instrument referred to herein shall mean such statute as from time to time amended, modified or supplemented, including by succession of
comparable successor statutes; and (xv)&nbsp;all terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant thereto unless otherwise defined therein. Each of the parties
hereto has participated in the negotiation of this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if it is drafted by all the parties hereto, and no presumption or burden of proof
shall arise favoring or disfavoring any party hereto by virtue of authorship of any of the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For purposes
of this Agreement, the term &#147;beneficially owned&#148; (and correlative terms) has the meaning ascribed to it in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> adopted by the SEC under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 <I>Further Assurances</I>. Acquiror and each Stockholder agrees to each execute and deliver, or cause to be executed and
delivered, all further documents and instruments and use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Law, to consummate and make
effective the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 <I>Amendments; Termination</I>. Any provision of this
Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement and by the Company, or in the case of a waiver, by the party against whom the
waiver is to be effective. This Agreement shall terminate upon the earliest to occur of (i)&nbsp;the termination of the Merger Agreement, (ii)&nbsp;any amendment of (or waiver with respect to) the Merger Agreement (as in effect as of the Effective
Date) that has the effect of reducing the per share Merger Consideration, (iii)&nbsp;the mutual written consent of Acquiror and each Stockholder and (iv)&nbsp;the receipt of the Company Stockholder Approval; <I>provided,</I>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I></I>that, notwithstanding anything in this Agreement to the contrary, the termination of this Agreement shall not relieve any party hereto of liability for any breach prior to such
termination. Subject to the foregoing, upon any termination of this Agreement, this Agreement shall thereupon become void and of no further force and effect, and there shall be no liability in respect of this Agreement or of any transactions
contemplated hereby on the part of any party hereto. Notwithstanding the preceding sentence, <U>Article</U><U></U><U>&nbsp;5</U> of this Agreement (except for <U>Section</U><U></U><U>&nbsp;5.02</U>) shall survive any termination of this Agreement.
The representations, warranties and covenants of each Stockholder contained herein shall not survive the termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 <I>Notices</I>. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be
deemed given if delivered to Acquiror in accordance with Section&nbsp;9.7 of the Merger Agreement and to any Stockholder at its address set forth in <U>Exhibit</U><U></U><U>&nbsp;A</U> attached hereto (or at such other address for a party as shall
be specified by like notice). Each Stockholder shall be required to give Acquiror prompt (and in any event within 24 hours) written notice of any breaches of any representation, warranty, covenant or agreement of any Stockholder set forth in this
Agreement that would prevent or delay the performance by such Stockholder of its obligations under this Agreement in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 <I>Expenses</I>. All costs and expenses incurred in connection with this Agreement shall be paid by the party incurring such
cost or expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 <I>Successors and Assigns</I>. The provisions of this Agreement shall be binding upon and inure to the
benefit of the parties hereto and their respective successors and assigns; <I>provided</I>, that no party hereto may assign, delegate or otherwise transfer any of its rights or obligations under this Agreement without the consent of the other party
hereto, except that Acquiror may transfer or assign its rights and obligations to any Affiliate of Acquiror. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07
<I>Governing Law; Submission to Jurisdiction.</I> This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable conflicts of law
principles. Each of Acquiror and each Stockholder agrees that a final judgment in any action or proceeding in such courts as provided above shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner
provided by Law. Each of the parties hereto (a)&nbsp;consents to submit himself, herself or itself to the exclusive jurisdiction of the Court of Chancery of the State of Delaware or, solely if such court lacks subject matter jurisdiction, the United
States District Court sitting in New Castle County in the State of Delaware (the &#147;<U>Chosen Courts</U>&#148;), with respect to any dispute arising out of, relating to or in connection with this Agreement or any of the actions contemplated
hereby, (b)&nbsp;agrees that he, she or it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such Chosen Court, and (c)&nbsp;agrees that he, she or it will not bring any action arising out
of, relating to or in connection with this Agreement or any actions contemplated by this Agreement in any court other than any such Chosen Court. Each of the parties hereto irrevocably and unconditionally waives any objection to the laying of venue
of any claim, action, suit, litigation, arbitration, proceeding or governmental or administrative investigation, audit, inquiry or action (&#147;<U>Legal Proceeding</U>&#148;) arising out of this Agreement or the transactions contemplated hereby in
the Chosen Courts, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such Chosen Court that any such Legal Proceeding brought in any such Chosen Court has been brought in an inconvenient forum. Each of
the parties hereto hereby agrees that service of any process, summons, notice or document by U.S. registered mail to the respective addresses in accordance with <U>Section</U><U></U><U>&nbsp;5.04</U> shall be effective service of process for any
proceeding arising out of, relating to or in connection with this Agreement or the actions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08
<I>Waiver of Jury Trial</I>. EACH OF THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND
UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF, RELATING TO OR IN </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
CONNECTION WITH THIS AGREEMENT OR THE ACTIONS CONTEMPLATED HEREBY. EACH OF THE PARTIES HERETO CERTIFIES AND ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS
REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (III)&nbsp;IT MAKES THIS WAIVER
VOLUNTARILY, AND (IV)&nbsp;EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION AND IN <U>SECTION 5.07</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 <I>Counterparts; Effectiveness</I>. This Agreement may be executed in one or more counterparts, all of which shall be
considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other party hereto, it being understood that all parties hereto need not sign the same
counterpart. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <I>Severability</I>. In the event that any provision of this Agreement, or the application thereof,
becomes or is declared by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be
interpreted so as reasonably to effect the intent of the parties hereto. The parties hereto further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent
possible, the economic, business and other purposes of such void or unenforceable provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <I>Remedies</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Generally</I>. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party hereto will be deemed
cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party hereto of any one remedy will not preclude the exercise of any other remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Specific Performance</I>. The parties hereto hereby agree that irreparable damage would occur in the event that any provision of this
Agreement were not performed in accordance with its specific terms or were otherwise breached, and that money damages or other legal remedies would not be an adequate remedy for any such damages. Accordingly, the parties hereto acknowledge and
hereby agree that in the event of any breach or threatened breach by any Stockholder, on the one hand, or Acquiror, on the other hand, of any of their respective covenants or obligations set forth in this Agreement, such Stockholder, on the one
hand, and Acquiror, on the other hand, shall be entitled to an injunction or injunctions to prevent or restrain breaches or threatened breaches of this Agreement by the other (as applicable), and to specifically enforce the terms and provisions of
this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of the other under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <I>Entire Agreement</I>. <I></I>This Agreement, the documents and&nbsp;instruments and other agreements among the parties
hereto as contemplated by or referred to herein, and to the extent referenced herein, the Merger Agreement, constitute the entire agreement between the parties hereto with respect to the subject matter hereof and supersede all prior agreements and
understandings, both written and oral, between the parties with respect to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <I>No Third-Party
Beneficiaries</I>. Each of Acquiror and each Stockholder agrees that (a)&nbsp;his, her or its respective representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other party hereto in accordance with
and subject to the terms of this Agreement and (b)&nbsp;this Agreement is not intended to, and shall not, confer upon any other person any rights or remedies hereunder; <U>provided</U>, <U>however</U>, that the Company is an express third party
beneficiary of this Agreement, and is entitled to directly enforce the provisions hereof (including <U>Section</U><U></U><U>&nbsp;5.03</U>) and to remedies hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <I>Ownership Interest</I>. Nothing contained in this Agreement shall be
deemed to vest in Acquiror any direct or indirect ownership or incidence of ownership of or with respect to any Company Shares beneficially owned by each Stockholder. All rights, ownership and economic benefits of and relating to such Company Shares
shall remain vested in and belong to each Stockholder, and the Acquiror shall not have any authority to direct such Stockholder in the voting or disposition of such Company Shares except as otherwise provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <I>Capacity</I>. Each Stockholder is entering into this Agreement solely in his, her or its capacity as the record holder or
beneficial owner of the Company Shares and nothing herein shall limit, restrict or otherwise affect any actions taken by such Stockholder in his or her capacity as director, officer or employee of the Company (if applicable) (including from acting
in such capacity or voting in such capacity in his or her sole discretion on any matter, including causing the Company or any of its Subsidiaries to exercise rights under the Merger Agreement (in accordance with the terms thereof)), and no such
actions or omissions shall be deemed a breach of this Agreement. Furthermore, nothing in this Agreement shall be construed to prohibit, limit or restrict any Stockholder, in his or her capacity as a director or officer of the Company or any of its
Subsidiaries (if applicable), from exercising such Stockholder&#146;s fiduciary duties as a director or officer of the Company or any of its Subsidiaries, in each cash, however, in accordance with the applicable terms of the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of this page intentionally left blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACQUIROR 10VB8, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Peter Seka</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Peter Seka</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title: Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jean-Christophe Roux</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Jean-Christopher</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">STOCKHOLDERS:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUND FAMILY TWELFTH INVESTMENT PARTNERSHIP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Zachary Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>G. Zachary Gund, Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Grant A. Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Grant A. Gund, Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GUND FAMILY THIRTEENTH INVESTMENT PARTNERSHIP</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Zachary Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>G. Zachary Gund, Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Grant A. Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Grant A. Gund, Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>G. ZACHARY GUND ARTICLE III, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Zachary Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>G. Zachary Gund, Manager</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>GCG INVESTMENTS, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Zachary Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>G. Zachary Gund, Manager</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:90pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Voting
Agreement</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">STOCKHOLDERS (cont.):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>DIONIS TRUST:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Gordon Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gordon Gund, solely in his capacity as Trustee of the Dionis Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Grant A. Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant A. Gund, solely in his capacity as Trustee of the Dionis Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Zachary Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">G. Zachary Gund, solely in his capacity as Trustee of the Dionis Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>MARITAL TRUST FOR GORDON GUND:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Gordon Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gordon Gund, solely in his capacity as Trustee of the Marital Trust for Gordon Gund</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Grant A. Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant A. Gund, solely in his capacity as Trustee of the Marital Trust for Gordon Gund</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ G. Zachary Gund</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">G. Zachary Gund, solely in his capacity as Trustee of the Marital Trust for Gordon Gund</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Alison Glover</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alison Glover, solely in her capacity as Trustee of the Marital Trust for Gordon Gund</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:185pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Voting
Agreement</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Stockholder Information</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Company<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Notice&nbsp;Address</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gund Family Twelfth Partnership</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">334,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gund Family Thirteenth Partnership</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,075,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">G. Zachary Gund Article III, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GCG Investments, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dionis Trust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181,869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Marital Trust for Gordon Gund</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>TOTAL</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>1,644,365</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom893453_4536"></A>Annex D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VOTING AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">VOTING
AGREEMENT (this &#147;<U>Agreement</U>&#148;), dated as of August&nbsp;13, 2024 (the &#147;<U>Effective Date</U>&#148;), among Acquiror 10VB8, LLC, a Delaware limited liability company (&#147;<U>Acquiror</U>&#148;), and KeyBank National Association
solely in its capacity as Trustee of the trusts set forth in Exhibit A and not in its individual corporate capacity (&#147;<U>Stockholder</U>&#148;), a stockholder of Kellanova, a Delaware corporation (the &#147;<U>Company</U>&#148;). Despite any
provision to the contrary, any Stockholder representations and assertions under this Voting Agreement shall be construed to solely refer to a stockholder that is a trustee bound to a trustee/beneficiary relationship and not a stockholder that is a
corporation or individual. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as of the date hereof, the Stockholder is the record or &#147;beneficial&#148; owner (as defined in
Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the U.S. Securities Exchange Act of 1934 (as amended, and the rules promulgated thereunder the &#147;<U>Exchange Act</U>&#148;)) of the number of shares of public common stock of the Company,
par value $0.25 per share (&#147;<U>Company Shares</U>&#148;), as set forth opposite such Stockholder&#146;s name on <U>Exhibit A</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution and delivery of this Agreement, Acquiror, Merger Sub 10VB8, LLC, a Delaware limited liability company
and direct or indirect, wholly owned subsidiary of Acquiror (&#147;<U>Merger Sub</U>&#148;), Mars, Incorporated, a Delaware corporation (for the purposes of specific sections only), and the Company, have entered into an Agreement and Plan of Merger,
dated as of the date hereof (as may be amended, supplemented or otherwise modified from time to time, the &#147;<U>Merger Agreement</U>&#148;), pursuant to which, among other things, upon the terms and subject to the conditions thereof, at the
Effective Time, Merger Sub will merge with and into the Company with the Company surviving the merger (the &#147;<U>Merger</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the affirmative vote of the holders of a majority of the issued and outstanding shares of Company Common Stock in favor of the
adoption of the Merger Agreement and the transactions contemplated thereby, including the Merger, is a condition to the consummation of the Merger; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, as of the date hereof and subject to the terms and conditions herein, the Stockholder has determined to vote in favor of the Merger
and the other transactions contemplated in the Merger Agreement and in furtherance thereof has agreed to enter into this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to induce Acquiror to enter into the Merger Agreement, Acquiror has requested Stockholder, and Stockholder has agreed, to
enter into this Agreement with respect to all Company Shares, now or hereafter &#147;beneficially owned&#148; by Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, in consideration of the foregoing, the mutual covenants and agreements set forth herein, and other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, intending to be legally bound, the parties
hereto agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 1 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">V<SMALL>OTING</SMALL> A<SMALL>GREEMENT</SMALL>; G<SMALL>RANT</SMALL> <SMALL>OF</SMALL> P<SMALL>ROXY</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 <I>Voting Agreement</I>. From the date hereof until the termination of this Agreement in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, Stockholder shall (x)&nbsp;appear at each meeting (whether annual or special and each adjourned or postponed meeting and including the Company Special Meeting) of the stockholders of the Company concerning
proposals related to the Merger, Merger Agreement, any Company Takeover Proposal or any other transaction contemplated by the Merger Agreement or at which any matter set forth in this <U>Section</U><U></U><U>&nbsp;1.01</U> is being considered,
however called, or otherwise cause all of the Company Shares owned (whether beneficially or of record) at such time by Stockholder to be counted as present thereat for purposes of calculating a quorum, and respond to each
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
request by the Company for written consent, if any, and (y)&nbsp;vote or cause to be voted (including by proxy or written consent, if applicable, with respect to) all Company Shares (including
any New Company Shares (as defined below), as applicable) owned (whether beneficially or of record) at such time by Stockholder: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) with
respect to each meeting at which a vote of Stockholder on the Merger is requested (a &#147;<U>Merger Proposal</U>&#148;), in favor of such Merger Proposal (and, in the event that such Merger Proposal is presented as more than one proposal, in favor
of each proposal that is part of such Merger Proposal), and in favor of any other transactions or matters expressly contemplated by the Merger Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) against any Company Takeover Proposal, without regard to the terms of such Company Takeover Proposal, or any other transaction, proposal,
agreement or action made in opposition to adoption of the Merger Agreement or in competition or inconsistent with the Merger and the other transactions or matters contemplated by the Merger Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) against any other action, agreement or transaction that is intended, or that would or would reasonably be expected, to materially impede,
interfere with, delay, postpone, discourage or adversely affect the Merger or any of the other transactions expressly contemplated by the Merger Agreement or the performance by Stockholder of his, her or its obligations under this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) against any action, proposal, transaction or agreement that would or would reasonably be expected to result in a breach in any material
respect of any covenant, representation or warranty or any other obligation or agreement of the Company contained in the Merger Agreement, or of Stockholder contained in this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) in favor of any other matter necessary to the consummation of the transactions contemplated by the Merger Agreement, including the Merger
(clauses&nbsp;(a) through (e)&nbsp;of this <U>Section</U><U></U><U>&nbsp;1.01</U>, the &#147;<U>Required Votes</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02 <I>Solicitation</I>. Without limiting the generality of <U>Section</U><U></U><U>&nbsp;5.15</U>, Stockholder further agrees
that, until the termination of this Agreement, Stockholder will not (a)&nbsp;solicit proxies or become a &#147;participant&#148; in a &#147;solicitation&#148; (as such terms are defined in Rule 14A under the Exchange Act) in connection with either
any proposal to approve the Merger Agreement and the Merger or any Company Takeover Proposal, (b)&nbsp;initiate a stockholders&#146; vote with respect to a Company Takeover Proposal or (c)&nbsp;become a member of a &#147;group&#148; (as such term is
used in Section&nbsp;13(d) of the Exchange Act) with respect to any voting securities of the Company with respect to a Company Takeover Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.03 <I>Irrevocable Proxy</I>. Stockholder hereby revokes any and all previous proxies granted by Stockholder with respect to
Company Shares owned (whether beneficially or of record) by it as of the date of this Agreement. By entering into this Agreement, Stockholder hereby irrevocably grants to, and appoints, Acquiror and any designee of Acquiror (determined in
Acquiror&#146;s sole discretion) as Stockholder&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> and proxy, with full power of substitution and resubstitution, for and in Stockholder&#146;s
name, to vote, or cause to be voted (including by proxy or written consent, if applicable) (until the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>) any Company Shares owned (whether beneficially or of
record) by Stockholder solely to the extent, and in the manner, expressly set forth with respect to the Required Votes in <U>Section</U><U></U><U>&nbsp;1.01</U>. The proxy granted by Stockholder pursuant to this
<U>Section</U><U></U><U>&nbsp;1.03</U>, except upon the termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>, is irrevocable and is granted in consideration of the Acquiror entering into this Agreement and the
Merger Agreement and incurring certain related fees and expenses. Stockholder hereby affirms that such irrevocable proxy is coupled with an interest by reason of the Merger Agreement and, except upon the termination of this Agreement in accordance
with <U>Section</U><U></U><U>&nbsp;5.03</U>, is intended to be irrevocable. Each Stockholder agrees, subject to this <U>Section</U><U></U><U>&nbsp;1.03</U> and unless and until this Agreement is terminated in accordance with
<U>Section</U><U></U><U>&nbsp;5.03</U>, to vote its Company Shares (including any New Company Shares) in accordance with <U>Section</U><U></U><U>&nbsp;1.01(a)</U> through <U>Section</U><U></U><U>&nbsp;1.01(e)</U> above. The parties agree that the
foregoing is a voting agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 2 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDER</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder represents and warrants to Acquiror that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 <I>Authorization</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Stockholder has all requisite power and authority to execute and deliver this Agreement and to consummate the transactions contemplated
hereby and to perform his, her or its covenants and other obligations hereunder. The execution and delivery of this Agreement by Stockholder, the performance by Stockholder of his, her or its covenants and obligations hereunder and the consummation
by Stockholder of the transactions contemplated hereby have been duly authorized by all necessary corporate action on the part of Stockholder (to the extent Stockholder is not a natural person), and no additional proceedings or actions on the part
of Stockholder are necessary to authorize the execution and delivery of this Agreement, the performance by Stockholder of his, her or its covenants or other obligations hereunder, or the consummation of the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement has been duly executed and delivered by Stockholder and, assuming the due authorization, execution and delivery by
Acquiror, constitutes a legal, valid and binding obligation of Stockholder, enforceable against Stockholder in accordance with its terms, except that such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium
and other similar Laws affecting or relating to creditors&#146; rights generally and by general principles of equity. No consent of Stockholder&#146;s spouse (if Stockholder is a natural person) is necessary under any community property or other
applicable Laws for Stockholder to enter into, and perform, his or her obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 <I><FONT
STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution, delivery and performance by Stockholder of this Agreement and the consummation of the transactions contemplated hereby do not and will not (i)&nbsp;violate any Law,
(ii)&nbsp;require any consent or other action by any person under any provision of any agreement or other instrument binding on Stockholder or (iii)&nbsp;result in the creation of any Lien upon the Company Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03 <I>Actions and Proceedings</I>. As of the date hereof, there are no (a)&nbsp;Legal Proceedings pending or, to the knowledge
of Stockholder, threatened against Stockholder or (b)&nbsp;material orders, writs, judgments, injunctions, decrees or awards of any kind or nature that, in the case of either clause (a)&nbsp;or (b), would prevent, seek to prevent or materially
delay, hinder or impair the exercise by Acquiror of its rights under this Agreement or the ability of Stockholder to fully perform his, her or its covenants and obligations pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04 <I>No Inconsistent Agreements</I>. Except for this Agreement, Stockholder has not: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) granted any proxies or powers of attorney, or any other authorization or consent with respect to any or all of his, her or its Company
Shares with respect to the matters set forth in <U>Section</U><U></U><U>&nbsp;1.01</U>; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) deposited any of his, her or its Company
Shares into a separate voting trust or entered into a voting agreement with respect to any of his, her or its Company Shares (or any other agreement or arrangement with respect to the voting of such Company Shares). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05 <I>Ownership</I>. As of the date hereof, (a)&nbsp;Stockholder owns (whether beneficially or of record) those Company Shares
set forth opposite Stockholder&#146;s name on <U>Exhibit A</U>. Stockholder is the sole beneficial owner and has (and, other than in connection with Transfers (as defined below) to Permitted Transferees (as defined below) in accordance with the
terms hereof), will have at all times through the Closing) sole beneficial ownership, sole voting power (including the right to control such vote as contemplated herein), sole power of disposition, sole power to issue instructions with respect to
the matters set forth in <U>Article 1</U> hereof, and sole power to agree to all of the matters set forth in this Agreement, free and clear of any adverse claim or other Liens (other than such Liens created by this Agreement, Liens applicable to the
Company Shares that may exist pursuant to securities Laws, under the Company&#146;s organizational documents, customary Liens pursuant to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terms of any custody or similar agreement applicable to the Company Shares held in brokerage accounts or Liens listed on <U>Exhibit</U><U></U><U>&nbsp;B</U> (collectively, &#147;<U>Permitted
Liens</U>&#148;)), (b) no person other than Stockholder has any right to direct or approve the voting or disposition of any of the Company Shares, and (c)&nbsp;Stockholder has not entered into any contract, option or other arrangement or
understanding with respect to the direct or indirect Transfer (as defined below) with respect to any of the Company Shares owned (whether beneficially or of record) by Stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06 <I>Broker Fees</I>. There is no investment banker, broker, finder, agent or other Person that has been retained by or is
authorized to act on behalf of Stockholder who is entitled to any financial advisor&#146;s, brokerage, finder&#146;s or other fee or commission in connection with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07 <I>Acknowledgement</I>. Stockholder understands and acknowledges that Acquiror is entering into the Merger Agreement in
reliance upon Stockholder&#146;s execution, delivery and performance of this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 3 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EPRESENTATIONS</SMALL> <SMALL>AND</SMALL> W<SMALL>ARRANTIES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> A<SMALL>CQUIROR</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acquiror represents and warrants to Stockholder that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 <I>Authorization</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Acquiror has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions
contemplated hereby and to perform its obligations hereunder. The execution and delivery of this Agreement by Acquiror has been duly authorized by all necessary corporate action on the part of Acquiror, and no other corporate proceedings on the part
of Acquiror are necessary to authorize this Agreement or the consummation of the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement has
been duly executed and delivered by Acquiror and, assuming the due authorization, execution and delivery by Stockholder, constitutes a legal, valid and binding obligation of Acquiror, enforceable against it in accordance with its terms, except that
such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar Laws affecting or relating to creditors&#146; rights generally and by general principles of equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 <I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT></I>. The execution, delivery and performance by Acquiror of
this Agreement and the consummation of the transactions contemplated hereby do not and will not (i)&nbsp;violate any Law, (ii)&nbsp;require any consent or other action by any person under any provision of any agreement or other instrument binding on
the Acquiror or (iii)&nbsp;result in the creation of any Lien upon any of the properties or assets of Acquiror. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03
<I>Actions and Proceedings</I>. As of the date hereof, there are no (a)&nbsp;Legal Proceedings pending or, to the knowledge of the Acquiror, threatened against Acquiror or any of its Affiliates or (b)&nbsp;material orders, writs, judgments,
injunctions, decrees or awards of any kind or nature that, in the case of either clause (a)&nbsp;or (b), would prevent, seek to prevent or materially delay, hinder or impair the exercise by Stockholder of its rights under this Agreement or the
ability of Acquiror to fully perform its covenants and obligations pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 4 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCKHOLDER</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder hereby covenants and agrees that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 <I>No Proxies for or Encumbrances on Company Shares</I>. Stockholder shall not, without the prior written consent of
Acquiror, directly or indirectly, (i)&nbsp;grant any proxies, consents or powers of attorney or enter </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
into any voting trust or other agreement or arrangement with respect to the voting of any Company Shares or deposit any Company Shares in a voting trust, or (ii)&nbsp;create or permit to exist
any Lien (other than Permitted Liens), or take or agree to take any other action, that would or would reasonably be expected to prevent Stockholder from voting the Company Shares owned (whether beneficially or of record) by it in accordance with
this Agreement or from complying in all material respects with the other obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 <I>No
Transfer of Company Shares</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the period beginning on the date hereof and ending as of the termination of this Agreement in
accordance with <U>Section</U><U></U><U>&nbsp;5.03</U>, except as consented to in advance in writing by Acquiror, Stockholder agrees not to, directly or indirectly, sell, transfer, assign, tender in any tender or exchange offer, pledge, hypothecate,
exchange or otherwise dispose of (including by merger, special purpose business combination, consolidation, testamentary disposition, operation of law or otherwise), either voluntarily or involuntarily (&#147;<U>Transfer</U>&#148;) the Company
Shares or any New Company Shares, other than to a Permitted Transferee (as defined below), or enter into any contract, option or other arrangement or understanding with respect to the direct or indirect Transfer of, any Company Shares or New Company
Shares; <I>provided</I>, that, a Transfer may be made to a Permitted Transferee only if (i)&nbsp;such Permitted Transferee agrees in writing to be bound by the terms of this Agreement as if they were a party hereto; (ii)&nbsp;such written instrument
expressly provides Acquiror with the ability to enforce the obligations of Stockholder and the Permitted Transferee with respect to the Company Shares, including causing such Company Shares to vote in accordance with the Required Votes; and
(iii)&nbsp;prompt notice of such Transfer to such Permitted Transferee is delivered to Acquiror pursuant to <U>Section</U><U></U><U>&nbsp;5.04</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) From and after the date of this Agreement through the term of this Agreement, Stockholder agrees not to request the Company to register or
otherwise recognize the transfer (book-entry or otherwise) of any Company Shares or any certificate or uncertificated interest representing any of Stockholder&#146;s Company Shares, except as permitted by, and in accordance with, this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any attempted Transfer of Company Shares in violation of this <U>Section</U><U></U><U>&nbsp;4.02</U> shall be null and void. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) A &#147;<U>Permitted Transferee</U>&#148; means, with respect to Stockholder, (i)&nbsp;to any person by will or the laws of intestacy,
(ii)&nbsp;a spouse, lineal descendant or antecedent, brother or sister, adopted child or grandchild of the spouse of any child, adopted child, grandchild or adopted grandchild of Stockholder (if Stockholder is a natural person), (iii) any trust, the
beneficiaries of which include only the beneficiaries identified in the trusts listed in Exhibit A and his or her family members (including the persons named in clause (ii)) (if Stockholder is a natural person), (iv) any partnership or limited
liability company, all partners or members of which include only Stockholder and his or her family members (including the persons named in clause (ii)) and any trust named in clause (iii) (if Stockholder is a natural person), (v) if Stockholder is
an entity, any of its partners (including limited or general partners), members, stockholders and affiliates in connection with a pro rata distribution of such Company Shares (including any New Company Shares), (vi) an entity qualified as a
501(c)(3) charitable organization, in connection with a <I>bona fide</I> gift or gifts thereto, (vii)&nbsp;in the event that Stockholder is a natural person, to any person by operation of law pursuant to a qualified domestic order, divorce
settlement, divorce decree or similar separation agreement and (viii)&nbsp;any trust resulting from the trust division, split, merger or modification of the trusts identified in Exhibit A. For the avoidance of doubt, a Permitted Transferee may
Transfer Company Shares to its own Permitted Transferees in accordance with the terms and subject to the conditions of this <U>Section</U><U></U><U>&nbsp;4.02</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 <I>Additional Company Shares</I>. Stockholder agrees that any Company Shares (or other voting securities of the Company or
any other securities exchangeable for, or convertible into, any voting securities of the Company) that Stockholder purchases or with respect to which Stockholder otherwise acquires record or beneficial ownership after the date of this Agreement and
prior to the termination of this Agreement (&#147;<U>New Company Shares</U>&#148;) shall be subject to the terms and conditions of this Agreement to the same extent as the Company Shares currently owned by Stockholder (it being understood, for the
avoidance of doubt, that any such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
New Company Shares shall be subject to the terms of this Agreement as though owned by Stockholder on the date hereof, and the representations and warranties in <U>Article 2</U> above shall be
true and correct as of the date that beneficial ownership of such New Company Shares is acquired). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 <I>No
Solicitation</I>. Stockholder hereby agrees that, during the term of this Agreement, Stockholder shall not take any action, in his, her or its capacity as a stockholder of the Company, that the Company otherwise is then-prohibited from taking under
Section&nbsp;6.3 of the Merger Agreement. Notwithstanding anything to the contrary in this Agreement, without limiting the generality of Section&nbsp;5.15 hereof, to the extent the Company is permitted to take certain actions set forth in
Section&nbsp;6.3 of the Merger Agreement with respect to a Company Takeover Proposal, Stockholder in his or her capacity as an officer or director of the Company, if Stockholder is an officer or director, will be free to participate in any
discussions or negotiations regarding such actions in accordance with and subject to the provisions of the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 <I>Disclosure</I>. Stockholder hereby consents to and authorizes the publication and disclosure by Acquiror and the Company
in the Proxy Statement or other disclosure document required by applicable Law to be filed with the SEC or other Governmental Entity in connection with this Agreement, the Merger Agreement or the transactions contemplated hereby or thereby, of
Stockholder&#146;s identity and ownership, this Agreement and the nature of Stockholder&#146;s commitments, arrangements and understandings pursuant to this Agreement and such other information required in connection with such disclosure;
<I>provided</I>, that Acquiror shall (with respect to any of its disclosures) give Stockholder and his legal counsel a reasonable opportunity to review and comment on such disclosures prior to any such disclosures being made public (<I>provided</I>,
that by executing this Agreement, Stockholder hereby consents to the filing of this Agreement by the Company in the Proxy Statement or other disclosure document required by applicable Law to be filed with the SEC or other Governmental Entity in
connection with this Agreement, the Merger Agreement or the transactions contemplated hereby). As promptly as practicable after obtaining actual knowledge thereof, Stockholder shall notify the Acquiror and the Company of any required corrections
with respect to such information previously supplied by Stockholder to Acquiror or the Company hereunder, if and to the extent that any such information shall have become false or misleading in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 <I>Appraisal and Dissenter&#146;s Rights</I>. Stockholder hereby irrevocably waives, and agrees not to exercise, any rights
of appraisal or rights of dissent from the Merger that such Stockholder may have with respect to the Company Shares or New Company Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 <I>Share Dividends, etc</I>. In the event of a stock split, stock dividend or distribution, or any <FONT
STYLE="white-space:nowrap">split-up,</FONT> reverse stock split, recapitalization, combination, reclassification, reincorporation, exchange of shares or the like, in each case affecting the Company Shares, the terms &#147;Company Shares&#148; and
&#147;New Company Shares&#148; shall be deemed to refer to and include such shares as well as all such stock dividends and distributions and any securities into which or for which any or all of such shares may be changed or exchanged or which are
received in such transaction. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 5 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">M<SMALL>ISCELLANEOUS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 <I>Definitional and Interpretative Provisions</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Capitalized terms used but not defined herein shall have the respective meanings set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For the purposes of this Agreement, (i)&nbsp;the definitions contained in this Agreement are applicable to the singular as well as the
plural forms of such terms and to the masculine as well as to the feminine and neuter </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
genders of such term; (ii)&nbsp;references to the terms Article, Section, paragraph and Exhibits are references to the Articles, Sections, paragraphs and Exhibits to this Agreement unless
otherwise specified; (iii)&nbsp;the words &#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this
Agreement, unless the context otherwise requires; (iv)&nbsp;the word &#147;extent&#148; in the phrase &#147;to the extent&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#147;if&#148;;
(v)&nbsp;whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;without limitation&#148;; (vi)&nbsp;unless otherwise specifically
provided for herein, the term &#147;or&#148; shall not be deemed to be exclusive; (vii)&nbsp;the word &#147;since&#148; when used in this Agreement in reference to a date shall be deemed to be inclusive of such date; (viii)&nbsp;references to
&#147;written&#148; or &#147;in<B> </B>writing&#148; include in electronic form; (ix)&nbsp;provisions shall apply, when appropriate, to successive events and transactions; (x)&nbsp;a reference to any person includes such person&#146;s successors and
permitted assigns; (xi)&nbsp;references to &#147;$&#148; shall mean U.S. dollars; (xii)&nbsp;any reference to &#147;days&#148; means calendar days unless Business Days are expressly specified; (xiii)&nbsp;when calculating the period of time before
which, within which or following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded; if the day at the end of the period is not a Business Day, then
such period shall end on the close of the next immediately following Business Day; (xiv)&nbsp;references in this Agreement to specific Laws or to specific provisions of Laws shall include all rules and regulations promulgated thereunder, and any
statute defined or referred to herein or in any agreement or instrument referred to herein shall mean such statute as from time to time amended, modified or supplemented, including by succession of comparable successor statutes; and (xv)&nbsp;all
terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant thereto unless otherwise defined therein. Each of the parties hereto has participated in the negotiation of
this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if it is drafted by all the parties hereto, and no presumption or burden of proof shall arise favoring or disfavoring any party
hereto by virtue of authorship of any of the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For purposes of this Agreement, the term
&#147;beneficially owned&#148; (and correlative terms) has the meaning ascribed to it in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> adopted by the SEC under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 <I>Further Assurances</I>. Acquiror and Stockholder will each execute and deliver, or cause to be executed and delivered,
all further documents and instruments and use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Law, to consummate and make effective the
transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 <I>Amendments; Termination</I>. Any provision of this Agreement may be
amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement and by the Company, or in the case of a waiver, by the party against whom the waiver is to be
effective. This Agreement shall terminate upon the earliest to occur of (i)&nbsp;the termination of the Merger Agreement, (ii)&nbsp;any amendment of (or waiver with respect to) the Merger Agreement (as in effect as of the Effective Date) that has
the effect of reducing the per share Merger Consideration, (iii)&nbsp;an Adverse Recommendation Change, (iv)&nbsp;the mutual written consent of Acquiror and Stockholder and (v)&nbsp;the receipt of the Company Stockholder Approval; <I>provided,
</I>that, notwithstanding anything in this Agreement to the contrary, the termination of this Agreement shall not relieve any party hereto of liability for any breach prior to such termination. Subject to the foregoing, upon any termination of this
Agreement, this Agreement shall thereupon become void and of no further force and effect, and there shall be no liability in respect of this Agreement or of any transactions contemplated hereby on the part of any party hereto. Notwithstanding the
preceding sentence, <U>Article</U><U></U><U>&nbsp;5</U> of this Agreement (except for <U>Section</U><U></U><U>&nbsp;5.02</U>) shall survive any termination of this Agreement. The representations, warranties and covenants of Stockholder contained
herein shall not survive the termination of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 <I>Notices</I>. All notices, requests, claims, demands and
other communications hereunder shall be in writing and shall be deemed given if delivered to Acquiror in accordance with Section&nbsp;9.7 of the Merger </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement and to Stockholder at its address set forth in <U>Exhibit A</U> attached hereto (or at such other address for a party as shall be specified by like notice). Stockholder shall be
required to give Acquiror prompt (and in any event within 24 hours) written notice of any breaches of any representation, warranty, covenant or agreement of Stockholder set forth in this Agreement that would prevent or delay the performance by
Stockholder of its obligations under this Agreement in any material respect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 <I>Expenses</I>. All costs and expenses
incurred in connection with this Agreement shall be paid by the party incurring such cost or expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 <I>Successors and
Assigns</I>. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns; <I>provided</I>, that no party hereto may assign, delegate or otherwise transfer any of
its rights or obligations under this Agreement without the consent of the other party hereto, except that Acquiror may transfer or assign its rights and obligations to any Affiliate of Acquiror. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07 <I>Governing Law; Submission to Jurisdiction.</I> This Agreement shall be governed by and construed in accordance with the
laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable conflicts of law principles. Each of Acquiror and Stockholder agrees that a final judgment in any action or proceeding in such courts as provided
above shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law. Each of the parties hereto (a)&nbsp;consents to submit himself, herself or itself to the exclusive jurisdiction of
the Court of Chancery of the State of Delaware or, solely if such court lacks subject matter jurisdiction, the United States District Court sitting in New Castle County in the State of Delaware (the &#147;<U>Chosen Courts</U>&#148;), with respect to
any dispute arising out of, relating to or in connection with this Agreement or any of the actions contemplated hereby, (b)&nbsp;agrees that he, she or it will not attempt to deny or defeat such personal jurisdiction by motion or other request for
leave from any such Chosen Court, and (c)&nbsp;agrees that he, she or it will not bring any action arising out of, relating to or in connection with this Agreement or any actions contemplated by this Agreement in any court other than any such Chosen
Court. Each of the parties hereto irrevocably and unconditionally waives any objection to the laying of venue of any claim, action, suit, litigation, arbitration, proceeding or governmental or administrative investigation, audit, inquiry or action
(&#147;<U>Legal Proceeding</U>&#148;) arising out of this Agreement or the transactions contemplated hereby in the Chosen Courts, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such Chosen Court
that any such Legal Proceeding brought in any such Chosen Court has been brought in an inconvenient forum. Each of the parties hereto hereby agrees that service of any process, summons, notice or document by U.S. registered mail to the respective
addresses in accordance with <U>Section</U><U></U><U>&nbsp;5.04</U> shall be effective service of process for any proceeding arising out of, relating to or in connection with this Agreement or the actions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08 <I>Waiver of Jury Trial</I>. EACH OF THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER
THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF, RELATING TO
OR IN CONNECTION WITH THIS AGREEMENT OR THE ACTIONS CONTEMPLATED HEREBY. EACH OF THE PARTIES HERETO CERTIFIES AND ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (III)&nbsp;IT MAKES THIS WAIVER VOLUNTARILY, AND (IV)&nbsp;EACH PARTY HAS BEEN
INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION AND IN <U>SECTION 5.07</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 <I>Counterparts; Effectiveness</I>. This Agreement may be executed in one or more counterparts, all of which shall be
considered one and the same agreement and shall become effective when one or more </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
counterparts have been signed by each of the parties hereto and delivered to the other party hereto, it being understood that all parties hereto need not sign the same counterpart. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <I>Severability</I>. In the event that any provision of this Agreement, or the application thereof, becomes or is declared
by a court of competent jurisdiction to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as
reasonably to effect the intent of the parties hereto. The parties hereto further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic,
business and other purposes of such void or unenforceable provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <I>Remedies</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Generally</I>. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party hereto will be deemed
cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party hereto of any one remedy will not preclude the exercise of any other remedy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Specific Performance</I>. The parties hereto hereby agree that irreparable damage would occur in the event that any provision of this
Agreement were not performed in accordance with its specific terms or were otherwise breached, and that money damages or other legal remedies would not be an adequate remedy for any such damages. Accordingly, the parties hereto acknowledge and
hereby agree that in the event of any breach or threatened breach by Stockholder, on the one hand, or Acquiror, on the other hand, of any of their respective covenants or obligations set forth in this Agreement, Stockholder, on the one hand, and
Acquiror, on the other hand, shall be entitled to an injunction or injunctions to prevent or restrain breaches or threatened breaches of this Agreement by the other (as applicable), and to specifically enforce the terms and provisions of this
Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of the other under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <I>Entire Agreement</I>. <I></I>This Agreement, the documents and&nbsp;instruments and other agreements among the parties
hereto as contemplated by or referred to herein, and to the extent referenced herein, the Merger Agreement, constitute the entire agreement between the parties hereto with respect to the subject matter hereof and supersede all prior agreements and
understandings, both written and oral, between the parties with respect to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <I>No Third-Party
Beneficiaries</I>. Each of Acquiror and Stockholder agrees that (a)&nbsp;his, her or its respective representations, warranties, covenants and agreements set forth herein are solely for the benefit of the other party hereto in accordance with and
subject to the terms of this Agreement and (b)&nbsp;this Agreement is not intended to, and shall not, confer upon any other person any rights or remedies hereunder; <U>provided</U>, <U>however</U>, that the Company is an express third party
beneficiary of this Agreement, and is entitled to directly enforce the provisions hereof (including <U>Section</U><U></U><U>&nbsp;5.03</U>) and to remedies hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <I>Ownership Interest</I>. Nothing contained in this Agreement shall be deemed to vest in Acquiror any direct or indirect
ownership or incidence of ownership of or with respect to any Company Shares beneficially owned by Stockholder. All rights, ownership and economic benefits of and relating to such Company Shares shall remain vested in and belong to Stockholder, and
the Acquiror shall not have any authority to direct Stockholder in the voting or disposition of such Company Shares except as otherwise provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <I>Capacity</I>. Stockholder is entering into this Agreement solely in his, her or its capacity as the record holder or
beneficial owner of the Company Shares and nothing herein shall limit, restrict or otherwise affect any actions taken by Stockholder in his or her capacity as director, officer or employee of the Company (if applicable) (including from acting in
such capacity or voting in such capacity in his or her sole discretion on any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
matter, including causing the Company or any of its Subsidiaries to exercise rights under the Merger Agreement (in accordance with the terms thereof)), and no such actions or omissions shall be
deemed a breach of this Agreement. Furthermore, nothing in this Agreement shall be construed to prohibit, limit or restrict Stockholder, in his or her capacity as a director or officer of the Company or any of its Subsidiaries (if applicable), from
exercising Stockholder&#146;s fiduciary duties as a director or officer of the Company or any of its Subsidiaries, in each cash, however, in accordance with the applicable terms of the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of this page intentionally left blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ACQUIROR 10VB8, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Peter Seka</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Peter Seka</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jean-Christophe Roux</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: Jean-Christophe Roux</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">KeyBank National Association solely in its capacity as Trustee of the trusts set forth in Exhibit A and not in its individual corporate capacity</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William Nottage</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Name: William Nottage</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Title: Family Wealth Office Director; SVP</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:96pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Voting Agreement</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Stockholder Information</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Company<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Notice&nbsp;Address</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo George Gund III</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">#7 dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-31-40</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,497,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo Agnes Gund #8</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fund A dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-31-40</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo Agnes Gund #8</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fund B dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-31-40</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo Agnes Gund #8</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fund C dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-31-40</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo Agnes Gund #8</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fund D dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-31-40</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo Gordon Gund #9</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-31-40</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,550,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo Graham De</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">C Gund #10 dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-31-40</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,989,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Successor</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trustee u/a/w George Gund fbo Geoffrey De C</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gund #11 dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">6-8-42</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,147,450</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBank National Association, Trustee u/a/w</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Agnes Gund #3 dated <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">11-21-68</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[***]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>TOTAL:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>18,327,318</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit B </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Permitted Liens</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[***] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom893453_4537"></A>Annex E </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 West Street | New York, NY 10282-2198 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-902-1000</FONT></FONT> | Fax: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-902-3000</FONT></FONT> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g893453g01n01.jpg" ALT="LOGO" STYLE="width:1.17708in;height:0.510417in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>PERSONAL AND CONFIDENTIAL</U> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August&nbsp;13, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">412 N Wells Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chicago, IL 60654 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have requested our opinion as to the fairness from a financial point of view to the holders (other than Mars, Incorporated (&#147;Parent&#148;), 10VB8,
LLC, (&#147;Acquiror&#148;) and their respective affiliates) of the outstanding shares of common stock, par value $0.25 per share (the &#147;Shares&#148;), of Kellanova (the &#147;Company&#148;) of the $83.50 in cash per&nbsp;Share to be paid to
such holders pursuant to the Agreement and Plan of Merger, dated as of August&nbsp;13, 2024 (the &#147;Agreement&#148;), by and among Parent, Acquiror, Merger Sub 10VB8, LLC, a wholly owned subsidiary of Acquiror, and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC and its affiliates are engaged in advisory, underwriting, lending, and financing, principal investing, sales and trading,
research, investment management and other financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> activities and services for various persons and entities. Goldman Sachs&nbsp;&amp; Co. LLC and its affiliates and employees, and funds or
other entities they manage or in which they invest or have other economic interests or with which they <FONT STYLE="white-space:nowrap">co-invest,</FONT> may at any time purchase, sell, hold or vote long or short positions and investments in
securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, Parent, affiliates of W.K. Kellogg Foundation Trust (&#147;Kellogg Foundation&#148;), a significant shareholder of the
Company, any of their respective affiliates and third parties or any currency or commodity that may be involved in the transactions contemplated by the Agreement (the &#147;Transaction&#148;). We have acted as financial advisor to the Company in
connection with, and have participated in certain of the negotiations leading to, the Transaction. We expect to receive fees for our services in connection with the Transaction, the principal portion of which is contingent upon consummation of the
Transaction, and the Company has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may arise, out of our engagement. We have provided certain financial advisory and/or underwriting services to the
Company and/or its affiliates from time to time for which Goldman Sachs Investment Banking has received, and may receive, compensation, including having acted as financial advisor to the Company in the
<FONT STYLE="white-space:nowrap">spin-off</FONT> of WK Kellogg Co. (&#147;SpinCo&#148;) completed on October&nbsp;2, 2023 (the <FONT STYLE="white-space:nowrap">&#147;Spin-Off&#148;).</FONT> We may also in the future provide financial advisory and/or
underwriting services to the Company, Parent, Kellogg Foundation and their respective affiliates for which Goldman Sachs Investment Banking may receive compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have reviewed, among other things, the Agreement; annual reports to stockholders and Annual Reports on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> of the Company for the three fiscal years ended January </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1, 2022; the registration statement on Form 10, as amended,
of SpinCo in connection with the <FONT STYLE="white-space:nowrap">Spin-Off;</FONT> certain interim reports to stockholders and Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> of the Company; certain other communications from
the Company to its stockholders; certain publicly available research analyst reports for the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 13, 2024 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company; and certain internal
financial analyses and forecasts for the Company prepared by management of the Company, as approved for our use by the Company (the &#147;Forecasts&#148;). We have also held discussions with members of the senior management of the Company regarding
their assessment of the past and current business operations, financial condition and future prospects of the Company; reviewed the reported price and trading activity for the Shares; compared certain financial and stock market information for the
Company with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent business combinations in the food industry and in other industries; and performed such other
studies and analyses, and considered such other factors, as we deemed appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of rendering this opinion, we have, with your consent,
relied upon and assumed the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, us, without assuming any responsibility for independent verification
thereof. In that regard, we have assumed with your consent that the Forecasts have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company. We have not made an independent
evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of the Company or any of its subsidiaries and we have not been furnished with any such evaluation or
appraisal. We have assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction in any way
meaningful to our analysis. We have assumed that the Transaction will be consummated on the terms set forth in the Agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to our
analysis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion does not address the underlying business decision of the Company to engage in the Transaction, or the relative merits of the
Transaction as compared to any strategic alternatives that may be available to the Company; nor does it address any legal, regulatory, tax or accounting matters. This opinion addresses only the fairness from a financial point of view to the holders
(other than Parent, Acquiror and their respective affiliates) of Shares, as of the date hereof, of the $83.50 in cash per Share to be paid to such holders pursuant to the Agreement. We do not express any view on, and our opinion does not address,
any other term or aspect of the Agreement or the Transaction or any term or aspect of any other agreement or instrument contemplated by the Agreement or entered into or amended in connection with the Transaction, including, the fairness of the
Transaction to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the amount or nature of any compensation to be paid
or payable to any of the officers, directors or employees of the Company, or class of such persons, in connection with the Transaction, whether relative to the $83.50 in cash per Share to be paid to the holders (other than Parent, Acquiror and their
respective affiliates) of Shares pursuant to the Agreement or otherwise. We are not expressing any opinion as to the prices at which the Shares will trade at any time or, as to the potential effects of volatility in the credit, financial and stock
markets on the Company, Acquiror, Parent or the Transaction, or as to the impact of the Transaction on the solvency or viability of the Company, Acquiror or Parent or the ability of the Company, Acquiror or Parent to pay their respective obligations
when they come due. Our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof and we assume no responsibility for updating, revising or
reaffirming this opinion based on circumstances, developments or events occurring after the date hereof. Our advisory services and the opinion expressed herein are provided for the information and assistance of the Board of Directors of the Company
in connection with its consideration of the Transaction and such opinion does not constitute a recommendation as to how any holder of Shares should vote with respect to such Transaction or any other matter. This opinion has been approved by a
fairness committee of Goldman Sachs &amp; Co. LLC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 13, 2024 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based upon and subject to the
foregoing, it is our opinion that, as of the date hereof, the $83.50 in cash per Share to be paid to the holders (other than Parent, Acquiror and their respective affiliates) of Shares pursuant to the Agreement is fair from a financial point of view
to such holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g893453g02n02.jpg" ALT="LOGO" STYLE="width:2.38702in;height:0.331731in;">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(GOLDMAN SACHS&nbsp;&amp; CO. LLC)</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">E-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><A NAME="rom893453_4538"></A>Annex F </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g893453g03g03.jpg" ALT="LOGO" STYLE="width:1.40201in;height:0.291457in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:56%; font-size:10pt; font-family:Times New Roman" ALIGN="center">August&nbsp;13, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kellanova </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">412 North Wells Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chicago, IL 60654 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Members of the Board: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We understand that
Kellanova, a Delaware corporation (&#147;Company&#148;), Acquiror 10VB8, LLC, a Delaware limited liability company (&#147;Acquiror&#148;), Merger Sub 10VB8, LLC, a Delaware limited liability company and wholly owned subsidiary of Acquiror
(&#147;Merger Sub&#148;),<B> </B>and, solely for the purposes of Section&nbsp;6.2(b), Section&nbsp;6.5, Section&nbsp;6.18 and Section&nbsp;9.15 of the Agreement (as defined below), Mars, Incorporated, a Delaware corporation (&#147;Parent&#148;),
propose to enter into an Agreement and Plan of Merger (the &#147;Agreement&#148;), pursuant to which Acquiror will acquire Company (the &#147;Transaction&#148;). Pursuant to the Agreement, Merger Sub will be merged with and into Company and each
issued and outstanding share of the common stock, par value $0.25<B> </B>per share, of Company (&#147;Company Common Stock&#148;), other than shares of Company Common Stock (i) owned or held in treasury by Company, (ii)&nbsp;owned by any direct or
indirect wholly owned subsidiary of Company or by Parent or any of its subsidiaries (including Acquiror and its subsidiaries) and (iii)&nbsp;held by holders who are entitled to and properly demand an appraisal of their shares of Company Common Stock
(such holders, collectively, &#147;Excluded Holders&#148;), will be converted into the right to receive in cash $83.50 (the &#147;Consideration&#148;). The terms and conditions of the Transaction are more fully set forth in the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You have requested our opinion as of the date hereof as to the fairness, from a financial point of view, to holders of Company Common Stock
(other than Excluded Holders) of the Consideration to be paid to such holders<B> </B>in the Transaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In connection with this opinion,
we have: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reviewed the financial terms and conditions of a draft, dated August&nbsp;13, 2024, of the Agreement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reviewed certain publicly available historical business and financial information relating to Company;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reviewed various financial forecasts and other data provided to us by Company<B> </B>relating to the business
of Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Held discussions with members of the senior management of Company with respect to the business and prospects of
Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reviewed public information with respect to certain other companies in lines of business we believe to be
generally relevant in evaluating the business of Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reviewed the financial terms of certain business combinations involving companies in lines of business we
believe to be generally relevant in evaluating the business<B> </B>of Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Reviewed historical stock prices and trading volumes of Company Common Stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Conducted such other financial studies, analyses and investigations as we deemed appropriate.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed and relied upon the accuracy and completeness of the foregoing information, without independent
verification of such information. We have not conducted any independent valuation or appraisal of any of the assets or liabilities (contingent or otherwise) of Company<B> </B>or concerning the solvency or fair value of Company<B>, </B>and we have
not been furnished with any such valuation or appraisal. With respect to the financial forecasts utilized in our analyses, we have assumed, with the consent of Company, that they have been </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 13, 2024 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">reasonably prepared on bases
reflecting the best currently available estimates and judgments as to the future financial performance of Company. We assume no responsibility for and express no view as to any such forecasts or the assumptions on which they are based. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made
available to us as of, the date hereof. We further note that volatility in the credit, commodities and financial markets may have an effect on Company<B> </B>or the Transaction and we are not expressing an opinion as to the effects of such
volatility on Company<B> </B>or the Transaction. We assume no responsibility for updating or revising our opinion based on circumstances or events occurring after the date hereof. We do not express any opinion as to the price at which shares of
Company Common Stock may trade at any time subsequent to the announcement of the Transaction. In connection with our engagement, we were not authorized to, and we did not, solicit indications of interest from third parties regarding a potential
transaction with Company.<B> </B>In addition, our opinion does not address the relative merits of the Transaction as compared to any other transaction or business strategy in which Company might engage or the merits of the underlying decision by
Company to engage in the Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In rendering our opinion, we have assumed, with the consent of Company, that the Transaction will
be consummated on the terms described in the Agreement, without any waiver or modification of any material terms or conditions. Representatives of Company have advised us, and we have assumed, that the Agreement, when executed, will conform to the
draft reviewed by us in all material respects. We also have assumed, with the consent of Company, that obtaining the necessary governmental, regulatory or third party approvals and consents for the Transaction will not have an adverse effect on
Company<B> </B>or the Transaction. We do not express any opinion as to any tax or other consequences that might result from the Transaction, nor does our opinion address any legal, tax, regulatory or accounting matters, as to which we understand
that Company obtained such advice as it deemed necessary from qualified professionals. We express no view or opinion as to any terms or other aspects (other than the Consideration<B> </B>to the extent expressly specified herein) of the Transaction,
including, without limitation, the form or structure of the Transaction or any agreements or arrangements entered into in connection with, or contemplated by, the Transaction, including, without limitation, the Voting Agreements (as defined in the
Agreement). In addition, we express no view or opinion as to the fairness of the amount or nature of, or any other aspects relating to, the compensation to any officers, directors or employees of any parties to the Transaction, or class of such
persons, relative to the Consideration<B> </B>or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Lazard Fr&#269;res&nbsp;&amp; Co. LLC (&#147;Lazard&#148;) is acting as
financial advisor to Company in connection with the Transaction and will receive a fee for such services, a portion of which is payable upon the rendering of this opinion and a substantial<B> </B>portion of which is contingent upon the closing of
the Transaction. We in the past have provided certain investment banking services to Parent, for which we have received compensation, including, during the past two years, having advised Parent with respect to its acquisitions of Cerba Vet, SYNLAB
Vet, and Heska. In addition, in the ordinary course, Lazard and its affiliates and employees may trade securities of Company, Parent and certain of their respective affiliates for their own accounts and for the accounts of their customers, may at
any time hold a long or short position in such securities, and may also trade and hold securities on behalf of Company, Parent and certain of their respective affiliates. The issuance of this opinion was approved by the Opinion Committee of Lazard.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our engagement and the opinion expressed herein are for the benefit of the Board of Directors of Company (in its capacity as such) and
our opinion is rendered to the Board of Directors of Company in connection with its evaluation of the Transaction.<B> </B>Our opinion is not intended to and does not constitute a recommendation to any stockholder as to how such stockholder should
vote or act with respect to the Transaction or any matter relating thereto.<B> </B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kellanova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 13, 2024 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on and subject
to the foregoing, we are of the opinion that, as of the date hereof, the Consideration to be paid to holders of Company Common Stock (other than Excluded Holders)<B> </B>in the Transaction is fair, from a financial point of view, to such holders.<B>
</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LAZARD FRERES&nbsp;&amp; CO. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By</P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g893453g05g05.jpg" ALT="LOGO" STYLE="width:1.3125in;height:0.4375in;">
</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Adam Taetle</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Managing Director</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g893453g01k01.jpg" ALT="LOGO" STYLE="width:7.84444in;height:10.1812in;">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">PRELIMINARY PROXY CARD, SUBJECT TO COMPLETION SCAN TO VIEW MATERIALS&nbsp;&amp; VOTE w KELLANOVA VOTE BY INTERNET 412 N. WELLS STREET
Before The Meeting&#151;Go to www.proxyvote.com or scan the QR Barcode above CHICAGO, IL 60654 Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the <FONT
STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The
Meeting&#151;Go to www.virtualshareholdermeeting.com/K2024SM You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">PHONE&#151;1-800-690-6903</FONT></FONT> Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the
<FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have
provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: <FONT STYLE="white-space:nowrap">V56776-TBD</FONT> KEEP THIS PORTION FOR YOUR RECORDS THIS
PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY KELLANOVA The Board of Directors recommends a vote FOR Proposal 1. For Against Abstain 1. or The otherwise Merger Proposal modified &#150; in To accordance adopt and
with approve its terms, the Agreement the &#147;Merger and Plan Agreement&#148;), of Merger, by dated and as among of August Kellanova, 13, 2024 a (as Delaware it may be Corporation amended, (&#147;Kellanova&#148;), supplemented ! ! ! Acquiror
10VB8, LLC, a Delaware limited liability company (&#147;Acquiror&#148;), Merger Sub 10VB8, LLC, a Delaware limited liability company and a wholly owned subsidiary of Acquiror (&#147;Merger Sub&#148;), and, solely for the limited purposes set forth
therein, Mars, Incorporated, a Delaware corporation, pursuant to which, among other things, Merger Sub will merge with and into Kellanova, with Kellanova surviving as a wholly owned subsidiary of Acquiror (the &#147;Merger&#148;). The Board of
Directors recommends a vote FOR Proposal 2. 2. The Advisory Compensation Proposal &#150; To approve, on an advisory, <FONT STYLE="white-space:nowrap">non-binding</FONT> basis, the compensation that may be paid or become payable to ! ! !
Kellanova&#146;s named executive officers that is based on or otherwise relates to the Merger. The Board of Directors recommends a vote FOR Proposal 3. 3. The Adjournment Proposal &#150; To approve one or more adjournments of the special meeting, if
necessary, to solicit additional proxies if a quorum is ! ! ! not present or there are not sufficient votes cast at the special meeting to approve the Merger Proposal. NOTE: The undersigned also authorizes the named proxies to vote in their
discretion upon such other business as may properly come before the meeting or any adjournment or postponement thereof. NOTE: Please sign exactly as name(s) appear(s) hereon. When signing as attorney, executor, administrator, trustee, or guardian,
please give full name and title as such. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g893453g02k02.jpg" ALT="LOGO" STYLE="width:7.84444in;height:10.1812in;">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">KELLANOVA INFORMATION ABOUT ATTENDING THE SPECIAL MEETING OF SHAREOWNERS You are cordially invited to attend the Special Meeting of
Shareowners of Kellanova (&#147;Special Meeting&#148;) to be held on [___], [___], 2024 at [___] [p.m.] (Central Time). The Special Meeting will be virtual and will be held entirely online via live webcast at
www.virtualshareholdermeeting.com/K2024SM. There will not be an option to attend the meeting in person. Attendance at the Special Meeting will be limited to Shareowners only. You are entitled to participate in the Special Meeting if you were a
Shareowner as of the close of business on [___], 2024, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee. To be admitted to the Special Meeting at www.virtualshareholdermeeting.com/K2024SM (the
&#147;Special Meeting Website&#148;), you must enter the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number found on your proxy card, voting instruction form or notice. You may vote the shares and submit your questions during the
Special Meeting by following the instructions available on the Special Meeting Website during the meeting. If you do not have access to the internet and are interested in attending, please contact Kellanova Investor Relations at (269) <FONT
STYLE="white-space:nowrap">961-2800</FONT> or you can also call (844) <FONT STYLE="white-space:nowrap">986-0822</FONT> (US) or (303) <FONT STYLE="white-space:nowrap">562-9302</FONT> (International). IMPORTANT NOTICE REGARDING THE AVAILABILITY OF
PROXY MATERIALS FOR THE SPECIAL MEETING OF SHAREOWNERS TO BE HELD ON [___], 2024: The Notice of the Special Meeting and the Proxy Statement are available at https://investor.kellanova.com. <FONT STYLE="white-space:nowrap">V56777-TBD</FONT> KELLANOVA
PROXY SOLICITED BY THE BOARD OF DIRECTORS FOR SPECIAL MEETING OF SHAREOWNERS, [___], 2024 The undersigned appoints Steve Cahillane and Don Knauss, or each one of them as shall be in attendance at the meeting, as proxy or proxies, with full power of
substitution, to represent the undersigned at the Special Meeting of Shareowners of Kellanova to be held on [___], 2024 and at any postponement or adjournment of the meeting, and to vote on behalf of the undersigned as specified on this Proxy the
number of shares of common stock of Kellanova as the undersigned would be entitled to vote if in attendance, upon the matters referred to on the reverse side hereof, and, in their discretion, upon any other business as may properly come before the
meeting. The undersigned acknowledges receipt of the Notice of the Special Meeting of Shareowners and of the accompanying proxy statement and revokes any proxy heretofore given with respect to such meeting. The votes entitled to be cast by the
undersigned will be cast as instructed. If this Proxy is executed, but no instruction is given, the votes entitled to be cast by the undersigned will be cast &#147;FOR&#148; proposals 1, 2 and 3, each of which is set forth on the reverse side
hereof. The votes entitled to be cast by the undersigned will be cast in the discretion of the Proxy holder on any other matter that may properly come before the meeting and any adjournment or postponement thereof. IMPORTANT &#151; This Proxy is
continued and must be signed and dated on the reverse side. </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>d893453dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:k="http://kellanova.com/20240911" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:srt="http://fasb.org/srt/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31">
<head>
<title>EX-FILING FEES</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;"><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P09_11_2024To09_11_2024" id="ixv-189">0000055067</ix:nonNumeric><ix:nonNumeric name="ffd:SubmissnTp" id="hidden121290917" contextRef="P09_11_2024To09_11_2024">PREM14A</ix:nonNumeric><ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="P09_11_2024To09_11_2024" id="ixv-191">EX-FILING FEES</ix:nonNumeric><ix:nonFraction name="ffd:FeeRate" contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="INF" id="ixv-192">0.0001476</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"/></ix:references><ix:resources><xbrli:context id="P09_11_2024To09_11_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-11</xbrli:startDate> <xbrli:endDate>2024-09-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>1</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-11</xbrli:startDate> <xbrli:endDate>2024-09-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> <xbrli:segment> <xbrldi:typedMember dimension="ffd:OfferingAxis"> <dei:lineNo>2</dei:lineNo> </xbrldi:typedMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-09-11</xbrli:startDate> <xbrli:endDate>2024-09-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div><div><div style="line-height:normal;background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: right;"><div style="font-weight:bold;display:inline;">Exhibit 107 </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CALCULATION OF FILING FEE TABLES </div></div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="ffd:FormTp" contextRef="P09_11_2024To09_11_2024" id="ixv-18"><div style="-sec-ix-hidden:hidden121290917;display:inline;">Schedule 14A</div></ix:nonNumeric> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Form Type) </div><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P09_11_2024To09_11_2024" id="ixv-224">KELLANOVA</ix:nonNumeric> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">(Exact Name of Registrant as Specified in its Charter) </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;display:inline;">Table 1: Transaction Valuation </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr>
<td style="width:44%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Proposed Maximum</div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Aggregate Value of</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">&#8195;Transaction&#8195;</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Fee</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">&#8195;rate&#8195;</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; padding-right:2pt;vertical-align:bottom;text-align:center;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">&#8195;Amount of&#8195;</div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;">Filing Fee</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis" format="ixt:fixed-false" id="ixv-225">Fees to be Paid</ix:nonNumeric></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TxValtn" contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-226">29,503,244,122.66</ix:nonFraction><div style="font-size:75%; vertical-align:top;display:inline;font-size:8.3px">(1)(2)</div>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;"><ix:nonFraction name="ffd:FeeRate" contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_pure" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-227">0.00014760</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:FeeAmt" contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-228">4,354,678.83</ix:nonFraction><div style="font-size:75%; vertical-align:top;display:inline;font-size:8.3px">(3)</div>&#8201;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis" format="ixt:fixed-false" id="ixv-229">Fees Previously Paid</ix:nonNumeric></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TxValtn" contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-230">0</ix:nonFraction></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:FeeAmt" contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-231">0</ix:nonFraction></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:2.00pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:2.00pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:2.00pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:2.00pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Transaction Valuation</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlTxValtn" contextRef="P09_11_2024To09_11_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-232">29,503,244,122.66</ix:nonFraction>&#8201;</td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Fees Due for Filing</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlFeeAmt" contextRef="P09_11_2024To09_11_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-233">4,354,678.83</ix:nonFraction>&#8201;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Fees Previously Paid</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="P09_11_2024To09_11_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-234">0</ix:nonFraction></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Fee Offsets</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style=" BORDER-LEFT:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="P09_11_2024To09_11_2024" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-235">0</ix:nonFraction></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; padding-left:8pt;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000;height:0.75pt">&#160;</td>
<td colspan="2" style="BORDER-LEFT:0.75pt solid #000000; BORDER-TOP:0.75pt solid #000000; BORDER-RIGHT:0.75pt solid #000000;height:0.75pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="padding-bottom:1pt ;BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000; padding-left:8pt;vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net Fee Due</div></div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-LEFT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:1pt ;BORDER-RIGHT:0.75pt solid #000000; BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;">$<ix:nonFraction name="ffd:NetFeeAmt" contextRef="P09_11_2024To09_11_2024" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-236">4,354,678.83</ix:nonFraction>&#8201;</td></tr></table><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><ix:nonNumeric name="ffd:OfferingNote" contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis" escape="true" id="ixv-166"><ix:nonNumeric name="ffd:OfferingNote" contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis" escape="true" id="ixv-167">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">As of September&#160;3, 2024, the maximum number of shares of common stock, par value $0.25 per share (&#8220;Common Stock&#8221;), to which the transaction pursuant to that certain Agreement and Plan of Merger, dated as of August&#160;13, 2024, by and among Kellanova, Acquiror 10VB8, LLC, Merger Sub 10VB8, LLC, and, solely for the limited purposes set forth therein, Mars, Incorporated applies is estimated to be 358,032,313, which consists of (a) 344,667,063 issued and outstanding shares of Common Stock entitled to receive the per share merger consideration of $83.50; (b) 2,944,914 shares of Common Stock underlying restricted stock units entitled to receive the per share merger consideration of $83.50, (c) 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 entitled to receive the per share merger consideration of $83.50 minus any applicable exercise price, (d) 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) entitled to receive the per share merger consideration of $83.50, (e) 354,853 shares of Common Stock underlying deferred stock units entitled to receive the per share merger consideration of $83.50, and (f) 47,000 shares of Common Stock reserved and available for future issuance under the Kellanova Amended and Restated 2002 Employee Stock Purchase Plan (&#8220;ESPP&#8221;). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">0-11</div> of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and solely for the purposes of calculating the filing fee, the proposed maximum aggregate value of the transaction was calculated, as of September&#160;3, 2024, based on the sum of (a)&#160;the product of 344,667,063 issued and outstanding shares of Common Stock and the per share merger consideration of $83.50; (b) the product of 2,944,914 shares of Common Stock underlying restricted stock units and the per share merger consideration of $83.50; (c) the product of 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 and $25.93 (which is the difference between the per share merger consideration of $83.50 and the weighted average exercise price of such outstanding and unexercised options); (d) the product of 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) and the per share merger consideration of $83.50; (e) the product of 354,853 shares of Common Stock underlying deferred stock units and the per share merger consideration of $83.50; and (f)&#160;the product of 47,000 shares of Common Stock reserved and available for future issuance under the ESPP and the per share merger consideration of $83.50. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with Section&#160;14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.00014760. </div></td></tr></table></ix:nonNumeric> </ix:nonNumeric> </div></div></div></div></div> <div>&#160;</div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g893453g01k01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g893453g01k01.jpg
M_]C_X1''17AI9@  34T *@    @ # $   ,    !"?8   $!  ,    !#.0
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   @    M $R  (    4    U(=I  0    !    Z    2  "  (  @ +<;
M   G$  MQL   "<0061O8F4@4&AO=&]S:&]P(#(U+C$Q("A7:6YD;W=S*0 R
M,#(T.C Y.C$Q(#$R.C$Y.C$W   $D   !P    0P,C,QH $  P    '__P
MH ( !     $   +FH , !     $   /           8! P #     0 &   !
M&@ %     0   6X!&P %     0   78!*  #     0 "   " 0 $     0
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M=X>7I[?'_]H # ,!  (1 Q$ /P#U5))<Q]:/K3G]*SJ<#I^*V^U]9ML>X/?
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MYXVB(_S5;224UVX]^UN_)LW  .VAD3'/NJ*EZ%L1]HL^,5_^DD9))2$T6_\
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MQ_\ Z124S&-40(%T'7^=?W_ZZI>@S<71;+N?TCHYW<>HLX8/6@(]=OD?5?\
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M<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M"7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT3W5T
M<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !2
M9W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O
M;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M      !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M    4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!
M %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M          !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F-
M60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1"
M;W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P
M4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE-
M ^T      ! !+     $  0$L     0 !.$))300F       .
M #^    X0DE- _(       H  /_______P  .$))300-       $    6CA"
M24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M   *  $          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O
M9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M!@       3A"24T#^       <   _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@     _____________________________P/H   X0DE-
M! @      !     !   "0    D      .$))301$       0     @   D
M  )      #A"24T$'@      !      X0DE-!!H      S<    &
M      /    "Y@    $ <P    $                          0
M       "Y@   \                       0
M   0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   \      4F=H=&QO;F<   +F    !G-L:6-E<U9L3',    !
M3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M!V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I
M;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M    26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   /
M %)G:'1L;VYG   "Y@    -U<FQ415A4     0       &YU;&Q415A4
M 0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .
M8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       )
M:&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=
M  EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.
M;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M      QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
M     #A"24T$*       #     (_\        #A"24T$$0       0$ .$))
M3004       $    !#A"24T$#      070    $   !\    H    70  .B
M   000 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0
M# @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,
M# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@
MH !\ P$B  (1 0,1 ?_=  0 "/_$ 3\   $% 0$! 0$!          ,  0($
M!08'" D*"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"
M!0<&" 4###,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,'
M)9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34
MY/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'
M!P8%-0$  A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T
M\24&%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]5227,?6
MCZTY_2LZG Z?BMOM?6;;'N#WP"W(=54RBG:ZRVUV)8_^=]3TJ,C95_A*TIZ=
M)<3A?7G)I:YN9CV9%-=53JL@AE;[26DWNW,=]CMNR8]3IV+B^_(J]7_0J[_S
M[I86B_I^34-HLLG:2*G,;E^O4QONR68N(_U>H>C[\2ST:/TWVBI)3U'"JCJ=
M,2:L@:Q'H6^$]JU0Z']8G=4RK\2W$?AWXS0ZQCW-<6R^RIM=P9_-7.;5Z[&?
MX3&NINK6T@;Z+HF(^8$^1X?^^:AZC4 T^E?#IC]#9V_>;LW-4CGU!X9Z=TD$
MSZ-D:#?]/9M5E)+7O^";Q_NG_&_]!:K.H5/.UM5\Z\TV-&GG8QJ1ZC2"T>G?
M[Q/\S9 TGW>SVK)NJH_:%N6<R]N4W-IK;0,JP5[3]GK]/[#ZGH>^I]EG\S[_
M .>1\SJ^:,FHX51=B-TRO4Q\D6@[F[/L_P"A].S>SU-_^B_G?TG\TEKW_!5X
M_P!T_P"-_P"@NE1ELO<6M9:P@;OTE;V#_.>T-W(ZYVGJWU@<Q[;V8[+@UA86
MT9CF[@YOVIKO4HI]OI[W4;';_P"0_P!)7*NJY'V&<@"K,:?TCC3<*6M-C:]V
MZX4[W-JM9[&7_3_FM]:*V57H*'G;K)(.)?;?2++:G4NDC:[N.SV_1?M=_P +
M75;_ ,&C)(4DDDDI_]#U55<JF^RR:S[=H'TB(,GW;5:224AH^TR[UMH'#0W\
MI,HR222E))))*4DDDDIY_P#9?3'7G+<^MV8XAWVHT W;@#4Q_K?S^^EC?3:_
M?^CH?_PJNT6#':[]:=:7.YL98^--& ;O9])#!Q]L?IX , FOO[7C_._S%(''
MVDN=?M<8VNV:B)[?FL]O^OJ)*9'+RQSE4:&#^KV^6O\ /_0_X1.W,O!]V53P
M?^T]@UU\;_Y*KFVLF?1RG:ZP:-1]%OT;/H[F)>NT[2:,LF9F:#S[G3^D^BDI
ML.R\D-G[52)D2<>PZCV_]R/WS_Z+2^UY.X3E4Q,C]7LU! <UK7?:/I*N+ZP0
M11EB !_@3,#8/\)_+2I?0ZQK7U9%;#&Y[S26Z'V[VU/L?[K&[?H)*=I))))3
M_]'U5))))2DDDDE*22224I))))3CM<X$G[+6',!.TW6<2![FFC^LY3.2?38\
M8=&^?>-Y@-'T75O&/^DV_P"$;^C]- %]@KD?9P=2 *'.#8V_2_6/Y+O_ #XK
M5;Z3%;L9MEH'N-8@']YP^ELWN_,WI*8U9+'./VC&H8TM,^F[U';I&YA8ZFGV
M_2_/_P &C^M@#0T@&#IM;_F_UG;E$OK.IPW3W):>3K^[_)2#J@TD89!DZ;3S
M_F?G;TE+NR.GM@NI (XEK9$#_P BE]HZ<(BILPW3:T'7Z'_4)J[PR7U8;VD"
M)V[3'TNX_DHGVVS='V>R) !@]_[*2FVDDDDI_]+U5))))2DDDDE*22224I))
M))3$5UCAH\> G@)TDE*22224I))))2DDDDE/_]/U5)!NMMK(V,:_0D[G[>(\
MG(9R<F8]%L0/\()F YS?H_FI*;22J_:<GM2TS_P@[\?FI_M.1_HF=H/J"""0
M/W?ZR2FRDJOVG(B?1:.2?T@[?V?W_8G&1?O -30V8<[U!H!])T;?S4E-E)1W
ML_>'W_-+>S]X=N_CPDIDDH^HS]X??\D)^;C5O]-[X<!/!.D[?I1M^DDI.DAU
M9%-K!8QP+3/.A]OTO:Z'>U.ZVMK2YS@ T2=? ;O^I24S25?[?AQ/JB")'/!T
M2^WX9_PH[^/;E)38258]1PF@DW- ')^>U6)$3.G,I*?_U/1,Z[*.4,?&HKM+
M:PYY> 3M>7,]NY]7M_1^_P!Z%3^V+;"VS&II&I]1[&N$Z,XJR'O][5:;_P L
M6?\ A:O_ *NU7$E- 8_4AP<72(_1.[:-_P +^:E]FZB.#B:1'Z)W8RW_  OY
MJOI)*<Y^'U!["PNQ@' @EE;VN@G=[7MMW-]WN0?V3F;@[U@8T(+[H/\ 6'K?
MG?G_ .D_/6NDDIR?V7GRYWKB7:_2MTT=7[/TOL]KTATK.&W]./:00=UNL!K0
MUT6_1]JUDDE.0.E9HF+P)[;[H&N\;?TWMVIV]*SF@#[1(:[=!?<9F):_]+[F
M>WZ"UDDE.55TW/J?O%S+"06D7>K8->3M?;]+\W^HB/P^H6-VN.+!(.E;P9'T
M=6W+1224Y7[,RX G'&WB&V^&T?X?\W\S]Q1?@7U5NLL=BLK8-SG.;8&@#QW7
M[6L;]):Z22G K97>+&X^3A7N:QSW,K<]QCEV[9D.=M>_Z;UK?:Q^SOMNS3T?
M6].>VWU-FY1RJ'NR&Y C97CWUN\9L-#VQ_VP]!_]9W_T#_\ 122G_]7T=Q<.
MJ7%I <,5A!<) .^[Z0$(5N=ET/V7VXS#M:[7U.'?HY_[>_S/_!$9I ZO83H!
MC,_ZNU-FTY%EX=4TN: V8VD2"[]]S7>UKTE(&]4LD!V1AD$':X.< XRYK=O+
M?S/?[D09F7N;-F, \MC5\D':[VZ?G-<AMQ<LN:362PP=CBUS6:S#??\ 03?9
M<QWTJW$=@[TY'Y_9^WVS_P!N_P#!I*2G+RW.AEV*W70'>XEI_M,_.">G-NWC
MU[<<,'.PN)@_0^EMV[FH+L;+#I:QP( C<:R"!'L=[@G^RY@!:&%P(+0#L&CH
M%GY_YZ2F_P#:L>=N\2$WVW$B?5;I$Z\3]&?\U4!AY18&FK4.D&6R#&KM'[-F
MGT-B<8F86AI:]H$'VEC3,%A,ML^FYCOW=B2F^<S% !-K0#P28"3LO':0'/#2
M9YTXT*H'$RBR!40X<'V"1 8&_P X?:UJ88F6&EHK<T.^D!L@MU]CFAZ2G0.5
MC [38T'F)U\4QS<0 DVM ;$DF.?HJ@,3,V%HK(!U<"6:Q.W\Y.,3++=OIEH=
M](G9R!S#=WTDE.@S)H>\,:\%YDAHY@<JJ[(SO1KM;9BEAEK["YP;NW;&;/I?
M2^C]+^<2PJ,AENZQI8P"-IV\PW_1EW\M7/1IV"O8WTP9#($3.^=O]?W)*:EE
MF9ZUE3W4>GM>\,:7>KZ<;6NVGV_SGYZ'_P"L[_Z!_P#HI7;V,].RS:-_IN;N
MC6.=NY4__6=_] __ $4DI__6]'<W=U2YL!V[%8-KOHF7W:._DH&1@5UVG[-T
M[%>W8(<6-$.$L+=&_0])&<T.ZG>TM#P[%8-IT!E]WM*!DXE=%D4X9M&P$?I;
M0"[^;V':RUG\U^>DIC]C<V2WI>+N(,Z- (<)<)]/_.]J7V-P=N;TO%!!!!#6
MS(]V[Z#?W=JBVD@B,!S0X.'\[= G^2VOV_23UU-W;K,)[(@M(MN=+@0YFFSV
MI*9MPVD$W=,Q]P<T@,:Q\G7>[<]E7]GVJ=&,VF+&=-IKL!D%@8""0=WOAJ&:
M*'$E^$\P=PW.M=R=O[I_-_,4F,KH?OKQ+"YIEDOM=J?I?2:]K6I*;0R,V?Z/
MH9CW#3]W?_YBF=DYX_[32/)P_P!>Z0S;MVW[.X=IA_\ Z23-SKW1&,Z#$R'C
M77]ZIO[J2DQ.;V943I'N<.WN_,_>2G-_<J[?G.^?YB",^XMDXSQV A__ *2W
M?^B_Y:*V[*<S<* )U <\@_VO9[4E+EV;V95Y>]W_ *32W9L_0JC^N[P_XO\
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MDZ>^^U_W;ZRDIM?9*M/=9H9_G;/_ ":0Q:@09LTC_"6'Z/\ ;_\ .T'=U?\
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MW B=[])'_%(OV/\ R=]AW_X'T=\?R?3W[4E/_]D .$))300A      !7
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    % !! &0
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MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
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M;[=OMU9W7,LW[GM-PW'=X+6U6'F:UVB:2]LKK:[BWNX9+:PNHOJYA:BZ;O\
MISW?%[Y =\[E^06V^C>VZK(UB+\(MB=\Y^7>'56)ZC[%7L3=?>79^RJF#<>S
M-O[WW_@]J)2[5VS10_PZGRE>HGC>;SDR%$'/+._[[<[_ &^Q[LS$?N2*Z8R0
M+!-XLES-&0\:22JE$11H#MD$ZLT&*WOE[2>U.R^T>]>Z/M]!#&Q]SK[8H!:;
MI+NVW_N^UV3;+Q6M[RXLK">Z+75S,_U$EM 2C+'X0"!F*%N;^9IV[UCO/X];
MB[!FVJ.DLAVA_,!Q7R&R-+MLIDL)UOT'WU%TKU)F\/4#(@4%50YG<&'IZYFU
MBNDJ#?27!0(W/N5NVV7FP7.X-%^Y6NMT6[(3N6&UNA;0,IK@AGC#?Q$^5<9#
M;)]R3V]YWY:]WMGY0CO_ /7.AV+D*7E^-[FL<VX[[L1WG=8)E\/]17AM[N2
M"A@6,4U!2&#O:7\R;Y=R=$;UW7OE-AX3LW:OQI^;'8U?CAM58L?ANR^C^_\
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ME@F=EQF,QVZZ2CJ9*"IIJJKHJ/%)384U8I),I6U<4R1>ZW15 KQ/^KY=7O\
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M65<]J/W7NM9C<70FUOCU\/\ =7SX_F*IG^^OGC\\<!FL+\'^E>^=Q[DW)NW
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MU_U_NK>.!Z[P)[)^.]4,YOO+[?Q=?0;1PYI,953?<U\D$/BI9FU6B<CW3D9
M60'S'^0]";_PH+^!'RF[TJOAA\\?@_M>D[,^2W\O3M=NR,?TS520K5]G;+GW
M!LO=]93[9BK*BGI<GN/ 9[8%(QQ@:*IR>-K*M:5VK8J6GJ/=:1@ RG@>B,?+
M[^<=\Q/YC7Q@[%^!_P 3_P"4+\Z]D_)?Y&;0R'3G9>1[NV!_=#J7I?!;MC7
M[\KW[!SE!C,=7@8VIJ*.DK\U3[=IJ;SBLD1GB%'+[K84*:UP/]7^JE>MC/\
ME;?#&L_E]? CXX?$O,;CH=W;JZMV;5MOK<F*CJ8\-E-_[RW%F=];V."6L$=2
M^ H-R[EJ:6@DDB@EGHX(I9(8I':-?=49M3%NC_\ OW5>O>_=>ZI0_GG?\R)^
M%O\ XU=_EQ__  0^ ]^ZLOG_ *O,=6Z=F=7=;=T;%W)UAV]L+9_9_7&\,>^*
MW5L7?NW<3NS:>X<>[I)]IE\#FZ6MQM=$DT:R)Y(V,<B*ZV901[JO5+\WP+^9
MO\NN23<W\J'L^#M?X^8\R5F4_EB?+'?6;R&P*"@CT32XKX@?)3,MG-Z_'VM>
M.!HZ+ ;@_CNT&K*V6HE:E544>ZM4'C_J_P!7_%4Z-M\3_P":+\>ODOO&7HK>
M..WM\4/F'AJ5)=U?#OY08B'K3NF-5DK*:3/=<Q5U2^W.[^O:VHQE1)0;@VG6
M92DJ*)4FF6F,@B'NM%2,^75DOOW6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW6MA_/2WA_*4^)N;V!\QOE=\6^LODO\ .JGPPP7Q?ZOR-36KG>PJG:M9-7X?
M-=D8*.O?9LW5W7.8R1FJ,]N+$Y,XX2_;X^.:KDAIF]U[K55_ER]/]O?SK_YJ
M&8^0GS3W0F]^N>J(\=\D/EQNFMAJ,?UUM_KG8=?55_47QQVEC9ZMH]J==9?/
M8V4"@2H-4^"Q66K*IYZNJEGD]U[I&?#/LC-_./\ X4-],?(+K7&5>/I>Y/YA
M6X_D#B:&FO'/C>G=FXW=67.2K/MU0:<KU7M>)ZTL &FR3A^6Y]U[J'WSOWOR
M?^?K\HNQ]A?';#_,/Y#[)^:O<]7UG\==_4.2W/A=SU/5>+J<%UNTN%QV:V[7
M;ABZNZ_P5%G,31I5I")J**H$;B,+[]U[JUGYB?,S^?\ _.KX[]B_&+OS^1W0
M5W7O9&*^RFR^&ZF[2_O?LG.TK?<;?W]L*OS/;>3H\-O?:.35*O'U1B;1*A5@
MT;NK>Z]U61V)T'\O_C5_(V[IZQ^4O2/:O16'J/YJ?QRWSU7MGM/ C;U;7?WF
MZ-WM0[_RF%I!4U,;T%7G-O4\TSQ,8FJYI.?+Y0ONO=!M_,L_[<T?R)/_ !6[
MYS?^_+VQ[]U[HRGS_P 'M#O+^>M\/^E/DAEI3\>J_8_\L;I_)IE\D^,Q$'3&
M[.L=M;GRF$7)2R11XG!;\[*W'7XW(2*Z(ZU4FH@BX]U[KZ->[>DNFMY=09CX
M_P"[NL-@Y3HC+;/?864ZHJ]L8:GZ\_N,E$M%'MR';-/2T^(QN&Q]#$@IHX(X
MEI/$C1:&12/=>Z^<]_PGUP^T]N?S>>[=L]?YB7</7NUOCS\^]K=>9^>9JJ7-
M=?[:W[M7![(RCUCL[U_WNUZ"ED%268U(82DDO<^Z]T/_ /PD ZZV9NCYF?(S
ML/<. QN9W;U)\9=D)UOE<C1T]74;/J>RM][AP^\\I@9)D=\=ELSA-M4]#)41
M:9?LGFAU>.:56]U[H>/^%G>P]GX[(_"WL^AV_CJ/?V[=A_)W8.YMT4].D.3S
MNT=JXWKW/[:PV4GC"M6T^!RVX*^6D,FIH/O9PA D8'W7NJV/GQ38'OK^<+\"
M^I/D_N3()T#DNA_Y5?56<R67RD^.I*+IKL78NV]Q;U@I\K+(J8O';[W_ +AR
M%#DJB,K?RLS'5&I'NO=?1[WE\>N@-W='9;XX[RZCZTKOCM5;.FV5D.I*O:N#
MQ_6]%LF&B:F7$T>WZ6EH\5@L?BZ0:Z9Z5:=J)T66%HW16'NO=?-I_D[?&V+Y
M7=[?S1?@3USELGNOJ#NWX>]_X79^X),E(M%'N?H#Y$[>R/PJ[<RE5+Y(*FNQ
M>X:E7AKI3KJ:?(5)60>0M[]U[H3?Y2W\SC??PR_EP?S<NAGJIMK]I83K^#M#
MH'#5M4]%5;3[I[)RU#\9^V\-B(3)#529S8^[Y\/GI%C8:)*>IE92 Q]^Z]TI
M_A#\1,YT1_PGM_F@?S!\=!E<9V1W_P!<M\<.L-PPR5%+FL#\5<%VQM#8/<^5
MH*V%E-53]KYVIS)R<NF]10X6E9GTZP?=>ZN<_P"$BG3?15-\4>_N_<9A=M5W
MR2R??^X>JMZ9V:GQU7NO8_5VU=L[2RG7FR\.\D3Y';.U=R1YF?,S10-%!DZR
M4-()#21>/W7NBV_\+!NG.C,%0?$/OG$8?;^ ^2&_-V=B=;;GR.*I*:DSW8_4
M&W=AOGHZS=GV^A\K'UWNM<;3X^MG1I:9,S)3+((Y0@]U[K:,_E0?]NR/@#_X
MJ#\?O_?9;<]^Z]U8%[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>ZUWMD?]Q1G=O\ XQZZ]_\ @EX_>_(]6_#_ *OGUL0^]=5Z
M][]U[J@'^99_V^1_X3\?^)'^?W_P,>+][\OSZNOP2?E_AZO^-[&W!_!(N+_B
MXN+^]=4ZI0ZW_G%478/;_7/Q8EZ#FV]\NLA\M/D%\>.\>EZOLH5E)T7U9\=-
MF2]F[D^4-=N6+8=/7;FZTWQUWN#:-5MA6Q>,I\QDMTKCX:]Y:*5I?=7TX)KC
MHN6V_P#A0#2;PS'Q#P\/2/1?4Z_*?XB]6?+),Y\E/F2W4>W,/3]F=Y[AZ4CZ
MCV%7XCXY]@U?:'8V*? _Q98Y*; T]32SK'JB<%O?NMB.H)!-/L^5>E)VS_PH
M%ZZZ)RN9Z^[1^.N\*/NSK/YI;^^//R#ZMVOO.#=&0Z6^,/7Z;7W'D/G[G*FE
MVA%7R=#UO6?9.U<W$*RAQL FRT]"<CKH))I?=:"$BOET=/JO^952]O?&CYZ?
M+K:G4D-3T7\2]S?)+!],[M3LF@J*#Y6X+XO;-KJ_?/8FVLG2[8GQ.RM@YWL?
M!9;;N'KUFSB54.+DR)M'(E/[]UK2:@>9Z*?\>?Y^O3OR;[P^#'Q_ZW^/W<-'
MOWY34^Z:3O&'>]%E-F4'Q%WKM_IO<_;^*ZZW/79G:<5)V5O#>V&VI/7XBGQ\
ME!]QM:6'.,4BE6E]^ZWH(#9X=.W0/\YW=WRSS7R0VE\=_B=C,ENSK.G?M3XW
M1]K]_MUMM?YB_$7!]L;\Z3WU\E>O=RXCIC?TFU*7;/8?7U12Q8.LHZIZR#)8
MRH-;!'6J4]UHJ1Q/2!;^>%V=B?AO\6OF7OSXD=2]9[!^:/=75W5O1DV]_F7-
MC=K;<VQV)LSLC==;V;\@M[1?&>HAZKQ&VI^OUI6I,?0[D>I&0C<S0M&T+>ZV
M$!- 3PKP_P!GIC^1W\_I?CHG0T59T7T7V-4]Q?$_(_*N*NZ_^939';.^X*'N
M;$=24?2GQ1S%3\<J>N^2?=6Z8LTF4PV*FH=I)D5IZBF61)(U=_=;T8)-?V?[
M/1L.U_YME#UGM_YX34GQ_P SNW?WQ,[X^./QEZ?ZOQW85!2;H^47>?RDZYZ<
MW;U=USBVDVE4T_7&X'W;W#!A*]",]%21XZIKB[(K0)[JM/GT[=9_S8]L]I4O
M\MB3"]-9G'9'Y\=G=X=+;WV]FMZ4E)G_ (P]L?';KCLC<_:VQMTX^/;4S;TR
M^W=]]89#;Q"G#+)'IR"WC>."3W7M-*YZD=N_S0JGKC^8;MGX"X_IO:5)E,OA
MNIMP4^^>[>_L)T#D>V\9V;N.;!YB'XB[0W+L3.8/Y)9_JBE@-1N'%#<>W,D)
M5:FHH:R9>?=> !%:].7SG_F?4_PT^37Q)^,6-Z*RW<.[OE)5Y*HI&Q_8NW-F
MY6BP&%WQL'9F=AV!MW)8S,2;_P!\8*@WQ+N2KQ^2J=JXB/;6"R50N7>JA2BD
M]UX+4$]1/E3_ #:.G_A]V#@V[7Q.$F^-?8WP][B^3O27R:VQV/@,QM3MK>W1
MU!!NO=/Q]VWC8:+^&5.[]W=;Y.BS>TJZGR]3%N3744M-3F2GUR^Z\%)P*UZ!
M*C_FS_)C/[9[3W'LO^73E-TO\2^K^N]Y?.;;[_)?:NW-R=/=D;NZOV[W;O?X
M^=+XW+]:B#O_ +1Z8ZOW135&>>MGV3AY\KJQU#5U-1]/=> 'KGIUVW_-5[^[
M0^1WQXZ8Z1^(?5'8/7WRUZ1D^5_Q^[HRGRVS^S(,W\6Z#(=8T^7WEOC8-9\6
MLGG=E=GTM#VG0S1;4CJ,E&\L<D,F3A969/=>H*?%GI4_"?\ FQQ_,WY)]B='
M8K9/Q^V-C]@=D?)CKJ;!U/RMJ=Q?)^KB^.O88Z]&^JSXWQ="X;%XO8V]JIEJ
M8JH;SJ9:*)U!CGU!O?NME: '/3'_ #SO^9$_"W_QJ[_+C_\ @A\![]UI?/\
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MJJ>&IIJB*6GJ*>H19H*B"9&BF@GAD#1RPS1L596!5E)!%C[]U[JJOK'^1_\
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M%V[)N2?!5T6W]U;PPN,VOBCG7@1)(IMP5U1A8G@IPB>ZWV]"MU)F_DYE]_\
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MBDZC^/>Z,)M'(;QS&\LONH]GS['V=D\?N2;([3D>;"]3[*VAO?'ICL;O#?\
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M"W-B:_MCK+?^ZMQX#;N.&QDJ-I[KH<U7X[<]1NZ@VW3Q5/7/:TVW):7,[HC
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MT^[!2RR'?!WYUW@"F%J72OIEE9ECDT0R1>Z]4TX=&B^,O0_7/1U!V!2;!S&
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MX'5&[>WNRNQ.R:[:]'@<E\C<WVKMW:^/VIB\Q4[UV[6TW0@.-[,S=75B'<.
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M4@_0^_=>ZR>_=>Z][]U[KWOW7NO>_=>ZQI+%(TBQR1R-"_BF5'5FBDT))XY
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6M9G_EY_,4PM'\A^O\
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M?7F[]WYW'=^Y7JSK7$]:4\.#P.WNA(=UY"IRVX,EV-4[7H-V;?I:O(T\K56
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MWF*S9NU*O+;FQ/\  =R92JV[B*C([@P7CCA_@N;K9:-ZG+8GQ0HOVT[20Z5
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MHL \--4)G*O)T5-AWIZTQBCG7)S3I1-#5F9!$P?3)K&DFX]^Z]TF?]*_5O\
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M29_WE+N;_P!)_P"^_P#[77O5>M^#)_#_ #'7O^@IW^29_P!Y2[F_])_[[_\
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MW^29_P!Y2[F_])_[[_\ M=>_5Z]X,G\/\QU[_H*=_DF?]Y2[F_\ 2?\ OO\
M^UU[]7KW@R?P_P QU[_H*=_DF?\ >4NYO_2?^^__ +77OU>O>#)_#_,=>_Z"
MG?Y)G_>4NYO_ $G_ +[_ /M=>_5Z]X,G\/\ ,=>_Z"G?Y)G_ 'E+N;_TG_OO
M_P"UU[]7KW@R?P_S'7O^@IW^29_WE+N;_P!)_P"^_P#[77OU>O>#)_#_ #'7
MO^@IW^29_P!Y2[F_])_[[_\ M=>_5Z]X,G\/\QU[_H*=_DF?]Y2[F_\ 2?\
MOO\ ^UU[]7KW@R?P_P QU[_H*=_DF?\ >4NYO_2?^^__ +77OU>O>#)_#_,=
M>_Z"G?Y)G_>4NYO_ $G_ +[_ /M=>_5Z]X,G\/\ ,=>_Z"G?Y)G_ 'E+N;_T
MG_OO_P"UU[]7KW@R?P_S'7O^@IW^29_WE+N;_P!)_P"^_P#[77OU>O>#)_#_
M #'7O^@IW^29_P!Y2[F_])_[[_\ M=>_5Z]X,G\/\QU[_H*=_DF?]Y2[F_\
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M^^__ +77OU>O>#)_#_,=>_Z"G?Y)G_>4NYO_ $G_ +[_ /M=>_5Z]X,G\/\
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M,G\/\QU[_H*=_DF?]Y2[F_\ 2?\ OO\ ^UU[]7KW@R?P_P QU[_H*=_DF?\
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M_GW&PO\ T#]O?_6[W[KU3U[_ $5]8?\ /N-A?^@?M[_ZW>_=>J>O?Z*^L/\
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M_GW&PO\ T#]O?_6[W[KU3U[_ $5]8?\ /N-A?^@?M[_ZW>_=>J>O?Z*^L/\
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MTIO&OJ-W1;"DVDVT-B]J9_'X3/Y]*YL%@ZO(TGW]73I4P/)[KVD]8*#^:_\
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M73/+3S1R-[K1!''JDO\ X54_]N6_D%_XD;XY?^_TV+[T>G(?[0?8>K_]@_\
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M,[-V7NJICJJK!Y'>&U=J[NPD60S]/Y!DJF675-52Q35=3[KQ(Q3HH>R?@_\
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MO5R;8V-C=@SOCZ^@C6ERD=;.\JQSQ"GB]UXCYYZ"'X\?/4]M8:IV?D>N^O\
M?'</:/:='6;1Z^V564^V]NUW2W9'7DG=FQ]Q;^SV[(:Q*S=VQ.JZ9L3NA8J:
M5ZC=&-EIJ6G2/7]M[KQ%#QZ$OJ?YH=4;\[ 3 X_H[([=@[^JML;BP^\9ZC8U
M5'V5@LIF-]=283/;VQD%>N=QV7HZ/IHQ)05D52T>*DI(TE\T552TGNO:32M>
MDQM[Y[; DBI\WM[IS<>X*?-[9%705&CJ_;:;=Q>8W!TSUWUMUI2Y&#-S1Y:@
MWCV!W#CUBK)G@H*"C%94U#K'!3)4^ZWI^?2DVE\K-FY&;OW>.U_CFNW]W_&K
MI/>6-[9W$U3M,4V W+UYG-]U=!T3A,EA(7S6YL%/D\#7Y9<A3TU/B*>"J5I-
M-89Z:#W6J<,]2^^-W?*_JGX\=E[RPF/^-VY$P?2NR(^K=O5V"STV-S7?F:K=
MG8J*'=&/I<AB]O0=;5>[,K4+1_8U25,$+4\C2,4D+>Z\*$CCT&^0_F UE3VU
MALMB]B[<SG661Z\V9L396/EIJQ>PLG\N]^=O8;K;<_5@WA#'D<?MK;'6LM?'
MBMS-+BON8,PC(;F-()?=>T]+>K_F T%+!E#MSXU]@+G*ZMS,N.VYNO([/ZTS
MV?SNPNF<5W7VO#FZ/<=3#/M;+[)VKD\=0T_\86EERN2G4+X:"&6NC]U[3\^O
M8#^8;M/?M#@-S['Z$[!W5C]S[SZVV/U1N"H@Q.%QN8W)V3N)MH[MQ^2W'F8H
M,+M+*;#JJ:LJLC1T]7D:VOQ-*U33Q2!TC/NO:?GTN=S_ "!W#UM\J'V;VKC,
M=B<#O&39>SOCAC,3M7'5U1V+1[FW+UWM[?&X?])]3N"*JPVY>O\ .;GFFR^U
M9L721R8&&FK:&IR,YJ(J?W6J5&.D-MCYVS9'N_/;:J-GG)=49;=G3'6^V,]1
M5NV8,KM+>_9>X>X]ATD.X:*FS>3K=RX'<&]>K8UCJJ*%?X?2UB.\<K15B4ON
MMT_;T,^'WSW;L[L?I/KSO.3J_=$W<&2[=QA;KW$93%8O$5.R<-B>P-CY:2DW
M+59/)5<\6,Q66I<@P=8?NY*"6(1,LBR^ZU04)'23[N^8_671N_\ -=?S[ @W
MID<)MS<F]Z.EV57[>FS'^DS$4.V=P5.S\KCLG3XO$[7W7FMJ[]H\K3UE1D?N
M)*2I,LL4<4L,LWNMA:^?0<[E^<F5W15T.QMM]1-29G"]S=-=/=_U&Y,QM?,;
M>Z[R_9/?T?4@VQ04M;58>?LN'<N-PN1F@R&,1THDGI3)3R5*U-%3^Z]3Y]&#
M^1/RBV9\:\YAZ_?NRLE%M6?9&Z\H>R9'Q-#C*G-8Z6BCV_TMLR2I+5&X^U=^
MU[">BPLDF/@DQ]%4U@GD%'+&GNM $\.BE=D_-ZOCWUG^I]^=29!,G-M"/868
MZ.PN8EKMXU';>[\E35F!.V.WMBM4PPX_(=25U15P24$$.6I<F5IQX*@H3[JP
M7S'2VZ2^5V!KMPT'QWSO6=2)<OVC5;-Z*V5_=_%X!:+I+8F)H&R]3G,#G\O5
MUU)F/CY/0T]#N6"6.*IAJ:_&_;QR?< K[K1'G7/2<V9\Z<ULBEWIDNW>LF@>
ME[%[#W9V#4[9RVSC1=6=/0?(7</QDZURL0QT4.9[4W!ELUL6IJ\C'%%]]3P+
M,-1<T%#+[KVG..GSMWY';EDV1\?^\J'X^XO#9_>>$^1HV[EM^;NP>3SW4VUL
M!T?OCN#;^Z(]LX&HJ\+NW(;UR'3V'>7&P5RR4-*W_ I'#@>Z\!Q%>N>R_G]"
MF0VEU[F>A-Z-W+D,)M??O:>SMDT=-N.NQ.T-V1=4XNF[*Q46U:'+TVZJBKR'
M:N-:MQB3I68R@I*V:>4PT].]7[KQ7YXZBKWYCNNNS>_=N)UQ+V!NW?G=%%LJ
MEVQB6PM%1;T7=$_7W7FV9]];RWEGLCDZ*+;4%160S4M/2MBJ;"+&*6E:I+Q2
M^Z]3AGI/93YY9"BZGQ&7ZIZ(S&*SV)V;MK<76?3^[]Q["P.VMR; SVVMK9#9
MN4W#O.BJ\ZVP9L1BJFLB@QU)#6R-54L*2RQT\ZS)[K>GU/0NI\VL3N[<QVWM
M3H/>.\LEDNR\OLWJ/+Y 8W;NU=\;AZ[W#V;M3L=SO3=5!0[=VCN[8<_4^X*B
M+$M4U.4KL:*:>!56HE6F]UJGSZ!39WS V)L3 =7=B[GZ9&:W9V_T1T?\B.]>
MPML3;;QN*V[B<UN+"]/;4KL/M*ISF9R.=SVW\KN94^VQ"^'^'I,\5743M3P5
M/NMD<<]#SNSYO;'IWV;M\=69W=3;ZV+@>PLQC_XGLN:@V[L_)]7]F=M9"?/+
M+E*I*VJQF%ZPJ::*"&.5:VOK*81N(//40^ZUI^?2)PG\R##YK$5DE-TINJFW
M1@-AT7=N]MKU.\MD11[5Z K.O-K=EIV(=S+7-M[<.X(MO;K@IWV[CIJBKCK:
M>8O,M"::NJ?=>T_/I/X7YI].T.\<1-M#XZ[DR/:]4N]JNLVAMS$PY;N_;'26
MY=^[-R^0WIN+:]!BJS,8FO[7W?O?';EI, ]3_N3PZMEIJM&II((_=>H3Q/0\
M1_,;#Q]9X'LK([$3!TDW<[]0]CPY7>.!IJ#X_O1U=3'4Y?OG,I32KL"LH*'[
M1'HC!4QI796@B^Z^TJHZ_P!^Z]3Y] WLWY?1=[9[I[K;:/0.X\!T_P!^;D["
MP=?O3)[BR_651-L)>M-U=@X7=NQ)<)0X6OS6?S&2V_)1[AQU#6QU&#>JC,M3
M,\C*ONO%:5->@YZF^3M!TA+OS9.?Z9HZ/;O7'<'===BHMOYO;E1!UE\?-O=P
MXWI9^P5R^7FKMV[_ -\[VWW4UV8S5"]0^3,;3KK+_8TU9[K9%<U\NGK)_.CM
M+>.;P-=L[X[T.'Q4C])YO8U?N[=NT\AOG<./[2^36:Z#R.#_ ()2R-C]C1[J
MV]@9,E39+^)U+44!TU%/)-_DP]U[2/7I1=N?-#-P]2]3;NZCZEP4^#[@ZF^3
M?9V9FW7789*_K?=?0NR)]Z0TPV:HCQ_855D=[8ZII9Y(:ZC0&%*D36D##W6J
M9R>EPW\P+#T6\#L'-]+=A0[SVG#O3*]O8/;YI]YS];[9VQG:3;M#NFFK=O4=
M5CMT8?*U63IYJN19J$8FD,TE028@DGNO:<5KCI)87Y\8;<6,R6.H>G]_]=I0
M[7V+NC=F=Q6,VWNZDZ[WCV;A=B=F[:VSNIZ40[(BR&X-D]B8^<Y!LHT,N7FF
MHZ?[B6)9Y/=;TGUZ,A\?._,/WW7[]IZGJC)=?5(Q&W=QTC;AJMJYB;L#KC<F
M9W]LS;6X<@=OU5>*&:HR?767A;&5KR2T]+X&U'SM''[JI%.B%U'S!W_MJ7NR
M@QW7_3]/WA'\C=N[+VW74^W<A28O=OP;VAW[-UO/NK)P?QU<EF\_UA35^X=L
MR".>GQ$&[LC3&.$1U;TS>ZMIK3TIT/%#\WNO6[&BZ^Z]Z)KNP<]A\KO:+:>3
MZLJMG93&9/JS!;*W1O;^^.R\C6IMXY.HWG7;9FQ-!B<:)Z>LR=1&16M3>6IC
M]UK2:5KCH0,_VW@Q\9L=\J^M=H=98W?J[>H]O8229H=Q8S:8WIVOMC"=A[+K
M\OA:;;V0AJ:'=>/TYRC1*6:+.8SQU,9FIBH]UZF:5Z2&"^:V+W5+@^NL1\=\
MY'NGM/<1@ZHV%GL]L3'X??FPJQNRLCF^P-Q92AFS6#VA'1TW5F<JJC$SK69.
MI)IS#'.TTYIO=>IQSTW[<^?&V=]Y[KC"[;Z)W!F<IV/D]NY+HUI\[LJ'^)]=
MYC<NZ-CY_L?,R2SR2==IM4[8J99\9:JR550U,"0(\_WE-1^Z]I^?3=C?YA6"
MR5%A9<3\?MQ1[Z[-VM1=J;+VI6[MZZHY]X=)TVP\YOC^_>:W;0Y');:P>>QV
M&VW4TD6 K*IJMJIX-$HHONJRD]UXK\^G6?\ F#==5N".^#UEDI=H4W:='@-K
M5&6R>#AWINK:@J^O=HYGNO:6S(Z;(5-'M? [\[;P^!EERE5B9?-5,6>,R4T5
M5[KVD\*](_"_S$8*/:^W=Q]N] 9FAW1M/85/O[M@=<SMV5B^H(=]97MC$==5
M-)GX,!1T]5MS=U%U+6KELU)-CZ# 3UE+#6.5>=Z?W7M/SZ-+\>^[MS]@T'R!
MS';> PG5S=1]LUNSJ_"UF?VYDZ3:&$Q?4/6._<I/GMY8K)U&$R,44N\*JJDJ
MY!0F"E<)+"@C\DGNM$4I]G1?,[\P<EVWUSBX>K:;;NS=QYOY1]7?'K-Y7<.,
M3L3 1;7[%V]@.Q,+O?:<$XVO1;C@W1UYN+&U6/-5&((S4E_'/$L,LWNK:?7T
MZ#>+YVY [4W_ +-3K3%[Q[?V2>W4WIV+L79U?6=6T>=V1E>RMK]5=WRX1SF*
MNIZ^W!FNK*@9JKDRS1;:K*62C^]JC&)![KVGAG'0J9;^89L+!;AJ=CYK:,V]
MG&R<%DX-U[,RV"R>UMT[@W%_%-CXK8=LB]'2T.[MV]X8N;9-'015&1I8\O4Q
M0U=3!(9(8_=:TGC\^L.._F'=29+;G7V]*3K^>EP59E]J[>J:>OR>WTW?LBES
MV9V1UGOBIQVV<1!F9)<;U-W%O>CV/N.0U%!2+G*6JI:26KDI_"_NO:?*O2HZ
MH^:^-[PWQA>LVZ+[(P)S.*V?DMTUOE@S<W7=/V=M3='8_3F4W+6;+3)8[#4N
MY]G;/EJI,C#DU."R]314A9IY'D@]UXK2N>@ZV+\P>O\ !=5[8P77WQSS,G42
M; WQV5MK&?WJVI.)_B[UCE,7A-]=LYJDSU9*U7N67-9V.4;=J*NLSF1$LE17
M34]4[1-[KVG/'/6>#^8]L"C&*W2G2FZL7LK/;?RN_LUO9J[:L5=C^FML=VT/
M0."WS5;6H)*G=N:K\EN+*+D:/ T]/-74V$U:_'D7CQDGNO:?GUSR7S+ZVW?O
MWI_%[WZ&KZ7<N02;MSJO,[EWKL&+:^V^AL]LOL5=Q=];QS[9Q<%M.EQFT-L9
M)*["5'WN1B%9"8PQ6J>C]UZASGIJJ_GZ<I6UU;M_K$X+:>-Q/8V1[6[%Q&9P
M69W!A:O953\<:KKG);/VSF\1@W[(P6^-C?('&5<E1.:"7'P,! M21"9_=>IP
MSUDH_FGM##;_ ,YE]K?'C>.5[9[FV;BNPMH1MV'MIX]^="[)P/9%;@MWU62R
MN;J<)UE%11;0R!7;442U3UV8CFD1II,G)1^ZW3'''1I=\_(S;.P^FNH.S-E[
M R6ZZ7O#<O5&V>N=HTE1MW:$C97O&:EJ]OU.XJS)U0QF#H8/XC]QDFA%94Z@
MP@AJ9F1']U6E2<] G#_,&ZFBZSRO:='USNEHJJEK:ZLV_1MM"'<>=R^)Z W+
MW5D\6B5&8HZ;)5U+0[,J<$E1)+]M-4K%.DIQ["H'NMZ36G2@I?FGA-LYVNZ^
MWYU#E.LMR;?7>+4^QZS<NSY,U'MWKOJO/=F5>^J3$13T%(>KLZ^UZW$8#.4D
ML]+69&AJHYUHGII$'NO:< UZ2]=_,/VD^?P.U=H=9Y+>^=W[#UU2];TF$W7M
MQ*/)[HWM-MR+<VV-YYBHC7#[/K^M:_=%,,Q]I/FI$]:B(5 6G;W7M/3?AOFK
MN[.];?+OM38O1&!;%]/].]?]U=8T65WUB,#E>TLEO+JC*;USV-WZ:;&UE-LB
MIVOE<&<?]V9*X5]*@FB8+I'OW7M.0*]9^N/D]L;:&0SG4N"Z)W)24N4R'R+3
M#I0[HHM[Y+M/O'J6B?>??FT*R/,UE5N>2IR.?RU728S,YF4Q99Z=E9*6!Z 5
M/NO4\Z])/>7\Q/:N;V7O:AZ"VC4YC>NUJOJ>;9\%;!MB7;F[^M-V+UC4UV[,
M"5S]%%%M6+=&[*[KU:AV1*3>>-GB*-%!J;W7@OF>A,Q/S0H]R;QQO6]/UMN'
M*=C[TW-'ULW564KMG4>!V]G-L5O;$'<=34[\6HJZ7.XO;^&ZVJ*G0U,&RB/3
M)11.6KS1^Z]3Y].'PJ^2F2[NQ-!B-_;&H]K=BTW7M-N[&YS&4F'@P^[.NJCL
M??VQ<34XRBQM9DJG:\='DMDL?X943N3%/%,AU-+%![KS"G1]_?NJ]>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=:Z?_"JG_MRW\@O_ !(WQR_]_IL7WH].P_V@^P]7_P"P?^/%V7_X:6W/_=/1
M^]]-'CTK??NO=>]^Z]U__]#?X]^Z]U[W[KW6O+_PJ=_[<F?*?_PY.@?_ '_7
M77OQX'IV#^T7J]SJG_F5W6W_ (8.S_\ WGL=[]TV>)Z7WOW6NO>_=>Z][]U[
MKWOW7NJ_^[][?#C:&^>Q-F=N=4TN;W/NO ;?WQFU78-)O6K[,FVQG=IXK#X?
M!T&*GRFX:[<.#S&\\6RTTM)20L*UIE>1%JG3W5LTK7H.:/N+X)[GFW%4XOH'
M)2[VW!@J/8=)LO%]&OA.Q>R\12Y.OV)G]O[/P=)#C:C,46P,IU-4X;.5)DIZ
M7'T^WH5,[4"T$DGNO$-YGJ56=\_R\=X45-7U_7&W<WL;8F+W/OG ;MK.E'?K
MQ]RX;;>Q-[;EVIMR:HPB4N7[,@QYP<SXQ:9YVR^-BIE)RE"(8?=>HW2WQ?:7
MQ&;;N2[>INC<A1;Q3M6+H(;'KNEH:3MFL[:P2X;(P[)P&WZNG6@FJ4QVW*'(
MG)4E8,3-08F&J>L:&BC>+W7N[A7'1=]N_(KX[;8P7:FT-M](]C=I=9=F]V46
M[.V]V;AV+2YR7NNL[QZ8['[BW%N;;6T<-B:.3*U_65+U'#MW+45?CL2V*IL2
M?7+44RF?W6Z$T->ALG^3'P8VM!F^K\'M#'9O&)A-M]78[;FQ^LH-RT_8T.;R
M6UJP]5[=Q.)IZC*9ZKPN1[HQE9EZ*O@@IZ:3/2SS.SBO:+W6J-QZA?*#N7J>
MA[-K=D;Q^+^0[&S6 RGQ3Q=?O'+[/HJ[^,8?N;L??^.VUA.MLGC!D-Q9;>&P
M-P;2J*TT9%'1QFMD;[A$$['W7@#3CT'&0W=\$Y=][C[$JNOI-U8[M;8VT)<Q
M@-D=2[BR6$;9,%;M?O&J[-[6Q<&#AQT.3V7N/LF.MGKXYI*F@%540&$U:52+
M[K?=PKT)M;\AOA)2MN#8T/3C56$R:CJ[!RXGI"ACZ_[4Q5=V-@^H<C@=D;J%
M'2;.R&UL;O\ Q]'05#UE704"_903Q,\ I97]UJC<:YZ$+Y+;RZY^'G3>W,CM
M?H;;FYMF[MWSUETEO7:>WZ:AV_/2]2[GS>:3>NX7IXL-7-NFFZ]VMFL]GI<9
M4-#]ZAK+U$<L[NWNO :CQZ"4_,?HO9P[<Z;["V/%/T=TE7];];]<YJLKJ'?E
M3VUCMN=8Y+LW?NX(=J9>CHM>U>D<)LB6>IR8JLB]:,=)-"&G\$<_NO:3BAR>
MG'=GR.^$*TF[]M5W467W%@:O<V^*/=<NW.A<ED,9E*'-=H;8'8O:<)H,3#DL
M]LC)]XY/'BNS]!%4&NW#325J&9:"IK*?W7J-^?2>[$[$^%_R,QD7QMH(MS/'
MO#M(;6H\1UAL/:V;GWX]#@=\=:Y??E+G)\!NZCQ^P\1B.NLWB*O<SR8VM@BP
MWB28P2TXJ?=>HPSTKME;WZDV)WQV)UKN3IG8O5M!@MU=)[;V/3Y:BRV7[.[-
MS*U&#V%U3W!@J#^#5VV<EL3'U.9DQ"YJCRE7F,+4TQ7+K1M,J+[KV2 :],N.
M[I^+?8O?W8^VMW].X.JH^VJ#JOK*@[;R.QLG54._GWOC]VR8_KS?N1R^'H_[
MLY)]R=6S4N/@#2)534E#(\D;R8\R>ZW0@ UZ>)^XO@9L3>.&.+Z[VS@NQ^M]
MG]B?W0.&Z;J5S.#@ZG[*?J;<6S\5)@L(T\NZ,5NS?,M118B-GR,N)R]5DZ2,
MTM343O[JN3TV1]D];_)3L;<FV>T-HT=7M+:W3&[=Q0=A;=W?O?#_ 'FRJ2NZ
M%WOFCC=O4\&+R>(HMX?Q&F>KO-]])CJ):&97CJ*B,^ZW0CAU@;Y8_!+=.1W+
MVQNOKFNQE2VRJ'(;E["[(Z6J\/3RXG);/P6_]B;?K\SN"A$*[D[(V!]CD,-1
M.5JZNEHXJ2I\-33Q4B>Z]1N%>NMP]W_!;L;()55W4]9N#?>#FAI*,8GJV%-Y
M[=[:[3W]N+;M/L'#;DHF@QU+WE6;XVKE\EY*3(NV+?'399ZVGC,=3+[KU"//
MI2]3=U_"'M?<G0G6^UMNMG,U1]72[<ZJCW]M')S9+;>*HMHY*'(]:[B@WDTV
MY,7OJ/86V:RHJX,K3>1J%)2]07J=$WNO485Z8).U_@(>N\OL+;FS=ETF+H^K
M]D;_ *';==U9G$HX,#V5O;?;;>J:N'%XAL[)+M[L'JK(UNX*>E=LCA6I(IYU
MC::F9_=>[L=(F/Y(]%X?Y 8CM?/=,[_VI'LC+?)_IFIW/5;$HDQ^U6VQO+X^
M4G87?%#B-O8:OS=+LWM-MT8.#*9S*9%*VGI<'2P?8ZY*I_?NMT-*=&4[XWO\
M1^G]Z['?N+8&WZ3+[:PW8':&QMSIL;&9N/$9+''-=A;JI</28E:K<;[NSU5@
MZ[,P114$B5V2I3*DAK_$&]UH5(P>@9[R^6?QWQ735+24?2E?O#+;"J,G4XOI
MK='6U7C8.K)=D[HP/5-7E-[8NCQV4CV3MY8^PXZ2EGIX*F&LQU;.%5J2.N,/
MNO &O'I?]J=M_%WKCLNKH-_[!Q65S_7^Z,+F\15;(ZFW!E=P;$_@/66WLYN+
M?6ZLW18N#&P;:V?U]%CI99Z::98L=1Q4XBEG@BA7W7@#3'#IEC^67QDAR>X-
MP[QZ7W'M/.X+L_LZGS.8R'5V*R^2H-K=-]D4^P:[Y)9K(83^(UF-ZKJ]X)":
M'+R$UMXI9O L='52P>Z]0^O4+?W;73M#\A-V?%-^A.KIXMH]/;2WMV#N?<\>
M(P6T-L_%G,8'?>W=\Y2JOM>6.N7"T^VOX%1;>H9IY)(:_P"XK!C\<BS3^Z]F
ME:]!J.]?C#VAFJ#;77G1^Q-X;4[;W3U)DNR8]U8Y<5EDS>X>Q>K=O[ W?78>
M"CRM#6SYG8/9B;DQ=:M2E35(X2J\4TE2L?NMT-,GAT])VO\ !&K[4Z^WY+U[
MF1O#KC$4G2^V]M4G6N.R>U>B=K[-WSUYD,/NR2GVW3Y/;.Q,!2YSL;;+T-=1
MUI II8/'3J:&H^V]U[NIT_0=N? C&S;VVICMB4W7 W=!VW7T^^\3U<FW:;>=
M#08+L# =@;WZ\WM18ZH2KA0X[-8JBE5HI:FIJ(TI(9:>OIGJ/=:[N/2[ZAVK
M\+LY5X?XN;>Z@V[!6=/[4V#VOM[;>[]B8"&>KQ=9M_"[7QV^=--'*\6XHJ;&
MTF,S,&2@H,@98ECFIFA"GW[K6>->O5W8OP>Q6]X]LUFTL'#OI-[]V]ATT)Z_
MR3YB?L3IC<6Q]E]@5D.0% TLNX<E4]BXD8JE:6V:QLC24L<E/32&+W7NX] #
M4?(OH'#8RBV%3_&2LW+LW97<'76>KZ[;G6N4?;V\<[OWKKN?LV;??5^UJB.J
MW3NK.[)J.JI*?,-G(*%1#JGA>6*.F63W5J$YKT*'87:O2VPNQ/CUUSU)TAL;
M>NYODO+N#Y!]#Y-JIMG[9D["QHVI%G=_Y')R[>K(MI04G6?8U?EJB6,+ELI&
M):"AH*RHJIQ%[K5#FIZ2/;7R;^,-=DY7V%U5U_V=OGJ3>_8>]Z.IS&(QN)Q@
MR&'Q/:N3W9V7LK-8ZDR[97R=V]*KA<C42)%*^5I16*)C34L[^ZV%/F<="9N#
MO?XG[-W4E!F>GIZOM/K&@V+@]K;:V1U9C]W[CK*+?&4R6Z<)%UY1[<%7*F%Q
MN[]D5E06K5QKX^OHA/HC,T,DONM4/7'._(?X/Y"#:&V\MLO'Y3KS;F?P%'LS
M=8ZEFJ>IL+V'V5@Z#(IL7&9-,7]CCM[Y+9O87WN4QQIT HJFJCJ"9HJF!/=>
MHW2ZINQ_BCOKMWK+ '9&+K=Y[\J.U\SUQNVJVAC8*+<.7Q#Y_:W8\8J4E7-2
MR;BQ'7=7-YZZC&.R]!CHI(YI2L ]^ZUFAZ3F'[>^&N3_ (IOV'K^DQR0[2W3
MLU<G6]7R4AS_ %]TWV9LOK/(4"X.*B>I3#[7[ S6,I:"BR=)25\,<(GAITI5
M25O=;HW#IBJ.^_B7G,I%E</A*_:VY.FMTY*CV++7[$W-M;;^;R6";OKKJ/=,
M&(P--3UN]>K]B9G%;W9JF2GDH\9(TV0IT5ZJDJ9O=>H>FVJ^27PWJ$PF\\AM
M+:*O3=<[[W;O6OR/1NX9MP8W;&-SV\>S-T[5@@3;%1D\1NC+]E]8U>Y3@LBJ
M5F2EQ_WL<4E6U.[>Z]0\.L,???PCV;2+5T_364PU9GLENG&]ATF-Z5GFW)U>
M^X=_T73&=':"XJFJLCM+&[@W5N%*%$IWGC?'--5*BX^&>>/W7J-TJ-[;P^'?
MQ5W%OS:6Y=F5>%IMR]:8G>61P=/A9]W[/S& Z9HS)B=N;:V:F1RL>'RV(BJY
M<HY_AM%1U$[3UU15M+'-+'[KV3T(G<&0^,>V=O\ 5>-[7ZLV_3[<[0W%L#;N
M!%3M;:CTVT\]'FGJ.OES$^/R'W&*&*WCOV6GI*K%FKBHJW+3OY(X)YIF]UH5
M\ND))W'\)>K>S-P;;&TL5LKL#);I[(S6Y<C2]65]%-2;EZAVUC<KD]Q5F7I\
M*\>-J<OB>U#_ ':G0HV?J\I6)CQ/4R50;W6\TX]%DZ!WU\+_ /9<\+UMG/C=
M+!DZ7<6'BHNFQUK+NK=_9VY<9N#L7J_;VZ=N+D,1@I-Z9!<3UEF8LSD)4I*.
MA@CJXZAEHYU:H]U8A@>/0G8KY'_&CL7L;:;[@ZRZWK.J:[=FYJWKKM&7!O41
MQ;OR%!TCN-LINC#UF I8=J&KW=N"KILQ5Y%ECQV>V[0_<,M5XFA]U4@@<<]+
MW<?;OPIV$G76[ZGK9&7<O6&<[4@K<)U;4U\FQ^GNZ,Y-/F=T=@XRGI?/@MJ[
M_P!W;PJ$DHI8)Y9*VMK96IDCCKYHO=>%3BO2&VSWA_+XZSR65R>SMOS[6I]F
M[ H1D,%MOKO=4>UZS;'>&V/[^[CS?]U<9CI<1O'<-#MOIR*DW/7"GK,GA(\?
M#C*MXC*E._NO$-U,K.Z?@!CMHXGJ7=76N%V5MK-[LK<ENS8>\NO,=MF3KC-[
M%S^W=J8K?79=%730UFWZ>'+5>&H\3F8WJ?#324X62&DIY33^Z]1JUKGJ/MCO
MOXMYNF[9["S'0L&T.K_BYU+UW-LW+U?4V0QFXLEUKW5A-UAL5M_9%-@HJ?\
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MLU\=^FMR87#;;W%L7%9[;>![1RG<U!MW--597!GL?+97<6=J-P5N+KYZBDR
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MO=>]^Z]U[W[KW6NG_P *J?\ MRW\@O\ Q(WQR_\ ?Z;%]Z/3L/\ :#[#U?\
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MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6NG_P *J?\ MRW\@O\ Q(WQR_\
M?Z;%]Z/3L/\ :#[#U?\ [!_X\79?_AI;<_\ =/1^]]-'CTK??NO=>]^Z]U__
MT]_CW[KW7O?NO=:\O_"IW_MR9\I__#DZ!_\ ?]==>_'@>G8/[1>KW.J?^97=
M;?\ A@[/_P#>>QWOW39XGI?>_=:ZKC_F%?$?)?*.O^%F1V_UYUSO2MZ-^</1
MG<N]ZW?,&$6KQ73^SHMW-O=,%493$9.;)5<U57T+C%HT25C1AF8&,>_=64TK
M]G5:5!_+Z_F0]3;)[&Q?QX[:SG7Q[,KOF%O;>6Q:3NRI79]+E=U_S(<+W5U%
MM_I+&1XZAH.FMX]D_$7-;JQE?G\>]-]EF<DD=;(TZTV2H?=6#*2-0Q_L=#)\
MI/AY\Q>V?Y?7PYZ]ECW;W3\@^C/E-T_WGOG^_>\NA4[<EVCLC=&_ZU*?&[IW
MYM7L'X];K[,V5MK<F.I*6?/8[*8[)&B::JDFJV-2WNM C4>%.@,^//P>_FI_
M'RJ^+^Q=F;AV?MC:/4?772U-2X_:G?6YL1\8=C;,V3T]OS$]Q?&;=?0W\!J,
MMV1O3N3N?-8_+1]FI#+68.G<R8K^$4N*IL#D_=;)2AZ6O1_Q-_FV5.Y.O)>R
M>]NP-C[7VUN3O'L*DH,]\A:K?QQ>]-U?%'I[;G5>V.P(,(:C,]M=-; ^6%%N
MS/4>"K\Q4"HQ:THKS+35=1BT]UHE<X'2F_E_?##^8!U!UC_,+S?8><H.MOE)
M\E>K^F,'U1VUO[MY_DEF5[RZS^*\?4N4[9WGN*; Q57]SYNY:9\[B,+)3U28
M_$U @2FBC48Z#W7F(.D>0Z;.F?@C\S=X;X^%W87R5GWA/C/CK\W=P]U8#96_
MOE)G^Z=]]6=8/\(]S=59JLS_ &>D=#%W'D.Q?E3,V>Q6,J(;[7VKFZFACFBI
M)YL/2>ZV6&: <.H'>?\ +W^1G:GS:[TS^#Z#Z<Q.T.T_FM\(/E9LOYPY7?F$
MB[5Z9VA\8^K^C=N]@;2V!LW%;=G["?LC?D_6&7VQ3)-74NW'V]N6MEK)I%U4
M%3[K51I KTP8[X<?S;(>K<]5MW7N3;V^,9U5\%MI4/7^T^^9\?@]Q8W9NX]U
M;@^;^ V8V'I-H[7V+VKV11G#8_%;O<4DK4\$L5+48DU-36'W6ZK7ACIL[?\
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MZ')9#)[HRW<74>_]M;CKJW?6+$B[JARC/6Y*J$D5)1^ZT2ND <>BP4W\K;Y
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M85*TN>W&F![6Z[AW+L^BJ8O]^VST](D\Z8^BFB]UO6: ?ZL=)7=?\G[K' ;
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MR;,8GK?96]=S_':7:28.AJ:BU!)5U]9/69.62JJ/=>U'B.DODOY(U;E_D7!
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M5&$W\V%Z_P 'M?:R9_X_5_0^\-CX.FVL9LC2X/)08#K7#M7U='42154]<E1
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M-05<U/&JQ2.A]UZI]>G^?XU_'NJZUP'3=3TCU54=4;5R=)F]M==3;#VU+L[
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M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K73_X54_\ ;EOY!?\
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MRQTN(EIUJI]%#!44\GNO4%*]*KI3O?Y6;O[IZ]V9V#M?!;5V[_<3"S[BASF
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M,UZ#3Y"?)/Y%=<_(F@V1MS'XW%;5R^Y^N=D]=83+=?9?/X[MAM\[ [+S&<W
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M?V[N?*;*P-5F]JYK<&X\)5_9K E/N#=.(&!W!FJJBIVAH,KE,GB (7GJXIY
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M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K73_X54_\ ;EOY!?\
MB1OCE_[_ $V+[T>G8?[0?8>K_P#8/_'B[+_\-+;G_NGH_>^FCQZ5OOW7NO>_
M=>Z__]#?X]^Z]U[W[KW6O+_PJ=_[<F?*?_PY.@?_ '_777OQX'IV#^T7J]SJ
MG_F5W6W_ (8.S_\ WGL=[]TV>)Z7WOW6NJG/YAOSI[/^''??PUH=O87:^X.B
M]W87Y0]F_+.DK,=7578.#Z)Z+VCUW-E^Q.LYZ3)1QO6=897L6GSN;H9*&M-?
MM^BK!&U/)&LA]U8+4$]5H'^;[\NCTCE?D%-G?C=BZ;XU?$OX ?(;L3IG);3S
M\6Y?G!F?F/2_>[DH>A]V1[]G?J_;$<C)MOK^HI,1O.3.;W$M/76@C6G?W5]*
MDT&:D]+?Y ?.7^8'TGOKYD[1QG=/6&_STY\Q_A!\7>L<-M[XSXF3?M1C/F<_
M6>]9:],3E>^MO;=WCV/LO:_8?\"PE%4Y# XS*STZUM7)$9?$GNO!5(4T\C_+
MJZCIO>7=G8&S=S;&W<IV;OK;/7O4[47<%5#UQ-FMS;LWQU_2;BW-ELYT/MW>
M&\XNK<EM//2O1OB:[+9"CK'!EHJNII@)6]TV:=$QZ?\ FOW5MRAV%N/N5<9V
MAL+.]"];]N]C;TVGA\'LI^NINR>VMY=?XR3#;2@R6=S6\\=$,71QFC@D:KM'
M/,DD\KQTOOW5M(\N/1DMJ_."GS?Q[WQ\A<]TUOS:>W=J4VP<]A*;(STBT&_-
ME]G8S:.<VIN3:VY<C3X;%U34F*WA"F8@TF+&Y"GGIEGJ%5)I/=5IFE>FC._/
MO"X?=.[J"'JS<&2V1UCN7<&#[5W[2[HVU*FU:+#=K9'IRGR&'VO125^>W=7U
M>[L<S2XZ!8:JGI@P'EJU^T;W6]/SZ!;;G\QG>U5O#,4U9TSD]P2;RQW4>8Z=
MZIV;G</N;>-3MG<G2F_.^]V9S(Y;;M+E!+N>MV+@::/&X":F@-3E5,,%7+1L
M^0C]U[3\^A9RWSKE;;\>;K^KMS==;0W:O>&,V%V'G]S;,CDSNXNILGGMOX_9
M6%PM8*S&1]R;TKMLY.OQ>VLM44<;XO&U#M4O5Q2X]/=>T_/INB_F%R5^9H<9
M@^C\SE*+?&<BV_T[EJCL':>*DWK5Q=]47Q[RE7NW 5,#;AZXH<=NJ>;(%GI<
MD\F,IV4(,@10#W7M/3-'_,WVQ4X;.;GH>DNQ\CMC:FPL/E]W9JCJ,<]'M;LO
M<--"V"ZZSN0>&/ X_$9;)U,=!!N.2N6C>I?6(?MDDG3W7M/E7/2\Z[^6VYO]
M%?=6]^Q*+9B[TVK\I]]_'[K_ *^AW72T=/G]PXS/X?;VU.O<3N;#8K<-9N/=
M&6FJ)YH?%B1D)!Z)Z*G>*81^Z\1D#Y=!=MW^91@J;;N3[5W=MK(ITWN.&JW%
ML[<\T^&Q$F*J4Z;ZPW=@^A*2*&LR<>\^\-X;HW'DZK'P22XS'2X."2I2L=Z9
MZ?W[K>G-*YZ,]@OE**C8G;>8WELR@Z]["Z=WQ@^M-P;(S>]8,IM[([ZWIB=D
MYCKS!8+?^WMOY./+56\D[$Q%)#34^,ER<62J13&C=FA:;W5:</3H%L;_ #$,
M%N[JI]\;)ZYR,NY,K@Z-MJ[<W%N; XZCJMUY'H3M7NY<5EZZ&:2LI<7B/]$N
M2Q]9/%3R3E%-3'"8TD">ZWI/2)P/\P7>&TL-N7<W<O5B+A:O'X/([5J-G;LV
M]6T]!N_+?'3HCMX]62M6#'SUF,DRG9M4L>Z:H4M+#&56H@2"+[I_=;*^AZ6]
M3\[:RNS[[%?JW<&W<_MO(UN)[-S>%W;LS<.'VANG%=]=?=+XC:6!J,M3XX[S
MIM]9/>\$[U_VN/\ X5BUJ?,L63A2B;W6M/SZ]1?S ,G59C!8"G^/>[]T9;/9
M+>N5Q,/6FZ,;V#3[MZAV/OG8W5F0[<Z\J*'#X\[DQ&0[&WMX*2EKDPYEPN-J
M,N9EI)*+[OW7M.*UZ$:3Y6;IS?1V+[0V1UUMG(;R'?W6G2.].LLQV534N1ZX
MK=W]U;+ZPW+B]ZY2EV]-'BNQMKXG=L=7)AEAFA:IEA$-54TLD53-[KU,TKT7
M#8G\Q7=.-ZVP"=@=5Y/=_;6Z*S&P]>8W:5=14U)VA1;@[%[CVEC*O[7%T6>D
MV9D*>@ZCJ9$H2N0FK6J:58CY7J8Z3W7M/SQT9#M3YDKUH>N)!TYOC*0[NZLH
M^YMWT&0R."VQNCKK9DV[^M-F5N-R&V<C//59G?N/R79D);%0R11'^'U49JEF
M^WCG]UX+6N>@NW/_ #'=NXC<N]]J;9ZUJ>P,AMC(9[(X3);9WQA8]L[NZWVI
MM3N'<FY=ZXW.Y?&XZ)JW&Y#HW.X9*"FCK::?*I$J5WA%5/2^Z]I\Z]=XG^8F
MF4W/M[9,70'8E9O.JQ6-WYN[:VVJR/>69VMT]N.IZP3;6_*"#;&'R,6Z\LU#
MVWC*O*X6G>*?%T])7L)Z@1T?W_NO:?GTY]>_-7/;IE[U[ W!LA,%UIUK\5-A
M?)3:&V,=NC9^Y-T;MVINFI[SS%%GY\MC\I!C]MUNYMK=<4D:8O(F**BJ=9%7
M.OF:'W7M/#[>DW5?S)L=@FW/2;NZ2W+A\KUWL+)=D=E4^,WMM+<..VYMO(8G
MK+)=918G-4QI:/<V6W[/VSBX*E8Q3T6 6*JJ*NJ-,M+-6>Z]I^?6;</\Q+&X
M;<%1U7N+K+=.U^S7HN]*+(R;:SNVMYX';&6Z$V=%OK?U12[BJ:2@Q%>T6SL_
MAJW!+D*>B7+U]35X^6.FFQE<$]U[3\^IM'_,.I*S'[EW!0=+[XDZTVSN;'X"
MH[LW/7TNU.LL9B,=O>OZ\[ W7V-G9<15#8J[/SN*EG>DIX<JS8^:&KJ6H*9I
M9(/=>T_//0E=Q?*S=W4W>64ZT7K3%;HVN_5W4.6VEE:7>4>*W'G>X>Y^\<ET
MWM39&5QU7BYZ#;>RP]+'5U&?EEE$3L8$IYJAX(9?=> J*]1LA\X,!ANN^O\
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M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K73_X54_\ ;EOY!?\
MB1OCE_[_ $V+[T>G8?[0?8>K_P#8/_'B[+_\-+;G_NGH_>^FCQZ5OOW7NO>_
M=>Z__]3?X]^Z]U[W[KW6O+_PJ=_[<F?*?_PY.@?_ '_777OQX'IV#^T7J]SJ
MG_F5W6W_ (8.S_\ WGL=[]TV>)Z7WOW6NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NM=/_A53_P!N6_D%_P")&^.7_O\ 38OO
M1Z=A_M!]AZO_ -@_\>+LO_PTMN?^Z>C][Z:/'I6^_=>Z][]U[K__U=_CW[KW
M7O?NO=:\O_"IW_MR9\I__#DZ!_\ ?]==>_'@>G8/[1>KW.J?^97=;?\ A@[/
M_P#>>QWOW39XGI?>_=:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>ZUT_^%5/_ &Y;^07_ (D;XY?^_P!-B^]'IV'^T'V'J_\
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MW[KW7O?NO=:\O_"IW_MR9\I__#DZ!_\ ?]==>_'@>G8/[1>KW.J?^97=;?\
MA@[/_P#>>QWOW39XGI?>_=:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>ZUT_^%5/_ &Y;^07_ (D;XY?^_P!-B^]'IV'^T'V'
MJ_\ V#_QXNR__#2VY_[IZ/WOIH\>E;[]U[KWOW7NO__7W^/?NO=>]^Z]UKR_
M\*G?^W)GRG_\.3H'_P!_UUU[\>!Z=@_M%ZO<ZI_YE=UM_P"&#L__ -Y['>_=
M-GB>E][]UKHOVX]M8[>?=[8?<%1G9\1C.JJ'(T6+H-T;DP5#%D:_=^3IJO(-
M3X'+8Q)ZR:FH8H_))K98TTK8%K^ZWY=*?_0AUW_RI;F_]&)V+_\ 97[]UZO7
MO]"'7?\ RI;F_P#1B=B__97[]UZO7O\ 0AUW_P J6YO_ $8G8O\ ]E?OW7J]
M>_T(==_\J6YO_1B=B_\ V5^_=>KU[_0AUW_RI;F_]&)V+_\ 97[]UZO7O]"'
M7?\ RI;F_P#1B=B__97[]UZO7O\ 0AUW_P J6YO_ $8G8O\ ]E?OW7J]>_T(
M==_\J6YO_1B=B_\ V5^_=>KU[_0AUW_RI;F_]&)V+_\ 97[]UZO7O]"'7?\
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MU[KWOW7NO>_=>Z][]U[K73_X54_]N6_D%_XD;XY?^_TV+[T>G8?[0?8>K_\
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M\_*7+P[>BW'493%[7^!/PPW%N"*FV744T&^YXL%C)YLE4IL.*I$^:6.-I,;
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M_P#3>/Q%_P"O/OW7M2?[[_F>O?[)'_-?_P"]W.YO_3>/Q%_Z\^_=>U)_OO\
MF>O?[)'_ #7_ /O=SN;_ --X_$7_ *\^_=>U)_OO^9Z]_LD?\U__ +W<[F_]
M-X_$7_KS[]U[4G^^_P"9Z]_LD?\ -?\ ^]W.YO\ TWC\1?\ KS[]U[4G^^_Y
MGHIV=ZX^>O5G:>Z.N,A_.K[BQ=4=P; J^P]^1_RQ_B[D.L=I[K[>3^ ;!I=T
M[N-+-3;>7<TF!IZ99O&<;13SP"KJ*=JF/5[K=5.='\^A=K.D?G]0[IVGLBI_
MX4$T8W=OG=NZMA;2V_#\%/A;59/-[WV-@:C=&\=HTE/2QS,NY-L[?I)*NMHI
M-%13Q+=U%P#[KU4_WW_/I:[;^)7\SG>6)ASVT/Y\%;NK!U$M3!!F=M_ GX89
MS$SST<\E+60PY'&1U5')+2U,31R*KDI(I5K$$>_=>JG^^_Y]/O\ LD/\U_\
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MMQ;>P>P.S*G!XVEJ:W)5FUNL.T-F[XWI44-+2132S2XC:6$K*YQI-H*5SR0
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M_P!<??NO4/7O]*G6'_/Q]A?^AAM[_P"N/OW7J'KW^E3K#_GX^PO_ $,-O?\
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M *X^_=>H>O?Z5.L/^?C["_\ 0PV]_P#7'W[KU#U[_2IUA_S\?87_ *&&WO\
MZX^_=>H>O?Z5.L/^?C["_P#0PV]_]<??NO4/7O\ 2IUA_P _'V%_Z&&WO_KC
M[]UZAZUK_P#A3OWWU/V1\&=N_ [K3>VWNQ_E;\P^^>@]F]*]-;%RU%NK>>6;
M%=I;<W#7[ER.&P<M=58K;%.,6E*M74B*.:JJ42,MHF,?NG(SI8,1CK9RVSC)
M\+MO;^&J9(I:G$X3%8RHE@U^&2>@H*>EEDA\BH_B>2(E=0!L>1[]TWT]^_=>
MZ][]U[K_U-_CW[KW7O?NO=<6575D=5='4JRL RLK"S*RFX*D&Q!]^Z]U1IW#
M_P )N/Y-'=F_LYV3N?X=8/;NY-RUE3D<Y3]8[_[/ZNVO6Y&LJ'J:FN@V5L7>
M.#VEB)9I9"2E#14L)))T:B2?=7$C+6A_D.@Q_P"@6+^29_WBUN;_ -* [[_^
MV+[U3K?C2?Q?R'7O^@6+^29_WBUN;_TH#OO_ .V+[]3KWC2?Q?R'7O\ H%B_
MDF?]XM;F_P#2@.^__MB^_4Z]XTG\7\AU[_H%B_DF?]XM;F_]* [[_P#MB^_4
MZ]XTG\7\AU[_ *!8OY)G_>+6YO\ TH#OO_[8OOU.O>-)_%_(=>_Z!8OY)G_>
M+6YO_2@.^_\ [8OOU.O>-)_%_(=>_P"@6+^29_WBUN;_ -* [[_^V+[]3KWC
M2?Q?R'7O^@6+^29_WBUN;_TH#OO_ .V+[]3KWC2?Q?R'7O\ H%B_DF?]XM;F
M_P#2@.^__MB^_4Z]XTG\7\AU[_H%B_DF?]XM;F_]* [[_P#MB^_4Z]XTG\7\
MAU[_ *!8OY)G_>+6YO\ TH#OO_[8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_2@.
M^_\ [8OOU.O>-)_%_(=>_P"@6+^29_WBUN;_ -* [[_^V+[]3KWC2?Q?R'7O
M^@6+^29_WBUN;_TH#OO_ .V+[]3KWC2?Q?R'7O\ H%B_DF?]XM;F_P#2@.^_
M_MB^_4Z]XTG\7\AU[_H%B_DF?]XM;F_]* [[_P#MB^_4Z]XTG\7\AU[_ *!8
MOY)G_>+6YO\ TH#OO_[8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_2@.^_\ [8OO
MU.O>-)_%_(=>_P"@6+^29_WBUN;_ -* [[_^V+[]3KWC2?Q?R'7O^@6+^29_
MWBUN;_TH#OO_ .V+[]3KWC2?Q?R'7O\ H%B_DF?]XM;F_P#2@.^__MB^_4Z]
MXTG\7\AU[_H%B_DF?]XM;F_]* [[_P#MB^_4Z]XTG\7\AU[_ *!8OY)G_>+6
MYO\ TH#OO_[8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_2@.^_\ [8OOU.O>-)_%
M_(=>_P"@6+^29_WBUN;_ -* [[_^V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_TH
M#OO_ .V+[]3KWC2?Q?R'7O\ H%B_DF?]XM;F_P#2@.^__MB^_4Z]XTG\7\AU
M[_H%B_DF?]XM;F_]* [[_P#MB^_4Z]XTG\7\AU[_ *!8OY)G_>+6YO\ TH#O
MO_[8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_2@.^_\ [8OOU.O>-)_%_(=>_P"@
M6+^29_WBUN;_ -* [[_^V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_TH#OO_ .V+
M[]3KWC2?Q?R'7O\ H%B_DF?]XM;F_P#2@.^__MB^_4Z]XTG\7\AU[_H%B_DF
M?]XM;F_]* [[_P#MB^_4Z]XTG\7\AU[_ *!8OY)G_>+6YO\ TH#OO_[8OOU.
MO>-)_%_(=>_Z!8OY)G_>+6YO_2@.^_\ [8OOU.O>-)_%_(=>_P"@6+^29_WB
MUN;_ -* [[_^V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_TH#OO_ .V+[]3KWC2?
MQ?R'7O\ H%B_DF?]XM;F_P#2@.^__MB^_4Z]XTG\7\AU[_H%B_DF?]XM;F_]
M* [[_P#MB^_4Z]XTG\7\AU[_ *!8OY)G_>+6YO\ TH#OO_[8OOU.O>-)_%_(
M=>_Z!8OY)G_>+6YO_2@.^_\ [8OOU.O>-)_%_(=>_P"@6+^29_WBUN;_ -*
M[[_^V+[]3KWC2?Q?R'7O^@6+^29_WBUN;_TH#OO_ .V+[]3KWC2?Q?R'7O\
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M *!8OY)G_>+6YO\ TH#OO_[8OOU.O>-)_%_(=>_Z!8OY)G_>+6YO_2@.^_\
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M7\AU[_H%B_DF?]XM;F_]* [[_P#MB^_4Z]XTG\7\AU[_ *!8OY)G_>+6YO\
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'>]^Z]U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g893453g01n01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g893453g01n01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[1*R4&AO=&]S:&]P(#,N,  X0DE-! 0
M      << @   @   #A"24T$)0      $.CQ7/,OP1BAHGMGK<5DU;HX0DE-
M!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0    !0<W13
M8F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX
M=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $       ]P<FEN
M=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M  IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8
M   )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G1/
M=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B
M;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M  !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M         $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M  !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M      !2<VQT56YT1B-0>&Q 6             IV96-T;W)$871A8F]O; $
M    4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M             %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R
M8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C
M=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R
M;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"
M24T#[0      $ !@     0 ! &     !  $X0DE-!"8       X
M    /X   #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _0
M     !( -0    $ +0    8       $X0DE- _<      !P  /__________
M__________________\#Z   .$))300(       0     0   D    )
M #A"24T$'@      !      X0DE-!!H      T$    &               Q
M    <0    8 9P P #$ ;@ P #$    !                          $
M             '$    Q                      $
M        $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<    Q     %)G:'1L;VYG    <0    9S;&EC97-6;$QS
M     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M      =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/
M<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54
M>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M,0    !29VAT;&]N9P   '$    #=7)L5$585     $       !N=6QL5$58
M5     $       !-<V=E5$585     $       9A;'1486=415A4     0
M    #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M    "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U
M;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F
M875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
M    3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N
M9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L
M;VYG       X0DE-!"@       P    "/_         X0DE-!!$       $!
M #A"24T$%       !     (X0DE-! P     "0P    !    50   "4   $
M   E    "/  &  !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@     '_
MVP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4
M$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_
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M>O'^,/I ^PV6XN93B]2#AC9+J@YIL:?3=1Z=-EN1O]5S*6;*?2LL?^CL]/\
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M4DE/_]DX0DE-!"$      %<    ! 0    \ 00!D &\ 8@!E "  4 !H &\
M= !O ', : !O '     4 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P
M "  ,@ P #( ,0    $ .$))300B      $R34T *@    @ !P$2  ,    !
M  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q  (
M   ?    <@$R  (    4    D8=I  0    !    J    -0   !@     0
M &     !061O8F4@4&AO=&]S:&]P(#(R+C @*%=I;F1O=W,I #(P,C0Z,#DZ
M,#<@,#0Z,3DZ,#<       .@ 0 #     ?__  "@ @ $     0   '&@ P $
M     0   #$         !@$#  ,    !  8   $:  4    !   !(@$;  4
M   !   !*@$H  ,    !  (   (!  0    !   !,@("  0    !
M      !(     0   $@    !.$))30/]       (          #_X0$Z17AI
M9@  34T *@    @ !P$2  ,    !  $   $:  4    !    8@$;  4    !
M    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4    D8=I  0
M   !    J    -0   !@     0   &     !061O8F4@4&AO=&]S:&]P(#(R
M+C @*%=I;F1O=W,I #(P,C0Z,#DZ,#<@,#0Z,3DZ,#<       .@ 0 #
M ?__  "@ @ $     0   '&@ P $     0   #$         !@$#  ,    !
M  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !  (   (!  0
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M              @&!P,$!0(!"?_$ $X0  $# P$$! @)"@4# P4   $" P0
M!1$&!Q(A,0@305$4(C9A<72QLA4C,C-R<X&ST18D-#5"4F*1H<$W0U1CPB53
M@I*B\$23E-+A_]H " $!   _ &IHHHK!)DLQP2\O='H)K21?;:M6ZF3DYQ\A
M7X5E-V@IYO\ _L5^%;,:2S(!+*]X XY$5FHHHHHHHQ111111BBBBBBBBBBBB
MBBBBBBBBBBBBBBL;SS;+9<=6E*1S*C@51NU';:S8BY%@Q'7'4K>9WV90'%/
M'E4"TEJS56N925M3KK#86%#"U*6 4_RK;UE8=86:$J9'U)/7N-K=*&T+!...
M.=57/VBZKC)ZAZ[71#J2,E3R@>^F4Z/-]N%XMDU=QE2'U)DA(+JRK W :NBC
M-%% HJC]N6T*=I.7&;B>%87'6X>J=W>(..ZJ<5M]O0:"O^I\_P#5?_RFFV9W
MMZ^V-^3(ZS>1(+8ZQ6\<;J3_ 'J6T4=AJC-O.T2=I!]Y$3PO"4M'XEW<^5GS
M54\;;Q>7)T-H_">'%@'\Y\X\U,]LNO;M_P!'0I\CK.L=+@/6*WCP61S^RI;1
MCST44448H!HHHYT4<J!111110*.VBBO*B$(4I7(#)I<>D!M-<:7+L-J<02ZT
MRXD.,G]_)X_92^Z;M/PUJB)UH)=>F-ES"L#*E\<4]&S>Q(L&G$0T!0PXM7%6
M]S-260RF1'=9=SN.)*3CN-*CTH-$_!RW;S!0</RF6<K<!X=2>STIJ?=&9?66
MFX$=DH>X*O7%1[5^K+=I>"Z_<7%H"$I4=ULJX%6Z.7GJG9VW)Z=/?9T\\TM+
M2R%==&(X=G,UFM>W'P2X)C:D>0@[I4>IC$\.SD:N73.H(6H8*9-O6M:.K0LE
M2"GY0R.==CMI9^DV?S^'ZJY[QI>7#\0GTT\.QGR9E>M'W$5/2< GNJ!Z_P!I
M%HTBPL2WG$/AM#@PR5C!7N]GH-5I$V]>&3%B.^V8Z5Y),8@[F?3W5!ML^KH>
MK&G7(CBEN*ZL#+90/%)[ZJV)E-TMX/\ W$^T4ZNQ'_#VV_2>^]570VA:N9TG
M;7I<A>XEMHN$]65]N*J='2(MBR0))_\ Q%5++SMCM$6R29+$A?7HW=W>CJQQ
M4!_<U7CO2,4B0M/A#6X%8'YH>7\ZLO9SM9MFJ0RUUZU2'%K2 &"D82G-8=H^
MUZVZ:4TW'?4'3UJ5;T<J&\G'XU7<3I&A3@#\AO=QV1%?C5P:"VC6K53/YL\X
MMS>0WQ9*1O$5.ZUY\MJ!$=DR"0TV,J(&3BJKU/MGL\"0Y&AR'.O0YN$*CJ(J
M*W+;#?H#*I+ZX@CH WB&,GB<=_G%;6F-O]MFRD,7"2=\E"3N15#B3@U=5CO4
M.]Q/"8"UJ:WBG*DE/$5N2W1'BO/'DV@J_D*IK6&VV!I^^OV]Z04K;"21X,I7
M-(//[:\Z:VZ6FY2T-O25E)6$G$90X5J:WVZQ;5+<;MT@;J7 D;\8GANY]M<R
MQ](>(_(;1.D@!2L'<B*Y8]-7?I/4<+4=N9E05K6%MASQD%/ UW***X6LKH+5
M97W#C*FU@$KW>.Z:0^ZSW;Q=Q/DN+6H("/'65\L]I]-2;8Q%$C639*=X(F1S
M\G./C*>5M"6T[J0 /,,5ZJ![8M/HU#IIB,&@I29:',AGK#P0L<OMJ#=&FSSK
M3;;BW.:E(*Y84.N;4CAN#OJY[K<6;:RER0XTA*CNCK%A(S]M(QM.UM<]8WAI
M*)<R+&5'2VI")2G$$I6I62. SQ'\A5^]'31UM;LIE3XL2<Y(BLJ*GXR5'/')
MR<Y-<OI+Z/A(LDF=;6(\)X*90%1XR4J R<\1BJFV1:]NFF[TS!D2IDAAZ5':
M^-EJ0E*4JP>!R,8/*G7LEQ;NMN;ELE!0LD#<6%#@2.?V4NO2;_3X?JKGO&EX
M<^9'IIXMC/DS*];5[B*W=I>JF],64/?%J6Z5-@%[JR#ND_VI'KU>;GJNYMN3
M)DS'5]66W'E.@@$JSQ/GIJ=DN@+4-)I7*@0G795N9(<<AH*DJ+?R@3S/&J.V
MT:<_)K5JVV72J.&&SNI;ZM.3GL!Q4&C<;K;S_NI]HIU=B/\ A[;?I/?>JJ-=
M(] 5I::#C]$/OBE"ZIMIE*MU))X<JO[8-H3X>@+FW62I]EN6MI3$ACK$J'5I
M(SO'O5GEV5PMONBX.GWXSL*/'2EY]P8:C);   [O355P;E,M+J7+;)D,K1DI
M##BD'B,'&/-3(;)]!HU':')M_=\+6\RR\CPV/UQ1OI)5@J/HR>W JJ]M^E86
MGM5SF8;4=+3:6L!MA+:>* >0J/[,;S-LNJK6EJ5(++DUI2D)>4A) 4.!%/)I
MR:;C98THC!<!.-[>Y*(Y_95(=)/6,JWQD6R&Z]',N*3OM2"@@[_/ Y\J7+34
MDLWD2;E,,T.J3E,A>>.\..233EW6U6+4.C;@IFT6QKXQ+>\VPVO&%(/<.^DU
MU5 $+4]W;BKZCJ)CJ4]6G=QNK.,8Y<JNGHR:DG*N\>V2Y4EYM77.$NOJ(^3W
M&F8NQ"K/,/86%>PTDNV=A*M?SR0/D-=G^V*X.D+>NX:DM\-AY;'7.A)4V,X\
M^ 135:=V4VN5IV'\()B2G\$J=?A)6I1WCS).>5*3J&VI@SNI;PVHIR%)1ND<
M3^%6ST>-4S($Z;$???>:2TVV@+?4 GQCR!IMZ*^=M5=M[G*C:<CA"L;SBTGA
MG]@TFT+]7J(Y[U6;T?6T*U*\5CB'XY'_ *S3DR'VV$%3F<>85B1-86"4E7\J
M^+DL*&%;V/17R"U&;!\'21QXY)JF>DCJ)VW6J$VP[NJ$O=/B _L&E5A,8F-L
M@<59//S'\*=?8A$5'TC;U*  7#:Q@^:N?TA$(5HJ25#CUK7O4G3V6[F74<"V
M]O ]V%4W71ZU"J=I6W0W'"I?QRB-P ?.*[:A'2=&)\+U1SWC2[N?,CTT\6QC
MR9E>MJ]Q%4YTFKXIU+<)+A^)G*&-T?ND<ZI&PM)_*",A0\4A6?\ TJI\-#-(
M1H^R;@QF QV_[::7WI1QT"X/NX\?<9&<^<U1D/\ 6=N^L3[13K[$?\/;;])W
M[U51SI&>2\SU0^\*3]_YE/IIR.CIY(S/7U_=MU#.E"?B+6/]][V"EQBC\^1W
M8/L-/%LG &CK=N_Z&-]W2_\ 23.=5W'/<Q[@JI["HMW^V%' A]!_J*>?9DM3
MFAK6I9RHI7G_ .XJJSZ0.SR3J)MN;;F&U.QXQ0%+>*<$JSRJEM+;%=27.X@2
M&(BVV\.8\(QVCNIF;Y)MFB-)SH[J7&@I27L)ROFI*?\ C2>:EDIN&I+S*9)+
M3TIYU!(P<*6HBIIL#D+9UM&"#CXIWL_AIP)*BK3CBCS,4G_VTE^V7R^G_0:]
MP5I;*R1KFT8_U ]AIWK 2;/&/;@^TTBNO.-]:S_V_P#DJNALND*8O;^X<9+8
MY?Q4]2#D5]H[:I;I&(<-BBE*5$=>OE] TI\7] 5C]ZK,Z/GE*]]?']\TT.T:
MTR+M8EL1%2$N%Q!^(!WL#T4JVKXFK-(NEUQJ\*97OK*GBXD )/LXU$Y.N[ZJ
M(E:?">*NQY?G\]7ST;;]<+JA_P -ZWA*"?'6I7#<\]1WI2/*,H(R<)F#M_VZ
MIB,,7J/]$^Q5.YLB\BK1ZFU[*X'2#\BI/UK7O4GDCY^5])7M-,/T8<Y@\3CJ
MG^'_ )&L/2?_ $^%ZHY[QI=G/F$^FGBV,>3,KUM7N(I>.D4,7^6<G]/5[#5<
MV/RCB_15[JJ>[1'D?8_4&/NTU0'2D_2G_H,^TU0T+]9V[ZQ/M%.QL1_P]MOT
MG?O55&^D9Y+S/5#[PI0'OF4^FG(Z.ODC,]?7]VW4+Z4/S-L^O=]@I<HGZ<CT
M'V4\6R?R.M_J,;[NE_Z27E7<?0Q[@JIK)^OK9]<CVBGGV7^0EJ^BO[Q5;^I[
MY;K);WGKE)BM;J-X)?6$@C..VE\UYMU++BXE@@VV20Z6PJ.\=XIP>/B^>N/I
MG1M\U="<N&H%7: EIPL%M:5%)2 ""=[SJQ]E5?J..BWWJY0FU;XCR'&=X\SN
MJ(R?Y5+-A'EM&^J=]VG%?\F5^J?\*3#;+Y?3_H->X*TMEGEQ:/6![#3O6#]3
M1O0?::1;7?Z]:^K_ .2JW-F?Z[>^DW[U/8W\FO5';51=(8+_ ">BD$8ZU?N&
ME"A_JY7TJL[H]C.I'_KX_OFG,JK]OD)J3I&<ZM 4MJ$^4DD\.%)HLE,1*,\
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M<4L8&/%(_"M7X$C8QUCW\Q^%=&.REA!2@D@G/&LE:=RM[5P86T^I:4JP"4$
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E@UYH%>J^&OE>A7PU\%>ARKR:*^BOHHHHHHHHHHHHHHHHHK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g893453g02k02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g893453g02k02.jpg
M_]C_X1>;17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    @    <@$R  (    4
M    DH=I  0    !    J    -0 +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P(#(U+C$Q("A7:6YD;W=S*0 R,#(T.C Y.C$Q(# Y.C(Y.C,T
M  .@ 0 #     ?__  "@ @ $     0   N:@ P $     0   \
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   680        !(     0   $@
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MX(?8&-K:2UW\_P"H?M3F_F-_/9Z7L4138YWJ&MK;=A+G.J8YSR6O9N;&2_\
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M[B0 X[:K#S[N=FW\Y)3G/94+;&MM8Q];"YSVNQ@YV[8[]('4>QOZ7;N_T?\
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MDIS7X_4F-?87X[P&GV.K<1^\[\_=^D_PBL_:Q^SOMNS3T?6].?Y/J;-R+?\
MS%G]5WY%2_\ 6=_] _\ T4DI_]7TEO\ RQ9_X79_U=JN*B7;.J7.T&W%8=3
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M;-T#=[\D 22_VO\ LOTFS6S_ -5J;,B^H;SNC<&-DWN.C9_FGX^[Z+F_U_\
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M]WO1/_6=_P#0/_T4C_:FW5W,%=C"UA)+VP-1Q_6_D('_ *SO_H'_ .BDE/\
M_]?T6X3U#)'/ZHWL#^==^:_V?YZP_3EDTAH=;)IW,P(EOMVPQ_\ AO\ !_\
M@GIK=L<&]1R'.<6 8C27M$N #KO<T0_W-_JJE7U/ICH>,W*<"'%NZEX$ 0YW
M]%;_ )W^D24U-[#8T&;/4L%M@CIX)TW[+/TCMVUSKM]C/]/=Z::H[6U@5D"D
MN))9@-W6P[T7M#;O;:_]%Z/\WO\ ](M2JS%NQ_M%>7DFII/NV%KM-K3##0VS
M9N<W\W_P-/ZN',?;+@7-$$CF!O\ 49-6W?L]GL_XM)3E@ !YVAI-8+F,;@.#
MV@[7SN?5_A*G6^[]'ZG^$35M:U[&M=6TEVX933A--?L!]S!6_P#24W-_P?\
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MT/26_P#+%G_A=G_5VJXJ=]&8W,^TXWIOW5BMS+"YL;7%[7-<QMG[[DMW5_\
M1X__ &X__P!))*;B2I[NK_Z/'_[<?_Z22W=7_P!'C_\ ;C__ $DDIN)*GNZO
M_H\?_MQ__I)+=U?_ $>/_P!N/_\ 222FXDJ>[J_^CQ_^W'_^DDMW5_\ 1X__
M &X__P!))*;B2I[NK_Z/'_[<?_Z22W=7_P!'C_\ ;C__ $DDIN)*GNZO_H\?
M_MQ__I)+=U?_ $>/_P!N/_\ 222FXDJ>[J_^CQ_^W'_^DDMW5_\ 1X__ &X_
M_P!))*;%_P#,6?U7?D5+_P!9W_T#_P#12F_]KO8YGIXPW B=[])'_%(OV/\
MR=]AW_X'T=\?R?3W[4E/_]G_[1_F4&AO=&]S:&]P(#,N,  X0DE-! 0
M  \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':NKP7#
M3CA"24T$.@      ]P   !     !       +<')I;G1/=71P=70    %
M %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I
M;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4    "@!! &0
M;P!B &4 ( !0 $0 1@      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 2P    !  $!+
M  $  3A"24T$)@      #@             _@   .$))300-       $
M6CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))301$       0     @
M D    )      #A"24T$'@      !      X0DE-!!H      X$    &
M          /    "Y@   "8 2P!% $P 3 !! $X 3P!6 $$ 7P!6 %\ 4 !2
M %@ 60!? %0 0@!$ %\ ,@ T %\ (  X #$ ,P Y #( 7P @ "T ( !# #,
M+0 R     0                         !              +F   #P
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   #P
M  !29VAT;&]N9P   N8    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    "
M.$))300,     !9]     0   'P   "@   !=   Z(   !9A !@  ?_8_^T
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M2L_[DIJ\SIV,SUL>C%J<=K7%EE+/I-]0M-C?ZOT?\(DIV$EG,ZNUQ=[:R!N
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M2&>W2:;@"0)-9')#?^J<DIJ8EECO6#I@4GE]SN UH]N156S^N_=[T3_UG?\
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MX79_U=JN*G?1F-S/M.-Z;]U8K<RPN;&UQ>US7,;9^^Y+=U?_ $>/_P!N/_\
M222FXDJ>[J_^CQ_^W'_^DDMW5_\ 1X__ &X__P!))*;B2I[NK_Z/'_[<?_Z2
M2W=7_P!'C_\ ;C__ $DDIN)*GNZO_H\?_MQ__I)+=U?_ $>/_P!N/_\ 222F
MXDJ>[J_^CQ_^W'_^DDMW5_\ 1X__ &X__P!))*;B2I[NK_Z/'_[<?_Z22W=7
M_P!'C_\ ;C__ $DDIN)*GNZO_H\?_MQ__I)+=U?_ $>/_P!N/_\ 222FQ?\
MS%G]5WY%2_\ 6=_] _\ T4IO_:[V.9Z>,-P(G>_21_Q2+]C_ ,G?8=_^!]'?
M'\GT]^U)3__9 #A"24T$(0      5P    $!    #P!! &0 ;P!B &4 ( !0
M &@ ;P!T &\ <P!H &\ <    !0 00!D &\ 8@!E "  4 !H &\ = !O ',
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M86-K970@96YD/2)W(C\^_^X (4%D;V)E &1      0, $ ," P8
M      #_VP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! 0$! 0(" 0("
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# __" !$( \ "Y@,!$0 "$0$#$0'_Q #U  $  @,! 0$! 0
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M_]H # ,! 0(1 Q$   #]_
M
M
M
M
M
M                                                     !51:?KM
M"6F-I*^F"(96Q298SQ;M
M!^1)N-%^Q.T>FRB)E)NWUQ JP:=2D_3BP
M                !_)_0
M
M                              !Q ;Y)+2.:Z'W/N*5QH2W9N=-6PJ4+
MEZI5^>)K]^#E^01TJA+W.N.9R]H&:L-6I2(BM$M/BQE0C-3_ '.!3EE-]R6>
MN=SU19                              %85U,J4ML4@Q=A2(#=2=#<4J
M(UO)$Y<--=*6+-QG4^2V%3$'E-A(&(S60ROA<5*TK(98)+;H
M                !2E?S8NETI*MV=,4Y^K3]J_;,FI_!-!VR9_'7.D95:*2
MV=E'EL<0 UU08T(Y\-]@&.;R[">$P9AY8;LEXV<B,DQ:2D[IDE_0:Q>]
M                       !J1QJ;MPS4%>C"<F5NH1*:T%KL=LF>(C4D)):
MW,9IJNP%?%MFG\I69KOTQQ':M(G/5K"Q=NR'B$R?%V)--6%BZ*1P6(.DC(
M
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MYT\73Y=CJ'UMZSX(K_;/:5_EN79SCFNNMQS!;RR6*2*9836W]S6);E,]@&0
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M3-))"1ZNYV=K&        !6U<6?Z:&NZFUI%*SRD6GJ/Z,@640
M 8HU\W4           &),L              #G8U'RQZ38D2KNQJ<3S94U;*
M$#$_I?!G:0
M
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M,=K&36'-RK89+^W/\G)1J4%NVS6]:PRS'9<M*C+_ "1++U?N.?#6>.N;
M     IDL"M7/9HE-3-9+::(N&,&NSI)9#I)Q7I=^38S$'G)$-7,L:R3ND2&T
M&+7Y&'-9)F3(D7K"2]*F*LK&:_!=X21TB==9)X2NS4L)H))9J!\#=4^Z[JD;
MK&)CUEQ+:L\KF[:,S04F6>4DL@PBEJQ+,&-;BD_)2EJ=6<:NRIOQ%ZPRO2Y@
M        5V6J[6Z251NMW2X+,'KF(C>W=4LVE7YK"UG9(QML*DMI2)K;C+)(
M!'!:Q.835BB8$@9=Z2(UV]+!)1^:F^KL,\]UWXQZUU6^3&#6,5V)-5-G-=+-
M%=3?C'F +(I!"Q6OA,N=(V*3-:.MC4@DCI9(373Z+GTD$T LPE26H)6P"?1/
M0240ZO3I@        4H:IZLW$5%L4KZ2H8 GI*MM$U-?622D^I2":E:L.;%)
M9>SEW-S-9;%FMK6&3<ROLMRK*>KOQIQ+9J9:!(I+-)SY:T:6S-SIYEEW!)92
MBK5R$CP_DT-=W/>D6+(Q.;.C+K!4*:EZSQDPI+A6-;(I :[0GB,P1 L_I :[
M*D:+NQ%!;A-5.EK(        K0M8UFT\"324O64S>DVXH4U<QF.UQA,Z9$B%
M=8)W2LJVF36%U,LFG/EJR284CLN S!*^U?\ 3;4YV-=1V:(KT_9I>UF4T1=N
M3-E5VN@+,,DL&O&B&?(H7=C2R:$]YH)JR^A,8N<)+3R&JDY&CG^'B*\M26F-
M-S23TK8UNQ\"2$HFUUS8        '&5JJ34G$FD,+U18YS36]6>5<ZE\F>3\
MW,5=+&.<C4;+($E9&K0W-LTU0P42S9S[;G!.EK'Y^'7JJQL14E=(6W;,$D1K
M+<=![GEDU,I7:6T-S9].8TWV/N.'C>UG9%SYRMPI+XJF9*NKW"8YZM5MEM!9
M:]GG@U."6'3EXW_!(Q(R5!:RR?H6<^"\Z=I+SYO-U6FLJEBK*4-7'9M\EP60
M       !I1%ZX<VL^QLAJ!K9*16M9U3 $;EN$U%=",V:8>TU(L,F4(,70%EY
M) 2!%E@W=(F78C;DJZUZCX%@4K N2/D9@F!*W+9]/,:^3BFFKKQKA(!J1OJ:
M*N',N;:>4@$GXAU< 90V9($:SZ7-9J>UOB1ZLOI'"X4W(^J:@MSV0
M!PM;@^:DNR.%[0N?,AN.3/1$E63,^D*K@5W%//&;22JV$@ TY=;68$Z'LTG6
M.%K=+9RR$Y;%6=BV. C?:1CG\U3>:P9VCN*J+SYF^L%YPK-4+ML&DAEWV:(-
M=@7/B4Z8:.\-Y\>G313J(S0Y8/EL%5IF:4-9&+JW/%5N93TIUQ8X7.GAEODQ
M5FZSYL*?H,<^!CI&J]%&,@5Q7M4P        *E+HBYPEY-9,0>PSI%:Y\RJ9
M@FU-<7<D\)&RRPG^$#+,";>     8(SH,$9T    UTPR[V@    &",Z#!F<
M  !@C.F",Z         #GFU1MK-EH$DA.8#=N6?=%6K9<243#1HRU!MM7)H5
M>*-[K^S6HZ'7-Y60                                  !_A_H/\/\
M0  #_#_0  #_  _T
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MN>,_L\Y]CZGV/L0DL@&QIZCYGD,4N10?(R!CCW'I,0%_U,Z?8R0
M
M
M
M
M
M                                            !KA"RRFD4K)R1PNY
MF /8>@P9N)'A*B18LHI%ZRBD5K)J1TNXF"/4>HP!NI'1*B1:LH)%ZRBD5K)B
M1XNWF%/N>XUPWA(W65DBQ902+UE-(I62TC]=M,,?0R)K)O9&Q*J1:LG)&*RD
MD5+)2: NUF)/],H:L;\D:K*J1:LGI&"RDD5+)*:&NT&-/X,P:F;^D:+89/2
M#2"K#5A$KNL^I!RRBFFF3/::DLFI"RV%2OBV 2OZV"2O*SRD)+)R:B>\R)IJ
MRHD)+89*^+/R0"M@DKRL\)"RR4FJKZTRQI*RPD'+8=*]K/[, -6$9KNU.Z0R
MLCIK*_9,T:&LN)!JV'2OBS\S +5@DKRLZI#BR&FNK_IL"1\LPI!:V&2OJS\S
M +5@DKRLZ)$"[\F#/F;*1TLQI!*W49]P
M            !0=JJZS FEK)B4_:Z^,38@  '\G#1N,90
M                      /+6MRYQ/[/N::N](+IW/4AD #ABW>1FUJ
M                                     ?FO=/TY.>; !^>1U[NN>_(
M                                        !^=.=>_]Y;: #\\CKW=<
M]^0                                         #\Z<Z]_[RVT 'YY'
M7NZY[\@                                         'YTYU[_WEMH
M/SR.O=USWY                                          /SISKW_O
M+;0 ?GD=>[KGOR                                          ?G3G
M7O\ WEMH /SR.O=USWY
M /SISKW_ +RVT 'YY'7NZY[\@                 %6%K*LUDO)J9YC<"BJ
MWI2&BT*2$                  ?G3G7O_>6V@ _/(Z]W7/?D
M       _"@ZV,B2%WJXA1:F3?S8EZR<5J^=64_1VP                 !^
M=.=>_P#>6V@ _/(Z]W7/?D                  Q1JYZ#X&=/,9 U==I3_3
M_#+@                 'YTYU[_ -Y;: #\\CKW=<]^0
M                          #\Z<Z]_P"\MM !^>1U[NN>_(
M                               !^=.=>_\ >6V@ _/(Z]W7/?D
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M\Z<Z]_[RVT 'YY'7NZY[\@
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MZ$L4QFK"W-3VH0EZ]W%!9JSUE&VIQ2-":#?4]A7A?-'5^XLLGYTYU[_WEMH
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MC%U8G=*G342U;]F(&K),P/+)EGF6,S=B#2QJ6.+1,@
M        #\Z<Z]_[RVT 'YY'7NZY[\E<ETTV(UHBA?J30E=%E<DQ(^/FOW3;
M#=R"ESR?0QA-II)ZC^B.ED1(J7_3PE]60                          !
M^=.=>_\ >6V@ _/(Z]W7/?D
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M(,D?4LNDJ%*UUD^)J2S"D>$IQ$53L6%3GE-?*I(/[DFRSLHP
M  /SISKW_O+;0 ?GD=>[KGOR0@LQI!ZR8F7(O61D^9EC&GT/(>L_L]9C09$\
M!YCV&*(O674]1[3$$9++*>8B-9;3)']'\F&/8#+D*K(:8-1LR?(S1A3,GS/.
M> ]IY#(F9              !^=.=>_\ >6V@ _/(Z]W7/?D
M                             _.G.O?^\MM !^>1U[NN>_)5!>;C6IQ/
MMFD FL]Y6*.VUSLI3IK"DI)IYF3>S*&'-\2(EVTB!9&39"+5E!-5-&6:4Q!Z
MS6#55F)-*/8?8^9A3T&OK)*0&LB)F#Y']FS%5UMJGW-?/D8DW _@KDME$DQ
M           /SISKW_O+;0 ?GD=>[KGOR<Z%XF-Y4N_,\];OJ,Q19=G67F>S
MJ0<>PKZU#A;!(!6*%^J653,$9KKALI%"^0P)T"9I*UJYT>9YZ2YNVZ3-1%DT
MU,H_-6GN=B)=2(%A->@[-"&MQ-A244P*VO2C\O\ M6(2IR_,W@]9-*40:L8G
M69C8            ?G3G7O\ WEMH /SR.O=USWY        !YST
M\1[0                      #\Z<Z]_P"\MM !^>1U[NN>_(
M                               !^=.=>_\ >6V@ _/(Z]W7/?D
M                                     _.G.O?^\MM !^>1U[NN>_(
M                                        !^=.=>_]Y;: #\\CKW=<
M]^0                                         #\Z<Z]_[RVT 'YY'
M7NZY[\@                                         'YTYU[_WEMH
M/SR.O=USWY                                          /SISKW_O
M+;0 ?GD=>[KGOR                                          ?G3G
M7O\ WEMH .&+=Y&;6H                                         !
M^:]T_3DYYL '\G#1N,90
M +IW/4AD
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MBO\ R$ G4$A  @  0E3 4@ __890(  4B #((&D "0 (!**?\@#KI" "F!
MC2$Z0F-,@BD9"/<%(3TA&FF!I ( *8&D "5,Z0F(2"*>HRF-,H"D!"0#&D!C
M2 @'=.!_5&FF   C2$5?Y5  5#2$::0&03E3(?TB/^(  @(!*0#2(  >Y=0B
M8RF(P B$3&.HC,9:A&)U2 :A@!$([XZR"8Q^J?ZXZC$Q]@C5$QB8C$ZIQ,8F
M,3$(G5$QE,8F,!.8!4,#J"-0SZP%0Q*H(F,!.8B,]0P C,!JF$QCK+4,3&.H
M#,8[H 1@1&)U!$QB8C$QD R@)QJ&-0SF,IC'48&<3&)C B, ,H$1'V3&!F,
M(Q,9>Y4CTZ!3TG3 ]("05^RG_&GO]@?X@ B(]8E^H) % 15_C5[1_P Y= D
M#U 8&8P !IZ2J'KT"*>@A( _2(_/NB?7I ?Y:90(!(0@)!%(R@) $@U!W= B
M4P"4I $5#T&0C5'2/F-,#( H (Z2&0 $I!(!^?01'O\ TB,5=P@$@$)] #H$
M#W>Z"$O;W1JJ@1J")U0$PC55$ZI3$?9(90(2]NH0C55&H9?J@1$8D,I=.^.L
M"$HE&GK$A]LA#LS&6D9RZ#2( ("$:1G(92Z $X&8!V!I$/;(9]F0]J0^T0&<
MAD(B(>Y4C(-00-03"H(GUF$5" B(@,:NE-4H 0GJ@1 8F$"/Z0$--0_JG*)A
M+5TGU"H("KIT"-03U  @(:=775$PC4$:@@*H"H):@B82U!.KNGUG(!$(F AT
M"D1 8F #,)S"0R$*>@@/34$!5%(A&J*A 0U!&H)@(!6%01,-0U!*8:P&-728
M3&H(I$ "H>DP"D1ZC5UF P-0>( R@1_3[D%(C&D8TC TR@::@@0$(TC  (QI
M&-(QI$8TC+WD1$?[P%4H"H):HU!(*NM70-?4)2U!&KKJ"-7_ (&4A.  ):0$
M=(2TA+2$:0C2$H"FF<  2TA A(0ZTZ0GI")3@0D%(3JI -6GH%-,]/32$QZ#
M(( .M4  :=( $#3U&D(TA&D(J[P ! 0"02 9!(*.ND(T@$:>H $M,::9QI"-
M( (A[ E+2$2Z $Q&D(J"4 $XTA&D(D$M 3&4J0 8TP'6-(1I"! (D$#2$:0"
M!I  ]RZRF,:AB8QJ&4ZHU#$QE$Q]DQ" J$/9,0 :A&)U1,8$1& $0'4,3&6H
M9S&052CJ,3$(U#[ J$(U#*-0Q,8F,:A@1&J $8&H1@!E$Q&-0SF,:A")B,3$
M8U#$Q]FH9:AC5TB8R&JJ!J$8"<:A&!$1@)@,QB8Q,8U# B(P RC4,@@:A$=0
MQ,8&H1@:A$=0Q,9>Y!*!E 2   !@93 -0@ 0(!(*0$:H&0C(!B0  @$Y!%0
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M*@"!JF 52@*I0(S$:N@5R$*I1JZ4U2C5 U (>Y!3, IZZ8T=1  #3&GH-(
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MJ&>J-0A$Q@:NGN0=T@GTD( $2 8JE    %(3  $) $5!(0E(  8'O *9!33
MT@ " #5(!BH  :.M57< 3@*0C2$!$@&! )4@$2 (J  IH_RD P-( -0   $Q
M&D(D$2IF(!*G_*5,QZ"$I!2$#W@ 2D$#33.02E2 CWA2 AI"8RT@$Q&D BH
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MB&H8F,YC$Q$/<J:0&)!$@ 0#I_\ 80 *::9TC_D&D:@ !B00'2  )R 8E3(
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M/G+J-$HD$52@-(!IZC @ !I& IZZ>L@EIF( %4:0C2$:0$1HD 4_I  F/?2
M:?8'>/?3*   @  !  $1[_<]GZ@]_8V?J#W^Y@/2D0D(A C.*1 (U2BFH "=
M("(TA&KK.F.D]?Z1J :@&D!Z ,XU]=014(# #2(:IC$PD(@(C5TU3'5.!&F>
MJD("H I&J=(52'4 AKD #3,1 8I$-.F-,!3(>DJ1I")TP%5,PJTC4,Q]SV?J
M#W]C9^H/?\*[/U![^QL_4'O^%=GZ@]_8V?J#WQ1WR"J!  "732$!2 !I"8 $
M:0EI">D(J  $*)QI"4@"-(1*D J  COI&FF>F!  B>D IF TA,:>@T@$:0@
MF.D C32 T_Y &H I 0$)14   TA TR#2$5  0 3@0    $-/0  !$ "-(1I
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MF5,!2 P !$@E\Y $2D%4A@.M(!(*NM>D)R 8E2(R"*0G R"FD)QIBH G*)3
M D&F)4SB72H)#*F<@E()R"0@$=P4P,A&H)0%/32$  # RE((T@,  #  $Y3J
ME**.\9#%8 $!,:1I"<@G+I4$@D&F02  CO#33.H.@  Q5 3$! !$0  TTSD
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M5'0(JJ_33W5#TI'H S@>HQL_4'O[&S]0>_V::H"D1B0QI&)#$AE(8$)1IJF
M",2&4A@*1$1I&84B(A.<JH"8P(5! @(1IZ::HD,2&- Q(8 !&)#&FJ-(RZC
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M](U2ZU=:A  B7Z9A R@92&4NDI!'>("  (4@(! 2&![J>ZH0E3W!(8'_ "F
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MZ@]\4=\@J@0   .@4TS&D($  -(0%-,P )#2$  !   TB 2D$JJ0")!+2$"
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MT44U.>6[=-><?BZ]Y$C8KY)L['R":3,LS)KR;.0K"7<10%1>:V1(TVI<BE_
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M;V\<-JRIGUR:_)7=&EVRY($OJDL96!$G*GXR\3'XH/"M:>LS6?B*>V1O[RV
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MM3;UB9\55D4"_P".9#32NZ<,Y-Q=67W(T6R_N*? 7%/5@_'7CT!M<<V'1:T
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M@K*BF1Y*FV\=HF]MI^KJ3JSL\EW34.%RB&O"'*I=3*YUM9,OY3<FW0_&$\.
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M%-:)P&@M#<WK.O)['FP\8P6'F<1+R2FQ9VMXQ%_C7M2B<C+@RA=G7-RLBQ9
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MP!GUFM-\1M.#.7MMM2%;>VJV/%*>2BA0*MD(I3C\JG[+9!_8O8_*=^R6E/\
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M?PC1&[(A9#G,EMSR*<,W+=DQI3[3^LP*,A^Z8.0UK_D;W9#S]I60V;7R&O\
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MN,":*<W(T]17D/T0O62&-+D-O(7UZGMG3,]HI>3%]1)Z$H3?(7H-IVQC>@^
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M#:\EJ^L8T $Y3L(,;?6<SRJ&).WFH!8!N; >$-HCJ&M<9>ZF0TCO_P )_/\
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M&J47E8 *BM\ N\%$W?S.I><3(>[]SB4*ZOZJMXR>$:?R@9UL-G] 9)HT'2S
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MHJAT&B:O6 Y:- RRP)S3ZF:E;^4>&,88CWB",<7"[/X_WBHSKG/M\6ZZM</
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MGUPAK,B:8+.J?<XU&8;^XI2OI^I2N]_^;9 I@7K#0/)EESB':K\3L>?4#)M
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M,CB&W.QYD,3+D1GN-NI6TYUIYM*OI4GJ>_+Y=YWGQ[,T[WAK;.UZS6O$V?\
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M.8^V+'[^H1P[:)E8]"W)%(9N<L4X34J-2;<Q1:E0X+%CI;?>19*)H<<4XO\
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M5$9_>N.)=^YSZ.H7XP]6>E/1E.V:_P#FOS]Z4PW5!X?"8U!J^Y\W^9!;8,L
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M=YWG?Y._#3"WFD/O\<4RRIQ"77DL\3UY33?>\6YQKBT_5WG._3\^?/\ [?\
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M9=FUSAT:U''*L]!<)S[$$K%M'5^U!#QO+;@9I,P9>@%(U0"+D5TM- RHY:'
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MXCJVE<7SYI[SOPV2KYH2='/)ZIF>&(PR<)U/''6>J;E0GGV%IX\PM'SXKO\
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MBW3>G<TD#X@38!-:-6>2['!?>BV<.U- EQ)7ZX_(LA#:U0N%%Q'"7(D;A%R
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MUF(MD.'TW,\B'TI7IC5/$MG(4RR7)-G,ZU1,^NMZ'Z_5F9?U1JYE=BY4^C'
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MN0_7<ZK VGXQE]$V==_ Y9<0@[3QIJSU:^Q!3(0JZWQ@EWLSDQ^!Q'7;4?\
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M2B@INJ$F*U41H^IM%:_5G>MO\H?%,,(&2X[?X3D-V/\ ;5Q*T)^-NE$M4M,
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MBM97&7VQ3)L@BL5$<GN)*O+@=B(C7QC7KD'LU=YJW:W@]P-Z7BEVT2X5URA
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M.GM")2NQA;K U426ZP:;Y;=V'U_=.Z="_=4H0ZL&OUC09<$=Y4L%>R*I:*/
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MV[73,BNV!L04A$G 5@B1HDR6",(AOO*&&8L0@PZY%?\ H?0V^VKJ>)6GO;1
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MR&U-IBL;_7K%6K1;)O)7OV^X5IO->S(?F5AL?KNH7D('%W6G,9T-V1FRH%:
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MYF%K%U$^.UK3E$ 4NP0!3O*]((U1"9L;CK_)$.-YOJ>@835K+KGHWT)ZMSR
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MF.-<?01@5S+;'!&BI%>-#+!#@%4V&4F?9)1,0/D3)\E4*/\ 0_;)S%TZ0?\
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M^!+GPYO !E]Z+QUMYQ+G&N*^?\OQH>.XR[E&;GKUZOSW)#VE$:03LEBY2$^
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M9G0:Q!DV^E(BWR.RWUZ9(E)+0"D?YL$H4J-\V^XUYNKMCA1?X8SV/6,\ GS
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MW\D\* ;UBV=V,69O$W3"3,VM0$/RM")BF )6Z=GQ6XY!JREP,=,"9+0ZEZ7
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MGHTZ"XVXA/%-J7E=/+4G5M*O>S3;K$H%%R&G-VZQE&L[JZ[?;R,GDXL!$#8
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M0!W$8(&,Z=8[C1SCQ6YEK:9CLQU$^[?"-GH-L0CK29[%AF*3]#O&%M$:C$]
M&;]B4<AI)2D9@>SJF"2=2F:+IYW3%KDZ"#Y&,61 !VRRQT=+T=GCL7K:W?J>
M1UQ>-+,V$W7^XQN]!WD3^BMC7/UPU0&3;,*O%_U&)+^V$)).+Z^J/]J3SK:?
MH<3_ "_,$Z)O]]D=J_K,+Z=K7Y[59>6!KU.K]TK><^=1KR C3S>.9L,OD] =
M"U+*LI<[Q<M?.]^>J>0B_JJZFL+NE3N]>H8U.89N,N69%+7I\_3QEDY;6(;K
M5SDUF>05";C38+4:5$0GKR>O?4XK1//V\[Z;ODF_G@Y'FAUO/:;0"U># ;-5
M+6-KPX##2:"2VVR594E<J3QV0MF6I/>_4A"OBT:"6NEK"3K36_,-:DCA+ )<
M&)'\O>D"?I.N2HRIXV3*[(M=@**%DN+6I"!Z.*C\:?\ F[WT+L-@DV$A6/3>
M"2</TO%N/1(6>\EF3G"MNU2KN0(\:P531[G''BVR$V#*9ZY,#Q2"?I(([([E
M^N:KZ;TK=G<)I]_I.."[=6*  )CQ^DQ:L,LAG2+34P8R;IEK4'IT-EJ8MD:W
MUQ;[[K+KSO%M_P#4M5QBX:=K&<Y?@_G[);95\]RW2;+DA+4K7N9_61AC63=M
MH!6MWTH"S=C-6 X@<U-_2&RS\V1,;D/<AIC><LPT GZSWX%03O[EV/S#.$:=
M!RFV;5%\X;?A6<9IM.A$*IHN#ACQ.K5\T0"D5Q9KC$BP_ER6X/.O+0PPVGCW
M$MLM(3R0XIY_G$(2GG'WEK=6Z]\N?[RNJ5U2OGWO>_\ ;\>RZ%N5VWT-[47Y
M=]6:OF^RQ==.F,/W.J461*LG;SYXIS1Y-5Q'1,K%' \:55?T,.0$Q'>/,2C4
M/DDIR)9M-I.[8ACF;?M_>C]MNE9T:1G2A5FE4?2\!?5:!H;/]*OD>;::G7'2
M45OLQR&YQ!?K;7W./+ZCWS44^C;;>]8NOB"U^\:0="E[ X:\_P!OM8 ^"U["
MJ.<)LQGJ<+Q&S_PVNN#D<X^-_5W''5M=^GOQI( )9/4M7SR/^XKX7Q:#YOM6
MW29GK0**-PJW)UX4_IJM8*DP>8^A(I486 QU7]<7HYH@ZS)@<E+&Q\J\Q%+9
MZ*Q;(,[\F.^@G\K+[):PV^:5=;MKEJSI$;5=BJ6D6N]%JOD X&B4B *M/VGY
M]EA=G//LQ8L5%@L=SU6U;3E&'Z)[9\:IL=RM"'&KI9,]S:A^FO.4J[?B)'B#
MFT"W(-HRZ67998F')3#''T+(+6MRA^3KWKFB7K6\5W6^:UJEU+V&00N9S#X/
MGKOIFNUB^E?^!(F5-W7]7'T5A2/H9=%UI<7G5=;[WO[>6"Z3KVCV/09NN>,=
M0':P?L<95S]'^5=[R#02\F'I1"/,4];;+GNI1'JY:.?C1^268H(F\A*BB>]8
MU:7SVVC4+P6\N"[5JIST"4G2M>@W+VM5:G;(.&\5O4_F=E;95B4D9UWD"F]2
M(G16_N,IYWK3-VI1O=K[D]!]K;OR_>5(.\?PW[0"8;7H4BEC,2/;JBZ0ICVE
M95JD6;9TUF5<T_KM:G#A_;.\TPTB?0B] M^A67)[]21+8BSOW30JCJ;\ 6^B
M#-AV*Y02X'30EX&E!+T RM<Q@HW-9D-/N?<^Y\_#F82-Q]$#^>N=_P#5(+:M
M:F[AHI^]E:AY?M>_6*C9#1[%;#AQ.7SKZ)K42(3)5M LW*KM>E(:DMRE_FM>
ME_-#.DW75LNK>;8CN5.[H%IG7VV8H8U8YK56/Y"0O1Z<5N=@KQ1O,8]B!MG)
M4HC :G2F4ON0N0T,W@Q#L/HP(+%?NC89CC>P*UYN3YFJV4'L9P5PMYZLF#NW
M4C+E3-5L-SE!Q12/2THAVVQPI[AV*AA27+_=+B&]1E;2]J/JX*[JFD:S.LN%
MV4/7/5NCU:MU[/L_<UHRQ79=8K(*$/AJ[3PO&88YY"7>_7_Q]OJ >A;GL%1C
M^.,.N RKYC,SQP%1;3,TSTR,+GY$#0=%S]N-8;:/##VONP?S%/,"6^._;^VW
MQ?C6%H4SU=KT(C^VAXFU0F[GFR$ZE6 &FW'3;4S;=5VD7'UK-/XY>/QA,5LI
MSL2Q]?'#IB/Q%<7Q+Y6Z3-9T).@F]\FTR9I@*V%@5Z36BO[CKF921X6UBE#C
M(6.G/)"@T9R*J._%'_2AI3?4I[RW>:@NE7W0<DN_F1KT/$JNGW ]I=DQ:XA-
M/@YIR!6KW:YQ2ZJH&JBB#TA@69G$OQ"5:F.0'667I#'/8&>7/:M?SZF^<J[C
MV>YI0L0T^SY&0AE=;S9C2S6^6DE4IT(M<+&LJ0_0J_%)KE5J$W79?5#9$B1)
M<^,C]%W#9CFCY5EWE@#4?25.#,OM9[HE$F^S_0>!RO< 6K@H<X<"O%,%Y$'M
M1QP>RB#-J! PVPVRF+!0G9;Q9+[8K5<T9_[L<A7Y^QOD#;L:N:3OHRG3A-G@
M/H>7%# 14%H5)C.\XW$CL=97\DI5\><P8:-V(,&X=E4>*RN1*F/?3_ X-:W9
M,V<_)GSYDAU:G'I#[KK[[JE..+4M2E=^/+ISBYL4O7/<?E!X.1&DR0J7&2?U
M,34SL-UX9+B*FBS=;/2X<R&_]V))8>[QQM7R3\I$?CST;K[+K/)$9242&.NH
M4CCT=:T.(0\UU7U([U*N<5SGSYW_ +/CW[IOF?9]@L/GG,<OS' P^A[)=C>M
MI=]>+U*31=JUS%[+H!8Q)_0<@IUN@Q#_ -O[=2?N@M^/&AI6**)>]8Y!KOI?
M>(7F/&<D\S^EB=S/;IH3U^S^:<(:[4[Q0".N#RTK92@'3G<D@&6P<8@F6Y/)
MR8@E#;$EB&W4O/&D[7=\.W_;<F]3ZVQH&JW:JU_T9YZ\F!"-U(96P;M=D*P/
MXC]7-@K-3JA$>1%>)Q#+\Z?*2])$//R_/6AR+13+MGMP\N8>=1;()HG8KR<U
M:;7UKT&:9-(?E5XB#6W^'Q#B'%$/U5,WDC^3C?QYJ99T/=A]?O\ FWI#2KA2
M!/H#90] -6[)3_F*-09:Z6+N\2O0189FTD4NC(K# PCR8[R;'D<7WXRZU;!4
M0EVRPWCWN73:U.'6ZQEM>_*\QV?0]"1VXDSC4P-+&:/1X?68<:&A;U>DLLLK
M7,9<5V)J(#8<VCU@A0>4 @(O59I6P4O/+@W>PY>:9J &/M%4JMD*V3*C(-V$
M4G1T+@D(TP?-0W#5*7!C_N1MG]HT"36]<V'V^"\SWXC8"4<MY[VC"7HPX5@%
M.L2X;S(\+IN?AGK'2XO9+/8Q@.;@M-K7)A<5:[\%S[-__;13?8(;Q:5_/,GG
M]O?M9;2Z]@\K6X(R"Y_"SE6#[9;(D1%:[_\ 58A7FGBB)C+JF1Z\OV7U!"KV
MP7H-5/W#[J0*YS9;?GPR6-PK6JYG]2ISM1:D3*78))TX9CCVC!2*ZD *81*1
MQ3JYSKU)R^S5/#K/O5SI^H[)^-0*AZ-N>?C<XS&-GH=%%BQZA6;/>B][N>DZ
M#'$QCK\,8(@#D=(/PG)'6A;H'T+%RHO'OEU$XC K./7R<NGSP.E;]::+0JG3
MM*,/#Y*JC&JMQO\ &9/R%1ENQ&HLCC;2WN(:5;O)5L8QD'?*_P"C?"H+2CU6
MFZ/$SG6//WIW3"02 !BL"K6-TFAFG+;GY 18X'Z@]R?7O^,Q*0F>IAC.IGG*
MPT"I6Z9Z!\UT$K*NX0L;#O5*[Z]3:23"P8HZ6S*CI*+,,QI+GU=?0,<D?86U
M*^R\C7^20P&UX==_W2=#\]K?L%MLQ+4A<R\U*HR0MBJC,GKE6!4*GW2,^/4!
M[];TF$ZJ8P[&6WR+*A*L>1* YEHF.HW'.[B#J&OBAU+&3+()@5_+]$MM_IP"
MF72^VBG62$=B3JS(Z/\ E&)Q.-.-PF9\UC1-ZG;<2\YWZYX92?/EXRG4;"$R
MS$;T;:9HZ\V]&8S6B@%=A%[+JYEKD*X$(MG&)?*0!4O@1$5B3/HWH/;\;S:%
MD6H47UN=K5;SFVGR6D5<_P"61.E7&%'M$DK <"EQ6ITK,IO5?@QFG*N36RQ(
M7.:=<>CP: 3Q*I(V#0]=RK*\EO)$!MN98',GZ%G.CZ?>F"KFK4ZM7:QE<* 9
M.6:E-"N<Y:79@E4;],_-D-0-VI=BEY=6-G#G/*&?0K%,YZ'TFA:-HFGT2W6P
MT#S#!*M)L=LC3PM;K<R0S !J9>(1XSY K(;:C*=0 U@J.*T]-Q\(4Z>7S_A<
M^[70]RKGJ#=*'8R< &98%R(+Y"95E=;5.@12[,/[4:8E#K*FT^AY5\U.PO>=
MR8_SYAJZ+8; ^G/\@N1#$=.W*NZ<"&R&WHPV9HK]?+5\QUGK/94A CKG5];1
MSFYF2MA)VBU>HM\PTGC].TN!IU^I/F&D73QU-] &:Z/H.5 3%R*C@694"/(?
M&CDCN3K89E2),N.RF2]RM00GF2R<-TJJ8,:W[)&\\W.R:P0.[G<K/7V0.4,"
M*#%!U9NLTFH2K@T]=5"Y!46^S&7&']1(F-:20W G5M$_A[]POUAF.7NU.1<,
M^:J&=X_YDVC40(ZPBQ!AR#?T==IC<'D$GR1';[,7-4X]+BPU-JOVS8QF4HM?
M_'69>ILBK&;W*PIBB+%H]ZSC+(^1:78[,,^B5'A7/7 4ERS#8;+*!W)R?T]2
MXK+DSTM@V^UG)8-@P2!A18/<LA+6=P)=Q^PU2S&YW9U6MO))>HRZT9K#\)IM
M4V;R='XB5]377>QVK+2ZY$SS3\XB=W^G,SZJ!UR)/I&JX+@QW:RU<N6HD*[W
M&;,2D/4\F()5\--X9!OJ86]UY3<UF,.[>\:QR5H^NX%Y@V##PE5N]KB5&O6C
MTSL="P.%G^N60N&F3Y@ZCW32AA*0>%0H[9 8B5'1#8D-L.R??HK8IH61;*OJ
M.#!N,TTW8I^?N0'O,F9F$&ZA7[+*ESZ&T=EDWES ZG)*F9;2G>RY:7D/*!-&
M;9G]LN@']X/7<8R]F'RRTNF@,DK_ )VVQ[D+1((N?^=>Q55CJY-CC>.(?FD&
M6OKDI[Q#\>LT^O8Y5+!NE:HWHN^ZY6P0+;-!J]HYYQWPUYT[2<=_LYI)^SC#
MVT7:OR70T^QQFH0=MR/'>00?>5]JV:/5^:[0C1DCYLDO"*9)(5#;!X:[[SCX
MNU446Z%*0B@2\%ZR=F!76HTUEY$B0MI#Z%?)SE3RZ;4336<:AH?I#;Z[(]/W
M(O=]KQ;R'CG]@K4NJS45DA8SMZO%QLU_L+M6BEC<P@"#]'M%),IUM41O&[O/
MRW"(D#U]BVB;)YA#/WL^/<J3E#H;&Y"*5Z M9/D4)'CWO#6Y3[MD$,H@5FQM
M(AR(TZ&XDAVF^G2>:"!6$[IB_I+5,!9ESRL70GC>0_PQ(RS-=4AK:?!UF_[+
M DF/I%P79KHN? 1!ZY(?4YUNE-Y@ML-K,(_E-LVG.<_T%_/"NC5 2N*0UW&\
MLVI]+$W.C-@D=4T,.*7!<>9C=BKFC>3%D8GBD'B>B2ZOYI<K_LD3Z/I'I5^R
M'M[IM[P:;6$V>HZ-=[+;+ ^*,Y<4/=9:?>*3H*X'52$RY\%<![X]$0\=L.6!
M[]7\Y\^;QBNSALTU\9GM@RG5M]7F$X?'&Z\,KI"Y2GAHM$J!9PC$VOE(!/ZF
MD1UH8=><R:MY-RZY_3MZK?F#1YM5H>RD;<S=YF>UNZ7?98=DC5>9D-4Q_.B-
MU$PI8XF9?,/PW),]3\?[,:).J-FAXYYO#2-'\EW_ -CU^-.N>@D8U2I^4F:T
M**9?9'8@Z*[9+9I3-S'2!QN$F'!KW$2T2H))3,?LNH J)B<TWDQ#1,HR*VPA
M51URR:* .:5BU$V,_ILN[!Z:G$06<9-S4 @LK$EDUD);7YA%#L=#42)/D7DA
M3\7R^Q[]XC]%>B//9&MD;3=)N66G$@8$K)%Z6T78&B+6W8*W<H9,9,'HCMCR
M,=R%+B3&?IDN4[:-YNN>BK*(P(!H&C7LBN=6,XCF>TJ*:(&B*GU32(P(N6YQ
M3_&^./?[RN,M]5U#?QW+:CFF7&=Q?]*Y;AT:T6D#M.0Y@S4]9\X7/T)"T.3G
MND!QFQ]>J,:F21KT!:([1E74/1Y4?JGF8L.E#<E=(8A9K]ON9BK:$I&PL&Z#
M,P E8JT]H6E78U4HV0/534+E1S L:-&$5D!4A0U+STMZ9)9'?]2K=[N]=-Q=
M J0 _4@&B4"^W_*-!ATZUNPG[-3'+OF%GJ%FGT\W)&QWWQDB4["_*8;D(;1(
M;0ZG*E9UF5;I;>(9_:,MRN)7&I0L=3J)=2%2+6P% %QI2!TG^("M&%RI4F2T
M_,=DQNN]=^MY]3GWK7:JW6&?TTV8^[83@P*U^D5D>HM8ROW"4J,G]-KXM/9,
MY_Y_:B1^=<=4E'\OQ?R9JK%+4*T/+KEF5D+Z!KFHWM@?C5]E\L%WI%2,W*]&
M7,_HMEEM-RIS 1X>R^F/'^OO6XL;C,36-6'TBQU.-F[8=F^%;<["IKN4D[EG
M>M=:D&HIV'6YM0,6C-*\1<?=6MF4Q#2VI:HK[S;H[^UFD1+=T55],I$);Q(V
M+=14-CJ3M&TVMN/A"8QY\3<*PYR/):6I7$K99>;^A]EIQ!RQW*C/?Q/89&/$
M"-IK-IM])LR36 6.PVK'+)!.TXZ#)C+/0S%K(?BD8[C<MV+([%?<>BH;910)
M-V_C-$K!X]S*4;8"&VZL%UFA"K9&<<OW/[=8]Z':0W6CHUE"2<668<'O1H<;
M[K?>1(_6<SQ.%E=+.8'2K?0=ES:NB2920 Y<ZA=HFN4[1&+ -,_J5I*3KQSA
MN7/ES)GZ](DO.3U2TRG_ +MNWB30QR];OF0C<&M]S3-,LS#N3!SI^RC:C,@L
MDFP_&HQJT3G>2T1D$%)=2VI_K332&_,/ZCEHB2OQE-@D/,KRB=B;DY3('9],
MRR*@7*:,MR3,/E$G*A.1RJY\=Y3;,AQ"I4=AYN;1A@2X,Y/"D5([%S^U[3KM
MDS>FN9MHT+8ZG.J]<M=[)!*:Q6KX(8((["3';^TQR.Y]43G6?BX#D2S &W7Z
MUM[';X>8;=H^964V?[0 .53;9)CYK>ZT30/-4*$,'S_MI1#F]:C2'4JEI:?Y
M5<VS>KAJ50Z0$@5RIU6OPVX <$$&,)CPH$&*USG$-MMI^:E*ZIQQ?>K6I2U*
M5T-@\S,1W,RK-U>TJHB(9FS#S-*T9V[E]'1?J1=H)N/>*;<X=T/39T8F,(Q9
MD7LIQIIQ#"U-=MS>:5IX82T*S+N>AVLY8+)=;WH%L4.A!T'[M?+J7L%OM$^&
M'&QX<7\R:ZW"A,-QXZ6F&T-IE;-.I!$E<)FE"MH<'D[UH!#/$;&#J(ZAA]89
MRB9:'LR9T454P\2)%+I$\F1NQFWFEHD<^[VT:0!-6;.ZTY,N]C.CK1M^BKQR
MOD-'N$B[70Y$I%QNTO.*H^;N963,Z]'B1N,OS7DL_;0ZI';/IZ*]'3>[G2*U
MG%FL/Y1#L@K2J>5MYNM@78O9G1[# LI?2[R76F6WU]FJXM:DH;XC/.A3ZLPN
MV04C'_/-7$TCT3H&>$H]%"ER%GQ;*+37@6BB^6^+*(QYSPF&9CS9)-M4I'.O
MM*>3V^9YVN7WF<:(^9G&<X3M>S(H0<L=U"/M$P]1*HB^)#YT>CZE'X9AS 30
M]^!)4M$=33*U-=NA3.JN]!LND%!QK1;O8;#9[UH5\)!X2AP9ZW7^\F;%<#T<
M'"=<;'Q9$U<0>AYU,9IKCKG%+O%]JIM%RE4.=E1JU4?0]&RVP6O+24]\K,S6
MYELRME2FW&C*)2WY#0TFN5&C/2I"V$MJD/\ 7&C%5S*J@7V,;JGGN/ &P.QJ
M[%Q2CRSTVIYM%J:'/X7BU@(]9IR6F6X:>]9D=:4I324(24\:XL!5DV,JRZ]Y
M54PP::5L*J2#OD&P1YSHJ1;B9HC-5 F621(8:E276T]^EKGTM)2A- IM<];P
M!8NCYS1*+U#?GNH2T%)U.K<&OSK)S]2MLZ7!78W(')2XGWWFHSBU(;7]OZ4I
M7]7LB&KYMJ2C_P#URH7/H<[\OI<_DL?^]]/R[_)_V=^?Q01NF>F&K6-H^\X[
MMB6X>+UJM39S.0'UVN-3F)8RRJ8@QK+8(\)<N:XQ*>:C1E-,(;4ZIU,+(KGI
M%\V"<[$N#%JT:WFI\&[6B1>#I\Z8?X6"38D^O-0.V!<,4W D,]$P(\=F,MOC
M#?4E,=J59M<S'"V8)QEW(;OJ6GZ/F,3,^071;E6%4B_6ZQ@!<>6-?6Q)D,,H
MERT.+Z\ZXI:U*13I5"LTN.G4<[VARS3-=V&=HT[2<A%1PF3'S.G3;Y(O]@C9
M@*A1V@ V>1DBA2HS+L>,AYI#B263FH-@OE/,#K>'*<TZZW+2[+-%7N*0@V@>
M[=;N=.7%,4D/*/Q^)1.3UF.O[;74)YSG*^S10\ZOCJKF5*QZM@F++:)5:"9]
MGG)Z*B''5D@9E@(\X8P16RLER/\ JDN.AIJ1(=;892W3M2* 6)=]H%>NM5J%
MB7)GHD!:_HLFHS+F-9BM2FQTAL[)H8E:UOLNN-]AIXTI'%N<7GU/3DM?DU7+
M!&G@*-7B4DT7#B >T#2H?41$F 5*3(YX;<Q9N7'ELD4RV_M/J2WQ'/E\G*KG
M_;B@%_\ 4]F)#N&D:'I"A X0.8$A@8&7H=HM$P& $#8R&8\**XU'1Q/U=3U?
M5*[I6&7[( EDRO7M.G;/H-5E%K1'2;U,E<1V@2KO&,P3L2P5\WVX"8\UM8V7
M#2RMOZ&TH;4I"O[8I>>I>MRK^-UQZ!VR6Q-!E;"%KK-2#[#-RU!U.;3-6%UN
M.U$8L+HI95M+#*^/_=89<;(0%Y>.*!B$C<W/X:/E[)8*F/'^ED0?[=*P&JAD
MQ.KH6E:/(@_D3@<:,T)3*?D/,QVG9+ZG*96DCM+XC.)Y65G5E_MXW'NA4(<=
MK8NGFJE4=+[H?;^$H9:LA(<22"9)<$O_ (K+RV%266GD'\BT>IB[KG%I =K-
M@JMC0\3@E!'&VD--R'Y#RY_)L5QAMYB8EU,R/*:1(:=0^A#G"##5*FG21G3<
M^V.PVZZ7.\WC0+/I&3NA',RL=HT&V60Q<['_  &BN0F1<.;.>@1(\?C*&.-J
M<2LSFFE"))FIFWPLZ0P/-G:P7@EJT<&V>M'@%FJY(/9*Y8:Y9 \2? GP)<>5
M%EQVW&W$J3\=:5G\!25[G"]+.=_4SR5.[F/[#5&T1WJ"J/K*<7 :4MC_ .D7
M%I[U;"NJ5\RR,I#GZN&)_E)BT[M]OAG/ZK'G&)]@G0*!GYZRDZ;GPR6:)OR%
M1@L&"PGZ^-H2EE#;:16M7 #8[)9@EFJEW%!S&C:/.S>#>J+$_"IEY8R1ZUJR
M]-PJ[7$K@D?TC\F/*;;E(5R4VV\FL =&KE>U"^CJQM-3-DB$FVE\\Z*WV]'[
M?K"*AF5N/&JA2G].:*LL65X;"BO&>,J3(4MI:D*;R*?7+>=I(^Q4RV59FSZU
MK5HL6=V+-W(+F=%\MNQ^[D;IF$^B*',_I;P&>/<B\XKY*[]QWZV2$@!<.6M@
MM1+"C1H^L:M$U+^(LWIUESRKV'^TF-=&KIPVFA7,N%G2>3>.%19*1%F]?9<Z
MCX#/X[F86A+KV>L94&2'E&5,0*!&N5DT)JO-1IQ.7&4UVYV\D07(6A4MU^6O
MZW5)^E/-L&:5E0JU0?1?]FO]M#$LO9XG+Q_9 [&>SCLMP8<A.BE5=R(WUOH]
M43KW$_)_[O.]YVVV8Y0WHUMNESS_ $4M<:W;;K4;;"OF65.11*#;JQ8JQ8A)
M6FFZ]3)CXKCHER'R4/DOL2>/-/O(74=!:@7B%=*?6*O2F[&.US6!Y2W5.DE)
MARI -2DP[JRO6Q]?,D94F-RS?JJD.3)*?JZW*DH=N%D_@+BIMZOQS4[!#[8[
M9P"K1;3EUCQBW7$56T'$@0!NX9O;9X\L[!CQ_P!16]R4_P 7+0V^DE7 .59^
M6*#_ #>8\QTP3H#EH*TA&4RF0KT#/K'#BE5SY-:43JXU;LMOZR[7(W%M/\<_
M^BW_ %.\E0TS0_0AW/))X;7[5H^B00X/**9RDU%HCI^QDC&IZ'9)<)UYR5.)
MO-,QX_XT*+';;B]=D&+P0S%) R8,:G8^1)MMO$BL@['N5:-U':+%4*>NR]JM
M,/:J"LD]L],%PXD@B],>D.+[(=<=4V!L^4!3(EG%A7GJ-$ED;"I,/(@!L-90
M%7A.(,(>AR0%CKL A *-*28AS8;3[,I#B$JY?YN85N<*,ZO91]TTZRF[7;KI
M:+_<!=8"TR':+78[F=/F"QQ%7KD&$I];WU+9BM\5\_IYWX+:$,I78UD,:US=
MW_E8;0H'#V%RAF,R):"'JZC7:V%L%@I1Z5$*+BQ&FR:U\D2D.R4(>2),HJUA
MK)X+8M2LL*QT+2M-SVRKE;;;V[]K@F;8:5;P1DA4] N3#1*>&??<%=F,M.MQ
MVULM*0]1-$KT>S5*09J-@>#2),^&RLQ0[<"O=2F_?&2X,Q*PULK4&8A/'.(<
M7'XAQ*VU+0JL:;/",R+U3:W;:C6K J1-0^*KEZG54E;!C45N2@>\V8G4@4XM
M;K+CK?8B>-J1Q3G%FA#64J[73%?L5.9J;MWT%^GU:CW2X"KY?*%GM4>M2P&;
M430K.#BNGPX&..'F8S*84MIV"GD;F5Q@("DUO)1GJX=[9V(<ZY8YEGMN]T6"
M,509U3%N.NU4 ./66"T1L[G^YR8N(KZ(RY!&9+2S6+:]:XD*(9&6&!/I-\N^
M;V,<9#NK='S8-IS^P5JPQ^-*<5Q;/)/V'T*ZAU"T]^7QEX*'E8Z,,R CH9.G
ML\-69]V6[KT0A#UV->YDLU(FZD-U=)1YVRQK*X68.2OHD3$O/MMN)NE.[ECA
M4-?LMKV(V%=DO.AV@PG(J88*'Z%GH*PV&UDCU6K6>&3#\FOLC9$3H9]7%Q%-
M+0A2>:T#A7(=>9,*NQK$0C:CIC8R^S:E5DTFN632ZRFV\K&D7$754(A),&X<
MXDZRRQ]UYSL:-UFO PV<CX(JJ8K8_.U?AH*V)Q W&+;) R[%1FW'S#KSL(G(
MK,%2I+BESD=C\XA]/%+XH7?*#6C],,C 5.KSH^MZ+HXJI6"%GM+8SJCRKG2(
MML14+N;J]%B,"XI$O"F3OQ(T="W5_BQNLY_4D9@%=K.79G>,;HP.;+-$!P7,
M=*%@@EZI[D>>4DH+C+()K4)A_L[\E[[;'R0M/UK^I'F4M5%6S$TTGF=.4Z\G
M;%=U2J:W'_$AAYMAM14M9YOZ7%2VB'(=FJEP_L,]9=0IIM24VT329Q"ZJT"N
M:K/O=LNM[NMX.Z)4,Q+XS6;99K;;;,9.V4F%RT[)",<G/OLHAK3SZ/K;;6BU
M:;21%@KAZ[&K!:+*&&WV^M9X1M]L[#5:KGS+5656<1+?97![3DXDR+;ER7^N
M/+7UY]]QW_J3XS+;=;Q5KQ(;@EVOM:*$<CK.468%MFX#LZ% 9HV[@IVNZN8.
M!!YAGC-,>AQ@SW&%/3.3G6H_-@JV@Z-;92/&P[8JOZ'+5*LY5&OIZX[GLM:H
MO@:0N/:(HZC4=TKE5L19I!*>F+7_ /A)ED?D/;?[W6Z!HEMKEEAU>!^ZACTT
MC8/[([_<9%7S_P 2TK1PX^;I](K02ON&*\4O<N*0E@(XY$R$RS&()>>9>6O+
M\6IEHN#]2<U/.?'6NT"R&,<$4LU+T#S18=(.?V=4O@-W?394<-EAYL>V+FQJ
MY]?WFH[4V&U*<^*GG$+TQ6][S+1/V=R6IZ!6H8&ABQ6"6;.PF)U3/_T1=>9C
MG@=6OS-F,@UA;"\2(K(UEV6U(1UH@URX5I)@0S2Z;Z=VO%;MD9JZXH ' L3H
M%-(/4*^U:DK2_P"BRFIV$\D/87I4GZZ^0KAU?&&V&6HLGXSB@YG<;3&"C/4F
M%>5]2J-O)8^*I$^7LU*?MY%^E9_($J]!6@\+ 6 42BV7DN)6V9<=;#31",P4
M1\>CA9[5K;KY2MO^] EQ<T*PUXO:*O,"Z-M,&14CKP4&#E!WE#(S4U4:>UU^
M/R=W[/&H?XS#1;"R7H6VSJ[9?VA\B]*,GJF+IU,LF;6/.R.<56QQ,Y)  "I
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M]KSUW3?8-$P^"171\N@CQE+!DZ)<U?*KVJ41-QYT5''G8\ULBQ\&?+AKTH0
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M4,%SX"!4X:/',0D0X0^:+;3&=9;0EMQA/&U<ZCG.?"[FFEU--P=%Q CEK37
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MDG[3BUIXE7>]Y\?YI?.?_P!>[,__ ))_B7?*5HM$N%''J*)GW.K6ZOV"J0E
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M3E?1:3G-,5<*]S/NA%N\908Y<^D?X<Z+6\KB.2/R?L]5WY?5\_C_ #2^<_\
MZ]V9_P#R3_$R[431:+=:8/>)1Y]NJ5NK]DK$&0&1]TNQ,/AB$T5&>%-]^J2E
M;J5,)_E7Q//A#K7JCS@ZTZA+C;C>X9DMMQM:>*0M"TV?J5H6GO.\[SOR[SX+
MN97J.=:8W7W8;!Y>?W:M7- 1\BV\\/9+JKA,DD:[.9C.*92]]'74MJZGY\3W
MY3AA'TWY[@$A<Z8,)CYNSYQ%G#B0Z2[#(#YT1^R-OQ)T&8PMIYIQ*7&G$*2K
MG%<[SXDU[,]IR;13\,<X7E@Z+HU/MQB*):D,1'2DD97S)":P.;ERFFE/J1QK
MCCB4]5\U<YTG4[GZ"Q"HVD*ZRR9K5GU>A@+ )>D16)L=HF&*GXA& Z_"DMO(
M2ZVCJFG$KY\TJYWHVITOT#B-OM1IQ]H/6JOJU#L%@+.QHKTZ2V-#"3TLC.<C
MPHSCR^--KZAIM2^_)*>]Y'KNF;3DN=V"6.;+Q 5ZT:GU$Q*$NR'XC12.,/F1
M\UX<Y*BNM)?2CK?7&U)XKYI[SD 6-]->?"!,K.ABQ@Z#L^<2YQ$F1DM0QXZ!
M$8LCDB9.G3'D-,LMI4XZXM*4\ZKO.? A>J:EG69HL#LQ@"O0+O6:8@V\.;9>
M(,B%6,F-X2=@M26U/)9^OK27$]5\N*Y\UNN^J/.#33:%....;AF2&VT(YU2U
MK6JS\2A"4\^?>][\N<^(=TONB46D4X@^.BP+9;[=7ZU69TDPWUT3'AGC)"$+
MDOE&D]5&0AU2GT\^:.*Y\?YI?.?_ ->[,_\ Y)_C^UKFD4+^RO@KIWNF?QA7
MO[/N!..=9Z8_C/\ 4?X<_2N/<^CLC\G[/U?R?5\_C_-+YS_^O=F?_P D_P 3
M+E0-$HMYJ ^00AS[53[: LU;@RQ+:'BL68<"D)HR-(&,N)7(0MU*F4JYU?.<
M[\(=:]4><'6G4)<;<;W#,EMN-K3Q2%H6FS]2M"T]YWG>=^7>?!=>5ZEG.F(K
M[D)D\K/[O6;FD(Z2;?='-%U5PF2X-<GM175,I>^CKJ6U=3\^)[\B DIZ8\^C
M2HF?,%%1A#9LYAD!A0=)<AD!I"%(LC<F%/@2V5M/,N)2XTXCJ5<XKG>?#]<S
M3:LET2PQ1[A>2"HNCTZVF8XIE]B*\3?%@#)":R/:E2FFU/*1QM+CB4]5\U<Y
MTC4KOO\ B=-M0?L9):LVK5:)7K +[,BLSHG"(4N>ADH794*2V\W]UM/UM.)6
MGYI5SO1E3I?H+$+=:33CS(:M5C5Z&?L!9Z-%?G2&A@84?ED9[C$*,X\M+3:^
MI:;4OOR2GO>0P&G;/E&<G2 [AB %OFBU"H%IPE4EZ$DI#&V P/F21W9D9QKC
MZ$*:^ZVI/U?4GO.01@[TUY\GDBDZ&,&#X6SYQ*G$21&2U"'CH,1BR./RYTZ8
M^AIEEM*G'75I2GG5=YSX$O:IJ&=YFR??E103N@7:M4QHU)@LHD38XERQDQJ2
M3\..XE;J&>K4VA7%*YSG>=^''GO5/G!III"G'77-QS%#;;:$]4MQQ:K1Q*$(
M3SO>][WG.<Y\12 ^5&G0)T9B9"FPWVI429$E-)?C2HLEA2V9$:0RM*T+0KJ5
MI[SO.]YW_9/9KKF?TC4\ZM+$:+9Z#H]4 W>E6.-#G12D2.>JMF@$P1=B*3@L
M2&T2&'$H?90XGG%H3WG_ -CZ\0_Z4<'_ /D"^)V,9MBN2Y[CQ1FQQR>3T?.*
M=4\U(Q[BJ6JW,3J*!#0*O+9M*I[_ $DER*I,[KSGWN+^M7S:88_;V\.L,,-H
M9999\G8*VTRTVGB&VFFT4%*&VVT)YQ*><YSG.?+GP>$^?,(QK"A5J)1C-G&8
MWE](S$?9"\.$V-B%3T.D@P<8P2BCF41VWY"7'4,IXA*N)YSGQ/)3_ ?BF:1*
MD)Y8G/E^5\+DS2)4K,>(%"<^4]1%OS"!*?)<??><4IQYYQ2U]ZI7>],6G ?,
M7GK#;-8A+ "P6+'L6S?,SIP%%F?J,8*8+TNM!"!,3'(=^^W&?<6RA[_?XGBO
MY?BQ:#HOBCR1?[[;R/"]MN]U\WXY:K?:"W(L:#PG8K*=IL\R;(\@PF6?O27G
M7/M-(1]7TI3S@O2<>\?>6\HT4'&)PPM^S7S]DU%NH>(;AK'&8HNU5>I"SH^,
M7'N*8E(:?0F0RKJ%\4GO>?'= V_R;YHV2^=$0 ';MJN$9;H=NZ!%NS) P)VR
M6ZJES/1 Y\A(6Q&^]]EE;[G4)YU:N]KURI_AGQW5+?438VRU2UUKS+BH*R5B
MQAI+<T0?KQP728I0*;%3&DO1I49UI]AU/%(4E7.=^*[-]!^=,(W:94&2<>IR
M]DR+/]/DUA@TJ$LRQ77[M7CCH5DLL;'[*3&ZUQ_L=OJ^*^A/RZAS]O?P^XA7
M/DI"_)^#+0KG_;\NI50>\[SY\^!=%W/%,DV>D RL$Z%IVL9O3M%JH<X,ARQP
MTR+KUO#&! \J/'SWV&)#3*'FF7G$)5Q*U<[_ /8^O$/^E'!__D"^&_.Q7$,A
M)>?F0(RJM860S6F3,<:JX21$EAJVWF4@*Y2D 1$J P[%A\@\CQW&6U(0GJ$]
MY_\ 8^O$/^E'!_\ Y O@CC>8XED><Y"838D%\KH>;4VH9N41;^/IMB2-'KX8
M?6)R;0F4[PCQV*KDWCBOO?7]7?FTPQ^WMX=888;0RRRSY.P5MIEIM/$-M--H
MH*4-MMH3SB4\YSG.<^7/BPC_ #W@F+81 MT^&4M<+&LMHV81+.3'1.P!Y&PQ
MJ0"!LFI\"!W[#+TE+KC3/^XGO$_R?$\F0\">*9Q(J0GERA"9Y7PN3.)%2LQ\
MB4)SY;U$6_,($B$EQ^0\XI3CSSBEK[U2N]Z5MV!>7_.^'VLZ&17#EGQ_%,US
M2PF:\W.:)H E35+K04D1#(),(D<BO.K8X^A+GT_5SG?BQ:%H_BGR3H%^MY!)
M:V7B[><,<M5OM!1$2- 22L5E.TV>:-D$P(3+''I+[KG&64(^?TI3S@C2<A\=
M^6,KT6OM$F0-^S?SYDM'NH1DS ?%%VA%IK%1%G!K147*<C24LOHX_'<4VOZD
M*[SO+]N'D_S3LM[X(@U_EUU;"<NT2V\ C'YDD:$Y8[?5C!C@@?)(R'&(WWOL
MM+?<4A/.K5WH&V5;PIXWK5IJIH98ZQ9:_P"8L3#6"N6$+,:(!CP$R.I$8B'-
M"9["'XTJ.XV^P\A*T*2KG._%=D>@_.V%[M(IZ"C=2?V7)*!I[U70<_!Z:177
M;M7SBPB"_P"F1ORN1NM<D?CM?<^K[:?DMIW]O?P\ZTXGJ'&W/)V"K;6E7/EU
M*T*H/4J3WG_;SO\ )\"\\VW%,DV*@!"8TV%H^IYQ3M"IX@R&ARAX<N+K-M#%
MPL F)@3GV(TAIA#K#+RT(4E*U<[_ /8^O$/^E'!__D"^$>=)^'8_.\^-@(-5
M;PF9FE+DXVW5Q<B/,&5M&8/!5TE( =+B-.L0^0?QV7&D*0CBD\[S_P"Q]>(?
M]*.#_P#R!?!+(<KQ+(\TR8RJP+,9?G^;4VFYV57;$.-VI9*E5P,-K4Y5E;=6
MDAUV,OLQ*N\>^OG>_#4>/^WKX=888;0RRRSY.P5IIEII/$-M--HH*4-MMH3S
MB4\YSG.<^7/BQ0_/>!8KA$.WS8!&VQ<:RNBY?&M! 7%<@C)]B8I (&T;FCH3
MJF6'9/'5LM*ZA'>)[WGP2+E/ _BPD6,DR)HP4G^6<-F$2I@Q-?)%BQ*;(HKD
MF<3*$93LB2^ZI;K[[BEK4I2N]Z4M^!^7O.V'VPX%Y6S5HR#%,US2Q&*[R<P3
MX *&Z960I(@%X2C-R/Q775L??;2Y]/UIYWE@T/3/%ODS1- MLQDC:KS>O.6/
M6VXV8A'@Q!;$ZP68_3B!HS,8&P&(Z'9+[BTL,MM\[Q"$\X&TG(_'/E?+=$KJ
M"+=?OV<^>\DI%T!(+CY DL@-::S41AP8@H+ENQI'&'T<?CN+;7]2%=YUB];I
MY4\V[3=XP:)7(UQUG#<PT:U1Z] E39T$"Q8;A5S)=H-"FDY+S45+W&&W9#BT
MIXI:N]!6JK^$_&];M%6,C+'6;(!\PXD'/UVPA9C)$,>!&!](CD1!D20CMOQI
M4=QM]AY"5H4E7.=Y6^^A//>'[O\ P:LJY4/[9<GH6H?PJX<1";-KK?\ &X Y
M^AK,-C8R978OVNR$QV^.?5Q"?DXR_P#M[>'GF74*;=:=\G8*XVXVOG4J0XA=
M!ZE:%<[\N\[SO.\^!V;;3BN2Z_G8@B),":#J.<TZ_P!+%E@$=^("*#JM; Q8
M'"(A8LEQJ(^TPEV,VXI+:D\5WG?_ +'UXA_THX/_ /(%\)\Z2L0R"3Y\17HU
M13A,C-:8]C::I">:D0ZPG,' JJ3RO1'V$+:A?@_C-K0GJ4<[SG?C_P"Q]>(?
M]*.#_P#R!?$_)\EQ;)<NRPJ\=D$\TSK.:=2<_)/VE*TV9^?3:T&&5V8]8DN*
MY/4Y&4J9Q7?N]7\^_#4>/^WKX=888;0RRRSY.P5IIEII/$-M--HH*4-MMH3S
MB4\YSG.<^7/BQQ//6 XIA$6X3!Y"VQL9RNBY?'M) 3%<A"YUC9I $&V;F#8;
MRV8[LGCJV6E]0CO$][SX*G#'@GQ<6-'BI,Z<,$_+>'3RADX:G2"ADR5(2J*[
M+(E2Q*4[(DR'EK>??<6XM2EJ[WI.XX'Y=\ZXA;C03M:,VG(,3S3-;&6KBI\8
MIVODSE,K(4G/"=)PF9/8CKJV/OM(<^GZTI[P_HNG^+_)^CZ#:Y,>9:+U??.F
M/W"Y629$@1!426?L]AIQ$V8DQ1D!B,VY(?<4AAEMOG>(0GG FD9/XW\JYAH=
M:[.[7+[GGGG(Z5= '2@^2()]"6FMU 8<%=(BIKT5_P"P^W]Z.\MM?S0I7.QK
MQNWE;S?M5UA!H]<AW#6L.S'1[1$KT.7,GQ ,:P7&KF2S :+.(R'FXJ7N,(=?
M<6E/%+5WH6RUWP?XS V.MF!=AKI\+Y?Q$6: 6 ).8)A3@4K!H[$X48$$HK4B
M+)8<;?COMI<;4E2>=Y6^>A?/F'[ORFN%'JAS9<GH>H<JKQQN&R:=K?+N .<!
MN&&1T=,I47[79"6&^.?5Q"?D['D?MZ^'7V'VUM/,O>3L%=:>:<3U#C3K:Z"I
M#C;B.]XI/>=YWG?EWX&YELN*9)K>;!IP<H'SW3<WIU]HXHG76'8M?(C:G:@Q
M4#!G HKZVX;S4=#D5M:DM]3SO>?'_P!CZ\0_Z4<'_P#D"^.><W,.Q]SSWP W
M5.80O,Z6K&N59J0F6U6^9@H)VD< -RT<=3#_  ?Q^.<XKB/GSY_'_P!CZ\0_
MZ4<'_P#D"^">59%B61Y7EYJ2<FF<WSC-J;1Z$6F6=GD>RRR=/K 877I\FPL<
MXB<X['6J6CGR=ZOG\GPU'C_MZ^'6&&&T,LLL^3<%:99:;3Q#;33:*"E#;;:.
M<XE/.<YSG/ESXLC/GKS]B6#LW*0,EV]K&<IHF7MVJ4%8E1@TFR(I $&DY($Q
MISS<5<KCJF$/+2CJ>+5SI8Z:\%>+RYP^6)GCIDIY<PX@5-'3<Z04,FBQ&71G
M9A$L7)RW9$J2\M;TA]Q;BU*6KO>S;K@_EGSEB=R)A7JT1MN1XAF>;V8A79$V
M(2? 33U-K 8K+"OD1[#ZXKCJF%/,-KZGJD)[P]HNH^,?*&DZ#:GXLJSWN_>=
M<@N-RL<J% BBH4D]9[%3R)LP_$%P6(S2Y#[BFX[*&T]XA"><!:-EGC+RCFNA
M5=Z7(K-[H'G;(:;<J[(GP)0J<^"M%=IXXV(>FBYS\9U4=]M3D=Y;:N]0M7.P
MKMO'ECSCMER'!6:V/MNN8AF6D6>!78TR81C@(1ZY5@R5BA6"!"0^B*AU+"7G
MW%\3Q2U=Z(L /P9XP#'J^6&'P!L3Y=P\<7!G0DY@F&-""4.C,S!I802BM2(L
MEE:'H[[:7$*2M/.\K;7H7S]B.\-4U\G*J#6S931-0;JDHVS$C&9-;1=P)Q(-
M\O'@,-REQ>-*D(9;2YU7$)YQV/(_;U\.OL/MK9>9>\FX*ZT\TXGJ'&G6UT%2
M'&W$=[Q2>\[SO._+OP,RS8,3R/5LQ"RPD\/G.DYO3;U0Q,ZM,JC5R:,J%H#%
M*_ EU^.M3<)QJ.A<1'>I:ZGG?E\?_8^O$/\ I1P?_P"0+X_]N?,.Q_GGO] [
M4_[">9I2^8U_"RI'9:JU_9AP+_!'Z J5W[O8?X/XW7/][Z/G_+\?_8^O$/\
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MP@5N-'8@L]5]+:>K5S_JGH+_ -1O.7_/2B_%+_HE7/\ P>'_ +/J?^DF ?\
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M%PH%KUZH>8;TBN4#6'[1F5^TO,+5;D%3>UM+CXC"/5I+(9UVH\ZHZY!+M/\
M7HSKD5B12:_KE,SJSARO[7$;T+0DU^^Z@'M\965!<FJQ>H:7?H)2.?.EK>&T
MH.438 BPTF)-1.BJ9?\ H9G/:IHMKT%%=JV?Z%^Z\>G&;[8+-*H@1(FT^,(%
M22>%P94F9*$PCAIN% @P&')O79_8P]KLB5QMRO9+7JGE[.H$/5)# 35SO&>;
M/E]9&TIWR3*]3C=(8Q6[DA^HI-C6FT W04XE 9).=Y+9(QVU*:9K5:IN& 3^
MP5?%]4UO5*;5:AMVM#] ,Y1O]]\^IS/()6:5J>2HLS2C64G" P[:F'H(W[P^
M$\Q*4[*E1+#K!$H'H#L<$%6'7I >QD8P^UV^:+!5&MF:K14%+>?/$[0<B#60
MX9,@B0(O(B1?K>=1\\_Q2A4G)Q>@G-X]3XU:M$T2I:S4*W"#X#G-'T>L7P?A
MYHH(T<7+N3.B#8$D$2-M.1/D[-:FO,_9:=W\EG%'RVCQ*=^W0:VS:&K%;[E%
ML,VV:; WRDHJF-V\,P*@U*!5&,//%FK&2:GN/R) ^%R%%<Y,F1KB2J5OMU5-
M/5;!0;=LJQ\S4[@R,L^F9=6CW8-B#SHQX+.+@"\F.Z_'DMR4)D+^EQ*_DKXU
M0-0[3<=1SDGY+8U\3A&D:19;>SFNP<WW+?/^93A6D7HG:+=1\NV IJ3_ .KQ
M)#T^'![5)<T;';7^6P^.\W&Z;Y[LVSGM!\QP@]^!OZ(%S&/F/H1C;QALX7I9
M"<7L;-TS2U8*6Y'&I/?9LPV5%>0Z.7R6B+;Y.B!:\&T/+MDU?#[PNG*(_P &
M'CV6VV8 _BJI1S,F8;&A;*+3&E\A3'GY$%]UR/UZ0EI,AVTUG:]<N]4B>9[U
MZST+$LLG64FHGZSKHWT/K=78WBS7.)-9<N&2X3^6U2Q^>1G>.5LA&C$+"VM$
MNLMQZ7H7IH;Y^RVDZWXB.>OJV>"F[JZ*R&36)&;1R%+TPD4^^[>!96+KP25$
M(AX@R7R2W*'(@27>QI3]3Q&Z5:K+*/;B9R^TVAO/M8QJ1,!2?(R/3-7+ <MU
MMYZ^5\K!*\>"$$%>]8E,L<EQNH6XY&CX!:+;5LZS##=)M6GU&R[3/$WJ^4B3
M?*KZ@.812\BZ>K9$?!Q,]=:V+9GC[-:N2:\5/RVPD=*):V>/:.+V2!4Z%K]
M-"&+GA8^LW.N77'F+ @NX%&VPA:R9 7IP0T@.^H+=*XEFMV)N-)[$0E<=]MO
M!\XRH-5)^G^BM:7F=7-:"LRF@TL< H-TU6ZVP_# KAE++/A4R@36101B<-<*
M$Y#*52X[#;[J*7@L6F8J)/4NW^C*_P"E[>J7<R%?_"\]77!Q<61BHIB<U)D3
M=3J6\0G_ +1B8KM3)PI,:1PFE#2W\BR/'JJ,.7_4*ELNA_J9[/=AU 2/K^-P
M:;'_ (?9IV)!B=P?+7BWZ,(@<**6F"!A<DS7V9CB8T&5@4*%4@X]%YL/E&D[
MCAY>B:Q.U'!;;ZEBQW(PG0=>&0F<>H=JHZK&'?\ X8+1DFB\-U3G_<?R8/'X
MWH\,)RX#3=(V7S*3\[9^(.W,3?6&U^S,GKM8_MFT:$2E@OQ+,!8<D'1 H0VH
M=QYP;V1.ZEQQ>\9UKD"EMW_!]5B46:?SN.<'TZXUVT9S1=4IY^$$LA(R:KA=
ML#>VX)*"Y.GM(FPUNLR5M/)0W+TM%+RM/FR%[95XI= =(V1W=E$$:BG %ZVW
M(:E=K*V4[0ZGG*AP7TBNK<Z3X1^_WD#X$^A-TRO)WJ[H_D#0?2F>4K+2URE6
M&L6FC7+):@.S^Z'"S9"-; ]R1MP6;^JB1T.4*5&F1>0""N1WW=7KNSYU-K9?
M-;17Q8'18&8:IDN?ZT$LE1%V)XA2ZGLS#%[BR*6;DRPQ)3BI,-]V,U(8>Y]]
MR+%N>BA*=E+?G2D>U GB8D&(R[1*VZ::*:=7<#G:Y!=&SE5CL 5LUOA_8J78
M'2!*KL.D$DV)#K,'INW:>5JMCTW2=]]%VF\VNLPK)%Y8S8S9[K2$RR:[+9[-
M(?[ A5)J' 1&<C1(@>-#BML\ZPIUSSBW8=#SZSZ>W^X?^X+FM7)N![A7<UKF
M4T3,]G"Q6[3315IZ4T1=0( VVPPU1 >IQI3'7YZ'V7):ZL*HN#B+!I]9PRV[
M'JE(K%1VS66]!-TK>=%P567Y"0S2KD'<_EWDGCEA(C#UL9>@Q%/#8#T=[KTN
M;#,":CG^#=I!#W(>\-T^08*727:!D]K-6+]"VZU)ASQX@D+K<T<4&SJA#['E
MDNH8?9,P_FXSQFSW\* !7VOWS5\MNT2I22$JHS+1D&G6W,2QVJ+,<X89KUCD
M57\^+'F?5)B-R>,...J;Z\YIX/$:+3/1B)6%VK=,*,T2A;#3@QL'3=RK.7V.
M(-GWOL.#Z-9'4JY1['%F4Q^ P:D0'1D+Z^SX$U<'5Z>0J.R6=^OW!P>Q38%B
MRL%:;I5")T,Y39 /272EKRP\Q8PW1!<>=^Y. %&Y#$M'UL+1\>&7PT^AUG>1
MMG]-5+6Z!8:9L>?5W"C$[S/1KURFZWEA^TQ[-HUGKYDHSP*1B$8 &SA)39P5
M);BNHXYF&V#ZW2N6%K.JCH6V8;%IFOW>P,#3FZ+P^43#ZI5X4?/\@IY8A6['
M-KY6WM.J+<$K9Y&0EF9)CS8TLV=FQ.'_ -UI/(4XV6FP>)&>T_.L02GD*5,>
MB\2&A2'8\+GT?*''=6TQ]MM:D]](7?'(F;&1&2?MZ9CM=OKVHV2TLPK'"I>M
M>E2<VJU 37ID>/4#]FKH><ARTRF2$>,_'@L.P9#?U+8BALXQ<]:<+:W&H8+8
M.P,NUJ9?JTNRXU6M2+[59]'A0'\-K%'IIFY#@TP#(EN%G65.STRD.<:'.Y!9
M U*@W C$SKV!?X*"%RM];CL$,>\[6'1!XQX0"FM5ZQ1K-+$IA.J+1I?!R'.R
M8B42$\5\3,DWNM9D.L)CSID7I6JD<H<LWZ0(#Z(3L=;LF<V7^*ITR47-U"PU
M]/8AJ(F)&+PY/5+@P7&?H>K=%ILNFWH&$OGGJA;32QM$U4Y<J0YZ(OT>CUXV
M;U@$A6.YC)AQCXPM!"'^+('(7W/H7$1(AO.98J?MN8N33?[O>H8(<>CYB:2Q
M/PJM$MAC-T)#"[OUQJ/"[4.\BJ2YR5Q#$7CTIQ2)"G]5VJKX5T_C\7*_8M[S
M&7(H.NU2)4S'EV<9%T@-L^OGQR<J+\]!SJS/:BM5=R3)KLI+,?O"O%//QR&-
M7"EX5/VBY7OR35,HLP&5=XV8 6/44G78I7FCA2))RR&9>2KPBP=9<&D(*+;V
M2.0EL.MY[C/K&/.LF=KWF7[7]62!-,=J>X[M"NE;QO&\N+3/[.:7F<B1;J+6
M''YX1)602D*%5.49ZTYV=(=C)E7O6*IEF4#L7RFE>&= LX$^>LI/2[<-];5Z
MM6"VUZMFX#HBIUDEEX^UQGH4Z7$(1SKB%QULP.?*7STKZT(4[-%X-D%TV+*,
M\SJ$S=26R7&[9ILJO.P>QW"P-R(@6I +'JPR>X^%B "A:$"Y'>0[)FNKA-ZD
M#V//I];-9O<A8,'H$3+]1R2A:Y7CM1"69L]3*?LC3-]&OU<L1EA"B'E2HBI<
M'CT>2M+ZF(UDRG+CN<64'?:UZXK>6Z(*S'7HX3.=0\VT)@Z]RR:)898W,]I^
M=CB&!9,=57&'0D\9UMQ^4IJ8W&\[7#3;17[)JUSP?.+2=ML&OS( @F>LM)%&
M(Y<@!_6?NNRG.SFW""8\F(U(D?=ZPF*VM#;?[?UF5?,NN^Z7;#_W!9=HM]T&
MW$)F:!E7U[%QE-Z7H53L,>99SBYL2*.:FM28?!8^1(>2S(<1UJ94GLMP(E:Q
MX/*/'.D:SGU<H&MZ1>3<KU@PP8*A\YO%+#ISFFPL<ISBRS\VU]82>^TZPE U
MMO\ -7@X?(@%),V[;_1%.Q)1#0'S/*[30EAJ-^M9JZK%@'X)*S304.E=ZP+3
M,'IGK<^UV7&YW[R NH;CEN5*STB,]O!)8/,CMF7;H]J\/!]$,&+I$,6571$F
MH[(SDAKD$$Y"8(UGLB#]\B4^J1]D2N[9 -AVW3[QYJIV37R%BOI<7G+13>A-
M_/7>N.T"S5L=IVOGL'#YI,D./59QN-:V"HMU' W')28N"DK4"&YC0I6%>^I.
MS9(=I&E4DQJ!K 2-. 5;1:*6LTRL7^CTN\CS,$I7TSQK!,9")S$R.S'N0Y#4
MBS@\RR,=BN(UG]ON':Q)2T:'9M*M\+U11<QG6J/5K0:+<8%2\J5H41V)+._K
M$BRI9<;DN0G>]EKPD\[4,3C^>=_]9^@O-8(=PA=HVV5,+B(3=8XB^DERUIK%
MC*7RXX,0_+"L08/*V+F1UKF$'_OH9_Z/07_J-YR_YZ47XI?]$JY_X/#_ -GU
M/_23 /\ GWG7QFW] :?_ .7AW_1)H^C5V':ZG++U4])"SURFXKI>D6L)>*I.
M4N%(BR..A;77(4UKG%\3UV.GB^*1U2>Z_P MN=!C?]O8RG!]?_*?*(_CH9G[
M3[%.B%?QR#/V6P+4E:6>QOL*[Q7^_P!5\6/7JE4Y5;NMN+F+'9?T6VW4?3S-
MIL(P0&L-PFYI&L3>:N70^- Q&YQG@CA29]A*GGUKZI7:G*U&H?Q 1HT@\]5#
M$ _:*F>#Q[8&<KUO#-'J<;KYF16+B"<_#,B'GW!9:,E#<N.\E".)LV9CLBK,
M"@W#*\]Q"Q56&HI&$D,FR@87"YS1>,,D4*A Z@)/2X\-$?K2T,O?3U7>)1],
M#9">3BY-_%:@/VX9._7+8R!&[,-K#E*9UF!1HY]JBP])E5!WHV8<;&I)3X7R
M9DO/(2GG+!2A&:<C4:R$ 9*50W;C?YM#$/UO0^:N#8I=)GVJ35<]&#]$YPJF
M$!B#8:I'.<4TI'.(^+#<]!H';F;L]:M=3(,V2V7<M788B]4UO/;DY6:;,LKM
M/IARST=OHJ<5#P()21!<=:7(ZEUWBZML16+E=4SVF;?2_1;+M2[I3NCW;3*%
M1/X.K\NS5LW9Y6,A3CO'>,D[5 $+L90%"CC.NL(^I_F;5Z'DU54 R&IWRB9X
M$G,RRHBO4[3X$<5H%:_32LN9#+"+8-BML3&9R)*7&N=3_)SJN=@9FS1CJZB$
ML=+MU3CS-4UT@<S^Q9T/0'H9+,+A/ODFXY:NHAD]A#T5V>,:BPG'(Z$\9=<0
MHGCN$A:I4*_4[":/'*/62GYKU?LVD%)U_-DCD.00(%!Y6YECT@NXJ3U*YCDM
M<CGU?<ZKNGYEDU(JF>6'0\^<R**>L/+7>P58R,WIM8TFZ936JR=LTF%4LSL9
M"O\ 5< !>#A,>2XEQN.GB>I[G RK@H=?&A?3=+]&Z81,F[[9;[?"5!S:X4.G
MM0--(V]W0JX;I:RPE5?E,$TM@88I,:"W';4GB:'0$9D@6%S$S;+'0RU=MU\J
M^@5NP7]LRUH1R'JU<M K4'2^B)L,WMADO&''CRY*U3U2%=^?*H:JF>YXW6\U
M_LSAU&;7""D5NI<\PE[\SG40?T65X'A?V6'KC8D*;[S_ (<R5*Y+XMQ/?IK]
M[K]0 E(Q;5E>I:O=Z?:#\19/2;C5F@LO1@UIK-@BOS1MUI4E,29%:D*#%QCW
M6GX[S#G4J[4:G($5O6=Z95/;AV>^66YZ;H@?*A"T,QX9&^6.R6Z93<W$F%HB
M0F7DB0_)ZTL-,JDJXX&WFRBX W1RE[F)IIR]Z3<B80?INFP6JE)7G%,N-OGT
M2JWJYC4]&I6#&Q)\IEYYA'>I?>2YG<C.*O$ET6KR-#+Y;8LTUS2!\8*)U4O^
MIZ)6Z9<*9?HD^+F5H-1$.2*S$F<K27HS7VX2/L-\1>-9*YA5"F@:7D0S!= L
M!*"J?_&./!R5E+0*!814MUX*3!(FV\C]Q+L93K[4G[+JULH;0AZKYD,.B0;J
M13+<$[>[]?/P80$1$  Q(B5?[/:)@0$&#0&8T0?#<8A1VF^<;:3_ "_"].M]
M$E-Z#)!CJP7M]-NV@YF=L];#S7"(8!=)V;6JI.W@*&F/NJAQ3'YS$3C[R6DH
M2\[Q?-<)YE EWE-^%:NW*<-VI-?9U8+5%T4=J<>C-G446-IK5+7^E+L+8U)A
MX>E##DA;:$)2$HQ3, <RIUS$BWG ($<D%^11^(G44ULOGC*VR2)"@\Y&>AN*
M6I:I7/P&_D[SYK^KH+4J=FX^7Z#M&F4R*'LY>7'EZ5<MXD4ZTZ.)!CY!9+\^
MQ6:9D04KU4)"9 YX$S+C*C*9Z[\0K'5<^8CV>%H)#5^VLM8+9:+:4TLKF;F-
MDKU9+5:3QJPVRT3<O<_1')A.3+>5"2A/S^I"%) &9]!;K3E![HY(;8JQ>+YG
MI2"-TV[O:KIHPW8Z?;*\4-TRTWSJC4\03D20ZIB$N_CI^A/T\K]HAAM%R^]P
M*S9ATD88D_IY6-%G"KC2K=5K16B$,A!FCB<&"5$%ADMF3&DLL2HKR'$(7R-H
MX.@URI%*6=U'3I-^,GC4DE&LNG@@H[7- MULLQR;,-FK6"J<+]6*EY$E];</
MCBW>=XI70E7)8I5S-"1G)G-F! NQV^'7;9D]PL,F]3Z-;FP5GAQ-)H,NTDG2
M\4<:Z2@19SZI,5MIQ?5]/XCJ-48M>7V<4.#&JN^1,CDRH >:/)">,EPQ$:>'
MS!A$5&D1Y,:4S)9?90XASB^<[\:L'J=$I]XJ7H!149LYLZ>):V2UU,!)2J3Q
M%]O]R.6VS6^-7U*G06HDPB\V+=5(;90RXIWG8) +FC,@X/O]1U!FUV:TW:[W
M:1=Z!3R5 HA<I>+I9;!;S4>ETPQ+'"H,R:^/'QI+J6&&_K5WMICT6N0JXS=K
MS:-*M2(2Y3G#-YNL[A*TV.3^5(D=3-,SN?<<2W]#7.__ $*$\_D^,X@-9F'A
MHR+2+OK>:RQ\PT/+4Z_:83N);1S @W#)L&$1+_)T T@T/6^L:3BD78TB.Y'^
MEI(*@G<GJY>FUK%BWG<%72*)TL:-Q@WRE?J-$89>FK[T>MS.0;C;ZNJFQWAC
M#K3R'$]5TI#_ +/"/"!K0ZUK9>Z<TC4TZB2T^H5!S/J]?YNNINW-1D6R%07G
M :IRC'7Y =Q<)Y3D9:VE9M41.1CQE'R7K2J-G8^RW:'FD)R-=GM)A/&\VCV5
MNBW.0,T!_IJ(X:'D%Q":42&>MNMH4FF72@F;[27Q&CB='T7C%_OEF/[4Y3Z+
M=*;F])T2]7"U';D0S#/)MWD%QU;3,_14D64=_&XA3R78-5TZL,644(LH"Y@'
M4SRP,[5KE5IJ2%<M]/M5<GB+13[6$E<[V,2&3(DUI#CB$N<0XXE5;G9S0!U;
M(U.O7NL!2;9 X2*)%ZA<A&AZ.Z4)F2A&?8#=YO(&(5*DR#DHG.FL_==D*4I?
MU55W2ZO(*%*-.,$:99@-GMU#NE5?L8.76K(S7[S0#U8N D=9@$YR&3B,3D1"
M,?Z42&W>(1],'33&7PB5P'V+-;HU*F6"WOAY-[QV#%%Y=H9:I+L/:B<T:BB8
M+$,=89L&0:8AL-L<D_90E'+)8\YJP4M4[Q?W+L4'5K0+>7R[NDU#7(V@D[#7
M:/$MLK.JK:(&SU+\\FZ(@0GGS$=_DO[BUR$KOELKP*(+L6GFQ-DOI5A<E3]E
M. JF!HP@C-2\^XRV]!J=8@0D\:2VGK49/>\ZOJE=[M']F SE^[=TZAV1PO9N
M556IIK"J6G559QPWS.%:FFJ*_ Y9>B>G.1_]W\K^3GQ4J'*RJM3:91<FNN%5
M>LSTSYX<;D6BC:V(N]!<A3)K[1(#9!M0&LR$2N/KZF(CZ5)[U75/8Y0C3S)S
MHMF\O5*T:?;M%O/*[W\2HPSRG]%M=KN:*NRX$;@1U?>Y :=9ZVWQ*^KYW^VB
M7EXM^_JNPK37I"RUE_A:5J *N+J 34YV<I-\SB?J(:LKY"BV1X2X;CL-M\;E
M)^TWU->H%3C5^@UJ?9K U5Z^LGR*V3MES,V303\(/PM-=EDC!HK,*$E1VE..
M?3QY:$<;;[Q+^BU[/((ZWO:C<=J;))+V.3&'ZCH=/>HE]N 0+,,R 0 A<ZU)
M=;*(@QH\>=)=<EO-KF+6_P!J4J-FOZ!/I'\:MU\K3;E?Z*:2-T6_*U*[UTR:
MIEJ!%K14+)HBNF) 4H],$]G?\1,=/><^"-O,TZK5\76]>.^K"U@*$Y@\8%UK
ME<)C+#K!*?,)MPX4EBLRY29"G5)@M,=4OK:?E]7.MYG %0:K:CMFTA+H26N>
M,-&M-L!*^62SQIBI,M$A-H/V"00ZMI?V5=D=ZWQ*/IYPC_"68/5J1.IK^<PR
M0._:8+-U/.Y%R'Z%W/\ -ST.Y,FLLHL>Z"HY&.'K;XH=&D-<ZRRA/S3UO)J+
M6&*Y06X]A96&ASRSLF6];2!,O:BI(_+(2;&5L5E,F9<X@4DRW2,R=)=DNOK?
M6ISL6Z96!$G;10KO=6'KN]H5MTNV#;]VKALFN(VSV^U6RT'RAT%4*I!K_P"(
M4E2%AX4%N(PW'0CZ/@6 )XN*DUP77@]3_A?^)+NQ535;K>A&=8JP:X5>/9V@
M%[@U#2;$0-!D&HT_]((37W8?V.NK^H"]$5G5'UJY2=8DU<<0MD4=;K3)VBZ5
M_0=:77P!4UR8:7;KK4A\^7R-'<^V]$3QO[:/J3U=^U7+1EHM\JDP<R,'$FK2
M DVG,1UFD7*/F5V;K)T-%O.;+M,MR<^ ,-SA$J0OJGH[GP4W2!6)XO2ST@9/
ML141<;N(!6<L%K#E*#G[50QEDBT"T64745I&QR9 7)GLPF&&DO<1'8XVL)H8
M&IZ!8*" N-;E!WC#CA>JU_;Z01I=L'E!HHG'EC8]]HTJ5%XJ2A*G8W5K85Q2
M?KXF8!B56#L@S&:Q2^0XYCZ[;#Q )933M5B. W"#DA%5C6IV>EB8J/\ \23Q
MQO[JNHZGA"XVFDU<[K7Y67:*?&_Q2;CJ(&,Q+/KQW3+5G0VPQ:X:LU))B'&
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M.]Y\O^CT%_ZC><O^>E%^*7_1*N?^#P_]GU/_ $DP#_GWG7QFW] :?_Y>'?\
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MY!86I_D9+" NE>M(?DBG5G$/3.Q4F]U^BYS6X.CZK2_7&]9[-"D.6"KS:K;
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MF6-<$GJC48.I0ZIFVC(RP5L76*S$J]AT$]#&,@>(C,COU5;C[D:,W/?XXWX
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M)C1_H82K\=I'UJ6OZG%?'H+_ -1O.7_/2B_%+_HE7/\ P>'_ +/J?^DF ?\
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MTY)FI@RUJ Q7941F5\VD. F-UNN=58/J#,:EM0[!8X<<#;R5F&=9G5\"\3_
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M9C'=D1!=R?DN[5YM.C1B:8"ADVF.?J'6K"/)*+0T1Y$;KC#[LR.VA:EOLI7
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MU4;6*Y78*K/,:$%/4&NU8,K_ +[* [/:J=4&F24GB.SU5=R2PGL:0VXY;JO
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M"5YU=?N8Z0P1A,2(C,V-'D):DH0^EQ"?_FQZ"_\ 4;SE_P ]*+\4O^B5<_\
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M_P#&;<;4MM4QAR/9W.D/2E?]93W_ .)B#+LO9ZY_#JHA9:8WV&&04MZL1G)
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M S[7$9'2FFG5H&2,]#[]Z%V2-55>O_'U&V+2,P;N-.JMJJ!7]N<M<]&[7YT
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M^G>8Z%Z*]R9Z!N H_JH^Q%K8'5C1;S!G=VUL'!E:;;P(ZM72[KJJYI.7RS&
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MV$U6I4_(JR>/=K(*5=1TK]/BN14.*_&EO18/6FI;[;UJT6X+<+.UJORK(Q2
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ME@9<;HT-E]=-CV_@6Q6"#6IX6U=DB$"2D*P/1QK[$*2^Y%[]*65H^OOVW/\
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MC+;*G&AQ1GKQ$8]'B.08DYM_Y)?^I,1:)"CI<9;JN1$U:21AV8G!/BI8ZN3
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M*2KG?GSO/Y.\_P"CT%_ZC><O^>E%^*7_ $2KG_@\/_9]3_TDP#_GWG7QFW]
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M*1"(!9L!R.^TU"88DN(B9[A=;@8S%QS]O-[5,P$3,YK];W<QYY]"V MH>1V
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M:GX>N'?6&]^N?/\ O/A/]QI,K(J_7/!OEBG?V-R0V*'#,:^HT/&YOFRJUBR
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MJ5Q12*Q63UEYGM.F6RYU^JSLZRJM%;4QP2.?/D!,-V4GC+2N]YSGQI_F?']
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M$]FRV5DWVN,\^/=/E'SCZ!PK+LIWW3-[]$8'Z8$EM3KWJJEZ-M>I@=5*Y1H
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M2OBRFG>5[MYUK(36/VSK_P#MJ:@)U^'?H?\ 9M5K#8Y]IKNJY,*HH8E#MQ6
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MNV9E7-MUW 87(=A>N)C')T/0LBA:BZ1)2TE:E(X6K1%^/)@_<[&XVOQYZ$*
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MFR++894V-$DOM?\ 1Z"_]1O.7_/2B_%+_HE7/_!X?^SZG_I)@'_/O.OC-OZ
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MW,\\9?MEX]!V2M&,XP CK5QU"Y>@)'H=5BJ6^0LT#WC");5CD+$RW*8@4Y/
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M5]<H9]R1/<?F-0=: \G8UEVW+\]>7?3.>76B!+39*]6JYK&QBL]O^86&':+
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M2Y<QR%,F_::0M;;9;7Y= B/Z"<M]#T$F969LO8<B^9G5C-'I-U17.&N5>+;
M]-/2!2B+4)N7+'\9CR7'FHT9+2.$,U;@3V=$T35XEBJEKO-&N0Z^:Y$EP-1-
M"KQ2K-7[@)8T&#-6R8@QIS0^>U]"7F%I;;XEO+K_ %E)^EQWJS+@05%CHTJ'
M*4PD.,U$^ M0<H/ME?L]9,"8TN"4A3HY&+)92ZV\E?/J^ MASK+0];/@#^I6
MP><;(6 D85:=M=KK^M64F3,ER,TY8- DU,>\3FSER),A^/QSJ_K6XI::&QF-
M&M=.SVK7/S>:K]7N-D9'-TP@49-7/#M*;JUJB*M];C'GT3G:[8E3HT&<YR0A
MAIY7U]5KP"HS0=[D10$4I.#7.]BP=C75:@_0*V2MU*@V9BD7*P Z2_\ I<4F
M5'3"+,)IEI+W$L,\;S2C%<\_(HF1A05;I5#;MEXAT5%<K!*O&:_7[53(5FCU
MG108@M4QTEB)8HI6.AZ(A?T?5]7>P\]RRHXA2ZA8:+L^;7FTVAK6)5Y&UG>K
M>[<M&8'#JE=Z_7-4 &+$7(&N5JWJE 6[#V--^WU+*F'+8/L@ /&I;CF9W[1K
M#:C4B$V0)>>0- CT2^VPWV:.B0I-*$Y""?7(1^+&YP6EQU'T_<^K6IE0K@4\
M)UMBY#-8J<:]6:T9H9_MGA";G?6YF72K03S>OS].@&HI8FY#%0Y!9LC^6ZIS
MDQ;CMPL.3TA8"S:"+HX2\6HK:;G=K;:P^9CR@C/!9ZU7NQ6:PDH%)#FI,,6T
M[)4B%$=^RUQ+24I3Z("W'&:R:%>LC%*L'HF$Y).1&=2-9V*K02F$3GZ>6B*B
MR0@RGC6T]A=B_>[&XMW[CBW%+>T\IG067?9%CH]N>LBW2:)B['FU7N5*HQ3[
M+4]N$EZN5;03,)A/&N-]:GN=6E2N(4D/YPMV:5VPX?7P]" ALY*(F200X7ET
MP"1SQF/U4O\ /2]3B57'28#_ %[K[$F$T[Q?W$<5\1:=W/)B(L+3B>TQ[.SH
M&F1]1YK1H6^!,Z*[LK%R;UR1;B];DK$RIKAM;T@/WD!Q2H:4L<)8==J<*N64
M&:BW13%,M?)-C'%JPS":'M0"D@Q(F$B$AMF.A?);SZYO)"$O_=^_SCGQ&#7'
M,R-T@MU8U1"7\9Z;K5NFVZAGC;=EFT+1"MCO9,IIE%C6-O\ /@AK"\3&#)KC
MCT-AAQUQ2[Q=SV?HM-AT2IW.B65VXV:XW$4BF:-''1-!J]8K=HL)>MT,'>8P
M>&@O&!1!K1%,1CDCCGVF_ISO*7*R^4HN4$\\,T$58K):[1-!%LH,"S^>$5V.
MQG"MG+RZL7"Q'HZYTR2I76$)<^M'/I^,EY5<Y#!N84[>GLD_&?*K_@AW3&YS
M5Z6+^^0>^[VQMDW^/?D?>^G[G?H^C^3Y$KCI&>0;/83>7%\5/3'B]C'L6'+3
M1N-995.L8P09'BK .B6"+R9!7-8??&277EPW&%2'^N:"]>L[%G9>I0\XAW8B
MJ::'%B7]D!@K8LN(#RXDG )UH[03YN3.%$A;T,A#EN<>;>XXAM29N2+!+/YZ
M5$6( ;K]W,'="[8PUM4159AUH+7LG8CEHC'$EI+<GA"3)^XR[UKO_#YQ/),^
MM9/%05F$,6)S#IVUWNWV*9(\Y%2QG"&9=BM]H.G)(W)IQR7^A0UR%1(##ZF&
MVN,?)OEP$%,S>.)O!2D&31FQ7W2K%<(1',[(4N.;O5"]G+B0NN>M9]:SDXB#
M9 3QC(F;-D/14-+?=ZO1Z86S,;9@&O5*HT?3V;D7LMU(WJN4$9)#TMBR'K::
M,GR1*LP92OPR*Y7ZBRZEMY+_ -YIIQ%)K<^NV,U$SG4QVUTLK8].U.RW$)IP
MO\M$:SMWZP70E>9BGH1&3"DQ))%Z!-&RGX4AAV(\ZRL'7B6+!6@H&K62A,#@
MIVXUF.8SVWVY=]LV;W+E;L8E5_S4S<77"#U=.=(A5/NN=Y%YQUSBC5$M%=H\
M8OO=HJE[GU*85Z,(Z)9L%'T!VL&1(5LE%DRU9R+S^O*ZB VEB.S!9Z\CJ5*Z
MNJJTJL/%25%*$#5)LP.R6NBW:GD3 :;7#;U6OE".5FY@&CP B]"(,Q)[3,^*
MOK4A#B.<YRK&\VS*L4DC2<LAXG5'*[%='1P>603:;+'I\* R_P 'I@</I_,6
MXII4EU]2EK<5U2OG9+K>,\@GK%<J=5:%;I#I:QPA]HK%%N\?1J1%L($:8A@#
M)&GW&-^6+(2(KA$?QY]EA]N/)D-.WBE6$35"FW&969;S;H(.Y6 !J86?GT29
M0LLU*"4J=B$VR@SQ8[DL3 (CGQSLJ,J4QU3K:WT](X)9*QRQ9,9J#]#,50\9
ML!CIBJ2H?8,H86/$2LFRDERXRN\=DOS');JN]4MWJN]5\9_>;#7H92V981L!
M;/S;ZY2958(VFMD*A8)4%#+[4=QPG6BLB(YQY#B>-N]ZGG%?)7+8_)QP<XS<
MQNGB"HCEGO**T,'[;(8D[,Q2JFBSIK&<+UI;/4V5RO1!;IQIY]N8IYN0^EP"
M#!5K.Z_G-S]!XWZ ](PB@X^4*7@YYSY2B62M4<(T2CU.J')17,Z[ ,%4--O.
M 1?(_&WG%(<9IO;S6X5C[GUZ :93>S7)2/T&]U=$UL!9(GXLB/\ 7-&((O\
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M:=7J,:M19M8:*T 87GU@?,'2(O&N.CX?6XROQGYB)%,M+WI0K>K#N7[?./\
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M9[1W (HZQL,MK240C9/L[@IBOPE-,/R'7N1VAYW9J[;8>@YCYWSCRQ7[;(W
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M]0&]_P"(OQ_E:LW^H#>_\1?C_*U9O]0&]_XB_'^5JS?Z@-[_ ,1?C_*U9O\
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M_*U9O]0&]_XB_'^5JS?Z@-[_ ,1?C_*U9O\ 4!O?^(OP_I_F'S#6*CJ#D6=
MBZ39CUPTJ[!(!)CL4A#JQW0[!9I%21.AK6Q(6,Y$>D1W%LNK6TKJ/_Q??__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g893453g02n02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g893453g02n02.jpg
M_]C_X  02D9)1@ ! 0$!H &@  #_[1,*4&AO=&]S:&]P(#,N,  X0DE-! 0
M      << @   @   #A"24T$)0      $.CQ7/,OP1BAHGMGK<5DU;HX0DE-
M!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0    !0<W13
M8F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX
M=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $       ]P<FEN
M=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M  IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8
M   )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G1/
M=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B
M;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M  !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M         $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M  !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M      !2<VQT56YT1B-0>&Q >@            IV96-T;W)$871A8F]O; $
M    4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M             %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R
M8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C
M=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R
M;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"
M24T#[0      $ &@     0 ! :     !  $X0DE-!"8       X
M    /X   #A"24T$#0      !    %HX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _0
M     !( -0    $ +0    8       $X0DE- _<      !P  /__________
M__________________\#Z   .$))300(       0     0   D    )
M #A"24T$'@      !      X0DE-!!H      T$    &              "*
M   #X0    8 9P P #( ;@ P #(    !                          $
M             ^$   "*                      $
M        $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   "*     %)G:'1L;VYG   #X0    9S;&EC97-6;$QS
M     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M      =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/
M<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54
M>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
MB@    !29VAT;&]N9P   ^$    #=7)L5$585     $       !N=6QL5$58
M5     $       !-<V=E5$585     $       9A;'1486=415A4     0
M    #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M    "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U
M;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F
M875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
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M$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_
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M;8E/6)+GJOKKTO[9DX64'8]N']J?DN'OKKJQGBMMMUL,VV95;V75X];;;/\
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M /_9.$))300A      !7     0$    / $$ 9 !O &( 90 @ %  : !O '0
M;P!S &@ ;P!P    % !! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @
M #( ,  R #$    ! #A"24T$(@     !,DU- "H    (  <!$@ #     0 !
M   !&@ %     0   &(!&P %     0   &H!*  #     0 "   !,0 "
M'P   '(!,@ "    %    )&':0 $     0   *@   #4   !H     $   &@
M     4%D;V)E(%!H;W1O<VAO<" R,BXP("A7:6YD;W=S*0 R,#(T.C Y.C W
M(# T.C(V.C4V       #H $  P    '__P  H ( !     $   /AH , !
M  $   "*          8! P #     0 &   !&@ %     0   2(!&P %
M 0   2H!*  #     0 "   " 0 $     0   3(" @ $     0
M    2     $   !(     3A"24T#_0      "           _^$!.D5X:68
M $U- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    'P   '(!,@ "    %    )&':0 $
M 0   *@   #4   !H     $   &@     4%D;V)E(%!H;W1O<VAO<" R,BXP
M("A7:6YD;W=S*0 R,#(T.C Y.C W(# T.C(V.C4V       #H $  P    '_
M_P  H ( !     $   /AH , !     $   "*          8! P #     0 &
M   !&@ %     0   2(!&P %     0   2H!*  #     0 "   " 0 $
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M(",F)RDJ*1D?+3 M*# E*"DH_\  "P@ 9 +, 0$1 /_$ !T  0 " @,! 0
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M;DZDQBTN<ZC@D\KX>X+O<G7RTK2X#C5-BF,45KHQ\,+-.=[N=[E;$OA( ))
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MR:"5O2]CQL."UK&..<:QJM?5VBV0P5#SU%^MD?A\EN"^%H/LOH !V!W1$1"
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-(B(B(B(B(B(B(B__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g893453g03g03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g893453g03g03.jpg
M_]C_X  02D9)1@ ! 0$ QP#'  #_[1#84&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 ,<    !  $ QP    $  3A"24T$)@
M#@             _@   .$))300-       $    6CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]       $@ U     0 M    !@       3A"24T#]P      '
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))300>       $     #A"24T$&@     #00    8
M         #H   $7    !@!G #  ,P!G #  ,P    $
M         0             !%P   #H                      0
M                   0     0       &YU;&P    "    !F)O=6YD<T]B
M:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L
M;VYG          !"=&]M;&]N9P   #H     4F=H=&QO;F<   $7    !G-L
M:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)
M1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M#$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M"D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<    Z     %)G:'1L;VYG   !%P    -U<FQ415A4     0
M &YU;&Q415A4     0       $US9V5415A4     0      !F%L=%1A9U1%
M6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%
M6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX
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M/(994^]__<I)3T'UBZMD='Z<<^FEF1MLJK=6]YK_ )ZRO%8X6-KO^A9=N?\
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M_M#T_P#V%]7[)_[1_P!F_P#FI27SZDDI_]DX0DE-!"$      %<    ! 0
M  \ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '     4 $$ 9 !O &(
M90 @ %  : !O '0 ;P!S &@ ;P!P "  ,@ P #( ,0    $ .$))300B
M  $R34T *@    @ !P$2  ,    !  $   $:  4    !    8@$;  4    !
M    :@$H  ,    !  (   $Q  (    ?    <@$R  (    4    D8=I  0
M   !    J    -0   #'     0   ,<    !061O8F4@4&AO=&]S:&]P(#(R
M+C @*%=I;F1O=W,I #(P,C0Z,#DZ,#<@,#0Z,3@Z,C(       .@ 0 #
M ?__  "@ @ $     0   1>@ P $     0   #H         !@$#  ,    !
M  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !  (   (!  0
M   !   !,@("  0    !              !(     0   $@    !.$))30/]
M       (          #_X0$Z17AI9@  34T *@    @ !P$2  ,    !  $
M  $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q  (    ?
M    <@$R  (    4    D8=I  0    !    J    -0   #'     0   ,<
M   !061O8F4@4&AO=&]S:&]P(#(R+C @*%=I;F1O=W,I #(P,C0Z,#DZ,#<@
M,#0Z,3@Z,C(       .@ 0 #     ?__  "@ @ $     0   1>@ P $
M 0   #H         !@$#  ,    !  8   $:  4    !   !(@$;  4    !
M   !*@$H  ,    !  (   (!  0    !   !,@("  0    !
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M  (" P$!              <(!08" P0!"?_$ $T0  $"!0$$ @T'"@0& P
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M!FJI4WDMLLIR 3Q42<  ><B*0W16JOJ??84A"W'II_HI9E.2&T%6$@^8$9/
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;1ZRF-IDY26DF S)R[,NR.2&D!"1ZA'="$?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g893453g05g05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g893453g05g05.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_[1% 4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 )     !  $ D     $  3A"24T$)@
M#@             _@   .$))300-       $    6CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]       $@ U     0 M    !@       3A"24T#]P      '
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))300>       $     #A"24T$&@     #00    8
M         #\   "]    !@!G #  -0!G #  -0    $
M         0              O0   #\                      0
M                   0     0       &YU;&P    "    !F)O=6YD<T]B
M:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L
M;VYG          !"=&]M;&]N9P   #\     4F=H=&QO;F<   "]    !G-L
M:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)
M1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M#$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M"D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<    _     %)G:'1L;VYG    O0    -U<FQ415A4     0
M &YU;&Q415A4     0       $US9V5415A4     0      !F%L=%1A9U1%
M6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%
M6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX
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MZKU+I>1D^KA/R<MEG3.GASZWT8N.?M'4.H]3%6YEF5F4[,!F)=^APF9U=/\
M2;LA)3VR22R'_6;IKLT8&#NZADBQK,C[,-]>.TE_JV9N7_1<?T6U6?H'W?:G
M_P W72DI_]#M/KKU+JN)TVC"Z*T.ZIU6\8>,XD@U![;++LO:QKG?J]57T_\
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M(0      5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
M<    !0 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #  ,@ Q
M     0 X0DE-!"(      3)-30 J    "  ' 1(  P    $  0   1H !0
M  $   !B 1L !0    $   !J 2@  P    $  @   3$  @   !\   !R 3(
M @   !0   "1AVD !     $   "H    U    )     !    D     %!9&]B
M92!0:&]T;W-H;W @,C(N," H5VEN9&]W<RD ,C R-#HP.3HP-R P-#HQ.3HT
M,@       Z !  ,    !__\  * "  0    !    O: #  0    !    /P
M       & 0,  P    $ !@   1H !0    $   $B 1L !0    $   $J 2@
M P    $  @   @$ !     $   $R @( !     $              $@    !
M    2     $X0DE- _T       @          /_A 3I%>&EF  !-30 J
M"  ' 1(  P    $  0   1H !0    $   !B 1L !0    $   !J 2@  P
M  $  @   3$  @   !\   !R 3(  @   !0   "1AVD !     $   "H
MU    )     !    D     %!9&]B92!0:&]T;W-H;W @,C(N," H5VEN9&]W
M<RD ,C R-#HP.3HP-R P-#HQ.3HT,@       Z !  ,    !__\  * "  0
M   !    O: #  0    !    /P         & 0,  P    $ !@   1H !0
M  $   $B 1L !0    $   $J 2@  P    $  @   @$ !     $   $R @(
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M (,!B@$!$0#_Q  =  $  @(# 0$             !P@%!@(#! $)_\0 1!
M 0,# P(% 00( @8+     0 " P0%$08'$B$Q"!,B05%A%#)"<14C)#-2@9&A
M%K$W0U-C<J(8)416<Y2SP]'2\/_:  @! 0  /P"U*(B(B(B(B(B(B(B(L(_5
M-GCOWZ&DKF-N1.!!Q=D^GD>N,=NO=9M$1$1%YKA7TUOA\ZLE$4><<B">O?V_
M)<J*L@K8!-2R"2,]G '\UWHB(B(B(B(B(B(B(B(B(B(B(B(M!W=W#H="6"2H
MG>'5;P!'$' ..3C.#\95;MA-,7C<?7D^I[[+,*:$M,CF%S!)RBD8...V"P95
MSFCBT-'8#"^HB(BB+=O>NS:,IYJ6BGCJ[KQ],<;VDL.,@D'V5<;I2Z\W'H[G
MJ&YRS4-KI()*D2F-S(RU@+N/3IGBXG^2EKP=7:LGL]TH9YW5$,=4_C(23V9&
M!@E611$1$1$1$1$1$1$1$1$1$1$1$6$UCJ.ATM8:JYW*>.*.)CN(>]K>;N)(
M:,D9)QVRJ.7RZ7S>C<(Q48F^S/>YT4;@_#&=R" 7 'I[*[F@=)T&C=.TUJMS
M &1 @R$#D_U.=U( SCD?9;$B(BZ:NJ@HX'3U<T4$+>[Y'AK1_,JM6\N_C9'F
MQZ##ZNK=T=/$!*UW1CAY;HY,]N0/3V6-V>V(K;Q71ZBU\^H<[ESC@E<_S"0?
MQMD9U;CMU6Q^)[4U'IC1\.E[%'##456(GPPAH)B?%(S[K2#W ]L+9/"UI$Z;
MV^CJ)XWMFN+F5@YC! ?%'TZ@?'U4S(B(B(B(B(B(B(B(B(B(B(B(B\=XN=):
M+=45U?,R*GA8Z1Q<X#( )(&3WP"J2;];GUFO]1_H>S/E%LBE\ED;2X"1XD>&
MN(!(.0X=5/'ALVNBTE88[K<8FNN=6UL@+V@F+((+0>(('T4WHB(L3J/4-NT]
M;Y*NZ5,<,;!V<\ G\@2%4C7FZ&IMU;R;/HQE53VPX ?'YD9=@!WKXDC.0<?1
M2_L]L3:=*0QUM[@AKKGWQ*QDC6=7CTDM!&6N&?R4NWZZ4MBLU37U;FQT]-&7
MGL.@5.;'3UF\>]C:N<2/MU#,QY)R6.B94#IUY GB_LKGVVCBM]OIJ.F:&P4\
M;8HV@  -:, 8'Y+T(B(B(B(B(B(B(B(B(B(B(B(N,LC(HW22.#6-&7.)P %2
MCQ'[MU&I+K-8[/+)';('%DA#OON'-CACX((ZK+>%W:DW6L;J6\Q@TD1Q#$]O
M=V(WM>/ZE7":T-:&M& /9?41%'FZ>ZEET';W.J9/M%8X89#$0X\CR S@Y'5J
MK8RGUEOO?WE_F4=H#B>$A/ #[PQD=>RM#MGMQ9M!6P06V%CJEQS+4\.+I#DX
MSU^#A;JJP^*;7[ZJ6+1MD+GU$WIGX'(>U[<@=,Y4F^'[0<6C='P.D:TUM4/-
M<_&"&O:P\?ZA2BB(L/JO45!IBRU5SNDH9! PO(!')V/8#/4JLE[\1M_K[I43
M:;LCY+;2@N<X.> YK2>IP#CH0INV:W+IMPK,9FP.IZN'+)8S[%H9R[_5ZD5$
M1$1$1$1$) '50GO?O71:.II;?:G">[.&/Q-X=&N&#@CJ"NSPSZKU#JO3\]9J
M&:2=F#Y4KW EQYN!Z =,8"FA$7365,='2R5$[N,<;2YQQGH%&VWV\EAUOJ.>
MUVA[G@$")YC>TO\ 0YQSD#&.)4GHB(B*%O$SN -+:2FM]))BNKFN@Z9RP.8[
M#NV.X55]F]#U.O=9T\4K>=(R9DU4XX]3/,:'^XST=[+] =/6BEL5FH[;0L#*
M>FA9"P 8Z-:&C^P"R"(OCG!HRX@#Y*@/>K?>BTZVHM&GR:BZ%I878<WR\A[<
M@XP2' *.ML=I[SN1=1JC6,SQ22O\Y@<6OYAQ;( 0"",\C[*V%@LE!8;='16N
MG9!3Q@-#6]NBR2U#='65+HG2E5<ZAWZQ@!C9@^KUM![ _P 2K1X<](UFMM;3
M:JOV9X*=XEAD?@EQ#B,8R",!7%8QL;&L8,-:, ? 7U$7743QT\+I9G!K&]R5
M3'=;5URW7U]3Z;L;W"WF1L;0#@<B,'HX#W"F*Z:2M6U^R5[^SPL-=+0O$C\8
M+GE@);T)'=G=:MX-:66:EN]U<.,4LT\?'V#B87*S*(B(B(B(B^.<&M+G'  R
M2JR^(??-UM=-I_24^*T'$U2 #Y)!8X>E["#D9'0]%7?;C1]RU]JB*BIFES"X
M">7T_JP0<'&1G[OLOT.TO8Z33ME@MMO9Y=/%DAN2>I.3W)/<_*RJ(H]WVU!3
M:>V_K:FI>&\G-8T8/7)Q[ _*@_P7Z:D?5W:]5,7%D1A-._.>66S-=V/3^85L
MD1$1>*]7&"T6NIKZIW&"!O)YZ]OY K\\M?WJOW%W(>YK3)53S"BIVY;ZAS(9
M[-'O[_U5VME] TNAM*4]/&S]KF:)9G=>A<UN6XY$=V]PI 1%CM07N@L%LEK[
MK.(*6+')Y:78R0.P!/<A5/W-WKO.NJYVG-$4Q;#.?++FR,=YV1]W$C!QZ^^5
MO&RNP=/:7PWS5?[1<2X3,@(+/+?EKP[DR3!P01C"L/%&V&)D<8PQ@#6CX 7)
M<99&QQN>\X:T9*I9NUJ"OW@W,IM.V-Q-#"XBG< TYY0L>[HX-/>,]RK;Z'TW
M2Z5T[36RB9QCC'(]3]X]3W)]_JL\B+KJ)HZ>%TLSN+&]RJA;V;L5^O+N-):)
M:9J:7+26EO[3Z62=I& MXEKO?JICV&VDIM!6XUE6?.O%0W$LN"WIG(& \MZ?
M1:/XOM3R24-!I6VR9K)YF2OC 'J8YLK<=1@=<>ZE;8K3(TMMW;Z7'%]2UE6\
M?#GQ,S[GX4@(B(B\EUN--:Z&6KK9!'!&"2X@GVS[?DH;T?O9'JS=N#3=J@Y6
MUPE_:!)T?QC+@>)8".H^5-Z(B'H,E5Y\16\HT]#+8K$]KJ]^6R2##@S!(<T@
MCNJDV*U7#55_BH:)CYZZIY$ #)/%I)_L%^@>TVWM!H&P,HZ=H?5'/FR]?5ZW
M$8SV^\MY1%\>X,8YSC@-&252OQ2Z[=J75$-@H96FEI)"QQ&#R+N!!^?E63V(
MTP[2VW-KHI\&JX.$K@,9_6/(Z?DY2$B(B*MGBYUZ;?:VZ:H) )JCDVJ P2&E
MK7-_)='A:VK^Q1#4UZB(G?\ N&.R""',<UW?!"LTB$@ D]@HJW/WKT_HNF>R
M*5E?7C_L\4@:X=6_(^'9_DJ[LI=<;\W=LSW/I[6TY;/Y0X-P,'/'&>K<*SVV
M.U]ET+0-920A]6?OREQ<#UST![+?T10%XH=R7:>M(L5JE:+E5<3RZ'AAS3@@
M_(*Y^&#;3_#=E-[ND;A<:S&&NR#'P?*W\NH(4](BZZF>.G@DFF<&QQM+G$^P
M'55%WTW3N.L;V_2>D6OE@#BUYCPXR\2UP(/< 8*E_8K:&DT';?M5<!/>)OWL
MG4#TN>&X:3T]+@I2O5R@M%IJKA5N#:>G87O)., *GV@H9]T]_)+C4@OI+<\R
M@@=#&R; '3Z/5RX(FPPQQ1C#&-#6CX Z!<T1%@=4:OL>EZ=TM[N,%( ,@2'&
M>F57[7WB5#YY+9HZD?)4R9CBJ0YDC7./)HP"/GB5I%'HC<O<^<3W\S44#SR\
MUT'%K@>O9I^I5A-GMH+9M_$*G/GW0CUSASL$X(. 3TZ%2DB(H5\0V[-+HZTR
M6JWRMDN]3'C#'-)8QPD;G'($$.;W5):FHKK]=3),Z6HJZB3Y+B23_,JZ?AQV
MGCTC:&W:[P#]+5(#@V1OJAQS:1AS06Y!"G%$115X@=PH-%:3F9#+&;E4 -CB
MY N+"2TD#(/3Y5/]FM/S:QW#I*2<R3.(=*][B7$\1GJ<'X7Z*,:UC0UC0UH[
M # 7U$1%IFZ.O;=H2P/K:V>,5+L>3 7M#Y/6T.X@D9P'952-H[+<-U=S/TE>
MN<]- ]CI^CB"W!:.^1[#NKQT-+%14D5-3L:R*-H8T-&.@&%WKP7^YQ6:S5MP
MJ 3'30OE+6XR[BTG S[]%475^\VK]P:DT6A[76_8B>+A'3N=*WKD9,;C[=UM
MFV?AUF?4LN6NJR2JD[MC;*_D.CFGD'M_X<*Q]HM-#9Z5M/;:6&GB'M'&&_Y
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M3Q/142W(O=VW*U'<KL9BVT4TKV0/E+O+8TGD&DY+0?@ J6/!?IEQJ;M?:B$
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4$1$1$1$1$1$1$1$1$1$1$1%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g893453g96r99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g893453g96r99.jpg
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M 0$! 0$! 0$! 0$!_\  $0@ +@"X P$1  (1 0,1 ?_$ !X   (# 0 " P
M           (!PD*!@,% 0($_\0 -!   00" 0,# P($!04     ! (#!08!
M!P@ "1(1$Q05%B$*(A<C.7@8,36TM3(X=G>W_\0 '@$  0,% 0$
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MB*N?<C"H,0T%AQ>,D@T:L-BNQ;1CV7#LF2EG-F)1PI9TN*').E-Y#,"<):;
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MF"P\D+;%9J4U:X<*=RD%VFQX,TQ^8(D2VI*7HS7 T3]1!Y4ZUJV1QY$Q?HX
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M>#(-2+A #H#TF.VELK0GE*2"0,D$$@>9Z8R#T\LCX:T<%W%=NQ=&[=(VSO\
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3.+<?===<<=<6XMQ:E*422=?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140654517819296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Sep. 11, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000055067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">KELLANOVA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">Schedule 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">PREM14A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140654517860448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Sep. 11, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TxValtn', window );">Transaction Valuation</a></td>
<td class="nump">$ 29,503,244,122.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 4,354,678.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">As of September&#160;3, 2024, the maximum number of shares of common stock, par value $0.25 per share (&#8220;Common Stock&#8221;), to which the transaction pursuant to that certain Agreement and Plan of Merger, dated as of August&#160;13, 2024, by and among Kellanova, Acquiror 10VB8, LLC, Merger Sub 10VB8, LLC, and, solely for the limited purposes set forth therein, Mars, Incorporated applies is estimated to be 358,032,313, which consists of (a) 344,667,063 issued and outstanding shares of Common Stock entitled to receive the per share merger consideration of $83.50; (b) 2,944,914 shares of Common Stock underlying restricted stock units entitled to receive the per share merger consideration of $83.50, (c) 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 entitled to receive the per share merger consideration of $83.50 minus any applicable exercise price, (d) 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) entitled to receive the per share merger consideration of $83.50, (e) 354,853 shares of Common Stock underlying deferred stock units entitled to receive the per share merger consideration of $83.50, and (f) 47,000 shares of Common Stock reserved and available for future issuance under the Kellanova Amended and Restated 2002 Employee Stock Purchase Plan (&#8220;ESPP&#8221;). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">0-11</div> of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and solely for the purposes of calculating the filing fee, the proposed maximum aggregate value of the transaction was calculated, as of September&#160;3, 2024, based on the sum of (a)&#160;the product of 344,667,063 issued and outstanding shares of Common Stock and the per share merger consideration of $83.50; (b) the product of 2,944,914 shares of Common Stock underlying restricted stock units and the per share merger consideration of $83.50; (c) the product of 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 and $25.93 (which is the difference between the per share merger consideration of $83.50 and the weighted average exercise price of such outstanding and unexercised options); (d) the product of 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) and the per share merger consideration of $83.50; (e) the product of 354,853 shares of Common Stock underlying deferred stock units and the per share merger consideration of $83.50; and (f)&#160;the product of 47,000 shares of Common Stock reserved and available for future issuance under the ESPP and the per share merger consideration of $83.50. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with Section&#160;14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.00014760. </div></td></tr></table> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TxValtn', window );">Transaction Valuation</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01476%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">As of September&#160;3, 2024, the maximum number of shares of common stock, par value $0.25 per share (&#8220;Common Stock&#8221;), to which the transaction pursuant to that certain Agreement and Plan of Merger, dated as of August&#160;13, 2024, by and among Kellanova, Acquiror 10VB8, LLC, Merger Sub 10VB8, LLC, and, solely for the limited purposes set forth therein, Mars, Incorporated applies is estimated to be 358,032,313, which consists of (a) 344,667,063 issued and outstanding shares of Common Stock entitled to receive the per share merger consideration of $83.50; (b) 2,944,914 shares of Common Stock underlying restricted stock units entitled to receive the per share merger consideration of $83.50, (c) 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 entitled to receive the per share merger consideration of $83.50 minus any applicable exercise price, (d) 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) entitled to receive the per share merger consideration of $83.50, (e) 354,853 shares of Common Stock underlying deferred stock units entitled to receive the per share merger consideration of $83.50, and (f) 47,000 shares of Common Stock reserved and available for future issuance under the Kellanova Amended and Restated 2002 Employee Stock Purchase Plan (&#8220;ESPP&#8221;). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">Pursuant to Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">0-11</div> of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and solely for the purposes of calculating the filing fee, the proposed maximum aggregate value of the transaction was calculated, as of September&#160;3, 2024, based on the sum of (a)&#160;the product of 344,667,063 issued and outstanding shares of Common Stock and the per share merger consideration of $83.50; (b) the product of 2,944,914 shares of Common Stock underlying restricted stock units and the per share merger consideration of $83.50; (c) the product of 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 and $25.93 (which is the difference between the per share merger consideration of $83.50 and the weighted average exercise price of such outstanding and unexercised options); (d) the product of 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) and the per share merger consideration of $83.50; (e) the product of 354,853 shares of Common Stock underlying deferred stock units and the per share merger consideration of $83.50; and (f)&#160;the product of 47,000 shares of Common Stock reserved and available for future issuance under the ESPP and the per share merger consideration of $83.50. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(3)</td>
<td style="vertical-align:top;text-align:left;"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;">In accordance with Section&#160;14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.00014760. </div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TxValtn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TxValtn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140654517895840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Sep. 11, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">4,354,678.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlTxValtn', window );">Total Transaction Valuation</a></td>
<td class="nump">29,503,244,122.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 4,354,678.83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlTxValtn">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlTxValtn</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MT>L,]>&+JD15'<6+LBSLN-)%IFQFNJJ#, OT_)YS=>V82M/\3T2O4$L#!!0
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M0Z*H.0</SJ.@.Z>"W7]"9O=02P,$%     @ ?8DK69>*NQS     $P(   L
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M%4X9?^3+X5U;?0!02P$"% ,4    " !]B2M9!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( 'V)*UG;
MXX21[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( 'V)*UF97)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ?8DK6?TM2CM# @
M,P8  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( 'V)*UF1;0&^B@4  ',7   8              " @88*
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !]B2M9Q-47
MA$\"  #M!0  &               @(%&$   >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ ?8DK6;PJ)H(4 P  %A$   T
M ( !RQ(  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !]B2M9EXJ[',     3
M @  "P              @ $*%@  7W)E;',O+G)E;'-02P$"% ,4    " !]
MB2M94G%OM5T!  !( P  #P              @ 'S%@  >&PO=V]R:V)O;VLN
M>&UL4$L! A0#%     @ ?8DK6;MLZNRZ    &@,  !H              ( !
M?1@  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ ?8DK
M6:;\2ELC 0  WP0  !,              ( !;QD  %M#;VYT96YT7U1Y<&5S
;72YX;6Q02P4&      L "P#* @  PQH

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>15</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="d893453dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d893453dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d893453dexfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="d893453dexfilingfees.htm">d893453dexfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="18">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d893453dexfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "d893453dexfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 15,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024q2": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 18,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P09_11_2024To09_11_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d893453dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_11_2024To09_11_2024",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d893453dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d893453dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d893453dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P09_11_2024To09_11_2024",
      "name": "ffd:TtlPrevslyPdAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d893453dexfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P09_11_2024To09_11_2024",
      "name": "ffd:TtlPrevslyPdAmt",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d893453dexfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-24-217313-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-217313-xbrl.zip
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M,/E+0F@KLI4<S\H(0!$QD;$\_TE-T3"DA"$Y#)*;'$[//Z>#-WLS\"OG\O?
M):XY_PF(SO@G\'!':*6H3473XCL7?0M=S16T<<]<[%Q..663+4ST75L33D]O
MOL@&9&1#8_3;I#*6(IV02:%/EI!RKF05%)E*Y,=+MP-V2OR*C)+FMC#50N9O
M[\)U&>$W<Z'^"ETH<K+TWR(GSZ78!/O0T(D8P67,).Z9<Q5L\EE^O?VTS#$J
M]EO0>0_+<CJ[EA-50AF*"5E1+/YL7Y/,JY"PV,K4*,)2"K;HR&D9X#_"TMUW
MU.3C5J-4HTX[06J1(6_;F(VHHXCK%L(!=^,6)K6236EN43]WO192/=Y&4</
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MY<Y@917*N0Z8,<;@=9GAXB3:N[V^CI-G"67?-;JGMOIMCPIZ%J377Q'27R?
M]$:<XI8Z_3"Q"D'1,F3;!9TJCZX4(2,FC CY6V($C'(!;;TI1+(S(@"QXM
MI#4K@,. T3B:# ?BACC"$\2+,D%,EPS>SG%6U")1QA+90?0-PZ_^AX2$=8P7
MG\,2)S(\/^UD$IUVLE2 W.%D)BQ&-<6J:DD<& [HX4@VD%8C@ ZI(A7,(!S_
MPT%;D&T/TAGQ.\#L!^AA+.GQ(B!;,'NGUTK-"CH(2RSJ2T5-.HR.AH92C-\1
MXFP'Y;&)PLTTX6+('I"FLIJ)FCH L1N,\+ ML3\;32^I%'A 8)#E$3VN$MA>
MAPCY<R?K$U0# L2WUG*/]D^*]I57A/;G#L(&+#%-&7=W%%:@@,;A*5ER+5P]
M&!W&D)?$VV(&/"4&F@0* <@-$.2P=+8#BU,OG'TQU"62!(VRI*C 0R 3FY@R
MB<[0XAO_-<&\?#SINO-*E_[*RB83U67QSUQ O_AW,CK_!U!+ 0(4 Q0    (
M 'V)*UDF;H D=0T  #%H   8              "  0    !D.#DS-#4S9&5X
D9FEL:6YG9F5E<RYH=&U02P4&      $  0!&    JPT

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d893453dexfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="P09_11_2024To09_11_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <context id="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-11</startDate>
            <endDate>2024-09-11</endDate>
        </period>
    </context>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="P09_11_2024To09_11_2024" id="ixv-189">0000055067</dei:EntityCentralIndexKey>
    <ffd:SubmissnTp contextRef="P09_11_2024To09_11_2024" id="hidden121290917">PREM14A</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="P09_11_2024To09_11_2024" id="ixv-191">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:FeeRate
      contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis"
      decimals="INF"
      id="ixv-192"
      unitRef="Unit_pure">0.0001476</ffd:FeeRate>
    <ffd:FormTp contextRef="P09_11_2024To09_11_2024" id="ixv-18">Schedule 14A</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="P09_11_2024To09_11_2024" id="ixv-224">KELLANOVA</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg
      contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis"
      id="ixv-225">false</ffd:PrevslyPdFlg>
    <ffd:TxValtn
      contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-226"
      unitRef="Unit_USD">29503244122.66</ffd:TxValtn>
    <ffd:FeeRate
      contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis"
      decimals="INF"
      id="ixv-227"
      unitRef="Unit_pure">0.0001476</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis"
      decimals="2"
      id="ixv-228"
      unitRef="Unit_USD">4354678.83</ffd:FeeAmt>
    <ffd:PrevslyPdFlg
      contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis"
      id="ixv-229">false</ffd:PrevslyPdFlg>
    <ffd:TxValtn
      contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-230"
      unitRef="Unit_USD">0</ffd:TxValtn>
    <ffd:FeeAmt
      contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis"
      decimals="0"
      id="ixv-231"
      unitRef="Unit_USD">0</ffd:FeeAmt>
    <ffd:TtlTxValtn
      contextRef="P09_11_2024To09_11_2024"
      decimals="2"
      id="ixv-232"
      unitRef="Unit_USD">29503244122.66</ffd:TtlTxValtn>
    <ffd:TtlFeeAmt
      contextRef="P09_11_2024To09_11_2024"
      decimals="2"
      id="ixv-233"
      unitRef="Unit_USD">4354678.83</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="P09_11_2024To09_11_2024"
      decimals="0"
      id="ixv-234"
      unitRef="Unit_USD">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="P09_11_2024To09_11_2024"
      decimals="0"
      id="ixv-235"
      unitRef="Unit_USD">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="P09_11_2024To09_11_2024"
      decimals="2"
      id="ixv-236"
      unitRef="Unit_USD">4354678.83</ffd:NetFeeAmt>
    <ffd:OfferingNote
      contextRef="P09_11_2024To09_11_2024_1TypedMemberffdOfferingAxis"
      id="ixv-166">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;As of September&#160;3, 2024, the maximum number of shares of common stock, par value $0.25 per share (&#x201c;Common Stock&#x201d;), to which the transaction pursuant to that certain Agreement and Plan of Merger, dated as of August&#160;13, 2024, by and among Kellanova, Acquiror 10VB8, LLC, Merger Sub 10VB8, LLC, and, solely for the limited purposes set forth therein, Mars, Incorporated applies is estimated to be 358,032,313, which consists of (a) 344,667,063 issued and outstanding shares of Common Stock entitled to receive the per share merger consideration of $83.50; (b) 2,944,914 shares of Common Stock underlying restricted stock units entitled to receive the per share merger consideration of $83.50, (c) 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 entitled to receive the per share merger consideration of $83.50 minus any applicable exercise price, (d) 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) entitled to receive the per share merger consideration of $83.50, (e) 354,853 shares of Common Stock underlying deferred stock units entitled to receive the per share merger consideration of $83.50, and (f) 47,000 shares of Common Stock reserved and available for future issuance under the Kellanova Amended and Restated 2002 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Pursuant to Rule &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;0-11&lt;/div&gt; of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), and solely for the purposes of calculating the filing fee, the proposed maximum aggregate value of the transaction was calculated, as of September&#160;3, 2024, based on the sum of (a)&#160;the product of 344,667,063 issued and outstanding shares of Common Stock and the per share merger consideration of $83.50; (b) the product of 2,944,914 shares of Common Stock underlying restricted stock units and the per share merger consideration of $83.50; (c) the product of 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 and $25.93 (which is the difference between the per share merger consideration of $83.50 and the weighted average exercise price of such outstanding and unexercised options); (d) the product of 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) and the per share merger consideration of $83.50; (e) the product of 354,853 shares of Common Stock underlying deferred stock units and the per share merger consideration of $83.50; and (f)&#160;the product of 47,000 shares of Common Stock reserved and available for future issuance under the ESPP and the per share merger consideration of $83.50. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;In accordance with Section&#160;14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.00014760. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ffd:OfferingNote>
    <ffd:OfferingNote
      contextRef="P09_11_2024To09_11_2024_2TypedMemberffdOfferingAxis"
      id="ixv-167">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(1)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;As of September&#160;3, 2024, the maximum number of shares of common stock, par value $0.25 per share (&#x201c;Common Stock&#x201d;), to which the transaction pursuant to that certain Agreement and Plan of Merger, dated as of August&#160;13, 2024, by and among Kellanova, Acquiror 10VB8, LLC, Merger Sub 10VB8, LLC, and, solely for the limited purposes set forth therein, Mars, Incorporated applies is estimated to be 358,032,313, which consists of (a) 344,667,063 issued and outstanding shares of Common Stock entitled to receive the per share merger consideration of $83.50; (b) 2,944,914 shares of Common Stock underlying restricted stock units entitled to receive the per share merger consideration of $83.50, (c) 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 entitled to receive the per share merger consideration of $83.50 minus any applicable exercise price, (d) 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) entitled to receive the per share merger consideration of $83.50, (e) 354,853 shares of Common Stock underlying deferred stock units entitled to receive the per share merger consideration of $83.50, and (f) 47,000 shares of Common Stock reserved and available for future issuance under the Kellanova Amended and Restated 2002 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(2)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;Pursuant to Rule &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;0-11&lt;/div&gt; of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), and solely for the purposes of calculating the filing fee, the proposed maximum aggregate value of the transaction was calculated, as of September&#160;3, 2024, based on the sum of (a)&#160;the product of 344,667,063 issued and outstanding shares of Common Stock and the per share merger consideration of $83.50; (b) the product of 2,944,914 shares of Common Stock underlying restricted stock units and the per share merger consideration of $83.50; (c) the product of 6,817,154 shares of Common Stock underlying outstanding and unexercised options that have an exercise price that is less than $83.50 and $25.93 (which is the difference between the per share merger consideration of $83.50 and the weighted average exercise price of such outstanding and unexercised options); (d) the product of 3,201,330 shares of Common Stock underlying performance stock units (assuming performance is calculated at the maximum level of performance) and the per share merger consideration of $83.50; (e) the product of 354,853 shares of Common Stock underlying deferred stock units and the per share merger consideration of $83.50; and (f)&#160;the product of 47,000 shares of Common Stock reserved and available for future issuance under the ESPP and the per share merger consideration of $83.50. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:4%;vertical-align:top;text-align:left;"&gt;(3)&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: left; line-height: normal;"&gt;In accordance with Section&#160;14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.00014760. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
